000005|N05AX0801|Risperdal|töflur|0,5|mg|20|stk|1|þpakki||N05AX08|01.04.2000||R|1|0|0|0|0|0|JAS|0|0|0|100|SEK|1309|2924|lyfalmen|V0045|1735|1|20|0|2,0000|Vistor hf|Janssen-Cilag AB|Risperídón||1309||1309|2924||1 000018|G01AF0501|Pevaryl|krem/sti|||15|g|1|sett|krem+3 stílar|G01AF05|01.05.1978||L|0|0|0|0|0|0|MCS|0|0|0|100|IKR|||lyflausa|||0|15|0|4,5000|Vistor hf|McNeil Sweden AB|Ekónazól|||||||1 000054|B03XA0103|NeoRecormon|stl|4000|ae/spr|0,3|ml|6|spr||B03XA01|01.02.2002||R|0|0|0|1|0|1|ROC|0|0|0|100|DKK|28673|38966|lyfsjukr|||1|1,8|0|24,0000|Icepharma hf|Roche|Epóetín||28673||28673|38966||2 000145|B03XA0103|NeoRecormon|stl|6000|ae/spr|0,3|ml|6|spr||B03XA01|01.02.2002||R|0|0|0|1|0|1|ROC|0|0|0|100|DKK|43085|57195|lyfsjukr|||1|1,8|0|36,0000|Icepharma hf|Roche|Epóetín||43085||43085|57195||2 000159|N05AH0302|Zyprexa Velotab|munndr.t|5|mg|28|stk|1|þpakki||N05AH03|01.06.2002||R|0|0|0|0|0|0|ELD|0|0|0|100|XEU|8067|12226|lyfalmen|V0457|6628|1|28|0|14,0000|Icepharma hf|Eli Lilly Nederland B.V.|Olanzapín||8067||8067|12226||2 000184|N05AH0302|Zyprexa Velotab|munndr.t|15|mg|28|stk|1|þpakki||N05AH03|01.06.2002||R|0|0|0|0|0|0|ELD|0|0|0|100|XEU|20737|28929|lyfalmen|V0475|13785|1|28|0|42,0000|Icepharma hf|Eli Lilly Nederland B.V.|Olanzapín||20737||20737|28929||2 000193|N05AH0302|Zyprexa Velotab|munnltfl|20|mg|28|stk|1|þpakki||N05AH03|01.12.2003||R|0|0|0|0|0|0|ELD|0|0|0|100|XEU|26786|36580|lyfalmen|V0540|20024|1|28|0|56,0000|Icepharma hf|Eli Lilly Nederland B.V.|Olanzapín||26786||26786|36580||2 000223|G02CX0101|Tractocile|stl|7,5|mg/ml|0,9|ml|1|hgl|lausn|G02CX01|01.12.2006||R|0|0|0|1|0|1|FER|0|0|0|100|DKK|4150|6834|lyfsjukr|||1|0,9|0|0,0400|Vistor hf|Ferring|Atosíban||4150||4150|6834||1 000225|QM01AC0601|Metacam|mixtúra|1,5|mg/ml|100|ml|1|fl||QM01AC06|01.05.2004||R|0|0|0|0|0|0|BOI|0|0|0|100|DKK|4042|7839|vetalmen|||0|100|0||Vistor hf|Boehringer Ingelheim|||4042||4042|7839||1 000237|G02CX0101|Tractocile|irþ|7,5|mg/ml|5|ml|1|hgl|lausn|G02CX01|01.12.2006||R|0|0|0|1|0|1|FER|0|0|0|100|DKK|11116|16422|lyfsjukr|||1|5|0|0,2300|Vistor hf|Ferring|Atosíban||11116||11116|16422||1 000299|N06AB0311|Fluoxetin Mylan|hylki|20|mg|250|stk|1|glas||N06AB03|01.11.2015||R|1|0|0|0|G|0|MYL|0|0|0|100|SEK|4645|7516|lyfalmen|||2|250|0|250,0000|Icepharma hf|Mylan AB|Flúoxetín||4645||4645|7516||2 000402|J01CR0202|Augmentin|sts|1200|mg/hgl|5|hgl|1|pakki|1000+200 mg|J01CR02|01.01.2000||R|0|0|0|0|0|1|GPH|0|0|0|100|IKR|2175|4116|lyfsjukr|||1|5|0|1,6700|Vistor hf|GlaxoSmithKline Pharma A/S|Amoxicillín og ensímblokkar||2175||2175|4116||1 000552|G04BE0105|Caverject Dual|sts|20|mcg/lykj|2|lykjur|1|pakki|2ja hólfa lykja|G04BE01|01.03.2002||R|0|0|0|0|0|0|PER|0|0|0|100|DKK|4251|6973|lyfalmen|||1|2|0|2,0000|Icepharma hf|Pfizer ApS|Alprostadíl||4251||4251|6973||1 000555|N03AX1101|Topimax|hylki|15|mg|60|stk|1|plglas||N03AX11|01.05.2001||R|1|0|0|0|G|0|JAS|0|0|0|100|SEK|2778|4946|lyfalmen|||1|60|0|3,0000|Vistor hf|Janssen-Cilag AB|Tópíramat||2778||2778|4946||1 000641|B05BA0202|Intralipid 200 mg/ml|irl|200|mg/ml|100|ml|10|pokar||B05BA02|01.04.2004||R|0|0|0|0|0|1|FKA|0|0|0|100|DKK|13608|19852|lyfsjukr|||1|1000|0||Vistor hf|Fresenius Kabi AB|Fitusambönd||13608||13608|19852||1 000646|C08CA0101|Norvasc|töflur|10|mg|30|stk|1|þpakki||C08CA01|01.01.1992||R|1|0|0|0|G|0|PER|0|0|0|100|DKK|2680|4811|lyfalmen|||1|30|0|60,0000|Icepharma hf|Pfizer ApS|Amlódipín||2680||2680|4811||1 000663|B05BA0202|Intralipid 200 mg/ml|irl|200|mg/ml|500|ml|12|pokar||B05BA02|01.12.2014||R|0|0|0|0|0|1|FKA|0|0|0|100|DKK|32929|44349|lyfsjukr|||1|6000|0||Vistor hf|Fresenius Kabi AB|Fitusambönd||32929||32929|44349||1 000784|G04BE0105|Caverject Dual|sts|10|mcg/lykj|2|lykjur|1|pakki|2ja hólfa lykja|G04BE01|01.03.2002||R|0|0|0|0|0|0|PER|0|0|0|100|DKK|3161|5473|lyfalmen|||1|2|0|1,0000|Icepharma hf|Pfizer ApS|Alprostadíl||3161||3161|5473||1 000801|R06AA0201|Benylan|mixtúra|2,8|mg/ml|125|ml|1|glas||R06AA02|01.05.1999||L|0|0|0|0|0|0|MCN|0|0|1|100|IKR|||lyflausa|||0|125|0|1,7500|Vistor hf|McNeil Denmark ApS|Dífenhýdramín|||||||1 000815|R06AA0201|Benylan|mixtúra|1,4|mg/ml|125|ml|1|glas||R06AA02|01.06.2001||L|0|0|0|0|0|0|MCN|0|0|1|100|IKR|||lyflausa|||0|125|0|0,8750|Vistor hf|McNeil Denmark ApS|Dífenhýdramín|||||||1 000879|L03AB0702|Rebif|stl|44|mcg/spr|0,5|ml|12|spr|Áfylltar sprautur|L03AB07|01.01.2001||R|0|0|0|1|0|1|MSE|0|0|0|100|SEK|91501|118431|lyfsjukr|||1|6|0|122,7907|Icepharma hf|Merck Serono Europe Ltd|Interferón beta-1a||91501||91501|118431||2 001167|H01CC0101|Orgalutran|stl|0,5|mg/ml|0,5|ml|1|spr||H01CC01|01.05.2001||R|0|0|0|1|0|1|MLD|0|0|0|100|DKK|4732|7635|lyfsjukr|||1|0,5|0|1,0000|Vistor hf|Merck Sharp & Dohme Limited|Ganirelix||4732||4732|7635||1 001194|M01AH0101|Celebra|hylki|200|mg|10|stk|1|þpakki||M01AH01|01.03.2003||R|1|0|0|0|G|0|PER|0|0|1|100|DKK|1273|2874|lyfalmen|V0037|1062|1|10|0|10,0000|Icepharma hf|Pfizer ApS|Celekoxíb||1273||1273|2874||1 001225|C10AA0501|Zarator|töflur|80|mg|30|stk|1|þpakki||C10AA05|01.06.2002||R|1|0|0|0|0|0|PER|0|0|0|100|DKK|4234|6950|lyfalmen|||1|30|0|120,0000|Icepharma hf|Pfizer ApS|Atorvastatín||4234||4234|6950||1 001239|C10AA0501|Zarator|töflur|80|mg|100|stk|1|þpakki||C10AA05|01.06.2002||R|1|0|0|0|0|0|PER|0|0|0|100|DKK|14003|20396|lyfalmen|V0115|11919|1|100|0|400,0000|Icepharma hf|Pfizer ApS|Atorvastatín||14003||14003|20396||1 001291|C07AB0206|Seloken ZOC|forðatfl|23,75|mg|100|stk|1|plglas||C07AB02|01.05.2006||R|1|0|0|0|G|0|AZD|0|0|0|100|SEK|1872|3699|lyfalmen|V0050|1875|1|100|0|15,8300|Vistor hf|AstraZeneca A/S DK|Metóprólól||1872||1872|3699||1 001399|H01CC0101|Orgalutran|stl|0,5|mg/ml|0,5|ml|5|spr||H01CC01|01.05.2001||R|0|0|0|1|0|1|MLD|0|0|0|100|DKK|23663|32630|lyfsjukr|||1|2,5|0|5,0000|Vistor hf|Merck Sharp & Dohme Limited|Ganirelix||23663||23663|32630||1 001490|A10AD0502|NovoMix 30 Penfill|stl|100|ein/ml|3|ml|5|rörlyk|í lyfjapenna|A10AD05|01.08.2002||R|0|0|0|0|G|0|NAS|0|0|0|100|DKK|5324|8450|lyfalmen|||1|15|0|37,5000|Vistor hf|Novo-Nordisk A/S|Insulín aspart||5324||5324|8450||1 001512|C04AD0301|Trental|forðatfl|400|mg|100|stk|1|þpakki||C04AD03|01.05.2002||R|1|0|0|0|G|0|SNO|0|0|0|100|NOK|3014|5271|lyfalmen|||1|100|0|40,0000|Vistor hf|Sanofi-aventis Norge AS|Pentoxífýllín||3014||3014|5271||1 001517|N06AB0308|Fluoxetin Actavis|hylki|20|mg|30|stk|1|þpakki||N06AB03|01.03.2000|30.04.2016|R|1|0|0|0|G|0|ACA|0|0|0|100|IKR|883|2223|lyfalmen|||2|30|0|30,0000|Actavis Group hf|Actavis hf|Flúoxetín||800||800|2223||1 001528|N06AB0308|Fluoxetin Actavis|hylki|20|mg|100|stk|1|þpakki||N06AB03|01.03.2000|30.04.2016|R|1|0|0|0|G|0|ACA|0|0|0|100|IKR|2456|3801|lyfalmen|||2|100|0|100,0000|Actavis Group hf|Actavis hf|Flúoxetín||1946||1946|3801||1 001588|B05BA1014|Kabiven|irl|900|kcal|1026|ml|4|pokar||B05BA10|01.08.2003||R|0|0|0|0|0|1|FKA|0|0|0|100|DKK|19223|27581|lyfsjukr|||1|4104|0||Vistor hf|Fresenius Kabi AB|Blöndur||19223||19223|27581||1 001599|B03AC0002|Venofer|stl|20|mg/ml|5|ml|5|lykjur||B03AC|01.07.2005||R|0|1|0|0|G|0|VIF|0|0|1|100|CHF|14756|21432|lyfalmen|V0637|18834|1|25|0|5,0000|Vistor hf|Vifor France SA|Járn, stungulyf||14756||14756|21432||1 001605|B05BA1014|Kabiven|irl|1400|kcal|1540|ml|4|pokar||B05BA10|01.08.2003||R|0|0|0|0|0|1|FKA|0|0|0|100|DKK|26645|36401|lyfsjukr|||1|6160|0||Vistor hf|Fresenius Kabi AB|Blöndur||26645||26645|36401||1 001874|G02AB0101|Methergin|stl|0,2|mg/ml|1|ml|10|lykjur||G02AB01|01.11.2001||R|0|0|0|0|0|1|HES|0|0|0|100|DKK|2120|4040|lyfsjukr|||1|10|0|10,0000|Vistor hf|Novartis Healthcare A/S|Metýlergómetrín||2120||2120|4040||1 001878|S01EC0401|Azopt|augndr|10|mg/ml|5|ml|3|glös||S01EC04|01.11.2001||R|0|0|0|0|G|0|ALA|0|0|0|100|USD|4183|6880|lyfalmen|V0444|6880|1|15|0|75,0000|Vistor hf|Alcon Laboratories Ltd.|Brinzólamíð||4183||4183|6880||1 001954|N05AX0802|Rison|filmhtfl|1|mg|60|stk|1|glas||N05AX08|01.05.2000||R|1|0|0|0|G|0|ACA|0|0|0|100|IKR|1660|2361|lyfalmen|V0291|2361|2|60|0|12,0000|Actavis Group hf|Actavis hf|Risperídón||900||900|2361||1 001957|N05AX0802|Rison|filmhtfl|4|mg|60|stk|1|glas||N05AX08|01.05.2000||R|1|0|0|0|G|0|ACA|0|0|0|100|IKR|6375|8004|lyfalmen|V0297|6765|2|60|0|48,0000|Actavis Group hf|Actavis hf|Risperídón||5000||5000|8004||1 001962|N01BX0401|Capsina|krem|0,75|mg/g|45|g|1|túpa||N01BX04|01.06.1998||R|0|0|0|0|0|0|BIG|0|0|1|100|SEK|3398|5799|lyfalmen|||1|45|0||Icepharma hf|Bioglan AB|Capsaicin||3398||3398|5799||2 001965|N05AX0802|Rison|filmhtfl|2|mg|60|stk|1|glas||N05AX08|01.05.2000||R|1|0|0|0|G|0|ACA|0|0|0|100|IKR|3098|3806|lyfalmen|V0292|3806|2|60|0|24,0000|Actavis Group hf|Actavis hf|Risperídón||1950||1950|3806||1 001980|A02BC0501|Nexium|sh-tfl|20|mg|28|stk|1|veski||A02BC05|01.11.2000||R|1|0|0|0|0|0|AZD|0|0|0|100|SEK|2382|4401|lyfalmen|V0004|2490|1|28|0|18,6700|Vistor hf|AstraZeneca A/S DK|Esómeprazól||2382||2382|4401||1 001986|N05AX0802|Rison|filmhtfl|3|mg|60|stk|1|glas||N05AX08|01.05.2000||R|1|0|0|0|G|0|ACA|0|0|0|100|IKR|4764|5816|lyfalmen|V0296|5389|2|60|0|36,0000|Actavis Group hf|Actavis hf|Risperídón||3410||3410|5816||1 002033|A02BC0501|Nexium|sh-tfl|40|mg|28|stk|1|veski||A02BC05|01.11.2000||R|1|0|0|0|0|0|AZD|0|0|0|100|SEK|3505|5946|lyfalmen|V0005|2344|1|28|0|37,3300|Vistor hf|AstraZeneca A/S DK|Esómeprazól||3505||3505|5946||1 002071|A07EC0204|Asacol|sh-tfl|400|mg|100|stk|1|þpakki||A07EC02|01.01.2000||R|1|0|0|0|G|0|TIL|0|0|0|100|SEK|4116|6787|lyfalmen|V0723|6787|1|100|0|26,6667|Icepharma hf|Tillotts Pharma AB|Mesalazín (5-amínósalicýlsýra)||||4116|6787||2 002194|B05BA1010|Kabiven Peripheral|irl|1000|kcal|1440|ml|4|pokar|fleyti|B05BA10|01.02.2002||R|0|0|0|0|0|1|FRP|0|0|0|100|DKK|22449|31094|lyfsjukr|||1|5760|0||Icepharma hf|Fresenius Kabi|Blöndur||22449||22449|31094||2 002208|A10AB0504|NovoRapid|stl|100|ae/ml|10|ml|1|hgl||A10AB05|01.04.2006||R|0|0|0|0|G|0|NAS|0|0|0|100|DKK|2727|4876|lyfalmen|||1|10|0|25,0000|Vistor hf|Novo-Nordisk A/S|Insúlín aspart||2727||2727|4876||1 002328|R03DC0301|Singulair|tuggutfl|4|mg|98|stk|1|þpakki||R03DC03|01.08.2002||R|1|0|0|0|G|0|MSD|0|0|0|100|DKK|13263|19377|lyfalmen|V0492|8471|1|98|0|39,2000|Vistor hf|M.S.D.|Montelúkast||13263||13263|19377||1 002487|R06AX1304|Loritin|töflur|10|mg|10|stk|1|þpakki||R06AX13|01.10.2000||L|1|0|0|0|0|0|ACA|0|0|1|100|IKR|||lyflausa|||0|10|0|10,0000|Actavis Group hf|Actavis hf|Lóratadín|||||||1 002499|R06AX1304|Loritin|töflur|10|mg|30|stk|1|þpakki||R06AX13|01.10.2000||L|1|0|0|0|0|0|ACA|0|0|1|100|IKR|||lyflausa|||0|30|0|30,0000|Actavis Group hf|Actavis hf|Lóratadín|||||||1 002510|R06AX1304|Loritin|töflur|10|mg|100|stk|1|þpakki||R06AX13|01.10.2000||L|1|0|0|0|G|0|ACA|0|0|1|100|IKR|||lyfalmen|V0362|2043|2|100|0|100,0000|Actavis Group hf|Actavis hf|Lóratadín|||||2353||1 002754|N07BA0107|Nicotinell Mint|munnstfl|1|mg|204|stk|1|pakki||N07BA01|01.06.2002||L|0|0|0|0|0|0|SDF|0|0|1|100|IKR|||lyflausa|||0|204|0|6,8000|Artasan ehf|GlaxoSmithKline Consumer Healthcare A/S|Nikótín|||||||1 002830|S01ED0106|Timosan Depot|augngel|1|mg/g|5|g|1|glas||S01ED01|01.08.2000||R|0|0|0|0|G|0|SAO|0|0|0|100|XEU|928|2399|lyfalmen|||1|5|0|28,0000|Icepharma hf|Santen Oy|Tímólól||928||928|2399||2 002853|M03AX0101|Botox|sts|100|ae/hgl|1|hgl|1|pakki||M03AX01|01.07.1994||R|0|0|0|1|0|1|IRE|0|0|0|100|XEU|22035|30571|lyfsjukr|||1|1|0||Actavis ehf|Allergan Pharmaceuticals Ireland|Clostridium botulinum toxín-A||22035||22035|30571||1 003023|C09DA0104|Cozaar Comp Forte|filmhtfl|125|mg|98|stk|1|þpakki|100+25 mg|C09DA01|01.06.2007||R|1|0|0|0|0|0|MSD|0|0|0|100|DKK|12311|13807|lyfalmen|V0089|2650|1|98|0|98,0000|Vistor hf|M.S.D.|Lósartan og þvagræsilyf||9216||9216|13807||1 003078|N03AX1401|Keppra|filmhtfl|250|mg|100|stk|1|þpakki||N03AX14|01.10.2005||R|1|0|0|0|0|0|UCB|0|0|0|100|DKK|6884|10597|lyfalmen|V0515|3346|1|100|0|16,6700|Vistor hf|U.C.B|Levetíracetam||6884||6884|10597||1 003112|N03AX1401|Keppra|filmhtfl|500|mg|100|stk|1|þpakki||N03AX14|01.10.2005||R|1|0|0|0|0|0|UCB|0|0|0|100|DKK|11238|16590|lyfalmen|V0253|6065|1|100|0|33,3300|Vistor hf|U.C.B|Levetíracetam||11238||11238|16590||1 003158|N03AX1401|Keppra|filmhtfl|1000|mg|100|stk|1|þpakki||N03AX14|01.10.2005||R|1|0|0|0|0|0|UCB|0|0|0|100|DKK|21622|30048|lyfalmen|V0516|5506|1|100|0|66,6700|Vistor hf|U.C.B|Levetíracetam||21622||21622|30048||1 003164|L01CA0401|Navelbine|hylki|20|mg|1|stk|1|pakki|mjúkt|L01CA04|01.05.2007||R|0|0|0|1|G|0|PFP|0|0|0|100|SEK|8394|12676|lyfalmen|||1|1|0||Vistor hf|Pierre Fabre Pharma|Vínorelbín||8394||8394|12676||1 003175|L01CA0401|Navelbine|hylki|30|mg|1|stk|1|pakki|mjúkt|L01CA04|01.05.2007||R|0|0|0|1|G|0|PFP|0|0|0|100|SEK|12395|18183|lyfalmen|||1|1|0||Vistor hf|Pierre Fabre Pharma|Vínorelbín||12395||12395|18183||1 003192|QM01AX9001|Cartrophen vet.|stl|100|mg/ml|10|ml|1|hgl|lausn f.hunda|QM01AX90|01.08.2015||R|0|0|0|0|0|0|AEL|1|0|0|100|XEU|7217|13863|vetalmen|||0|10|0||Icepharma hf|Arthropharm Europe Limited|Pentosan Polysulfate Sodium||7217||7217|13863||2 003310|R03AK0701|Symbicort Turbuhaler|innönddu|164,5|mcg/sk|120|skammtar|1|pakki|160+4,5 mcg/sk|R03AK07|01.05.2001||R|0|0|0|0|G|0|AZD|0|0|0|100|SEK|5980|9353|lyfalmen|V0356|7997|1|120|0|30,0000|Vistor hf|AstraZeneca A/S DK|Formóteról og budesonide||5980||5980|9353||1 003325|R03AK0702|Symbicort mite Turbuhaler|innönddu|84,5|mcg/sk|120|skammtar|1|pakki|80+4,5 mcg/sk|R03AK07|01.08.2002||R|0|0|0|0|G|0|AZD|0|0|0|100|SEK|5608|8841|lyfalmen|||1|120|0|30,0000|Vistor hf|AstraZeneca A/S DK|Formóteról og budesonide||5608||5608|8841||1 003455|A02BB0101|Cytotec|töflur|0,2|mg|60|stk|1|þpakki||A02BB01|01.08.2002||R|1|0|0|0|G|0|PER|0|0|0|100|DKK|2731|4881|lyfalmen|||1|60|0|15,0000|Icepharma hf|Pfizer ApS|Mísóprostól||2731||2731|4881||1 003775|V03AF0701|Fasturtec|st/irþ|1,5|mg/ml|1,5|mg|3|hgl|+leysir|V03AF07|01.12.2015||R|0|0|0|1|0|1|SGA|0|0|0|100|NOK|31050|41973|lyfsjukr|||1|4,5|0|0,1500|Vistor hf|Sanofi-aventis groupe|Rasburicase||31050||31050|41973||1 003859|N05AH0205|Clozapine Actavis|töflur|25|mg|100|stk|1|glas||N05AH02|01.10.2014||R|2|0|0|0|G|0|AGT|0|0|0|100|XEU|1937|3788|lyfalmen|||2|100|0|8,3300|Actavis Group hf|Actavis Group hf|Klózapín||1937||1937|3788||1 003880|N05AH0205|Clozapine Actavis|töflur|100|mg|500|stk|1|glas||N05AH02|01.06.2015||R|2|0|0|0|G|0|AGT|0|0|0|100|XEU|34879|46025|lyfalmen|||2|500|0|166,6700|Actavis Group hf|Actavis Group hf|Klózapín||34254||34254|46025||1 003927|N06AB0602|Sertral|töflur|50|mg|28|stk|1|þpakki||N06AB06|01.11.2000||R|1|0|0|0|G|0|ACA|0|0|0|100|IKR|1002|2071|lyfalmen|V0151|1689|2|28|0|28,0000|Actavis Group hf|Actavis hf|Sertralín||689||689|2071||1 003939|M01AB0505|Voltaren|sh-tfl|50|mg|20|stk|1|þpakki||M01AB05|01.03.1984||R|1|0|0|0|G|0|HES|0|0|1|100|DKK|512|1827|lyfalmen|||1|20|0|10,0000|Vistor hf|Novartis Healthcare A/S|Díklófenak||512||512|1827||1 003950|N06AB0602|Sertral|töflur|50|mg|98|stk|1|þpakki||N06AB06|01.11.2000||R|1|0|0|0|G|0|ACA|0|0|0|100|IKR|2389|2606|lyfalmen|V0322|1956|2|98|0|98,0000|Actavis Group hf|Actavis hf|Sertralín||1078||1078|2606||1 003988|M01AB0505|Voltaren|sh-tfl|50|mg|100|stk|1|þpakki||M01AB05|01.03.1984||R|1|0|0|0|G|0|HES|0|0|1|100|DKK|1874|3702|lyfalmen|V0469|1948|1|100|0|50,0000|Vistor hf|Novartis Healthcare A/S|Díklófenak||1874||1874|3702||1 004002|L04AD0101|Sandimmun|irþ|50|mg/ml|5|ml|10|lykjur||L04AD01|01.10.1985||R|0|0|0|0|0|1|HES|0|0|0|100|DKK|16681|24082|lyfsjukr|||1|50|0|10,0000|Vistor hf|Novartis Healthcare A/S|Ciklospórín||16681||16681|24082||1 004014|N03AF0201|Trileptal|mixtúra|60|mg/ml|250|ml|1|fl||N03AF02|01.01.2002||R|0|0|0|0|G|0|HES|0|0|0|100|DKK|6975|10723|lyfalmen|||1|250|0|15,0000|Vistor hf|Novartis Healthcare A/S|Oxkarbazepín||6975||6975|10723||1 004028|A07DA0301|Imodium|mixtúra|0,2|mg/ml|100|ml|1|fl||A07DA03|01.01.1990||L|0|0|0|0|0|0|MCS|0|0|0|100|IKR|||lyflausa|||0|100|0|2,0000|Vistor hf|McNeil Sweden AB|Lóperamíð|||||||1 004050|R03AK0601|Seretide|innúðal|75|mcg/sk|120|skammtar|1|pakki|25+50 mcg/sk|R03AK06|01.10.2002||R|0|0|0|0|G|0|GPH|0|0|0|100|GBP|3680|6187|lyfalmen|||1|120|0|30,0000|Vistor hf|GlaxoSmithKline Pharma A/S|Salmeteról og fluticason||3680||3680|6187||1 004086|N06AB0601|Zoloft|töflur|25|mg|7|stk|1|þpakki||N06AB06|01.05.2003||R|1|0|0|0|0|0|PER|0|0|0|100|DKK|522|1841|lyfalmen|||1|7|0|3,5000|Icepharma hf|Pfizer ApS|Sertralín||522||522|1841||1 004111|N05CD0102|Dalmadorm medium|hylki|15|mg|30|stk|1|þpakki||N05CD01|01.12.2000||R|1|0|0|0|0|0|MAB|0|0|1|100|SEK|1009|2511|lyfalmen|||1|30|0|15,0000|Vistor hf|Meda AB|Flúrazepam||1009||1009|2511||1 004259|N05AE0401|Zeldox|hylki|40|mg|14|stk|1|þpakki|hart hylki|N05AE04|01.03.2003||R|1|0|0|0|0|0|PER|0|0|0|100|DKK|4017|6651|lyfalmen|||1|14|0|7,0000|Icepharma hf|Pfizer ApS|Ziprasidon||4017||4017|6651||1 004282|R03AK0601|Seretide|innúðal|150|mcg/sk|120|skammtar|1|pakki|25+125 mcg/sk|R03AK06|01.10.2002||R|0|0|0|0|G|0|GPH|0|0|0|100|GBP|5848|9171|lyfalmen|||1|120|0|30,0000|Vistor hf|GlaxoSmithKline Pharma A/S|Salmeteról og fluticason||5848||5848|9171||1 004293|R03AK0601|Seretide|innúðal|275|mcg/sk|120|skammtar|1|pakki|25+250 mcg/sk|R03AK06|01.10.2002||R|0|0|0|0|G|0|GPH|0|0|0|100|GBP|8166|12362|lyfalmen|||1|120|0|30,0000|Vistor hf|GlaxoSmithKline Pharma A/S|Salmeteról og fluticason||8166||8166|12362||1 004352|J02AC0301|Vfend|irs|200|mg|1|hgl|1|pakki||J02AC03|01.11.2002||R|0|1|0|0|0|1|IPI|0|0|0|100|DKK|18564|26674|lyfsjukr|||1|1|0|0,5000|Icepharma hf|Pfizer Limited|Voricónazól||18564||18564|26674||1 004374|A04AA0101|Zofran|töflur|4|mg|10|stk|1|þpakki||A04AA01|01.01.2009||R|1|0|0|0|G|0|HES|0|0|1|100|DKK|5721|5199|lyfalmen|V0381|3861|1|10|0|2,5000|Vistor hf|Novartis Healthcare A/S|Ondansetrón||2962||2962|5199||1 004388|QJ51RC2501|Benestermycin, vet.|spenalyf|||5|ml|20|spr||QJ51RC25|01.12.1978||R|0|0|0|0|0|0|BOI|0|0|0|100|DKK|6781|13035|vetalmen|||0|100|0||Vistor hf|Boehringer Ingelheim|||6781||6781|13035||1 004455|N02AX0208|Zytram|forðatfl|75|mg|56|stk|1|glas||N02AX02|01.01.2001||R|1|0|1|0|G|0|NOP|0|0|1|100|DKK|2862|5061|lyfalmen|||1|56|0|14,0000|Icepharma hf|Norpharma |Tramadól||2862||2862|5061||2 004478|N02AX0208|Zytram|forðatfl|100|mg|56|stk|1|glas||N02AX02|01.01.2001||R|1|0|1|0|G|0|NOP|0|0|1|100|DKK|3817|6376|lyfalmen|V0226|2585|1|56|0|18,6667|Icepharma hf|Norpharma |Tramadól||3817||3817|6376||2 004500|N02AX0208|Zytram|forðatfl|200|mg|56|stk|1|glas||N02AX02|01.01.2001||R|1|0|1|0|G|0|NOP|0|0|1|100|DKK|7175|10998|lyfalmen|V0228|4621|1|56|0|37,3333|Icepharma hf|Norpharma |Tramadól||7175||7175|10998||2 004502|J07BC0101|Engerix-B|stl|20|mcg/ml|0,5|ml|1|dæla|einnota dæla|J07BC01|01.01.1990||R|0|0|0|0|0|0|GPH|0|0|0|100|GBP|2027|3912|lyfalmen|||1|0,5|0||Vistor hf|GlaxoSmithKline Pharma A/S|Lifrarbólga-B, hreinsaðir mótefnavakar||2027||2027|3912||1 004586|A10BB1201|Amaryl|töflur|4|mg|90|stk|1|þpakki||A10BB12|01.06.2005||R|1|0|0|0|G|0|SNO|0|0|0|100|NOK|2534|2467|lyfalmen|V0494|1810|1|90|0|180,0000|Vistor hf|Sanofi-aventis Norge AS|Glímepíríð||977||977|2467||1 004589|N06AB0402|Oropram|töflur|20|mg|100|stk|1|glas||N06AB04|01.01.2001||R|1|0|0|0|G|0|ACA|0|0|0|100|IKR|2426|3508|lyfalmen|V0318|3508|2|100|0|100,0000|Actavis Group hf|Actavis hf|Cítalópram||1733||1733|3508||1 004612|D06BX0105|Metronidazol Actavis|krem|10|mg/g|25|g|1|túpa||D06BX01|01.07.1987||R|0|0|0|0|0|0|AGT|0|0|1|100|DKK|1667|3417|lyfalmen|||2|25|0||Actavis Group hf|Actavis Group hf|Metrónídazól||1667||1667|3417||1 004613|J07BC0101|Engerix-B|stl|20|mcg/ml|1|ml|1|áfspr||J07BC01|01.01.1990||R|0|0|0|0|0|0|GPH|0|0|0|100|GBP|2993|5242|lyfalmen|||1|1|0||Vistor hf|GlaxoSmithKline Pharma A/S|Lifrarbólga-B, hreinsaðir mótefnavakar||2993||2993|5242||1 004645|N06AB0402|Oropram|töflur|40|mg|100|stk|1|glas||N06AB04|01.01.2001||R|1|0|0|0|G|0|ACA|0|0|0|100|IKR|4346|5210|lyfalmen|V0320|3669|2|100|0|200,0000|Actavis Group hf|Actavis hf|Cítalópram||2970||2970|5210||1 004667|N06AB0402|Oropram|töflur|10|mg|100|stk|1|glas||N06AB04|01.01.2001||R|1|0|0|0|G|0|ACA|0|0|0|100|IKR|1549|2606|lyfalmen|V0317|2606|2|100|0|50,0000|Actavis Group hf|Actavis hf|Cítalópram||1078||1078|2606||1 004678|N06AB0402|Oropram|töflur|20|mg|28|stk|1|glas||N06AB04|01.01.2001||R|1|0|0|0|G|0|ACA|0|0|0|100|IKR|850|1828|lyfalmen|||2|28|0|28,0000|Actavis Group hf|Actavis hf|Cítalópram||513||513|1828||1 004687|A02AA0403|Magnesia "medic"|filmhtfl|500|mg|100|stk|1|glas||A02AA04|01.02.2006||L|1|0|0|0|0|0|MET|0|0|0|100|DKK|||lyfalmen|||0|100|0|16,6700|Vistor hf|Medic Team|Magnesíum hýdroxíð|||||1816||1 004688|L04AC0301|Kineret|stl|100|mg/spr|0,67|ml|7|spr||L04AC03|01.07.2002||R|0|1|0|1|0|1|BIO|0|0|0|100|DKK|32952|44378|lyfsjukr|||1|4,69|0|7,0000|Swedish Orphan Biovitrum AB|Swedish Orphan Biovitrum AB|Anakinra||32952||32952|44378||3 004696|R05DA0901|Dexomet|mixtúra|3|mg/ml|150|ml|1|glas||R05DA09|01.06.2001||L|0|0|0|0|0|0|AGP|0|0|1|100|IKR|||lyflausa|||0|150|0|5,0000|Actavis Group hf|Actavis Group PTC ehf|Dextrómetorfan|||||||1 004746|A10AE0405|Lantus [Clikstar]|stl|100|ein/ml|3|ml|5|rörlyk|Clikstar/JuniorStar pennar|A10AE04|01.06.2004||R|0|0|0|0|G|0|SDE|0|0|0|100|NOK|7519|11471|lyfalmen|||1|15|0|37,5000|Vistor hf|Sanofi - aventis Deutschland GmbH|Insulín glargín||7519||7519|11471||1 004855|P01AB0105|Metronidazol Actavis|töflur|250|mg|24|stk|1|þpakki||P01AB01|01.12.1972||R|1|0|0|0|0|0|AGT|0|0|1|100|DKK|740|2141|lyfalmen|||2|24|0|3,0000|Actavis Group hf|Actavis Group hf|Metrónídazól||740||740|2141||1 004880|J01FA1001|Zitromax|irs|500|mg|10|ml|1|hgl||J01FA10|01.05.2003||R|0|0|0|0|0|1|PER|0|0|0|100|DKK|4773|7692|lyfsjukr|||1|10|0|1,0000|Icepharma hf|Pfizer ApS|Azitrómýcín||4773||4773|7692||1 004888|P01AB0105|Metronidazol Actavis|töflur|500|mg|8|stk|1|glas||P01AB01|01.03.1981||R|1|0|0|0|0|0|AGT|0|0|1|100|DKK|303|1539|lyfalmen|||2|8|0|2,0000|Actavis Group hf|Actavis Group hf|Metrónídazól||303||303|1539||1 004921|P01AB0105|Metronidazol Actavis|töflur|500|mg|14|stk|1|glas||P01AB01|01.01.1988||R|1|0|0|0|0|0|AGT|0|0|1|100|DKK|814|2243|lyfalmen|||2|14|0|3,5000|Actavis Group hf|Actavis Group hf|Metrónídazól||814||814|2243||1 004976|P01AB0105|Metronidazol Actavis|töflur|500|mg|30|stk|1|glas||P01AB01|01.01.1988||R|1|0|0|0|0|0|AGT|0|0|1|100|DKK|1030|2540|lyfalmen|||2|30|0|7,5000|Actavis Group hf|Actavis Group hf|Metrónídazól||1030||1030|2540||1 005048|N07BA0107|Nicotinell Mint|munnstfl|2|mg|36|stk|1|pakki||N07BA01|01.04.2003||L|0|0|0|0|0|0|SDF|0|0|1|100|IKR|||lyflausa|||0|36|0|2,4000|Artasan ehf|GlaxoSmithKline Consumer Healthcare A/S|Nikótín|||||||1 005059|N07BA0107|Nicotinell Mint|munnstfl|2|mg|96|stk|1|pakki||N07BA01|01.04.2003||L|0|0|0|0|0|0|SDF|0|0|1|100|IKR|||lyflausa|||0|96|0|6,4000|Artasan ehf|GlaxoSmithKline Consumer Healthcare A/S|Nikótín|||||||1 005070|N07BA0107|Nicotinell Mint|munnstfl|2|mg|204|stk|1|pakki||N07BA01|01.04.2003||L|0|0|0|0|0|0|SDF|0|0|1|100|IKR|||lyflausa|||0|204|0|13,6000|Artasan ehf|GlaxoSmithKline Consumer Healthcare A/S|Nikótín|||||||1 005085|J07AJ5205|Boostrix|stl|||0,5|ml|1|spr|áfyllt, dreifa|J07AJ52|01.01.2007||R|0|0|0|0|0|0|GPH|0|0|0|100|GBP|1642|3382|lyfalmen|||1|0,5|0||Vistor hf|GlaxoSmithKline Pharma A/S|Kíghósti, í blöndum með öðrum toxóíðum||1642||1642|3382||1 005089|J07AL0103|Pneumovax|stl|||0,5|ml|1|hgl|lausn|J07AL01|01.11.2008||R|0|0|0|0|0|0|SPM|0|0|0|100|XEU|3083|5366|lyfalmen|||1|0,5|0||Icepharma hf|Sanofi Pasteur MSD|Hreinsuð pneumococca poly­sakkaríð mótefnavakar||3083||3083|5366||2 005096|J07AJ5205|Boostrix|stl|||0,5|ml|10|áf.spr|áfyllt, dreifa|J07AJ52|01.09.2014||R|0|0|0|0|0|0|GPH|0|0|0|100|GBP|16425|23730|lyfalmen|||1|5|0||Vistor hf|GlaxoSmithKline Pharma A/S|Kíghósti, í blöndum með öðrum toxóíðum||||16425|23730||1 005108|G04CA0201|Omnic|forðahlk|0,4|mg|90|stk|1|þpakki||G04CA02|01.08.1998||R|1|0|0|0|G|0|ASP|0|0|0|100|XEU|7728|6538|lyfalmen|V0148|3141|1|90|0|90,0000|Vistor hf|Astellas Pharma A/S|Tamsúlósín||3935||3935|6538||1 005178|J01CF0102|Staklox|hylki|250|mg|30|stk|1|þpakki||J01CF01|01.05.2001||R|0|0|0|0|0|0|ACA|0|0|1|100|DKK|2918|4287|lyfalmen|V0353|4150|2|30|0|3,7500|Actavis Group hf|Actavis hf|Díkloxacillín||2299||2299|4287||1 005189|J01CF0102|Staklox|hylki|500|mg|20|stk|1|þpakki||J01CF01|01.05.2001||R|0|0|0|0|0|0|ACA|0|0|1|100|DKK|2249|4218|lyfalmen|||2|20|0|5,0000|Actavis Group hf|Actavis hf|Díkloxacillín||2249||2249|4218||1 005200|J01CF0102|Staklox|hylki|500|mg|30|stk|1|þpakki||J01CF01|01.05.2001||R|0|0|0|0|0|0|ACA|0|0|1|100|DKK|2525|4102|lyfalmen|V0337|3737|2|30|0|7,5000|Actavis Group hf|Actavis hf|Díkloxacillín||2165||2165|4102||1 005241|R03AK0701|Symbicort Turbuhaler|innönddu|164,5|mcg/sk|360|skammtar|1|pakki|160+4,5 mcg/sk|R03AK07|01.05.2001||R|0|0|0|0|G|0|AZD|0|0|0|100|SEK|17940|25815|lyfalmen|V0356|23991|1|360|0|90,0000|Vistor hf|AstraZeneca A/S DK|Formóteról og budesonide||17940||17940|25815||1 005303|N02CC0303|Zomig Nasal|nefúði|5|mg/sk|5|mg|2|stauk||N02CC03|01.02.2003||R|0|0|0|0|G|0|ASZ|0|0|0|100|SEK|2832|5020|lyfalmen|||1|10|0|4,0000|Vistor hf|AstraZeneca UK Ltd|Zolmítriptan||2832||2832|5020||1 005330|D08AG0201|Betadine|húðlausn|100|mg/ml|500|ml|1|fl|sprittlausn|D08AG02|01.09.1982||L|0|0|0|0|0|0|NOR|0|0|0|100|IKR|||lyflausa|||0|500|0||Icepharma hf|Norpharma a/s|Joð/pólývídón|||||||2 005336|R01AA0704|Otrivin ukonserveret|nefúði|0,5|mg/ml|10|ml|1|glas|sk-úðari|R01AA07|01.07.2003||L|0|0|0|0|0|0|NHE|0|0|1|100|IKR|||lyflausa|||0|10|0|6,2500|Artasan ehf|Novartis Healthcare A/S-A|Xýlómetazólín|||||||1 005363|L02AE0301|Zoladex|vefjalyf|10,8|mg|1|áf.spr|1|pakki||L02AE03|01.04.1996||R|0|0|0|1|G|0|AZA|0|0|0|100|SEK|50344|66376|lyfalmen|V0451|62513|1|1|0|83,7209|Vistor hf|AstraZeneca AB|Góserelín||50344||50344|66376||1 005390|R03BB0101|Atrovent|innúðal|20|mcg/sk|200|skammtar|1|stauk||R03BB01|01.08.2004||R|0|0|0|0|G|0|BOI|0|0|0|100|DKK|1577|3293|lyfalmen|||1|200|0|33,3300|Vistor hf|Boehringer Ingelheim|Ípratrópíumbrómíð||1577||1577|3293||1 005576|R05CA0301|Tussol|mixtúra|||150|ml|1|glas||R05CA03|01.10.2001||L|0|0|0|0|0|0|APC|0|0|1|100|IKR|||lyflausa|||0|150|0||Actavis Group PTC ehf|Actavis Group PTC ehf|Slímlosandi lyf nema slímþynnir (mucolytica)- guaifenesin|||||||1 005588|R03BB0401|Spiriva|innönddu|18|mcg/hylk|30|hylki|1|pakki|hart hylki|R03BB04|01.01.2003||R|0|0|0|0|G|0|BII|0|0|0|100|DKK|5268|8373|lyfalmen|||1|30|0|30,0000|Vistor hf|Boehringer Ingelheim International|Tíótrópíumbrómíð||5268||5268|8373||1 005600|R03BB0401|Spiriva|innönddu|18|mcg/hylk|30|hylki|1|pakki|hart hylki + Handihaler|R03BB04|01.01.2003||R|0|0|0|0|G|0|BII|0|0|0|100|DKK|5423|8586|lyfalmen|||1|30|0|30,0000|Vistor hf|Boehringer Ingelheim International|Tíótrópíumbrómíð||5423||5423|8586||1 005606|J07AH0703|NeisVac-C|stl|||0,5|ml|1|spr|áfyllt sprauta|J07AH07|01.09.2001|29.02.2016|R|0|0|0|0|0|0|PIS|0|0|0|100|USD|4405|7185|lyfalmen|||1|0,5|0||Icepharma hf|Pfizer ApS|Hreinsuð meningókokka C, poly­sakkaríð mótefnavakar||4405||4405|7185||2 005624|A10BB0902|Diamicron Uno|töflur|30|mg|30|stk|1|þpakki||A10BB09|01.04.2002||R|1|0|0|0|G|0|LLS|0|0|0|100|DKK|1647|3389|lyfalmen|||1|30|0|15,0000|Icepharma hf|Les Laboratoires Servier|Glíklazíð||1647||1647|3389||2 005641|A10BB0902|Diamicron Uno|töflur|30|mg|60|stk|1|þpakki||A10BB09|01.04.2002||R|1|0|0|0|G|0|LLS|0|0|0|100|DKK|3293|5655|lyfalmen|V0020|1562|1|60|0|30,0000|Icepharma hf|Les Laboratoires Servier|Glíklazíð||3293||3293|5655||2 005672|A10BB0902|Diamicron Uno|töflur|30|mg|180|stk|1|þpakki||A10BB09|01.04.2002||R|1|0|0|0|G|0|LLS|0|0|0|100|DKK|5182|8255|lyfalmen|V0020|4687|1|180|0|90,0000|Icepharma hf|Les Laboratoires Servier|Glíklazíð||5182||5182|8255||2 005674|A10BB0902|Diamicron Uno|töflur|30|mg|90|stk|1|þpakki||A10BB09|01.04.2002||R|1|0|0|0|G|0|LLS|0|0|0|100|DKK|3785|6332|lyfalmen|V0020|2344|1|90|0|45,0000|Icepharma hf|Les Laboratoires Servier|Glíklazíð||3785||3785|6332||2 005790|N06AB1001|Cipralex|töflur|5|mg|100|stk|1|plglas||N06AB10|01.08.2002||R|1|0|0|0|0|0|LBK|0|0|0|100|DKK|4796|7723|lyfalmen|V0324|1988|1|100|0|50,0000|Lundbeck Export A/S|H. Lundbeck A/S|Escítalópram||4796||4796|7723||1 005822|QP54AA0102|Oramec Drench, vet.|mixtúra|0,8|mg/ml|5|l|1|fl||QP54AA01|01.08.2001||R|0|0|0|0|0|0|MEF|0|0|0|100|XEU|15817|27262|vetorma|||0|5|0||Vistor hf|Merial (MSD)|Ivermectinum||15817||15817|27262||1 005845|N06AB1001|Cipralex|töflur|10|mg|100|stk|1|plglas||N06AB10|01.08.2002||R|1|0|0|0|0|0|LBK|0|0|0|100|DKK|7698|11718|lyfalmen|V0325|1566|1|100|0|100,0000|Lundbeck Export A/S|H. Lundbeck A/S|Escítalópram||7698||7698|11718||1 005885|N05AH0301|Zyprexa|sts|10|mg|1|hgl|1|pakki||N05AH03|01.02.2004||R|0|0|0|0|G|0|ELD|0|0|0|100|XEU|2420|4453|lyfalmen|||1|1|0|1,0000|Icepharma hf|Eli Lilly Nederland B.V.|Olanzapín||2420||2420|4453||2 005902|N06AB1001|Cipralex|töflur|15|mg|100|stk|1|plglas||N06AB10|01.08.2002||R|1|0|0|0|0|0|LBK|0|0|0|100|DKK|13533|18825|lyfalmen|V0326|3673|1|100|0|150,0000|Lundbeck Export A/S|H. Lundbeck A/S|Escítalópram||12862||12862|18825||1 005910|C09CA0301|Diovan|filmhtfl|80|mg|28|stk|1|þpakki||C09CA03|01.01.2001||R|1|0|0|0|0|0|HES|0|0|0|100|DKK|3145|5451|lyfalmen|||1|28|0|28,0000|Vistor hf|Novartis Healthcare A/S|Valsartan||3145||3145|5451||1 005963|J01CR0204|Amoxin comp|filmhtfl|875|mg|14|stk|1|þpakki|875+125 mg|J01CR02|01.02.2013||R|0|0|0|0|0|0|ROY|0|0|1|100|IKR|1816|2014|lyfalmen|V0169|2014|2|14|0|12,2500|Medical ehf|ratiopharm Oy|Amoxicillín og ensímblokkar||648||648|2014||2 006024|A10AD0501|NovoMix 30 FlexPen|stl|100|ein/ml|3|ml|5|rörlyk|í lyfjapenna|A10AD05|01.07.2002||R|0|0|0|0|G|0|NAS|0|0|0|100|DKK|5088|8125|lyfalmen|||1|15|0|37,5000|Vistor hf|Novo-Nordisk A/S|Insulín aspart||5088||5088|8125||1 006079|J02AX0403|Cancidas|irþ|70|mg/hgl|1|hgl|1|pakki||J02AX04|01.02.2002||R|0|0|0|1|0|1|MSD|0|0|0|100|DKK|88380|114484|lyfsjukr|||1|1|0|1,4000|Vistor hf|M.S.D.|Caspofungin||88380||88380|114484||1 006102|A10AB0501|NovoRapid FlexPen|stl|100|ein/ml|3|ml|5|rörlyk|einnota pennar|A10AB05|01.12.2001||R|0|0|0|0|G|0|NAS|0|0|0|100|DKK|4872|7828|lyfalmen|||1|15|0|37,5000|Vistor hf|Novo-Nordisk A/S|Insúlín aspart||4872||4872|7828||1 006115|J02AX0403|Cancidas|irþ|50|mg/hgl|1|hgl|1|pakki||J02AX04|01.02.2002||R|0|0|0|1|0|1|MSD|0|0|0|100|DKK|67520|88100|lyfsjukr|||1|1|0|1,0000|Vistor hf|M.S.D.|Caspofungin||67520||67520|88100||1 006239|J01CF0501|Heracillin|töflur|500|mg|30|stk|1|glas||J01CF05|01.10.1995||R|0|0|0|0|0|0|REP|0|0|1|100|SEK|2166|4103|lyfalmen|||1|30|0|7,5000|Vistor hf|Recip AB|Flúkloxacillín||2166||2166|4103||1 006443|QM01AC0601|Metacam|stl|20|mg/ml|50|ml|1|hgl||QM01AC06|01.05.2004||R|0|0|0|0|0|0|BOI|1|0|0|100|DKK|3140|6128|vetalmen|||0|50|0||Vistor hf|Boehringer Ingelheim|||||3140|6128||1 006547|B01AX0501|Arixtra|stl|2,5|mg/spr|0,5|ml|10|áf.spr||B01AX05|01.07.2012||R|0|0|0|0|G|0|APP|0|0|0|100|GBP|6061|9465|lyfalmen|V0478|9465|1|5|0|10,0000|Artasan ehf|Aspen Pharma Trading Limited|Fondaparinux||6061||6061|9465||1 006637|D05AX5201|Daivobet|smyrsli|||120|g|1|túpa|50 mcg/g+0,5 mg/g|D05AX52|01.04.2013||R|0|0|0|0|G|0|LEP|0|0|0|100|DKK|11593|17079|lyfalmen|||1|120|0||Vistor hf|LEO Pharma A/S|Kalcípótríól í blöndum||11593||11593|17079||1 006732|A16AB0401|Fabrazyme|irþ|5|mg/ml|35|mg|1|hgl|lausn|A16AB04|01.05.2012||R|0|1|0|1|0|1|GEA|0|1|0|100|DKK|438729|503669|lyfsjukr|||1|35|0|7,0000|Vistor hf|Genzyme Europe B.V.|Agalsidase beta||400483||400483|503669||1 006928|C09CA0101|Cozaar|töflur|100|mg|98|stk|1|þpakki||C09CA01|01.05.2002||R|1|0|0|0|0|0|MSD|0|0|0|100|DKK|12901|18879|lyfalmen|V0099|3829|1|98|0|196,0000|Vistor hf|M.S.D.|Lósartan||12901||12901|18879||1 007133|C10AA0701|Crestor|filmhtfl|10|mg|98|stk|1|þpakki||C10AA07|01.07.2003||R|1|0|0|0|0|0|AZD|0|0|0|100|SEK|11575|17054|lyfalmen|V0117|6880|1|98|0|98,0000|Vistor hf|AstraZeneca A/S DK|Rósuvastatín||11575||11575|17054||1 007155|C10AA0701|Crestor|filmhtfl|20|mg|98|stk|1|þpakki||C10AA07|01.06.2003||R|1|0|0|0|0|0|AZD|0|0|0|100|SEK|17094|24650|lyfalmen|V0118|11082|1|98|0|196,0000|Vistor hf|AstraZeneca A/S DK|Rósuvastatín||17094||17094|24650||1 007165|C09AA0105|Captopril Actavis|töflur|50|mg|100|stk|1|þpakki||C09AA01|01.05.2013||R|1|0|0|0|G|0|ACA|0|0|0|100|XEU|1814|3619|lyfalmen|||2|100|0|100,0000|Actavis Group hf|Actavis hf|Kaptópríl||1814||1814|3619||1 007186|C10AA0701|Crestor|filmhtfl|40|mg|98|stk|1|þpakki||C10AA07|01.07.2003||R|1|0|0|0|0|0|AZD|0|0|0|100|SEK|20729|28919|lyfalmen|V0195|25379|1|98|0|392,0000|Vistor hf|AstraZeneca A/S DK|Rósuvastatín||20729||20729|28919||1 007297|N07BA0110|Nicotinell Lakrids|tyggigúm|2|mg|204|stk|1|þpakki||N07BA01|01.04.2002||L|0|0|0|0|0|0|SDF|0|0|1|100|IKR|||lyflausa|||0|204|0|13,6000|Artasan ehf|GlaxoSmithKline Consumer Healthcare A/S|Nikótín|||||||1 007375|N07BA0110|Nicotinell Lakrids|tyggigúm|4|mg|204|stk|1|þpakki||N07BA01|01.04.2002||L|0|0|0|0|0|0|SDF|0|0|1|100|IKR|||lyflausa|||0|204|0|27,2000|Artasan ehf|GlaxoSmithKline Consumer Healthcare A/S|Nikótín|||||||1 007378|J01XX0801|Zyvoxid|irl|2|mg/ml|300|ml|10|pokar||J01XX08|01.12.2001||R|0|0|0|1|0|1|PER|0|1|0|100|DKK|85308|110598|lyfsjukr|||1|3000|0|5,0000|Icepharma hf|Pfizer ApS|Linezolíd||85308||85308|110598||1 007424|J01XX0801|Zyvoxid|töflur|600|mg|30|stk|1|þpakki||J01XX08|01.12.2001||R|0|0|0|1|0|1|PER|0|1|0|100|DKK|218445|277264|lyfsjukr|||1|30|0|15,0000|Icepharma hf|Pfizer ApS|Linezolíd||218445||218445|277264||1 007434|S01ED5106|Xalcom|augndr|5,05|mg/ml|2,5|ml|1|glas|5mg/ml+50mcg/ml |S01ED51|01.12.2001||R|0|0|0|0|G|0|PER|0|0|0|100|DKK|2688|4822|lyfalmen|V0374|3553|1|2,5|0|25,0000|Icepharma hf|Pfizer ApS|Tímólól í blöndum||2688||2688|4822||1 007448|B05XC04|Cernevit|sts|||5|ml|10|hgl||B05XC|01.05.2002||R|0|0|0|0|0|1|CPS|0|0|0|100|SEK|7277|11138|lyfsjukr|||1|50|0||Icepharma hf|Clintec parenteral SA|Vítamín||7277||7277|11138||2 007449|V03AB3401|Fomepizole OPi|irþ|5|mg/ml|20|ml|5|hgl||V03AB34|01.09.2003||R|0|0|0|0|0|1|OPO|0|0|0|100|XEU|99048|127977|lyfsjukr|||1|100|0||Swedish Orphan International AB|OPi Orphan Pharma international (S)|Fómepízól||99048||99048|127977||3 007462|N01AB0801|Sevorane|innönd.l|||250|ml|1|plastf||N01AB08|01.03.2002||R|0|0|0|0|0|1|ABV|0|0|0|100|DKK|20575|28724|lyfsjukr|||1|250|0||Vistor hf|AbbVie Ltd.|Sevóflúran||20575||20575|28724||1 007505|G04BD0702|Detrusitol Retard|forðahlk|2|mg|30|stk|1|plglas||G04BD07|01.01.2001||R|1|0|0|0|G|0|PER|0|0|0|100|DKK|5858|9185|lyfalmen|||1|30|0|15,0000|Icepharma hf|Pfizer ApS|Tólteródín||5858||5858|9185||1 007601|A16AB0301|Replagal|irþ|1|mg/ml|3,5|ml|1|hgl|lausn|A16AB03|01.09.2014||R|0|0|0|1|0|1|SHG|0|1|0|100|XEU|218066|276793|lyfsjukr|||1|3,5|0|3,5000|Shire Human Genetics Therapies AB|Shire Human Genetic Therapies AB|Agalsídasi alfa||||218066|276793||3 007760|G04BD0702|Detrusitol Retard|forðahlk|4|mg|30|stk|1|plglas||G04BD07|01.01.2001||R|1|0|0|0|G|0|PER|0|0|0|100|DKK|4333|7086|lyfalmen|V0618|5735|1|30|0|30,0000|Icepharma hf|Pfizer ApS|Tólteródín||4333||4333|7086||1 007769|G04BD0702|Detrusitol Retard|forðahlk|4|mg|100|stk|1|plglas||G04BD07|01.01.2001||R|1|0|0|0|G|0|PER|0|0|0|100|DKK|15572|22556|lyfalmen|V0589|9281|1|100|0|100,0000|Icepharma hf|Pfizer ApS|Tólteródín||15572||15572|22556||1 007778|N05AX0802|Rison|filmhtfl|0,5|mg|60|stk|1|glas||N05AX08|01.10.2001||R|1|0|0|0|G|0|ACA|0|0|0|100|IKR|1540|2499|lyfalmen|V0290|2430|2|60|0|6,0000|Actavis Group hf|Actavis hf|Risperídón||1000||1000|2499||1 007852|G02BB0101|NuvaRing|sk-hring|||3|stk|1|pakki|með forðaverkun|G02BB01|01.11.2002||R|0|0|0|0|0|0|ORG|0|0|0|100|DKK|3525|5974|lyfalmen|||1|3|0|84,0000|Vistor hf|N.V. Organon|Skeiðarinnleg með progestógeni og östrógeni||3525||3525|5974||1 007878|V07AB0001|Sterilt vatten Baxter Viaflo|leysir|||50|ml|50|pokar|leysir f.stungulyf|V07AB|01.08.2005||L|0|0|0|0|0|0|BAM|0|0|0|100|IKR|||lyflausa|||0|2500|0||Icepharma hf|Baxter Medical AB|Leysi- og þynningarvökvar, þ.m.t. skolvökvar|||||||2 007921|S01GX0901|Opatanol|augndr|1|mg/ml|5|ml|1|glas||S01GX09|01.05.2004||R|0|0|0|0|0|0|ALA|0|0|0|100|USD|1336|2961|lyfalmen|||1|5|0||Vistor hf|Alcon Laboratories Ltd.|Ólópatadín||1336||1336|2961||1 007986|D07AA0208|Mildison Lipid|krem|10|mg/g|15|g|1|túpa|feitt|D07AA02|01.01.1990||L|0|0|0|0|0|0|ASP|0|0|1|100|IKR|||lyflausa|||0|15|0||Vistor hf|Astellas Pharma A/S|Hýdrókortisón|||||||1 008023|A10BA0201|Glucophage|töflur|1000|mg|30|stk|1|þpakki||A10BA02|01.01.2002||R|1|0|0|0|G|0|MCK|0|0|0|100|SEK|336|1585|lyfalmen|V0502|861|1|30|0|15,0000|Icepharma hf|Merck Santé s.a.s.|Metformín||336||336|1585||2 008194|D07AA0208|Mildison Lipid|krem|10|mg/g|30|g|1|túpa|feitt|D07AA02|01.01.1990||L|0|0|0|0|0|0|ASP|0|0|1|100|IKR|||lyflausa|||0|30|0||Vistor hf|Astellas Pharma A/S|Hýdrókortisón|||||||1 008196|D07AA0208|Mildison Lipid|krem|10|mg/g|100|g|1|túpa|feitt|D07AA02|01.01.1990||R|0|0|0|0|G|0|ASP|0|0|1|100|XEU|1322|2942|lyfalmen|||1|100|0||Vistor hf|Astellas Pharma A/S|Hýdrókortisón||1322||1322|2942||1 008243|D07AC0101|Betnovat|húðlausn|1|mg/g|30|ml|1|plglas|í hársvörð|D07AC01|01.01.1985||R|0|0|0|0|G|0|GPH|0|0|1|100|GBP|452|1744|lyfalmen|||1|30|0||Vistor hf|GlaxoSmithKline Pharma A/S|Betametasón||452||452|1744|30.4.2016|1 008301|N02AX0209|Tramol-L|forðatfl|100|mg|20|stk|1|þpakki||N02AX02|01.04.2002||R|1|0|1|0|G|0|EHF|0|0|1|100|XEU|998|2496|lyfalmen|||2|20|0|6,6700|Actavis Group PTC hf|Actavis ehf|Tramadól||998||998|2496||1 008326|D07AC0101|Betnovat|húðlausn|1|mg/g|100|ml|1|plglas|í hársvörð|D07AC01|01.07.1988||R|0|0|0|0|G|0|GPH|0|0|1|100|GBP|1030|2540|lyfalmen|||1|100|0||Vistor hf|GlaxoSmithKline Pharma A/S|Betametasón||1030||1030|2540||1 008338|N02AX0209|Tramol-L|forðatfl|100|mg|100|stk|1|þpakki||N02AX02|01.04.2002||R|1|0|1|0|G|0|EHF|0|0|1|100|XEU|2538|4616|lyfalmen|V0226|4616|2|100|0|33,3300|Actavis Group PTC hf|Actavis ehf|Tramadól||2538||2538|4616||1 008360|N02AX0209|Tramol-L|forðatfl|150|mg|100|stk|1|þpakki||N02AX02|01.04.2002||R|1|0|1|0|G|0|EHF|0|0|1|100|XEU|3825|6387|lyfalmen|V0227|6387|2|100|0|50,0000|Actavis Group PTC hf|Actavis ehf|Tramadól||3825||3825|6387||1 008368|N02AX0209|Tramol-L|forðatfl|200|mg|100|stk|1|þpakki||N02AX02|01.04.2002||R|1|0|1|0|G|0|EHF|0|0|1|100|XEU|5180|8252|lyfalmen|V0228|8252|2|100|0|66,6700|Actavis Group PTC hf|Actavis ehf|Tramadól||5180||5180|8252||1 008370|V04CJ0101|Thyrogen|sts|0,9|mg/hgl|2|hgl|1|pakki|lausn|V04CJ01|01.01.2006||R|0|0|0|1|0|1|GEZ|0|0|0|100|DKK|128710|165659|lyfsjukr|||1|2|0||Vistor hf|Genzyme BV|Thýrótrópín||128710||128710|165659||1 008396|H03AA0104|Euthyrox|töflur|50|mcg|100|stk|1|þpakki||H03AA01|01.05.2002||R|1|0|0|0|G|0|MKA|0|0|0|100|SEK|460|1755|lyfalmen|V0696|1755|1|100|0|33,3300|Icepharma hf|Merck KgaA|Levótýroxínnatríum||460||460|1755||2 008435|H03AA0104|Euthyrox|töflur|100|mcg|100|stk|1|þpakki||H03AA01|01.05.2002||R|1|0|0|0|G|0|MKA|0|0|0|100|SEK|604|1944|lyfalmen|V0697|1944|1|100|0|66,6700|Icepharma hf|Merck KgaA|Levótýroxínnatríum||597||597|1944||2 008484|QP52AC1303|Zerofen, vet.|mixtúra|10|%|1000|ml|1|plbrús||QP52AC13|01.11.2001||R|0|0|0|0|0|0|CHP|0|0|0|100|IKR|5494|9469|vetorma|||0|1000|0||Icepharma hf|Chanelle Pharmaceuticals |||5494||5494|9469||2 008497|QN05CM9203|Chanazine, vet.|stl|10|%|50|ml|1|hgl||QN05CM92|01.11.2001||R|0|0|0|0|0|0|CHP|1|0|0|100|XEU|9508|18209|vetalmen|||0|50|0||Icepharma hf|Chanelle Pharmaceuticals |||9508||9508|18209||2 008519|R06AE0705|Cetirizin ratiopharm|filmhtfl|10|mg|100|stk|1|þpakki||R06AE07|01.09.2012||L|1|0|0|0|G|0|RAT|0|0|1|100|XEU|||lyfalmen|V0575|2227|2|100|0|100,0000|LYFIS ehf|ratiopharm GmbH|Cetirizín|||||2227||2 008545|G03FB0506|NovoFem|filmhtfl|||84|stk|1|skífup|1+1mg|G03FB05|01.06.2002||R|0|0|0|0|G|0|NAS|0|0|0|100|DKK|2546|4627|lyfalmen|||1|84|0|84,0000|Vistor hf|Novo-Nordisk A/S|Noretísterón og östrógen||2546||2546|4627||1 008673|R06AE0705|Cetirizin ratiopharm|filmhtfl|10|mg|10|stk|1|þpakki||R06AE07|01.09.2012||L|1|0|0|0|0|0|RAT|0|0|1|100|IKR|||lyflausa|||0|10|0|10,0000|LYFIS ehf|ratiopharm GmbH|Cetirizín|||||||2 008745|N07BA0110|Nicotinell Lakrids|tyggigúm|2|mg|24|stk|1|þpakki||N07BA01|01.12.2003||L|0|0|0|0|0|0|SDF|0|0|1|100|IKR|||lyflausa|||0|24|0|1,6000|Artasan ehf|GlaxoSmithKline Consumer Healthcare A/S|Nikótín|||||||1 008767|L03AB1101|Pegasys|stl|135|mcg/spr|0,5|ml|4|spr|áfyllt sprauta|L03AB11|01.11.2002||R|0|0|0|1|0|1|RRL|0|0|0|100|DKK|91101|117925|lyfsjukr|||1|2|0|20,7700|Icepharma hf|Roche Registration Limited|Peginterferón alfa 2a||91101||91101|117925||2 008768|N07BA0110|Nicotinell Lakrids|tyggigúm|4|mg|24|stk|1|þpakki||N07BA01|01.12.2003||L|0|0|0|0|0|0|SDF|0|0|1|100|IKR|||lyflausa|||0|24|0|3,2000|Artasan ehf|GlaxoSmithKline Consumer Healthcare A/S|Nikótín|||||||1 008782|L03AB1101|Pegasys|stl|180|mcg/spr|0,5|ml|4|spr|áfyllt sprauta|L03AB11|01.11.2002||R|0|0|0|1|0|1|RRL|0|0|0|100|DKK|94508|122234|lyfsjukr|||1|2|0|27,6900|Icepharma hf|Roche Registration Limited|Peginterferón alfa 2a||94508||94508|122234||2 008904|D10AF0101|Dalacin|húðlausn|10|mg/ml|60|ml|1|glas||D10AF01|01.01.1994||R|0|0|0|0|0|0|PER|0|0|0|100|DKK|1910|3751|lyfalmen|||1|60|0||Icepharma hf|Pfizer ApS|Klindamýcín||1910||1910|3751||1 008927|G04BE0801|Cialis|filmhtfl|20|mg|4|stk|1|þpakki||G04BE08|01.02.2003||R|0|0|0|0|0|0|LIL|0|0|0|100|XEU|6224|9689|lyfalmen|V0145|9054|1|4|0|8,0000|Icepharma hf|Lilly ICOS Limited|Tadalafíl||||6224|9689||2 008950|G04BE0801|Cialis|filmhtfl|20|mg|8|stk|1|þpakki||G04BE08|01.02.2003||R|0|0|0|0|0|0|LIL|0|0|0|100|XEU|12341|18108|lyfalmen|V0145|18108|1|8|0|16,0000|Icepharma hf|Lilly ICOS Limited|Tadalafíl||||12341|18108||2 008959|R01AA0706|Naso-ratiopharm|nefúði|0,5|mg/ml|10|ml|1|glas|lausn|R01AA07|01.12.2012||L|0|0|0|0|0|0|RAT|0|0|1|100|IKR|||lyflausa|||0|10|0|6,2500|LYFIS ehf|ratiopharm GmbH|Xýlómetazólín|||||||2 009078|N06AG0202|Moclobemid ratiopharm|filmhtfl|300|mg|30|stk|1|þpakki||N06AG02|01.02.2013||R|1|0|0|0|G|0|RAT|0|0|0|100|XEU|1545|2811|lyfalmen|V0064|2764|2|30|0|30,0000|LYFIS ehf|ratiopharm GmbH|Móklóbemíð||1227||1227|2811||2 009099|N06AG0202|Moclobemid ratiopharm|filmhtfl|300|mg|60|stk|1|þpakki||N06AG02|01.03.2014||R|1|0|0|0|G|0|RAT|0|0|0|100|IKR|4383|5527|lyfalmen|V0064|5527|2|60|0|60,0000|LYFIS ehf|ratiopharm GmbH|Móklóbemíð||3200||3200|5527||2 009113|B05DB0005|Balance|kvið.sk|1,5|%|2500|ml|4|pokar|lausn|B05DB|01.04.2011||R|0|0|0|0|0|1|FMC|0|0|0|100|XEU|6982|10732|lyfsjukr|||1|10000|0||Icepharma hf|Fresenius Medical Care Deutschland GmbH|Hýpertónískar lausnir||6982||6982|10732||2 009117|N06AG0202|Moclobemid ratiopharm|filmhtfl|150|mg|100|stk|1|þpakki||N06AG02|01.02.2013||R|1|0|0|0|G|0|RAT|0|0|0|100|XEU|3106|4415|lyfalmen|V0063|4415|2|100|0|50,0000|LYFIS ehf|ratiopharm GmbH|Móklóbemíð||2392||2392|4415||2 009189|N02BA0111|ASA-ratiopharm|töflur|500|mg|50|stk|1|þpakki||N02BA01|01.09.2014||L|0|0|0|0|0|0|RAT|0|0|1|100|IKR|||lyflausa|||2|50|0|8,3333|LYFIS ehf|ratiopharm GmbH|Acetýlsalicýlsýra|||||||2 009213|B05DB0005|Balance|kvið.sk|2,3|%|2500|ml|4|pokar|lausn|B05DB|01.04.2011||R|0|0|0|0|0|1|FMC|0|0|0|100|XEU|6982|10732|lyfsjukr|||1|10000|0||Icepharma hf|Fresenius Medical Care Deutschland GmbH|Hýpertónískar lausnir||6982||6982|10732||2 009214|M01AH0401|Dynastat|sts|40|mg/hgl|10|hgl|1|pakki||M01AH04|01.06.2002||R|0|0|0|0|0|0|IPI|0|0|1|100|DKK|10566|15665|lyfalmen|||1|10|0|10,0000|Icepharma hf|Pfizer Limited|Parekoxíb||10566||10566|15665||1 009216|B05DB0005|Balance|kvið.sk|4,25|%|2500|ml|4|pokar|lausn|B05DB|01.04.2011||R|0|0|0|0|0|1|FMC|0|0|0|100|XEU|6982|10732|lyfsjukr|||1|10000|0||Icepharma hf|Fresenius Medical Care Deutschland GmbH|Hýpertónískar lausnir||6982||6982|10732||2 009270|R01AA0706|Naso-ratiopharm|nefúði|1|mg/ml|10|ml|1|glas|lausn|R01AA07|01.12.2012||L|0|0|0|0|0|0|RAT|0|0|1|100|IKR|||lyflausa|||0|10|0|12,5000|LYFIS ehf|ratiopharm GmbH|Xýlómetazólín|||||||2 009278|J02AC0301|Vfend|töflur|50|mg|30|stk|1|þpakki||J02AC03|01.11.2002||R|1|1|0|0|0|1|IPI|0|0|0|100|DKK|45941|60807|lyfsjukr|||1|30|0|3,7500|Icepharma hf|Pfizer Limited|Voricónazól||45941||45941|60807||1 009285|D11AH0101|Protopic|smyrsli|0,03|%|30|g|1|túpa||D11AH01|01.07.2003||R|0|0|0|0|G|0|ASP|0|0|1|100|XEU|4579|7425|lyfalmen|||1|30|0||Vistor hf|Astellas Pharma A/S|Takrólímus||4579||4579|7425||1 009409|G03CA0316|Vivelle Dot|forðapl|37,5|mcg/sólh|8|stk|1|pakki||G03CA03|01.07.2002||R|0|0|0|0|G|0|HES|0|0|0|100|DKK|1005|2505|lyfalmen|||1|8|0|21,0000|Vistor hf|Novartis Healthcare A/S|Estradíól||1005||1005|2505||1 009443|G03CA0316|Vivelle Dot|forðapl|50|mcg/sólh|8|stk|1|pakki||G03CA03|01.07.2002||R|0|0|0|0|G|0|HES|0|0|0|100|DKK|1108|2647|lyfalmen|||1|8|0|28,0000|Vistor hf|Novartis Healthcare A/S|Estradíól||1108||1108|2647||1 009465|G03CA0316|Vivelle Dot|forðapl|75|mcg/sólh|8|stk|1|pakki||G03CA03|01.07.2002||R|0|0|0|0|G|0|HES|0|0|0|100|DKK|1282|2887|lyfalmen|||1|8|0|42,0000|Vistor hf|Novartis Healthcare A/S|Estradíól||1282||1282|2887||1 009489|G03CA0316|Vivelle Dot|forðapl|100|mcg/sólh|8|stk|1|pakki||G03CA03|01.07.2002||R|0|0|0|0|G|0|HES|0|0|0|100|DKK|1606|3333|lyfalmen|||1|8|0|56,0000|Vistor hf|Novartis Healthcare A/S|Estradíól||1606||1606|3333||1 009525|B05DB0005|Balance|kvið.sk|1,5|%|2000|ml|4|pokar|lausn|B05DB|01.11.2009||R|0|0|0|0|0|1|FMC|0|0|0|100|XEU|5871|9203|lyfsjukr|||1|8000|0||Icepharma hf|Fresenius Medical Care Deutschland GmbH|Hýpertónískar lausnir||5871||5871|9203||2 009560|B05DB0005|Balance|kvið.sk|4,25|%|2000|ml|4|pokar|lausn|B05DB|01.11.2009||R|0|0|0|0|0|1|FMC|0|0|0|100|XEU|6533|10114|lyfsjukr|||1|8000|0||Icepharma hf|Fresenius Medical Care Deutschland GmbH|Hýpertónískar lausnir||6533||6533|10114||2 009591|B05DB0005|Balance|kvið.sk|2,3|%|2000|ml|4|pokar|lausn|B05DB|01.11.2009||R|0|0|0|0|0|1|FMC|0|0|0|100|XEU|5871|9203|lyfsjukr|||1|8000|0||Icepharma hf|Fresenius Medical Care Deutschland GmbH|Hýpertónískar lausnir||5871||5871|9203||2 009609|J02AC0301|Vfend|töflur|200|mg|30|stk|1|þpakki||J02AC03|01.11.2002||R|1|1|0|0|0|1|IPI|0|0|0|100|DKK|166381|212511|lyfsjukr|||1|30|0|15,0000|Icepharma hf|Pfizer Limited|Voricónazól||166381||166381|212511||1 009649|D11AH0101|Protopic|smyrsli|0,1|%|30|g|1|túpa||D11AH01|01.07.2003||R|0|0|0|0|G|0|ASP|0|0|1|100|XEU|4436|7228|lyfalmen|||1|30|0||Vistor hf|Astellas Pharma A/S|Takrólímus||4436||4436|7228||1 009679|J05AF0701|Viread|filmhtfl|245|mg|30|stk|1|glas||J05AF07|01.04.2003||R|1|1|0|1|0|1|GSL|0|0|0|100|DKK|49788|65673|lyfsjukr|||1|30|0|30,0000|Gilead Nordic|Gilead Science International Ltd|Tenófóvír dísóproxíl||49788||49788|65673||2 009900|N01BB0303|Carbocain dental|stl|30|mg/ml|1,8|ml|100|rörlyk|sjálfs|N01BB03|01.03.1984||R|0|0|0|0|0|0|DPL|0|0|1|100|XEU|8692|11809|lyfalmen|||1|180|0||Vistor hf|Dentsply Limited|Mepívakaín||7764||7764|11809||1 009905|N01BB5402|Citanest Dental Octapressin|stl|||1,8|ml|100|rörlyk||N01BB54|01.12.1983||R|0|0|0|0|0|0|DPL|0|0|1|100|XEU|9418|13043|lyfalmen|||1|180|0||Vistor hf|Dentsply Limited|Prílókaín í blöndum||8661||8661|13043||1 009911|N01BB5204|Xylocain Dental adrenalin|stl|20|mg/ml|1,8|ml|100|rörlyk|20mg+12.5mcg/ml|N01BB52|01.12.1983||R|0|0|0|0|0|0|DPL|0|0|1|100|XEU|7488|11429|lyfalmen|||1|180|0||Vistor hf|Dentsply Limited|Lídókaín í blöndum||7488||7488|11429||1 009942|N01BB5402|Citanest Dental Octapressin|stl|||1,8|ml|100|rörlyk|sjálfsog|N01BB54|01.12.1983||R|0|0|0|0|0|0|DPL|0|0|1|100|XEU|9418|13043|lyfalmen|||1|180|0||Vistor hf|Dentsply Limited|Prílókaín í blöndum||8661||8661|13043||1 009945|N01BB5204|Xylocain Dental adrenalin|stl|20|mg/ml|1,8|ml|100|rörlyk|20mg+12.5mcg/ml-sjálfsog|N01BB52|01.12.1983||R|0|0|0|0|0|0|DPL|0|0|1|100|XEU|7591|11570|lyfalmen|||1|180|0||Vistor hf|Dentsply Limited|Lídókaín í blöndum||7591||7591|11570||1 009947|N01BB0303|Carbocain dental|stl|30|mg/ml|1,8|ml|100|rörlyk||N01BB03|01.12.1983||R|0|0|0|0|0|0|DPL|0|0|1|100|XEU|8692|11072|lyfalmen|||1|180|0||Vistor hf|Dentsply Limited|Mepívakaín||7229||7229|11072||1 009993|QP52AF0201|Banminth, vet.|pasta|115,3|mg/g|3|g|1|spr||QP52AF02|01.01.2013||R|0|0|0|0|0|0|ZOE|0|0|0|100|DKK|1091|1880|vetorma|||0|3|0||Icepharma hf|Zoetis Finland OY|||1091||1091|1880||2 010002|N06AX1102|Remeron Smelt|munndr.t|15|mg|30|stk|1|þpakki||N06AX11|01.05.2003||R|0|0|0|0|0|0|ORG|0|0|0|100|DKK|1895|3730|lyfalmen|V0329|1810|1|30|0|15,0000|Vistor hf|N.V. Organon|Mirtazapín||1895||1895|3730||1 010182|J05AB1401|Valcyte|filmhtfl|450|mg|60|stk|1|plglas||J05AB14|01.11.2002||R|1|0|0|0|0|1|ROA|0|0|0|100|DKK|178568|227669|lyfsjukr|||1|60|0|30,0000|Icepharma hf|Roche A.S.|Valgancíklóvír||178568||178568|227669||2 010234|J01DH0301|Invanz|irs|1|g/hgl|1|hgl|1|pakki||J01DH03|01.08.2002||R|0|0|0|1|0|1|MSD|0|0|0|100|DKK|6022|9411|lyfsjukr|||1|1|0|1,0000|Vistor hf|M.S.D.|Ertapenem||6022||6022|9411||1 010240|N06AX1102|Remeron Smelt|munndr.t|30|mg|96|stk|1|þpakki||N06AX11|01.05.2003||R|0|0|0|0|0|0|ORG|0|0|0|100|DKK|11309|16688|lyfalmen|V0331|2636|1|96|0|96,0000|Vistor hf|N.V. Organon|Mirtazapín||11309||11309|16688||1 010254|N06AX1102|Remeron Smelt|munndr.t|45|mg|96|stk|1|þpakki||N06AX11|01.05.2003||R|0|0|0|0|0|0|ORG|0|0|0|100|DKK|15945|23069|lyfalmen|V0304|8793|1|96|0|144,0000|Vistor hf|N.V. Organon|Mirtazapín||15945||15945|23069||1 010290|N06DX0101|Ebixa|mixtúra|5|mg/sk|50|g|1|fl|dæluskammtur|N06DX01|01.08.2010||R|0|0|0|0|G|0|LBK|0|0|0|100|DKK|12604|18470|lyfalmen|||1|50|0|25,0000|Lundbeck Export A/S|H. Lundbeck A/S|Memantín||||12604|18470||1 010334|N06DX0101|Ebixa|töflur|10|mg|100|stk|1|þpakki||N06DX01|01.10.2002||R|1|0|0|0|G|0|LBK|0|0|0|100|DKK|18912|27153|lyfalmen|V0605|5203|1|100|0|50,0000|Lundbeck Export A/S|H. Lundbeck A/S|Memantín||18912||18912|27153||1 010361|C09DA0701|MicardisPlus|töflur|92,5|mg|98|stk|1|þpakki|80 + 12,5 mg|C09DA07|01.02.2008||R|0|0|0|0|0|0|BII|0|0|0|100|DKK|9943|14808|lyfalmen|||1|98|0|98,0000|Vistor hf|Boehringer Ingelheim International |Telmisartan og þvagræsilyf||9943||9943|14808||1 010446|A07EC0204|Asacol|sh-tfl|800|mg|60|stk|1|þpakki||A07EC02|01.01.2003||R|1|0|0|0|G|0|TIL|0|0|0|100|SEK|5559|8774|lyfalmen|V0724|8774|1|60|0|32,0000|Icepharma hf|Tillotts Pharma AB|Mesalazín (5-amínósalicýlsýra)||||5559|8774||2 010534|B05BA0108|Vaminolac|irl|||100|ml|10|fl||B05BA01|01.03.2004||R|0|0|0|0|0|1|FKA|0|0|0|100|DKK|8117|12294|lyfsjukr|||1|1000|0||Vistor hf|Fresenius Kabi AB|Amínósýrur||8117||8117|12294||1 010573|S01AE0501|Oftaquix|augndr|5|mg/ml|5|ml|1|glas||S01AE05|01.08.2002||R|0|0|0|0|0|0|SAO|0|0|1|100|XEU|1099|2635|lyfalmen|||1|5|0||Icepharma hf|Santen Oy|Levófloxacín||1099||1099|2635||2 010705|A02BC0110|Omeprazol ratiopharm|sþ-hylki|20|mg|28|stk|1|glas|hart|A02BC01|01.02.2012||L|1|0|0|0|0|0|RAT|0|0|0|100|IKR|||lyflausa|||0|28|0|28,0000|LYFIS ehf|ratiopharm GmbH|Ómeprazól|||||||2 010716|A02BC0110|Omeprazol ratiopharm|sþ-hylki|20|mg|56|stk|1|glas|hart|A02BC01|01.02.2012||R|1|0|0|0|G|0|RAT|0|0|0|100|IKR|2373|2499|lyfalmen|V0006|1582|2|56|0|56,0000|LYFIS ehf|ratiopharm GmbH|Ómeprazól||1000||1000|2499||2 010746|M05BA0702|Optinate Septimum|filmhtfl|35|mg|12|stk|1|þpakki||M05BA07|01.12.2002|31.03.2016|R|1|0|0|0|0|0|APC|0|0|0|100|NOK|8378|4631|lyfalmen|||1|12|0|84,0000|Actavis Group PTC ehf|Actavis Group PTC ehf|Rísedrónsýru||2549||2549|4631||1 010804|C02KX0101|Tracleer|filmhtfl|62,5|mg|56|stk|1|þpakki||C02KX01|01.11.2003||R|1|1|0|1|0|1|ACV|0|1|0|100|SEK|304497|384289|lyfsjukr|||1|56|0|14,0000|Vistor hf|Actelion Registration Ltd.|Bósentan||304497||304497|384289||3 010826|C02KX0101|Tracleer|filmhtfl|125|mg|56|stk|1|þpakki||C02KX01|01.11.2003||R|1|1|0|1|0|1|ACV|0|1|0|100|SEK|304497|384289|lyfsjukr|||1|56|0|28,0000|Vistor hf|Actelion Registration Ltd.|Bósentan||304497||304497|384289||3 010924|L01DC0103|Bleomycin Baxter|sts|15000|ae|10|hgl|1|pakki||L01DC01|01.04.1998||R|0|0|0|1|0|1|BAM|0|0|0|100|SEK|41345|54994|lyfsjukr|||2|10|0||Icepharma hf|Baxter Medical AB|Bleómýcín||41345||41345|54994||2 010935|J01CF0201|Ekvacillin|sts/irs|1|g|10|hgl|1|pakki||J01CF02|01.10.2003||R|0|0|0|0|0|1|REP|0|0|0|100|SEK|2569|4658|lyfsjukr|||1|10|0|5,0000|Vistor hf|Recip AB|Kloxacillín||2569||2569|4658|31.3.2016|1 010947|C08CA0203|Felodipin ratiopharm|forðatfl|5|mg|100|stk|1|þpakki||C08CA02|01.11.2014||R|1|0|0|0|G|0|RAT|0|0|0|100|IKR|2700|2499|lyfalmen|V0058|2499|2|100|0|100,0000|LYFIS ehf|ratiopharm GmbH|Felódipín||1000||1000|2499||2 010951|N05AX1201|Abilify|töflur|10|mg|28|stk|1|þpakki||N05AX12|01.01.2005||R|1|1|0|0|0|0|OTS|0|0|0|100|DKK|17842|25680|lyfalmen|V0204|15014|1|28|0|18,6670|Vistor hf|Otsuka Pharmaceutical Europe Ltd.|Aripiprazól||17842||17842|25680||1 010953|N05AX1201|Abilify|töflur|15|mg|28|stk|1|þpakki||N05AX12|01.01.2005||R|1|1|0|0|0|0|OTS|0|0|0|100|DKK|17634|25394|lyfalmen|V0716|13270|1|28|0|28,0000|Vistor hf|Otsuka Pharmaceutical Europe Ltd.|Aripiprazól||17634||17634|25394||1 010980|C08CA0203|Felodipin ratiopharm|forðatfl|10|mg|100|stk|1|þpakki||C08CA02|01.11.2014||R|1|0|0|0|G|0|RAT|0|0|0|100|IKR|3200|3875|lyfalmen|V0059|3875|2|100|0|200,0000|LYFIS ehf|ratiopharm GmbH|Felódipín||2000||2000|3875||2 011008|N05AX1201|Abilify|töflur|10|mg|56|stk|1|þpakki||N05AX12|01.01.2005||R|1|1|0|0|0|0|OTS|0|0|0|100|DKK|30379|41124|lyfalmen|V0683|21002|1|56|0|37,3330|Vistor hf|Otsuka Pharmaceutical Europe Ltd.|Aripiprazól||30379||30379|41124||1 011019|N05AX1201|Abilify|töflur|15|mg|56|stk|1|þpakki||N05AX12|01.01.2005||R|1|1|0|0|0|0|OTS|0|0|0|100|DKK|30172|40862|lyfalmen|V0684|21002|1|56|0|56,0000|Vistor hf|Otsuka Pharmaceutical Europe Ltd.|Aripiprazól||30172||30172|40862||1 011163|A07EA0601|Entocort|forðahlk|3|mg|100|stk|1|glas||A07EA06|01.10.1996||R|1|0|0|0|G|0|TTT|0|0|0|100|SEK|15071|21866|lyfalmen|||1|100|0|33,3300|Icepharma hf|Tillotts Pharma GmbH|Búdesóníð||15071||15071|21866||2 011207|M01AH0501|Arcoxia|filmhtfl|60|mg|28|stk|1|þpakki||M01AH05|01.10.2002||R|1|0|0|0|G|0|MSD|0|0|1|100|DKK|3985|6607|lyfalmen|||1|28|0|28,0000|Vistor hf|M.S.D.|Etoríkoxíb||3985||3985|6607||1 011271|M01AH0501|Arcoxia|filmhtfl|90|mg|28|stk|1|þpakki||M01AH05|01.10.2002||R|1|0|0|0|G|0|MSD|0|0|1|100|DKK|4141|6822|lyfalmen|||1|28|0|42,0000|Vistor hf|M.S.D.|Etoríkoxíb||4141||4141|6822||1 011314|N06AB1001|Cipralex|töflur|20|mg|100|stk|1|plglas||N06AB10|01.08.2002||R|1|0|0|0|0|0|LBK|0|0|0|100|DKK|14349|20872|lyfalmen|V0327|1988|1|100|0|200,0000|Lundbeck Export A/S|H. Lundbeck A/S|Escítalópram||14349||14349|20872||1 011326|M01AH0501|Arcoxia|filmhtfl|120|mg|7|stk|1|þpakki||M01AH05|01.01.2010||R|1|0|0|0|G|0|MSD|0|0|1|100|DKK|1057|2577|lyfalmen|||1|7|0|14,0000|Vistor hf|M.S.D.|Etoríkoxíb||1057||1057|2577||1 011369|C09CA0102|Lopress|töflur|50|mg|28|stk|1|glas||C09CA01|01.11.2002|31.03.2016|R|1|0|0|0|0|0|ACA|0|0|0|100|XEU|826|2259|lyfalmen|||2|28|0|28,0000|Actavis Group hf|Actavis hf|Lósartan||826||826|2259||1 011380|C09CA0102|Lopress|töflur|50|mg|98|stk|1|glas||C09CA01|01.11.2002||R|1|0|0|0|G|0|ACA|0|0|0|100|XEU|2162|3199|lyfalmen|V0069|2988|2|98|0|98,0000|Actavis Group hf|Actavis hf|Lósartan||1509||1509|3199||1 011409|R03AK0703|Symbicort forte Turbuhaler|innönddu|329|mcg/sk|60|skammtar|1|pakki|320+9 mcg/sk|R03AK07|01.05.2003||R|0|0|0|0|G|0|AZD|0|0|0|100|SEK|5901|9244|lyfalmen|V0357|8497|1|60|0|30,0000|Vistor hf|AstraZeneca A/S DK|Formóteról og budesonide||5901||5901|9244||1 011489|N06BA0402|Concerta|forðatfl|18|mg|30|stk|1|glas||N06BA04|01.01.2003||R|1|1|1|0|0|0|JAS|0|0|0|100|SEK|5647|8553|lyfalmen|V0691|5876|1|30|0|18,0000|Vistor hf|Janssen-Cilag AB|Metýlfenídat||5399||5399|8553||1 011555|N06BA0402|Concerta|forðatfl|36|mg|30|stk|1|glas||N06BA04|01.01.2003||R|1|1|1|0|0|0|JAS|0|0|0|100|SEK|7282|7861|lyfalmen|V0624|6954|1|30|0|36,0000|Vistor hf|Janssen-Cilag AB|Metýlfenídat||4896||4896|7861||1 011561|QN05CM9203|Chanazine, vet.|stl|2|%|25|ml|1|hgl||QN05CM92|01.09.2002||R|0|0|0|0|0|0|CHP|1|0|0|100|XEU|1703|3347|vetalmen|||0|25|0||Icepharma hf|Chanelle Pharmaceuticals |||1703||1703|3347||2 011609|N01AX1401|S-Ketamin "Pfizer"|stl|25|mg/ml|2|ml|10|lykjur|lausn|N01AX14|01.08.2005||R|0|0|1|0|0|1|PER|0|0|0|100|DKK|4162|6851|lyfsjukr|||1|20|0||Icepharma hf|Pfizer ApS|Esketamín||4162||4162|6851||1 011690|J05AB0402|Copegus|töflur|200|mg|168|stk|1|plglas||J05AB04|01.03.2003||R|0|0|0|1|0|1|ROA|0|0|0|100|DKK|56774|74508|lyfsjukr|||1|168|0|33,6000|Icepharma hf|Roche A.S.|Ribavirin||56774||56774|74508||2 011718|QJ01CE0101|Geepenil, vet.|sts|24|g|1|hgl|1|pakki|+ leysir, lausn|QJ01CE01|01.09.2012||R|0|0|0|0|0|0|OCO|0|0|0|100|SEK|2386|4689|vetalmen|||0|1|0||Icepharma hf|Orion Corporation (I)|Benzylpenicillín sodíum||2386||2386|4689||2 011863|N06AB0602|Sertral|töflur|100|mg|28|stk|1|þpakki||N06AB06|01.10.2005||R|1|0|0|0|0|0|ACA|0|0|0|100|IKR|1425|2170|lyfalmen|V0152|2128|2|28|0|56,0000|Actavis Group hf|Actavis hf|Sertralín||761||761|2170||1 011880|N06AB0602|Sertral|töflur|100|mg|98|stk|1|þpakki||N06AB06|01.10.2005||R|1|0|0|0|G|0|ACA|0|0|0|100|IKR|3925|3955|lyfalmen|V0323|3223|2|98|0|196,0000|Actavis Group hf|Actavis hf|Sertralín||2058||2058|3955||1 011953|N01BB0103|Marcain spinal|stl|5|mg/ml|4|ml|5|gl-lyk||N01BB01|01.01.2003||R|0|0|0|0|0|1|AZD|0|0|0|100|SEK|3741|6271|lyfsjukr|||1|20|0||Vistor hf|AstraZeneca A/S DK|Búpívakaín||3741||3741|6271||1 011969|N01BB0105|Marcain spinal tung|stl|5|mg/ml|4|ml|5|gl-lyk||N01BB01|01.01.2003||R|0|0|0|0|0|1|AZD|0|0|0|100|SEK|2070|3971|lyfsjukr|||1|20|0||Vistor hf|AstraZeneca A/S DK|Búpívakaín||2070||2070|3971||1 011985|N06DX0101|Ebixa|filmhtfl|10|mg|28|stk|1|þpakki||N06DX01|01.06.2009||R|1|0|0|0|G|0|LBK|0|0|0|100|DKK|5861|9189|lyfalmen|V0604|2761|1|28|0|14,0000|Lundbeck Export A/S|H. Lundbeck A/S|Memantín||||5861|9189||1 012030|J05AG0301|Stocrin|filmhtfl|600|mg|30|stk|1|glas||J05AG03|01.01.2003||R|1|0|0|1|0|1|MSD|0|0|0|100|DKK|24905|34201|lyfsjukr|||1|30|0|30,0000|Vistor hf|M.S.D.|Efavirenz||24905||24905|34201||1 012243|G04CB0201|Avodart|hylki|0,5|mg|30|stk|1|þpakki|hylki mjúk|G04CB02|01.03.2012||R|1|0|0|0|G|0|GPH|0|0|0|100|GBP|3649|6145|lyfalmen|||1|30|0|30,0000|Vistor hf|GlaxoSmithKline Pharma A/S|Dútasteríð||3649||3649|6145||1 012273|G04BE0801|Cialis|filmhtfl|10|mg|4|stk|1|þpakki||G04BE08|01.02.2003||R|0|0|0|0|0|0|LIL|0|0|0|100|XEU|5989|9365|lyfalmen|||1|4|0|4,0000|Icepharma hf|Lilly ICOS Limited|Tadalafíl||5989||5989|9365||2 012278|N07BA0106|Nicotinell|forðapl|7|mg/sólh|7|stk|1|pakki||N07BA01|01.04.1992||L|0|0|0|0|0|0|SDF|0|0|1|100|IKR|||lyflausa|||0|7|0|3,5000|Artasan ehf|GlaxoSmithKline Consumer Healthcare A/S|Nikótín|||||||1 012326|N06BA0402|Concerta|forðatfl|54|mg|30|stk|1|glas||N06BA04|01.08.2005||R|1|1|1|0|0|0|JAS|0|0|0|100|SEK|9081|10186|lyfalmen|V0622|9009|1|30|0|54,0000|Vistor hf|Janssen-Cilag AB|Metýlfenídat||6585||6585|10186||1 012461|N07BA0109|Nicotinell Fruit|tyggigúm|4|mg|24|stk|1|þpakki||N07BA01|01.01.2015||L|0|0|0|0|0|0|SDF|0|0|1|100|IKR|||lyflausa|||0|24|0|3,2000|Artasan ehf|GlaxoSmithKline Consumer Healthcare A/S|Nikótín|||||||1 012504|N07BA0109|Nicotinell Fruit|tyggigúm|2|mg|24|stk|1|þpakki||N07BA01|01.12.2003||L|0|0|0|0|0|0|SDF|0|0|1|100|IKR|||lyflausa|||0|24|0|1,6000|Artasan ehf|GlaxoSmithKline Consumer Healthcare A/S|Nikótín|||||||1 012508|N07BA0107|Nicotinell Mint|tyggigúm|4|mg|24|stk|1|þpakki||N07BA01|01.12.2003||L|0|0|0|0|0|0|SDF|0|0|1|100|IKR|||lyflausa|||0|24|0|3,2000|Artasan ehf|GlaxoSmithKline Consumer Healthcare A/S|Nikótín|||||||1 012577|N07BA0107|Nicotinell Mint|tyggigúm|2|mg|24|stk|1|þpakki||N07BA01|01.12.2003||L|0|0|0|0|0|0|SDF|0|0|1|100|IKR|||lyflausa|||0|24|0|1,6000|Artasan ehf|GlaxoSmithKline Consumer Healthcare A/S|Nikótín|||||||1 012716|N07BA0106|Nicotinell|forðapl|14|mg/sólh|7|stk|1|pakki||N07BA01|01.04.1992||L|0|0|0|0|0|0|SDF|0|0|1|100|IKR|||lyflausa|||0|7|0|7,0000|Artasan ehf|GlaxoSmithKline Consumer Healthcare A/S|Nikótín|||||||1 012799|N07BA0106|Nicotinell|forðapl|21|mg/sólh|7|stk|1|pakki||N07BA01|01.04.1992||L|0|0|0|0|0|0|SDF|0|0|1|100|IKR|||lyflausa|||0|7|0|10,5000|Artasan ehf|GlaxoSmithKline Consumer Healthcare A/S|Nikótín|||||||1 012864|M01AE0113|Ibuxin|filmhtfl|200|mg|20|stk|1|þpakki||M01AE01|01.09.2014||L|1|0|0|0|0|0|ROY|0|0|1|100|IKR|||lyflausa|||2|20|0|3,3333|Medical ehf|ratiopharm Oy|Íbúprófen|||||||2 012880|J01CR0202|Augmentin|mixtduft|62,5|mg/ml|80|ml|1|glas|50+12.5 mg|J01CR02|01.10.1989||R|0|0|0|0|0|0|GPH|0|0|1|100|IKR|718|2110|lyfalmen|||1|80|0|4,0000|Vistor hf|GlaxoSmithKline Pharma A/S|Amoxicillín og ensímblokkar||718||718|2110||1 012921|G03AA1301|Evra|forðapl|||9|stk|1|pakki|6 mg+600 mcg|G03AA13|01.11.2003||R|0|0|0|0|0|0|JCI|0|0|0|100|SEK|3969|6585|lyfalmen|||1|9|0||Vistor hf|Janssen-Cilag International N.V.|Norelgestromín og ethinylestradíól||3969||3969|6585||1 012953|G03BA0306|Testogel|hlaup|50|mg|30|sk-pokar|1|pakki||G03BA03|01.12.2003||R|0|0|0|0|G|0|LBI|0|0|0|100|DKK|5514|8712|lyfalmen|||1|30|0|30,0000|Icepharma hf|Laboratoires Besins International|Testósterón||5514||5514|8712||2 012966|N03AX1208|Gabapentin ratiopharm|hylki|300|mg|100|stk|1|þpakki||N03AX12|01.03.2012||R|1|0|0|0|G|0|RGM|0|0|0|100|XEU|2466|3035|lyfalmen|V0250|2561|2|100|0|16,6667|Medical ehf|ratiopharm GmbH|Gabapentín||1390||1390|3035||2 012988|N03AX1208|Gabapentin ratiopharm|hylki|400|mg|100|stk|1|þpakki||N03AX12|01.03.2012||R|1|0|0|0|G|0|RGM|0|0|0|100|XEU|3229|3514|lyfalmen|V0251|2972|2|100|0|22,2200|Medical ehf|ratiopharm GmbH|Gabapentín||1738||1738|3514||2 013068|N06BA0403|Ritalin Uno|hylki|20|mg|30|stk|1|glas||N06BA04|01.02.2004||R|1|1|1|0|0|0|HES|0|0|0|100|DKK|5204|8285|lyfalmen|||1|30|0|20,0000|Vistor hf|Novartis Healthcare A/S|Metýlfenídat||5204||5204|8285||1 013070|QM01AE9101|Rimadyl vet.|tuggutfl|50|mg|100|stk|1|pakki||QM01AE91|01.08.2005||R|0|0|0|0|0|0|ZOE|0|0|0|100|DKK|6156|11850|vetalmen|||0|100|0||Icepharma hf|Zoetis Finland OY|||6156||6156|11850||2 013079|N06BA0403|Ritalin Uno|hylki|40|mg|30|stk|1|glas||N06BA04|01.02.2004||R|1|1|1|0|0|0|HES|0|0|0|100|DKK|8417|12707|lyfalmen|||1|30|0|40,0000|Vistor hf|Novartis Healthcare A/S|Metýlfenídat||8417||8417|12707||1 013082|QM01AE9101|Rimadyl vet.|tuggutfl|50|mg|20|stk|1|pakki||QM01AE91|01.08.2005||R|0|0|0|0|0|0|ZOE|0|0|0|100|DKK|1550|3046|vetalmen|||0|20|0||Icepharma hf|Zoetis Finland OY|||1550||1550|3046||2 013172|J06BB0101|Rhophylac|stl|1500|ae|2|ml|1|spr||J06BB01|01.02.2004||R|0|0|0|0|0|1|ZLB|0|0|0|100|SEK|5950|9312|lyfsjukr|||1|2|0||Icepharma hf|ZLB GmbH|And-D(rh) immúnóglóbúlín||5950||5950|9312||2 013302|C02CA0405|Cardosin Retard|forðatfl|4|mg|100|stk|1|þpakki||C02CA04|01.09.2009||R|1|0|0|0|G|0|ANO|0|0|0|100|XEU|2444|4486|lyfalmen|V0042|4486|2|100|0|100,0000|Actavis Group PTC hf|Actavis Nordic A/S|Doxazósín||2444||2444|4486||1 013308|QM01AE9101|Rimadyl vet.|tuggutfl|20|mg|100|stk|1|pakki||QM01AE91|01.08.2005||R|0|0|0|0|0|0|ZOE|0|0|0|100|DKK|4043|7841|vetalmen|||0|100|0||Icepharma hf|Zoetis Finland OY|||4043||4043|7841||2 013317|QM01AE9101|Rimadyl vet.|tuggutfl|100|mg|100|stk|1|pakki||QM01AE91|01.08.2005||R|0|0|0|0|0|0|ZOE|0|0|0|100|DKK|9435|18071|vetalmen|||0|100|0||Icepharma hf|Zoetis Finland OY|||9435||9435|18071||2 013328|QM01AE9101|Rimadyl vet.|tuggutfl|20|mg|20|stk|1|pakki||QM01AE91|01.08.2005||R|0|0|0|0|0|0|ZOE|0|0|0|100|DKK|990|1946|vetalmen|||0|20|0||Icepharma hf|Zoetis Finland OY|||990||990|1946||2 013341|B02BD0206|Advate|sts|1500|ae|1|hgl|1|pakki|+leysir|B02BD02|01.06.2005||R|0|0|0|1|0|1|BAL|0|1|0|100|SEK|120446|155381|lyfsjukr|||1|1|0|3,0000|Lyfjaver ehf|Baxter Medical AB (L)|Storkuþáttur VIII||||120446|155381||3 013347|L01XE0201|Iressa|töflur|250|mg|30|stk|1|þpakki||L01XE02|01.03.2010||R|0|0|0|1|0|1|AZD|0|1|0|100|SEK|309910|341124|lyfsjukr|||1|30|0||Vistor hf|AstraZeneca A/S DK|Gefitiníb||269791||269791|341124||1 013365|B02BD0206|Advate|sts|1000|ae|1|hgl|1|pakki|+leysir|B02BD02|01.06.2005||R|0|0|0|1|0|1|BER|0|1|0|100|SEK|78730|102278|lyfsjukr|||1|1|0|2,0000|Lyfjaver ehf|Baxter AG (L)|Storkuþáttur VIII||||78730|102278||3 013551|N02AA0503|Oxynorm|stl|10|mg/ml|1|ml|5|lykjur||N02AA05|01.08.2009||R|0|0|1|0|0|0|NOP|0|0|0|100|DKK|1125|2671|lyfalmen|||1|5|0|1,6700|Icepharma hf|Norpharma|Oxýcódon||1125||1125|2671||2 013593|A01AA3001|Xerodent|munnstfl|||90|stk|1|plglas|28,6 mg /0,25 mg|A01AA30|01.01.2008||L|0|0|0|0|0|0|AGT|0|0|1|100|IKR|||lyfalmen|||0|90|0||Actavis Group hf|Actavis Group hf|Blöndur|||||1656||1 013615|M01AE0113|Ibuxin|filmhtfl|400|mg|100|stk|1|þpakki||M01AE01|01.01.2013||R|1|0|0|0|G|0|ROY|0|0|1|100|XEU|673|1641|lyfalmen|V0562|1641|2|100|0|33,3300|Medical ehf|ratiopharm Oy|Íbúprófen||377||377|1641||2 013628|N02AA0503|Oxynorm|stl|10|mg/ml|2|ml|5|lykjur||N02AA05|01.08.2009||R|0|0|1|0|0|0|NOP|0|0|0|100|DKK|2161|4097|lyfalmen|||1|10|0|3,3300|Icepharma hf|Norpharma|Oxýcódon||2161||2161|4097||2 013707|N01BB0203|Xylocain|hlaup|20|mg/ml|30|g|1|túpa||N01BB02|01.10.2003||R|0|0|0|0|0|0|AZD|0|0|0|100|SEK|346|1598|lyfalmen|||1|30|0||Vistor hf|AstraZeneca A/S DK|Lídókaín||346||346|1598||1 013756|C09DA0307|Diovan Comp 160/25 mg|filmhtfl|185|mg|28|stk|1|þpakki||C09DA03|01.04.2005||R|1|0|0|0|0|0|HES|0|0|0|100|DKK|4149|6833|lyfalmen|||1|28|0|28,0000|Vistor hf|Novartis Healthcare A/S|Valsartan og þvagræsilyf||4149||4149|6833||1 013901|A10AC0108|Insulatard InnoLet|stl|100|ae/ml|3|ml|5|spr|áfylltar spr.|A10AC01|01.02.2002||R|0|0|0|0|G|0|NAS|0|0|0|100|DKK|5441|8611|lyfalmen|||1|15|0|37,5000|Vistor hf|Novo-Nordisk A/S|Insúlín (manna)||5441||5441|8611||1 013950|A10AB0101|Actrapid|stl|100|ae/ml|10|ml|1|hgl||A10AB01|01.03.2004||R|0|0|0|0|G|0|NAS|0|0|0|100|DKK|2144|4073|lyfalmen|||1|10|0|25,0000|Vistor hf|Novo-Nordisk A/S|Insúlín (manna)||2144||2144|4073||1 013957|A10AC0109|Insulatard FlexPen|stl|100|ae/ml|3|ml|5|pennar||A10AC01|01.02.2004||R|0|0|0|0|G|0|NAS|0|0|0|100|DKK|4088|6749|lyfalmen|||1|15|0|37,5000|Vistor hf|Novo-Nordisk A/S|Insúlín (manna)||4088||4088|6749||1 013971|L01XE0101|Glivec|filmhtfl|100|mg|60|stk|1|þpakki||L01XE01|01.06.2012||R|0|0|0|1|0|1|NEL|0|1|0|100|DKK|163956|209495|lyfsjukr|||1|60|0||Vistor hf|Novartis Europharm Ltd|Imatiníb||163956||163956|209495||1 013982|L01XE0101|Glivec|filmhtfl|400|mg|30|stk|1|þpakki||L01XE01|01.05.2004||R|0|0|0|1|0|1|NEL|0|1|0|100|DKK|298414|376723|lyfsjukr|||1|30|0||Vistor hf|Novartis Europharm Ltd|Imatiníb||298414||298414|376723||1 014010|A10AC0103|Insulatard|stl|100|ae/ml|10|ml|1|hgl||A10AC01|01.04.1986||R|0|0|0|0|G|0|NAS|0|0|0|100|DKK|2121|4042|lyfalmen|||1|10|0|25,0000|Vistor hf|Novo-Nordisk A/S|Insúlín (manna)||2121||2121|4042||1 014031|A02BC0501|Nexium|sts|40|mg|5|ml|10|hgl|lausn|A02BC05|01.04.2004||R|0|0|0|0|0|1|AZD|0|0|0|100|SEK|6801|10483|lyfsjukr|||1|50|0|13,3300|Vistor hf|AstraZeneca A/S DK|Esómeprazól||6801||6801|10483||1 014081|N03AX1401|Keppra|mixtúra|100|mg/ml|300|ml|1|glas||N03AX14|01.12.2006||R|0|0|0|0|0|0|UCB|0|0|0|100|DKK|16034|23191|lyfalmen|||1|300|0|20,0000|Vistor hf|U.C.B|Levetíracetam||16034||16034|23191||1 014094|H05AA0202|Forsteo|stl|250|mcg/ml|2,4|ml|1|penni|20 mcg/80 mcl|H05AA02|01.11.2003||R|0|0|0|0|0|0|ELD|0|0|0|100|XEU|49912|65829|lyfalmen|||1|2,4|0|28,0000|Icepharma hf|Eli Lilly Nederland B.V.|Teriparatíð||49912||49912|65829||2 014147|J01CA0417|Amoxicillin Sandoz|mixtduft|100|mg/ml|60|ml|1|glas||J01CA04|01.08.2015||R|0|0|0|0|0|0|SHS|0|0|1|100|DKK|2233|4196|lyfalmen|V0479|3806|2|60|0|6,0000|Artasan ehf|Sandoz A/S|Amoxicillín||2233||2233|4196||1 014158|J01CA0417|Amoxicillin Sandoz|mixtduft|100|mg/ml|100|ml|1|glas||J01CA04|01.08.2015||R|0|0|0|0|0|0|SHS|0|0|1|100|DKK|2825|5011|lyfalmen|||2|100|0|10,0000|Artasan ehf|Sandoz A/S|Amoxicillín||2825||2825|5011||1 014185|R03AK0703|Symbicort forte Turbuhaler|innönddu|329|mcg/sk|180|skammtar|1|pakki|320+9 mcg/sk|R03AK07|01.08.2009||R|0|0|0|0|G|0|AZD|0|0|0|100|SEK|17704|25490|lyfalmen|V0357|25490|1|180|0|90,0000|Vistor hf|AstraZeneca A/S DK|Formóteról og budesonide||17704||17704|25490||1 014365|M01AE0113|Ibuxin|filmhtfl|600|mg|30|stk|1|þpakki||M01AE01|01.01.2013||R|1|0|0|0|G|0|ROY|0|0|1|100|XEU|324|1568|lyfalmen|V0563|1565|2|30|0|15,0000|Medical ehf|ratiopharm Oy|Íbúprófen||324||324|1568||2 014435|QM01AE0303|Dolovet vet.|duft|2,4|g|15|g|3|pokar||QM01AE03|01.06.2009||R|0|0|0|0|0|0|VET|0|0|0|100|XEU|2237|4397|vetalmen|||0|45|0||Dýraheilsa ehf|Vetcare Ltd.|||2237||2237|4397||2 014510|J05AF0801|Hepsera|töflur|10|mg|30|stk|1|glas||J05AF08|01.03.2009||R|0|0|0|1|0|1|GSL|0|0|0|100|DKK|73113|95174|lyfsjukr|||1|30|0|30,0000|Gilead Nordic|Gilead Science International Ltd|Adefovír||||73113|95174||2 014541|QA02BX1202|Orbesealer vet.|spenalyf|2,6|g/dælu|24|dælur|1|pakki||QA02BX12|01.04.2005||R|0|0|0|0|0|0|ZOE|0|0|0|100|XEU|5033|9719|vetalmen|||0|24|0||Icepharma hf|Zoetis Finland OY|Bismuthi subnitras||5033||5033|9719||2 014597|M01AE0113|Ibuxin|filmhtfl|600|mg|100|stk|1|þpakki||M01AE01|01.01.2013||R|1|0|0|0|G|0|ROY|0|0|1|100|XEU|817|2004|lyfalmen|V0564|2004|2|100|0|50,0000|Medical ehf|ratiopharm Oy|Íbúprófen||641||641|2004||2 014679|N02AA0501|Oxycontin|forðatfl|5|mg|28|stk|1|þpakki||N02AA05|01.12.2005||R|1|0|1|0|G|0|NOP|0|0|0|100|DKK|829|2263|lyfalmen|V0596|1863|1|28|0|1,8600|Icepharma hf|Norpharma |Oxýcódon||829||829|2263||2 014696|C03EA0111|Miloride|töflur|55|mg|100|stk|1|glas|5+50 mg|C03EA01|01.02.2010||R|1|0|0|0|G|0|MYL|0|0|0|100|SEK|1004|2256|lyfalmen|V0558|2256|2|100|0|100,0000|Icepharma hf|Mylan AB|Hýdróklórtíazíð og kalíumsparandi lyf||824||824|2256||2 014795|C03EA0112|Miloride mite|töflur|27,5|mg|100|stk|1|glas|2,5+25 mg|C03EA01|01.11.2009||R|1|0|0|0|G|0|MYL|0|0|0|100|SEK|1171|2193|lyfalmen|V0559|2193|2|100|0|100,0000|Icepharma hf|Mylan AB|Hýdróklórtíazíð og kalíumsparandi lyf||778||778|2193||2 014847|L04AA1801|Certican|töflur|0,25|mg|60|stk|1|þpakki||L04AA18|01.04.2007||R|0|0|0|1|G|0|HES|0|0|0|100|DKK|23399|32296|lyfalmen|||1|60|0|10,0000|Vistor hf|Novartis Healthcare A/S|Everolímus||23399||23399|32296||1 014852|A06AD6502|Movicol|mixtduft|13,8|g|20|pokar|1|pakki|lausn|A06AD65|01.09.2011||L|0|0|0|0|0|0|NOI|0|0|0|100|IKR|||lyflausa|||0|20|0|10,0000|Artasan ehf|Norgine A/S|Makrógól 3350|||||||1 014853|L04AA1801|Certican|töflur|0,75|mg|60|stk|1|þpakki||L04AA18|01.04.2007||R|0|0|0|1|G|0|HES|0|0|0|100|DKK|60635|79392|lyfalmen|||1|60|0|30,0000|Vistor hf|Novartis Healthcare A/S|Everolímus||60635||60635|79392||1 014859|L04AA1801|Certican|töflur|0,5|mg|60|stk|1|þpakki||L04AA18|01.04.2007||R|0|0|0|1|G|0|HES|0|0|0|100|DKK|40634|54095|lyfalmen|||1|60|0|20,0000|Vistor hf|Novartis Healthcare A/S|Everolímus||40634||40634|54095||1 015316|N06AX1103|Miron|filmhtfl|30|mg|100|stk|1|plglas||N06AX11|01.07.2003||R|1|0|0|0|G|0|ACA|0|0|0|100|XEU|2411|3865|lyfalmen|V0673|3737|2|100|0|100,0000|Actavis Group hf|Actavis hf|Mirtazapín||1993||1993|3865||1 015343|A10AE0501|Levemir FlexPen|stl|100|ae/ml|3|ml|5|pennar||A10AE05|01.12.2005||R|0|0|0|0|G|0|NAS|0|0|0|100|DKK|7074|10859|lyfalmen|||1|15|0|37,5000|Vistor hf|Novo-Nordisk A/S|Insúlín detemír||7074||7074|10859||1 015344|N06AX1103|Miron|filmhtfl|30|mg|30|stk|1|þpakki||N06AX11|01.07.2003||R|1|0|0|0|G|0|ACA|0|0|0|100|XEU|829|2263|lyfalmen|||2|30|0|30,0000|Actavis Group hf|Actavis hf|Mirtazapín||829||829|2263||1 015419|G03CA0316|Vivelle Dot|forðapl|25|mcg/sólh|8|stk|1|pakki||G03CA03|01.02.2006||R|0|0|0|0|G|0|HES|0|0|0|100|DKK|963|2448|lyfalmen|||1|8|0|14,0000|Vistor hf|Novartis Healthcare A/S|Estradíól||963||963|2448||1 015442|N02CC0103|Imigran Radis|filmhtfl|100|mg|6|stk|1|þpakki||N02CC01|01.10.2005||R|0|0|0|0|G|0|GPH|0|0|0|100|GBP|1788|2522|lyfalmen|V0234|1383|1|6|0|12,0000|Vistor hf|GlaxoSmithKline Pharma A/S|Súmatriptan||1017||1017|2522||1 015443|N02CC0103|Imigran Radis|filmhtfl|50|mg|12|stk|1|þpakki||N02CC01|01.10.2005||R|0|0|0|0|G|0|GPH|0|0|0|100|GBP|2553|2522|lyfalmen|V0233|1757|1|12|0|12,0000|Vistor hf|GlaxoSmithKline Pharma A/S|Súmatriptan||1017||1017|2522||1 015448|A10AE0502|Levemir Penfill|stl|100|ae/ml|3|ml|5|rörlyk||A10AE05|01.03.2007||R|0|0|0|0|G|0|NAS|0|0|0|100|DKK|8310|12560|lyfalmen|||1|15|0|37,5000|Vistor hf|Novo-Nordisk A/S|Insúlín detemír||8310||8310|12560||1 015532|L01CX0101|Yondelis|irþ|1|mg/hgl|1|hgl|1|pakki||L01CX01|01.03.2008||R|0|0|0|1|0|1|PAM|0|0|0|100|DKK|281082|355167|lyfsjukr|||1|1|0||Lyfjaver ehf|Pharma Mar S.A.|Trabectedín||281082||281082|355167||3 015598|L01CX0101|Yondelis|irþ|0,25|mg/hgl|1|hgl|1|pakki||L01CX01|01.03.2008||R|0|0|0|1|0|1|PAM|0|0|0|100|DKK|80763|104850|lyfsjukr|||1|1|0||Lyfjaver ehf|Pharma Mar S.A.|Trabectedín||80763||80763|104850||3 015605|N04BA0301|Stalevo|filmhtfl|262,5|mg|30|stk|1|glas|50+12,5+200mg|N04BA03|01.03.2004||R|1|0|0|0|G|0|ORC|0|0|0|100|DKK|4696|7586|lyfalmen|||1|30|0|3,3300|Vistor hf|Orion Corporation|Levódópa, dópadekarboxýlasa­hemill og COMT-hemill||4696||4696|7586||1 015652|N04BA0301|Stalevo|filmhtfl|262,5|mg|100|stk|1|glas|50+12,5+200mg|N04BA03|01.03.2004||R|1|0|0|0|G|0|ORC|0|0|0|100|DKK|11940|17556|lyfalmen|||1|100|0|11,1100|Vistor hf|Orion Corporation|Levódópa, dópadekarboxýlasa­hemill og COMT-hemill||11940||11940|17556||1 015655|N04BA0301|Stalevo|filmhtfl|387,5|mg|30|stk|1|glas|150+37,5+200mg|N04BA03|01.03.2004||R|1|0|0|0|G|0|ORC|0|0|0|100|DKK|4696|7586|lyfalmen|||1|30|0|10,0000|Vistor hf|Orion Corporation|Levódópa, dópadekarboxýlasa­hemill og COMT-hemill||4696||4696|7586||1 015663|N04BA0301|Stalevo|filmhtfl|387,5|mg|100|stk|1|glas|150+37,5+200mg|N04BA03|01.03.2004||R|1|0|0|0|G|0|ORC|0|0|0|100|DKK|12907|18887|lyfalmen|||1|100|0|33,3300|Vistor hf|Orion Corporation|Levódópa, dópadekarboxýlasa­hemill og COMT-hemill||12907||12907|18887||1 015707|N04BA0301|Stalevo|filmhtfl|325|mg|30|stk|1|glas|100+25+200mg|N04BA03|01.03.2004||R|1|0|0|0|G|0|ORC|0|0|0|100|DKK|4696|7586|lyfalmen|||1|30|0|6,6700|Vistor hf|Orion Corporation|Levódópa, dópadekarboxýlasa­hemill og COMT-hemill||4696||4696|7586||1 015718|N04BA0301|Stalevo|filmhtfl|325|mg|100|stk|1|glas|100+25+200mg|N04BA03|01.03.2004||R|1|0|0|0|G|0|ORC|0|0|0|100|DKK|11814|17383|lyfalmen|||1|100|0|22,2200|Vistor hf|Orion Corporation|Levódópa, dópadekarboxýlasa­hemill og COMT-hemill||11814||11814|17383||1 015723|J05AE0801|Reyataz|hylki|200|mg|60|stk|1|plglas||J05AE08|01.06.2008||R|1|0|0|1|0|1|BRS|0|0|0|100|DKK|62292|81488|lyfsjukr|||1|60|0|40,0000|Vistor hf|Bristol-Myers Squibb|Atazanavír||62292||62292|81488||1 015733|L04AA0602|Myfortic|sh-tfl|180|mg|120|stk|1|þpakki||L04AA06|01.11.2004||R|0|0|0|1|G|0|HES|0|0|0|100|DKK|19452|27896|lyfalmen|||1|120|0|10,8000|Vistor hf|Novartis Healthcare A/S|Mýcófenólsýra||19452||19452|27896||1 015755|L04AA0602|Myfortic|sh-tfl|360|mg|120|stk|1|þpakki||L04AA06|01.11.2004||R|0|0|0|1|G|0|HES|0|0|0|100|DKK|38905|51908|lyfalmen|||1|120|0|21,6000|Vistor hf|Novartis Healthcare A/S|Mýcófenólsýra||38905||38905|51908||1 015823|QP54AB5205|Advocate stórir kettir|bl.lausn|110|mg|0,8|ml|3|pípett|100+10 mg|QP54AB52|01.02.2006||R|0|0|0|0|0|0|BAN|0|0|0|100|DKK|2832|4881|vetorma|||0|2,4|0||Icepharma hf|Bayer Animal Health GmbH|||2832||2832|4881||2 015855|QP54AB5206|Advocate yfirstærðar hundar|bl.lausn|125|mg|4|ml|3|pípett|100+25 mg|QP54AB52|01.02.2006||R|0|0|0|0|0|0|BAN|0|0|0|100|DKK|5370|9256|vetorma|||0|12|0||Icepharma hf|Bayer Animal Health GmbH|||5370||5370|9256||2 015873|QP54AB5202|Advocate litlir kettir|bl.lausn|110|mg|0,4|ml|3|pípett|100+10 mg|QP54AB52|01.02.2006||R|0|0|0|0|0|0|BAN|0|0|0|100|DKK|2113|3642|vetorma|||0|1,2|0||Icepharma hf|Bayer Animal Health GmbH|||2113||2113|3642||2 015882|QP54AB5203|Advocate millistórir hundar|bl.lausn|125|mg|1|ml|3|pípett|100+25 mg|QP54AB52|01.02.2006||R|0|0|0|0|0|0|BAN|0|0|0|100|DKK|2947|5079|vetorma|||0|3|0||Icepharma hf|Bayer Animal Health GmbH|||2947||2947|5079||2 015904|QP54AB5204|Advocate stórir hundar|bl.lausn|125|mg|2,5|ml|3|pípett|100+25 mg|QP54AB52|01.02.2006||R|0|0|0|0|0|0|BAN|0|0|0|100|DKK|5155|8885|vetorma|||0|7,5|0||Icepharma hf|Bayer Animal Health GmbH|||5155||5155|8885||2 015910|D01AC0804|Ketoconazol ratiopharm|hársápa|20|mg/ml|100|ml|1|fl||D01AC08|01.04.2012||L|0|0|0|0|0|0|RPO|0|0|1|100|IKR|||lyflausa|||0|100|0||LYFIS ehf|ratiopharm Oy|Ketókónazól|||||||2 015912|D11AH0101|Protopic|smyrsli|0,03|%|10|g|1|túpa||D11AH01|01.03.2009||R|0|0|0|0|G|0|ASP|0|0|1|100|XEU|1775|3565|lyfalmen|||1|10|0||Vistor hf|Astellas Pharma A/S|Takrólímus||||1775|3565||1 015923|D11AH0101|Protopic|smyrsli|0,1|%|10|g|1|túpa||D11AH01|01.10.2007||R|0|0|0|0|G|0|ASP|0|0|1|100|XEU|1993|3865|lyfalmen|||1|10|0||Vistor hf|Astellas Pharma A/S|Takrólímus||1993||1993|3865||1 015929|N02AA0110|Morphine Sulphate BP|stl|10|mg/ml|1|ml|10|lykjur||N02AA01|01.07.2003||R|0|0|1|0|0|0|MAP|0|0|0|100|GBP|1449|3117|lyfalmen|||2|10|0|3,3300|Icepharma hf|Martindale Pharmaceuticals|Morfín||1449||1449|3117||2 015944|QP54AB5201|Advocate litlir hundar|bl.lausn|125|mg|0,4|ml|3|pípett|100+25 mg|QP54AB52|01.02.2006||R|0|0|0|0|0|0|BAN|0|0|0|100|DKK|2834|4885|vetorma|||0|1,2|0||Icepharma hf|Bayer Animal Health GmbH|||2834||2834|4885||2 015956|D01AC0804|Ketoconazol ratiopharm|hársápa|20|mg/ml|60|ml|1|fl||D01AC08|01.04.2012||L|0|0|0|0|0|0|RPO|0|0|1|100|IKR|||lyflausa|||0|60|0||LYFIS ehf|ratiopharm Oy|Ketókónazól|||||||2 015964|N06AB0501|Seroxat|töflur|10|mg|28|stk|1|þpakki||N06AB05|01.12.2006||R|1|0|0|0|0|0|GPH|0|0|0|100|GBP|1640|3379|lyfalmen|||1|28|0|14,0000|Vistor hf|GlaxoSmithKline Pharma A/S|Paroxetín||1640||1640|3379||1 016021|N02AB0203|Pethidine BP|stl|50|mg/ml|1|ml|10|lykjur||N02AB02|01.07.2003||R|0|0|1|0|0|0|MAP|0|0|0|100|GBP|1077|2605|lyfalmen|||2|10|0|1,2500|Icepharma hf|Martindale Pharmaceuticals|Petidín||1077||1077|2605||2 016032|N02AB0203|Pethidine BP|stl|50|mg/ml|2|ml|10|lykjur||N02AB02|01.01.2004||R|0|0|1|0|0|0|MAP|0|0|0|100|GBP|1141|2693|lyfalmen|||2|20|0|2,5000|Icepharma hf|Martindale Pharmaceuticals|Petidín||1141||1141|2693||2 016285|N03AX1601|Lyrica|hylki|150|mg|14|stk|1|þpakki||N03AX16|01.12.2004||R|1|0|0|0|0|0|PER|0|0|0|100|DKK|2419|4452|lyfalmen|||1|14|0|7,0000|Icepharma hf|Pfizer ApS|Pregabalín||2419||2419|4452||1 016294|N03AX1601|Lyrica|hylki|75|mg|56|stk|1|þpakki||N03AX16|01.12.2004||R|1|0|0|0|0|0|PER|0|0|0|100|DKK|6032|9425|lyfalmen|V0686|3744|1|56|0|14,0000|Icepharma hf|Pfizer ApS|Pregabalín||6032||6032|9425||1 016315|N03AX1601|Lyrica|hylki|150|mg|56|stk|1|þpakki||N03AX16|01.12.2004||R|1|0|0|0|0|0|PER|0|0|0|100|DKK|9142|13705|lyfalmen|V0687|5952|1|56|0|28,0000|Icepharma hf|Pfizer ApS|Pregabalín||9142||9142|13705||1 016317|C03CA0110|Impugan|töflur|40|mg|1000|stk|1|glas||C03CA01|01.01.2016||R|2|0|0|0|G|0|AGT|0|0|0|100|XEU|4531|7359|lyfalmen|||2|1000|0|1000,0000|Actavis Group hf|Actavis Group hf|Fúrósemíð||4531||4531|7359||1 016318|N03AX1601|Lyrica|hylki|75|mg|14|stk|1|þpakki||N03AX16|01.12.2004||R|1|0|0|0|0|0|PER|0|0|0|100|DKK|1597|3320|lyfalmen|||1|14|0|3,5000|Icepharma hf|Pfizer ApS|Pregabalín||1597||1597|3320||1 016323|N03AX1601|Lyrica|hylki|300|mg|56|stk|1|þpakki||N03AX16|01.12.2004||R|1|0|0|0|0|0|PER|0|0|0|100|DKK|13133|19198|lyfalmen|V0689|6672|1|56|0|56,0000|Icepharma hf|Pfizer ApS|Pregabalín||13133||13133|19198||1 016337|C08CA0302|Lomir Retard|forðahlk|5|mg|100|stk|1|þpakki||C08CA03|01.04.1992||R|1|0|0|0|G|0|HES|0|0|0|100|DKK|7281|11144|lyfalmen|||1|100|0|100,0000|Vistor hf|Novartis Healthcare A/S|Ísradipín||7281||7281|11144||1 016382|J02AC0301|Vfend|mixtúra|40|mg/ml|70|ml|1|fl||J02AC03|01.03.2005||R|0|1|0|0|0|1|IPI|0|0|0|100|DKK|85139|110385|lyfsjukr|||1|70|0|7,0000|Icepharma hf|Pfizer Limited|Voricónazól||85139||85139|110385||1 016385|L01BC0108|Cytarabine Pfizer|stl/irl|100|mg/ml|10|ml|1|hgl||L01BC01|01.10.1995||R|0|0|0|1|0|1|PER|0|0|0|100|DKK|3330|5706|lyfsjukr|||1|10|0||Icepharma hf|Pfizer ApS|Cýtarabín||3330||3330|5706||1 016395|N03AX1601|Lyrica|hylki|25|mg|56|stk|1|þpakki||N03AX16|01.01.2007||R|1|0|0|0|0|0|PER|0|0|0|100|DKK|2347|4353|lyfalmen|V0685|1375|1|56|0|4,6667|Icepharma hf|Pfizer ApS|Pregabalín||2347||2347|4353||1 016502|N07BA0111|Nicorette Classic|tyggigúm|2|mg|30|stk|1|þpakki||N07BA01|01.03.2004||L|0|0|0|0|0|0|MCN|0|0|1|100|IKR|||lyflausa|||0|30|0|2,0000|Vistor hf|McNeil Denmark ApS|Nikótín|||||||1 016524|N07BA0111|Nicorette Classic|tyggigúm|2|mg|210|stk|1|þpakki||N07BA01|01.03.2004||L|0|0|0|0|0|0|MCN|0|0|1|100|IKR|||lyflausa|||0|210|0|14,0000|Vistor hf|McNeil Denmark ApS|Nikótín|||||||1 016527|J01CE0206|Apocillin|mixt.kyr|50|mg/ml|200|ml|1|glerfl||J01CE02|01.06.2015||R|0|0|0|0|0|0|AGP|0|0|1|100|XEU|1161|2720|lyfalmen|||2|200|0|5,0000|Actavis Group hf|Actavis Group PTC ehf|Fenoxýmetýlpenicillín||1161||1161|2720||1 016528|N07BA0111|Nicorette Classic|tyggigúm|4|mg|210|stk|1|þpakki||N07BA01|01.03.2004||L|0|0|0|0|0|0|MCN|0|0|1|100|IKR|||lyflausa|||0|210|0|28,0000|Vistor hf|McNeil Denmark ApS|Nikótín|||||||1 016572|N07BA0113|Nicorette Freshmint|tyggigúm|2|mg|210|stk|1|þpakki||N07BA01|01.09.2005||L|0|0|0|0|0|0|MCN|0|0|1|100|IKR|||lyflausa|||0|210|0|14,0000|Vistor hf|McNeil Denmark ApS|Nikótín|||||||1 016589|N07BA0113|Nicorette Freshmint|tyggigúm|4|mg|30|stk|1|þpakki||N07BA01|01.01.2005||L|0|0|0|0|0|0|MCN|0|0|1|100|IKR|||lyflausa|||0|30|0|4,0000|Vistor hf|McNeil Denmark ApS|Nikótín|||||||1 016590|N07BA0113|Nicorette Freshmint|tyggigúm|2|mg|30|stk|1|þpakki||N07BA01|01.01.2005||L|0|0|0|0|0|0|MCN|0|0|1|100|IKR|||lyflausa|||0|30|0|2,0000|Vistor hf|McNeil Denmark ApS|Nikótín|||||||1 016596|N05AX1201|Abilify|töflur|5|mg|28|stk|1|þpakki||N05AX12|01.02.2006||R|1|1|0|0|0|0|OTS|0|0|0|100|DKK|15551|22527|lyfalmen|V0690|14454|1|28|0|9,3330|Vistor hf|Otsuka Pharmaceutical Europe Ltd.|Aripiprazól||15551||15551|22527||1 016611|N07BA0113|Nicorette Freshmint|tyggigúm|4|mg|210|stk|1|þpakki||N07BA01|01.09.2005||L|0|0|0|0|0|0|MCN|0|0|1|100|IKR|||lyflausa|||0|210|0|28,0000|Vistor hf|McNeil Denmark ApS|Nikótín|||||||1 016622|A06AG1101|Microlax|innhl|||5|ml|50|túpa||A06AG11|01.09.2005||L|0|0|0|0|0|0|MCN|0|0|0|100|DKK|||lyfalmen|||0|250|0|50,0000|Vistor hf|McNeil Denmark ApS|Lárýlsúlfat, þ.m.t. í blöndum|||||7189||1 016635|N05AX1201|Abilify|töflur|5|mg|56|stk|1|þpakki||N05AX12|01.02.2006||R|1|1|0|0|0|0|OTS|0|0|0|100|DKK|30379|41124|lyfalmen|V0682|20512|1|56|0|18,6670|Vistor hf|Otsuka Pharmaceutical Europe Ltd.|Aripiprazól||30379||30379|41124||1 016637|J01CR0201|Amoksiklav|töflur|1000|mg|12|stk|1|pakki|875+125 mg|J01CR02|01.08.2003||R|0|0|0|0|0|0|LPM|0|0|1|100|IKR|1026|2174|lyfalmen|V0169|1726|2|12|0|10,5000|Actavis Group hf|LEK Pharmaceuticals d.d.|Amoxicillín og ensímblokkar||764||764|2174||1 016640|B03XA0103|NeoRecormon|stl|30000|ae/spr|0,6|ml|4|spr||B03XA01|01.05.2007||R|0|0|0|1|0|1|ROC|0|0|0|100|DKK|128382|165251|lyfsjukr|||1|2,4|0|120,0000|Icepharma hf|Roche|Epóetín||128382||128382|165251||2 016727|N06BA0403|Ritalin Uno|hylki|30|mg|30|stk|1|glas||N06BA04|01.02.2004||R|1|1|1|0|0|0|HES|0|0|0|100|DKK|6645|10268|lyfalmen|||1|30|0|30,0000|Vistor hf|Novartis Healthcare A/S|Metýlfenídat||6645||6645|10268||1 016736|N03AF0107|Tegretol Retard (Lyfjaver)|forðatfl|200|mg|200|stk|1|plglas||N03AF01|01.09.2003||R|1|0|0|0|G|0|LVR|0|0|0|100|DKK|2714|4858|lyfalmen|V0240|4858|3|200|0|40,0000|Lyfjaver ehf|Lyfjaver ehf|Karbamazepín||2714||2714|4858||3 016772|N03AF0107|Tegretol Retard (Lyfjaver)|forðatfl|400|mg|200|stk|1|plglas||N03AF01|01.09.2003||R|1|0|0|0|G|0|LVR|0|0|0|100|DKK|5009|8017|lyfalmen|V0433|8017|3|200|0|80,0000|Lyfjaver ehf|Lyfjaver ehf|Karbamazepín||5009||5009|8017||3 016791|H05BX0101|Mimpara|filmhtfl|60|mg|28|stk|1|pakki||H05BX01|01.05.2005||R|1|0|0|0|0|0|AEB|0|0|0|100|DKK|45524|60279|lyfalmen|V0721|50118|1|28|0|28,0000|Vistor hf|Amgen Europe B.V.|Cinacalcet||45524||45524|60279||1 016802|H05BX0101|Mimpara|filmhtfl|90|mg|28|stk|1|pakki||H05BX01|01.05.2005||R|1|0|0|0|0|0|AEB|0|0|0|100|DKK|67069|87530|lyfalmen|V0722|73279|1|28|0|42,0000|Vistor hf|Amgen Europe B.V.|Cinacalcet||67069||67069|87530||1 016868|H05BX0101|Mimpara|filmhtfl|30|mg|28|stk|1|pakki||H05BX01|01.05.2005||R|1|0|0|0|0|0|AEB|0|0|0|100|DKK|24935|34239|lyfalmen|V0720|28233|1|28|0|14,0000|Vistor hf|Amgen Europe B.V.|Cinacalcet||24935||24935|34239||1 016930|A16AB0401|Fabrazyme|irþ|5|mg/ml|5|mg|1|hgl|lausn|A16AB04|01.05.2012||R|0|1|0|1|0|1|GEA|0|1|0|100|DKK|71399|85130|lyfsjukr|||1|5|0|1,0000|Vistor hf|Genzyme Europe B.V.|Agalsidase beta||65172||65172|85130||1 016946|A02BC0301|Lanzo|munndr.t|15|mg|56|stk|1|þpakki||A02BC03|01.11.2009||R|0|0|0|0|0|0|PER|0|0|0|100|DKK|1582|3300|lyfalmen|||1|56|0|28,0000|Icepharma hf|Pfizer ApS|Lansóprazól||||1582|3300||1 016973|J05AF0901|Emtriva|hylki|200|mg|30|stk|1|glas||J05AF09|01.04.2004||R|1|0|0|1|0|1|GSL|0|0|0|100|DKK|35055|46593|lyfsjukr|||1|30|0|30,0000|Gilead Nordic|Gilead Science International Ltd|Emtrícítabín||34703||34703|46593||2 016979|N02AE0103|Norspan|forðapl|5|mcg/klst|4|stk|1|þpakki||N02AE01|01.01.2006||R|0|0|1|0|G|0|PRO|0|0|0|100|DKK|2735|4887|lyfalmen|||1|4|0|16,6700|Icepharma hf|Norpharma A/S|Búprenorfín||2735||2735|4887||2 016981|QA02BX1202|Orbesealer vet.|spenalyf|2,6|g/dælu|60|dælur|1|pakki||QA02BX12|01.12.2006||R|0|0|0|0|0|0|ZOE|0|0|0|100|DKK|16667|31791|vetalmen|||0|60|0||Icepharma hf|Zoetis Finland OY|Bismuthi subnitras||16667||16667|31791||2 017020|G03DA0201|Depo-Provera|stl|50|mg/ml|3|ml|1|hgl||G03DA02|01.12.1972||R|0|0|0|0|G|0|PER|0|0|0|100|DKK|1357|2990|lyfalmen|||1|3|0|21,4286|Icepharma hf|Pfizer ApS|Medroxýprógesterón||1357||1357|2990||1 017130|L01BC0109|DepoCyte|stl|50|mg/hgl|5|ml|1|hgl||L01BC01|01.07.2005||R|0|0|0|1|0|1|SKY|0|1|0|100|DKK|234308|296994|lyfsjukr|||1|5|0||Icepharma hf|SkyPharma PLC|Cýtarabín||234308||234308|296994||2 017182|N05CF0106|Zopiclone Actavis|filmhtfl|5|mg|500|stk|1|plglas||N05CF01|01.10.2012||R|2|0|0|0|0|0|APC|0|0|0|100|XEU|5987|9363|lyfalmen|||2|500|0|333,0000|Actavis Group PTC ehf|Actavis Group PTC ehf|Zópíklón||5987||5987|9363||1 017193|N05CF0106|Zopiclone Actavis|filmhtfl|7,5|mg|500|stk|1|glas||N05CF01|01.05.2013||R|2|0|0|0|0|0|APC|0|0|0|100|SEK|5454|8629|lyfalmen|||2|500|0|500,0000|Actavis Group PTC ehf|Actavis Group PTC ehf|Zópíklón||5454||5454|8629||1 017195|L01XX3201|Velcade|sts|3,5|mg/hgl|1|hgl|1|pakki|lausn|L01XX32|01.09.2004||R|0|1|0|1|0|1|JCI|0|1|0|100|SEK|130746|168191|lyfsjukr|||1|1|0||Vistor hf|Janssen-Cilag International N.V.|Bortezomíb||130746||130746|168191||1 017203|M05BA0601|Bondronat|irþ|1|mg/ml|6|ml|1|hgl||M05BA06|01.09.2004||R|0|0|0|1|0|1|ROC|0|0|0|100|DKK|30320|41049|lyfsjukr|||1|6|0|1,0000|Icepharma hf|Roche|Íbandrónsýra||30320||30320|41049||2 017234|L03AB0701|Avonex|stl|30|mcg/spr|0,5|ml|4|spr|lausn, áfylltar sprautur|L03AB07|01.12.2003||R|0|0|0|1|0|1|BIB|0|0|0|100|XEU|99665|128757|lyfsjukr|||1|2|0|27,9100|Icepharma hf|Biogen Idec Ltd|Interferón beta-1a||99665||99665|128757||2 017238|M05BA0601|Bondronat|filmhtfl|50|mg|28|stk|1|þpakki||M05BA06|01.08.2004||R|0|0|0|1|0|0|ROC|0|0|0|100|DKK|40835|54349|lyfalmen|||1|28|0|280,0000|Icepharma hf|Roche|Íbandrónsýra||40835||40835|54349||2 017247|M05BA0601|Bondronat|filmhtfl|50|mg|84|stk|1|þpakki||M05BA06|01.08.2004||R|0|0|0|1|0|0|ROC|0|0|0|100|DKK|110263|142716|lyfalmen|||1|84|0|840,0000|Icepharma hf|Roche|Íbandrónsýra||110263||110263|142716||2 017266|N02AE0103|Norspan|forðapl|10|mcg/klst|4|stk|1|þpakki||N02AE01|01.01.2006||R|0|0|1|0|G|0|PRO|0|0|0|100|DKK|4974|7968|lyfalmen|||1|4|0|33,3300|Icepharma hf|Norpharma A/S|Búprenorfín||4974||4974|7968||2 017326|N02AE0103|Norspan|forðapl|20|mcg/klst|4|stk|1|þpakki||N02AE01|01.01.2006||R|0|0|1|0|G|0|PRO|0|0|0|100|DKK|9043|13569|lyfalmen|||1|4|0|66,6600|Icepharma hf|Norpharma A/S|Búprenorfín||9043||9043|13569||2 017331|A04AD1201|Emend|hylki|||3|stk|1|þpakki|samsett pakkning|A04AD12|01.04.2004||R|1|0|0|0|0|1|MSD|0|0|0|100|DKK|7853|11931|lyfsjukr|||1|3|0|3,0000|Vistor hf|M.S.D.|Aprepitant||7853||7853|11931||1 017365|J01CR0201|Amoksiklav|filmhtfl|375|mg|20|stk|1|þpakki|250+125 mg|J01CR02|01.12.2003||R|0|0|0|0|0|0|LPM|0|0|1|100|XEU|906|2369|lyfalmen|||2|20|0|5,0000|Actavis Group hf|LEK Pharmaceuticals d.d.|Amoxicillín og ensímblokkar||906||906|2369||1 017384|H02AB0701|Deltison|töflur|50|mg|30|stk|1|glas||H02AB07|01.08.2005||R|1|0|0|0|G|0|REP|0|0|1|100|SEK|2543|4622|lyfalmen|||1|30|0|150,0000|Vistor hf|Recip AB|Prednisón||2543||2543|4622||1 017556|J01CR0201|Amoksiklav|filmhtfl|625|mg|20|stk|1|þpakki|500+125 mg|J01CR02|01.12.2003||R|0|0|0|0|0|0|LPM|0|0|1|100|IKR|1459|2711|lyfalmen|V0168|2662|2|20|0|10,0000|Actavis Group hf|LEK Pharmaceuticals d.d.|Amoxicillín og ensímblokkar||1154||1154|2711||1 017564|QM01AC0601|Metacam|mixtúra|15|mg/ml|100|ml|1|fl||QM01AC06|01.09.2004||R|0|0|0|0|0|0|BOI|0|0|0|100|DKK|5948|11455|vetalmen|||0|100|0||Vistor hf|Boehringer Ingelheim|||5948||5948|11455||1 017792|C03DA0401|Inspra|filmhtfl|50|mg|30|stk|1|þpakki||C03DA04|01.08.2005||R|1|0|0|0|0|0|PER|0|0|0|100|DKK|9232|13829|lyfalmen|V0197|11858|1|30|0|30,0000|Icepharma hf|Pfizer ApS|Eplerenón||9232||9232|13829||1 017809|N06DA0401|Reminyl|forðahlk|24|mg|84|stk|1|þpakki||N06DA04|01.08.2005|30.04.2016|R|1|0|0|0|G|0|JAS|0|0|0|100|SEK|28080|38216|lyfalmen|||1|84|0|126,0000|Vistor hf|Janssen-Cilag AB|Galantamín||28080||28080|38216||1 017963|C03DA0401|Inspra|filmhtfl|25|mg|30|stk|1|þpakki||C03DA04|01.08.2005||R|1|0|0|0|0|0|PER|0|0|0|100|DKK|8455|12760|lyfalmen|V0107|4091|1|30|0|15,0000|Icepharma hf|Pfizer ApS|Eplerenón||8455||8455|12760||1 018514|J07BA0101|FSME-Immun Junior|stl|1,2|mcg/sk|0,25|ml|1|spr|bóluefni|J07BA01|01.06.2004|29.02.2016|R|0|0|0|0|0|0|PIS|0|0|0|100|SEK|3442|5860|lyfalmen|||1|0,25|0||Icepharma hf|Pfizer ApS|Heilabólguveira óvirk, borin með blóðmaur||3442||3442|5860||2 018527|J07BA0102|FSME-Immun Vuxen|stl|2,4|mcg/sk|0,5|ml|1|spr|bóluefni|J07BA01|01.06.2004|29.02.2016|R|0|0|0|0|0|0|PIS|0|0|0|100|SEK|3708|6226|lyfalmen|||1|0,5|0||Icepharma hf|Pfizer ApS|Heilabólguveira óvirk, borin með blóðmaur||3708||3708|6226||2 018535|N03AX0901|Lamictal|dreifit.|25|mg|42|stk|1|þpakki||N03AX09|01.11.2004||R|1|0|0|0|G|0|GPH|0|0|0|100|IKR|908|1753|lyfalmen|V0243|1405|1|42|0|3,5000|Vistor hf|GlaxoSmithKline Pharma A/S|Lamótrigín||458||458|1753||1 018594|G04BD0801|Vesicare|filmhtfl|10|mg|30|stk|1|þpakki||G04BD08|01.11.2004||R|1|0|0|0|G|0|ASP|0|0|0|100|XEU|6451|10001|lyfalmen|||1|30|0|60,0000|Vistor hf|Astellas Pharma A/S|Sólífenacín||6451||6451|10001||1 018663|J01DD0401|Rocephalin|sts|1|g|1|stk|5|hgl|+ leysir, lausn|J01DD04|01.10.1985||R|0|0|0|0|0|1|ROC|0|0|0|100|DKK|12148|17843|lyfsjukr|||1|5|0|2,5000|Icepharma hf|Roche|Ceftríaxón||12148||12148|17843||2 018677|G04BD0801|Vesicare|filmhtfl|10|mg|90|stk|1|þpakki||G04BD08|01.11.2004||R|1|0|0|0|G|0|ASP|0|0|0|100|XEU|16401|23697|lyfalmen|V0441|20622|1|90|0|180,0000|Vistor hf|Astellas Pharma A/S|Sólífenacín||16401||16401|23697||1 018682|H02AB0604|Decortin H|töflur|5|mg|100|stk|1|þpakki||H02AB06|01.06.2004||R|1|0|0|0|G|0|MKA|0|0|1|100|SEK|821|2252|lyfalmen|V0414|1977|1|100|0|50,0000|Icepharma hf|Merck KgaA|Prednisólón||821||821|2252||2 018685|G04BD0801|Vesicare|filmhtfl|5|mg|30|stk|1|þpakki||G04BD08|01.11.2004||R|1|0|0|0|G|0|ASP|0|0|0|100|XEU|5195|8273|lyfalmen|V0438|6818|1|30|0|30,0000|Vistor hf|Astellas Pharma A/S|Sólífenacín||5195||5195|8273||1 018689|J01EA0108|Idotrim|filmhtfl|100|mg|100|stk|1|glas||J01EA01|01.08.2015||R|1|0|0|0|0|0|COR|0|0|1|100|DKK|1565|3267|lyfalmen|||2|100|0|25,0000|Vistor hf|Orion Corporation|Trímetóprím||1558||1558|3267||1 018694|G04BD0801|Vesicare|filmhtfl|5|mg|90|stk|1|þpakki||G04BD08|01.11.2004||R|1|0|0|0|G|0|ASP|0|0|0|100|XEU|13503|19708|lyfalmen|V0440|16988|1|90|0|90,0000|Vistor hf|Astellas Pharma A/S|Sólífenacín||13503||13503|19708||1 018714|C03DA0401|Inspra|filmhtfl|50|mg|100|stk|1|þpakki||C03DA04|01.08.2005||R|1|0|0|0|0|0|PER|0|0|0|100|DKK|29991|40633|lyfalmen|V0111|14780|1|100|0|100,0000|Icepharma hf|Pfizer ApS|Eplerenón||29991||29991|40633||1 018718|L03AX0302|BCG-medac|duft|||3|hgl|1|pakki|+ leysir|L03AX03|01.01.2016||R|0|0|0|1|0|1|WIL|0|0|0|100|XEU|42744|56763|lyfsjukr|||1|3|0||Williams & Halls efh|medac Gesellschaft|BCG bóluefni||42744||42744|56763||2 018726|J06BA0209|Nanogam|irl|50|mg/ml|20|ml|1|hgl||J06BA02|01.08.2015||R|0|0|0|0|0|1|SPP|0|1|0|100|XEU|7942|12054|lyfsjukr|||1|20|0||Williams & Halls efh|Sanquin Plasma Product|Immúnóglóbúlín, normal, manna, gefin í æð||7942||7942|12054||2 018770|J01EA0108|Idotrim|filmhtfl|160|mg|14|stk|1|glas||J01EA01|01.08.2015||R|1|0|0|0|0|0|COR|0|0|1|100|DKK|313|1550|lyfalmen|||2|14|0|5,6000|Vistor hf|Orion Corporation|Trímetóprím||311||311|1550||1 018779|L03AX1301|Copaxone|stl|20|mg/spr|28|spr|1|pakki|+ leysir|L03AX13|01.08.2004||R|0|0|0|1|0|1|TEP|0|0|0|100|NOK|79963|103838|lyfsjukr|||1|28|0|28,0000|Vistor hf|Teva Pharmaceuticals Limited UK|Glatíramer acetat||79963||79963|103838||1 018975|J05AE0701|Telzir|filmhtfl|700|mg|60|stk|1|glas||J05AE07|01.12.2004||R|1|0|0|1|0|1|VIH|0|0|0|100|GBP|55484|72877|lyfsjukr|||1|60|0|30,0000|Vistor hf|Viiv Healthcare UK Ltd|Fosamprenavír||55484||55484|72877||1 018980|QN01BB5202|Lidokel Adrenalin vet. Kela|stl|20|mg/ml|100|ml|1|hgl|20mg/ml+36mcg/ml|QN01BB52|01.02.2004||R|0|0|0|0|0|0|KEL|1|0|0|100|NOK|942|1851|vetalmen|||0|100|0||Icepharma hf|Kela Laboratoria NV|||942||942|1851||2 018995|N02AB0301|Durogesic|forðapl|75|mcg/klst|5|stk|1|þpakki||N02AB03|01.01.1996||R|0|0|1|0|G|0|JAS|0|0|0|100|SEK|5288|8401|lyfalmen|V0221|7019|1|5|0|22,5000|Vistor hf|Janssen-Cilag AB|Fentanýl||5288||5288|8401||1 019066|V08AB0201|Omnipaque|stl|140|mg J/ml|50|ml|10|plastf||V08AB02|01.04.2011||R|0|0|0|0|0|1|GEH|0|0|0|100|NOK|5693|8958|lyfsjukr|||1|500|0||Icepharma hf|GE Healthcare AS|Jóhexól||5693||5693|8958||2 019094|N02AB0301|Durogesic|forðapl|50|mcg/klst|5|stk|1|þpakki||N02AB03|01.01.1996||R|0|0|1|0|G|0|JAS|0|0|0|100|SEK|3828|6391|lyfalmen|V0220|5485|1|5|0|15,0000|Vistor hf|Janssen-Cilag AB|Fentanýl||3828||3828|6391||1 019098|J06BA0209|Nanogam|irl|50|mg/ml|400|ml|1|hgl||J06BA02|01.08.2015||R|0|0|0|0|0|1|SPP|0|1|0|100|XEU|158836|203128|lyfsjukr|||1|400|0||Williams & Halls efh|Sanquin Plasma Product|Immúnóglóbúlín, normal, manna, gefin í æð||158836||158836|203128||2 019099|V08AB0201|Omnipaque|stl|300|mg J/ml|50|ml|10|plastf||V08AB02|01.06.2004||R|0|0|0|0|0|1|GEH|0|0|0|100|NOK|17307|24944|lyfsjukr|||1|500|0||Icepharma hf|GE Healthcare AS|Jóhexól||17307||17307|24944||2 019108|N02AB0301|Durogesic|forðapl|25|mcg/klst|5|stk|1|þpakki||N02AB03|01.01.1996||R|0|0|1|0|G|0|JAS|0|0|0|100|SEK|2107|4022|lyfalmen|V0219|3296|1|5|0|7,5000|Vistor hf|Janssen-Cilag AB|Fentanýl||2107||2107|4022||1 019112|V08AB0201|Omnipaque|stl|350|mg J/ml|50|ml|10|plastf||V08AB02|01.06.2004||R|0|0|0|0|0|1|GEH|0|0|0|100|NOK|20699|28881|lyfsjukr|||1|500|0||Icepharma hf|GE Healthcare AS|Jóhexól||20699||20699|28881||2 019121|V08AB0901|Visipaque|stl|270|mg J/ml|50|ml|10|plastf|lausn|V08AB09|01.06.2004||R|0|0|0|0|0|1|GEH|0|0|0|100|NOK|18612|26740|lyfsjukr|||1|500|0||Icepharma hf|GE Healthcare AS|Jódixanól||18612||18612|26740||2 019132|V08AB0901|Visipaque|stl|320|mg J/ml|50|ml|10|plastf|lausn|V08AB09|01.06.2004||R|0|0|0|0|0|1|GEH|0|0|0|100|NOK|25047|34380|lyfsjukr|||1|500|0||Icepharma hf|GE Healthcare AS|Jódixanól||25047||25047|34380||2 019150|J06BA0209|Nanogam|irl|50|mg/ml|200|ml|1|hgl||J06BA02|01.08.2015||R|0|0|0|0|0|1|SPP|0|1|0|100|XEU|79418|103149|lyfsjukr|||1|200|0||Williams & Halls efh|Sanquin Plasma Product|Immúnóglóbúlín, normal, manna, gefin í æð||79418||79418|103149||2 019167|N02AB0301|Durogesic|forðapl|100|mcg/klst|5|stk|1|þpakki||N02AB03|01.01.1996||R|0|0|1|0|G|0|JAS|0|0|0|100|SEK|6500|10069|lyfalmen|V0223|7612|1|5|0|30,0000|Vistor hf|Janssen-Cilag AB|Fentanýl||6500||6500|10069||1 019175|C09CA0601|Atacand|töflur|32|mg|98|stk|1|þpakki||C09CA06|01.02.2010||R|1|0|0|0|0|0|AZD|0|0|0|100|SEK|10119|15050|lyfalmen|||1|98|0|392,0000|Vistor hf|AstraZeneca A/S DK|Candesartan||10119||10119|15050||1 019214|J06BA0209|Nanogam|irl|50|mg/ml|100|ml|1|hgl||J06BA02|01.08.2015||R|0|0|0|0|0|1|SPP|0|1|0|100|XEU|39709|52925|lyfsjukr|||1|100|0||Williams & Halls efh|Sanquin Plasma Product|Immúnóglóbúlín, normal, manna, gefin í æð||39709||39709|52925||2 019221|J06BA0209|Nanogam|irl|50|mg/ml|50|ml|1|hgl||J06BA02|01.08.2015||R|0|0|0|0|0|1|SPP|0|1|0|100|XEU|19855|28451|lyfsjukr|||1|50|0||Williams & Halls efh|Sanquin Plasma Product|Immúnóglóbúlín, normal, manna, gefin í æð||19855||19855|28451||2 019295|B01AE0601|Angiox|sts/irs|250|mg|10|hgl|1|pakki|þykkni, lausn|B01AE06|01.05.2005||R|0|1|0|1|0|1|THE|0|0|0|100|XEU|658786|824925|lyfsjukr|||1|10|0|10,0000|The Medicines Company UK Ltd.|The Medicines Company UK Ltd.|Bívalirúdín||658786||658786|824925||1 019308|QG03XB9001|Alizin, vet|stl|30|mg/ml|10|ml|1|hgl|fyrir hunda (tíkur)|QG03XB90|01.05.2012||R|0|0|0|0|0|0|VIR|1|0|0|100|XEU|3732|7251|vetalmen|||0|10|0||Vistor hf|Virbac S.A|Aglepristonum||3732||3732|7251||1 019339|N07BA0110|Nicotinell Lakrids|tyggigúm|2|mg|96|stk|1|þpakki||N07BA01|01.12.2006||L|0|0|0|0|0|0|SDF|0|0|1|100|IKR|||lyflausa|||0|96|0|6,4000|Artasan ehf|GlaxoSmithKline Consumer Healthcare A/S|Nikótín|||||||1 019372|C03CA0110|Impugan|töflur|20|mg|100|stk|1|glas||C03CA01|01.02.2014||R|1|0|0|0|G|0|AGT|0|0|0|100|SEK|363|1575|lyfalmen|V0633|1575|2|100|0|50,0000|Actavis Group hf|Actavis Group hf|Fúrósemíð||329||329|1575||1 019403|QJ51CE0901|Carepen vet.|spenalyf|600|mg|10|g|100|dælur||QJ51CE09|01.04.2010||R|0|0|0|0|0|0|CAR|0|0|0|100|DKK|28956|55106|vetalmen|||0|1000|0||Vistor hf|Vetcare Ltd.|Benzylpenicillínprokaín||28956||28956|55106||1 019421|N06AX2102|Yentreve|hylki|20|mg|56|stk|1|þpakki|sýruþ.hylki, hörð|N06AX21|01.10.2004||R|0|0|0|0|0|0|ELD|0|0|0|100|XEU|6059|9462|lyfalmen|||1|56|0|18,6700|Icepharma hf|Eli Lilly Nederland B.V.|Duloxetín||6059||6059|9462||2 019445|L01XC0701|Avastin|irþ|25|mg/ml|4|ml|1|hgl|lausn|L01XC07|01.05.2005||R|0|0|0|1|0|1|RRL|0|1|0|100|DKK|41745|55500|lyfsjukr|||1|4|0||Icepharma hf|Roche Registration Limited|Bevacizúmab||41745||41745|55500||2 019469|N06AX2102|Yentreve|hylki|40|mg|56|stk|1|þpakki|sýruþ.hylki, hörð|N06AX21|01.10.2004||R|0|0|0|0|0|0|ELD|0|0|0|100|XEU|6059|9462|lyfalmen|||1|56|0|37,3300|Icepharma hf|Eli Lilly Nederland B.V.|Duloxetín||6059||6059|9462||2 019621|C09AA0504|Ramipril ratiopharm|töflur|5|mg|100|stk|1|þpakki||C09AA05|01.06.2014||R|1|0|0|0|G|0|RGM|0|0|0|100|IKR|1099|1535|lyfalmen|V0496|1535|2|100|0|200,0000|Medical ehf|ratiopharm GmbH|Ramipríl||300||300|1535||2 019659|N07BA0107|Nicotinell Mint|tyggigúm|4|mg|96|stk|1|þpakki||N07BA01|01.12.2006||L|0|0|0|0|0|0|SDF|0|0|1|100|IKR|||lyflausa|||0|96|0|12,8000|Artasan ehf|GlaxoSmithKline Consumer Healthcare A/S|Nikótín|||||||1 019669|C09AA0504|Ramipril ratiopharm|töflur|2,5|mg|100|stk|1|þpakki||C09AA05|01.06.2014||R|1|0|0|0|G|0|RGM|0|0|0|100|IKR|980|1535|lyfalmen|V0648|1535|2|100|0|100,0000|Medical ehf|ratiopharm GmbH|Ramipríl||300||300|1535||2 019670|N07BA0109|Nicotinell Fruit|tyggigúm|4|mg|96|stk|1|þpakki||N07BA01|01.12.2006||L|0|0|0|0|0|0|SDF|0|0|1|100|IKR|||lyflausa|||0|96|0|12,8000|Artasan ehf|GlaxoSmithKline Consumer Healthcare A/S|Nikótín|||||||1 019672|N07BA0110|Nicotinell Lakrids|tyggigúm|4|mg|96|stk|1|þpakki||N07BA01|01.12.2006||L|0|0|0|0|0|0|SDF|0|0|1|100|IKR|||lyflausa|||0|96|0|12,8000|Artasan ehf|GlaxoSmithKline Consumer Healthcare A/S|Nikótín|||||||1 019682|C09AA0504|Ramipril ratiopharm|töflur|10|mg|100|stk|1|þpakki||C09AA05|01.06.2014||R|1|0|0|0|G|0|RGM|0|0|0|100|IKR|1543|2223|lyfalmen|V0649|2223|2|100|0|400,0000|Medical ehf|ratiopharm GmbH|Ramipríl||800||800|2223||2 019711|L01BC0501|Gemzar|irs|200|mg|1|hgl|1|pakki||L01BC05|01.03.1999||R|0|0|0|1|0|1|ELI|0|0|0|100|XEU|3296|5659|lyfsjukr|||1|1|0||Icepharma hf|Eli Lilly Danmark A/S|Gemcitabín||3296||3296|5659||2 019713|N07BA0114|Nicotinell Classic|tyggigúm|2|mg|204|stk|1|þpakki||N07BA01|01.01.2005||L|0|0|0|0|0|0|SDF|0|0|1|100|IKR|||lyflausa|||0|204|0|13,6000|Artasan ehf|GlaxoSmithKline Consumer Healthcare A/S|Nikótín|||||||1 019760|L01BC0501|Gemzar|irs|1|g|1|hgl|1|pakki||L01BC05|01.03.1999||R|0|0|0|1|0|1|ELI|0|0|0|100|XEU|14478|21050|lyfsjukr|||1|1|0||Icepharma hf|Eli Lilly Danmark A/S|Gemcitabín||14478||14478|21050||2 019781|L01XC0701|Avastin|irþ|25|mg/ml|16|ml|1|hgl|lausn|L01XC07|01.05.2005||R|0|0|0|1|0|1|RRL|0|1|0|100|DKK|159672|204167|lyfsjukr|||1|16|0||Icepharma hf|Roche Registration Limited|Bevacizúmab||159672||159672|204167||2 019782|N07BA0107|Nicotinell Mint|tyggigúm|2|mg|96|stk|1|þpakki||N07BA01|01.12.2006||L|0|0|0|0|0|0|SDF|0|0|1|100|IKR|||lyflausa|||0|96|0|6,4000|Artasan ehf|GlaxoSmithKline Consumer Healthcare A/S|Nikótín|||||||1 019786|J01CA0411|Amoxicillin Mylan|hylki|500|mg|20|stk|1|glas||J01CA04|01.04.1993||R|0|0|0|0|0|0|MYL|0|0|1|100|SEK|945|2149|lyfalmen|V0159|1948|2|20|0|10,0000|Icepharma hf|Mylan AB|Amoxicillín||746||746|2149||2 019793|N07BA0109|Nicotinell Fruit|tyggigúm|2|mg|96|stk|1|pakki||N07BA01|01.12.2006||L|0|0|0|0|0|0|SDF|0|0|1|100|IKR|||lyflausa|||0|96|0|6,4000|Artasan ehf|GlaxoSmithKline Consumer Healthcare A/S|Nikótín|||||||1 019797|L01BA0401|Alimta|irþ|500|mg/hgl|1|hgl|1|pakki||L01BA04|01.03.2005||R|0|0|0|1|0|1|ELD|0|1|0|100|XEU|150705|193015|lyfsjukr|||1|1|0||Icepharma hf|Eli Lilly Nederland B.V.|Pemetrexed||150705||150705|193015||2 019811|N06BA0901|Strattera|hylki|10|mg|28|stk|1|þpakki|hart|N06BA09|01.08.2006||R|1|0|0|1|0|0|ELI|0|0|0|100|XEU|11436|16863|lyfalmen|||1|28|0|3,5000|Icepharma hf|Eli Lilly Danmark A/S|Atomoxetín||11436||11436|16863||2 019833|N06BA0901|Strattera|hylki|18|mg|28|stk|1|þpakki|hart|N06BA09|01.08.2006||R|1|0|0|1|0|0|ELI|0|0|0|100|XEU|11436|16863|lyfalmen|||1|28|0|6,3000|Icepharma hf|Eli Lilly Danmark A/S|Atomoxetín||11436||11436|16863||2 019857|N06BA0901|Strattera|hylki|25|mg|28|stk|1|þpakki|hart|N06BA09|01.08.2006||R|1|0|0|1|0|0|ELI|0|0|0|100|XEU|11436|16863|lyfalmen|||1|28|0|8,7500|Icepharma hf|Eli Lilly Danmark A/S|Atomoxetín||11436||11436|16863||2 019882|N06BA0901|Strattera|hylki|40|mg|28|stk|1|þpakki|hart|N06BA09|01.08.2006||R|1|0|0|1|0|0|ELI|0|0|0|100|XEU|11436|16863|lyfalmen|||1|28|0|14,0000|Icepharma hf|Eli Lilly Danmark A/S|Atomoxetín||11436||11436|16863||2 019904|N06BA0901|Strattera|hylki|60|mg|28|stk|1|þpakki|hart|N06BA09|01.08.2006||R|1|0|0|1|0|0|ELI|0|0|0|100|XEU|11436|16863|lyfalmen|||1|28|0|21,0000|Icepharma hf|Eli Lilly Danmark A/S|Atomoxetín||11436||11436|16863||2 019916|V03AF0801|Kepivance|sts|6,25|mg/hgl|6|hgl|1|pakki|lausn|V03AF08|01.07.2006|30.04.2016|R|0|0|0|1|0|1|BIO|0|0|0|100|DKK|700004|876189|lyfsjukr|||1|6|0|8,9300|Swedish Orphan Biovitrum AB|Swedish Orphan Biovitrum AB|Palifermín||700004||700004|876189||3 019931|N04BC0403|Adartrel|filmhtfl|0,25|mg|12|stk|1|þpakki||N04BC04|01.12.2006||R|1|0|0|0|G|0|GPH|0|0|0|100|GBP|323|1567|lyfalmen|||1|12|0|0,5000|Vistor hf|GlaxoSmithKline Pharma A/S|Rópíníról||||323|1567||1 019938|J05AR0201|Kivexa|filmhtfl|900|mg|30|stk|1|þpakki|600+300 mg|J05AR02|01.05.2004||R|0|1|0|1|0|1|GGL|0|0|0|100|GBP|60564|79302|lyfsjukr|||1|30|0|30,0000|GlaxoSmithKline ehf|Glaxo Group Limited|Lamívúdín og abacavír||60564||60564|79302||1 019968|J01CA0411|Amoxicillin Mylan|hylki|500|mg|30|stk|1|glas||J01CA04|01.04.1995||R|0|0|0|0|0|0|MYL|0|0|1|100|SEK|1173|2559|lyfalmen|V0160|2361|2|30|0|15,0000|Icepharma hf|Mylan AB|Amoxicillín||1044||1044|2559||2 020016|B03AA0704|Duroferon|forðatfl|100|mg|100|stk|1|glas||B03AA07|01.03.1979||L|1|0|0|0|0|0|AHN|0|0|1|100|IKR|||lyflausa|||0|100|0|50,0000|Aco Hud Nordic AB|Aco Hud Nordic AB|Ferrósúlfat|||||||1 020048|M02AA1502|Voltaren|hlaup|11,6|mg/g|100|g|1|túpa||M02AA15|01.03.2009||L|0|0|0|0|0|0|NHE|0|0|1|100|IKR|||lyflausa|||0|100|0||Artasan ehf|Novartis Healthcare A/S-A|Díklófenak|||||||1 020156|C08DB0109|Dilmin|töflur|60|mg|100|stk|1|þpakki||C08DB01|01.09.2013||R|0|0|0|0|G|0|RGM|0|0|0|100|XEU|2482|4538|lyfalmen|||2|100|0|25,0000|Medical ehf|ratiopharm GmbH|Diltíazem||2482||2482|4538||2 020227|J07CA0204|Boostrix Polio|stl|||0,5|ml|1|áf.spr|dreifa|J07CA02|01.09.2014||R|0|0|0|0|0|0|GPH|0|0|0|100|GBP|2451|4496|lyfalmen|||1|0,5|0||Vistor hf|GlaxoSmithKline Pharma A/S|Barnaveiki, kíghósti, mænusótt, stífkrampi||||2451|4496||1 020244|J07CA0204|Boostrix Polio|stl|||0,5|ml|10|áf.spr|dreifa|J07CA02|01.09.2007||R|0|0|0|0|0|0|GPH|0|0|0|100|GBP|24514|33706|lyfalmen|||1|5|0||Vistor hf|GlaxoSmithKline Pharma A/S|barnaveiki, kíghósti, mænusótt, stífkrampi||24514||24514|33706||1 020276|A06AB0203|Dulcolax (Lyfjaver)|eþ-stíll|10|mg|50|stk|1|þpakki||A06AB02|01.07.2005||R|0|0|0|0|0|0|LVR|0|0|0|100|NOK|2004|3881|lyfalmen|||3|50|0|50,0000|Lyfjaver ehf|Lyfjaver ehf|Bisakódýl||2004||2004|3881||3 020282|L01XX2301|Lysodren|töflur|500|mg|100|stk|1|glas||L01XX23|01.04.2015||R|0|0|0|1|0|1|LHR|0|0|0|100|XEU|86229|111763|lyfsjukr|||1|100|0||Laboratoire HRA Pharma|Laboratoire HRA Pharma|Mitotanum||86229||86229|111763||0 020292|M02AA1502|Voltaren|hlaup|11,6|mg/g|50|g|1|túpa||M02AA15|01.06.2010||L|0|0|0|0|0|0|NHE|0|0|1|100|IKR|||lyflausa|||0|50|0||Artasan ehf|Novartis Healthcare A/S-A|Díklófenak|||||||1 020338|G04CA0203|Omnic Ocas|forðatfl|0,4|mg|90|stk|1|þpakki||G04CA02|01.04.2006|31.03.2016|R|1|0|0|0|G|0|ASP|0|0|0|100|XEU|6103|9522|lyfalmen|||1|90|0|90,0000|Vistor hf|Astellas Pharma A/S|Tamsúlósín||6103||6103|9522||1 020355|L02AE0203|Eligard|sts|22,5|mg/sk|2|spr|1|sett|+ leysir|L02AE02|01.07.2006||R|0|0|0|1|G|0|ASP|0|0|0|100|XEU|44991|59605|lyfalmen|||1|2|0|155,7500|Vistor hf|Astellas Pharma A/S|Leuprórelín||44991||44991|59605||1 020364|N04BC0403|Adartrel|filmhtfl|0,5|mg|84|stk|1|þpakki||N04BC04|01.06.2006||R|1|0|0|0|G|0|GPH|0|0|0|100|GBP|3458|4259|lyfalmen|||1|84|0|7,0000|Vistor hf|GlaxoSmithKline Pharma A/S|Rópíníról||2279||2279|4259||1 020417|N04BC0403|Adartrel|filmhtfl|2|mg|84|stk|1|þpakki||N04BC04|01.12.2006||R|1|0|0|0|G|0|GPH|0|0|0|100|GBP|6568|4922|lyfalmen|||1|84|0|28,0000|Vistor hf|GlaxoSmithKline Pharma A/S|Rópíníról||2761||2761|4922||1 020427|L02AE0203|Eligard|sts|7,5|mg/sk|2|spr|1|sett|+ leysir|L02AE02|01.07.2006||R|0|0|0|1|G|0|ASP|0|0|0|100|XEU|20917|29157|lyfalmen|||1|2|0|51,9400|Vistor hf|Astellas Pharma A/S|Leuprórelín||20917||20917|29157||1 020444|D07AB0201|Locoid|krem|1|mg/g|30|g|1|túpa||D07AB02|01.07.1985||R|0|0|0|0|G|0|ASP|0|0|1|100|XEU|518|1835|lyfalmen|||1|30|0||Vistor hf|Astellas Pharma A/S|Hýdrókortisón bútýrat||518||518|1835||1 020457|D07AB0201|Locoid|krem|1|mg/g|100|g|1|túpa||D07AB02|01.03.1977||R|0|0|0|0|G|0|ASP|0|0|1|100|XEU|1605|3331|lyfalmen|||1|100|0||Vistor hf|Astellas Pharma A/S|Hýdrókortisón bútýrat||1605||1605|3331||1 020685|C08DB0109|Dilmin|forðatfl|120|mg|100|stk|1|þpakki||C08DB01|01.09.2013||R|0|0|0|0|G|0|RGM|0|0|0|100|XEU|11192|4649|lyfalmen|V0599|4649|2|100|0|50,0000|Medical ehf|ratiopharm GmbH|Diltíazem||2562||2562|4649||2 020711|G03AD0102|Postinor|töflur|1,5|mg|1|stk|1|þpakki||G03AD01|01.01.2007||L|0|0|0|0|0|0|LUM|0|0|0|100|IKR|||lyflausa|||0|1|0|1,0000|Gedeon Ricther Nordics AB|Medimpex UK Limited|Levonorgestrel|||||||1 020770|QP54AA5101|Eqvalan Duo|pasta|||7,74|g|1|sk-dæl||QP54AA51|01.10.2006||R|0|0|0|0|0|0|MES|0|0|0|100|XEU|1969|3394|vetorma|||0|7,74|0||Vistor hf|Merial SAS|Ivermectinum í blöndum||1969||1969|3394||1 020845|N07XX0401|Xyrem|mixtúra|500|mg/ml|180|ml|1|glas|millist., mælispr. + 2 bollar|N07XX04|01.02.2016||R|0|1|1|1|0|0|UCP|0|0|0|100|DKK|53021|69762|lyfalmen|||1|180|0||Vistor hf|UCB Pharma Ltd.|sodium oxybate||||53021|69762||1 020861|QP52AF0203|Nematel Vet.|pasta|439|mg/g|52|g|1|spr||QP52AF02|01.08.2011||R|0|0|0|0|0|0|VEB|0|0|0|100|XEU|2303|3969|vetorma|||0|52|0||Dýraheilsa ehf|Le Vet Beheer B.V.|||2303||2303|3969||2 020924|J01FA1003|Zithromax (Lyf og heilsa)|töflur|500|mg|3|stk|1|þpakki||J01FA10|01.09.2007||R|1|0|0|0|0|0|DAC|0|0|1|100|DKK|1524|3220|lyfalmen|V0174|2654|3|3|0|5,0000|D.A.C. ehf|D.A.C. ehf|Azitrómýcín||1524||1524|3220||2 020992|C09AA0402|Coversyl Novum|filmhtfl|5|mg|30|stk|1|glas||C09AA04|01.08.2011||R|1|0|0|0|0|0|LLS|0|0|0|100|DKK|2591|4688|lyfalmen|||1|30|0|37,5000|Icepharma hf|Les Laboratoires Servier|Perindópríl||2591||2591|4688||2 021053|D10AD0301|Differin|hlaup|0,1|%|60|g|1|túpa||D10AD03|01.12.2007||R|0|0|0|0|0|0|GAN|0|0|0|100|SEK|2108|4024|lyfalmen|||1|60|0||Icepharma hf|Galderma Nordic AB|Adapalen||2108||2108|4024||2 021161|M01AB0513|Vostar-S|filmhtfl|50|mg|30|stk|1|þpakki||M01AB05|01.03.2005||R|1|0|0|0|G|0|ACA|0|0|1|100|IKR|581|1637|lyfalmen|V0188|1516|2|30|0|15,0000|Actavis Group hf|Actavis hf|Díklófenak||374||374|1637||1 021169|S01XA1201|Corneregel|augnhl|50|mg/g|10|g|1|túpa||S01XA12|01.08.2005||R|0|0|0|0|G|0|GEM|0|0|0|100|XEU|1490|3173|lyfalmen|||1|10|0||Actavis Group hf|Gerhard Mann|Dexpantenól||1490||1490|3173||1 021227|M01AB0513|Vostar-S|filmhtfl|50|mg|100|stk|1|þpakki||M01AB05|01.03.2005||R|1|0|0|0|G|0|ACA|0|0|1|100|IKR|1287|2196|lyfalmen|V0189|2123|2|100|0|50,0000|Actavis Group hf|Actavis hf|Díklófenak||780||780|2196||1 021341|R03AK0603|Seretide Diskus (Lyfjaver)|innönddu|550|mcg/sk|60|skammtar|1|pakki|50+500 mcg, discus|R03AK06|01.05.2012||R|0|0|0|0|G|0|LVR|0|0|0|100|GBP|5877|9211|lyfalmen|V0437|9211|3|60|0|30,0000|Lyfjaver ehf|Lyfjaver ehf|Salmeteról og fluticason||5877||5877|9211||3 021345|R03DC0301|Singulair|filmhtfl|10|mg|98|stk|1|þpakki||R03DC03|01.09.1998||R|1|0|0|0|G|0|MSD|0|0|0|100|DKK|15181|22017|lyfalmen|V0490|2274|1|98|0|98,0000|Vistor hf|M.S.D.|Montelúkast||15181||15181|22017||1 021365|R03AK0603|Seretide Diskus (Lyfjaver)|innönddu|300|mcg/sk|60|skammtar|1|pakki|50+250 mcg, discus|R03AK06|01.05.2012||R|0|0|0|0|G|0|LVR|0|0|0|100|GBP|4595|7447|lyfalmen|V0436|7447|3|60|0|30,0000|Lyfjaver ehf|Lyfjaver ehf|Salmeteról og fluticason||4595||4595|7447||3 021428|A06AB0201|Dulcolax|eþ-stíll|10|mg|6|stk|1|pakki||A06AB02|01.01.1995||L|0|0|0|0|0|0|BOI|0|0|0|100|IKR|||lyflausa|||0|6|0|6,0000|Vistor hf|Boehringer Ingelheim|Bisakódýl|||||||1 021494|N01AX1003|Propolipid|stl|10|mg/ml|20|ml|5|hgl|innr.lyf, fleyti|N01AX10|01.07.2005||R|0|0|0|0|0|1|FKA|0|0|0|100|DKK|1400|3049|lyfsjukr|||2|100|0||Vistor hf|Fresenius Kabi AB|Própófól||1400||1400|3049||1 021593|H01BA0201|Minirin|frþ.tfl|60|mcg|30|stk|1|þpakki||H01BA02|01.10.2005||R|0|0|0|0|G|0|FEL|0|0|0|100|DKK|3815|6373|lyfalmen|||1|30|0|4,5000|Vistor hf|Ferring Lægemidler A/S|Desmópressín||3815||3815|6373||1 021604|H01BA0201|Minirin|frþ.tfl|60|mcg|100|stk|1|þpakki||H01BA02|01.10.2005||R|0|0|0|0|G|0|FEL|0|0|0|100|DKK|11842|17422|lyfalmen|||1|100|0|15,0000|Vistor hf|Ferring Lægemidler A/S|Desmópressín||11842||11842|17422||1 021613|C10AA0701|Crestor|filmhtfl|5|mg|98|stk|1|þpakki||C10AA07|01.01.2006||R|1|0|0|0|0|0|AZD|0|0|0|100|SEK|12273|18015|lyfalmen|||1|98|0|49,0000|Vistor hf|AstraZeneca A/S DK|Rósuvastatín||12273||12273|18015||1 021614|H01BA0201|Minirin|frþ.tfl|120|mcg|30|stk|1|þpakki||H01BA02|01.10.2005||R|0|0|0|0|G|0|FEL|0|0|0|100|DKK|6295|9787|lyfalmen|||1|30|0|9,0000|Vistor hf|Ferring Lægemidler A/S|Desmópressín||6295||6295|9787||1 021625|A07EC0203|Pentasa Sachets|forðakyr|2|g|60|pokar|1|pakki||A07EC02|01.05.2011||R|0|0|0|0|G|0|FER|0|0|0|100|DKK|13375|19532|lyfalmen|||1|60|0|80,0000|Vistor hf|Ferring|Mesalazín (5-amínósalicýlsýra)||13375||13375|19532||1 021636|N01AX1003|Propolipid|stl|10|mg/ml|100|ml|10|hgl|innr.lyf, fleyti|N01AX10|01.07.2005||R|0|0|0|0|0|1|FKA|0|0|0|100|DKK|14002|20395|lyfsjukr|||2|1000|0||Vistor hf|Fresenius Kabi AB|Própófól||14002||14002|20395||1 021641|H01BA0201|Minirin|frþ.tfl|120|mcg|100|stk|1|þpakki||H01BA02|01.10.2005||R|0|0|0|0|G|0|FEL|0|0|0|100|DKK|19966|28603|lyfalmen|||1|100|0|30,0000|Vistor hf|Ferring Lægemidler A/S|Desmópressín||19966||19966|28603||1 021647|N01AX1003|Propolipid|stl|20|mg/ml|50|ml|10|hgl|innr.lyf, fleyti|N01AX10|01.07.2005||R|0|0|0|0|0|1|FKA|0|0|0|100|DKK|16102|23285|lyfsjukr|||2|500|0||Vistor hf|Fresenius Kabi AB|Própófól||16102||16102|23285||1 021659|V01AA0304|Alutard SQ, derm. pter.|stl|||5|ml|4|hgl|byrjunarsett|V01AA03|01.07.1999||R|0|0|0|1|G|0|ALK|0|0|0|100|DKK|21552|29960|lyfalmen|||1|20|0||Vistor hf|ALK-Abello A/S|rykmaurar||21552||21552|29960||1 021676|N01AX1003|Propolipid|stl|10|mg/ml|50|ml|10|hgl|innr.lyf, fleyti|N01AX10|01.07.2005||R|0|0|0|0|0|1|FKA|0|0|0|100|DKK|8051|12204|lyfsjukr|||2|500|0||Vistor hf|Fresenius Kabi AB|Própófól||8051||8051|12204||1 021677|B02AA0202|Tranexamsyre "Pfizer"|stl|100|mg/ml|5|ml|10|lykjur||B02AA02|01.11.2005||R|0|0|0|0|0|1|PER|0|0|0|100|DKK|4063|6715|lyfsjukr|||1|50|0|2,5000|Icepharma hf|Pfizer ApS|Tranexamsýra||4063||4063|6715||1 021709|V01AA0304|Alutard SQ, derm. pter.|stl|0,1|mi.SQ/ml|5|ml|1|hgl|framhaldssett|V01AA03|01.07.1999||R|0|0|0|1|G|0|ALK|0|0|0|100|DKK|17255|24872|lyfalmen|||1|5|0||Vistor hf|ALK-Abello A/S|rykmaurar||17255||17255|24872||1 021721|N06AX2101|Cymbalta|sh-hylki|30|mg|28|stk|1|þpakki||N06AX21|01.04.2005||R|0|0|0|0|0|0|ELD|0|0|0|100|XEU|3080|5362|lyfalmen|V0692|2778|1|28|0|14,0000|Icepharma hf|Eli Lilly Nederland B.V.|Duloxetín||3080||3080|5362||2 021967|N06AX2101|Cymbalta|sh-hylki|60|mg|28|stk|1|þpakki||N06AX21|01.04.2005||R|0|0|0|0|0|0|ELD|0|0|0|100|XEU|5202|8282|lyfalmen|V0693|4088|1|28|0|28,0000|Icepharma hf|Eli Lilly Nederland B.V.|Duloxetín||5202||5202|8282||2 021975|N06AX2101|Cymbalta|sh-hylki|60|mg|98|stk|1|þpakki||N06AX21|01.04.2005||R|0|0|0|0|0|0|ELD|0|0|0|100|XEU|16853|24319|lyfalmen|V0694|11504|1|98|0|98,0000|Icepharma hf|Eli Lilly Nederland B.V.|Duloxetín||16853||16853|24319||2 021999|L01XX3501|Xagrid|hylki|0,5|mg|100|stk|1|glas|hart|L01XX35|01.10.2012||R|0|0|0|1|0|1|SHI|0|0|0|100|DKK|68094|88826|lyfsjukr|||1|100|0||Lyfjaver ehf|Shire Pharmaceuticals Contracts Ltd.|Anagrelidum||68094||68094|88826||3 022045|L01XE0301|Tarceva|filmhtfl|25|mg|30|stk|1|þpakki||L01XE03|01.01.2006||R|0|0|0|1|0|1|RRL|0|1|0|100|DKK|73330|95449|lyfsjukr|||1|30|0||Icepharma hf|Roche Registration Limited|Erlótiníb||73330||73330|95449||2 022050|J01CF0202|Cloxacillin Villerton|sts/irs|1|g|10|hgl|1|pakki||J01CF02|01.03.2016||R|0|0|0|0|0|1|VIN|0|0|0|100|XEU|2386|4406|lyfsjukr|||1|10|0|5,0000|Icepharma hf|Villerton Invest SA|Kloxacillín||2386||2386|4406||2 022112|B05AA0112|Flexbumin|irl|200|g/líter|100|ml|12|pokar|lausn|B05AA01|01.06.2010||R|0|0|0|0|0|1|BAM|0|0|0|100|SEK|104948|136106|lyfsjukr|||1|1200|0||Icepharma hf|Baxter Medical AB|Albúmín||104948||104948|136106||2 022128|A01AA0117|Fludent Banan|munnstfl|0,25|mg|200|stk|1|plglas||A01AA01|01.01.2008|31.03.2016|L|0|0|0|0|0|0|AGT|0|0|1|100|IKR|||lyflausa|||0|200|0|45,4500|Actavis Group hf|Actavis Group hf|Natríumflúoríð|||||||1 022165|A10AB0606|Apidra [Clikstar]|stl|100|ein/ml|3|ml|5|lykjur|Clikstar/JuniorStar pennar|A10AB06|01.07.2010||R|0|0|0|0|G|0|SAA|0|0|0|100|NOK|3910|6504|lyfalmen|||1|15|0|37,5000|Vistor hf|Sanofi - Aventis|Insúlín glúlisín||3910||3910|6504||1 022191|L01XE0301|Tarceva|filmhtfl|100|mg|30|stk|1|þpakki||L01XE03|01.01.2006||R|0|0|0|1|0|1|RRL|0|1|0|100|DKK|256169|324183|lyfsjukr|||1|30|0||Icepharma hf|Roche Registration Limited|Erlótiníb||256169||256169|324183||2 022205|L01XE0301|Tarceva|filmhtfl|150|mg|30|stk|1|þpakki||L01XE03|01.01.2006||R|0|0|0|1|0|1|RRL|0|1|0|100|DKK|269432|340678|lyfsjukr|||1|30|0||Icepharma hf|Roche Registration Limited|Erlótiníb||269432||269432|340678||2 022218|QP52AA5102|Drontal Comp.vet.|töflur|||24|stk|1|þpakki||QP52AA51|01.01.2006||R|0|0|0|0|0|0|BAN|0|0|0|100|DKK|11202|19308|vetorma|||0|24|0||Icepharma hf|Bayer Animal Health GmbH|||11202||11202|19308||2 022250|M03AX0103|Vistabel|sts|50|ein/hgl|1|hgl|1|pakki|4 Allerg.ein/0,1ml|M03AX01|01.02.2008||R|0|0|0|1|0|0|IRE|0|0|0|100|XEU|14297|20801|lyfalmen|||1|1|0||Actavis ehf|Allergan Pharmaceuticals Ireland|Clostridium botulinum toxín-A||14297||14297|20801||1 022261|QP52AA5107|Profender fyrir kisur 5-8 kg|bl.lausn|1,12|ml/sk|1,12|ml|2|skammt||QP52AA51|01.09.2006||R|0|0|0|0|0|0|BAN|0|0|0|100|DKK|2011|3466|vetorma|||0|2,24|0||Icepharma hf|Bayer Animal Health GmbH|||2011||2011|3466||2 022269|C08CA0101|Norvasc|töflur|5|mg|30|stk|1|þpakki||C08CA01|01.01.1992||R|1|0|0|0|G|0|PER|0|0|0|100|DKK|1149|2704|lyfalmen|||1|30|0|30,0000|Icepharma hf|Pfizer ApS|Amlódipín||1149||1149|2704||1 022281|QP52AA5102|Drontal Comp.vet.|töflur|||2|stk|1|þpakki||QP52AA51|01.10.1991||R|0|0|0|0|0|0|BAN|0|0|0|100|DKK|1270|2189|vetorma|||0|2|0||Icepharma hf|Bayer Animal Health GmbH|||1270||1270|2189||2 022293|C08CA0101|Norvasc|töflur|5|mg|100|stk|1|þpakki||C08CA01|01.01.1992||R|1|0|0|0|G|0|PER|0|0|0|100|DKK|3367|2671|lyfalmen|V0056|1995|1|100|0|100,0000|Icepharma hf|Pfizer ApS|Amlódipín||1125||1125|2671||1 022368|C08CA0101|Norvasc|töflur|10|mg|100|stk|1|þpakki||C08CA01|01.01.1992||R|1|0|0|0|G|0|PER|0|0|0|100|DKK|5970|3572|lyfalmen|V0057|2038|1|100|0|200,0000|Icepharma hf|Pfizer ApS|Amlódipín||1780||1780|3572||1 022407|QP52AA5106|Profender fyrir kisur 2,5-5 kg|bl.lausn|0,7|ml/sk|0,7|ml|2|skammt||QP52AA51|01.09.2006||R|0|0|0|0|0|0|BAN|0|0|0|100|DKK|1904|3282|vetorma|||0|1,4|0||Icepharma hf|Bayer Animal Health GmbH|||1904||1904|3282||2 022440|D07AB0203|Locoid Lipid|krem|1|mg/g|30|g|1|túpa|feitt|D07AB02|01.07.1986||R|0|0|0|0|G|0|ASP|0|0|1|100|XEU|540|1865|lyfalmen|||1|30|0||Vistor hf|Astellas Pharma A/S|Hýdrókortisón bútýrat||540||540|1865||1 022451|D07AB0203|Locoid Lipid|krem|1|mg/g|100|g|1|túpa|feitt|D07AB02|01.04.1987||R|0|0|0|0|G|0|ASP|0|0|1|100|XEU|1624|3357|lyfalmen|||1|100|0||Vistor hf|Astellas Pharma A/S|Hýdrókortisón bútýrat||1624||1624|3357||1 022465|QP52AA5105|Profender fyrir kisur 0,5-2,5 kg|bl.lausn|0,35|ml/sk|0,35|ml|2|skammt||QP52AA51|01.09.2006||R|0|0|0|0|0|0|BAN|0|0|0|100|DKK|1233|2125|vetorma|||0|0,7|0||Icepharma hf|Bayer Animal Health GmbH|||1233||1233|2125||2 022532|C09DA0303|Diovan Comp 160/12,5 mg|filmhtfl|172,5|mg|28|stk|1|þpakki||C09DA03|01.11.2003||R|1|0|0|0|0|0|HES|0|0|0|100|DKK|4148|6832|lyfalmen|||1|28|0|28,0000|Vistor hf|Novartis Healthcare A/S|Valsartan og þvagræsilyf||4148||4148|6832||1 022537|N06AB0504|Paxetin|töflur|20|mg|100|stk|1|glas||N06AB05|01.01.2005||R|1|0|0|0|G|0|ACA|0|0|0|100|IKR|2129|3148|lyfalmen|V0321|3148|2|100|0|100,0000|Actavis Group hf|Actavis hf|Paroxetín||1472||1472|3148||1 022577|N06AB0504|Paxetin|töflur|20|mg|60|stk|1|þpakki||N06AB05|01.08.2013||R|1|0|0|0|G|0|ACA|0|0|0|100|IKR|1554|2460|lyfalmen|V0321|1889|2|60|0|60,0000|Actavis Group hf|Actavis hf|Paroxetín||972||972|2460||1 022757|S01XA2019|Oftagel|augnhl|2,5|mg/g|0,5|g|60|sk-hyl||S01XA20|01.07.2012||L|0|0|0|0|G|0|SAO|0|0|0|100|XEU|||lyfalmen|||0|30|0||Icepharma hf|Santen Oy|Gervitár og aðrar óvirkar samsetningar|||||4505||2 022783|B01AX0501|Arixtra|stl|10|mg/spr|0,8|ml|10|áf.spr||B01AX05|01.10.2011||R|0|0|0|0|G|0|APP|0|0|0|100|GBP|24119|33206|lyfalmen|||1|8|0|40,0000|Artasan ehf|Aspen Pharma Trading Limited|Fondaparinux||24119||24119|33206||1 022815|B01AX0501|Arixtra|stl|5|mg/spr|0,4|ml|10|áf.spr||B01AX05|01.10.2011||R|0|0|0|0|G|0|APP|0|0|0|100|GBP|12059|17720|lyfalmen|||1|4|0|20,0000|Artasan ehf|Aspen Pharma Trading Limited|Fondaparinux||12059||12059|17720||1 022831|B01AX0501|Arixtra|stl|7,5|mg/spr|0,6|ml|10|áf.spr||B01AX05|01.04.2012||R|0|0|0|0|G|0|APP|0|0|0|100|GBP|18108|26046|lyfalmen|V0473|26046|1|6|0|30,0000|Artasan ehf|Aspen Pharma Trading Limited|Fondaparinux||18108||18108|26046||1 022845|S01XA2019|Oftagel|augnhl|2,5|mg/g|0,5|g|30|sk-hyl||S01XA20|01.05.2007||L|0|0|0|0|G|0|SAO|0|0|0|100|XEU|||lyfalmen|||0|15|0||Icepharma hf|Santen Oy|Gervitár og aðrar óvirkar samsetningar|||||2814||2 022904|D10BA0102|Decutan|hylki|10|mg|30|stk|1|þpakki||D10BA01|01.02.2006||R|0|1|0|1|G|0|ACA|0|0|0|30|IKR|1407|3059|lyfalmen|||2|30|0|10,0000|Actavis Group hf|Actavis hf|Ísótretínóín||1407||1407|3059||1 022915|D10BA0102|Decutan|hylki|20|mg|30|stk|1|þpakki||D10BA01|01.02.2006||R|0|1|0|1|G|0|ACA|0|0|0|30|IKR|2450|3448|lyfalmen|V0125|2144|2|30|0|20,0000|Actavis Group hf|Actavis hf|Ísótretínóín||1690||1690|3448||1 023063|J05AR0301|Truvada|filmhtfl|445|mg|30|stk|1|glas|200+245 mg|J05AR03|01.03.2006||R|0|0|0|1|0|1|GSL|0|0|0|100|DKK|70939|92424|lyfsjukr|||1|30|0|30,0000|Gilead Nordic|Gilead Science International Ltd|Tenófóvír dísóproxíl og emtrícítabín||70939||70939|92424||2 023066|V03AE0301|Fosrenol|tuggutfl|500|mg|90|stk|1|pakki||V03AE03|01.03.2006||R|1|0|0|1|0|0|SHI|0|0|0|100|DKK|22809|31550|lyfalmen|||1|90|0|20,0000|Lyfjaver ehf|Shire Pharmaceuticals Contracts Ltd.|Lanthanum karbónat||22809||22809|31550||3 023080|V03AE0301|Fosrenol|tuggutfl|750|mg|90|stk|1|pakki||V03AE03|01.03.2006||R|1|0|0|1|0|0|SHI|0|0|0|100|DKK|35611|47742|lyfalmen|||1|90|0|30,0000|Lyfjaver ehf|Shire Pharmaceuticals Contracts Ltd.|Lanthanum karbónat||35611||35611|47742||3 023114|D10BA0106|Isotretinoin ratiopharm|hylki|20|mg|30|stk|1|þpakki||D10BA01|01.09.2014||R|0|1|0|1|G|0|RAT|0|0|0|30|IKR|3000|2774|lyfalmen|V0125|2144|2|30|0|20,0000|LYFIS ehf|ratiopharm GmbH|Ísótretínóín||1200||1200|2774||2 023124|G04BD1001|Emselex|forðatfl|7,5|mg|98|stk|1|þpakki||G04BD10|01.07.2005||R|0|0|0|0|G|0|LUX|0|0|0|100|DKK|17644|25407|lyfalmen|||1|98|0|98,0000|POA Pharma Scandinavia AB|Merus Labs Luxco S.à R.L.|Darífenacín||17644||17644|25407||1 023125|D10BA0106|Isotretinoin ratiopharm|hylki|20|mg|60|stk|1|þpakki||D10BA01|01.09.2014||R|0|1|0|1|G|0|RAT|0|0|0|30|IKR|6500|4288|lyfalmen|V0125|4288|2|60|0|40,0000|LYFIS ehf|ratiopharm GmbH|Ísótretínóín||2300||2300|4288||2 023154|N03AX1208|Gabapentin ratiopharm|filmhtfl|800|mg|100|stk|1|þpakki||N03AX12|01.01.2014||R|1|0|0|0|G|0|RGM|0|0|0|100|IKR|14000|19015|lyfalmen|V0256|19015|2|100|0|44,4400|Medical ehf|ratiopharm GmbH|Gabapentín||13000||13000|19015||2 023162|N03AX1208|Gabapentin ratiopharm|filmhtfl|600|mg|100|stk|1|þpakki||N03AX12|01.01.2014||R|1|0|0|0|G|0|RGM|0|0|0|100|IKR|7500|10757|lyfalmen|V0254|10757|2|100|0|33,3300|Medical ehf|ratiopharm GmbH|Gabapentín||7000||7000|10757||2 023193|G04BD1001|Emselex|forðatfl|15|mg|98|stk|1|þpakki||G04BD10|01.07.2005||R|0|0|0|0|G|0|LUX|0|0|0|100|DKK|18217|26196|lyfalmen|||1|98|0|196,0000|POA Pharma Scandinavia AB|Merus Labs Luxco S.à R.L.|Darífenacín||18217||18217|26196||1 023329|N03AX1206|Gabapentin Mylan|hylki|300|mg|100|stk|1|glas||N03AX12|01.01.2010||R|1|0|0|0|G|0|MYL|0|0|0|100|SEK|2310|3645|lyfalmen|V0250|2561|2|100|0|16,6667|Icepharma hf|Mylan AB|Gabapentín||1833||1833|3645||2 023376|N03AX1206|Gabapentin Mylan|hylki|400|mg|100|stk|1|glas||N03AX12|01.01.2010||R|1|0|0|0|G|0|MYL|0|0|0|100|SEK|2981|4163|lyfalmen|V0251|2972|2|100|0|22,2200|Icepharma hf|Mylan AB|Gabapentín||2209||2209|4163||2 023409|N01BB2004|Oraqix|thhlaup|5|%|1,7|g|20|rörlyk||N01BB20|01.09.2006||R|0|0|0|0|0|0|DED|0|0|1|100|XEU|17031|24564|lyfalmen|||1|34|0||Vistor hf|Dentsply DeTrey GmbH|Blöndur||17031||17031|24564||1 023509|B01AC0401|Plavix|töflur|75|mg|100|stk|1|þpakki||B01AC04|01.07.2007||R|1|0|0|0|G|0|SNC|0|0|0|100|NOK|15122|21936|lyfalmen|V0029|6308|1|100|0|100,0000|Vistor hf|Sanofi Clir SNC|Klópídógrel||15122||15122|21936||1 023590|S01ED0106|Timosan Depot|augnhl|1|mg/g|0,4|g|30|sk-hyl||S01ED01|01.07.2007||R|0|0|0|0|G|0|SAO|0|0|0|100|XEU|2318|4313|lyfalmen|||1|12|0|30,0000|Icepharma hf|Santen Oy|Tímólól||2318||2318|4313||2 023608|N01AB0802|Sevofluran Baxter|innönd.l|100|%|250|ml|6|fl||N01AB08|01.04.2012||R|0|0|0|0|0|1|BAX|0|0|0|100|SEK|124339|147474|lyfsjukr|||2|1500|0||Icepharma hf|Baxter|Sevóflúran||114088||114088|147474||2 023641|C09AA0211|Enalapril Krka|töflur|10|mg|100|stk|1|þpakki||C09AA02|01.03.2014||R|1|0|0|0|G|0|KRK|0|0|0|100|IKR|900|2361|lyfalmen|V0066|2361|2|100|0|100,0000|LYFIS ehf|Krka Sverige AB|Enalapríl||900||900|2361||2 023649|C09AA0211|Enalapril Krka|töflur|20|mg|100|stk|1|þpakki||C09AA02|01.03.2014||R|1|0|0|0|G|0|KRK|0|0|0|100|IKR|1050|2567|lyfalmen|V0449|2567|2|100|0|200,0000|LYFIS ehf|Krka Sverige AB|Enalapríl||1050||1050|2567||2 023708|J05AE0101|Invirase|filmhtfl|500|mg|120|stk|1|glas||J05AE01|01.01.2006|30.04.2016|R|0|0|0|1|0|1|ROC|0|0|0|100|DKK|50485|66554|lyfsjukr|||1|120|0|33,3300|Icepharma hf|Roche|Saquínavír||50485||50485|66554||2 023738|C09AA0211|Enalapril Krka|töflur|5|mg|100|stk|1|þpakki||C09AA02|01.03.2014||R|1|0|0|0|G|0|KRK|0|0|0|100|IKR|700|2086|lyfalmen|V0448|1919|2|100|0|50,0000|LYFIS ehf|Krka Sverige AB|Enalapríl||700||700|2086||2 023847|N06AX1106|Mirtazapin Krka|filmhtfl|45|mg|100|stk|1|þpakki||N06AX11|01.04.2015||R|1|0|0|0|G|0|KRK|0|0|0|100|IKR|4900|5940|lyfalmen|||2|100|0|150,0000|LYFIS ehf|Krka Sverige AB|Mirtazapín||3500||3500|5940||2 023897|N06AX1106|Mirtazapin Krka|filmhtfl|30|mg|100|stk|1|þpakki||N06AX11|01.01.2015||R|1|0|0|0|G|0|KRK|0|0|0|100|IKR|2429|3737|lyfalmen|V0673|3737|2|100|0|100,0000|LYFIS ehf|Krka Sverige AB|Mirtazapín||1900||1900|3737||2 023968|G04BE0302|Revatio|filmhtfl|20|mg|90|stk|1|þpakki||G04BE03|01.08.2006||R|0|0|0|1|0|1|IPI|0|0|0|100|DKK|65924|86081|lyfsjukr|||1|90|0|36,0000|Icepharma hf|Pfizer Limited|Síldenafíl||65924||65924|86081||1 024018|N04BA0204|Sinemet 25/100|töflur|125|mg|100|stk|1|glas|25+100 mg|N04BA02|01.10.1985||R|1|0|0|0|G|0|MSD|0|0|0|100|DKK|2472|4525|lyfalmen|||1|100|0|16,6667|Vistor hf|M.S.D.|Levódópa og dópadekarboxýl­asa­hemill||2472||2472|4525||1 024056|N02AB0301|Durogesic|forðapl|12|mcg/klst|5|stk|1|þpakki||N02AB03|01.02.2006||R|0|0|1|0|G|0|JAS|0|0|0|100|SEK|2094|4004|lyfalmen|V0222|3152|1|5|0|3,6000|Vistor hf|Janssen-Cilag AB|Fentanýl||2094||2094|4004||1 024090|N04BD0201|Azilect|töflur|1|mg|30|stk|1|glas||N04BD02|01.10.2005||R|0|0|0|0|G|0|TPG|0|0|0|100|DKK|16283|23534|lyfalmen|V0726|21487|1|30|0|30,0000|Lundbeck Export A/S|Teva Pharma GmbH|Rasagilín||16283||16283|23534||1 024198|C07AB0213|Metoprololsuccinat Hexal|forðatfl|50|mg|100|stk|1|plglas|47,5 mg metoprololsuccinat|C07AB02|01.04.2015||R|1|0|0|0|G|0|SSA|0|0|0|100|DKK|1525|2401|lyfalmen|V0048|2401|2|100|0|31,6600|Artasan ehf|Hexal A/S|Metóprólól||929||929|2401||1 024200|N04BD0201|Azilect|töflur|1|mg|100|stk|1|þpakki||N04BD02|01.10.2005||R|0|0|0|0|G|0|TPG|0|0|0|100|DKK|56685|74396|lyfalmen|V0711|54723|1|100|0|100,0000|Lundbeck Export A/S|Teva Pharma GmbH|Rasagilín||56685||56685|74396||1 024231|C07AB0213|Metoprololsuccinat Hexal|forðatfl|100|mg|100|stk|1|plglas|95 mg metoprololsuccinat|C07AB02|01.04.2015||R|1|0|0|0|G|0|SSA|0|0|0|100|DKK|2046|3403|lyfalmen|V0049|3403|2|100|0|63,3300|Artasan ehf|Hexal A/S|Metóprólól||1657||1657|3403||1 024253|C07AB0213|Metoprololsuccinat Hexal|forðatfl|200|mg|100|stk|1|plglas|190 mg metoprololsuccinat|C07AB02|01.04.2015||R|1|0|0|0|G|0|SSA|0|0|0|100|DKK|4118|5663|lyfalmen|V0054|5663|2|100|0|126,6600|Artasan ehf|Hexal A/S|Metóprólól||3299||3299|5663||1 024307|V01AA1105|Alutard SQ, hundahar|stl|||5|ml|4|hgl|byrjunarsett|V01AA11|01.07.1999||R|0|0|0|1|G|0|ALK|0|0|0|100|DKK|21552|29960|lyfalmen|||1|20|0||Vistor hf|ALK-Abello A/S|dýr||21552||21552|29960||1 024478|V04CL0016|Soluprick SQ ALK553 - hundahár|húðst.pr|10|HEP|2|ml|1|hgl||V04CL|01.04.2006||R|0|0|0|0|0|0|ALK|0|0|0|100|DKK|6785|10461|lyfalmen|||1|2|0||Vistor hf|ALK-Abello A/S|Ofnæmisvakar (allergenar) til greiningar á ofnæmissjúkdómum||6785||6785|10461||1 024481|R03CC0301|Bricanyl|mixtúra|0,3|mg/ml|100|ml|1|fl||R03CC03|01.03.2006||R|0|0|0|0|G|0|AZD|0|0|0|100|SEK|369|1630|lyfalmen|||1|100|0|2,0000|Vistor hf|AstraZeneca A/S DK|Terbútalín||369||369|1630||1 024482|V04CL0017|Soluprick SQ ALK555 - kattahár|húðst.pr|10|HEP|2|ml|1|hgl||V04CL|01.04.2006||R|0|0|0|0|0|0|ALK|0|0|0|100|DKK|6785|10461|lyfalmen|||1|2|0||Vistor hf|ALK-Abello A/S|Ofnæmisvakar (allergenar) til greiningar á ofnæmissjúkdómum||6785||6785|10461||1 024504|V04CL0003|Soluprick SQ ALK106 - Rauðölur|húðst.pr|10|HEP|2|ml|1|hgl||V04CL|01.04.2006||R|0|0|0|0|0|0|ALK|0|0|0|100|DKK|11432|16857|lyfalmen|||1|2|0||Vistor hf|ALK-Abello A/S|Ofnæmisvakar (allergenar) til greiningar á ofnæmissjúkdómum||11432||11432|16857||1 024526|V04CL0006|Soluprick SQ ALK113 - Hesliviður|húðst.pr|10|HEP|2|ml|1|hgl||V04CL|01.04.2006||R|0|0|0|0|0|0|ALK|0|0|0|100|DKK|11451|16883|lyfalmen|||1|2|0||Vistor hf|ALK-Abello A/S|Ofnæmisvakar (allergenar) til greiningar á ofnæmissjúkdómum||11451||11451|16883||1 024565|V04CL0009|Soluprick SQ ALK218 - Hávingull|húðst.pr|10|HEP|2|ml|1|hgl||V04CL|01.04.2006||R|0|0|0|0|0|0|ALK|0|0|0|100|DKK|11568|17044|lyfalmen|||1|2|0||Vistor hf|ALK-Abello A/S|Ofnæmisvakar (allergenar) til greiningar á ofnæmissjúkdómum||11568||11568|17044||1 024583|V04CL0011|Soluprick SQ ALK225 - Vallarfoxgras|húðst.pr|10|HEP|2|ml|1|hgl||V04CL|01.04.2006||R|0|0|0|0|0|0|ALK|0|0|0|100|DKK|4892|7856|lyfalmen|||1|2|0||Vistor hf|ALK-Abello A/S|Ofnæmisvakar (allergenar) til greiningar á ofnæmissjúkdómum||4892||4892|7856||1 024590|M05BA0802|Aclasta|irl|5|mg|100|ml|1|fl|lausn|M05BA08|01.07.2005||R|0|1|0|1|0|0|NEL|0|0|0|100|DKK|48150|63601|lyfalmen|V0715|52354|1|100|0|1,2500|Vistor hf|Novartis Europharm Ltd|Zoledronsýra||48150||48150|63601||1 024600|V04CL0013|Soluprick SQ ALK231 - Rúgur|húðst.pr|10|HEP|2|ml|1|hgl||V04CL|01.04.2006||R|0|0|0|0|0|0|ALK|0|0|0|100|DKK|11568|17044|lyfalmen|||1|2|0||Vistor hf|ALK-Abello A/S|Ofnæmisvakar (allergenar) til greiningar á ofnæmissjúkdómum||11568||11568|17044||1 024603|V04CL0001|Soluprick Negativ Kontrol|húðst.pr|10|HEP|2|ml|1|hgl||V04CL|01.04.2006||R|0|0|0|0|0|0|ALK|0|0|0|100|DKK|1393|3040|lyfalmen|||1|2|0||Vistor hf|ALK-Abello A/S|Ofnæmisvakar (allergenar) til greiningar á ofnæmissjúkdómum||1393||1393|3040||1 024622|V04CL0005|Soluprick SQ ALK108 - Birkifrjó|húðst.pr|10|HEP|2|ml|1|hgl||V04CL|01.04.2006||R|0|0|0|0|0|0|ALK|0|0|0|100|DKK|4892|7856|lyfalmen|||1|2|0||Vistor hf|ALK-Abello A/S|Ofnæmisvakar (allergenar) til greiningar á ofnæmissjúkdómum||4892||4892|7856||1 024644|V04CL0015|Soluprick SQ ALK552 - Hrossaværur|húðst.pr|10|HEP|2|ml|1|hgl||V04CL|01.04.2006||R|0|0|0|0|0|0|ALK|0|0|0|100|DKK|6785|10461|lyfalmen|||1|2|0||Vistor hf|ALK-Abello A/S|Ofnæmisvakar (allergenar) til greiningar á ofnæmissjúkdómum||6785||6785|10461||1 024670|V04CL0014|Soluprick SQ ALK504 - Rykmaur|húðst.pr|10|HEP|2|ml|1|hgl||V04CL|01.04.2006||R|0|0|0|0|0|0|ALK|0|0|0|100|DKK|6785|10461|lyfalmen|||1|2|0||Vistor hf|ALK-Abello A/S|Ofnæmisvakar (allergenar) til greiningar á ofnæmissjúkdómum||6785||6785|10461||1 024681|V04CL0002|Soluprick Positiv Kontrol|húðst.pr|10|HEP|2|ml|1|hgl||V04CL|01.04.2006||R|0|0|0|0|0|0|ALK|0|0|0|100|DKK|1393|3040|lyfalmen|||1|2|0||Vistor hf|ALK-Abello A/S|Ofnæmisvakar (allergenar) til greiningar á ofnæmissjúkdómum||1393||1393|3040||1 024901|C07AB0212|Metoprolin|töflur|100|mg|100|stk|1|þpakki||C07AB02|01.01.2014||R|1|0|0|0|G|0|RGM|0|0|0|100|IKR|2162|2774|lyfalmen|V0106|2774|2|100|0|66,6660|Medical ehf|ratiopharm GmbH|Metóprólól||1200||1200|2774||2 025041|C09AA0211|Enalapril Krka|töflur|20|mg|250|stk|1|glas||C09AA02|01.12.2013||R|1|0|0|0|G|0|KRK|0|0|0|100|IKR|3115|5410|lyfalmen|V0483|5410|2|250|0|500,0000|LYFIS ehf|Krka Sverige AB|Enalapríl||3115||3115|5410||2 025046|C09AA0211|Enalapril Krka|töflur|10|mg|250|stk|1|glas||C09AA02|01.12.2013||R|1|0|0|0|G|0|KRK|0|0|0|100|IKR|2770|4935|lyfalmen|V0482|4935|2|250|0|250,0000|LYFIS ehf|Krka Sverige AB|Enalapríl||2770||2770|4935||2 025052|C09AA0211|Enalapril Krka|töflur|5|mg|250|stk|1|glas||C09AA02|01.12.2013||R|1|0|0|0|G|0|KRK|0|0|0|100|IKR|2000|3875|lyfalmen|V0450|3875|2|250|0|125,0000|LYFIS ehf|Krka Sverige AB|Enalapríl||2000||2000|3875||2 025142|D07AB0202|Locoid Crelo|húðfl|1|mg/g|30|g|1|glas|á húð|D07AB02|01.04.1994||R|0|0|0|0|G|0|ASP|0|0|1|100|XEU|550|1879|lyfalmen|||1|30|0||Vistor hf|Astellas Pharma A/S|Hýdrókortisón bútýrat||550||550|1879||1 025155|V01AA1105|Alutard SQ, hundahar|stl|0,1|mi.SQ/ml|5|ml|1|hgl|framhaldssett|V01AA11|01.07.1999||R|0|0|0|1|G|0|ALK|0|0|0|100|DKK|17255|24872|lyfalmen|||1|5|0||Vistor hf|ALK-Abello A/S|dýr||17255||17255|24872||1 025239|C07AB0212|Metoprolin|töflur|50|mg|100|stk|1|þpakki||C07AB02|01.01.2014||R|1|0|0|0|G|0|RGM|0|0|0|100|IKR|1480|2223|lyfalmen|V0051|2223|2|100|0|33,3333|Medical ehf|ratiopharm GmbH|Metóprólól||800||800|2223||2 025317|J05AF1001|Baraclude|filmhtfl|1|mg|30|stk|1|þpakki||J05AF10|01.09.2007||R|0|0|0|1|0|1|BSP|0|1|0|100|DKK|70775|92217|lyfsjukr|||1|30|0|60,0000|Vistor hf|Bristol-Myers Squibb Pharma (UK) Ltd |Entecavír||70775||70775|92217||1 025323|J05AF1001|Baraclude|filmhtfl|0,5|mg|30|stk|1|þpakki||J05AF10|01.09.2007||R|0|0|0|1|0|1|BSP|0|1|0|100|DKK|66106|86312|lyfsjukr|||1|30|0|30,0000|Vistor hf|Bristol-Myers Squibb Pharma (UK) Ltd |Entecavír||66106||66106|86312||1 025388|QM01AC0601|Metacam|stl|5|mg/ml|20|ml|1|hgl||QM01AC06|01.10.2006||R|0|0|0|0|0|0|BOI|1|0|0|100|DKK|8550|16392|vetalmen|||0|20|0||Vistor hf|Boehringer Ingelheim|||8550||8550|16392||1 025425|V01AA0217|Grazax 75.000 SQ-T|lausnart|75000|ein|30|stk|1|þpakki|frostþurrkaðar|V01AA02|01.02.2008||R|0|0|0|1|0|0|ALK|0|0|0|100|DKK|13878|20224|lyfalmen|||1|30|0||Vistor hf|ALK-Abello A/S|grasfrjó||13878||13878|20224||1 025588|M05BA0602|Bonviva|filmhtfl|150|mg|1|stk|1|þpakki||M05BA06|01.01.2006||R|0|0|0|0|0|0|RRL|0|0|0|100|DKK|4682|7567|lyfalmen|V0205|1272|1|1|0|30,0000|Icepharma hf|Roche Registration Limited|Íbandrónsýra||4682||4682|7567||2 025599|M05BA0602|Bonviva|filmhtfl|150|mg|3|stk|1|þpakki||M05BA06|01.01.2006||R|0|0|0|0|0|0|RRL|0|0|0|100|DKK|12547|18392|lyfalmen|V0205|3816|1|3|0|90,0000|Icepharma hf|Roche Registration Limited|Íbandrónsýra||12547||12547|18392||2 025736|V01AA0217|Grazax 75.000 SQ-T|lausnart|75000|ein|100|stk|1|þpakki|frostþurrkaðar|V01AA02|01.02.2008||R|0|0|0|1|0|0|ALK|0|0|0|100|DKK|40126|53452|lyfalmen|||1|100|0||Vistor hf|ALK-Abello A/S|grasfrjó||40126||40126|53452||1 025747|C01BB0101|Xylocard 100 mg/ 5 ml|stl|20|mg/ml|5|ml|5|gl-lyk||C01BB01|01.12.2006||R|0|0|0|0|0|1|AZD|0|0|0|100|SEK|6295|9787|lyfsjukr|||1|25|0|0,1667|Vistor hf|AstraZeneca A/S DK|Lídókaín||6295||6295|9787||1 025841|V01AA1106|Alutard SQ, kattahar|stl|||5|ml|4|hgl|byrjunarsett|V01AA11|01.07.1999||R|0|0|0|1|G|0|ALK|0|0|0|100|DKK|21552|29960|lyfalmen|||1|20|0||Vistor hf|ALK-Abello A/S|dýr||21552||21552|29960||1 025895|N02AA0505|Oxycodone ratiopharm|forðatfl|10|mg|28|stk|1|þpakki||N02AA05|01.04.2013||R|1|0|1|0|G|0|RAT|0|0|0|100|XEU|897|2302|lyfalmen|V0597|2302|2|28|0|3,7300|LYFIS ehf|ratiopharm GmbH|Oxýcódon||857||857|2302||2 025906|N02AA0505|Oxycodone ratiopharm|forðatfl|10|mg|98|stk|1|þpakki||N02AA05|01.04.2013||R|1|0|1|0|G|0|RAT|0|0|0|100|XEU|3025|4807|lyfalmen|||2|98|0|13,0700|LYFIS ehf|ratiopharm GmbH|Oxýcódon||2677||2677|4807|30.4.2016|2 025917|L04AX0201|Thalidomide Celgene|hylki|50|mg|28|stk|1|þpakki|hart|L04AX02|01.09.2011||R|0|1|0|1|0|1|CEE|0|1|0|100|XEU|46046|60940|lyfsjukr|||1|28|0|14,0000|Celgene Europe ltd|Celgene Europe ltd|Thalidómíde||||46046|60940||2 025927|N06AX2601|Brintellix|filmhtfl|20|mg|98|stk|1|þpakki||N06AX26|01.10.2014||R|1|0|0|0|0|0|LBK|0|0|0|100|DKK|40010|53305|lyfalmen|||1|98|0|196,0000|Lundbeck Export A/S|H. Lundbeck A/S|Vortioxetín||40010||40010|53305||1 025965|QP54AA0102|Oramec Drench, vet.|mixtúra|0,8|mg/ml|1|l|1|fl||QP54AA01|01.04.1992||R|0|0|0|0|0|0|MEF|0|0|0|100|XEU|3466|5974|vetorma|||0|1|0||Vistor hf|Merial (MSD)|Ivermectinum||3466||3466|5974|| 025997|A07DA0302|Loperamid Portfarma|töflur|2|mg|20|stk|1|þpakki||A07DA03|01.09.2015||L|1|0|0|0|0|0|POF|0|0|0|100|IKR|||lyflausa|||0|20|0|4,0000|Alvogen|Alvogen|Lóperamíð|||||||1 026000|QS02CA0301|Easotic|eyrnadr|||10|ml|1|fl|dreifa|QS02CA03|01.04.2012||R|0|0|0|0|0|0|VIR|0|0|0|100|XEU|1740|3420|vetalmen|||0|10|0||Vistor hf|Virbac S.A|Hýdrókortisón,miconazol,gentamicin||1740||1740|3420||1 026019|A07DA0302|Loperamid Portfarma|töflur|2|mg|100|stk|1|þpakki||A07DA03|01.09.2015||R|1|0|0|0|G|0|POF|0|0|0|100|IKR|820|2024|lyfalmen|V0447|2024|2|100|0|20,0000|Alvogen|Alvogen|Lóperamíð||655||655|2024||1 026021|QP54AA0102|Oramec Drench, vet.|mixtúra|0,8|mg/ml|2,5|l|1|fl||QP54AA01|01.04.1992||R|0|0|0|0|0|0|MEF|0|0|0|100|XEU|8269|14252|vetorma|||0|2,5|0||Vistor hf|Merial (MSD)|Ivermectinum||8269||8269|14252||1 026096|V01AA1106|Alutard SQ, kattahar|stl|0,1|mi.SQ/ml|5|ml|1|hgl|framhaldssett|V01AA11|01.07.1999||R|0|0|0|1|G|0|ALK|0|0|0|100|DKK|17255|24872|lyfalmen|||1|5|0||Vistor hf|ALK-Abello A/S|dýr||17255||17255|24872||1 026101|L01CA0501|Javlor|irþ|25|mg/ml|2|ml|1|hgl|lausn|L01CA05|01.12.2010||R|0|0|0|1|0|1|PFM|0|0|0|100|DKK|38057|50835|lyfsjukr|||1|2|0||Vistor hf|Pierre Fabre Médicament|Vínflúnín||38057||38057|50835||1 026114|L01CA0501|Javlor|irþ|25|mg/ml|10|ml|1|hgl|lausn|L01CA05|01.12.2010||R|0|0|0|1|0|1|PFM|0|0|0|100|DKK|190289|242246|lyfsjukr|||1|10|0||Vistor hf|Pierre Fabre Médicament|Vínflúnín||190289||190289|242246||1 026569|R02AA0305|Strepsils Cool|sogtfl|||24|stk|1|þpakki||R02AA03|01.09.2010||L|0|0|0|0|0|0|RBH|0|0|1|100|IKR|||lyflausa|||0|24|0|4,0000|Artasan ehf|Reckitt Benckiser Healthcare Ltd.-A|Díklórbenzýlalkóhól|||||||1 026571|N03AX1801|Vimpat|filmhtfl|50|mg|14|stk|1|þpakki||N03AX18|01.12.2009||R|1|0|0|0|G|0|UCB|0|0|0|100|DKK|1621|3353|lyfalmen|||1|14|0|2,3300|Vistor hf|U.C.B|Lacosamíð||||1621|3353||1 026582|N03AX1801|Vimpat|filmhtfl|50|mg|56|stk|1|þpakki||N03AX18|01.12.2009||R|1|0|0|0|G|0|UCB|0|0|0|100|DKK|6144|9579|lyfalmen|||1|56|0|9,3300|Vistor hf|U.C.B|Lacosamíð||||6144|9579||1 026593|N03AX1801|Vimpat|filmhtfl|100|mg|14|stk|1|þpakki||N03AX18|01.12.2009||R|1|0|0|0|G|0|UCB|0|0|0|100|DKK|3203|5531|lyfalmen|||1|14|0|4,6700|Vistor hf|U.C.B|Lacosamíð||||3203|5531||1 026605|N03AX1801|Vimpat|filmhtfl|100|mg|56|stk|1|þpakki||N03AX18|01.12.2009||R|1|0|0|0|G|0|UCB|0|0|0|100|DKK|12687|18585|lyfalmen|||1|56|0|18,6700|Vistor hf|U.C.B|Lacosamíð||||12687|18585||1 026627|N03AX1801|Vimpat|filmhtfl|150|mg|56|stk|1|þpakki||N03AX18|01.12.2009||R|1|0|0|0|G|0|UCB|0|0|0|100|DKK|19011|27289|lyfalmen|||1|56|0|28,0000|Vistor hf|U.C.B|Lacosamíð||||19011|27289||1 026638|N03AX1801|Vimpat|filmhtfl|200|mg|56|stk|1|þpakki||N03AX18|01.12.2009||R|1|0|0|0|G|0|UCB|0|0|0|100|DKK|25337|34747|lyfalmen|||1|56|0|37,3300|Vistor hf|U.C.B|Lacosamíð||||25337|34747||1 026682|J01XE0101|Furadantin|töflur|50|mg|100|stk|1|glas||J01XE01|01.03.2004||R|1|0|0|0|0|0|REP|0|0|1|100|SEK|1237|2825|lyfalmen|||2|100|0|25,0000|Vistor hf|Recip AB|Nítrófúrantóín||1237||1237|2825||1 026692|L01XE2701|IMBRUVICA|filmhtfl|140|mg|120|stk|1|glas||L01XE27|01.02.2016||R|1|0|0|1|0|1|JCI|0|1|0|100|SEK|1045858|1306335|lyfsjukr|||1|120|0||Vistor hf|Janssen-Cilag International N.V.|Ibrutinib||||1045858|1306335||1 026698|A02BC0110|Omeprazol ratiopharm|sþ-hylki|20|mg|14|stk|1|glas|hart|A02BC01|01.02.2012||L|1|0|0|0|0|0|RAT|0|0|0|100|IKR|||lyflausa|||0|14|0|14,0000|LYFIS ehf|ratiopharm GmbH|Ómeprazól|||||||2 026943|C09CA0106|Losatrix|filmhtfl|100|mg|100|stk|1|þpakki||C09CA01|01.01.2014||R|1|0|0|0|G|0|RGM|0|0|0|100|IKR|4765|3907|lyfalmen|V0099|3907|2|100|0|200,0000|Medical ehf|ratiopharm GmbH|Lósartan||2023||2023|3907||2 026946|J01CA0412|Amoxicillin Mylan (Lyf og heilsa)|hylki|500|mg|30|stk|1|glas||J01CA04|01.07.2011||R|0|0|0|0|0|0|HOL|0|0|1|100|SEK|1011|2514|lyfalmen|V0160|2361|3|30|0|15,0000|Lyf og heilsa|Lyf og heilsa|Amoxicillín||1011||1011|2514||2 026957|J01CA0412|Amoxicillin Mylan (Lyf og heilsa)|hylki|500|mg|20|stk|1|glas||J01CA04|01.05.2011||R|0|0|0|0|0|0|DAC|0|0|1|100|SEK|699|2084|lyfalmen|V0159|1948|3|20|0|10,0000|D.A.C. ehf|D.A.C. ehf|Amoxicillín||699||699|2084||2 027051|A10BX1201|Jardiance|filmhtfl|10|mg|90|stk|1|þpakki||A10BX12|01.07.2015||R|1|0|0|0|G|0|BOE|0|0|0|100|DKK|18347|26375|lyfalmen|||1|90|0|51,4300|Vistor hf|Boehringer Ingelheim International GmbH|Empagliflozin||18347||18347|26375||1 027058|N06AX1106|Mirtazapin Krka|filmhtfl|15|mg|100|stk|1|þpakki||N06AX11|01.01.2015||R|1|0|0|0|G|0|KRK|0|0|0|100|IKR|2043|3049|lyfalmen|V0672|3049|2|100|0|50,0000|LYFIS ehf|Krka Sverige AB|Mirtazapín||1400||1400|3049||2 027094|J01XE0101|Furadantin|töflur|5|mg|50|stk|1|glas||J01XE01|01.03.2004||R|1|0|0|0|0|0|REP|0|0|1|100|SEK|368|1629|lyfalmen|||2|50|0|1,2500|Vistor hf|Recip AB|Nítrófúrantóín||368||368|1629||1 027202|S01ED5111|Azarga|augndr|15|mg/ml|5|ml|1|glas|10+5 mg/ml|S01ED51|01.10.2009||R|0|0|0|0|G|0|ALA|0|0|0|100|USD|2170|4109|lyfalmen|||1|5|0|25,0000|Vistor hf|Alcon Laboratories Ltd.|Tímólól í blöndum||2170||2170|4109||1 027235|G03HA0104|Cyproteron Mylan|töflur|50|mg|50|stk|1|glas||G03HA01|01.04.1997||R|1|0|0|0|G|0|MYL|0|0|0|100|SEK|5526|8728|lyfalmen|||2|50|0|25,0000|Icepharma hf|Mylan AB|Cýpróterón||5526||5526|8728||2 027281|N06DA0204|Donepezil Actavis|filmhtfl|5|mg|100|stk|1|þpakki||N06DA02|01.05.2009||R|1|0|0|0|G|0|ACA|0|0|0|100|XEU|11663|7209|lyfalmen|V0341|7209|2|100|0|66,6600|Actavis Group hf|Actavis hf|Dónepezíl||4422||4422|7209||1 027305|N06DA0204|Donepezil Actavis|filmhtfl|10|mg|100|stk|1|þpakki||N06DA02|01.05.2009||R|1|0|0|0|G|0|ACA|0|0|0|100|XEU|12558|7209|lyfalmen|V0342|7209|2|100|0|133,3300|Actavis Group hf|Actavis hf|Dónepezíl||4422||4422|7209||1 027505|B05BB0121|Plasmalyte|irl|||1000|ml|10|pokar|lausn|B05BB01|01.05.2014||R|0|0|0|0|0|1|BAM|0|0|0|100|SEK|2431|4468|lyfsjukr|||1|10000|0||Icepharma hf|Baxter Medical AB|Elektrólýtar||2431||2431|4468||2 027586|N03AX1501|Zonegran|hylki|25|mg|56|stk|1|þpakki||N03AX15|01.03.2007||R|1|0|0|0|G|0|EIS|0|0|0|100|SEK|6249|9723|lyfalmen|||1|56|0|7,0000|Vistor hf|Eisai Ltd|Zonisamíð||6249||6249|9723||1 027649|H03AA0105|Levaxin|töflur|0,05|mg|100|stk|1|glas||H03AA01|01.04.2004||R|1|0|0|0|G|0|TDA|0|0|0|100|DKK|538|1863|lyfalmen|||2|100|0|33,3300|Vistor hf|Takeda Danmark A/S|Levótýroxínnatríum||538||538|1863||1 027656|H03AA0105|Levaxin|töflur|0,1|mg|100|stk|1|glas||H03AA01|01.03.2003||R|1|0|0|0|G|0|TDA|0|0|0|100|DKK|620|1976|lyfalmen|||2|100|0|66,6667|Vistor hf|Takeda Danmark A/S|Levótýroxínnatríum||620||620|1976||1 027733|N05AH0409|Quetiapin Orion|filmhtfl|25|mg|100|stk|1|þpakki||N05AH04|01.10.2012|31.03.2016|R|1|0|0|0|G|0|OPF|0|0|0|100|IKR|2109|2155|lyfalmen|||2|100|0|6,2500|Alvogen|Orion Corporation|Quetíapín||750||750|2155||1 027968|N05AX1201|Abilify|munndr.t|10|mg|28|stk|1|þpakki||N05AX12|01.01.2007||R|0|1|0|0|0|0|OTS|0|0|0|100|DKK|18298|26308|lyfalmen|||1|28|0|18,6670|Vistor hf|Otsuka Pharmaceutical Europe Ltd.|Aripiprazól||18298||18298|26308||1 027976|N05AH0307|Zypadhera|sts|210|mg|1|hgl|1|pakki|+leysir|N05AH03|01.02.2010||R|0|1|0|0|0|1|ELD|0|0|0|100|XEU|21041|29313|lyfsjukr|||1|1|0|21,0000|Icepharma hf|Eli Lilly Nederland B.V.|Olanzapín||||21041|29313||2 027977|N05AX1201|Abilify|munndr.t|15|mg|28|stk|1|þpakki||N05AX12|01.01.2007||R|0|1|0|0|0|0|OTS|0|0|0|100|DKK|20751|28947|lyfalmen|||1|28|0|28,0000|Vistor hf|Otsuka Pharmaceutical Europe Ltd.|Aripiprazól||20751||20751|28947||1 027988|N05AH0307|Zypadhera|sts|300|mg|1|hgl|1|pakki|+leysir|N05AH03|01.02.2010||R|0|1|0|0|0|1|ELD|0|0|0|100|XEU|28739|39050|lyfsjukr|||1|1|0|30,0000|Icepharma hf|Eli Lilly Nederland B.V.|Olanzapín||28739||28739|39050||2 027999|N05AH0307|Zypadhera|sts|405|mg|1|hgl|1|pakki|+leysir|N05AH03|01.02.2010||R|0|1|0|0|0|1|ELD|0|0|0|100|XEU|42466|56412|lyfsjukr|||1|1|0|40,5000|Icepharma hf|Eli Lilly Nederland B.V.|Olanzapín||||42466|56412||2 028045|G03AB0801|Qlaira|töflur|||84|stk|1|þpakki|3x28 stk|G03AB08|01.11.2009||R|0|0|0|0|0|0|BAP|0|0|0|100|DKK|3832|6397|lyfalmen|||1|84|0|84,0000|Icepharma hf|Bayer Schering Pharma AG|Kaflaskipt lyf, prógestógen og östrógen||3832||3832|6397||2 028110|A10BD0701|Janumet|filmhtfl|900|mg|196|stk|1|þpakki|50/850 mg|A10BD07|01.03.2013||R|1|0|0|0|G|0|MLD|0|0|0|100|DKK|20265|28332|lyfalmen|V0387|28332|1|196|0|98,0000|Vistor hf|Merck Sharp & Dohme Limited|Metforminum og sitagliptinum||20265||20265|28332||1 028112|R06AX2602|Nefoxef|filmhtfl|120|mg|30|stk|1|þpakki||R06AX26|01.07.2008||L|1|0|0|0|0|0|MUN|0|0|1|100|IKR|||lyfalmen|||0|30|0|30,0000|Icepharma hf|Mundipharma|Fexófenadín|||||2567|| 028121|A10BD0701|Janumet|filmhtfl|1050|mg|196|stk|1|þpakki|50/1000mg|A10BD07|01.01.2010||R|1|0|0|0|G|0|MLD|0|0|0|100|DKK|18111|26050|lyfalmen|V0386|26050|1|196|0|98,0000|Vistor hf|Merck Sharp & Dohme Limited|Metforminum og sitagliptinum||18111||18111|26050||1 028124|R06AX2602|Nefoxef|filmhtfl|120|mg|100|stk|1|þpakki||R06AX26|01.07.2008||R|1|0|0|0|G|0|MYL|0|0|1|100|SEK|1757|3541|lyfalmen|V0364|3297|2|100|0|100,0000|Icepharma hf|Mylan AB|Fexófenadín||1757||1757|3541||2 028249|C10AA0507|Atorvastatin Hexal|filmhtfl|40|mg|100|stk|1|þpakki||C10AA05|01.10.2015||R|1|0|0|0|G|0|SSA|0|0|0|100|DKK|3155|2935|lyfalmen|V0114|2567|2|100|0|200,0000|Artasan ehf|Hexal A/S|Atorvastatín||1317||1317|2935||1 028268|R03DX0501|Xolair|stl|150|mg|1|áf.spr|1|pakki||R03DX05|01.04.2011||R|0|0|0|1|0|1|NEL|0|1|0|100|DKK|45158|59817|lyfsjukr|||1|1|0|9,3800|Vistor hf|Novartis Europharm Ltd|Omalizúmab||45158||45158|59817||1 028314|J07AP0301|Typhim Vi|stl|25|mcg/spr|0,5|ml|1|áf.spr|m/ aðsk. nál|J07AP03|01.05.2008||R|0|0|0|0|0|0|SPM|0|0|0|100|XEU|2346|4351|lyfalmen|||1|0,5|0||Icepharma hf|Sanofi Pasteur MSD|Taugaveiki, hreinsaðir mótefnavakar||2346||2346|4351||2 028333|J07CA0602|Pentavac|sts|||0,5|ml|10|hgl|+ 10 áf. spr.|J07CA06|01.02.2013||R|0|0|0|0|0|0|SPM|0|0|0|100|XEU|36477|48837|lyfalmen|||1|5|0||Icepharma hf|Sanofi Pasteur MSD|Barnaveiki, haemophilus influenza B, kíghósti, mænusótt, stí||36477||36477|48837||2 028351|J07BL0101|Stamaril|sts|||0,5|ml|10|hgl|+ 10 áf.spr. með leysi|J07BL01|01.01.1996||R|0|0|0|0|0|0|SPM|0|0|0|100|XEU|37700|50384|lyfalmen|||1|5|0||Icepharma hf|Sanofi Pasteur MSD|Gulusótt, veikluð veira||||37700|50384||2 028387|M03BX0105|Baklofen Mylan|töflur|25|mg|50|stk|1|glas||M03BX01|01.10.2008||R|1|0|0|0|G|0|MYL|0|0|1|100|SEK|1614|3344|lyfalmen|V0202|3344|2|50|0|25,0000|Icepharma hf|Mylan AB|Baklófen||1614||1614|3344||2 028405|M01AE0217|Naproxen-E Mylan|sh-tfl|500|mg|50|stk|1|plglas||M01AE02|01.07.1993||R|1|0|0|0|G|0|MYL|0|0|1|100|SEK|1809|3612|lyfalmen|V0428|3029|2|50|0|50,0000|Icepharma hf|Mylan AB|Naproxen||1809||1809|3612||2 028575|N03AX0901|Lamictal|dreifit.|5|mg|56|stk|1|þpakki||N03AX09|01.05.2009||R|1|0|0|0|G|0|GPH|0|0|0|100|IKR|1278|2881|lyfalmen|||1|56|0|0,9334|Vistor hf|GlaxoSmithKline Pharma A/S|Lamótrigín||||1278|2881||1 028586|N03AX0901|Lamictal|dreifit.|100|mg|98|stk|1|þpakki||N03AX09|01.05.2009||R|1|0|0|0|G|0|GPH|0|0|0|100|IKR|5812|3930|lyfalmen|V0245|3528|1|98|0|32,6667|Vistor hf|GlaxoSmithKline Pharma A/S|Lamótrigín||2040||2040|3930||1 028598|N03AX0901|Lamictal|dreifit.|200|mg|98|stk|1|þpakki||N03AX09|01.05.2009||R|1|0|0|0|G|0|GPH|0|0|0|100|IKR|10358|8775|lyfalmen|V0232|7844|1|98|0|65,3333|Vistor hf|GlaxoSmithKline Pharma A/S|Lamótrigín||5560||5560|8775||1 028599|N04BC0503|Pramipexole Portfarma|töflur|0,088|mg|30|stk|1|þpakki||N04BC05|01.02.2010||R|1|0|0|0|G|0|POF|0|0|0|100|XEU|711|2093|lyfalmen|V0266|2093|2|30|0|1,0600|Alvogen|Alvogen|Pramipexól||705||705|2093||1 028606|QN05CM1801|Dexdomitor|stl|0,5|mg/ml|10|ml|1|hgl||QN05CM18|01.11.2007||R|0|0|0|0|0|0|OCO|1|0|0|100|DKK|7096|13633|vetalmen|||0|10|0||Icepharma hf|Orion Corporation (I)|||7096||7096|13633||2 028610|N04BC0503|Pramipexole Portfarma|töflur|0,18|mg|100|stk|1|þpakki||N04BC05|01.02.2010||R|1|0|0|0|G|0|POF|0|0|0|100|XEU|2899|4197|lyfalmen|V0267|4197|2|100|0|7,2000|Alvogen|Alvogen|Pramipexól||2234||2234|4197||1 028632|M05BA0805|Zoledronic Acid Hospira|irþ|4|mg/hgl|5|ml|1|hgl|lausn|M05BA08|01.01.2016||R|0|1|0|1|0|1|VOG|0|0|0|100|XEU|2430|4467|lyfsjukr|||2|5|0|1,0000|Alvogen HS|Hospira UK Ltd.|Zoledronsýra||2430||2430|4467||1 028739|C08CA0502|Adalat Oros|forðatfl|30|mg|28|stk|1|þpakki||C08CA05|01.03.2013||R|1|0|0|0|G|0|BGB|0|0|0|100|DKK|1513|3205|lyfalmen|||1|28|0|28,0000|Icepharma hf|Bayer Pharma AG|Nífedipín||||1513|3205||2 028907|J02AC0103|Fluconazole Portfarma|hylki|50|mg|7|stk|1|þpakki||J02AC01|01.05.2010||R|1|0|0|0|0|0|POF|0|0|1|100|IKR|1362|1783|lyfalmen|V0551|1783|2|7|0|1,7500|Alvogen|Alvogen|Flúkónazól||480||480|1783||1 028918|J02AC0103|Fluconazole Portfarma|hylki|50|mg|30|stk|1|þpakki||J02AC01|01.05.2010||R|1|0|0|0|0|0|POF|0|0|1|100|IKR|4998|3201|lyfalmen|V0552|3201|2|30|0|7,5000|Alvogen|Alvogen|Flúkónazól||1510||1510|3201||1 028929|J02AC0103|Fluconazole Portfarma|hylki|150|mg|1|stk|1|þpakki||J02AC01|01.05.2010||L|1|0|0|0|0|0|POF|0|0|1|100|IKR|||lyflausa|||2|1|0|0,7500|Alvogen|Alvogen|Flúkónazól|||||||1 028940|J02AC0103|Fluconazole Portfarma|hylki|150|mg|2|stk|1|þpakki||J02AC01|01.05.2010||R|1|0|0|0|0|0|POF|0|0|1|100|IKR|523|1842|lyfalmen|V0555|1842|2|2|0|1,5000|Alvogen|Alvogen|Flúkónazól||523||523|1842||1 028953|J02AC0103|Fluconazole Portfarma|hylki|150|mg|4|stk|1|þpakki||J02AC01|01.05.2010||R|1|0|0|0|0|0|POF|0|0|1|100|IKR|2031|1907|lyfalmen|V0556|1907|2|4|0|3,0000|Alvogen|Alvogen|Flúkónazól||570||570|1907||1 029066|R01AD0801|Flixonase|nefúði|50|mcg/sk|120|skammtar|1|stauk||R01AD08|01.04.1992||R|0|0|0|0|G|0|GPH|0|0|1|100|IKR|1121|2499|lyfalmen|V0625|1778|1|120|0|30,0000|Vistor hf|GlaxoSmithKline Pharma A/S|Flútíkasón||1000||1000|2499||1 029078|N06AX2201|Valdoxan|filmhtfl|25|mg|28|stk|1|þpakki||N06AX22|01.01.2010||R|1|1|0|0|0|0|LLS|0|0|0|100|DKK|5877|9211|lyfalmen|||1|28|0|28,0000|Icepharma hf|Les Laboratoires Servier|Agómelatín||5877||5877|9211||2 029100|N06AX2201|Valdoxan|filmhtfl|25|mg|84|stk|1|þpakki||N06AX22|01.01.2010||R|1|1|0|0|0|0|LLS|0|0|0|100|DKK|14647|21282|lyfalmen|||1|84|0|84,0000|Icepharma hf|Les Laboratoires Servier|Agómelatín||14647||14647|21282||2 029198|R06AX2201|Kestine|filmhtfl|20|mg|30|stk|1|þpakki||R06AX22|01.06.2012||R|1|0|0|0|G|0|APS|0|0|1|100|DKK|2585|4680|lyfalmen|||1|30|0|60,0000|Vistor hf|Almirall-Prodesfarma S.A.|Ebastín||2585||2585|4680||1 029276|J04BA0202|Dapsone|töflur|50|mg|28|stk|1|þpakki||J04BA02|01.04.2013||R|0|0|0|1|G|0|AUK|0|0|0|100|XEU|1134|2683|lyfalmen|||2|28|0|28,0000|Actavis Group hf|Actavis UK Ltd.|Dapsón||1134||1134|2683||1 029287|C03DB0105|Amiloride|töflur|5|mg|28|stk|1|þpakki||C03DB01|01.04.2009||R|0|0|0|0|G|0|AUK|0|0|0|100|GBP|306|1543|lyfalmen|||2|28|0|14,0000|Actavis Group hf|Actavis UK Ltd.|Amiloridhýdróklóríð||306||306|1543||1 029381|R06AX1301|Clarityn|töflur|10|mg|30|stk|1|þpakki||R06AX13|01.04.2014||L|1|0|0|0|0|0|BAB|0|0|1|100|IKR|||lyflausa|||1|30|0|30,0000|Icepharma hf|Bayer AB|Lóratadín|||||||2 029429|L01XX4101|Halaven|stl|0,44|mg/ml|2|ml|1|hgl|lausn|L01XX41|01.11.2011||R|0|0|0|1|0|1|EIS|0|1|0|100|SEK|55475|72866|lyfsjukr|||1|2|0||Vistor hf|Eisai Ltd|Eribulin||55475||55475|72866||1 029517|L01BB0503|Fludarabin Actavis|sts/irs|25|mg/ml|50|mg|1|hgl||L01BB05|01.04.2009||R|0|0|0|1|0|1|AGP|0|0|0|100|XEU|17544|25270|lyfsjukr|||2|50|0||Actavis Group hf|Actavis Group PTC ehf|Flúdarabín||17544||17544|25270||1 029528|L01CA0402 |Vinorelbin Actavis|irþ|10|mg/ml|5|ml|1|hgl||L01CA04|01.04.2009||R|0|0|0|1|0|1|AGP|0|0|0|100|XEU|3817|6376|lyfsjukr|||2|5|0||Actavis Group hf|Actavis Group PTC ehf|Vínorelbín||3817||3817|6376||1 029706|C09DA0601|Atacand Plus|töflur|44,5|mg|98|stk|1|þpakki|32+12,5 mg|C09DA06|01.02.2010||R|1|0|0|0|0|0|AZD|0|0|0|100|SEK|11631|17131|lyfalmen|||1|98|0|98,0000|Vistor hf|AstraZeneca A/S DK|Candesartan og þvagræsilyf||||11631|17131||1 029729|C09DA0601|Atacand Plus|töflur|57|mg|98|stk|1|þpakki|32+25 mg|C09DA06|01.02.2010||R|1|0|0|0|0|0|AZD|0|0|0|100|SEK|11283|16652|lyfalmen|||1|98|0|98,0000|Vistor hf|AstraZeneca A/S DK|Candesartan og þvagræsilyf||||11283|16652||1 029800|J01AA0208|Oracea|hylki|40|mg|56|stk|1|þpakki|með br.losunarhraða|J01AA02|01.12.2011||R|0|0|0|0|0|0|GAN|0|0|1|100|SEK|5499|8691|lyfalmen|||1|56|0|22,4000|Icepharma hf|Galderma Nordic AB|Doxýcýklín||5499||5499|8691||2 029811|B02BX0401|Nplate|sts|250|mcg|1|hgl|1|pakki||B02BX04|01.04.2010||R|0|1|0|1|0|1|AEB|0|1|0|100|DKK|85003|110213|lyfsjukr|||1|1|0|8,3300|Vistor hf|Amgen Europe B.V.|Romiplóstím||85003||85003|110213||1 029822|B02BX0401|Nplate|sts|500|mcg|1|hgl|1|pakki||B02BX04|01.04.2010||R|0|1|0|1|0|1|AEU|0|1|0|100|DKK|170005|217019|lyfsjukr|||1|1|0|16,6600|Vistor hf|Amgen Europe B.V.|Romiplóstím||170005||170005|217019||1 029860|N07BA0121|Nicorette Fruitmint|tyggigúm|2|mg|30|stk|1|þpakki||N07BA01|01.05.2006||L|0|0|0|0|0|0|MCN|0|0|1|100|IKR|||lyflausa|||0|30|0|2,0000|Vistor hf|McNeil Denmark ApS|Nikótín|||||||1 029869|N07BA0121|Nicorette Fruitmint|tyggigúm|2|mg|105|stk|1|þpakki||N07BA01|01.05.2006||L|0|0|0|0|0|0|MCN|0|0|1|100|IKR|||lyflausa|||0|105|0|7,0000|Vistor hf|McNeil Denmark ApS|Nikótín|||||||1 029878|N07BA0121|Nicorette Fruitmint|tyggigúm|2|mg|210|stk|1|þpakki||N07BA01|01.05.2006||L|0|0|0|0|0|0|MCN|0|0|1|100|IKR|||lyflausa|||0|210|0|14,0000|Vistor hf|McNeil Denmark ApS|Nikótín|||||||1 029887|N07BA0121|Nicorette Fruitmint|tyggigúm|4|mg|30|stk|1|þpakki||N07BA01|01.05.2006||L|0|0|0|0|0|0|MCN|0|0|1|100|IKR|||lyflausa|||0|30|0|4,0000|Vistor hf|McNeil Denmark ApS|Nikótín|||||||1 029896|N07BA0121|Nicorette Fruitmint|tyggigúm|4|mg|105|stk|1|þpakki||N07BA01|01.05.2006||L|0|0|0|0|0|0|MCN|0|0|1|100|IKR|||lyflausa|||0|105|0|14,0000|Vistor hf|McNeil Denmark ApS|Nikótín|||||||1 029905|N07BA0121|Nicorette Fruitmint|tyggigúm|4|mg|210|stk|1|þpakki||N07BA01|01.05.2006||L|0|0|0|0|0|0|MCN|0|0|1|100|IKR|||lyflausa|||0|210|0|28,0000|Vistor hf|McNeil Denmark ApS|Nikótín|||||||1 030170|J07AL0202|Prevenar 13|stl|2,2|mcg|0,5|ml|1|áf.spr||J07AL02|01.07.2014||R|0|0|0|0|0|0|IPI|0|0|0|100|DKK|7328|11208|lyfalmen|||1|0,5|0||Icepharma hf|Pfizer Limited|Hreinsuð pneumococca poly­sakkaríð mótefnavakar (cojugated)||7328||7328|11208||1 030546|N03AX1108|Topiramat Bluefish|filmhtfl|25|mg|60|stk|1|þpakki||N03AX11|01.09.2015||R|1|0|0|0|G|0|BLP|0|0|0|100|XEU|1860|1765|lyfalmen|V0247|1765|2|60|0|5,0000|LYFIS ehf|Bluefish Pharmaceuticals AB|Tópíramat||467||467|1765||2 030627|N05AH0201|Leponex|töflur|100|mg|100|stk|1|glas||N05AH02|01.04.1993||R|1|0|0|0|G|0|HES|0|0|0|100|DKK|8247|12473|lyfalmen|V0277|6559|1|100|0|33,3333|Vistor hf|Novartis Healthcare A/S|Klózapín||8247||8247|12473||1 030635|N05AH0201|Leponex|töflur|25|mg|100|stk|1|glas||N05AH02|01.04.1993||R|1|0|0|0|G|0|HES|0|0|0|100|IKR|2886|5094|lyfalmen|V0276|2567|1|100|0|8,3333|Vistor hf|Novartis Healthcare A/S|Klózapín||2886||2886|5094||1 030822|QI02AB0001|Startvac|stl|||2|ml|20|glös|fleyti|QI02AB|01.05.2010||R|0|0|0|0|0|0|LHS|0|0|0|100|XEU|14689|25318|vetorma|||0|40|0||Dýraheilsa ehf|Laboratorios Hipra S.A.|Óvirkar bakteríur í bóluefnum||14689||14689|25318||2 030940|C07AB0210|Metoprolol Mylan|töflur|50|mg|100|stk|1|glas||C07AB02|01.10.1995||R|1|0|0|0|G|0|MYL|0|0|0|100|SEK|1196|2489|lyfalmen|V0051|2223|2|100|0|33,3333|Icepharma hf|Mylan AB|Metóprólól||993||993|2489||2 031039|C07AB0210|Metoprolol Mylan|töflur|100|mg|100|stk|1|glas||C07AB02|01.10.1995||R|1|0|0|0|G|0|MYL|0|0|0|100|SEK|1716|3176|lyfalmen|V0106|2774|2|100|0|66,6667|Icepharma hf|Mylan AB|Metóprólól||1492||1492|3176||2 031070|A04AD0101|Scopoderm|forðapl|1|mg/72kls|2|stk|1|pakki||A04AD01|01.07.1985||L|0|0|0|0|0|0|NEH|0|0|1|100|DKK|||lyfalmen|||0|2|0|2,0000|Artasan ehf|Novartis Healthcare A/S|Skópólamín|||||2638||1 031088|A10AB0401|Humalog|stl|100|ae/ml|10|ml|1|hgl||A10AB04|01.01.1997||R|0|0|0|0|G|0|ELD|0|0|0|100|XEU|2599|4699|lyfalmen|||1|10|0|25,0000|Icepharma hf|Eli Lilly Nederland B.V.|Insúlín lispró||2599||2599|4699||2 031201|L01BA0109|Metoject|stl|50|mg/ml|0,25|ml|1|áfspr||L01BA01|01.12.2012||R|0|0|0|1|G|0|WIL|0|0|0|100|SEK|2509|4576|lyfalmen|||1|0,25|0||Williams & Halls efh|medac Gesellschaft|Metótrexat||2509||2509|4576||2 031773|C01DA0801|Sorbangil|töflur|20|mg|100|stk|1|glas||C01DA08|01.01.1985||R|1|0|0|0|G|0|REP|0|0|0|100|SEK|1774|3564|lyfalmen|||1|100|0|33,3333|Vistor hf|Recip AB|Ísósorbíð dínítrat||1774||1774|3564||1 031849|A10AB0503|NovoRapid Penfill|stl|100|ein/ml|3|ml|5|rörlyk||A10AB05|01.07.2002||R|0|0|0|0|G|0|NAS|0|0|0|100|DKK|5190|8266|lyfalmen|||1|15|0|37,5000|Vistor hf|Novo-Nordisk A/S|Insúlín aspart||5190||5190|8266||1 031942|H01BA0401|Glypressin|sts|1|mg/hgl|1|mg|5|hgl|og leysir|H01BA04|01.01.1998||R|0|0|0|0|0|1|FEL|0|0|0|100|DKK|19720|28265|lyfsjukr|||1|5|0|0,4200|Vistor hf|Ferring Lægemidler A/S|Terlípressín||19720||19720|28265||1 031971|C07AA0705|Sotalol Mylan|töflur|160|mg|100|stk|1|plglas||C07AA07|01.01.1994||R|1|0|0|0|G|0|MYL|0|0|0|100|SEK|1731|3505|lyfalmen|||2|100|0|100,0000|Icepharma hf|Mylan AB|Sótalól||1731||1731|3505||2 032175|N03AX1606|Pregabalin Mylan|hylki|75|mg|56|stk|1|þpakki||N03AX16|01.11.2015||R|0|0|0|0|0|0|GGE|0|0|0|100|SEK|4401|3744|lyfalmen|V0686|3744|2|56|0|14,0000|Mylan AB|Generics (UK) Ltd.|Pregabalín||1905||1905|3744||2 032399|C09CA0106|Losatrix|filmhtfl|25|mg|98|stk|1|þpakki||C09CA01|01.08.2015||R|1|0|0|0|G|0|RGM|0|0|0|100|IKR|2877|3875|lyfalmen|||2|98|0|49,0000|Medical ehf|ratiopharm GmbH|Lósartan||2000||2000|3875||2 032523|N05AX1201|Abilify|mixtúra|1|mg/ml|150|ml|1|fl||N05AX12|01.02.2007||R|0|1|0|0|G|0|OTS|0|0|0|100|DKK|18866|27089|lyfalmen|||1|150|0|10,0000|Vistor hf|Otsuka Pharmaceutical Europe Ltd.|Aripiprazól||18866||18866|27089||1 032664|QP54AA0103|Ivomec, vet.|stl|10|mg/ml|200|ml|1|fl||QP54AA01|01.01.1985||R|0|0|0|0|0|0|MEF|1|0|0|100|XEU|13043|22481|vetorma|||0|200|0||Vistor hf|Merial (MSD)|Ivermectinum||13043||13043|22481||1 032706|C03EA0113|Diuramin|töflur|55|mg|100|stk|1|þpakki|5+50 mg|C03EA01|01.05.2013||R|1|0|0|0|G|0|RGM|0|0|0|100|IKR|1198|2771|lyfalmen|V0558|2256|2|100|0|100,0000|Medical ehf|ratiopharm GmbH|Hýdróklórtíazíð og kalíumsparandi lyf||1198||1198|2771||2 033124|L02BX0201|Firmagon|sts|80|mg|1|hgl|1|pakki|leysir|L02BX02|01.11.2010||R|0|1|0|1|G|0|FER|0|0|0|100|DKK|19122|27442|lyfalmen|||1|1|0|29,6300|Vistor hf|Ferring|Degarelix||||19122|27442||1 033135|L02BX0201|Firmagon|sts|120|mg|2|hgl|1|pakki|leysir|L02BX02|01.11.2010||R|0|1|0|1|G|0|FER|0|0|0|100|DKK|38138|50938|lyfalmen|||1|2|0|88,8900|Vistor hf|Ferring|Degarelix||||38138|50938||1 033193|QP54AA0105|Noromectin|pasta|18,7|mg/g|7,49|g|1|áf.spr|Fyrir hesta|QP54AA01|01.11.2011||R|0|0|0|0|0|0|NOB|0|0|0|100|XEU|1095|1887|vetorma|||0|7,49|0||Norbrook Laboratories Limited|Norbrook Laboratories Limited|Ivermectinum||1095||1095|1887||2 033195|N02AA5501|Targin|forðatfl|15|mg|28|stk|1|þpakki|10+5 mg|N02AA55|01.10.2012||R|1|0|1|0|0|0|NOP|0|0|0|100|DKK|2756|4916|lyfalmen|||1|28|0|3,7400|Icepharma hf|Norpharma|Oxycodonum í blöndum||2756||2756|4916||2 033201|QJ01DD9001|Eficur vet.|stl|50|mg/ml|100|ml|1|hgl||QJ01DD90|01.02.2010||R|0|0|0|0|0|0|LHS|0|0|0|100|XEU|8196|15720|vetalmen|||0|100|0||Dýraheilsa ehf|Laboratorios Hipra S.A.|Ceftiofurhydróklóríð||||8196|15720||2 033206|N02AA5501|Targin|forðatfl|15|mg|98|stk|1|þpakki|10+5 mg|N02AA55|01.10.2012||R|1|0|1|0|0|0|NOP|0|0|0|100|DKK|9391|14048|lyfalmen|||1|98|0|13,0700|Icepharma hf|Norpharma|Oxycodonum í blöndum||9391||9391|14048||2 033218|N02AA5501|Targin|forðatfl|30|mg|28|stk|1|þpakki|20+10 mg|N02AA55|01.10.2012||R|1|0|1|0|0|0|NOP|0|0|0|100|DKK|5515|8713|lyfalmen|||1|28|0|7,4700|Icepharma hf|Norpharma|Oxycodonum í blöndum||5515||5515|8713||2 033229|N02AA5501|Targin|forðatfl|30|mg|98|stk|1|þpakki|20+10 mg|N02AA55|01.10.2012||R|1|0|1|0|0|0|NOP|0|0|0|100|DKK|16278|23527|lyfalmen|||1|98|0|26,1400|Icepharma hf|Norpharma|Oxycodonum í blöndum||16278||16278|23527||2 033251|S01CA0102|Tobradex|augndr|||5|ml|1|glas|3+1 mg/ml|S01CA01|01.06.2007||R|0|0|0|0|G|0|CLA|0|0|1|100|USD|1291|2899|lyfalmen|||1|5|0||Vistor hf|Alcon Nordic A/S|Dexametasón||1291||1291|2899||1 033357|M01AB0518|Diclomex Rapid|filmhtfl|50|mg|100|stk|1|þpakki||M01AB05|01.08.2013||R|1|0|0|0|G|0|ROY|0|0|1|100|XEU|1428|2123|lyfalmen|V0189|2123|2|100|0|50,0000|Medical ehf|ratiopharm Oy|Díklófenak||727||727|2123||2 033498|M01AB0518|Diclomex Rapid|filmhtfl|50|mg|30|stk|1|þpakki||M01AB05|01.08.2013||R|1|0|0|0|G|0|ROY|0|0|1|100|XEU|592|1516|lyfalmen|V0188|1516|2|30|0|15,0000|Medical ehf|ratiopharm Oy|Díklófenak||286||286|1516||2 033777|L02BG0404|Letromal|filmhtfl|2,5|mg|100|stk|1|þpakki||L02BG04|01.04.2011||R|0|0|0|0|G|0|WEH|0|0|0|100|XEU|16788|13309|lyfalmen|V0185|13309|2|100|0|100,0000|Williams & Halls efh|Williams & Halls ehf|Letrózól||8854||8854|13309||2 033895|J05AE1001|Prezista|filmhtfl|600|mg|60|stk|1|plglas||J05AE10|01.11.2009||R|1|0|0|1|0|1|JCI|0|0|0|100|SEK|84004|108949|lyfsjukr|||1|60|0|30,0000|Vistor hf|Janssen-Cilag International N.V.|Darunavír||84004||84004|108949||1 034033|QJ01MA9001|Baytril vet.|töflur|50|mg|10|stk|1|þpakki||QJ01MA90|01.03.2009||R|0|0|0|0|0|0|BAN|0|0|0|100|DKK|2218|4359|vetalmen|||0|10|0||Icepharma hf|Bayer Animal Health GmbH|Enrofloxacinum||||2218|4359||2 034124|C09BA0202|Enalapril comp ratiopharm|töflur|32,5|mg|100|stk|1|þpakki|20+12,5 mg|C09BA02|01.12.2013||R|1|0|0|0|G|0|ROY|0|0|0|100|XEU|1752|2150|lyfalmen|V0098|2150|2|100|0|100,0000|Medical ehf|ratiopharm Oy|Enalapríl og þvagræsilyf||747||747|2150||2 034157|J07AM5104|Diftavax|stl|||0,5|ml|1|spr|einnota sprauta|J07AM51|01.01.2000||R|0|0|0|0|0|0|SPM|0|0|1|100|XEU|668|2042|lyfalmen|||1|0,5|0||Icepharma hf|Sanofi Pasteur MSD|Stífkrampatoxóíð í blöndum með barnaveikistoxóíðum||668||668|2042||2 034401|J06BA0208|Privigen|irl|100|mg/ml|25|ml|1|hgl||J06BA02|01.10.2009||R|0|0|0|0|0|1|CSB|0|1|0|100|SEK|15947|23072|lyfsjukr|||1|25|0||Icepharma hf|CSL Behring GmbH|Immúnóglóbúlín, normal, manna, gefin í æð||15947||15947|23072||2 034468|B01AC2201|Efient|filmhtfl|5|mg|28|stk|1|þpakki||B01AC22|01.12.2009||R|0|1|0|0|G|0|ELD|0|0|0|100|XEU|7433|11353|lyfalmen|||1|28|0|14,0000|Icepharma hf|Eli Lilly Nederland B.V.|Prasugrel||||7433|11353||2 034479|B01AC2201|Efient|filmhtfl|10|mg|28|stk|1|þpakki||B01AC22|01.12.2009||R|0|1|0|0|G|0|ELD|0|0|0|100|XEU|7433|11353|lyfalmen|||1|28|0|28,0000|Icepharma hf|Eli Lilly Nederland B.V.|Prasugrel||||7433|11353||2 034494|N05CM1801|Dexdor|irþ|100|mcg/ml|10|ml|4|hgl|lausn|N05CM18|01.03.2012||R|0|0|0|1|0|1|ORC|0|0|0|100|DKK|60369|79055|lyfsjukr|||1|40|0|4,0000|Vistor hf|Orion Corporation|Dexmedetómid||60369||60369|79055||1 034934|S01BC0301|Voltaren Ophtha|augndr|1|mg/ml|0,3|ml|20|sk-hyl||S01BC03|01.04.1996||R|0|0|0|0|G|0|NOC|0|0|1|100|SEK|1524|3220|lyfalmen|V0367|3220|1|6|0||Vistor hf|Novartis Healthcare A/S|Díklófenak||1524||1524|3220||1 034983|S01BC0301|Voltaren Ophtha|augndr|1|mg/ml|0,3|ml|40|sk-hyl||S01BC03|01.04.1996||R|0|0|0|0|G|0|NOC|0|0|1|100|SEK|2550|4632|lyfalmen|||1|12|0||Vistor hf|Novartis Healthcare A/S|Díklófenak||2550||2550|4632||1 034988|L03AB0702|Rebif|stl|44|mcg/lykj|0,5|ml|4|rörlyk||L03AB07|01.03.2010||R|0|0|0|1|0|1|MSE|0|0|0|100|SEK|105226|136452|lyfsjukr|||1|2|0|40,9300|Icepharma hf|Merck Serono Europe Ltd|Interferón beta-1a||105226||105226|136452||2 035024|V03AB1402|Protaminsulfat Leo Pharma|stl|10|mg/ml|5|ml|5|hgl||V03AB14|01.06.2007||R|0|0|0|0|0|1|LEP|0|0|0|100|DKK|6679|10315|lyfsjukr|||1|25|0||Vistor hf|LEO Pharma A/S|Prótamín||6679||6679|10315||1 035113|B05XA0501|Addex-Magnesium|irþ|1|mmol/ml|10|ml|10|plhgl||B05XA05|01.03.2010||R|0|0|0|0|0|1|FKA|0|0|0|100|DKK|2009|3887|lyfsjukr|||1|100|0||Vistor hf|Fresenius Kabi AB|Magnesíum súlfat||2009||2009|3887||1 035134|B01AF0201|Eliquis|filmhtfl|5|mg|14|stk|1|þpakki||B01AF02|01.09.2014||R|1|1|0|0|G|0|BRP|0|0|0|100|DKK|2234|4197|lyfalmen|||1|14|0|7,0000|Icepharma hf|Bristol-Myers Squibb/Pfizer EEIG|Apixaban ||||2234|4197||1 035153|N02AB0306|Instanyl|nefúði|50|mcg|6|sk-ílát|1|pakki||N02AB03|01.08.2014||R|0|1|1|1|0|0|TPA|0|0|0|100|DKK|8618|12984|lyfalmen|||1|6|0|0,5000|Vistor hf|Takeda Pharma A/S|Fentanýl||8618||8618|12984||1 035212|A07EC0202|Pentasa|forðatfl|500|mg|300|stk|1|þpakki||A07EC02|01.04.1992||R|1|0|0|0|G|0|FER|0|0|0|100|DKK|14009|20404|lyfalmen|||1|300|0|100,0000|Vistor hf|Ferring|Mesalazín (5-amínósalicýlsýra)||14009||14009|20404||1 035494|C07AB0211|Metoprolol ratiopharm|forðatfl|23,75|mg|100|stk|1|þpakki||C07AB02|01.05.2012||R|1|0|0|0|G|0|RGM|0|0|0|100|XEU|1201|2397|lyfalmen|V0050|1875|2|100|0|15,8300|Medical ehf|ratiopharm GmbH|Metóprólól||926||926|2397||2 035515|N03AX0903|Lamotrin|dreifit.|50|mg|56|stk|1|þpakki||N03AX09|01.11.2005||R|0|0|0|0|G|0|ACA|0|0|0|100|IKR|1844|2047|lyfalmen|V0244|2047|2|56|0|9,3300|Actavis Group hf|Actavis hf|Lamótrigín||672||672|2047||1 035528|C07AB0211|Metoprolol ratiopharm|forðatfl|47,5|mg|100|stk|1|þpakki||C07AB02|01.06.2012||R|1|0|0|0|G|0|RGM|0|0|0|100|XEU|1194|2766|lyfalmen|V0048|2401|2|100|0|31,6600|Medical ehf|ratiopharm GmbH|Metóprólól||1194||1194|2766||2 035563|C07AB0211|Metoprolol ratiopharm|forðatfl|95|mg|100|stk|1|þpakki||C07AB02|01.05.2012||R|1|0|0|0|G|0|RGM|0|0|0|100|XEU|2131|3743|lyfalmen|V0049|3403|2|100|0|63,3300|Medical ehf|ratiopharm GmbH|Metóprólól||1904||1904|3743||2 035568|C09CA0601|Atacand|töflur|16|mg|98|stk|1|þpakki||C09CA06|01.02.2010||R|1|0|0|0|0|0|AZD|0|0|0|100|SEK|7890|11982|lyfalmen|V0080|6542|1|98|0|196,0000|Vistor hf|AstraZeneca A/S DK|Candesartan||7890||7890|11982||1 035597|C07AB0211|Metoprolol ratiopharm|forðatfl|190|mg|100|stk|1|þpakki||C07AB02|01.06.2012||R|1|0|0|0|G|0|RGM|0|0|0|100|XEU|4657|6110|lyfalmen|V0054|5663|2|100|0|126,6600|Medical ehf|ratiopharm GmbH|Metóprólól||3624||3624|6110||2 035722|N02CC0105|Sumatriptan Bluefish|töflur|50|mg|18|stk|1|þpakki||N02CC01|01.12.2015||R|1|0|0|0|G|0|BLP|0|0|0|100|IKR|4409|2636|lyfalmen|V0233|2636|2|18|0|18,0000|LYFIS ehf|Bluefish Pharmaceuticals AB|Súmatriptan||1100||1100|2636||2 035755|M01AE0102|Ibufen|filmhtfl|400|mg|100|stk|1|þpakki||M01AE01|01.12.2014|31.03.2016|R|1|0|0|0|G|0|AGP|0|0|1|100|XEU|677|1938|lyfalmen|||2|100|0|33,3333|Actavis Group hf|Actavis Group PTC ehf|Íbúprófen||593||593|1938||1 036062|V03AE0202|Renvela|filmhtfl|800|mg|180|stk|1|pakki||V03AE02|01.04.2010||R|0|1|0|0|0|0|GZE|0|0|0|100|NOK|21788|28003|lyfalmen|V0680|25734|1|180|0|22,5000|Vistor hf|Genzyme Europe B.V.|Sevelamer||20005||20005|28003||1 036108|L03AB0702|Rebif|stl|22|mcg/lykj|0,5|ml|4|rörlyk||L03AB07|01.03.2010||R|0|0|0|1|0|1|MSE|0|0|0|100|SEK|105226|136452|lyfsjukr|||1|2|0|20,4700|Icepharma hf|Merck Serono Europe Ltd|Interferón beta-1a||105226||105226|136452||2 036228|C09CA0601|Atacand|töflur|8|mg|98|stk|1|þpakki||C09CA06|01.02.2010||R|1|0|0|0|0|0|AZD|0|0|0|100|SEK|7013|10775|lyfalmen|V0081|5620|1|98|0|98,0000|Vistor hf|AstraZeneca A/S DK|Candesartan||7013||7013|10775||1 036442|J01CE0204|Kaavepenin|töflur|800|mg|20|stk|1|þpakki||J01CE02|01.01.1988||R|0|0|0|0|0|0|REP|0|0|1|100|SEK|702|2088|lyfalmen|||1|20|0|8,0000|Vistor hf|Recip AB|Fenoxýmetýlpenicillín||702||702|2088||1 036502|N06DA0301|Exelon|forðapl|13,3|mg/sólh|30|pokar|1|pakki||N06DA03|01.02.2014||R|0|1|0|0|G|0|NEL|0|0|0|100|DKK|17719|25511|lyfalmen|||1|30|0|42,0000|Vistor hf|Novartis Europharm Ltd|Rívastigmín||17719||17719|25511||1 036517|J01CE0204|Kaavepenin|mixt.kyr|100|mg/ml|60|ml|1|glas||J01CE02|01.07.1992||R|0|0|0|0|0|0|REP|0|0|1|100|SEK|1235|2822|lyfalmen|||1|60|0|3,0000|Vistor hf|Recip AB|Fenoxýmetýlpenicillín||1235||1235|2822||1 036529|QI09AB1302|Ingelvac MycoFLEX|stl|||50|ml|1|glas|handa svínum|QI09AB13|01.12.2013||R|0|0|0|0|0|0|BIV|0|0|0|100|DKK|3983|6865|vetorma|||1|50|0||Vistor hf|Boehringer Ingelheim Vetmedica GmbH|Óvirkar bakteríur í bóluefnum||3983||3983|6865||1 036541|A03AX1301|Minifom|dropar|||30|ml|1|glas|+drteljari|A03AX13|01.12.1975||L|0|0|0|0|0|0|AHN|0|0|0|100|IKR|||lyflausa|||0|30|0|6,0000|Aco Hud Nordic AB|Aco Hud Nordic AB|Silíkonsambönd|||||||1 036616|J01CE0204|Kaavepenin|mixt.kyr|100|mg/ml|125|ml|1|glas||J01CE02|01.07.1992||R|0|0|0|0|0|0|REP|0|0|1|100|SEK|2437|4476|lyfalmen|||1|125|0|6,2500|Vistor hf|Recip AB|Fenoxýmetýlpenicillín||2437||2437|4476||1 036665|J01CE0204|Kaavepenin|töflur|800|mg|30|stk|1|þpakki||J01CE02|01.01.1988||R|0|0|0|0|0|0|REP|0|0|1|100|SEK|739|2139|lyfalmen|||1|30|0|12,0000|Vistor hf|Recip AB|Fenoxýmetýlpenicillín||739||739|2139||1 036754|N03AX1608|Pregabalina Tecnigen|hylki|300|mg|56|stk|1|þpakki||N03AX16|01.01.2016||R|1|0|0|0|0|0|WEH|0|0|0|100|XEU|9648|6924|lyfalmen|V0689|6672|2|56|0|56,0000|Williams & Halls efh|Williams & Halls ehf|Pregabalín||4215||4215|6924||2 037287|N04BC0404|Requip Depot|forðatfl|2|mg|84|stk|1|þpakki||N04BC04|01.09.2008||R|1|0|0|0|G|0|GPH|0|0|0|100|GBP|7925|7304|lyfalmen|V0532|6441|1|84|0|28,0000|Vistor hf|GlaxoSmithKline Pharma A/S|Rópíníról||4491||4491|7304||1 037305|N04BC0404|Requip Depot|forðatfl|4|mg|84|stk|1|þpakki||N04BC04|01.09.2008||R|1|0|0|0|G|0|GPH|0|0|0|100|GBP|12841|10372|lyfalmen|V0533|9919|1|84|0|56,0000|Vistor hf|GlaxoSmithKline Pharma A/S|Rópíníról||6720||6720|10372||1 037323|N04BC0404|Requip Depot|forðatfl|8|mg|84|stk|1|þpakki||N04BC04|01.09.2008||R|1|0|0|0|G|0|GPH|0|0|0|100|GBP|20593|19744|lyfalmen|V0534|19617|1|84|0|112,0000|Vistor hf|GlaxoSmithKline Pharma A/S|Rópíníról||13529||13529|19744||1 037358|N04BA0201|Madopar|töflur|125|mg|100|stk|1|glas|100+25 mg|N04BA02|01.07.1990||R|1|0|0|0|G|0|ROC|0|0|0|100|DKK|2220|4178|lyfalmen|V0434|4178|1|100|0|16,6667|Icepharma hf|Roche|Levódópa og dópadekarboxýl­asa­hemill||2220||2220|4178||2 037584|N06AB0604|Sertralin Bluefish|filmhtfl|50|mg|30|stk|1|þpakki||N06AB06|01.02.2013||R|1|0|0|0|G|0|BLP|0|0|0|100|IKR|967|1810|lyfalmen|V0151|1810|2|30|0|30,0000|LYFIS ehf|Bluefish Pharmaceuticals AB|Sertralín||500||500|1810||2 037595|N06AB0604|Sertralin Bluefish|filmhtfl|50|mg|100|stk|1|þpakki||N06AB06|01.02.2013||R|1|0|0|0|G|0|BLP|0|0|0|100|IKR|2311|2499|lyfalmen|V0322|1996|2|100|0|100,0000|LYFIS ehf|Bluefish Pharmaceuticals AB|Sertralín||1000||1000|2499||2 037607|N06AB0604|Sertralin Bluefish|filmhtfl|100|mg|100|stk|1|þpakki||N06AB06|01.02.2013||R|1|0|0|0|G|0|BLP|0|0|0|100|IKR|4353|3875|lyfalmen|V0323|3289|2|100|0|200,0000|LYFIS ehf|Bluefish Pharmaceuticals AB|Sertralín||2000||2000|3875||2 037793|L02BB0308|Bicacta|filmhtfl|150|mg|30|stk|1|þpakki||L02BB03|01.03.2016||R|0|0|0|0|G|0|AGP|0|0|0|100|XEU|16476|8944|lyfalmen|V0421|7164|2|30|0|90,0000|Actavis Group hf|Actavis Group PTC ehf|Bíkalútamíð||5683||5683|8944||1 037846|A12BA0101|Kaleorid|forðatfl|750|mg|100|stk|1|glas||A12BA01|01.12.1972||L|1|0|0|0|G|0|LEP|0|0|0|100|DKK|||lyfalmen|||0|100|0|25,0000|Vistor hf|LEO Pharma A/S|Kalíumklóríð|||||2269||1 037853|A12BA0101|Kaleorid|forðatfl|750|mg|250|stk|1|glas||A12BA01|01.12.1972||L|1|0|0|0|G|0|LEP|0|0|0|100|DKK|||lyfalmen|||0|250|0|62,5000|Vistor hf|LEO Pharma A/S|Kalíumklóríð|||||3528||1 037895|C09CA0601|Atacand|töflur|4|mg|98|stk|1|þpakki||C09CA06|01.02.2010||R|1|0|0|0|0|0|AZD|0|0|0|100|SEK|7146|10958|lyfalmen|||1|98|0|49,0000|Vistor hf|AstraZeneca A/S DK|Candesartan||||7146|10958||1 038123|QM01AE9101|Rimadyl vet.|stl|50|mg/ml|20|ml|1|hgl||QM01AE91|01.04.2015||R|0|0|0|0|0|0|ZOE|1|0|0|100|DKK|5958|11474|vetalmen|||0|20|0||Icepharma hf|Zoetis Finland OY|||5958||5958|11474||2 038305|N06AX1611|Duofaxin|forðatfl|150|mg|98|stk|1|þpakki||N06AX16|01.07.2015||R|1|0|0|0|G|0|MEV|0|0|0|100|DKK|2720|4460|lyfalmen|V0335|3090|2|98|0|147,0000|Vistor hf|MediLink A/S|Venlafaxín||2425||2425|4460||1 038448|N06AB0501|Seroxat|töflur|20|mg|100|stk|1|þpakki||N06AB05|01.04.1993||R|1|0|0|0|G|0|GPH|0|0|0|100|IKR|2667|3312|lyfalmen|V0321|3148|1|100|0|100,0000|Vistor hf|GlaxoSmithKline Pharma A/S|Paroxetín||1591||1591|3312||1 038494|C10AA0106|Simvastatin Bluefish|filmhtfl|40|mg|100|stk|1|þpakki||C10AA01|01.02.2014||R|1|0|0|0|G|0|BLP|0|0|0|100|IKR|1347|2174|lyfalmen|V0110|2174|2|100|0|133,3333|LYFIS ehf|Bluefish Pharmaceuticals AB|Simvastatín||764||764|2174||2 038513|D06BA0101|Flamazine|krem|10|mg/g|50|g|1|túpa||D06BA01|01.10.1988||R|0|0|0|0|0|0|SON|0|0|1|100|DKK|921|2390|lyfalmen|||1|50|0||Icepharma hf|Smith & Nephew|Silfursúlfadíazín||921||921|2390||2 038607|L03AA1301|Neulasta|stl|6|mg/penna|0,6|ml|1|penni|áfylltur penni, lausn|L03AA13|01.07.2006||R|0|0|0|1|0|1|AEU|0|0|0|100|DKK|137928|177124|lyfsjukr|||1|0,6|0|20,0000|Vistor hf|Amgen Europe B.V.|Pegfilgrastím||137928||137928|177124||1 039141|B01AF0101|Xarelto|filmhtfl|15|mg|42|stk|1|þpakki||B01AF01|01.05.2012||R|1|1|0|0|G|0|BAP|0|0|0|100|DKK|12857|18819|lyfalmen|||1|42|0|31,5000|Icepharma hf|Bayer Schering Pharma AG|Rivaoxaban||||12857|18819||2 039147|N04BC0701|Apomorfin PharmSwed|irl|5|mg/ml|20|ml|5|hgl|lausn|N04BC07|01.03.2013||R|0|0|0|1|0|1|PSS|0|0|0|100|SEK|28892|39243|lyfsjukr|||1|100|0|25,0000|Williams & Halls efh|PharmSwed|Apómorfín||28892||28892|39243||2 039395|A04AA0107|Ondansetron Bluefish|filmhtfl|8|mg|50|stk|1|þpakki||A04AA01|01.09.2015||R|1|0|0|0|G|0|BLP|0|0|1|100|IKR|14342|12043|lyfalmen|||2|50|0|25,0000|LYFIS ehf|Bluefish Pharmaceuticals AB|Ondansetrón||7934||7934|12043||2 039430|J07AL5201|Synflorix|stl|||0,5|ml|1|áf.spr|m.nál, dreifa|J07AL52|01.04.2012||R|0|0|0|0|0|0|GBI|0|0|0|100|GBP|5900|9243|lyfalmen|||1|0,5|0||Vistor hf|GlaxoSmithKline Biologicals SA|Lungnabólga a.v.pneumok.Hreins pneumok polysakk móte.v Hae||5900||5900|9243||1 039631|C01BD0701|Multaq|filmhtfl|400|mg|20|stk|1|þpakki||C01BD07|01.08.2010||R|1|1|0|1|0|0|SGA|0|0|0|100|NOK|3327|5701|lyfalmen|||1|20|0|10,0000|Vistor hf|Sanofi-aventis groupe|Dronedarón||||3327|5701||1 039643|C01BD0701|Multaq|filmhtfl|400|mg|100|stk|1|þpakki||C01BD07|01.08.2010||R|1|1|0|1|0|0|SGA|0|0|0|100|NOK|15386|22299|lyfalmen|||1|100|0|50,0000|Vistor hf|Sanofi-aventis groupe|Dronedarón||||15386|22299||1 039676|N06AX0307|Mianserin Mylan|filmhtfl|30|mg|100|stk|1|þpakki||N06AX03|01.06.2010||R|1|0|0|0|G|0|MYL|0|0|0|100|SEK|3024|5284|lyfalmen|||2|100|0|50,0000|Icepharma hf|Mylan AB|Míanserín||3024||3024|5284||2 039698|C07AB0311|Atenolol Mylan|töflur|25|mg|98|stk|1|þpakki||C07AB03|01.04.1992||R|1|0|0|0|G|0|MYL|0|0|0|100|SEK|385|1608|lyfalmen|V0541|1465|2|98|0|32,6667|Icepharma hf|Mylan AB|Atenólól||353||353|1608||2 039709|C07AB0311|Atenolol Mylan|töflur|50|mg|98|stk|1|þpakki||C07AB03|01.01.1991||R|1|0|0|0|G|0|MYL|0|0|0|100|SEK|555|1655|lyfalmen|V0542|1604|2|98|0|65,3333|Icepharma hf|Mylan AB|Atenólól||387||387|1655||2 039776|J01FA1001|Zitromax|mixtúrud|40|mg/ml|15|ml|1|glas||J01FA10|01.07.1994||R|0|0|0|0|0|0|PER|0|0|1|100|DKK|950|2430|lyfalmen|||1|15|0|2,0000|Icepharma hf|Pfizer ApS|Azitrómýcín||950||950|2430||1 039784|J01FA1001|Zitromax|mixtúrud|40|mg/ml|22,5|ml|1|glas||J01FA10|01.01.1995||R|0|0|0|0|0|0|PER|0|0|1|100|DKK|1665|3414|lyfalmen|||1|22,5|0|3,0000|Icepharma hf|Pfizer ApS|Azitrómýcín||1665||1665|3414||1 039837|N02BE0107|Paratabs|filmhtfl|500|mg|30|stk|1|þpakki||N02BE01|01.03.2013||L|1|0|0|0|0|0|APC|0|0|1|100|IKR|||lyflausa|||0|30|0|5,0000|Actavis Group PTC ehf|Actavis Group PTC ehf|Paracetamól|||||||1 039909|L01AA0101|Sendoxan|sts|200|mg|1|stk|1|hgl||L01AA01|01.07.1992|29.02.2016|R|0|0|0|1|0|1|BAM|0|0|0|100|SEK|1151|2706|lyfsjukr|||1|1|0||Icepharma hf|Baxter Medical AB|Cýklófosfamíð||1151||1151|2706||2 039935|C10AA0105|Simvastatin Actavis|filmhtfl|40|mg|98|stk|1|þpakki||C10AA01|01.06.2009||R|1|0|0|0|G|0|AGP|0|0|0|100|IKR|1630|2174|lyfalmen|V0110|2131|2|98|0|130,6700|Actavis Group hf|Actavis Group PTC ehf|Simvastatín||764||764|2174||1 039957|J05AB1104|Valaciclovir Actavis|filmhtfl|500|mg|42|stk|1|þpakki||J05AB11|01.01.2010||R|1|0|0|0|G|0|AGP|0|0|1|100|GBP|7164|4735|lyfalmen|V0182|4735|2|42|0|7,0000|Actavis Group hf|Actavis Group PTC ehf|Valacíklóvír||2625||2625|4735||1 039958|L01AA0101|Sendoxan|sts|500|mg|1|stk|1|hgl||L01AA01|01.01.1988|29.02.2016|R|0|0|0|1|0|1|BAM|0|0|0|100|SEK|2885|5093|lyfsjukr|||1|1|0||Icepharma hf|Baxter Medical AB|Cýklófosfamíð||2885||2885|5093||2 039968|J05AB1104|Valaciclovir Actavis|filmhtfl|500|mg|10|stk|1|þpakki||J05AB11|01.01.2010||R|1|0|0|0|G|0|AGP|0|0|1|100|GBP|1721|1938|lyfalmen|V0033|1926|2|10|0|1,6667|Actavis Group hf|Actavis Group PTC ehf|Valacíklóvír||593||593|1938||1 040089|L01AA0101|Sendoxan|sts|1|g|1|stk|1|hgl||L01AA01|01.07.1994|29.02.2016|R|0|0|0|1|0|1|BAM|0|0|0|100|SEK|5755|9043|lyfsjukr|||1|1|0||Icepharma hf|Baxter Medical AB|Cýklófosfamíð||5755||5755|9043||2 040313|N02AB0306|Instanyl|nefúði|200|mcg|6|sk-ílát|1|pakki||N02AB03|01.08.2014||R|0|1|1|1|0|0|TPA|0|0|0|100|DKK|8708|13108|lyfalmen|||1|6|0|2,0000|Vistor hf|Takeda Pharma A/S|Fentanýl||8708||8708|13108||1 040421|QJ51CF0204|Orbenin vet.|spenalyf|500|mg/dælu|1|stk|24|spr||QJ51CF02|01.04.2015||R|0|0|0|0|0|0|ZOE|0|0|0|100|DKK|4994|9645|vetalmen|||0|24|0||Icepharma hf|Zoetis Finland OY|||4994||4994|9645||2 040426|R06AX2703|Desloratadine Actavis|filmhtfl|5|mg|30|stk|1|þpakki||R06AX27|01.05.2012||R|1|0|0|0|G|0|APC|0|0|1|100|XEU|565|1900|lyfalmen|V0366|1900|2|30|0|30,0000|Actavis Group PTC ehf|Actavis Group PTC ehf|Deslóratadín||565||565|1900||1 040543|S01XA2012|Dacriosol|augndr|3|mg/ml|15|ml|1|glas||S01XA20|01.03.2000||L|0|0|0|0|G|0|SAC|0|0|0|100|IKR|||lyfalmen|||0|15|0||Vistor hf|S.A. Alcon - Couvreur N.V.|Gervitár og aðrar óvirkar samsetningar|||||1871||1 040620|QJ01CA0401|Clamoxyl, vet.|töflur|40|mg|100|stk|1|þpakki||QJ01CA04|01.04.2015||R|0|0|0|0|0|0|ZOE|0|0|0|100|DKK|4240|8215|vetalmen|||0|100|0||Icepharma hf|Zoetis Finland OY|||4240||4240|8215||2 040708|G02AD0601|Misodel|sk-innl|200|mcg|5|stk|1|askja||G02AD06|01.09.2014||R|0|0|0|1|0|1|FEL|0|0|0|100|DKK|79929|103795|lyfsjukr|||1|5|0|5,0000|Vistor hf|Ferring Lægemidler A/S|Misóprostól||||79929|103795||1 040735|J01FA1005|Azithromycin Actavis|filmhtfl|500|mg|3|stk|1|þpakki||J01FA10|01.12.2012||R|1|0|0|0|0|0|APC|0|0|1|100|XEU|1113|2654|lyfalmen|V0174|2654|2|3|0|5,0000|Actavis Group PTC ehf|Actavis Group PTC ehf|Azitrómýcín||1113||1113|2654||1 040742|C08CA0203|Felodipin ratiopharm|forðatfl|2,5|mg|100|stk|1|þpakki||C08CA02|01.11.2014||R|1|0|0|0|G|0|RGM|0|0|0|100|IKR|3128|3875|lyfalmen|||2|100|0|50,0000|Medical ehf|ratiopharm GmbH|Felódipín||2000||2000|3875||2 040891|N06AB1007|Escitalopram Bluefish|filmhtfl|20|mg|28|stk|1|þpakki||N06AB10|01.08.2015||R|1|0|0|0|0|0|BLP|0|0|0|100|IKR|2060|3958|lyfalmen|||2|28|0|56,0000|LYFIS ehf|Bluefish Pharmaceuticals AB|Escítalópram||2060||2060|3958||2 041086|C01EB1701|Procoralan|filmhtfl|5|mg|56|stk|1|þpakki||C01EB17|01.04.2014||R|1|0|0|1|0|0|LLS|0|0|0|100|DKK|8609|12972|lyfalmen|||1|56|0|28,0000|Icepharma hf|Les Laboratoires Servier|Ivabradín||8609||8609|12972||2 041105|C01EB1701|Procoralan|filmhtfl|7,5|mg|56|stk|1|þpakki||C01EB17|01.04.2014||R|1|0|0|1|0|0|LLS|0|0|0|100|DKK|8609|12972|lyfalmen|||1|56|0|42,0000|Icepharma hf|Les Laboratoires Servier|Ivabradín||8609||8609|12972||2 041704|QG03XA9101|Improvac|stl|300|mcg|20|ml|12|fl||QG03XA91|01.08.2010|29.02.2016|R|0|0|0|0|0|0|ZBE|0|0|0|100|DKK|12578|21679|vetorma|||0|240|0||Icepharma hf|Zoetis Belgium S.A.|gonadotropin releasing factor analogue, conjugated||12578||12578|21679||2 041716|QG03XA9101|Improvac|stl|300|mcg|100|ml|10|glös||QG03XA91|01.10.2014|29.02.2016|R|0|0|0|0|0|0|ZBE|0|0|0|100|DKK|51799|89281|vetorma|||0|1000|0||Icepharma hf|Zoetis Belgium S.A.|gonadotropin releasing factor analogue, conjugated||51799||51799|89281||2 041749|QI04AB0101|Lambivac, vet.|stl|126|Lf/ml|100|ml|1|fl|dreifa|QI04AB01|01.04.2007||R|0|0|0|0|0|0|IBV|0|0|0|100|DKK|3189|5497|vetorma|||0|100|0||Vistor hf|Intervet International BV|||3189||3189|5497||1 041898|N06AX0307|Mianserin Mylan|filmhtfl|10|mg|90|stk|1|þpakki||N06AX03|01.06.2008||R|1|0|0|0|G|0|MYL|0|0|0|100|SEK|1020|2526|lyfalmen|||2|90|0|15,0000|Icepharma hf|Mylan AB|Míanserín||||1020|2526||2 041942|N06AX1106|Mirtazapin Krka|filmhtfl|15|mg|300|stk|1|glas||N06AX11|01.01.2015||R|1|0|0|0|G|0|KRK|0|0|0|100|IKR|7000|9381|lyfalmen|||2|300|0|150,0000|LYFIS ehf|Krka Sverige AB|Mirtazapín||6000||6000|9381||2 041951|N06AX1106|Mirtazapin Krka|filmhtfl|30|mg|250|stk|1|glas||N06AX11|01.01.2015||R|1|0|0|0|G|0|KRK|0|0|0|100|IKR|9000|9381|lyfalmen|||2|250|0|250,0000|LYFIS ehf|Krka Sverige AB|Mirtazapín||6000||6000|9381||2 041996|A06AG1101|Microlax|innhl|||5|ml|4|túpa||A06AG11|01.12.1972||L|0|0|0|0|0|0|MCN|0|0|0|100|IKR|||lyflausa|||0|20|0|4,0000|Vistor hf|McNeil Denmark ApS|Lárýlsúlfat, þ.m.t. í blöndum|||||||1 042036|C07AB0205|Seloken|stl|1|mg/ml|5|ml|5|lykjur||C07AB02|01.01.1985||R|0|0|0|0|G|0|AZD|0|0|0|100|SEK|1311|2927|lyfalmen|||1|25|0|0,1667|Vistor hf|AstraZeneca A/S DK|Metóprólól||1311||1311|2927||1 042305|B05BA0311|Glucos Fresenius Kabi|irl|100|mg/ml|1000|ml|10|plpok|Freeflex umbúðir|B05BA03|01.05.2007||R|0|0|0|0|0|1|FKA|0|0|0|100|DKK|2264|4238|lyfsjukr|||1|10000|0||Vistor hf|Fresenius Kabi AB|Kolvetni||2264||2264|4238||1 042314|B05BA0311|Glucos Fresenius Kabi|irl|100|mg/ml|500|ml|15|plpok|Freeflex umbúðir|B05BA03|01.05.2007||R|0|0|0|0|0|1|FKA|0|0|0|100|DKK|3574|6041|lyfsjukr|||1|7500|0||Vistor hf|Fresenius Kabi AB|Kolvetni||3574||3574|6041||1 042396|B05BA0311|Glucos Fresenius Kabi|irl|50|mg/ml|1000|ml|10|plpok|Freeflex umbúðir|B05BA03|01.05.2007||R|0|0|0|0|0|1|FKA|0|0|0|100|DKK|1942|3795|lyfsjukr|||1|10000|0||Vistor hf|Fresenius Kabi AB|Kolvetni||1942||1942|3795||1 042405|B05BB0213|Kalium-Natrium-Glucose "Fresenius Kabi"|irl|||1000|ml|10|plpok|Freeflex umbúðir|B05BB02|01.05.2007||R|0|0|0|0|0|1|FKA|0|0|0|100|DKK|2568|4657|lyfsjukr|||2|10000|0||Vistor hf|Fresenius Kabi AB|Elektrólýtar í blöndum með kol­vetnum||2568||2568|4657||1 042469|B05BB0114|Natriumklorid Fresenius Kabi|irl|9|mg/ml|1000|ml|10|plpok|Freeflex umbúðir|B05BB01|01.05.2007||R|0|0|0|0|0|1|FKA|0|0|0|100|DKK|1875|3703|lyfsjukr|||1|10000|0||Vistor hf|Fresenius Kabi AB|Elektrólýtar||1875||1875|3703||1 042524|B05BB0115|Ringer-acetat Fresenius Kabi|irl|||1000|ml|10|plpok|Freeflex umbúðir|B05BB01|01.05.2007||R|0|0|0|0|0|1|FKA|0|0|0|100|DKK|2124|4046|lyfsjukr|||1|10000|0||Vistor hf|Fresenius Kabi AB|Elektrólýtar||2124||2124|4046||1 042549|J07BF0301|Imovax Polio|stl|||0,5|ml|1|áf.spr|með nál|J07BF03|01.01.1996||R|0|0|0|0|0|0|SPM|0|0|0|100|XEU|2039|3929|lyfalmen|||1|0,5|0||Icepharma hf|Sanofi Pasteur MSD|Mænusótt, dauð veira||2039||2039|3929||2 042551|B05BB0209|Glucos 100 mg/ml med Na40 + K20 Fres|irl|||1000|ml|10|plpok||B05BB02|01.04.2009||R|0|0|0|0|0|1|FRP|0|0|0|100|DKK|2930|5155|lyfsjukr|||2|10000|0||Icepharma hf|Fresenius Kabi|Elektrólýtar í blöndum með kol­vetnum||2930||2930|5155||2 042573|QM01AH9201|Trocoxil|tuggutfl|20|mg|2|stk|1|þpakki||QM01AH92|01.12.2010||R|0|0|0|0|0|0|ZBE|0|0|0|100|DKK|1783|3504|vetalmen|||0|2|0||Icepharma hf|Zoetis Belgium S.A.|Mavakoxíb||1783||1783|3504||2 042584|QM01AH9201|Trocoxil|tuggutfl|30|mg|2|stk|1|þpakki||QM01AH92|01.12.2010||R|0|0|0|0|0|0|ZBE|0|0|0|100|DKK|2391|4699|vetalmen|||0|2|0||Icepharma hf|Zoetis Belgium S.A.|Mavakoxíb||2391||2391|4699||2 042595|QM01AH9201|Trocoxil|tuggutfl|75|mg|2|stk|1|þpakki||QM01AH92|01.12.2010||R|0|0|0|0|0|0|ZBE|0|0|0|100|DKK|4782|9243|vetalmen|||0|2|0||Icepharma hf|Zoetis Belgium S.A.|Mavakoxíb||4782||4782|9243||2 042607|QM01AH9201|Trocoxil|tuggutfl|95|mg|2|stk|1|þpakki||QM01AH92|01.12.2010||R|0|0|0|0|0|0|ZBE|0|0|0|100|DKK|5499|10603|vetalmen|||0|2|0||Icepharma hf|Zoetis Belgium S.A.|Mavakoxíb||5499||5499|10603||2 042615|B05BB0210|Rehydrex m. gl. 25 mg/ml Fresenius Kabi|irl|||1000|ml|10|plpok|Freeflex umbúðir|B05BB02|01.05.2007||R|0|0|0|0|0|1|FKA|0|0|0|100|DKK|2158|4092|lyfsjukr|||2|10000|0||Vistor hf|Fresenius Kabi AB|Elektrólýtar í blöndum með kol­vetnum||2158||2158|4092||1 042669|V07AB0013|Sterilt vatten/vann/vand Fresenius Kabi|leysir|||100|ml|40|plastl|fyrir stungulyf|V07AB|01.04.2008||L|0|0|0|0|0|0|FKA|0|0|0|100|IKR|||lyflausa|||0|4000|0||Vistor hf|Fresenius Kabi AB|Leysi- og þynningarvökvar, þ.m.t. skolvökvar|||||||1 042775|A06AB0603|Senokot (Icepharma)|töflur|7,5|mg|500|stk|1|glas||A06AB06|01.10.2012||R|1|0|0|0|0|0|FMV|0|0|0|100|GBP|3538|5992|lyfalmen|||3|500|0||Icepharma hf|Icepharma hf|Senna||3538||3538|5992||2 043232|N05CD0306|Flunitrazepam Mylan|töflur|1|mg|30|stk|1|þpakki||N05CD03|01.10.1992||R|1|0|1|0|0|0|MYL|0|0|0|100|SEK|493|1801|lyfalmen|||2|30|0|30,0000|Icepharma hf|Mylan AB|Flúnítrazepam||493||493|1801||2 043345|N03AX1405|Matever|filmhtfl|1000|mg|100|stk|1|þpakki||N03AX14|01.02.2012||R|1|0|0|0|0|0|PSA|0|0|0|100|XEU|14066|6523|lyfalmen|V0516|5506|2|100|0|66,6700|Alvogen|Pharmathen S.A.|Levetíracetam||3924||3924|6523||1 043379|R03AC1201|Serevent|innúðal|25|mcg/sk|120|skammtar|1|stauk|HFA 134a|R03AC12|01.04.2007||R|0|0|0|0|G|0|GPH|0|0|1|100|GBP|3801|6354|lyfalmen|||1|120|0|30,0000|Vistor hf|GlaxoSmithKline Pharma A/S|Salmeteról||3801||3801|6354||1 043729|N05CD0503|Halcion|töflur|0,125|mg|30|stk|1|þpakki||N05CD05|01.12.1983||R|1|0|0|0|0|0|PER|0|0|1|100|DKK|503|1815|lyfalmen|||1|30|0|15,0000|Icepharma hf|Pfizer ApS|Tríazólam||503||503|1815||1 043988|B03AA0705|Ferrous Sulphate|töflur|200|mg|100|stk|1|glas|sykurhúðaðar|B03AA07|01.09.2009||L|1|0|0|0|0|0|AUK|0|0|1|100|IKR|||lyflausa|||0|100|0|32,5000|Actavis Group hf|Actavis UK Ltd.|Ferrósúlfat|||||||1 044046|QJ01CA0401|Clamoxyl, vet.|töflur|40|mg|10|stk|1|þpakki||QJ01CA04|01.02.2016||R|0|0|0|0|0|0|ZOE|0|0|0|100|DKK|463|910|vetalmen|||0|10|0||Icepharma hf|Zoetis Finland OY|||||463|910||2 044360|B03AC0004|Venofer (Lyfjaver)|stl|20|mg/ml|5|ml|5|lykjur||B03AC|01.05.2006||R|0|1|0|0|G|0|LVR|0|0|1|100|CHF|12868|18834|lyfalmen|V0637|18834|3|25|0|5,0000|Lyfjaver ehf|Lyfjaver ehf|Járn, stungulyf||12868||12868|18834||3 044580|L01XE1001|Afinitor|töflur|5|mg|30|stk|1|þpakki||L01XE10|01.09.2011||R|0|0|0|1|0|1|NEL|0|1|0|100|DKK|339709|428083|lyfsjukr|||1|30|0||Vistor hf|Novartis Europharm Ltd|Everolímus||||339709|428083||1 044591|L01XE1001|Afinitor|töflur|10|mg|30|stk|1|þpakki||L01XE10|01.09.2011||R|0|0|0|1|0|1|NEL|0|1|0|100|DKK|450506|565883|lyfsjukr|||1|30|0||Vistor hf|Novartis Europharm Ltd|Everolímus||||450506|565883||1 044732|L01AA0101|Sendoxan|töflur|50|mg|100|stk|1|þpakki||L01AA01|01.06.2014||R|0|0|0|0|G|0|BAM|0|0|0|100|SEK|5301|8418|lyfalmen|||1|100|0||Icepharma hf|Baxter Medical AB|Cýklófosfamíð||5301||5301|8418||2 044739|N04BC0502|Sifrol|forðatfl|0,52|mg|100|stk|1|pakki||N04BC05|01.02.2010||R|0|0|0|0|G|0|BII|0|0|0|100|DKK|14596|21212|lyfalmen|V0635|15368|1|100|0|20,8000|Vistor hf|Boehringer Ingelheim International|Pramipexól||14596||14596|21212||1 044752|N04BC0502|Sifrol|forðatfl|2,1|mg|100|stk|1|pakki||N04BC05|01.02.2010||R|0|0|0|0|G|0|BII|0|0|0|100|DKK|38884|51881|lyfalmen|V0636|32660|1|100|0|84,0000|Vistor hf|Boehringer Ingelheim International|Pramipexól||38884||38884|51881||1 044763|N04BC0502|Sifrol|forðatfl|0,52|mg|10|stk|1|pakki||N04BC05|01.02.2010|31.03.2016|R|0|0|0|0|G|0|BII|0|0|0|100|DKK|1184|2752|lyfalmen|||1|10|0|2,0800|Vistor hf|Boehringer Ingelheim International|Pramipexól||1184||1184|2752||1 044888|QN05CM9001|Domosedan, vet.|munnh.hl|7,6|mg/ml|3|ml|1|áf.spr|munnsk.dæla|QN05CM90|01.01.2012||R|0|0|0|0|0|0|OCO|0|0|0|100|DKK|1860|3656|vetalmen|||0|3|0||Icepharma hf|Orion Corporation (I)|||1860||1860|3656||2 045332|V03AN0501|Lyfjaloft AGA 100%|lyfjagas|100|%|50|l|12|hylki|undir þrýstingi|V03AN05|01.10.2013||L|0|0|0|0|0|0|AGA|0|0|0|100|IKR|||lyflausa|||2|600|0||Ísaga ehf|AGA AB|Lyfjagös|||||||5 045475|A10BX1201|Jardiance|filmhtfl|25|mg|30|stk|1|þpakki||A10BX12|01.07.2015||R|1|0|0|0|G|0|BOE|0|0|0|100|DKK|6215|9677|lyfalmen|||1|30|0|42,8600|Vistor hf|Boehringer Ingelheim International GmbH|Empagliflozin||6215||6215|9677||1 045510|C10AA0105|Simvastatin Actavis|filmhtfl|20|mg|98|stk|1|þpakki||C10AA01|01.06.2009||R|1|0|0|0|G|0|AGP|0|0|0|100|IKR|1050|1841|lyfalmen|V0109|1804|2|98|0|65,3400|Actavis Group hf|Actavis Group PTC ehf|Simvastatín||522||522|1841||1 045533|C10AA0105|Simvastatin Actavis|filmhtfl|10|mg|98|stk|1|þpakki||C10AA01|01.06.2009||R|1|0|0|0|G|0|AGP|0|0|0|100|IKR|868|1711|lyfalmen|V0108|1677|2|98|0|32,6700|Actavis Group hf|Actavis Group PTC ehf|Simvastatín||428||428|1711||1 045588|J01DC0204 |Cefuroxim Villerton|sts|750|mg|10|hgl|1|pakki|lausn / dreifa|J01DC02|01.02.2016||R|0|0|0|0|0|1|VIN|0|0|0|100|DKK|1843|3659|lyfsjukr|||1|10|0|2,5000|Icepharma hf|Villerton Invest SA|Cefúroxím||||1843|3659||2 045599|J01DC0204|Cefuroxim Villerton|sts/irs|1500|mg|10|hgl|1|pakki|lausn|J01DC02|01.02.2016||R|0|0|0|0|0|1|VIN|0|0|0|100|DKK|2989|5236|lyfsjukr|||2|10|0|5,0000|Icepharma hf|Villerton Invest SA|Cefúroxím||||2989|5236||2 045634|N02AA5907|Pinex Comp Forte|eþ-stíll|530|mg|10|stk|1|pakki|30+500 mg|N02AA59|01.01.2011||R|0|0|0|0|0|0|AGT|0|0|1|100|XEU|355|1611|lyfalmen|||2|10|0|3,3333|Actavis Group hf|Actavis Group hf|Kódein í blöndum nema með geðlyfjum||355||355|1611||1 045765|C03CA0110|Impugan|dropar|10|mg/ml|30|ml|1|glas||C03CA01|01.06.2013||R|0|0|0|0|G|0|AGT|0|0|0|100|SEK|1878|3707|lyfalmen|||2|30|0|7,5000|Actavis Group hf|Actavis Group hf|Fúrósemíð||1878||1878|3707|31.3.2016|1 046077|QJ01DD9101|Convenia|sts|80|mg/ml|10|ml|1|hgl|+leysir, lausn|QJ01DD91|01.01.2008|29.02.2016|R|0|0|0|0|0|0|ZBE|0|0|0|100|DKK|18951|36124|vetalmen|||0|10|0||Icepharma hf|Zoetis Belgium S.A.|||18951||18951|36124||2 046248|S01EE0105|Monoprost|augndr|50|mcg/ml|0,2|ml|30|sk-hyl|30 (6x5)|S01EE01|01.03.2013||R|0|0|0|0|G|0|TEA|0|0|0|100|SEK|1411|3064|lyfalmen|||1|6|0|30,0000|Vistor hf|Laboratories THEA|Latanóprost||1411||1411|3064||1 046269|C09AA0502|Ramil|töflur|2,5|mg|100|stk|1|þpakki||C09AA05|01.03.2006||R|1|0|0|0|G|0|ACA|0|0|0|100|XEU|759|2033|lyfalmen|V0648|1535|2|100|0|100,0000|Actavis Group hf|Actavis hf|Ramipríl||662||662|2033||1 046405|A10BB1202|Glimeryl|töflur|1|mg|90|stk|1|þpakki||A10BB12|01.05.2006||R|1|0|0|0|G|0|ACA|0|0|0|100|XEU|587|1693|lyfalmen|V0021|1397|2|90|0|45,0000|Actavis Group hf|Actavis hf|Glímepíríð||415||415|1693||1 046414|A10BB1202|Glimeryl|töflur|2|mg|90|stk|1|þpakki||A10BB12|01.05.2006||R|1|0|0|0|G|0|ACA|0|0|0|100|XEU|714|1980|lyfalmen|V0022|1535|2|90|0|90,0000|Actavis Group hf|Actavis hf|Glímepíríð||623||623|1980||1 046423|A10BB1202|Glimeryl|töflur|3|mg|90|stk|1|þpakki||A10BB12|01.05.2006||R|1|0|0|0|G|0|ACA|0|0|0|100|XEU|914|2266|lyfalmen|V0023|1810|2|90|0|135,0000|Actavis Group hf|Actavis hf|Glímepíríð||831||831|2266||1 046485|L01BC0502|Gemcitabin Hospira|irþ|38|mg/ml|1|hgl|1|pakki||L01BC05|01.12.2015||R|0|0|0|1|0|1|HUK|0|0|0|100|SEK|7198|11030|lyfsjukr|||1|1|0||Icepharma hf|Hospira UK Ltd|Gemcitabín||7198||7198|11030||1 046687|A04AA0102|Ondansetron Vian|stl|2|mg/ml|4|ml|5|lykjur||A04AA01|01.02.2008|31.03.2016|R|0|0|0|0|G|0|VIS|0|0|1|100|DKK|5893|9233|lyfalmen|||1|20|0|2,5000|Icepharma hf|Vian SA|Ondansetrón||5893||5893|9233||2 046724|R01AD0802|Nasofan|nefúði|50|mcg/sk|150|skammtar|1|glas||R01AD08|01.12.2013||R|0|0|0|0|G|0|TSB|0|0|1|100|IKR|1350|2223|lyfalmen|V0625|2223|2|150|0|37,5000|Medical ehf|Teva Sweden AB|Flútíkasón||800||800|2223||2 046812|M05BA0603|Ibandronic acid Portfarma|filmhtfl|150|mg|3|stk|1|þpakki||M05BA06|01.02.2012||R|0|0|0|0|G|0|POF|0|0|0|100|IKR|4372|3816|lyfalmen|V0205|3816|2|3|0|90,0000|Alvogen|Alvogen|Íbandrónsýra||1957||1957|3816||1 046845|N06AB0605|Sertraline Portfarma|filmhtfl|50|mg|100|stk|1|þpakki||N06AB06|01.08.2014|31.03.2016|R|1|0|0|0|G|0|POF|0|0|0|100|IKR|2240|2423|lyfalmen|||2|100|0|100,0000|Alvogen|Alvogen|Sertralín||945||945|2423||1 047147|J01CF0104|Dicloxacillin Bluefish|hylki|250|mg|30|stk|1|þpakki||J01CF01|01.08.2015||R|0|0|0|0|0|0|BLP|0|0|1|100|IKR|3000|4150|lyfalmen|V0353|4150|2|30|0|3,7500|LYFIS ehf|Bluefish Pharmaceuticals AB|Díkloxacillín||2200||2200|4150||2 047159|C07AA0705|Sotalol Mylan|töflur|40|mg|100|stk|1|glas||C07AA07|01.01.1994||R|1|0|0|0|G|0|MYL|0|0|0|100|SEK|874|2325|lyfalmen|||2|100|0|25,0000|Icepharma hf|Mylan AB|Sótalól||874||874|2325||2 047442|N01AX1301|Niontix|lyfjagas|100|%|10|l|1|hylki||N01AX13|01.06.2008||R|0|0|0|0|0|1|AGA|0|0|0|100|IKR|13388|19549|lyfsjukr|||1|10|0||Ísaga ehf|AGA AB|di-Nitrogen oxíð||13388||13388|19549||5 047460|N01AX1301|Niontix|lyfjagas|100|%|50|l|1|hylki||N01AX13|01.06.2008||R|0|0|0|0|0|1|AGA|0|0|0|100|IKR|47555|62848|lyfsjukr|||1|50|0||Ísaga ehf|AGA AB|di-Nitrogen oxíð||47555||47555|62848||5 047986|L02BB0305|Bicalutamide Portfarma|filmhtfl|50|mg|30|stk|1|þpakki||L02BB03|01.02.2011||R|0|0|0|0|G|0|POF|0|0|0|100|XEU|11240|4928|lyfalmen|V0420|4928|2|30|0|30,0000|Alvogen|Alvogen|Bíkalútamíð||2765||2765|4928||1 047998|L02BB0305|Bicalutamide Portfarma|filmhtfl|150|mg|30|stk|1|þpakki||L02BB03|01.02.2011||R|0|0|0|0|G|0|POF|0|0|0|100|XEU|13497|8944|lyfalmen|V0421|7164|2|30|0|90,0000|Alvogen|Alvogen|Bíkalútamíð||5683||5683|8944||1 048015|B05AA0111|Albumin Baxter|irl|50|g/líter|250|ml|1|hgl||B05AA01|01.06.2007||R|0|0|0|0|0|1|BGM|0|0|0|100|SEK|4420|7206|lyfsjukr|||1|250|0||Icepharma hf|Baxalta Innovations GmbH|Albúmín||4420||4420|7206||2 048028|B05BB0114|Natriumklorid Fresenius Kabi|irl|9|mg/ml|100|ml|50|pokar|Freeflex umbúðir|B05BB01|01.12.2011||R|0|0|0|0|0|1|FKA|0|0|0|100|DKK|7956|12073|lyfsjukr|||1|5000|0||Vistor hf|Fresenius Kabi AB|Elektrólýtar||7956||7956|12073||1 048043|B05AA0111|Albumin Baxter|irl|200|g/líter|100|ml|1|hgl||B05AA01|01.06.2007||R|0|0|0|0|0|1|BGM|0|0|0|100|SEK|7170|10991|lyfsjukr|||1|100|0||Icepharma hf|Baxalta Innovations GmbH|Albúmín||7170||7170|10991||2 048100|N06AB1004|Esopram|töflur|5|mg|100|stk|1|þpakki||N06AB10|01.04.2010||R|1|0|0|0|G|0|APC|0|0|0|100|XEU|2408|2142|lyfalmen|V0324|1988|2|100|0|50,0000|Actavis Group PTC ehf|Actavis Group PTC ehf|Escítalópram||741||741|2142||1 048111|N06AB1004|Esopram|töflur|10|mg|28|stk|1|þpakki||N06AB10|01.04.2010||R|1|0|0|0|0|0|APC|0|0|0|100|XEU|1436|3099|lyfalmen|V0319|2939|2|28|0|28,0000|Actavis Group PTC ehf|Actavis Group PTC ehf|Escítalópram||1436||1436|3099||1 048122|N06AB1004|Esopram|töflur|10|mg|100|stk|1|plglas||N06AB10|01.04.2010||R|1|0|0|0|G|0|APC|0|0|0|100|XEU|3680|2142|lyfalmen|V0325|1566|2|100|0|100,0000|Actavis Group PTC ehf|Actavis Group PTC ehf|Escítalópram||741||741|2142||1 048144|N06AB1004|Esopram|töflur|15|mg|100|stk|1|plglas||N06AB10|01.04.2010||R|1|0|0|0|G|0|APC|0|0|0|100|XEU|6111|3879|lyfalmen|V0326|3673|2|100|0|150,0000|Actavis Group PTC ehf|Actavis Group PTC ehf|Escítalópram||2003||2003|3879||1 048166|N06AB1004|Esopram|töflur|20|mg|100|stk|1|plglas||N06AB10|01.04.2010||R|1|0|0|0|G|0|APC|0|0|0|100|XEU|6584|3190|lyfalmen|V0327|1988|2|100|0|200,0000|Actavis Group PTC ehf|Actavis Group PTC ehf|Escítalópram||1502||1502|3190||1 048199|A03CA0201|Librax|töflur|||100|stk|1|glas||A03CA02|01.12.1972||R|1|0|0|0|G|0|MAB|0|0|0|100|SEK|1074|2600|lyfalmen|||1|100|0||Vistor hf|Meda AB|Klídín og geðlyf||1074||1074|2600||1 048297|C09DA0101|Cozaar Comp|filmhtfl|112,5|mg|98|stk|1|þpakki|100+12,5 mg|C09DA01|01.06.2007||R|1|0|0|0|0|0|MSD|0|0|0|100|DKK|11334|16722|lyfalmen|||1|98|0|98,0000|Vistor hf|M.S.D.|Lósartan og þvagræsilyf||11334||11334|16722||1 048447|G03AA0901|Marvelon|töflur|||63|stk|1|þpakki|150/30 mcg|G03AA09|01.07.1986||R|0|0|0|0|0|0|ORG|0|0|0|100|DKK|1600|3324|lyfalmen|||1|63|0|84,0000|Vistor hf|N.V. Organon|Desógestrel og ethinylestradíól||1600||1600|3324||1 048488|L04AA0601|Cellcept|töflur|500|mg|150|stk|1|þpakki||L04AA06|01.03.1999||R|0|1|0|1|G|0|ROC|0|0|0|100|DKK|52276|68819|lyfalmen|V0187|13641|1|150|0|37,5000|Icepharma hf|Roche|Mýcófenólsýra||52276||52276|68819||2 048505|L03AX1601|Mozobil|stl|20|mg/ml|1,2|ml|1|hgl|lausn|L03AX16|01.07.2010||R|0|0|0|1|0|1|GZE|0|1|0|100|NOK|712212|891372|lyfsjukr|||1|1,2|0|1,4300|Vistor hf|Genzyme Europe B.V.|Plerixaforum||712212||712212|891372||1 048744|N02BE0101|Panodil|filmhtfl|500|mg|100|stk|1|glas||N02BE01|01.03.1984||R|1|0|0|0|0|0|HCA|0|0|1|100|DKK|366|1626|lyfalmen|V0230|1626|1|100|0|16,6667|Artasan ehf|GlaxoSmithKline CH A/S|Paracetamól||366||366|1626||1 048770|B05ZB0001|Hemosol BO|blóð.sk|||5000|ml|2|pokar||B05ZB|01.04.2013||R|0|0|0|1|0|1|GBL|0|0|0|100|SEK|3874|6454|lyfsjukr|||1|10000|0||Vistor hf|Gambro Lundia AB|Blóðsölt og stuðpúðalausn||3874||3874|6454||1 048784|B02BD0206|Advate|sts|500|ae|1|hgl|1|pakki|+leysir|B02BD02|01.12.2015||R|0|0|0|1|0|1|BER|0|1|0|100|SEK|40130|53457|lyfsjukr|||1|1|0|1,0000|Lyfjaver ehf|Baxter AG (L)|Storkuþáttur VIII||40130||40130|53457||3 049015|A02BA0201|Asyran|töflur|300|mg|100|stk|1|þpakki||A02BA02|01.10.1987||R|1|0|0|0|G|0|ACA|0|0|0|100|XEU|1783|3576|lyfalmen|||2|100|0|100,0000|Actavis Group hf|Actavis hf|Ranitidín||1783||1783|3576||1 049033|C08DB0108|Cardil|forðatfl|120|mg|60|stk|1|glas||C08DB01|01.05.2013||R|1|0|0|0|G|0|COR|0|0|0|100|DKK|4018|3549|lyfalmen|V0599|2789|2|60|0|30,0000|Vistor hf|Orion Corporation|Diltíazem||1763||1763|3549||1 049091|S01EE0101|Xalatan|augndr|50|mcg/ml|7,5|ml|1|pakki|3 glös í pakka|S01EE01|01.08.2013||R|0|0|0|0|G|0|PER|0|0|0|100|DKK|5548|8758|lyfalmen|V0376|3353|1|7,5|0|75,0000|Icepharma hf|Pfizer ApS|Latanóprost||||5548|8758||1 049116|H01CB0501|Signifor|sts|20|mg|1|hgl|1|pakki||H01CB05|01.10.2015||R|0|0|0|0|0|1|NEL|0|0|0|100|DKK|349275|439980|lyfsjukr|||1|1|0|16,6700|Vistor hf|Novartis Europharm Ltd|PAsireótið disapartate||349275||349275|439980||1 049169|M05BA0602|Bonviva|stl|1|mg/ml|3|ml|1|spr||M05BA06|01.10.2006||R|0|0|0|0|0|0|RRL|0|0|0|100|DKK|13892|20243|lyfalmen|||1|3|0|0,5000|Icepharma hf|Roche Registration Limited|Íbandrónsýra||13892||13892|20243||2 049319|H02AB0910|Hydrokortison Orion|töflur|10|mg|30|stk|1|þpakki||H02AB09|01.11.2015||R|0|0|0|0|G|0|ARN|0|0|1|100|DKK|1124|2669|lyfalmen|||2|30|0|10,0000|Vistor hf|Orion Corporation|Hýdrókortisón||1124||1124|2669||1 049551|D01AE1601|Loceryl|lakk|50|mg/ml|5|ml|1|glas||D01AE16|01.10.1992||R|0|0|0|0|0|0|GAN|0|0|1|100|CHF|4097|6761|lyfalmen|V0655|4701|1|5|0||Icepharma hf|Galderma Nordic AB|Amorolfín||4097||4097|6761||2 049579|C10AA0104|Simvastatin (Portfarma)|filmhtfl|20|mg|98|stk|1|þpakki||C10AA01|01.07.2006||R|1|0|0|0|G|0|POF|0|0|0|100|IKR|1154|2017|lyfalmen|V0109|1804|2|98|0|65,3400|Alvogen|Alvogen|Simvastatín||650||650|2017||1 049597|C10AA0104|Simvastatin (Portfarma)|filmhtfl|40|mg|100|stk|1|þpakki||C10AA01|01.07.2006||R|1|0|0|0|G|0|POF|0|0|0|100|IKR|1827|2464|lyfalmen|V0110|2174|2|100|0|133,3333|Alvogen|Alvogen|Simvastatín||975||975|2464||1 049650|D01BA0201|Lamisil|töflur|250|mg|28|stk|1|þpakki||D01BA02|01.04.1993||R|1|0|0|0|0|0|HES|0|0|0|100|DKK|11029|4812|lyfalmen|V0123|3798|1|28|0|28,0000|Vistor hf|Novartis Healthcare A/S|Terbínafín||2681||2681|4812||1 049678|C09AA0502|Ramil|töflur|5|mg|100|stk|1|þpakki||C09AA05|01.04.2006||R|1|0|0|0|G|0|ACA|0|0|0|100|XEU|963|2108|lyfalmen|V0496|1535|2|100|0|200,0000|Actavis Group hf|Actavis hf|Ramipríl||716||716|2108||1 049684|D01AE1501|Lamisil|krem|10|mg/g|30|g|1|túpa||D01AE15|01.04.1993||L|0|0|0|0|0|0|NHE|0|0|1|100|DKK|||lyflausa|||0|30|0||Artasan ehf|Novartis Healthcare A/S-A|Terbínafín|||||||1 049687|C09AA0502|Ramil|töflur|10|mg|100|stk|1|þpakki||C09AA05|01.08.2005||R|1|0|0|0|G|0|ACA|0|0|0|100|XEU|1249|2841|lyfalmen|V0649|2223|2|100|0|400,0000|Actavis Group hf|Actavis hf|Ramipríl||1249||1249|2841||1 049834|N02BE0113|Pinex Junior|eþ-stíll|125|mg|10|stk|1|þpakki||N02BE01|01.12.2011||L|0|0|0|0|0|0|AGT|0|0|1|100|IKR|||lyfalmen|||0|10|0|0,4167|Actavis Group hf|Actavis Group hf|Paracetamól|||||1465||1 049845|N02BE0113|Pinex Junior|eþ-stíll|250|mg|10|stk|1|þpakki||N02BE01|01.12.2011||L|0|0|0|0|0|0|AGT|0|0|1|100|IKR|||lyfalmen|||0|10|0|0,8333|Actavis Group hf|Actavis Group hf|Paracetamól|||||1465||1 049856|N02BE0114|Pinex|eþ-stíll|500|mg|10|stk|1|pakki||N02BE01|01.01.2012||L|0|0|0|0|0|0|AGT|0|0|1|100|IKR|||lyfalmen|||0|10|0|1,6667|Actavis Group hf|Actavis Group hf|Paracetamól|||||1563||1 049894|N02BG1001|Sativex|munnhúði|52|mg|10|ml|3|úðagl|27 mg + 25 mg|N02BG10|01.07.2013||R|0|0|1|1|0|0|GWP|0|0|0|100|DKK|72651|94590|lyfalmen|||1|30|0|37,1400|Vistor hf|GW Pharma Ltd.|Cannabinoids||72651||72651|94590||1 049902|J06BA0207|Kiovig|irl|100|mg/ml|200|ml|1|hgl||J06BA02|01.05.2013||R|0|0|0|0|0|1|BAA|0|1|0|100|SEK|167794|214269|lyfsjukr|||1|200|0||Icepharma hf|Baxter AG|Immúnóglóbúlín, normal, manna, gefin í æð||167794||167794|214269||2 049908|L04AA0601|Cellcept|hylki|250|mg|300|stk|1|þpakki||L04AA06|01.03.1999||R|0|1|0|1|G|0|ROC|0|0|0|100|DKK|54992|72255|lyfalmen|V0470|69753|1|300|0|37,5000|Icepharma hf|Roche|Mýcófenólsýra||54992||54992|72255||2 049913|J06BA0207|Kiovig|irl|100|mg/ml|10|ml|1|hgl||J06BA02|01.05.2013||R|0|0|0|0|0|1|BAA|0|1|0|100|SEK|8390|12670|lyfsjukr|||1|10|0||Icepharma hf|Baxter AG|Immúnóglóbúlín, normal, manna, gefin í æð||8390||8390|12670||2 049925|J06BA0207|Kiovig|irl|100|mg/ml|25|ml|1|hgl||J06BA02|01.05.2013||R|0|0|0|0|0|1|BAA|0|1|0|100|SEK|20975|29230|lyfsjukr|||1|25|0||Icepharma hf|Baxter AG|Immúnóglóbúlín, normal, manna, gefin í æð||20975||20975|29230||2 049936|J06BA0207|Kiovig|irl|100|mg/ml|50|ml|1|hgl||J06BA02|01.05.2013||R|0|0|0|0|0|1|BAA|0|1|0|100|SEK|41948|55757|lyfsjukr|||1|50|0||Icepharma hf|Baxter AG|Immúnóglóbúlín, normal, manna, gefin í æð||41948||41948|55757||2 049947|J06BA0207|Kiovig|irl|100|mg/ml|100|ml|1|hgl||J06BA02|01.05.2013||R|0|0|0|0|0|1|BAA|0|1|0|100|SEK|83742|108618|lyfsjukr|||1|100|0||Icepharma hf|Baxter AG|Immúnóglóbúlín, normal, manna, gefin í æð||83742||83742|108618||2 050292|C01DA0205|Nitroglyserin DAK|tungur.t|0,5|mg|100|stk|1|glas||C01DA02|01.06.2014||L|0|0|0|0|G|0|TPA|0|0|0|100|DKK|||lyfalmen|||0|100|0|20,0000|Vistor hf|Takeda Pharma A/S|Glýcerýltrínítrat|||||3512||1 050306|G04CA0104|Alfuzosin hydrochlorid ratiopharm|forðatfl|10|mg|90|stk|1|þpakki||G04CA01|01.12.2012||R|1|0|0|0|G|0|RAT|0|0|0|100|XEU|3320|5692|lyfalmen|||2|90|0|120,0000|LYFIS ehf|ratiopharm GmbH|Alfúzósín||3320||3320|5692||2 050346|L04AD0104|Ciqorin|hylki|100|mg|50|stk|1|þpakki||L04AD01|01.04.2014||R|0|0|0|0|G|0|TEV|0|0|0|100|IKR|25500|29894|lyfalmen|||2|50|0|20,0000|Medical ehf|Teva Pharma B.V.|Ciklospórín||21500||21500|29894||2 050438|L04AA2701|Gilenya|hylki|0,5|mg|7|stk|1|þpakki||L04AA27|01.09.2011||R|0|1|0|1|0|1|NEL|0|1|0|100|DKK|62635|81921|lyfsjukr|||1|7|0|7,0000|Vistor hf|Novartis Europharm Ltd|Fingolimod||||62635|81921||1 050510|A02BC0108|Omeprazol Actavis|sh-hylki|20|mg|28|stk|1|þpakki||A02BC01|01.05.2010||L|1|0|0|0|0|0|AGT|0|0|0|100|IKR|||lyflausa|||0|28|0|28,0000|Actavis Group hf|Actavis Group hf|Ómeprazól|||||||1 050563|N03AX1606|Pregabalin Mylan|hylki|25|mg|56|stk|1|þpakki||N03AX16|01.11.2015||R|0|0|0|0|0|0|GGE|0|0|0|100|SEK|1174|1897|lyfalmen|V0685|1375|2|56|0|4,6667|Mylan AB|Generics (UK) Ltd.|Pregabalín||563||563|1897||2 050605|N03AX1601|Lyrica|hylki|225|mg|14|stk|1|þpakki||N03AX16|01.04.2007||R|1|0|0|0|0|0|PER|0|0|0|100|DKK|2814|4995|lyfalmen|||1|14|0|10,5000|Icepharma hf|Pfizer ApS|Pregabalín||2814||2814|4995||1 050614|N03AX1601|Lyrica|hylki|225|mg|56|stk|1|þpakki||N03AX16|01.04.2007||R|1|0|0|0|0|0|PER|0|0|0|100|DKK|11188|16521|lyfalmen|V0688|6779|1|56|0|42,0000|Icepharma hf|Pfizer ApS|Pregabalín||11188||11188|16521||1 050660|C02CA0402|Carduran Retard|forðatfl|4|mg|100|stk|1|þpakki||C02CA04|01.01.2007||R|1|0|0|0|G|0|PER|0|0|0|100|DKK|4910|4874|lyfalmen|V0042|4486|1|100|0|100,0000|Icepharma hf|Pfizer ApS|Doxazósín||2726||2726|4874||1 050679|A02BC0108|Omeprazol Actavis|sh-hylki|10|mg|100|stk|1|glas||A02BC01|01.09.2010||R|1|0|0|0|G|0|AGT|0|0|0|100|IKR|4615|4976|lyfalmen|V0002|4639|2|100|0|50,0000|Actavis Group hf|Actavis Group hf|Ómeprazól||2800||2800|4976||1 050691|A02BC0108|Omeprazol Actavis|sh-hylki|20|mg|100|stk|1|glas||A02BC01|01.09.2010||R|1|0|0|0|G|0|AGT|0|0|0|100|IKR|4435|3049|lyfalmen|V0006|2825|2|100|0|100,0000|Actavis Group hf|Actavis Group hf|Ómeprazól||1400||1400|3049||1 050702|A02BC0108|Omeprazol Actavis|sh-hylki|40|mg|100|stk|1|plglas||A02BC01|01.08.2010||R|1|0|0|0|G|0|AGT|0|0|0|100|IKR|7275|3049|lyfalmen|V0001|2643|2|100|0|200,0000|Actavis Group hf|Actavis Group hf|Ómeprazól||1400||1400|3049||1 051109|V03AN0501|Lyfjaloft AGA 100%|lyfjagas|100|%|50|l|1|hylki|undir þrýstingi|V03AN05|01.10.2013||L|0|0|0|0|0|0|AGA|0|0|0|100|IKR|||lyflausa|||2|50|0||Ísaga ehf|AGA AB|Lyfjagös|||||||5 051110|N03AG0102|Orfiril|sh-tfl|300|mg|100|stk|1|glas||N03AG01|01.10.1995|29.02.2016|R|1|0|0|0|G|0|DEA|0|0|0|100|XEU|1622|3355|lyfalmen|||1|100|0|20,0000|Vistor hf|Desitin Artzneimittel|Valpróínsýra||1622||1622|3355||1 051349|R06AX2602|Nefoxef|filmhtfl|180|mg|30|stk|1|þpakki||R06AX26|01.07.2008||R|1|0|0|0|G|0|MYL|0|0|1|100|SEK|1082|2353|lyfalmen|V0363|2353|2|30|0|45,0000|Icepharma hf|Mylan AB|Fexófenadín||894||894|2353||2 051358|R06AX2602|Nefoxef|töflur|180|mg|100|stk|1|þpakki||R06AX26|01.07.2008||R|1|0|0|0|G|0|MYL|0|0|1|100|SEK|3328|4543|lyfalmen|V0365|4543|2|100|0|150,0000|Icepharma hf|Mylan AB|Fexófenadín||2485||2485|4543||2 051550|N03AX1401|Keppra|irþ|100|mg/ml|5|ml|10|hgl||N03AX14|01.02.2007||R|0|0|0|0|0|1|UCB|0|0|0|100|DKK|19606|28108|lyfsjukr|||1|50|0|3,3300|Vistor hf|U.C.B|Levetíracetam||19606||19606|28108||1 051732|C08CA0104|Amlódipín Portfarma|töflur|5|mg|100|stk|1|þpakki||C08CA01|01.12.2006||R|1|0|0|0|G|0|POF|0|0|0|100|XEU|1404|1995|lyfalmen|V0056|1995|2|100|0|100,0000|Alvogen|Alvogen|Amlódipín||634||634|1995||1 051750|C08CA0104|Amlódipín Portfarma|töflur|10|mg|100|stk|1|þpakki||C08CA01|01.12.2006|30.04.2016|R|1|0|0|0|G|0|POF|0|0|0|100|XEU|2374|2424|lyfalmen|||2|100|0|200,0000|Alvogen|Alvogen|Amlódipín||946||946|2424||1 051761|R03AC0302|Bricanyl Turbuhaler|innönddu|0,5|mg/sk|100|skammtar|1|stauk||R03AC03|01.07.2012||R|0|0|0|0|G|0|AZD|0|0|1|100|SEK|793|2214|lyfalmen|||1|100|0|25,0000|Vistor hf|AstraZeneca A/S DK|Terbútalín||793||793|2214||1 052286|N05BA1205|Alprazolam Mylan|töflur|0,25|mg|20|stk|1|þpakki||N05BA12|01.10.2009||R|1|0|0|0|0|0|MYL|0|0|1|100|SEK|183|1374|lyfalmen|V0047|1374|2|20|0|5,0000|Icepharma hf|Mylan AB|Alprazólam||183||183|1374||2 052297|N05BA1205|Alprazolam Mylan|töflur|0,25|mg|50|stk|1|þpakki||N05BA12|01.10.2009||R|1|0|0|0|0|0|MYL|0|0|0|100|SEK|432|1717|lyfalmen|V0305|995|2|50|0|12,5000|Icepharma hf|Mylan AB|Alprazólam||432||432|1717||2 052305|L01XE0601|Sprycel|filmhtfl|20|mg|60|stk|1|glas||L01XE06|01.09.2007||R|0|0|0|1|0|1|BSP|0|1|0|100|DKK|273174|345332|lyfsjukr|||1|60|0||Vistor hf|Bristol-Myers Squibb Pharma (UK) Ltd |Dasatíníb||273174||273174|345332||1 052309|N05BA1205|Alprazolam Mylan|töflur|0,5|mg|20|stk|1|þpakki||N05BA12|01.07.2009||R|1|0|0|0|0|0|MYL|0|0|1|100|SEK|306|1530|lyfalmen|V0439|1530|2|20|0|10,0000|Icepharma hf|Mylan AB|Alprazólam||296||296|1530||2 052320|N05BA1205|Alprazolam Mylan|töflur|0,5|mg|50|stk|1|þpakki||N05BA12|01.10.2009||R|1|0|0|0|0|0|MYL|0|0|0|100|SEK|631|1991|lyfalmen|||2|50|0|25,0000|Icepharma hf|Mylan AB|Alprazólam||631||631|1991||2 052331|N05BA1205|Alprazolam Mylan|töflur|0,25|mg|100|stk|1|glas||N05BA12|01.08.2009||R|1|0|0|0|0|0|MYL|0|0|0|100|SEK|630|1989|lyfalmen|V0305|1989|2|100|0|25,0000|Icepharma hf|Mylan AB|Alprazólam||630||630|1989||2 052333|L01XE0601|Sprycel|filmhtfl|50|mg|60|stk|1|glas||L01XE06|01.09.2007||R|0|0|0|1|0|1|BSP|0|1|0|100|DKK|552023|692142|lyfsjukr|||1|60|0||Vistor hf|Bristol-Myers Squibb Pharma (UK) Ltd |Dasatíníb||552023||552023|692142||1 052360|L01XE0601|Sprycel|filmhtfl|70|mg|60|stk|1|glas||L01XE06|01.09.2007||R|0|0|0|1|0|1|BSP|0|1|0|100|DKK|517556|649275|lyfsjukr|||1|60|0||Vistor hf|Bristol-Myers Squibb Pharma (UK) Ltd |Dasatíníb||517556||517556|649275||1 052405|S01ED5112|Ganfort|augndr|5,3|mg/ml|3|ml|1|glas||S01ED51|01.01.2010||R|0|0|0|0|G|0|IRE|0|0|0|100|XEU|3013|5269|lyfalmen|||1|3|0|30,0000|Actavis ehf|Allergan Pharmaceuticals Ireland|Tímólól í blöndum||3013||3013|5269||1 052505|B05BA1014|Kabiven|irl|1900|kcal|2053|ml|4|pokar|fleyti|B05BA10|01.03.2007||R|0|0|0|0|0|1|FKA|0|0|0|100|DKK|31553|42609|lyfsjukr|||1|8212|0||Vistor hf|Fresenius Kabi AB|Blöndur||31553||31553|42609||1 052515|B05BA1014|Kabiven|irl|2300|kcal|2566|ml|3|pokar||B05BA10|01.03.2007||R|0|0|0|0|0|1|FKA|0|0|0|100|DKK|25652|35145|lyfsjukr|||1|7698|0||Vistor hf|Fresenius Kabi AB|Blöndur||25652||25652|35145||1 052524|B05BA1010|Kabiven Peripheral|irl|1400|kcal|1920|ml|4|pokar|fleyti|B05BA10|01.03.2007||R|0|0|0|0|0|1|FRP|0|0|0|100|DKK|26087|35696|lyfsjukr|||1|7680|0||Icepharma hf|Fresenius Kabi|Blöndur||26087||26087|35696||2 052533|B05BA1010|Kabiven Peripheral|irl|1700|kcal|2400|ml|3|pokar|fleyti|B05BA10|01.03.2007||R|0|0|0|0|0|1|FRP|0|0|0|100|DKK|22874|31632|lyfsjukr|||1|7200|0||Icepharma hf|Fresenius Kabi|Blöndur||22874||22874|31632||2 052737|N05AX1205|Aripiprazol Krka|töflur|5|mg|56|stk|1|þpakki||N05AX12|01.03.2015||R|1|0|0|0|0|0|KRK|0|0|0|100|IKR|20582|22319|lyfalmen|V0682|20512|2|56|0|18,6670|LYFIS ehf|Krka Sverige AB|Aripiprazól||15400||15400|22319||2 052838|A10BX0701|Victoza|stl|6|mg/ml|3|ml|2|lyfjap|lausn,áfylltur lyfjapenni|A10BX07|01.01.2012||R|0|0|0|0|0|0|NAS|0|0|0|100|DKK|13384|19544|lyfalmen|||1|6|0|30,0000|Vistor hf|Novo-Nordisk A/S|Liraglútíð||13384||13384|19544||1 052997|N05CF0204|Zolpidem Mylan|filmhtfl|10|mg|30|stk|1|þpakki||N05CF02|01.03.2014||R|1|0|0|0|0|0|MYL|0|0|1|100|SEK|310|1499|lyfalmen|||2|30|0|30,0000|Icepharma hf|Mylan AB|Zolpidem||274||274|1499|29.2.2016|2 053006|N05CF0204|Zolpidem Mylan|filmhtfl|10|mg|100|stk|1|þpakki||N05CF02|01.11.2006||R|2|0|0|0|0|0|MYL|0|0|0|100|SEK|1149|2357|lyfalmen|||2|100|0|100,0000|Icepharma hf|Mylan AB|Zolpidem||897||897|2357||2 053055|C01BA0302|Durbis Retard|forðatfl|250|mg|100|stk|1|þpakki||C01BA03|01.05.1983||R|1|0|0|0|G|0|SNO|0|0|0|100|NOK|4023|6659|lyfalmen|||1|100|0|62,5000|Vistor hf|Sanofi-aventis Norge AS|Dísópýramíð||4023||4023|6659||1 053155|N02AA5501|Targin|forðatfl|60|mg|28|stk|1|þpakki|40+20 mg|N02AA55|01.10.2012||R|1|0|1|0|0|0|NOP|0|0|0|100|DKK|10833|16033|lyfalmen|||1|28|0|14,9400|Icepharma hf|Norpharma|Oxycodonum í blöndum||10833||10833|16033||2 053166|N02AA5501|Targin|forðatfl|60|mg|98|stk|1|þpakki|40+20 mg|N02AA55|01.10.2012||R|1|0|1|0|0|0|NOP|0|0|0|100|DKK|32266|43511|lyfalmen|||1|98|0|52,2700|Icepharma hf|Norpharma|Oxycodonum í blöndum||32266||32266|43511||2 053200|N02AA5501|Targin|forðatfl|7,5|mg|98|stk|1|þpakki|5+2,5 mg|N02AA55|01.10.2012||R|1|0|1|0|0|0|NOP|0|0|0|100|DKK|5402|8558|lyfalmen|||1|98|0|6,5400|Icepharma hf|Norpharma|Oxycodonum í blöndum||5402||5402|8558||2 053211|N02AA5501|Targin|forðatfl|7,5|mg|28|stk|1|þpakki|5+2,5 mg|N02AA55|01.10.2012||R|1|0|1|0|0|0|NOP|0|0|0|100|DKK|1584|3296|lyfalmen|||1|28|0|1,8700|Icepharma hf|Norpharma|Oxycodonum í blöndum||1579||1579|3296||2 053231|J07BB0201|Fluarix|stl|||0,5|ml|10|áf.spr||J07BB02|01.10.1994||R|0|0|0|0|0|0|GPH|0|0|0|100|GBP|5736|9017|lyfalmen|||1|5|0||Vistor hf|GlaxoSmithKline Pharma A/S|Inflúensa, hreinsaðir mótefnavakar||5736||5736|9017||1 053371|L04AA1301|Arava|töflur|10|mg|100|stk|1|glas||L04AA13|01.11.2000||R|0|1|0|1|G|0|SDE|0|0|0|100|NOK|25857|35405|lyfalmen|V0453|33109|1|100|0|50,0000|Vistor hf|Sanofi - aventis Deutschland GmbH|Leflúnómíð||25857||25857|35405||1 053905|N02AA0305|Hydromorphone Hydrochloride Inj. USP|stl|20|mg/ml|1|ml|10|lykjur||N02AA03|01.05.2006||R|0|0|1|0|0|0|MAP|0|0|0|100|GBP|10864|16075|lyfalmen|||2|10|0|50,0000|Icepharma hf|Martindale Pharmaceuticals|Hýdrómorphón||10864||10864|16075||2 053932|N05AX1201|Abilify|stl|7,5|mg/ml|1,33|ml|1|hgl||N05AX12|01.01.2010||R|0|1|0|0|0|0|OTS|0|0|0|100|DKK|1385|3029|lyfalmen|||1|1,33|0|0,6650|Vistor hf|Otsuka Pharmaceutical Europe Ltd.|Aripiprazól||1385||1385|3029||1 053991|D10AF0101|Dalacin|húðlausn|10|mg/ml|30|ml|1|glas||D10AF01|01.07.1985||R|0|0|0|0|0|0|PER|0|0|0|100|DKK|1033|2544|lyfalmen|||1|30|0||Icepharma hf|Pfizer ApS|Klindamýcín||1033||1033|2544||1 054054|R03DC0303|Montelukast Actavis|filmhtfl|10|mg|100|stk|1|þpakki||R03DC03|01.11.2011||R|1|0|0|0|G|0|AGP|0|0|0|100|XEU|5844|2478|lyfalmen|V0490|2320|2|100|0|100,0000|Actavis Group hf|Actavis Group PTC ehf|Montelúkast||985||985|2478||1 054213|J07AG0101|Act-Hib|sts|34|mcg/hgl|0,5|ml|1|hgl|+ leysir (10+24 mcg)|J07AG01|01.07.1994||R|0|0|0|0|0|0|SPM|0|0|0|100|XEU|3514|5959|lyfalmen|||1|0,5|0||Icepharma hf|Sanofi Pasteur MSD|Haemophilus influenzae B||3514||3514|5959||2 054247|R01AA0503|Nezeril|nefdr|0,25|mg/ml|0,1|ml|20|sk-hyl||R01AA05|01.01.1987||L|0|0|0|0|0|0|OME|0|0|1|100|IKR|||lyflausa|||0|2|0|1,2500|Vistor hf|Omega Pharma Nordic AB|Oxýmetazólín|||||||1 054278|D01AE1502|Lamisil Once|húðlausn|1|%|4|g|1|túpa||D01AE15|01.12.2006||L|0|0|0|0|0|0|NHE|0|0|1|100|IKR|||lyflausa|||0|4|0||Artasan ehf|Novartis Healthcare A/S-A|Terbínafín|||||||1 054321|J01CA0801|Selexid|filmhtfl|400|mg|15|stk|1|þpakki||J01CA08|01.04.2012||R|0|0|0|0|0|0|LEP|0|0|1|100|DKK|2141|4069|lyfalmen|||1|15|0|10,0000|Vistor hf|LEO Pharma A/S|Pívmecillínam||2141||2141|4069||1 054332|J01CA0801|Selexid|filmhtfl|400|mg|20|stk|1|þpakki||J01CA08|01.04.2012||R|0|0|0|0|0|0|LEP|0|0|1|100|DKK|2936|5163|lyfalmen|||1|20|0|13,3300|Vistor hf|LEO Pharma A/S|Pívmecillínam||2936||2936|5163||1 054369|J05AB0402|Copegus|filmhtfl|400|mg|56|stk|1|plglas||J05AB04|01.05.2007||R|0|0|0|1|0|1|ROA|0|0|0|100|DKK|38003|50767|lyfsjukr|||1|56|0|22,4000|Icepharma hf|Roche A.S.|Ribavirin||38003||38003|50767||2 054403|R01AA0503|Nezeril|nefdr|0,5|mg/ml|0,1|ml|20|sk-hyl||R01AA05|01.01.1987||L|0|0|0|0|0|0|OME|0|0|1|100|IKR|||lyflausa|||0|2|0|2,5000|Vistor hf|Omega Pharma Nordic AB|Oxýmetazólín|||||||1 054524|N05BB0101|Atarax|filmhtfl|25|mg|100|stk|1|þpakki||N05BB01|01.06.2014||R|1|0|0|0|0|0|UCN|0|0|1|100|DKK|1213|2792|lyfalmen|||1|100|0|33,3333|Vistor hf|UCB Nordic A/S|Hýdroxýzín||1213||1213|2792||1 054533|N05BB0101|Atarax|mixtúra|2|mg/ml|200|ml|1|glas||N05BB01|01.10.1994||R|0|0|0|0|0|0|UCN|0|0|0|100|SEK|419|1699|lyfalmen|||1|200|0|5,3333|Vistor hf|UCB Nordic A/S|Hýdroxýzín||419||419|1699||1 054552|N06AB0308|Fluoxetin Actavis|lausnart|20|mg|30|stk|1|þpakki||N06AB03|01.10.2006||R|1|0|0|0|0|0|ACA|0|0|0|100|XEU|1341|2968|lyfalmen|V0061|2968|2|30|0|30,0000|Actavis Group hf|Actavis hf|Flúoxetín||1341||1341|2968||1 054594|QN02AE0101|Vetergesic vet.|stl|300|mcg/ml|10|ml|1|hgl|lausn|QN02AE01|01.10.2010||R|0|0|1|0|0|0|CES|1|0|0|100|DKK|4296|8321|vetalmen|||0|10|0||Icepharma hf|Ceva Sante Animale|Buprenorphinhýdróklóríð||||4296|8321||2 054650|QG03DA0202|Veramix, vet.|sk-svamp|60|mg|1|stk|20|stk||QG03DA02|01.12.1978||R|0|0|0|0|0|0|ZOE|1|0|0|100|DKK|7174|12365|vetorma|||0|20|0||Icepharma hf|Zoetis Finland OY|Medroxyprogesteronum||7174||7174|12365||2 054974|R03BB0501|Eklira Genuair|innönddu|322|mcg|60|skammtar|1|innö.t||R03BB05|01.01.2013||R|0|0|0|0|G|0|ZEN|0|0|0|100|SEK|4988|7988|lyfalmen|V0707|7988|1|60|0|30,0000|Vistor hf|AstraZeneca AB|Aclídínumbrómíð||4988||4988|7988||1 055073|L04AA0606|Myfenax|hylki|250|mg|100|stk|1|þpakki||L04AA06|01.11.2013||R|1|0|0|1|G|0|TEV|0|0|0|100|XEU|18303|23251|lyfalmen|V0470|23251|2|100|0|12,5000|Medical ehf|Teva Pharma B.V.|Mýcófenólsýra||16077||16077|23251||2 055084|L04AA0606|Myfenax|filmhtfl|500|mg|50|stk|1|þpakki||L04AA06|01.11.2013||R|1|0|0|1|G|0|TEV|0|0|0|100|XEU|6453|5498|lyfalmen|V0187|4547|2|50|0|12,5000|Medical ehf|Teva Pharma B.V.|Mýcófenólsýra||3179||3179|5498||2 055164|S01AE0701|Vigamox|augndr|5|mg/ml|5|ml|1|glas|án rotvarnar|S01AE07|01.08.2010||R|0|0|0|0|0|0|CLA|0|0|1|100|USD|1786|3580|lyfalmen|||1|5|0||Vistor hf|Alcon Nordic A/S|Moxífloxacín||||1786|3580||1 055186|J01FA0103|Ery-Max|sh-hylki|250|mg|20|stk|1|glas||J01FA01|01.01.1986||R|1|0|0|0|0|0|REP|0|0|1|100|SEK|670|2044|lyfalmen|||1|20|0|5,0000|Vistor hf|Recip AB|Erýtrómýcín||670||670|2044||1 055257|G03AA0903|Benidette|töflur|||63|stk|1|þpakki|150/20 mcg|G03AA09|01.04.2013||R|0|0|0|0|0|0|AAB|0|0|0|100|XEU|1200|2351|lyfalmen|V0065|2351|2|63|0|84,0000|Actavis Group PTC ehf|Actavis BV|Desógestrel og ethinylestradíól||893||893|2351||1 055277|N02AA0101|Contalgin|forðatfl|60|mg|100|stk|1|þpakki||N02AA01|01.10.1995||R|1|0|1|0|G|0|PER|0|0|0|100|DKK|8334|12593|lyfalmen|||1|100|0|60,0000|Icepharma hf|Pfizer ApS|Morfín||8334||8334|12593||1 055481|A02BC0402|Rabeprazol Actavis|sh-tfl|10|mg|56|stk|1|þpakki||A02BC04|01.06.2011||R|0|0|0|0|G|0|APC|0|0|0|100|IKR|1765|2499|lyfalmen|V0467|2499|2|56|0|28,0000|Actavis Group PTC ehf|Actavis Group PTC ehf|Rabeprazól||1000||1000|2499||1 055749|N07BA0107|Nicotinell Mint|munnstfl|1|mg|36|stk|1|pakki||N07BA01|01.06.2000||L|0|0|0|0|0|0|SDF|0|0|1|100|IKR|||lyflausa|||0|36|0|1,2000|Artasan ehf|GlaxoSmithKline Consumer Healthcare A/S|Nikótín|||||||1 055939|N07BA0107|Nicotinell Mint|munnstfl|1|mg|96|stk|1|pakki||N07BA01|01.06.2000||L|0|0|0|0|0|0|SDF|0|0|1|100|IKR|||lyflausa|||0|96|0|3,2000|Artasan ehf|GlaxoSmithKline Consumer Healthcare A/S|Nikótín|||||||1 055968|R03AC1302|Oxis Turbuhaler|innönddu|4,5|mcg/sk|60|skammtar|1|stauk||R03AC13|01.01.2016||R|0|0|0|0|G|0|AZD|0|0|1|100|SEK|2607|4710|lyfalmen|||1|60|0|11,2500|Vistor hf|AstraZeneca A/S DK|Formóteról||2607||2607|4710||1 056015|C10AA0503|Atacor|filmhtfl|10|mg|100|stk|1|þpakki||C10AA05|01.06.2006||R|1|0|0|0|G|0|ACA|0|0|0|100|IKR|2834|2770|lyfalmen|V0112|1810|2|100|0|50,0000|Actavis Group hf|Actavis hf|Atorvastatín||1197||1197|2770||1 056024|C10AA0503|Atacor|filmhtfl|20|mg|100|stk|1|þpakki||C10AA05|01.06.2006||R|1|0|0|0|G|0|ACA|0|0|0|100|IKR|4425|2856|lyfalmen|V0113|2567|2|100|0|100,0000|Actavis Group hf|Actavis hf|Atorvastatín||1260||1260|2856||1 056033|C10AA0503|Atacor|filmhtfl|40|mg|100|stk|1|þpakki||C10AA05|01.06.2006||R|1|0|0|0|G|0|ACA|0|0|0|100|IKR|5897|2943|lyfalmen|V0114|2567|2|100|0|200,0000|Actavis Group hf|Actavis hf|Atorvastatín||1323||1323|2943||1 056308|N07XX0701|Fampyra|forðatfl|10|mg|28|stk|1|þpakki||N07XX07|01.03.2013||R|0|0|0|1|0|0|BIB|0|0|0|100|XEU|28987|39363|lyfalmen|||1|28|0|14,0000|Icepharma hf|Biogen Idec Ltd|Fampridine||28987||28987|39363||2 056442|QG03DA0401|Prid alpha|sk-innl|1,55|g|10|stk|1|pakki||QG03DA04|01.04.2011||R|0|0|0|0|0|0|CES|1|0|0|100|XEU|24385|42030|vetorma|||0|10|0||Icepharma hf|Ceva Sante Animale|Prógesterón||24385||24385|42030||2 056523|J01FA0103|Ery-Max|sh-hylki|250|mg|40|stk|1|glas||J01FA01|01.01.1986||R|1|0|0|0|0|0|REP|0|0|1|100|SEK|1091|2624|lyfalmen|||1|40|0|10,0000|Vistor hf|Recip AB|Erýtrómýcín||1091||1091|2624||1 056664|N06AX1608|Venlafaxin Actavis|forðahlk|75|mg|100|stk|1|glas|Til vélskömmtunar|N06AX16|01.10.2011||R|2|0|0|0|G|0|AGP|0|0|0|100|XEU|3362|3432|lyfalmen|||2|100|0|75,0000|Actavis Group hf|Actavis Group PTC ehf|Venlafaxín||1678||1678|3432||1 056675|N06AX1608|Venlafaxin Actavis|forðahlk|150|mg|100|stk|1|glas|Til vélskömmtunar|N06AX16|01.10.2011||R|2|0|0|0|G|0|AGP|0|0|0|100|XEU|3362|3432|lyfalmen|||2|100|0|150,0000|Actavis Group hf|Actavis Group PTC ehf|Venlafaxín||1678||1678|3432||1 056763|D11AH0201|Elidel|krem|1|%|15|g|1|túpa||D11AH02|01.09.2012||R|0|0|0|0|G|0|MAB|0|0|1|100|SEK|2537|4614|lyfalmen|||1|15|0||Vistor hf|Meda AB|Pímekrólímus||2537||2537|4614||1 056915|L04AA2301|Tysabri|irþ|300|mg/hgl|15|ml|1|hgl|lausn|L04AA23|01.09.2007||R|0|1|0|1|0|1|BIB|0|1|0|100|XEU|194421|247385|lyfsjukr|||1|15|0|30,0000|Icepharma hf|Biogen Idec Ltd|Natalizumab||194421||194421|247385||2 057042|C09DA0601|Atacand Plus|töflur|28,5|mg|98|stk|1|þpakki|16 + 12,5 mg|C09DA06|01.02.2010||R|1|0|0|0|0|0|AZD|0|0|0|100|SEK|8543|12881|lyfalmen|V0095|5911|1|98|0|98,0000|Vistor hf|AstraZeneca A/S DK|Candesartan og þvagræsilyf||8543||8543|12881||1 057304|V03AN0501|Lyfjaloft AGA 100%|lyfjagas|100|%|4|l|1|hylki|undir þrýstingi|V03AN05|01.08.2013||L|0|0|0|0|0|0|AGA|0|0|0|100|IKR|||lyflausa|||2|4|0||Ísaga ehf|AGA AB|Lyfjagös|||||||5 057307|H01CB0201|Sandostatin|stl|200|mcg/ml|5|ml|1|hgl||H01CB02|01.01.1991||R|0|0|0|0|0|1|HES|0|0|0|100|DKK|6824|10515|lyfsjukr|||1|5|0|1,4300|Vistor hf|Novartis Healthcare A/S|Oktreótíð||6824||6824|10515||1 057335|B05BA0312|Glucos Baxter Viaflo 50 mg/ml|irl|50|mg/ml|500|ml|20|pokar|lausn|B05BA03|01.07.2013||R|0|0|0|0|0|1|BAM|0|0|0|100|SEK|3424|5835|lyfsjukr|||1|10000|0||Icepharma hf|Baxter Medical AB|Kolvetni||3424||3424|5835||2 057349|H01CB0201|Sandostatin|stl|100|mcg/ml|1|ml|5|lykjur||H01CB02|01.01.1991||R|0|0|0|0|0|1|HES|0|0|0|100|DKK|3412|5818|lyfsjukr|||1|5|0|0,7100|Vistor hf|Novartis Healthcare A/S|Oktreótíð||3412||3412|5818||1 057401|N06DA0404|Galantamine Portfarma|forðahlk|16|mg|84|stk|1|þpakki||N06DA04|01.12.2011||R|1|0|0|0|G|0|POF|0|0|0|100|SEK|19434|27871|lyfalmen|||2|84|0|84,0000|Alvogen|Alvogen|Galantamín||19434||19434|27871||1 057422|B05XA3102|Tracel|irþ|||10|ml|20|plastl||B05XA31|01.01.1987||R|0|0|0|0|0|1|FKA|0|0|0|100|DKK|4420|7206|lyfsjukr|||1|200|0||Vistor hf|Fresenius Kabi AB|Elektrólýtar í blöndum með öðrum efnum||4420||4420|7206||1 057455|H01CB0201|Sandostatin|stl|50|mcg/ml|1|ml|5|lykjur||H01CB02|01.01.1991||R|0|0|0|0|0|1|HES|0|0|0|100|DKK|2403|4430|lyfsjukr|||1|5|0|0,3600|Vistor hf|Novartis Healthcare A/S|Oktreótíð||2403||2403|4430||1 057492|L01XC1001|Arzerra|irþ|20|mg/ml|50|ml|1|hgl|1000 mg pr. hgl.|L01XC10|01.03.2012||R|0|0|0|1|0|1|NEL|0|0|0|100|DKK|319924|403476|lyfsjukr|||1|50|0||Vistor hf|Novartis Europharm Ltd|Ofatúmúmabi||319924||319924|403476||1 057556|L02BX0301|Zytiga|töflur|250|mg|120|stk|1|glas||L02BX03|01.12.2011||R|0|0|0|0|0|1|JAS|0|1|0|100|SEK|398510|501215|lyfsjukr|||1|120|0|30,0000|Vistor hf|Janssen-Cilag AB|Abírateron||398510||398510|501215||1 057867|N06DX0107|Zalatine|filmhtfl|20|mg|98|stk|1|þpakki||N06DX01|01.03.2014||R|1|0|0|0|G|0|WEH|0|0|0|100|XEU|11459|10877|lyfalmen|V0607|10877|2|98|0|98,0000|Williams & Halls efh|Williams & Halls ehf|Memantín||7087||7087|10877||2 058014|N07BA0301|Champix|filmhtfl|1|mg|112|stk|1|þpakki||N07BA03|01.03.2009||R|0|0|0|0|0|0|IPI|0|0|1|100|DKK|18232|26217|lyfalmen|||1|112|0|56,0000|Icepharma hf|Pfizer Limited|Vareniclin||||18232|26217||1 058164|A03BB0101|Buscopan|stl|20|mg/ml|1|ml|5|lykjur||A03BB01|01.10.1995||R|0|0|0|0|G|0|BOI|0|0|0|100|DKK|385|1652|lyfalmen|||1|5|0|1,6667|Vistor hf|Boehringer Ingelheim|Bútýlskópólamín||385||385|1652||1 058207|H01CB0501|Signifor|sts|40|mg|1|hgl|1|pakki||H01CB05|01.10.2015||R|0|0|0|0|0|1|NEL|0|0|0|100|DKK|373413|470001|lyfsjukr|||1|1|0|33,3300|Vistor hf|Novartis Europharm Ltd|PAsireótið disapartate||373413||373413|470001||1 058272|L01XE1101|Votrient|filmhtfl|200|mg|30|stk|1|glas||L01XE11|01.02.2011||R|1|0|0|1|0|1|NEL|0|1|0|100|DKK|136570|175435|lyfsjukr|||1|30|0||Vistor hf|Novartis Europharm Ltd|Pazópaníb||136570||136570|175435||1 058283|QI01AD0401|Avipro Thymovac|frþlyf|||500|skammtar|10|pakkar||QI01AD04|01.07.2009||R|0|0|0|0|0|0|LOH|0|0|0|100|XEU|146502|252511|vetorma|||0|5000|0||Icepharma hf|Lohmann Animal Health|||||146502|252511||2 058294|QI01AD0401|Avipro Thymovac|frþlyf|||1000|skammtar|10|pakkar||QI01AD04|01.07.2009||R|0|0|0|0|0|0|LOH|0|0|0|100|XEU|222551|383589|vetorma|||0|10000|0||Icepharma hf|Lohmann Animal Health|||||222551|383589||2 058503|J01EA0107|Trimetoprim Meda|mixtúra|10|mg/ml|100|ml|1|fl|dreifa|J01EA01|01.01.2004||R|0|0|0|0|0|0|REP|0|0|1|100|SEK|883|2338|lyfalmen|||1|100|0|2,5000|Vistor hf|Recip AB|Trímetóprím||883||883|2338||1 058506|J05AF1001|Baraclude|mixtúra|0,05|mg/ml|210|ml|1|fl||J05AF10|01.09.2007||R|0|0|0|1|0|1|BSP|0|1|0|100|DKK|86018|111496|lyfsjukr|||1|210|0|21,0000|Vistor hf|Bristol-Myers Squibb Pharma (UK) Ltd |Entecavír||86018||86018|111496||1 058609|N05AX1302|Xeplion|stl|50|mg|1|stk|1|áf.spr|forðadreifa|N05AX13|01.04.2012||R|0|0|0|0|0|0|JCI|0|0|0|100|SEK|35123|47124|lyfalmen|||1|1|0|20,0000|Vistor hf|Janssen-Cilag International N.V.|Paliperídón||35123||35123|47124||1 058622|B05BA0312|Glucos Baxter Viaflo 50 mg/ml|irl|50|mg/ml|250|ml|30|pokar|lausn|B05BA03|01.07.2013||R|0|0|0|0|0|1|BAM|0|0|0|100|SEK|5033|8050|lyfsjukr|||1|7500|0||Icepharma hf|Baxter Medical AB|Kolvetni||5033||5033|8050||2 058735|C03CA0105|Lasix Retard|forðahlk|30|mg|100|stk|1|þpakki||C03CA01|01.10.1995||R|1|0|0|0|G|0|SNO|0|0|0|100|NOK|909|2373|lyfalmen|||1|100|0|75,0000|Vistor hf|Sanofi-aventis Norge AS|Fúrósemíð||909||909|2373||1 058768|C03CA0105|Lasix Retard|forðahlk|60|mg|100|stk|1|þpakki||C03CA01|01.10.1995||R|1|0|0|0|G|0|SNO|0|0|0|100|NOK|1543|3246|lyfalmen|||1|100|0|150,0000|Vistor hf|Sanofi-aventis Norge AS|Fúrósemíð||1543||1543|3246||1 059070|A02BC0108|Omeprazol Actavis|sh-hylki|20|mg|56|stk|1|þpakki||A02BC01|01.05.2011||R|1|0|0|0|G|0|AGT|0|0|0|100|IKR|2374|2894|lyfalmen|V0006|1582|2|56|0|56,0000|Actavis Group hf|Actavis Group hf|Ómeprazól||1287||1287|2894||1 059224|A04AA0501|Aloxi|stl|250|mcg|5|ml|1|hgl|lausn|A04AA05|01.04.2013||R|0|0|0|0|0|0|HBP|0|0|1|100|DKK|9982|14861|lyfalmen|||1|5|0|1,0000|Swedish Orphan Biovitrum AB|Helsinn Birex Pharmaceuticals Ltd.|Palonosetrón||9982||9982|14861||3 059569|L02AE0203|Eligard|sts|45|mg/sk|2|spr|1|sett|+ leysir|L02AE02|01.05.2008||R|0|0|0|1|G|0|ASP|0|0|0|100|XEU|85070|110297|lyfalmen|||1|2|0|311,1900|Vistor hf|Astellas Pharma A/S|Leuprórelín||85070||85070|110297||1 059644|J02AX0601|Ecalta|st/irþ|100|mg|30|ml|1|hgl||J02AX06|01.11.2015||R|0|0|0|1|0|1|PFF|0|0|0|100|DKK|57617|75575|lyfsjukr|||1|30|0|30,0000|Icepharma hf|Pfizer Limited|Anidulafungin||57617||57617|75575||1 059659|J07CA0601|Infanrix-Polio + Hib|sts|||0,5|ml|10|spr||J07CA06|01.01.2007||R|0|0|0|0|0|0|GPH|0|0|0|100|GBP|30982|41887|lyfalmen|||1|5|0||Vistor hf|GlaxoSmithKline Pharma A/S|barnaveiki, haemophilus influenza B, kíghósti, mænusótt, stí||30982||30982|41887||1 059767|N03AF0401|Zebinix|töflur|800|mg|30|stk|1|þpakki||N03AF04|01.03.2010||R|1|0|0|0|G|0|BPC|0|0|0|100|SEK|25044|34376|lyfalmen|||1|30|0|30,0000|Vistor hf|Bial-Portela & C.S.A.|Eslícarbazepín||25044||25044|34376||1 059795|C10AA0506|Atorvaratio|filmhtfl|40|mg|100|stk|1|þpakki||C10AA05|01.07.2014||R|1|0|0|0|G|0|TSB|0|0|0|100|IKR|5500|2567|lyfalmen|V0114|2567|2|100|0|200,0000|Medical ehf|Teva Sweden AB|Atorvastatín||1050||1050|2567||2 059803|C08CA0502|Adalat Oros|forðatfl|30|mg|98|stk|1|þpakki||C08CA05|01.04.2013||R|1|0|0|0|G|0|BAP|0|0|0|100|DKK|4948|7933|lyfalmen|||1|98|0|98,0000|Icepharma hf|Bayer Schering Pharma AG|Nífedipín||||4948|7933||2 059882|L04AD0203|Modigraf|mixt.kyr|0,2|mg|50|sk-pokar|1|pakki||L04AD02|01.04.2014||R|0|0|0|1|0|0|ASP|0|0|0|100|XEU|8078|12241|lyfalmen|||1|50|0|5,0000|Vistor hf|Astellas Pharma A/S|Tacrolimus||8078||8078|12241||1 059938|L04AD0203|Modigraf|mixt.kyr|1|mg|50|sk-pokar|1|pakki||L04AD02|01.04.2014||R|0|0|0|1|0|0|ASP|0|0|0|100|XEU|40392|53789|lyfalmen|||1|50|0|10,0000|Vistor hf|Astellas Pharma A/S|Tacrolimus||40392||40392|53789||1 060114|N02AB0305|Fentanyl ratiopharm|forðapl|25|mcg/klst|5|stk|1|skpoki||N02AB03|01.12.2012||R|0|0|1|0|G|0|RGM|0|0|0|100|XEU|1875|3296|lyfalmen|V0219|3296|2|5|0|7,5000|Medical ehf|ratiopharm GmbH|Fentanýl||1579||1579|3296||2 060123|N02AB0305|Fentanyl ratiopharm|forðapl|50|mcg/klst|5|stk|1|skpoki||N02AB03|01.12.2012||R|0|0|1|0|G|0|RGM|0|0|0|100|XEU|3326|5485|lyfalmen|V0220|5485|2|5|0|15,0000|Medical ehf|ratiopharm GmbH|Fentanýl||3170||3170|5485||2 060132|N02AB0305|Fentanyl ratiopharm|forðapl|75|mcg/klst|5|stk|1|skpoki||N02AB03|01.12.2012||R|0|0|1|0|G|0|RGM|0|0|0|100|XEU|4795|7019|lyfalmen|V0221|7019|2|5|0|22,5000|Medical ehf|ratiopharm GmbH|Fentanýl||4284||4284|7019||2 060141|N02AB0305|Fentanyl ratiopharm|forðapl|100|mcg/klst|5|stk|1|skpoki||N02AB03|01.12.2012||R|0|0|1|0|G|0|RGM|0|0|0|100|XEU|5779|7655|lyfalmen|||2|5|0|30,0000|Medical ehf|ratiopharm GmbH|Fentanýl||4746||4746|7655|30.4.2016|2 060337|QC01CE9001|Vetmedin vet.|tuggutfl|10|mg|50|stk|1|glas|fyrir hunda|QC01CE90|01.07.2015||R|0|0|0|0|0|0|BIV|0|0|0|100|DKK|8109|13290|vetalmen|||0|50|0||Vistor hf|Boehringer Ingelheim Vetmedica GmbH|Pimobendan||6915||6915|13290||1 060560|V03AC0301|Exjade|dreifit.|500|mg|84|stk|1|þpakki||V03AC03|01.03.2007||R|0|1|0|1|0|0|NEL|0|0|0|100|DKK|307498|388021|lyfalmen|||1|84|0||Vistor hf|Novartis Europharm Ltd|Deferasírox||307498||307498|388021||1 060569|V03AC0301|Exjade|dreifit.|250|mg|84|stk|1|þpakki||V03AC03|01.03.2007||R|0|1|0|1|0|0|NEL|0|0|0|100|DKK|163529|208964|lyfalmen|||1|84|0||Vistor hf|Novartis Europharm Ltd|Deferasírox||163529||163529|208964||1 060581|A10BD2001|Synjardy|filmhtfl|1012,5|mg|180|stk|1|þpakki|12,5mg/1000mg|A10BD20|01.01.2016||R|0|0|0|0|G|0|BOE|0|0|0|100|DKK|18708|26872|lyfalmen|V0713|26872|1|180|0|90,0000|Vistor hf|Boehringer Ingelheim International GmbH|Metforminum og empagliflozin||18708||18708|26872||1 060759|A10BB1203|Glimepirid Bluefish|töflur|2|mg|90|stk|1|þpakki||A10BB12|01.10.2015||R|1|0|0|0|G|0|BLP|0|0|0|100|IKR|907|1535|lyfalmen|V0022|1535|2|90|0|90,0000|LYFIS ehf|Bluefish Pharmaceuticals AB|Glímepíríð||300||300|1535||2 061112|L04AA3101|AUBAGIO|filmhtfl|14|mg|28|stk|1|þpakki||L04AA31|01.09.2014||R|1|1|0|1|0|1|SGA|0|1|0|100|DKK|126973|163499|lyfsjukr|||1|28|0|28,0000|Vistor hf|Sanofi-aventis groupe|Teriflúnomíð||||126973|163499||1 061227|L01XE0103|Mylaukim|filmhtfl|100|mg|60|stk|1|þpakki||L01XE01|01.09.2014||R|0|0|0|1|0|1|WEH|0|1|0|100|XEU|95543|123544|lyfsjukr|||2|60|0||Williams & Halls efh|Williams & Halls ehf|Imatiníb||95543||95543|123544||2 061293|N05AX1206|Aripiprazole ratiopharm|töflur|10|mg|28|stk|1|þpakki||N05AX12|01.10.2015||R|1|0|0|0|0|0|RAT|0|0|0|100|IKR|10093|15014|lyfalmen|V0204|15014|2|28|0|18,6670|LYFIS ehf|ratiopharm GmbH|Aripiprazól||10093||10093|15014||2 061414|QA04AD9001|Cerenia|töflur|60|mg|4|stk|1|þpakki||QA04AD90|01.02.2009||R|0|0|0|0|0|0|ZBE|0|0|0|100|DKK|2483|4880|vetalmen|||0|4|0||Icepharma hf|Zoetis Belgium S.A.|||||2483|4880||2 061442|QA04AD9001|Cerenia|töflur|24|mg|4|stk|1|þpakki||QA04AD90|01.02.2009||R|0|0|0|0|0|0|ZBE|0|0|0|100|DKK|1301|2557|vetalmen|||0|4|0||Icepharma hf|Zoetis Belgium S.A.|||||1301|2557||2 061451|QA04AD9001|Cerenia|stl|10|mg/ml|20|ml|1|hgl|lausn|QA04AD90|01.02.2009||R|0|0|0|0|0|0|ZBE|0|0|0|100|DKK|7685|14750|vetalmen|||0|20|0||Icepharma hf|Zoetis Belgium S.A.|||||7685|14750||2 061460|G03CX0102|Livial (Lyf og heilsa)|töflur|2,5|mg|84|stk|1|þpakki||G03CX01|01.04.2010||R|0|0|0|0|G|0|HOL|0|0|0|100|DKK|5516|8714|lyfalmen|V0133|7247|3|84|0|84,0000|Lyf og heilsa|Lyf og heilsa|Tíbólón||5516||5516|8714||2 061465|M02AA0701|Felden gel|hlaup|5|mg/g|50|g|1|túpa||M02AA07|01.04.1996||L|0|0|0|0|0|0|PER|0|0|1|100|IKR|||lyflausa|||0|50|0||Icepharma hf|Pfizer ApS|Píroxíkam|||||||1 061481|G03CX0101|Livial|töflur|2,5|mg|84|stk|1|þpakki||G03CX01|01.07.1998||R|0|0|0|0|G|0|ORG|0|0|0|100|DKK|5517|8716|lyfalmen|V0133|7247|1|84|0|84,0000|Vistor hf|N.V. Organon|Tíbólón||5517||5517|8716||1 061580|QP52AF0201|Banminth, vet.|pasta|439|mg/g|26|g|1|spr||QP52AF02|01.04.1992||R|0|0|0|0|0|0|ZOE|0|0|0|100|DKK|1538|2651|vetorma|||0|26|0||Icepharma hf|Zoetis Finland OY|||1538||1538|2651||2 061937|L04AD0101|Sandimmun|irþ|50|mg/ml|1|ml|10|lykjur||L04AD01|01.10.1985||R|0|0|0|0|0|1|HES|0|0|0|100|DKK|3745|6277|lyfsjukr|||1|10|0|2,0000|Vistor hf|Novartis Healthcare A/S|Ciklospórín||3745||3745|6277||1 061961|J01XX0901|Cubicin|sts/irs|350|mg|1|hgl|1|pakki|lausn|J01XX09|01.04.2007||R|0|1|0|1|0|1|NEL|0|0|0|100|DKK|14324|20838|lyfsjukr|||1|1|0|1,2500|Vistor hf|Novartis Europharm Ltd|Daptomýcín||14324||14324|20838||1 061970|J01XX0901|Cubicin|sts/irs|500|mg|1|hgl|1|pakki|lausn|J01XX09|01.04.2007||R|0|1|0|1|0|1|NEL|0|0|0|100|DKK|19934|28559|lyfsjukr|||1|1|0|1,7900|Vistor hf|Novartis Europharm Ltd|Daptomýcín||19934||19934|28559||1 062117|N05BA1204|Tafil Retard|forðatfl|0,5|mg|30|stk|1|þpakki||N05BA12|01.04.1996||R|1|0|0|0|0|0|PER|0|0|1|100|DKK|415|1693|lyfalmen|V0307|1563|1|30|0|15,0000|Icepharma hf|Pfizer ApS|Alprazólam||415||415|1693||1 062202|N06DX0102|Memantine Merz|filmhtfl|10|mg|30|stk|1|þpakki||N06DX01|01.07.2013||R|1|0|0|0|G|0|LBK|0|0|0|100|DKK|2632|3055|lyfalmen|V0604|2958|2|30|0|15,0000|Lundbeck Export A/S|H. Lundbeck A/S|Memantín||1404||1404|3055||1 062341|L04AA0604|Mykofenolatmofetil Actavis|filmhtfl|500|mg|150|stk|1|þpakki||L04AA06|01.08.2010||R|0|0|0|1|G|0|AGP|0|0|0|100|XEU|14558|13641|lyfalmen|V0187|13641|2|150|0|37,5000|Actavis Group hf|Actavis Group PTC ehf|Mýcófenólsýra||9095||9095|13641||1 062575|J05AX1501|Sovaldi|filmhtfl|400|mg|28|stk|1|glas||J05AX15|01.09.2015||R|0|0|0|1|0|1|GIL|0|1|0|100|XEU|1925686|2400594|lyfsjukr|||1|28|0|28,0000|Gilead Sience Sweden AB|Gilead Science International Limited|Sofosbuvir||||1925686|2400594||1 062614|QG03XA9101|Improvac|stl|300|mcg|100|ml|10|glös||QG03XA91|01.04.2015||R|0|0|0|0|0|0|ZBE|0|0|0|100|DKK|51531|88819|vetorma|||0|1000|0||Icepharma hf|Zoetis Belgium S.A.|gonadotropin releasing factor analogue, conjugated||51531||51531|88819||2 062704|R02AA0305|Strepsils Cool|sogtfl|||36|stk|1|þpakki||R02AA03|01.09.2010||L|0|0|0|0|0|0|RBH|0|0|1|100|IKR|||lyflausa|||0|36|0|6,0000|Artasan ehf|Reckitt Benckiser Healthcare Ltd.-A|Díklórbenzýlalkóhól|||||||1 062729|N05BA1204|Tafil Retard|forðatfl|0,5|mg|60|stk|1|þpakki||N05BA12|01.04.1996||R|1|0|0|0|0|0|PER|0|0|0|100|DKK|837|2274|lyfalmen|V0308|2017|1|60|0|30,0000|Icepharma hf|Pfizer ApS|Alprazólam||837||837|2274||1 062737|B03BA0102|Betolvex|töflur|1|mg|100|stk|1|glas||B03BA01|01.03.2008||R|1|0|0|0|G|0|AGT|0|0|1|100|XEU|2043|3934|lyfalmen|||2|100|0|100,0000|Actavis Group hf|Actavis Group hf|Cyanocobalamin||2043||2043|3934||1 062745|QP53AF0102|Sebacil vet.|húðlausn|500|mg/ml|1000|ml|1|fl||QP53AF01|01.05.2005||R|0|0|0|0|0|0|BAN|0|0|0|100|DKK|16266|28036|vetorma|||0|1000|0||Icepharma hf|Bayer Animal Health GmbH|||16266||16266|28036||2 062987|J07BM0201|Cervarix|stl|||0,5|ml|1|áf.spr|dreifa|J07BM02|01.11.2007||R|0|0|0|0|0|0|GBI|0|0|0|100|GBP|12595|15492|lyfalmen|||1|0,5|0||Vistor hf|GlaxoSmithKline Biologicals SA|Papillomavírus (manna gerð 16, 18)||10440||10440|15492||1 062996|J07BM0201|Cervarix|stl|||0,5|ml|10|áf.spr|dreifa|J07BM02|01.03.2014||R|0|0|0|0|0|0|GBI|0|0|0|100|GBP|125952|162229|lyfalmen|||1|5|0||Vistor hf|GlaxoSmithKline Biologicals SA|Papillomavírus (manna gerð 16, 18)||125952||125952|162229||1 063057|J05AB0901|Famvir|töflur|125|mg|10|stk|1|þpakki||J05AB09|01.10.1995||R|1|0|0|0|G|0|HES|0|0|1|100|DKK|5169|8237|lyfalmen|||1|10|0|1,6667|Vistor hf|Novartis Healthcare A/S|Famcíclóvír||5169||5169|8237||1 063180|N05AH0205|Clozapine Actavis|töflur|25|mg|100|stk|1|þpakki||N05AH02|01.05.2015||R|1|0|0|0|G|0|AGT|0|0|0|100|XEU|1653|2625|lyfalmen|V0276|2567|2|100|0|8,3300|Actavis Group hf|Actavis Group hf|Klózapín||1092||1092|2625||1 063255|N05AH0205|Clozapine Actavis|töflur|100|mg|100|stk|1|þpakki||N05AH02|01.07.2014||R|1|0|0|0|G|0|AGT|0|0|0|100|XEU|5101|6724|lyfalmen|V0277|6559|2|100|0|33,3333|Actavis Group hf|Actavis Group hf|Klózapín||4070||4070|6724||1 063661|A06AD1107|Medilax|mixtúra|667|mg/ml|500|ml|1|plastf||A06AD11|01.06.2007||L|0|0|0|0|0|0|MET|0|0|0|100|DKK|||lyfalmen|||0|500|0|49,7761|Vistor hf|Medic Team|Laktúlósa|||||2912||1 063697|D01BA0203|Terbinafin Actavis|töflur|250|mg|28|stk|1|þpakki||D01BA02|01.11.2006||R|1|0|0|0|0|0|ACA|0|0|0|100|XEU|1964|3825|lyfalmen|V0123|3798|2|28|0|28,0000|Actavis Group hf|Actavis hf|Terbínafín||1964||1964|3825||1 063715|R06AX2702|Aerius (Lyf og heilsa)|töflur|5|mg|100|stk|1|þpakki||R06AX27|01.07.2011||R|1|0|0|0|G|0|HOL|0|0|1|100|XEU|3754|6289|lyfalmen|V0458|3485|3|100|0|100,0000|Lyf og heilsa|Lyf og heilsa|Deslóratadín||3754||3754|6289||2 063818|J06BB0102|Rhesonativ|stl|625|ae/ml|2|ml|1|lykja||J06BB01|01.05.2008||R|0|0|0|0|0|1|OCT|0|0|0|100|DKK|7029|10797|lyfsjukr|||1|2|0||Vistor hf|Octapharma AB|And-D(rh) immúnóglóbúlín||7029||7029|10797||1 063923|QP54AB5207|Equest Pramox vet|hlaup|||11,8|g|1|sk-dæl|19,5mg/g+121,7mg/g|QP54AB52|01.12.2006||R|0|0|0|0|0|0|ZFO|0|0|0|100|XEU|2289|3945|vetorma|||0|11,8|0||Vistor hf|Zoetis Finland Oy|||2289||2289|3945||2 063926|L04AC0701|RoActemra|stl|162|mg|4|áf.spr|1|pakki||L04AC07|01.12.2014||R|0|1|0|1|0|1|RRL|0|1|0|100|DKK|132602|170500|lyfsjukr|||1|4|0|32,4000|Icepharma hf|Roche Registration Limited|Tocilizúmabi||132602||132602|170500||2 063941|N05BA1204|Tafil Retard|forðatfl|1|mg|30|stk|1|þpakki||N05BA12|01.04.1996||R|1|0|0|0|0|0|PER|0|0|1|100|DKK|879|2332|lyfalmen|V0309|1956|1|30|0|30,0000|Icepharma hf|Pfizer ApS|Alprazólam||879||879|2332||1 063958|N05BA1204|Tafil Retard|forðatfl|1|mg|60|stk|1|þpakki||N05BA12|01.04.1996||R|1|0|0|0|0|0|PER|0|0|0|100|DKK|1841|3656|lyfalmen|V0310|2867|1|60|0|60,0000|Icepharma hf|Pfizer ApS|Alprazólam||1841||1841|3656||1 064023|B02BD0206|Advate|sts|1000|ae|1|hgl|1|pakki|+leysir|B02BD02|01.07.2014||R|0|0|0|1|0|1|BER|0|1|0|100|SEK|78730|102278|lyfsjukr|||1|1|0|2,0000|Lyfjaver ehf|Baxter AG (L)|Storkuþáttur VIII||||78730|102278||3 064034|B02BD0206|Advate|sts|1500|ae|1|hgl|1|pakki|+leysir|B02BD02|01.07.2014||R|0|0|0|1|0|1|BAL|0|1|0|100|SEK|120446|155381|lyfsjukr|||1|1|0|3,0000|Lyfjaver ehf|Baxter Medical AB (L)|Storkuþáttur VIII||||120446|155381||3 064069|B01AC2101|Remodulin|irl|2,5|mg/ml|20|ml|1|hgl|lausn|B01AC21|01.11.2008||R|0|1|0|1|0|1|UTE|0|0|0|100|XEU|846450|1058327|lyfsjukr|||1|20|0|11,6300|Icepharma hf|United Therapeutics Europe Ltd.|Treprostiníl natríum||||846450|1058327||2 064106|B01AC2101|Remodulin|irl|1|mg/ml|20|ml|1|hgl|lausn|B01AC21|01.11.2008||R|0|1|0|1|0|1|UTE|0|0|0|100|XEU|391861|492945|lyfsjukr|||1|20|0|4,6500|Icepharma hf|United Therapeutics Europe Ltd.|Treprostiníl natríum||||391861|492945||2 064170|N05BA1204|Tafil Retard|forðatfl|2|mg|30|stk|1|þpakki||N05BA12|01.04.1996||R|1|0|0|0|0|0|PER|0|0|1|100|DKK|1933|3783|lyfalmen|V0311|2867|1|30|0|60,0000|Icepharma hf|Pfizer ApS|Alprazólam||1933||1933|3783||1 064224|B01AC2101|Remodulin|irl|10|mg/ml|20|ml|1|hgl|lausn|B01AC21|01.11.2008||R|0|1|0|1|0|1|UTE|0|0|0|100|XEU|3918613|4879237|lyfsjukr|||1|20|0|46,5100|Icepharma hf|United Therapeutics Europe Ltd.|Treprostiníl natríum||||3918613|4879237||2 064233|B01AC2101|Remodulin|irl|5|mg/ml|20|ml|1|hgl|lausn|B01AC21|01.11.2008||R|0|1|0|1|0|1|UTE|0|0|0|100|XEU|1539000|1919665|lyfsjukr|||1|20|0|23,2600|Icepharma hf|United Therapeutics Europe Ltd.|Treprostiníl natríum||||1539000|1919665||2 064270|B01AC0406|Clopidogrel Krka|filmhtfl|75|mg|28|stk|1|þpakki||B01AC04|01.07.2013||R|1|0|0|0|G|0|KNM|0|0|0|100|XEU|2026|3583|lyfalmen|V0009|3387|2|28|0|28,0000|LYFIS ehf|Krka d.d. Novo mesto|Klópídógrel||1788||1788|3583||2 064281|B01AC0406|Clopidogrel Krka|filmhtfl|75|mg|100|stk|1|þpakki||B01AC04|01.07.2013||R|1|0|0|0|G|0|KNM|0|0|0|100|XEU|6272|6315|lyfalmen|V0029|6308|2|100|0|100,0000|LYFIS ehf|Krka d.d. Novo mesto|Klópídógrel||3773||3773|6315||2 064402|QJ01AA0603|Engemycin, vet.|stl|100|mg/ml|100|ml|1|hgl||QJ01AA06|01.06.2013||R|0|0|0|0|0|0|IBV|0|0|0|100|DKK|1074|2111|vetalmen|||0|100|0||Vistor hf|Intervet International BV|||1074||1074|2111|30.4.2016|1 064727|QI09AE0401|Enterisol Ileitis vet.|frþlyf|||50|skammtar|1|hgl|+100 ml leysir, dreifa|QI09AE04|01.02.2016||R|0|0|0|0|0|0|BIV|0|0|0|100|DKK|6101|10516|vetorma|||0|50|0||Vistor hf|Boehringer Ingelheim Vetmedica GmbH|lawsonia||||6101|10516||1 064732|A03BB0101|Buscopan|húðuðtfl|10|mg|100|stk|1|þpakki||A03BB01|01.03.2012||R|1|0|0|0|G|0|BOI|0|0|0|100|DKK|1898|3735|lyfalmen|||1|100|0|16,6700|Vistor hf|Boehringer Ingelheim|Bútýlskópólamín||1898||1898|3735||1 064733|J07BB0203|Vaxigrip|stl|||0,5|ml|1|áfspr||J07BB02|01.10.1985||R|0|0|0|0|0|0|SPM|0|0|0|100|XEU|907|2097|lyfalmen|||1|0,5|0||Icepharma hf|Sanofi Pasteur MSD|Inflúensa, hreinsaðir mótefnavakar||708||708|2097||2 064742|B02BD0101|Octaplex|irs|500|ae|1|hgl|1|pakki|+leysir,lausn|B02BD01|01.12.2011||R|0|0|0|1|0|1|OCT|0|0|0|100|DKK|44517|59006|lyfsjukr|||1|1|0|1,4300|Vistor hf|Octapharma AB|Storkuþættir lX,ll,Vll,X||44517||44517|59006||1 064840|A03FA0102|Afipran|töflur|10|mg|50|stk|1|glas||A03FA01|01.03.2013||R|1|0|0|0|G|0|ASS|0|0|1|100|DKK|750|2155|lyfalmen|||2|50|0|6,6700|Vistor hf|Takeda AS|Metóklópramíð||750||750|2155||1 064939|G04BD0804|Solifenacin Actavis|filmhtfl|10|mg|90|stk|1|þpakki||G04BD08|01.03.2015||R|1|0|0|0|G|0|AGP|0|0|0|100|XEU|16309|20622|lyfalmen|V0441|20622|2|90|0|180,0000|Actavis Group hf|Actavis Group PTC ehf|Sólífenacín||14167||14167|20622||1 064956|A03FA0102|Afipran|stl|5|mg/ml|2|ml|10|lykjur|lausn|A03FA01|01.03.2013||R|0|0|0|0|G|0|ASS|0|0|1|100|DKK|432|1717|lyfalmen|||2|20|0|3,3300|Vistor hf|Takeda AS|Metóklópramíð||432||432|1717||1 065032|D10AF5101|Duac|hlaup|||25|g|1|túpa|50 mg/g + 10 mg/g|D10AF51|01.01.2007||R|0|0|0|0|0|0|SLL|0|0|0|100|DKK|1763|3549|lyfalmen|||1|25|0||Vistor hf|Stiefel Laboratories (Ireland) Ltd.|Klindamýcín í blöndum||1763||1763|3549||1 065314|G01AF0201|Canesten|sk-tfl|100|mg|6|stk|1|pakki|+stjaka|G01AF02|01.12.1982||L|0|0|0|0|0|0|BAE|0|0|0|100|IKR|||lyflausa|||0|6|0|6,0000|Icepharma hf|Bayer AB|Klótrímazól|||||||2 065332|G01AF0201|Canesten|sk-tfl|500|mg|1|stk|1|pakki|+stjaka|G01AF02|01.04.1985||L|0|0|0|0|0|0|BAE|0|0|0|100|IKR|||lyflausa|||0|1|0|5,0000|Icepharma hf|Bayer AB|Klótrímazól|||||||2 065339|A07EA0604|Cortiment|freyðit|9|mg|30|stk|1|þpakki||A07EA06|01.09.2015||R|0|0|0|0|G|0|FEL|0|0|0|100|DKK|14280|20777|lyfalmen|||1|30|0|30,0000|Vistor hf|Ferring Lægemidler A/S|Búdesóníð||14280||14280|20777||1 065441|V08AB0901|Visipaque|stl|320|mg J/ml|20|ml|10|glhgl||V08AB09|01.12.2009||R|0|0|0|0|0|1|GEH|0|0|0|100|NOK|10019|14912|lyfsjukr|||1|200|0||Icepharma hf|GE Healthcare AS|Jódixanól||10019||10019|14912||2 065711|L02AE0306|Zoladex (Lyfjaver)|vefjalyf|10,8|mg|1|áf.spr|1|pakki||L02AE03|01.06.2011||R|0|0|0|1|G|0|LVR|0|0|0|100|SEK|50305|66326|lyfalmen|V0451|62513|3|1|0|83,7209|Lyfjaver ehf|Lyfjaver ehf|Góserelín||50305||50305|66326||3 065729|N07BA0142|Nicorette Invisi|forðapl|15|mg/16kls|14|stk|1|þpakki||N07BA01|01.03.2010||L|0|0|0|0|0|0|MCN|0|0|1|100|IKR|||lyflausa|||0|14|0|15,0000|Vistor hf|McNeil Denmark ApS|Nikótín|||||||1 065740|N07BA0142|Nicorette Invisi|forðapl|15|mg/16kls|7|stk|1|þpakki||N07BA01|01.03.2010||L|0|0|0|0|0|0|MCN|0|0|1|100|IKR|||lyflausa|||0|7|0|7,5000|Vistor hf|McNeil Denmark ApS|Nikótín|||||||1 065751|J01CR0204|Amoxin comp|mixtduft|80|mg/ml|70|ml|1|glas|80+11,4 mg|J01CR02|01.02.2013||R|0|0|0|0|0|0|RGM|0|0|1|100|IKR|954|2014|lyfalmen|V0163|2014|2|70|0|5,6000|Medical ehf|ratiopharm GmbH|Amoxicillín og ensímblokkar||648||648|2014||2 065752|N07BA0142|Nicorette Invisi|forðapl|10|mg/16kls|14|stk|1|þpakki||N07BA01|01.03.2010||L|0|0|0|0|0|0|MCN|0|0|1|100|IKR|||lyflausa|||0|14|0|10,0000|Vistor hf|McNeil Denmark ApS|Nikótín|||||||1 065753|N02AB0303|Fentanyl Actavis|forðapl|12|mcg/klst|5|stk|1|þpakki||N02AB03|01.05.2016||R|0|0|1|0|G|0|AGP|0|0|0|100|XEU|1475|3152|lyfalmen|V0222|3152|2|5|0|3,6000|Actavis Group hf|Actavis Group PTC ehf|Fentanýl||1475||1475|3152||1 065775|N07BA0142|Nicorette Invisi|forðapl|25|mg/16kls|14|stk|1|þpakki||N07BA01|01.03.2010||L|0|0|0|0|0|0|MCN|0|0|1|100|IKR|||lyflausa|||0|14|0|25,0000|Vistor hf|McNeil Denmark ApS|Nikótín|||||||1 065786|N07BA0142|Nicorette Invisi|forðapl|25|mg/16kls|7|stk|1|þpakki||N07BA01|01.03.2010||L|0|0|0|0|0|0|MCN|0|0|1|100|IKR|||lyflausa|||0|7|0|12,5000|Vistor hf|McNeil Denmark ApS|Nikótín|||||||1 065870|V08AB0201|Omnipaque|stl|180|mg J/ml|10|ml|10|glhgl||V08AB02|01.12.2009||R|0|0|0|0|0|1|GEH|0|0|0|100|NOK|3165|5479|lyfsjukr|||1|100|0||Icepharma hf|GE Healthcare AS|Jóhexól||3165||3165|5479||2 065934|C08CA1301|Lerkanidipin Actavis|filmhtfl|10|mg|28|stk|1|þpakki||C08CA13|01.04.2014||R|1|0|0|0|G|0|AGP|0|0|0|100|SEK|544|1871|lyfalmen|||2|28|0|28,0000|Actavis Group hf|Actavis Group PTC ehf|Lerkanidipín||544||544|1871||1 065945|C08CA1301|Lerkanidipin Actavis|filmhtfl|10|mg|98|stk|1|þpakki||C08CA13|01.04.2014||R|1|0|0|0|G|0|AGP|0|0|0|100|SEK|1642|3382|lyfalmen|||2|98|0|98,0000|Actavis Group hf|Actavis Group PTC ehf|Lerkanidipín||1642||1642|3382||1 065956|C08CA1301|Lerkanidipin Actavis|filmhtfl|20|mg|98|stk|1|þpakki||C08CA13|01.04.2014||R|1|0|0|0|G|0|AGP|0|0|0|100|SEK|3053|5324|lyfalmen|||2|98|0|196,0000|Actavis Group hf|Actavis Group PTC ehf|Lerkanidipín||3053||3053|5324||1 066195|QM01AC0605|Melovem|stl|5|mg/ml|100|ml|1|hgl||QM01AC06|01.08.2011||R|0|0|0|0|0|0|DOR|1|0|0|100|DKK|4058|7869|vetalmen|||0|100|0||Icepharma hf|Dopharma Reserch B.V|||4058||4058|7869||2 066235|N05AX1209|Aripiprazole Sandoz|töflur|15|mg|28|stk|1|þpakki||N05AX12|01.04.2016||R|1|1|0|0|G|0|HSS|0|0|0|100|DKK|8826|13270|lyfalmen|V0716|13270|2|28|0|28,0000|Artasan ehf|Sandoz GmbH|Aripiprazól||8826||8826|13270||1 066278|R03BB0403|Spiriva Respimat|innöndl|2,5|mcg/sk|60|skammtar|1|pakki|lausn|R03BB04|01.04.2008||R|0|0|0|0|G|0|BII|0|0|0|100|DKK|5333|8463|lyfalmen|||1|60|0|30,0000|Vistor hf|Boehringer Ingelheim International |Tíótrópíumbrómíð||5333||5333|8463||1 066287|B05AA0704|Voluven|irl|60|mg/ml|500|ml|20|pokar|Freeflex umbúðir|B05AA07|01.05.2008||R|0|0|0|0|0|1|FKA|0|0|0|100|DKK|28032|38156|lyfsjukr|||1|10000|0||Vistor hf|Fresenius Kabi AB|Hýdróxyetýl sterkja||28032||28032|38156||1 066399|N07BA0106|Nicotinell|forðapl|7|mg/sólh|21|stk|1|pakki||N07BA01|01.04.1992||L|0|0|0|0|0|0|SDF|0|0|1|100|IKR|||lyflausa|||0|21|0|10,5000|Artasan ehf|GlaxoSmithKline Consumer Healthcare A/S|Nikótín|||||||1 066407|N07BA0106|Nicotinell|forðapl|14|mg/sólh|21|stk|1|pakki||N07BA01|01.04.1992||L|0|0|0|0|0|0|SDF|0|0|1|100|IKR|||lyflausa|||0|21|0|21,0000|Artasan ehf|GlaxoSmithKline Consumer Healthcare A/S|Nikótín|||||||1 066411|A01AA0101|Duraphat|tannpast|5|mg/ml|51|g|1|túpa||A01AA01|01.04.2011||R|0|0|0|0|0|0|GOG|0|0|1|100|DKK|851|2294|lyfalmen|||1|51|0||Icepharma hf|Colgate Palmolive A/S|Natríumflúoríð||851||851|2294||2 066423|N07BA0106|Nicotinell|forðapl|21|mg/sólh|21|stk|1|pakki||N07BA01|01.04.1992||L|0|0|0|0|0|0|SDF|0|0|1|100|IKR|||lyflausa|||0|21|0|31,5000|Artasan ehf|GlaxoSmithKline Consumer Healthcare A/S|Nikótín|||||||1 066593|A02BC0111|Omeprazol Pensa|sþ-hylki|20|mg|100|stk|1|glas|2x50 stk|A02BC01|01.12.2012||R|1|0|0|0|G|0|PEN|0|0|0|100|IKR|2100|3875|lyfalmen|V0006|2825|2|100|0|100,0000|Lyfjaver ehf|Pensa Pharma AB|Ómeprazól||2000||2000|3875||3 066751|C01BD0103|Cordarone (Lyf og heilsa)|töflur|100|mg|30|stk|1|þpakki||C01BD01|01.11.2006||R|1|0|0|0|G|0|HOL|0|0|0|100|NOK|872|2322|lyfalmen|V0036|2322|3|30|0|15,0000|Lyf og heilsa|Lyf og heilsa|Amíódarón||872||872|2322||2 066862|A02BC0108|Omeprazol Actavis|sh-hylki|20|mg|14|stk|1|þpakki||A02BC01|01.05.2010||L|1|0|0|0|0|0|AGT|0|0|0|100|IKR|||lyflausa|||0|14|0|14,0000|Actavis Group hf|Actavis Group hf|Ómeprazól|||||||1 066897|L01CD0104|Paclitaxel Actavis|irþ|6|mg/ml|50|ml|1|hgl|lausn|L01CD01|01.06.2010||R|0|0|0|1|0|1|AGP|0|0|0|100|XEU|3522|5970|lyfsjukr|||2|50|0||Actavis Group hf|Actavis Group PTC ehf|Paklítaxel||3522||3522|5970||1 067001|B05BA0311|Glucos Fresenius Kabi|irl|50|mg/ml|100|ml|50|pokar|Freeflex umbúðir|B05BA03|01.12.2011||R|0|0|0|0|0|1|FKA|0|0|0|100|DKK|7957|12074|lyfsjukr|||1|5000|0||Vistor hf|Fresenius Kabi AB|Kolvetni||7957||7957|12074||1 067877|B05BA0314|Glucos Baxter Viaflo|irl|100|mg/ml|1000|ml|10|pokar|lausn|B05BA03|01.09.2015||R|0|0|0|0|0|1|BAM|0|0|0|100|SEK|2407|4435|lyfsjukr|||1|10000|0||Icepharma hf|Baxter Medical AB|Kolvetni||||2407|4435||2 068358|L01XC1001|Arzerra|irþ|20|mg/ml|5|ml|3|hgl|100 mg pr. hgl.|L01XC10|01.03.2012||R|0|0|0|1|0|1|NEL|0|0|0|100|DKK|110373|142853|lyfsjukr|||1|15|0||Vistor hf|Novartis Europharm Ltd|Ofatúmúmabi||110373||110373|142853||1 068381|B02BX0501|Revolade|filmhtfl|25|mg|14|stk|1|þpakki||B02BX05|01.04.2011||R|1|1|0|1|0|1|NEL|0|1|0|100|DKK|78508|101998|lyfsjukr|||1|14|0|7,0000|Vistor hf|Novartis Europharm Ltd|Eltrombópag||78508||78508|101998||1 068437|C01BC0401|Tambocor|töflur|100|mg|20|stk|1|þpakki||C01BC04|01.04.1987||R|1|0|0|1|G|0|MEB|0|0|0|100|SEK|1414|3068|lyfalmen|||1|20|0|10,0000|Vistor hf|Meda AB (V)|Flekaíníð||1414||1414|3068||1 068445|C01BC0401|Tambocor|töflur|100|mg|100|stk|1|þpakki||C01BC04|01.04.1987||R|1|0|0|1|G|0|MEB|0|0|0|100|SEK|4827|7766|lyfalmen|||1|100|0|50,0000|Vistor hf|Meda AB (V)|Flekaíníð||4827||4827|7766||1 068509|R01AD0902|Kalmente|nefúði|50|mcg/sk|140|skammtar|1|úðagl||R01AD09|01.11.2015||R|0|0|0|0|G|0|IPC|0|0|1|100|IKR|1181|2748|lyfalmen|V0677|2748|2|140|0|35,0000|Alvogen|Alvogen IPco S.á.r.l.|Mómetasón||1181||1181|2748||1 068776|R06AX2704|Desloratadine ratiopharm|munndr.t|5|mg|30|stk|1|þpakki||R06AX27|01.04.2014||L|0|0|0|0|0|0|RGM|0|0|1|100|IKR|||lyflausa|||2|30|0|30,0000|Medical ehf|ratiopharm GmbH|Deslóratadín||||||| 068811|L01BA0109|Metoject|stl|50|mg/ml|0,55|ml|1|áfspr||L01BA01|01.12.2012||R|0|0|0|1|G|0|WIL|0|0|0|100|SEK|3110|5403|lyfalmen|||1|0,55|0||Williams & Halls efh|medac Gesellschaft|Metótrexat||3110||3110|5403||2 068896|B05XA0303|Natriumklorid B.Braun|irþ|1|mmol/ml|20|ml|20|plastl||B05XA03|01.09.2010||R|0|0|0|0|0|1|BRA|0|0|0|100|XEU|2269|4245|lyfsjukr|||2|400|0||Actavis Group hf|Braun|Natríumklóríð||2269||2269|4245||1 068905|B05XA0103|Kaliumklorid B.Braun|irþ|1|mmol/ml|20|ml|20|plastl||B05XA01|01.09.2010||R|0|0|0|0|0|1|BRA|0|0|0|100|XEU|2121|4042|lyfsjukr|||2|400|0||Actavis Group hf|Braun|Kalíumklóríð||2121||2121|4042||1 068923|V07AB0004|Natriumklorid 9 mg/ml Braun|leysir|0,9|%|10|ml|20|lykjur|leysir f.stungulyf|V07AB|01.01.2009||L|0|0|0|0|0|0|BRA|0|0|0|100|IKR|||lyfalmen|||0|200|0||Actavis Group hf|Braun|Leysi- og þynningarvökvar, þ.m.t. skolvökvar|||||3246||1 068933|V07AB0004|Natriumklorid 9 mg/ml Braun|leysir|0,9|%|20|ml|20|lykjur|leysir f.stungulyf|V07AB|01.01.2009||L|0|0|0|0|0|0|BRA|0|0|0|100|IKR|||lyfalmen|||0|400|0||Actavis Group hf|Braun|Leysi- og þynningarvökvar, þ.m.t. skolvökvar|||||3429||1 068951|V07AB0009|Sterilt Vann B. Braun|leysir|||10|ml|20|lykja|leysir f.stungulyf|V07AB|01.01.2009||L|0|0|0|0|0|0|BRA|0|0|0|100|IKR|||lyfalmen|||0|200|0||Actavis Group hf|Braun|Leysi- og þynningarvökvar, þ.m.t. skolvökvar|||||3201||1 068960|V07AB0009|Sterilt Vann B. Braun|leysir|||20|ml|20|lykja|leysir f.stungulyf|V07AB|01.01.2009||L|0|0|0|0|0|0|BRA|0|0|0|100|IKR|||lyfalmen|||0|400|0||Actavis Group hf|Braun|Leysi- og þynningarvökvar, þ.m.t. skolvökvar|||||3379||1 069106|H01BA0201|Minirin|frþ.tfl|240|mcg|30|stk|1|þpakki||H01BA02|01.08.2012||R|0|0|0|0|G|0|FEL|0|0|0|100|DKK|12780|18713|lyfalmen|||1|30|0|18,0000|Vistor hf|Ferring Lægemidler A/S|Desmópressín||12780||12780|18713||1 069115|H01BA0201|Minirin|frþ.tfl|240|mcg|100|stk|1|þpakki||H01BA02|01.08.2012||R|0|0|0|0|G|0|FEL|0|0|0|100|DKK|40340|53723|lyfalmen|||1|100|0|60,0000|Vistor hf|Ferring Lægemidler A/S|Desmópressín||40340||40340|53723||1 069347|C02KX0501|Adempas|filmhtfl|1|mg|84|stk|1|þpakki||C02KX05|01.12.2014||R|1|0|0|1|0|1|BYE|0|1|0|100|DKK|363877|458141|lyfsjukr|||1|84|0|18,6700|Vistor hf|Bayer Pharma AG|Riociguatum||363877||363877|458141||1 069799|D01AE1501|Lamisil|krem|10|mg/g|15|g|1|túpa||D01AE15|01.04.1993||L|0|0|0|0|0|0|NHE|0|0|1|100|IKR|||lyflausa|||0|15|0||Artasan ehf|Novartis Healthcare A/S-A|Terbínafín|||||||1 070113|B01AC0601|Hjartamagnyl|sþ-tfl|75|mg|500|stk|1|glas||B01AC06|01.10.2012||L|1|0|0|0|0|0|AGT|0|0|0|100|IKR|||lyflausa|||0|500|0|500,0000|Actavis Group hf|Actavis Group hf|Asetýlsalicýlsýra|||||||1 070142|G04BD0704|Tolterodin Actavis|forðahlk|4|mg|100|stk|1|þpakki||G04BD07|01.01.2013||R|1|0|0|0|G|0|APC|0|0|0|100|XEU|5928|9281|lyfalmen|V0589|9281|2|100|0|100,0000|Actavis Group PTC ehf|Actavis Group PTC ehf|Tólteródín||5928||5928|9281||1 070797|N05AX0801|Risperdal|mixtúra|1|mg/ml|100|ml|1|fl|með skammtasprautu|N05AX08|01.01.1997||R|0|0|0|0|G|0|JAS|0|0|0|100|SEK|9881|14722|lyfalmen|||1|100|0|20,0000|Vistor hf|Janssen-Cilag AB|Risperídón||9881||9881|14722||1 070971|N06AB0606|Sertralin Hexal|filmhtfl|100|mg|100|stk|1|þpakki||N06AB06|01.03.2016||R|1|0|0|0|G|0|SSA|0|0|0|100|DKK|3333|3289|lyfalmen|V0323|3289|2|100|0|200,0000|Artasan ehf|Hexal A/S|Sertralín||1574||1574|3289||1 071223|N02BG0801|Prialt|irl|100|mcg/ml|1|ml|1|hgl||N02BG08|01.06.2007||R|0|0|0|1|0|1|EIS|0|0|0|100|SEK|56370|73997|lyfsjukr|||1|1|0|8,3300|Vistor hf|Eisai Ltd|Ziconotíð||56370||56370|73997||1 071232|N02BG0801|Prialt|irl|100|mcg/ml|5|ml|1|hgl||N02BG08|01.06.2007||R|0|0|0|1|0|1|EIS|0|0|0|100|SEK|285090|360152|lyfsjukr|||1|5|0|41,6500|Vistor hf|Eisai Ltd|Ziconotíð||285090||285090|360152||1 071458|N07BA0150|Nicotinell Spearmint|tyggigúm|2|mg|24|stk|1|þpakki||N07BA01|01.09.2013||L|0|0|0|0|0|0|SDF|0|0|1|100|IKR|||lyflausa|||0|24|0|1,6000|Artasan ehf|GlaxoSmithKline Consumer Healthcare A/S|Nikótín|||||||1 071468|N03AX1108|Topiramat Bluefish|filmhtfl|25|mg|60|stk|1|þpakki||N03AX11|01.04.2014||R|1|0|0|0|G|0|BLP|0|0|0|100|XEU|1566|1765|lyfalmen|V0247|1765|2|60|0|5,0000|LYFIS ehf|Bluefish Pharmaceuticals AB|Tópíramat||467||467|1765||2 071479|N03AX1108|Topiramat Bluefish|filmhtfl|50|mg|60|stk|1|þpakki||N03AX11|01.08.2014||R|1|0|0|0|G|0|BLP|0|0|0|100|XEU|2828|3304|lyfalmen|V0248|3304|2|60|0|10,0000|LYFIS ehf|Bluefish Pharmaceuticals AB|Tópíramat||1585||1585|3304||2 071490|N03AX1108|Topiramat Bluefish|filmhtfl|100|mg|60|stk|1|þpakki||N03AX11|01.04.2014||R|1|0|0|0|G|0|BLP|0|0|0|100|XEU|5101|3688|lyfalmen|V0249|3688|2|60|0|20,0000|LYFIS ehf|Bluefish Pharmaceuticals AB|Tópíramat||1864||1864|3688||2 071501|N03AX1108|Topiramat Bluefish|filmhtfl|200|mg|60|stk|1|þpakki||N03AX11|01.12.2013||R|1|0|0|0|G|0|BLP|0|0|0|100|XEU|9033|13555|lyfalmen|V0252|13555|2|60|0|40,0000|LYFIS ehf|Bluefish Pharmaceuticals AB|Tópíramat||9033||9033|13555||2 071528|N03AX1608|Pregabalina Tecnigen|hylki|75|mg|56|stk|1|þpakki||N03AX16|01.01.2016||R|1|0|0|0|0|0|WEH|0|0|0|100|XEU|4380|4427|lyfalmen|V0686|3744|2|56|0|14,0000|Williams & Halls efh|Williams & Halls ehf|Pregabalín||2401||2401|4427||2 071591|N05AH0405|Seroquel Prolong|forðatfl|150|mg|30|stk|1|þpakki||N05AH04|01.10.2011|31.03.2016|R|1|1|0|0|0|0|ASA|0|0|0|100|SEK|7386|11288|lyfalmen|||1|30|0|11,2500|Vistor hf|Astra Zeneca A/S|Quetíapín||||7386|11288||1 071611|G04BE0305|Vizarsin (Lyfis)|filmhtfl|100|mg|12|stk|1|pakki||G04BE03|01.08.2010||R|1|0|0|0|0|0|LYF|0|0|0|100|IKR|10129|4898|lyfalmen|V0144|4873|3|12|0|24,0000|LYFIS ehf|LYFIS ehf|Síldenafíl||2743||2743|4898||2 071975|L01BB0501|Fludara|filmhtfl|10|mg|20|stk|1|þpakki||L01BB05|01.09.2011||R|0|0|0|1|0|1|GZE|0|0|0|100|NOK|68232|89001|lyfsjukr|||1|20|0||Vistor hf|Genzyme Europe B.V.|Flúdarabín||68232||68232|89001||1 071998|H03AA0104|Euthyrox|töflur|100|mcg|100|stk|1|þpakki||H03AA01|01.06.2015||R|1|0|0|0|G|0|MKA|0|0|0|100|SEK|604|1954|lyfalmen|V0697|1944|1|100|0|66,6700|Icepharma hf|Merck KgaA|Levótýroxínnatríum||604||604|1954||2 072021|H03AA0104|Euthyrox|töflur|50|mcg|100|stk|1|þpakki||H03AA01|01.06.2015||R|1|0|0|0|G|0|MKA|0|0|0|100|SEK|460|1755|lyfalmen|V0696|1755|1|100|0|33,3300|Icepharma hf|Merck KgaA|Levótýroxínnatríum||460||460|1755||2 072044|B01AC0402|Grepid|töflur|75|mg|30|stk|1|þpakki||B01AC04|01.01.2010||R|1|0|0|0|G|0|PSA|0|0|0|100|XEU|1887|3629|lyfalmen|V0009|3629|2|30|0|30,0000|Alvogen|Pharmathen S.A.|Klópídógrel||1821||1821|3629||1 072132|QN05CM9001|Domosedan, vet.|stl|10|mg/ml|5|ml|1|hgl||QN05CM90|01.01.1991||R|0|0|0|0|0|0|ORF|1|0|0|100|DKK|6340|12199|vetalmen|||0|5|0||Vistor hf|Orion-Farmos|||6340||6340|12199||1 072233|N07BA0107|Nicotinell Mint|tyggigúm|2|mg|300|stk|1|þpakki||N07BA01|01.02.2010||L|0|0|0|0|0|0|SDF|0|0|1|100|IKR|||lyflausa|||0|300|0|20,0000|Artasan ehf|GlaxoSmithKline Consumer Healthcare A/S|Nikótín|||||||1 072380|B01AC0402|Grepid|töflur|75|mg|100|stk|1|þpakki||B01AC04|01.12.2009||R|1|0|0|0|G|0|PSA|0|0|0|100|XEU|6272|6308|lyfalmen|V0029|6308|2|100|0|100,0000|Alvogen|Pharmathen S.A.|Klópídógrel||3768||3768|6308||1 072641|V04CX0001|Lung test gas CO (HE) Aga|lyfjagas|0,28|%|20|l|1|hylki|undir þrýstingi|V04CX|01.05.2012||R|0|0|0|0|0|1|AGA|0|0|0|100|IKR|143477|184025|lyfsjukr|||1|20|0||Ísaga ehf|AGA AB|Carbon monoxide||143477||143477|184025||5 072654|V04CX0002|Lung test gas CO (C2H2/CH4) Aga|lyfjagas|0,3|%|20|l|1|hylki|undir þrýstingi|V04CX|01.05.2012||R|0|0|0|0|0|1|AGA|0|0|0|100|IKR|143477|184025|lyfsjukr|||1|20|0||Ísaga ehf|AGA AB|Carbon monoxide||143477||143477|184025||5 072735|L01BA0110|Metojectpen|stl|20|mg|1|áf-penni|1|pakki||L01BA01|01.05.2016||R|0|0|0|1|G|0|WIL|0|0|0|100|XEU|3122|5419|lyfalmen|||1|1|0||Williams & Halls efh|medac Gesellschaft|Metótrexat||3122||3122|5419||2 072751|N01AH0301|Sufenta|stl|5|mcg/ml|2|ml|5|lykjur||N01AH03|01.06.2000||R|0|0|1|0|0|1|JAS|0|0|0|100|SEK|535|1859|lyfsjukr|||1|10|0||Vistor hf|Janssen-Cilag AB|Súfentaníl||535||535|1859||1 073027|J05AG0401|Intelence|töflur|200|mg|60|stk|1|glas||J05AG04|01.04.2012||R|0|0|0|1|0|1|JCI|0|0|0|100|SEK|56340|73960|lyfsjukr|||1|60|0|30,0000|Vistor hf|Janssen-Cilag International N.V.|Etravírín||56340||56340|73960||1 073030|N05AH0410|Quetiapin Actavis|filmhtfl|200|mg|100|stk|1|þpakki||N05AH04|01.08.2013||R|1|0|0|0|G|0|AGP|0|0|0|100|XEU|8003|7677|lyfalmen|V0286|7415|2|100|0|50,0000|Actavis Group hf|Actavis Group PTC ehf|Quetíapín||4762||4762|7677||1 073178|A10BA0204|Metformin Sandoz|filmhtfl|500|mg|100|stk|1|þpakki||A10BA02|01.01.2016||R|0|0|0|0|G|0|SHS|0|0|0|100|DKK|418|1600|lyfalmen|V0500|1600|2|100|0|25,0000|Artasan ehf|Sandoz A/S|Metformín||347||347|1600||1 073276|C02KX0401|Opsumit|filmhtfl|10|mg|30|stk|1|þpakki||C02KX04|01.09.2014||R|1|1|0|1|0|1|ACV|0|1|0|100|SEK|351101|442251|lyfsjukr|||1|30|0|30,0000|Vistor hf|Actelion Registration Ltd.|Macitentan||||351101|442251||1 073313|L01XE1601|Xalkori|hylki|200|mg|60|stk|1|þpakki||L01XE16|01.05.2013||R|1|1|0|1|0|1|IPI|0|1|0|100|DKK|607217|760788|lyfsjukr|||1|60|0||Icepharma hf|Pfizer Limited|Crizotiníb||607217||607217|760788||2 073559|G04CA5201|Duodart|hylki|0,9|mg|30|stk|1|glas|0,5 mg + 0,4 mg|G04CA52|01.12.2010||R|0|0|0|0|G|0|GPH|0|0|0|100|GBP|3418|5827|lyfalmen|||1|30|0|30,0000|Vistor hf|GlaxoSmithKline Pharma A/S|Dútasteríð og tamsúlósínhýdroklóríð||3418||3418|5827||1 073682|L01XE1301|Giotrif|filmhtfl|50|mg|28|stk|1|þpakki||L01XE13|01.05.2016||R|0|0|0|1|0|1|BOE|0|0|0|100|DKK|263689|333535|lyfsjukr|||1|28|0||Vistor hf|Boehringer Ingelheim International GmbH|Afatiníb||263689||263689|333535||1 073708|L02BG0405|Letrozol Actavis|filmhtfl|2,5|mg|100|stk|1|þpakki||L02BG04|01.09.2011||R|0|0|0|0|G|0|AGP|0|0|0|100|XEU|16788|13309|lyfalmen|V0185|13309|2|100|0|100,0000|Actavis Group hf|Actavis Group PTC ehf|Letrózól||8854||8854|13309||1 073825|N05BA1203|Tafil|töflur|0,25|mg|20|stk|1|þpakki||N05BA12|01.04.1987||R|1|0|0|0|0|0|PER|0|0|1|100|DKK|275|1501|lyfalmen|V0047|1374|1|20|0|5,0000|Icepharma hf|Pfizer ApS|Alprazólam||275||275|1501||1 073841|N05BA1203|Tafil|töflur|0,25|mg|100|stk|1|þpakki||N05BA12|01.04.1987||R|1|0|0|0|0|0|PER|0|0|0|100|DKK|865|2313|lyfalmen|V0305|1989|1|100|0|25,0000|Icepharma hf|Pfizer ApS|Alprazólam||865||865|2313||1 073858|N05BA1203|Tafil|töflur|0,5|mg|20|stk|1|þpakki||N05BA12|01.04.1987||R|1|0|0|0|0|0|PER|0|0|1|100|DKK|466|1764|lyfalmen|V0439|1530|1|20|0|10,0000|Icepharma hf|Pfizer ApS|Alprazólam||466||466|1764||1 073874|N05BA1203|Tafil|töflur|0,5|mg|100|stk|1|þpakki||N05BA12|01.04.1987||R|1|0|0|0|0|0|PER|0|0|0|100|DKK|1265|2863|lyfalmen|||1|100|0|50,0000|Icepharma hf|Pfizer ApS|Alprazólam||1265||1265|2863||1 073933|C09AA0211|Enalapril Krka|töflur|2,5|mg|100|stk|1|þpakki||C09AA02|01.04.2014||R|1|0|0|0|G|0|KRK|0|0|0|100|IKR|1479|2397|lyfalmen|||2|100|0|25,0000|LYFIS ehf|Krka Sverige AB|Enalapríl||926||926|2397||2 073935|QP54AA0107|Noromectin Drench|mixtúra|0,8|mg/ml|1|l|1|fl|lausn|QP54AA01|01.11.2011||R|0|0|0|0|0|0|NOB|0|0|0|100|IKR|3396|5853|vetorma|||0|1|0||Norbrook Laboratories Limited|Norbrook Laboratories Limited|Ivermectinum||3396||3396|5853||2 073947|L04AX0102|Imurel|töflur|25|mg|50|stk|1|þpakki||L04AX01|01.12.2010||R|0|0|0|0|G|0|APP|0|0|0|100|GBP|959|2442|lyfalmen|||1|50|0|8,3333|Artasan ehf|Aspen Pharma Trading Limited|Azatíóprín||959||959|2442||1 074042|C09DB0101|Exforge|filmhtfl|85|mg|28|stk|1|pakki||C09DB01|01.04.2007||R|1|0|0|0|0|0|NEL|0|0|0|100|DKK|2875|5079|lyfalmen|||1|28|0|28,0000|Vistor hf|Novartis Europharm Ltd|Valsartín og amlódipín||2875||2875|5079||1 074468|N05BA0105|Stesolid|töflur|5|mg|25|stk|1|glas||N05BA01|01.12.1972||R|1|0|0|0|0|0|AGT|0|0|1|100|DKK|641|2004|lyfalmen|||2|25|0|12,5000|Actavis Group hf|Actavis Group hf|Díazepam||641||641|2004||1 074477|N02BE0118|Paracetamol-ratiopharm|töflur|500|mg|30|stk|1|þpakki||N02BE01|01.10.2013||L|1|0|0|0|0|0|RGM|0|0|1|100|IKR|||lyflausa|||2|30|0|5,0000|Medical ehf|ratiopharm GmbH|Paracetamól|||||||2 074484|N05BA0105|Stesolid|töflur|5|mg|50|stk|1|glas||N05BA01|01.12.1980||R|1|0|0|0|0|0|AGT|0|0|0|100|DKK|554|1885|lyfalmen|||2|50|0|25,0000|Actavis Group hf|Actavis Group hf|Díazepam||554||554|1885||1 074492|N05BA0105|Stesolid|töflur|5|mg|100|stk|1|glas||N05BA01|01.08.2011||R|1|0|0|0|0|0|AGT|0|0|0|100|DKK|900|2361|lyfalmen|||2|100|0|50,0000|Actavis Group hf|Actavis Group hf|Díazepam||900||900|2361||1 074608|N03AX1606|Pregabalin Mylan|hylki|300|mg|56|stk|1|þpakki||N03AX16|01.11.2015||R|0|0|0|0|0|0|GGE|0|0|0|100|SEK|6846|6779|lyfalmen|V0689|6672|2|56|0|56,0000|Mylan AB|Generics (UK) Ltd.|Pregabalín||4110||4110|6779||2 074617|QI06AA0402|Fel-O-Vax PCT vet.|stl|||1|ml|25|spr|áfyllt sprauta|QI06AA04|01.06.2000||R|0|0|0|0|0|0|PAL|1|0|0|100|DKK|20321|35025|vetorma|||0|25|0||Icepharma hf|Pfizer Oy Animal Health|||20321||20321|35025||2 074667|N06AA0905|Amitriptyline|filmhtfl|10|mg|98|stk|1|þpakki||N06AA09|01.03.2011||R|1|0|0|0|G|0|AUK|0|0|0|100|GBP|407|1682|lyfalmen|||2|98|0|13,0700|Actavis Group hf|Actavis UK Ltd.|Amitriptýlín||407||407|1682||1 074679|N06AA0905|Amitriptyline|filmhtfl|25|mg|98|stk|1|þpakki||N06AA09|01.02.2011||R|1|0|0|0|G|0|AUK|0|0|0|100|GBP|763|2172|lyfalmen|||2|98|0|32,6600|Actavis Group hf|Actavis UK Ltd.|Amitriptýlín||763||763|2172||1 074758|C01AA0503|Lanoxin|mixtúra|50|mcg/ml|60|ml|1|glas||C01AA05|01.12.2010||R|0|0|0|0|G|0|APP|0|0|0|100|GBP|897|2357|lyfalmen|||1|60|0|12,0000|Artasan ehf|Aspen Pharma Trading Limited|Digoxín||897||897|2357||1 074782|C01AA0503|Lanoxin|töflur|0,25|mg|100|stk|1|glas||C01AA05|01.09.2010||R|1|0|0|0|G|0|APP|0|0|0|100|GBP|479|1781|lyfalmen|||1|100|0|100,0000|Artasan ehf|Aspen Pharma Trading Limited|Digoxín||479||479|1781||1 075009|L04AX0102|Imurel|töflur|50|mg|100|stk|1|þpakki||L04AX01|01.08.2011||R|0|0|0|0|G|0|APP|0|0|0|100|GBP|2214|4170|lyfalmen|||1|100|0|33,3333|Artasan ehf|Aspen Pharma Trading Limited|Azatíóprín||2214||2214|4170||1 075031|R03AC1801|Onbrez Breezhaler|innönddu|150|mcg|30|hylki|1|pakki||R03AC18|01.03.2010||R|0|1|0|0|G|0|NEL|0|0|1|100|DKK|4960|7949|lyfalmen|||1|30|0|30,0000|Vistor hf|Novartis Europharm Ltd|Indacaterol||4960||4960|7949||1 075042|R03AC1801|Onbrez Breezhaler|innönddu|150|mcg|90|hylki|1|pakki||R03AC18|01.03.2010||R|0|1|0|0|G|0|NEL|0|0|1|100|DKK|14541|21136|lyfalmen|||1|90|0|90,0000|Vistor hf|Novartis Europharm Ltd|Indacaterol||14541||14541|21136||1 075064|R03AC1801|Onbrez Breezhaler|innönddu|300|mcg|30|hylki|1|pakki||R03AC18|01.03.2010||R|0|1|0|0|G|0|NEL|0|0|1|100|DKK|5238|8332|lyfalmen|||1|30|0|60,0000|Vistor hf|Novartis Europharm Ltd|Indacaterol||5238||5238|8332||1 075069|R06AX2601|Telfast|töflur|180|mg|30|stk|1|þpakki||R06AX26|01.11.1999||R|1|0|0|0|G|0|SNO|0|0|1|100|NOK|1364|2430|lyfalmen|V0363|2353|1|30|0|45,0000|Vistor hf|Sanofi-aventis Norge AS|Fexófenadín||950||950|2430||1 075075|R03AC1801|Onbrez Breezhaler|innönddu|300|mcg|90|hylki|1|pakki||R03AC18|01.03.2010||R|0|1|0|0|G|0|NEL|0|0|1|100|DKK|15339|22235|lyfalmen|||1|90|0|180,0000|Vistor hf|Novartis Europharm Ltd|Indacaterol||15339||15339|22235||1 075078|N07BA0131|Nicorette Microtab Classic|tungur.t|2|mg|90|stk|1|þpakki||N07BA01|01.10.2008||L|0|0|0|0|0|0|MCN|0|0|1|100|IKR|||lyflausa|||0|90|0|6,0000|Vistor hf|McNeil Denmark ApS|Nikótín|||||||1 075087|N02BE5102|Parkodin|töflur|510|mg|300|stk|1|plglas|10+500 mg|N02BE51|01.07.2007||R|2|0|1|0|0|0|AGP|0|0|1|100|IKR|3144|5450|lyfalmen|||2|300|0|50,0000|Actavis Group hf|Actavis Group PTC ehf|Paracetamól í blöndum nema með geðlyfjum (psycholeptica)||3144||3144|5450||1 075096|N02AA5902|Parkodin forte|töflur|530|mg|300|stk|1|plglas|30+500 mg|N02AA59|01.07.2007||R|2|0|1|0|0|0|AGP|0|0|1|100|IKR|4555|7392|lyfalmen|||2|300|0|100,0000|Actavis Group hf|Actavis Group PTC ehf|Kódein í blöndum nema með geðlyfjum||4555||4555|7392||1 075140|R03AL0601|Spiolto Respimat|innöndl|5|mcg|1|rörlyk|1|pakki|2,5+2,5 mcg|R03AL06|01.01.2016||R|0|0|0|0|G|0|BOE|0|0|0|100|DKK|7723|11752|lyfalmen|||1|1|0||Vistor hf|Boehringer Ingelheim International GmbH|Olodaterol og tiotropiumbromide||7723||7723|11752||1 075187|A06AD0001|Moviprep|mixtduft|||4|pokar|1|pakki||A06AD|01.09.2011||R|0|0|0|0|0|0|NBV|0|0|0|100|DKK|2232|4194|lyfalmen|||1|4|0||Norgine BV|Norgine BV|Hægðalyf með osmótíska verkun||||2232|4194||1 075451|G04CB0103|Finasteride Portfarma|filmhtfl|5|mg|98|stk|1|þpakki||G04CB01|01.05.2011||R|1|0|0|0|G|0|POF|0|0|0|100|XEU|3701|4577|lyfalmen|V0445|4577|2|98|0|98,0000|Alvogen|Alvogen|Fínasteríð||2510||2510|4577||1 075470|L01CD0201|Taxotere|irþ|20|mg|1|ml|1|hgl|lausn|L01CD02|01.06.2010|30.04.2016|R|0|0|0|1|0|1|AVS|0|0|0|100|NOK|22636|31331|lyfsjukr|||1|1|0||Vistor hf|Aventis Pharma SA|Docetaxel||22636||22636|31331||1 075482|L01CD0201|Taxotere|irþ|80|mg|4|ml|1|hgl|lausn|L01CD02|01.06.2010|30.04.2016|R|0|0|0|1|0|1|AVS|0|0|0|100|NOK|61712|80754|lyfsjukr|||1|4|0||Vistor hf|Aventis Pharma SA|Docetaxel||61712||61712|80754||1 075777|QG03DA0201|Perlutex, vet.|töflur|5|mg|20|stk|1|þpakki||QG03DA02|01.03.2011||R|0|0|0|0|0|0|DEC|0|0|0|100|DKK|1100|2162|vetalmen|||0|20|0||Vistor hf|Dechra Veterinary Products A/S|Medroxyprogesteronum||1100||1100|2162||1 075865|G04BD0803|Solifenacin Portfarma|filmhtfl|5|mg|90|stk|1|þpakki||G04BD08|01.06.2013||R|1|0|0|0|G|0|POF|0|0|0|100|XEU|11527|16988|lyfalmen|V0440|16988|2|90|0|90,0000|Alvogen|Alvogen|Sólífenacín||11527||11527|16988||1 075869|B05DB0005|Balance|kvið.sk|1,5|%|5000|ml|2|pokar|lausn|B05DB|01.11.2009||R|0|0|0|0|0|1|FMC|0|0|0|100|XEU|5020|8032|lyfsjukr|||1|10000|0||Icepharma hf|Fresenius Medical Care Deutschland GmbH|Hýpertónískar lausnir||5020||5020|8032||2 075888|B05DB0005|Balance|kvið.sk|2,3|%|5000|ml|2|pokar|lausn|B05DB|01.11.2009||R|0|0|0|0|0|1|FMC|0|0|0|100|XEU|5020|8032|lyfsjukr|||1|10000|0||Icepharma hf|Fresenius Medical Care Deutschland GmbH|Hýpertónískar lausnir||5020||5020|8032||2 075906|B05DB0005|Balance|kvið.sk|4,25|%|5000|ml|2|pokar|lausn|B05DB|01.11.2009||R|0|0|0|0|0|1|FMC|0|0|0|100|XEU|5466|8646|lyfsjukr|||1|10000|0||Icepharma hf|Fresenius Medical Care Deutschland GmbH|Hýpertónískar lausnir||5466||5466|8646||2 075936|P01BC0104|Quinine Sulphate Actavis|filmhtfl|200|mg|28|stk|1|þpakki||P01BC01|01.07.2010||R|1|0|0|0|0|0|AUK|0|0|0|100|GBP|549|1878|lyfalmen|||2|28|0|3,7300|Actavis Group hf|Actavis UK Ltd.|Kínín||549||549|1878||1 075947|J01EE0107|Trimezol|töflur|480|mg|20|stk|1|þpakki|80+400 mg|J01EE01|01.12.2009||R|0|0|0|0|0|0|AEA|0|0|1|100|XEU|573|1911|lyfalmen|||2|20|0|5,0000|Actavis hf|Actavis EAD|Súlfametoxazól og trímetóprím||573||573|1911||1 076024|A10BH0101|Januvia|filmhtfl|100|mg|28|stk|1|þpakki||A10BH01|01.01.2010||R|1|0|0|0|G|0|MSD|0|0|0|100|DKK|5776|9072|lyfalmen|||1|28|0|28,0000|Vistor hf|M.S.D.|Sítagliptín||5776||5776|9072||1 076033|A10BH0101|Januvia|filmhtfl|100|mg|98|stk|1|þpakki||A10BH01|01.11.2007||R|1|0|0|0|G|0|MSD|0|0|0|100|DKK|17697|25480|lyfalmen|||1|98|0|98,0000|Vistor hf|M.S.D.|Sítagliptín||||17697|25480||1 076043|A10BH0101|Januvia|filmhtfl|25|mg|98|stk|1|þpakki||A10BH01|01.02.2013||R|1|0|0|0|G|0|MSD|0|0|0|100|DKK|17788|25606|lyfalmen|||1|98|0|24,5000|Vistor hf|M.S.D.|Sítagliptín||17788||17788|25606||1 076052|A10BH0101|Januvia|filmhtfl|50|mg|98|stk|1|þpakki||A10BH01|01.10.2012||R|1|0|0|0|G|0|MSD|0|0|0|100|DKK|17788|25606|lyfalmen|||1|98|0|49,0000|Vistor hf|M.S.D.|Sítagliptín||17788||17788|25606||1 076067|QJ01CA0401|Clamoxyl, vet.|töflur|40|mg|10|stk|1|þpakki||QJ01CA04|01.05.2016||R|0|0|0|0|0|0|ZOE|0|0|0|100|DKK|463|910|vetalmen|||0|10|0||Icepharma hf|Zoetis Finland OY|||||463|910||2 076237|G04BE0309|Vizarsin|filmhtfl|50|mg|4|stk|1|þpakki||G04BE03|01.07.2015||R|1|0|0|0|0|0|KNM|0|0|0|100|IKR|1605|2177|lyfalmen|V0143|1457|2|4|0|4,0000|LYFIS ehf|Krka d.d. Novo mesto|Síldenafíl||766||766|2177||2 076248|G04BE0309|Vizarsin|filmhtfl|50|mg|8|stk|1|þpakki||G04BE03|01.07.2015||R|1|0|0|0|0|0|KNM|0|0|0|100|IKR|2971|3195|lyfalmen|V0143|2914|2|8|0|8,0000|LYFIS ehf|Krka d.d. Novo mesto|Síldenafíl||1506||1506|3195||2 076259|G04BE0309|Vizarsin|filmhtfl|50|mg|12|stk|1|þpakki||G04BE03|01.07.2015||R|1|0|0|0|0|0|KNM|0|0|0|100|IKR|3742|4394|lyfalmen|V0143|4371|2|12|0|12,0000|LYFIS ehf|Krka d.d. Novo mesto|Síldenafíl||2377||2377|4394||2 076270|G04BE0309|Vizarsin|filmhtfl|100|mg|4|stk|1|þpakki||G04BE03|01.07.2015||R|1|0|0|0|0|0|KNM|0|0|0|100|IKR|1667|2373|lyfalmen|V0144|1624|2|4|0|8,0000|LYFIS ehf|Krka d.d. Novo mesto|Síldenafíl||909||909|2373||2 076282|G04BE0309|Vizarsin|filmhtfl|100|mg|8|stk|1|þpakki||G04BE03|01.07.2015||R|1|0|0|0|0|0|KNM|0|0|0|100|IKR|3208|3521|lyfalmen|V0144|3249|2|8|0|16,0000|LYFIS ehf|Krka d.d. Novo mesto|Síldenafíl||1743||1743|3521||2 076293|G04BE0309|Vizarsin|filmhtfl|100|mg|12|stk|1|þpakki||G04BE03|01.07.2015||R|1|0|0|0|0|0|KNM|0|0|0|100|IKR|7023|4898|lyfalmen|V0144|4873|2|12|0|24,0000|LYFIS ehf|Krka d.d. Novo mesto|Síldenafíl||2743||2743|4898||2 076361|V03AN0101|Conoxia|lyfjagas|100|%|2|l|1|hylki|undir þrýstingi/LIV|V03AN01|01.12.2009||L|0|0|0|0|0|0|AGA|0|0|0|100|IKR|||lyflausa|||0|2|0||Ísaga ehf|AGA AB|Súrefni|||||||5 076369|N05AX0805|Risperidon Portfarma|filmhtfl|0,5|mg|20|stk|1|þpakki||N05AX08|01.07.2007||R|1|0|0|0|0|0|POF|0|0|0|100|IKR|445|1735|lyfalmen|V0045|1735|2|20|0|2,0000|Alvogen|Alvogen|Risperídón||445||445|1735||1 076378|N05AX0805|Risperidon Portfarma|filmhtfl|0,5|mg|60|stk|1|þpakki||N05AX08|01.07.2007||R|1|0|0|0|G|0|POF|0|0|0|100|IKR|1691|2430|lyfalmen|V0290|2430|2|60|0|6,0000|Alvogen|Alvogen|Risperídón||950||950|2430||1 076387|N05AX0805|Risperidon Portfarma|filmhtfl|1|mg|60|stk|1|þpakki||N05AX08|01.07.2007||R|1|0|0|0|G|0|POF|0|0|0|100|IKR|1660|2361|lyfalmen|V0291|2361|2|60|0|12,0000|Alvogen|Alvogen|Risperídón||900||900|2361||1 076403|S01GX0801|Zaditen|augndr|0,25|mg/ml|5|ml|1|glas||S01GX08|01.06.2013||R|0|0|0|0|G|0|TEA|0|0|0|100|SEK|1458|3129|lyfalmen|||1|5|0||Vistor hf|Laboratories THEA|Ketotifen||1458||1458|3129||1 076628|N05AX0806|Risperidon Krka|filmhtfl|0,5|mg|60|stk|1|þpakki||N05AX08|01.08.2014||R|1|0|0|0|G|0|KRK|0|0|0|100|IKR|1500|2430|lyfalmen|V0290|2430|2|60|0|6,0000|LYFIS ehf|Krka Sverige AB|Risperídón||950||950|2430||2 076667|B02BD0207|ReFacto AF|sts|3000|ae|1|áf.spr|1|pakki|+leysir|B02BD02|01.11.2014||R|0|0|0|1|0|1|PZE|0|1|0|100|DKK|243561|308502|lyfsjukr|||1|1|0|6,0000|Icepharma hf|Pfizer Ltd.|Storkuþáttur VIII||243561||243561|308502||1 076680|B02BD0207|ReFacto AF|sts|2000|ae|1|áf.spr|1|pakki|+leysir|B02BD02|01.11.2014||R|0|0|0|1|0|1|PZE|0|1|0|100|DKK|162374|207528|lyfsjukr|||1|1|0|4,0000|Icepharma hf|Pfizer Ltd.|Storkuþáttur VIII||162374||162374|207528||1 076691|B02BD0207|ReFacto AF|sts|1000|ae|1|áf.spr|1|pakki|+leysir|B02BD02|01.11.2014||R|0|0|0|1|0|1|PZE|0|1|0|100|DKK|81312|105544|lyfsjukr|||1|1|0|2,0000|Icepharma hf|Pfizer Ltd.|Storkuþáttur VIII||81312||81312|105544||1 076702|B02BD0207|ReFacto AF|sts|500|ae|1|áf.spr|1|pakki|+leysir|B02BD02|01.11.2014||R|0|0|0|1|0|1|PZE|0|1|0|100|DKK|40895|54425|lyfsjukr|||1|1|0|1,0000|Icepharma hf|Pfizer Ltd.|Storkuþáttur VIII||40895||40895|54425||1 076781|N02AA0506|Oxikodon Depot Actavis|forðatfl|10|mg|98|stk|1|glas||N02AA05|01.09.2015||R|1|0|1|0|G|0|APC|0|0|0|100|XEU|2752|4782|lyfalmen|V0598|4782|2|98|0|13,0700|Actavis Group PTC ehf|Actavis Group PTC ehf|Oxýcódon||2659||2659|4782||1 076871|G01AF0202|Canesten (Lyf og heilsa)|sk-tfl|500|mg|1|stk|1|pakki|+stjaka|G01AF02|01.12.2009||L|0|0|0|0|0|0|HOL|0|0|0|100|IKR|||lyflausa|||0|1|0|5,0000|Lyf og heilsa|Lyf og heilsa|Klótrímazól|||||||2 076876|M01AE0219|Alpoxen|töflur|500|mg|25|stk|1|þpakki||M01AE02|01.05.2014||R|0|0|0|0|G|0|AGP|0|0|1|100|SEK|430|1714|lyfalmen|||2|25|0|25,0000|Actavis Group hf|Actavis Group PTC ehf|Naproxen||430||430|1714||1 077213|A02BC0509|Esomeprazole Alvogen|sþ-tfl|40|mg|30|stk|1|þpakki||A02BC05|01.09.2015||R|1|0|0|0|0|0|IPC|0|0|0|100|IKR|2559|2511|lyfalmen|V0005|2511|2|30|0|40,0000|Alvogen|Alvogen IPco S.á.r.l.|Esómeprazól||1009||1009|2511||1 077324|B02BD0102|Cofact|sts|500|ae|1|hgl|1|pakki|+leysir,lausn|B02BD01|01.02.2015||R|0|0|0|1|0|1|SPP|0|0|0|100|XEU|48124|63568|lyfsjukr|||1|1|0|1,4300|Williams & Halls efh|Sanquin Plasma Product|Storkuþættir lX,ll,Vll,X||48124||48124|63568||2 077420|N02BE5102|Parkodin|töflur|510|mg|30|stk|1|pakki|þp 10+500 mg|N02BE51|01.01.1985||R|1|0|0|0|0|0|AGP|0|0|1|100|IKR|367|1627|lyfalmen|||2|30|0|5,0000|Actavis Group hf|Actavis Group PTC ehf|Paracetamól í blöndum nema með geðlyfjum (psycholeptica)||367||367|1627||1 077446|N02BE5102|Parkodin|töflur|510|mg|100|stk|1|pakki|þp 10+500 mg|N02BE51|01.01.1985||R|1|0|0|0|0|0|AGP|0|0|1|100|IKR|1042|2556|lyfalmen|||2|100|0|16,6667|Actavis Group hf|Actavis Group PTC ehf|Paracetamól í blöndum nema með geðlyfjum (psycholeptica)||1042||1042|2556||1 077606|N06BA0405|Medikinet|töflur|5|mg|30|stk|1|þpakki||N06BA04|01.01.2015||R|1|1|1|0|0|0|PUT|0|0|0|100|IKR|819|2249|lyfalmen|||2|30|0|5,0000|LYFIS ehf|Medice Arzneimittel Putter GmbH|Metýlfenídat||819||819|2249||2 077615|N06BA0405|Medikinet|töflur|10|mg|30|stk|1|þpakki||N06BA04|01.01.2015||R|1|1|1|0|0|0|PUT|0|0|0|100|IKR|874|2325|lyfalmen|V0671|2325|2|30|0|10,0000|LYFIS ehf|Medice Arzneimittel Putter GmbH|Metýlfenídat||874||874|2325||2 077624|N06BA0405|Medikinet|töflur|20|mg|30|stk|1|þpakki||N06BA04|01.01.2015||R|1|1|1|0|0|0|PUT|0|0|0|100|IKR|1700|3462|lyfalmen|||2|30|0|20,0000|LYFIS ehf|Medice Arzneimittel Putter GmbH|Metýlfenídat||1700||1700|3462||2 077633|N06BA0406|Medikinet CR|hylki|10|mg|30|stk|1|þpakki|með breyttan losunarhraða|N06BA04|01.01.2015||R|1|1|1|0|0|0|PUT|0|0|0|100|IKR|3300|5664|lyfalmen|||2|30|0|10,0000|LYFIS ehf|Medice Arzneimittel Putter GmbH|Metýlfenídat||3300||3300|5664||2 077642|N06BA0406|Medikinet CR|hylki|20|mg|30|stk|1|þpakki|með breyttan losunarhraða|N06BA04|01.01.2015||R|1|1|1|0|0|0|PUT|0|0|0|100|IKR|5000|8004|lyfalmen|||2|30|0|20,0000|LYFIS ehf|Medice Arzneimittel Putter GmbH|Metýlfenídat||5000||5000|8004||2 077652|N06BA0406|Medikinet CR|hylki|30|mg|30|stk|1|þpakki|með breyttan losunarhraða|N06BA04|01.01.2015||R|1|1|1|0|0|0|PUT|0|0|0|100|IKR|6300|9794|lyfalmen|||2|30|0|30,0000|LYFIS ehf|Medice Arzneimittel Putter GmbH|Metýlfenídat||6300||6300|9794||2 077661|N06BA0406|Medikinet CR|hylki|40|mg|30|stk|1|þpakki|með breyttan losunarhraða|N06BA04|01.01.2015||R|1|1|1|0|0|0|PUT|0|0|0|100|IKR|8120|12299|lyfalmen|||2|30|0|40,0000|LYFIS ehf|Medice Arzneimittel Putter GmbH|Metýlfenídat||8120||8120|12299||2 077875|A02BA0205|Zantac|stl|25|mg/ml|2|ml|5|lykjur||A02BA02|01.10.1987||R|0|0|0|0|G|0|GPH|0|0|0|100|GBP|742|2143|lyfalmen|||1|10|0|0,8333|Vistor hf|GlaxoSmithKline Pharma A/S|Ranitidín||742||742|2143||1 077881|N05AH0413|Quetiapin ratiopharm|forðatfl|50|mg|100|stk|1|þpakki||N05AH04|01.05.2016||R|1|0|0|0|0|0|TEV|0|0|0|100|IKR|8800|13235|lyfalmen|V0275|13235|2|100|0|12,5000|Medical ehf|Teva Pharma B.V.|Quetíapín||8800||8800|13235||2 078193|D01AC0102|Canesten (Lyf og heilsa)|krem|1|%|20|g|1|túpa||D01AC01|01.12.2009||L|0|0|0|0|0|0|HOL|0|0|1|100|IKR|||lyflausa|||0|20|0||Lyf og heilsa|Lyf og heilsa|Klótrímazól|||||||2 078307|J02AC0103|Fluconazole Portfarma|hylki|200|mg|28|stk|1|þpakki||J02AC01|01.12.2010||R|1|0|0|0|0|0|POF|0|0|1|100|IKR|11524|12822|lyfalmen|V0419|11967|2|28|0|28,0000|Alvogen|Alvogen|Flúkónazól||8500||8500|12822||1 078568|J01CE0204|Kaavepenin|töflur|250|mg|20|stk|1|þpakki||J01CE02|01.10.1985||R|0|0|0|0|0|0|REP|0|0|1|100|SEK|455|1748|lyfalmen|||1|20|0|2,5000|Vistor hf|Recip AB|Fenoxýmetýlpenicillín||455||455|1748||1 078576|J01CE0204|Kaavepenin|töflur|250|mg|40|stk|1|þpakki||J01CE02|01.10.1985||R|0|0|0|0|0|0|REP|0|0|1|100|SEK|693|2076|lyfalmen|||1|40|0|5,0000|Vistor hf|Recip AB|Fenoxýmetýlpenicillín||693||693|2076||1 078688|N01BB0204|Lidokain FarmaPlus|stl|10|mg/ml|20|ml|5|hgl|með rotvörn|N01BB02|01.04.2012||R|0|0|0|0|0|0|FPL|0|0|1|100|XEU|1256|2851|lyfalmen|V0560|2851|2|100|0||FarmaPlus AS|FarmaPlus AS|Lídókaín||1256||1256|2851||2 078699|N01BB0204|Lidokain FarmaPlus|stl|20|mg/ml|20|ml|5|hgl|með rotvörn|N01BB02|01.04.2012||R|0|0|0|0|0|0|FPL|0|0|1|100|XEU|1405|3056|lyfalmen|V0561|3056|2|100|0||FarmaPlus AS|FarmaPlus AS|Lídókaín||1405||1405|3056||2 079061|C09CA0101|Cozaar|töflur|50|mg|98|stk|1|þpakki||C09CA01|01.01.1995||R|1|0|0|0|0|0|MSD|0|0|0|100|DKK|8017|5755|lyfalmen|V0069|2988|1|98|0|98,0000|Vistor hf|M.S.D.|Lósartan||3366||3366|5755||1 079109|J05AX1401|Daklinza|filmhtfl|60|mg|28|stk|1|þpakki||J05AX14|01.10.2015||R|1|0|0|1|0|1|BMS|0|1|0|100|DKK|1297289|1619044|lyfsjukr|||1|28|0|28,0000|Vistor hf|Bristol-Myers Squibb Pharma EEIG|Daclatasvír||1297289||1297289|1619044||1 079358|N07BA0143|Nicotinell IceMint|tyggigúm|4|mg|24|stk|1|þpakki||N07BA01|01.05.2010||L|0|0|0|0|0|0|SDF|0|0|1|100|IKR|||lyflausa|||0|24|0|3,2000|Artasan ehf|GlaxoSmithKline Consumer Healthcare A/S|Nikótín|||||||1 079381|N07BA0143|Nicotinell IceMint|tyggigúm|4|mg|204|stk|1|þpakki||N07BA01|01.05.2010||L|0|0|0|0|0|0|SDF|0|0|1|100|IKR|||lyflausa|||0|204|0|27,2000|Artasan ehf|GlaxoSmithKline Consumer Healthcare A/S|Nikótín|||||||1 079409|N03AX1604|Brieka|hylki|225|mg|100|stk|1|glas||N03AX16|01.10.2015||R|1|0|0|0|0|0|AGP|0|0|0|100|XEU|20498|12784|lyfalmen|V0688|12105|2|100|0|75,0000|Actavis Group hf|Actavis Group PTC ehf|Pregabalín||8473||8473|12784||1 079410|N05AX1207|Lemilvo|töflur|10|mg|100|stk|1|glas||N05AX12|01.03.2016||R|1|1|0|0|G|0|AGP|0|0|0|100|XEU|40563|38204|lyfalmen|V0683|37504|2|100|0|66,6700|Actavis Group hf|Actavis Group PTC ehf|Aripiprazól||28070||28070|38204||1 079495|N06AB0308|Fluoxetin Actavis|lausnart|20|mg|100|stk|1|þpakki||N06AB03|01.05.2010||R|1|0|0|0|G|0|ACA|0|0|0|100|XEU|3143|5448|lyfalmen|V0315|5448|2|100|0|100,0000|Actavis Group hf|Actavis hf|Flúoxetín||3143||3143|5448||1 079597|L02BG0305|Anastrozole Teva|filmhtfl|1|mg|100|stk|1|þpakki||L02BG03|01.05.2014||R|0|0|0|0|G|0|TSB|0|0|0|100|IKR|9500|6077|lyfalmen|V0184|5218|2|100|0|100,0000|Medical ehf|Teva Sweden AB|Anastrózól||3600||3600|6077||2 079654|R05CB0106|Mucolysin|freyðit|600|mg|10|stk|1|pakki||R05CB01|01.04.2016||L|0|0|0|0|0|0|SHS|0|0|1|100|IKR|||lyflausa|||2|10|0|12,0000|Artasan ehf|Sandoz A/S|Acetýlcýstein|||||||1 079749|J01CF0101|Diclocil|sts/irs|1|g|1|stk|5|hgl||J01CF01|01.04.1987||R|0|0|0|0|0|1|BRS|0|0|0|100|DKK|1863|3686|lyfsjukr|||1|5|0|2,5000|Vistor hf|Bristol-Myers Squibb|Díkloxacillín||1863||1863|3686||1 080106|J01MA0203|Siprox|töflur|250|mg|10|stk|1|þpakki||J01MA02|01.10.1992||R|1|0|0|0|0|0|ACA|0|0|1|100|IKR|393|1663|lyfalmen|V0176|1663|2|10|0|2,5000|Actavis Group hf|Actavis hf|Cíprófloxacín||393||393|1663||1 080115|J01MA0203|Siprox|töflur|250|mg|20|stk|1|þpakki||J01MA02|01.10.1992||R|1|0|0|0|0|0|ACA|0|0|1|100|IKR|638|2000|lyfalmen|V0418|2000|2|20|0|5,0000|Actavis Group hf|Actavis hf|Cíprófloxacín||638||638|2000||1 080124|J01MA0203|Siprox|töflur|500|mg|10|stk|1|þpakki||J01MA02|01.05.2008||R|1|0|0|0|0|0|ACA|0|0|1|100|IKR|647|2013|lyfalmen|V0177|2013|2|10|0|5,0000|Actavis Group hf|Actavis hf|Cíprófloxacín||647||647|2013||1 080133|J01MA0203|Siprox|töflur|500|mg|20|stk|1|þpakki||J01MA02|01.01.1994||R|1|0|0|0|0|0|ACA|0|0|1|100|IKR|1168|2730|lyfalmen|V0411|2730|2|20|0|10,0000|Actavis Group hf|Actavis hf|Cíprófloxacín||1168||1168|2730||1 080145|QG02AD9002|Genestran|stl|75|mcg/ml|20|ml|1|hgl|lausn|QG02AD90|01.11.2011||R|0|0|0|0|0|0|ANI|1|0|0|100|IKR|4985|9628|vetalmen|||0|20|0||Dýraheilsa ehf|aniMedica GmbH|||4985||4985|9628||2 080156|QN02AF0101|Morphasol handa hundum og köttum|stl|4|mg/ml|10|ml|1|hgl||QN02AF01|01.06.2010||R|0|0|0|0|0|0|ANI|1|0|0|100|XEU|3606|7012|vetalmen|||0|10|0||Dýraheilsa ehf|aniMedica GmbH|Bútorfanóltartrat||||3606|7012||2 080162|N03AX1608|Pregabalina Tecnigen|hylki|150|mg|56|stk|1|þpakki||N03AX16|01.01.2016||R|1|0|0|0|0|0|WEH|0|0|0|100|XEU|7422|6275|lyfalmen|V0687|5952|2|56|0|28,0000|Williams & Halls efh|Williams & Halls ehf|Pregabalín||3744||3744|6275||2 080256|A10BB0903|Gliclazide LYFIS|töflur|30|mg|90|stk|1|þpakki||A10BB09|01.10.2014||R|1|0|0|0|G|0|LYF|0|0|0|100|IKR|4000|4081|lyfalmen|V0020|2344|2|90|0|45,0000|LYFIS ehf|LYFIS ehf|Glíklazíð||2150||2150|4081||2 080331|L02BB0306|Bicalutamid LYFIS|filmhtfl|150|mg|30|stk|1|þpakki||L02BB03|01.06.2012||R|0|0|0|0|G|0|LYF|0|0|0|100|XEU|13497|9964|lyfalmen|V0421|7164|2|30|0|90,0000|LYFIS ehf|LYFIS ehf|Bíkalútamíð||6424||6424|9964||2 080424|G01AF0502|Pevaryl Depot|sk-stíll|150|mg|1|stk|1|still||G01AF05|01.04.1989||L|0|0|0|0|0|0|MCS|0|0|0|100|IKR|||lyflausa|||0|1|0|1,5000|Vistor hf|McNeil Sweden AB|Ekónazól|||||||1 080447|QP52AA5103|Drontal Vet.|filmhtfl|250|mg|24|stk|1|þpakki|230+20 mg|QP52AA51|01.11.2011||R|0|0|0|0|0|0|BAN|0|0|0|100|DKK|9792|16877|vetorma|||0|24|0||Icepharma hf|Bayer Animal Health GmbH|||9792||9792|16877||2 080470|L02BG0406|Letrozole Bluefish|filmhtfl|2,5|mg|30|stk|1|þpakki||L02BG04|01.03.2012||R|0|0|0|0|G|0|BLP|0|0|0|100|XEU|8708|6251|lyfalmen|||2|30|0|30,0000|LYFIS ehf|Bluefish Pharmaceuticals AB|Letrózól||3726||3726|6251||2 080507|N06AA1001|Noritren|töflur|50|mg|100|stk|1|glas||N06AA10|01.04.1986||R|1|0|0|0|G|0|LBK|0|0|0|100|DKK|2058|3955|lyfalmen|||1|100|0|66,6667|Lundbeck Export A/S|H. Lundbeck A/S|Nortriptýlín||2058||2058|3955||1 080524|N06AX1202|Wellbutrin Retard|töflur|300|mg|30|stk|1|glas|m/br. losunarhraða|N06AX12|01.07.2007||R|0|0|0|0|0|0|GPH|0|0|0|100|GBP|5514|8712|lyfalmen|||1|30|0|30,0000|Vistor hf|GlaxoSmithKline Pharma A/S|Bupropionum||5514||5514|8712||1 080538|G04BE0306|Sildenafil Actavis|filmhtfl|50|mg|4|stk|1|pakki||G04BE03|01.08.2010||R|1|0|0|0|0|0|AGP|0|0|0|100|XEU|1502|2196|lyfalmen|V0143|1457|2|4|0|4,0000|Actavis Group hf|Actavis Group PTC ehf|Síldenafíl||780||780|2196||1 080542|N06AX1202|Wellbutrin Retard|töflur|150|mg|30|stk|1|glas|m/br. losunarhraða|N06AX12|01.07.2007||R|0|0|0|0|0|0|GPH|0|0|0|100|GBP|2696|4833|lyfalmen|||1|30|0|15,0000|Vistor hf|GlaxoSmithKline Pharma A/S|Bupropionum||2696||2696|4833||1 080550|G04BE0306|Sildenafil Actavis|filmhtfl|50|mg|12|stk|1|pakki||G04BE03|01.08.2010||R|1|0|0|0|0|0|AGP|0|0|0|100|XEU|3567|4410|lyfalmen|V0143|4371|2|12|0|12,0000|Actavis Group hf|Actavis Group PTC ehf|Síldenafíl||2389||2389|4410||1 080561|G04BE0306|Sildenafil Actavis|filmhtfl|100|mg|4|stk|1|pakki||G04BE03|01.08.2010||R|1|0|0|0|0|0|AGP|0|0|0|100|XEU|1516|2361|lyfalmen|V0144|1624|2|4|0|8,0000|Actavis Group hf|Actavis Group PTC ehf|Síldenafíl||900||900|2361||1 080564|L01DB0601|Zavedos|sts|5|mg|1|stk|1|hgl||L01DB06|01.01.1992||R|0|0|0|1|0|1|PER|0|0|0|100|DKK|13452|19638|lyfsjukr|||1|1|0||Icepharma hf|Pfizer ApS|Ídarúbicín||13452||13452|19638||1 080573|G04BE0306|Sildenafil Actavis|filmhtfl|100|mg|12|stk|1|pakki||G04BE03|01.08.2010||R|1|0|0|0|0|0|AGP|0|0|0|100|XEU|6694|5039|lyfalmen|V0144|4873|2|12|0|24,0000|Actavis Group hf|Actavis Group PTC ehf|Síldenafíl||2846||2846|5039||1 080820|L01DB0601|Zavedos|sts|10|mg|1|stk|1|hgl||L01DB06|01.01.1992||R|0|0|0|1|0|1|PER|0|0|0|100|DKK|26519|36242|lyfsjukr|||1|1|0||Icepharma hf|Pfizer ApS|Ídarúbicín||26519||26519|36242||1 080987|G03XB0101|Mifepristone Linepharma|töflur|200|mg|1|stk|1|þpakki||G03XB01|01.06.2015||R|0|0|0|1|0|1|LPF|0|0|0|100|XEU|2869|5066|lyfsjukr|||1|1|0|0,3300|Alvogen|Linepharma France|Mifepriston||2865||2865|5066||1 081305|L01XE1601|Xalkori|hylki|250|mg|60|stk|1|þpakki||L01XE16|01.05.2013||R|1|1|0|1|0|1|IPI|0|1|0|100|DKK|660017|826456|lyfsjukr|||1|60|0||Icepharma hf|Pfizer Limited|Crizotiníb||660017||660017|826456||2 081490|A01AB0301|Corsodyl|munnh.hl|10|mg/g|50|g|1|túpa||A01AB03|01.07.2013||L|0|0|0|0|0|0|BEE|0|0|1|100|IKR|||lyflausa|||0|50|0|16,6667|Artasan ehf|SmithKline Beecham Ltd.|Klórhexidín|||||||1 081501|A01AB0301|Corsodyl|munnh.l|2|mg/ml|300|ml|1|fl||A01AB03|01.10.2013||L|0|0|0|0|0|0|BEE|0|0|1|100|IKR|||lyflausa|||0|300|0|20,0000|Artasan ehf|SmithKline Beecham Ltd.|Klórhexidín|||||||1 081525|V03AN0101|Conoxia|lyfjagas|100|%|10|l|1|hylki|undir þrýstingi|V03AN01|01.04.2007||L|0|0|0|0|0|0|AGA|0|0|0|100|IKR|||lyflausa|||0|10|0||Ísaga ehf|AGA AB|Súrefni|||||||5 081534|V03AN0101|Conoxia|lyfjagas|100|%|20|l|1|hylki|undir þrýstingi|V03AN01|01.04.2007||L|0|0|0|0|0|0|AGA|0|0|0|100|IKR|||lyflausa|||0|20|0||Ísaga ehf|AGA AB|Súrefni|||||||5 081543|V03AN0101|Conoxia|lyfjagas|100|%|50|l|1|hylki|undir þrýstingi|V03AN01|01.04.2007||L|0|0|0|0|0|0|AGA|0|0|0|100|IKR|||lyflausa|||0|50|0||Ísaga ehf|AGA AB|Súrefni|||||||5 081552|V03AN0101|Conoxia|lyfjagas|100|%|5|l|1|hylki|undir þrýstingi|V03AN01|01.04.2007||L|0|0|0|0|0|0|AGA|0|0|0|100|IKR|||lyflausa|||0|5|0||Ísaga ehf|AGA AB|Súrefni|||||||5 081561|V03AN0101|Conoxia|lyfjagas|100|%|50|l|12|hylki|undir þrýstingi|V03AN01|01.04.2007||L|0|0|0|0|0|0|AGA|0|0|0|100|IKR|||lyflausa|||0|600|0||Ísaga ehf|AGA AB|Súrefni|||||||5 081589|V03AN0101|Conoxia|lyfjagas|100|%|1|l|1|hylki|undir þrýstingi|V03AN01|01.04.2007||L|0|0|0|0|0|0|AGA|0|0|0|100|IKR|||lyflausa|||0|1|0||Ísaga ehf|AGA AB|Súrefni|||||||5 081613|N07BA0143|Nicotinell IceMint|tyggigúm|2|mg|24|stk|1|þpakki||N07BA01|01.05.2010||L|0|0|0|0|0|0|SDF|0|0|1|100|IKR|||lyflausa|||0|24|0|1,6000|Artasan ehf|GlaxoSmithKline Consumer Healthcare A/S|Nikótín|||||||1 081625|V03AN0101|Conoxia|lyfjagas|100|%|2|l|1|hylki|undir þrýstingi|V03AN01|01.04.2007||L|0|0|0|0|0|0|AGA|0|0|0|100|IKR|||lyflausa|||0|2|0||Ísaga ehf|AGA AB|Súrefni|||||||5 081634|V03AN0101|Conoxia|lyfjagas|100|%|4|l|1|hylki|undir þrýstingi|V03AN01|01.04.2007||L|0|0|0|0|0|0|AGA|0|0|0|100|IKR|||lyflausa|||0|4|0||Ísaga ehf|AGA AB|Súrefni|||||||5 081635|N07BA0143|Nicotinell IceMint|tyggigúm|2|mg|204|stk|1|þpakki||N07BA01|01.05.2010||L|0|0|0|0|0|0|SDF|0|0|1|100|IKR|||lyflausa|||0|204|0|13,6000|Artasan ehf|GlaxoSmithKline Consumer Healthcare A/S|Nikótín|||||||1 081645|N03AX1405|Matever|filmhtfl|250|mg|100|stk|1|þpakki||N03AX14|01.02.2012||R|1|0|0|0|0|0|PSA|0|0|0|100|XEU|4838|3956|lyfalmen|V0515|3346|2|100|0|16,6700|Alvogen|Pharmathen S.A.|Levetíracetam||2059||2059|3956||1 081669|G03DA0404|Lutinus|sk-tafla|100|mg|21|stk|1|þpakki||G03DA04|01.04.2011||R|0|0|0|1|G|0|FEL|0|0|0|100|DKK|4145|6827|lyfalmen|||1|21|0|23,3300|Vistor hf|Ferring Lægemidler A/S|Prógesterón||4145||4145|6827||1 081671|V03AN0101|Conoxia|lyfjagas|100|%|4|l|1|hylki|undir þrýstingi|V03AN01|01.04.2007||L|0|0|0|0|0|0|AGA|0|0|0|100|IKR|||lyflausa|||0|4|0||Ísaga ehf|AGA AB|Súrefni|||||||5 081708|G03AC0903|Desogestrel ratiopharm|filmhtfl|75|mcg|84|stk|1|þpakki|3x28 stk|G03AC09|01.02.2014||R|0|0|0|0|0|0|RGM|0|0|0|100|IKR|1750|2636|lyfalmen|V0590|2625|2|84|0|84,0000|Medical ehf|ratiopharm GmbH|Desógestrel||1100||1100|2636|| 081745|N05CD0801|Dormicum|stl|5|mg/ml|1|ml|10|lykjur||N05CD08|01.07.1985||R|0|0|0|0|0|1|ROC|0|0|0|100|DKK|1892|3726|lyfsjukr|||1|10|0|3,3333|Icepharma hf|Roche|Mídazólam||1892||1892|3726||2 081900|N05AX1209|Aripiprazole Sandoz|töflur|10|mg|14|stk|1|þpakki||N05AX12|01.04.2016||R|1|1|0|0|0|0|HSS|0|0|0|100|DKK|7020|10785|lyfalmen|V0204|7507|2|14|0|9,3300|Artasan ehf|Sandoz GmbH|Aripiprazól||7020||7020|10785||1 081987|A10AB0602|Apidra [Solostar]|stl|100|ein/ml|3|ml|5|lyfjap|áfylltir lyfjapennar|A10AB06|01.01.2008||R|0|0|0|0|G|0|SAA|0|0|0|100|NOK|4251|6973|lyfalmen|||1|15|0|37,5000|Vistor hf|Sanofi - Aventis|Insúlín glúlisín||4251||4251|6973||1 081996|A10AE0403|Lantus [SoloStar]|stl|100|ein/ml|3|ml|5|lyfjap|áfylltir lyfjapennar|A10AE04|01.01.2008||R|0|0|0|0|G|0|SDE|0|0|0|100|NOK|5987|9363|lyfalmen|||1|15|0|37,5000|Vistor hf|Sanofi - aventis Deutschland GmbH|Insulín glargín||5987||5987|9363||1 082021|L02BG0302|Anastrozol Actavis|filmhtfl|1|mg|98|stk|1|þpakki||L02BG03|01.03.2011||R|0|0|0|0|G|0|AGP|0|0|0|100|XEU|15324|8522|lyfalmen|V0184|5114|2|98|0|98,0000|Actavis Group hf|Actavis Group PTC ehf|Anastrózól||5376||5376|8522||1 082233|V03AN0101|Conoxia|lyfjagas|100|%|36|l|1|hylki|kælt|V03AN01|01.04.2007||L|0|0|0|0|0|0|AGA|0|0|0|100|IKR|||lyflausa|||0|36|0||Ísaga ehf|AGA AB|Súrefni|||||||5 082237|V03AF0101|Uromitexan|stl|100|mg/ml|4|ml|15|lykjur||V03AF01|01.04.2015||R|0|0|0|0|0|1|BAM|0|0|0|100|SEK|27808|37872|lyfsjukr|||1|60|0||Icepharma hf|Baxter Medical AB|Mesna||27808||27808|37872||2 082512|QI06AH0701|Leucofeligen FeLV/RCP|stl|||10|hgl|1|pakki|frostþurrkað stungulyf|QI06AH07|01.05.2014||R|0|0|0|0|0|0|VIR|1|0|0|100|XEU|9276|15988|vetorma|||0|10|0||Vistor hf|Virbac S.A|.||9276||9276|15988||1 082523|QI06AH0701|Leucofeligen FeLV/RCP|stl|||50|hgl|1|pakki|frostþurrkað stungulyf|QI06AH07|01.05.2014||R|0|0|0|0|0|0|VIR|1|0|0|100|XEU|45585|78570|vetorma|||0|50|0||Vistor hf|Virbac S.A|.||45585||45585|78570||1 082548|D07AC1301|Elocon|krem|0,1|%|30|g|1|túpa||D07AC13|01.02.2014||R|0|0|0|0|G|0|MBV|0|0|1|100|DKK|595|1941|lyfalmen|||1|30|0||Vistor hf|Merck Sharp & Dohme B.V.|Mómetasón||595||595|1941||1 082675|N02BE0118|Paracetamol-ratiopharm|töflur|1000|mg|100|stk|1|þpakki||N02BE01|01.10.2013||R|1|0|0|0|0|0|RGM|0|0|1|100|XEU|661|1945|lyfalmen|V0229|1945|2|100|0|33,3300|Medical ehf|ratiopharm GmbH|Paracetamól||598||598|1945||2 082685|R03BA0502|Flixotide Diskus|innönddu|250|mcg/sk|60|skammtar|1|pakki|í diskus-t|R03BA05|01.07.1995||R|0|0|0|0|G|0|GPH|0|0|0|100|GBP|2674|4803|lyfalmen|||1|60|0|25,0000|Vistor hf|GlaxoSmithKline Pharma A/S|Flútíkasón||2674||2674|4803||1 082719|R03BA0502|Flixotide Diskus|innönddu|500|mcg/sk|60|skammtar|1|pakki|í diskus-t|R03BA05|01.07.1995||R|0|0|0|0|G|0|GPH|0|0|0|100|GBP|4930|7908|lyfalmen|||1|60|0|50,0000|Vistor hf|GlaxoSmithKline Pharma A/S|Flútíkasón||4930||4930|7908||1 082797|N02BE0117|Panodil Zapp|filmhtfl|500|mg|20|stk|1|þpakki||N02BE01|01.02.2012|31.03.2016|L|0|0|0|0|0|0|HCA|0|0|1|100|IKR|||lyflausa|||0|20|0|3,3333|Artasan ehf|GlaxoSmithKline CH A/S|Paracetamól|||||||1 082830|N02BE0117|Panodil Zapp|filmhtfl|500|mg|20|stk|1|þpakki||N02BE01|01.01.2016||L|0|0|0|0|0|0|HCA|0|0|1|100|IKR|||lyflausa|||0|20|0|3,3333|Artasan ehf|GlaxoSmithKline CH A/S|Paracetamól|||||||1 082883|R03BA0201|Pulmicort|innúðal|0,125|mg/ml|2|ml|20|plhylk|í vél|R03BA02|01.01.1997||R|0|0|0|0|G|0|AZD|0|0|0|100|SEK|3386|5783|lyfalmen|||1|40|0|3,3400|Vistor hf|AstraZeneca A/S DK|Búdesóníð||3386||3386|5783||1 082933|R03BA0201|Pulmicort|innúðal|0,25|mg/ml|2|ml|20|plhylk|í vél|R03BA02|01.01.1997||R|0|0|0|0|G|0|AZD|0|0|0|100|SEK|3686|6196|lyfalmen|||1|40|0|6,6700|Vistor hf|AstraZeneca A/S DK|Búdesóníð||3686||3686|6196||1 082940|C09CA0602|Candpress|töflur|16|mg|100|stk|1|þpakki||C09CA06|01.01.2012||R|1|0|0|0|0|0|AGP|0|0|0|100|XEU|4141|6675|lyfalmen|V0080|6675|2|100|0|200,0000|Actavis Group hf|Actavis Group PTC ehf|Candesartan||4034||4034|6675||1 082958|N06DA0301|Exelon|hylki|1,5|mg|56|stk|1|þpakki||N06DA03|01.10.2008||R|1|0|0|0|G|0|HES|0|0|0|100|DKK|11782|17339|lyfalmen|V0354|16718|1|56|0|9,3350|Vistor hf|Novartis Healthcare A/S|Rívastigmín||11782||11782|17339||1 083053|A09AA0206|Creon 10.000|sh-hylki|||100|stk|1|plglas||A09AA02|01.12.2015||R|1|0|0|0|G|0|BGP|0|0|0|100|DKK|2841|5033|lyfalmen|V0706|5033|1|100|0|16,6700|Vistor hf|BGP Products ApS|Hvatablöndur (lípasi, próteasi o.s.frv.)||2841||2841|5033||1 083121|N06DA0301|Exelon|hylki|3|mg|56|stk|1|þpakki||N06DA03|01.10.2008||R|1|0|0|0|G|0|HES|0|0|0|100|DKK|12184|17892|lyfalmen|V0344|15760|1|56|0|18,6700|Vistor hf|Novartis Healthcare A/S|Rívastigmín||12184||12184|17892||1 083154|R03BA0201|Pulmicort|innúðal|0,5|mg/ml|2|ml|20|plhylk|í vél|R03BA02|01.01.1997||R|0|0|0|0|G|0|AZD|0|0|0|100|SEK|5003|8008|lyfalmen|V0701|6628|1|40|0|13,3400|Vistor hf|AstraZeneca A/S DK|Búdesóníð||5003||5003|8008||1 083275|N03AX1604|Brieka|hylki|75|mg|100|stk|1|glas||N03AX16|01.10.2015||R|1|0|0|0|0|0|AGP|0|0|0|100|XEU|9761|7269|lyfalmen|V0686|6686|2|100|0|25,0000|Actavis Group hf|Actavis Group PTC ehf|Pregabalín||4466||4466|7269||1 083413|QN05CM9102|Narcostart|stl|1|mg/ml|10|mg|1|hgl|fyrir hunda og ketti|QN05CM91|01.07.2013||R|0|0|0|0|0|0|BVL|1|0|0|100|XEU|5539|10679|vetalmen|||0|10|0||Dýraheilsa ehf|Le Vet B.V.|Metetomidinum||5539||5539|10679||2 083634|N06DA0301|Exelon|hylki|6|mg|112|stk|1|þpakki||N06DA03|01.01.1999||R|1|0|0|0|G|0|HES|0|0|0|100|DKK|26702|36473|lyfalmen|V0346|33649|1|112|0|74,6667|Vistor hf|Novartis Healthcare A/S|Rívastigmín||26702||26702|36473||1 083644|N02BE0101|Panodil|filmhtfl|500|mg|300|stk|1|glas||N02BE01|01.02.2013||R|1|0|0|0|0|0|HCA|0|0|1|100|DKK|906|2135|lyfalmen|V0231|2039|1|300|0|50,0000|Artasan ehf|GlaxoSmithKline CH A/S|Paracetamól||736||736|2135||1 084192|N05BA1206|Alprazolam Krka|forðatfl|2|mg|30|stk|1|þpakki||N05BA12|01.08.2012||R|1|0|0|0|0|0|KRK|0|0|1|100|XEU|1821|2867|lyfalmen|V0311|2867|2|30|0|60,0000|LYFIS ehf|Krka Sverige AB|Alprazólam||1268||1268|2867||2 084456|N07BA0150|Nicotinell Spearmint|tyggigúm|4|mg|204|stk|1|þpakki||N07BA01|01.09.2013||L|0|0|0|0|0|0|SDF|0|0|1|100|IKR|||lyflausa|||0|204|0|27,2000|Artasan ehf|GlaxoSmithKline Consumer Healthcare A/S|Nikótín|||||||1 084591|L04AB0101|Enbrel|stl|25|mg|4|áf.spr|1|pakki|lausn|L04AB01|01.04.2012||R|0|1|0|1|0|1|IPI|0|1|0|100|DKK|61644|80668|lyfsjukr|||1|4|0|14,2900|Icepharma hf|Pfizer Limited|Etanercept||61644||61644|80668||1 084807|L01XE2301|Tafinlar|hylki|75|mg|28|stk|1|glas||L01XE23|01.11.2013||R|1|0|0|1|0|1|NEL|0|1|0|100|DKK|232202|294374|lyfsjukr|||1|28|0||Vistor hf|Novartis Europharm Ltd|Dabrafeníb||232202||232202|294374||1 084878|N03AF0301|Inovelon|filmhtfl|100|mg|10|stk|1|þpakki||N03AF03|01.09.2007|31.03.2016|R|0|0|0|1|G|0|EIS|0|0|0|100|SEK|804|2229|lyfalmen|||1|10|0|0,7100|Vistor hf|Eisai Ltd|Rúfínamíð||804||804|2229||1 084924|J05AG0301|Stocrin|filmhtfl|200|mg|90|stk|1|glas||J05AG03|01.10.2013||R|1|0|0|1|0|1|MSD|0|0|0|100|DKK|39128|52190|lyfsjukr|||1|90|0|30,0000|Vistor hf|M.S.D.|Efavirenz||39128||39128|52190||1 085068|N02AA0101|Contalgin|forðatfl|100|mg|100|stk|1|þpakki||N02AA01|01.10.1985||R|1|0|1|0|G|0|PER|0|0|0|100|DKK|11398|16810|lyfalmen|||1|100|0|100,0000|Icepharma hf|Pfizer ApS|Morfín||11398||11398|16810||1 085171|A10BX0401|Byetta|stl|5|mcg/sk|60|skammtar|1|penni|lausn|A10BX04|01.10.2015||R|0|0|0|0|0|0|BRI|0|0|0|100|SEK|14577|21186|lyfalmen|||1|60|0|20,0000|Vistor hf|Bristol-Myers Squibb/AstraZeneca EEIG|Exenatíð||14577||14577|21186||1 085184|L01XD0301|Metvix|krem|160|mg/g|2|g|1|túpa||L01XD03|01.09.2010||R|0|0|0|1|G|0|GAN|0|0|0|100|NOK|31558|42615|lyfalmen|||1|2|0||Icepharma hf|Galderma Nordic AB|Metýlamínólevúlínat||31558||31558|42615||2 085205|S01AE0501|Oftaquix|augndr|5|mg/ml|0,5|ml|30|sk-hyl||S01AE05|01.03.2008||R|0|0|0|0|0|0|SAO|0|0|1|100|XEU|2335|4336|lyfalmen|||1|15|0||Icepharma hf|Santen Oy|Levófloxacín||2335||2335|4336||2 085316|N06DA0301|Exelon|hylki|4,5|mg|112|stk|1|þpakki||N06DA03|01.01.1999||R|1|0|0|0|G|0|HES|0|0|0|100|DKK|26702|36473|lyfalmen|V0345|33649|1|112|0|56,0000|Vistor hf|Novartis Healthcare A/S|Rívastigmín||26702||26702|36473||1 085407|R03AC0206|Ventoline|innönd.l|1|mg/ml|20|lykjur|1|pakki|lausn f. eimgjafa|R03AC02|01.04.1992||R|0|0|0|0|G|0|GPH|0|0|1|100|IKR|756|2163|lyfalmen|||1|20|0|5,0000|Vistor hf|GlaxoSmithKline Pharma A/S|Salbútamól||756||756|2163||1 085488|B05BB0117|Natriumklorid Baxter Viaflo 9 mg/ml|irl|9|mg/ml|250|ml|30|pokar|lausn|B05BB01|01.07.2013||R|0|0|0|0|0|1|BAM|0|0|0|100|SEK|4640|7509|lyfsjukr|||1|7500|0||Icepharma hf|Baxter Medical AB|Elektrólýtar||4640||4640|7509||2 085542|G03GA0202|Menopur|sts|||75|ae|5|hgl|+ leysir|G03GA02|01.03.2001||R|0|0|0|1|G|0|FEL|0|0|0|100|DKK|18503|26590|lyfalmen|V0412|23807|1|375|0|5,0000|Vistor hf|Ferring Lægemidler A/S|Menótrópín||18503||18503|26590||1 085551|G03GA0202|Menopur|sts|||75|ae|10|hgl|+ leysir|G03GA02|01.03.2001||R|0|0|0|1|G|0|FEL|0|0|0|100|DKK|35509|47613|lyfalmen|V0412|47613|1|750|0|10,0000|Vistor hf|Ferring Lægemidler A/S|Menótrópín||35509||35509|47613||1 085574|B01AF0201|Eliquis|filmhtfl|5|mg|100|stk|1|þpakki||B01AF02|01.09.2014||R|1|1|0|0|G|0|BRP|0|0|0|100|DKK|15565|21399|lyfalmen|V0652|21296|1|100|0|50,0000|Icepharma hf|Bristol-Myers Squibb/Pfizer EEIG|Apixaban ||14732||14732|21399||1 085770|G04BE0804|Adcirca|filmhtfl|20|mg|56|stk|1|þpakki||G04BE08|01.12.2010||R|0|0|0|1|0|1|ELD|0|0|0|100|XEU|81270|105491|lyfsjukr|||1|56|0|112,0000|Icepharma hf|Eli Lilly Nederland B.V.|Tadalafíl||81270||81270|105491||2 085771|N07XX0202|Riluzol Actavis|filmhtfl|50|mg|56|stk|1|þpakki||N07XX02|01.11.2012||R|1|0|0|1|G|0|AGP|0|0|0|100|SEK|19292|27025|lyfalmen|V0579|27025|2|56|0|28,0000|Actavis Group hf|Actavis Group PTC ehf|Rílúzól||18819||18819|27025||1 085804|M05BX0401|Prolia|stl|60|mg/ml|1|ml|1|áf.spr|lausn|M05BX04|01.10.2010||R|0|1|0|0|0|0|AEB|0|0|0|100|DKK|28983|39358|lyfalmen|||1|1|0|181,8100|Vistor hf|Amgen Europe B.V.|Denosúmab||28983||28983|39358||1 085830|L01XA0211|Carboplatin Actavis|irþ|10|mg/ml|60|ml|1|hgl||L01XA02|01.05.2013||R|0|0|0|1|0|1|APC|0|0|0|100|XEU|3804|6358|lyfsjukr|||2|60|0||Actavis Group PTC ehf|Actavis Group PTC ehf|Karbóplatín||3804||3804|6358||1 085838|S01EE0301|Lumigan|augndr|0,1|mg/ml|3|ml|1|glös|lausn|S01EE03|01.10.2011||R|0|0|0|0|G|0|IRE|0|0|0|100|XEU|2405|4432|lyfalmen|V0465|3631|1|3|0|30,0000|Actavis ehf|Allergan Pharmaceuticals Ireland|Bimatóprost||2405||2405|4432||1 085849|S01EE0301|Lumigan|augndr|0,1|mg/ml|3|ml|3|glös|lausn|S01EE03|01.10.2011||R|0|0|0|0|G|0|IRE|0|0|0|100|XEU|7099|10893|lyfalmen|V0465|10893|1|9|0|90,0000|Actavis ehf|Allergan Pharmaceuticals Ireland|Bimatóprost||7099||7099|10893||1 085860|N05CF0101|Imovane|filmhtfl|5|mg|30|stk|1|þpakki||N05CF01|01.12.2013||R|1|0|0|0|0|0|SNO|0|0|1|100|NOK|338|1587|lyfalmen|||1|30|0|20,0000|Vistor hf|Sanofi-aventis Norge AS|Zópíklón||338||338|1587||1 085969|R06AX2601|Telfast|töflur|120|mg|100|stk|1|þpakki||R06AX26|01.11.1999||R|1|0|0|0|G|0|SNO|0|0|1|100|NOK|1580|3297|lyfalmen|V0364|3297|1|100|0|100,0000|Vistor hf|Sanofi-aventis Norge AS|Fexófenadín||1580||1580|3297||1 086108|R06AX2601|Telfast|töflur|180|mg|100|stk|1|þpakki||R06AX26|01.11.1999||R|1|0|0|0|G|0|SNO|0|0|1|100|NOK|4015|4781|lyfalmen|V0365|4543|1|100|0|150,0000|Vistor hf|Sanofi-aventis Norge AS|Fexófenadín||2658||2658|4781||1 086142|N07XX0701|Fampyra|forðatfl|10|mg|56|stk|1|þpakki||N07XX07|01.03.2013||R|0|0|0|1|0|0|BIB|0|0|0|100|XEU|53898|70871|lyfalmen|||1|56|0|28,0000|Icepharma hf|Biogen Idec Ltd|Fampridine||53898||53898|70871||2 086191|N03AX2201|Fycompa|filmhtfl|8|mg|28|stk|1|þpakki||N03AX22|01.01.2015||R|1|0|0|0|G|0|EUR|0|0|0|100|SEK|21138|29436|lyfalmen|||1|28|0|28,0000|Vistor hf|Eisai Europe Ltd.|Perampanel||21138||21138|29436||1 086207|J01DD0202|Fortum|sts|1|g/hgl|5|hgl|1|pakki||J01DD02|01.08.2002||R|0|0|0|0|0|1|GPH|0|0|0|100|GBP|7723|11752|lyfsjukr|||1|5|0|1,2500|Vistor hf|GlaxoSmithKline Pharma A/S|Ceftazidím||7723||7723|11752||1 086231|J01DD0202|Fortum|sts|2|g/hgl|5|hgl|1|pakki||J01DD02|01.08.2002||R|0|0|0|0|0|1|GPH|0|0|0|100|GBP|8383|12661|lyfsjukr|||1|5|0|2,5000|Vistor hf|GlaxoSmithKline Pharma A/S|Ceftazidím||8383||8383|12661||1 086324|A02BC0501|Nexium|sþ-tfl|40|mg|100|stk|1|glas||A02BC05|01.09.2013||R|1|0|0|0|0|0|AZD|0|0|0|100|SEK|12249|17982|lyfalmen|V0012|5114|1|100|0|133,3300|Vistor hf|AstraZeneca A/S DK|Esómeprazól||12249||12249|17982||1 086368|G03GA0202|Menopur|sts|||600|ae|1|hgl|+ leysir|G03GA02|01.04.2011||R|0|0|0|1|G|0|FEL|0|0|0|100|DKK|26338|36013|lyfalmen|||1|600|0|8,0000|Vistor hf|Ferring Lægemidler A/S|Menótrópín||||26338|36013||1 086380|G03GA0202|Menopur|sts|||1200|ae|1|hgl|+ leysir|G03GA02|01.04.2011||R|0|0|0|1|G|0|FEL|0|0|0|100|DKK|47683|63010|lyfalmen|||1|1200|0|16,0000|Vistor hf|Ferring Lægemidler A/S|Menótrópín||||47683|63010||1 086434|L04AA2401|Orencia|stl/irþ|250|mg/hgl|1|hgl|1|hgl|+ sprauta|L04AA24|01.02.2008||R|0|0|0|1|0|1|BSP|0|1|0|100|DKK|46563|61594|lyfsjukr|||1|1|0|9,2600|Vistor hf|Bristol-Myers Squibb Pharma (UK) Ltd |Abatacept||46563||46563|61594||1 086530|G02BA0302|Mirena|leginnle|20|mcg/sólh|1|stk|1|pakki||G02BA03|01.08.2012||R|0|0|0|0|0|0|BOY|0|0|0|100|DKK|15066|21859|lyfalmen|||1|1|0||Icepharma hf|Bayer OY|Plast lyfjalykkja (IUD) með prógestógen||||15066|21859||2 086969|J05AB1401|Valcyte|mixtúrud|50|mg/ml|100|ml|1|glerfl|lausn|J05AB14|01.09.2009||R|0|0|0|0|0|1|ROA|0|0|0|100|DKK|44663|59190|lyfsjukr|||1|100|0|5,5000|Icepharma hf|Roche A.S.|Valgancíklóvír||44663||44663|59190||2 087046|R06AX2706|Flynise|filmhtfl|5|mg|30|stk|1|þpakki||R06AX27|01.10.2015||L|1|0|0|0|0|0|APC|0|0|1|100|IKR|||lyflausa|||2|30|0|30,0000|Actavis Group PTC ehf|Actavis Group PTC ehf|Deslóratadín|||||||1 087215|A03AX1335|Imogaze|hylki|240|mg|30|stk|1|þpakki|mjúk hylki|A03AX13|01.12.2008||L|1|0|0|0|0|0|MCS|0|0|0|100|IKR|||lyflausa|||0|30|0|14,4000|Vistor hf|McNeil Sweden AB|Silíkonsambönd|||||||1 087233|N05CF0201|Stilnoct|töflur|10|mg|30|stk|1|þpakki||N05CF02|01.08.2012||R|1|0|0|0|0|0|SNO|0|0|1|100|NOK|313|1553|lyfalmen|V0060|1499|1|30|0|30,0000|Vistor hf|Sanofi-aventis Norge AS|Zolpidem||313||313|1553||1 087260|J05AX0901|Celsentri|filmhtfl|150|mg|60|stk|1|þpakki||J05AX09|01.04.2008||R|1|0|0|1|0|1|VIH|0|0|0|100|DKK|110502|143014|lyfsjukr|||1|60|0|15,0000|Vistor hf|ViiV Healthcare UK Ltd|Maravíroc||110502||110502|143014||1 087304|N05CF0101|Imovane|töflur|7,5|mg|10|stk|1|þpakki||N05CF01|01.10.1995||R|1|0|0|0|0|0|SNO|0|0|1|100|NOK|212|1414|lyfalmen|V0312|415|1|10|0|10,0000|Vistor hf|Sanofi-aventis Norge AS|Zópíklón||212||212|1414||1 087312|N05CF0101|Imovane|töflur|7,5|mg|30|stk|1|þpakki||N05CF01|01.10.1995||R|1|0|0|0|0|0|SNO|0|0|0|100|NOK|187|1380|lyfalmen|V0312|1246|1|30|0|30,0000|Vistor hf|Sanofi-aventis Norge AS|Zópíklón||187||187|1380||1 087320|N05CF0101|Imovane|töflur|7,5|mg|100|stk|1|þpakki||N05CF01|01.10.1995||R|1|0|0|0|0|0|SNO|0|0|0|100|NOK|1571|3285|lyfalmen|||1|100|0|100,0000|Vistor hf|Sanofi-aventis Norge AS|Zópíklón||1571||1571|3285||1 087332|N06DA0204|Donepezil Actavis|filmhtfl|5|mg|250|stk|1|glas||N06DA02|01.01.2014||R|2|0|0|0|G|0|APC|0|0|0|100|XEU|29743|17774|lyfalmen|||2|250|0|166,6700|Actavis Group PTC ehf|Actavis Group PTC ehf|Dónepezíl||12098||12098|17774||1 087354|N06DA0204|Donepezil Actavis|filmhtfl|10|mg|250|stk|1|glas||N06DA02|01.01.2014||R|2|0|0|0|G|0|APC|0|0|0|100|XEU|29743|17774|lyfalmen|||2|250|0|333,3300|Actavis Group PTC ehf|Actavis Group PTC ehf|Dónepezíl||12098||12098|17774||1 087445|A02BX1301|Gaviscon|mixtúra|||500|ml|1|glas||A02BX13|01.08.1984||L|0|0|0|0|0|0|NDR|0|0|0|100|IKR|||lyfalmen|||0|500|0||Vistor hf|Nordic Drugs AB|Algínsýra|||||3746||1 087727|D07AC1301|Elocon|húðlausn|0,1|%|100|ml|1|túpa||D07AC13|01.02.2014||R|0|0|0|0|G|0|MBV|0|0|1|100|DKK|1861|3684|lyfalmen|||1|100|0||Vistor hf|Merck Sharp & Dohme B.V.|Mómetasón||1861||1861|3684||1 087759|G03GB0202|Pergotime|töflur|50|mg|5|stk|1|þpakki||G03GB02|01.07.1986||R|0|0|0|0|G|0|MEC|0|0|0|100|SEK|846|2287|lyfalmen|||1|5|0|27,7778|Icepharma hf|Merck AB|Klómífen||846||846|2287||2 087788|B01AC0403|Clopidogrel Actavis|filmhtfl|75|mg|28|stk|1|þpakki||B01AC04|01.11.2010||R|1|0|0|0|G|0|APC|0|0|0|100|XEU|2026|3463|lyfalmen|V0009|3387|2|28|0|28,0000|Actavis Group PTC ehf|Actavis Group PTC ehf|Klópídógrel||1701||1701|3463||1 087867|QP52AA5108|Prazitel Plus|töflur|||104|stk|1|þpakki|50/144/150|QP52AA51|01.07.2010||R|0|0|0|0|0|0|CHP|0|0|0|100|XEU|28952|49902|vetorma|||0|104|0||Icepharma hf|Chanelle Pharmaceuticals|||28952||28952|49902||2 087932|A02BX1301|Gaviscon|tuggutfl|||20|stk|1|þpakki||A02BX13|01.10.1993||L|1|0|0|0|0|0|NDR|0|0|0|100|IKR|||lyflausa|||0|20|0||Vistor hf|Nordic Drugs AB|Algínsýra|||||||1 087969|QD07AC0001|Cortavance|húðúði|0,584|mg/ml|76|ml|1|fl|lausn|QD07AC|01.04.2012||R|0|0|0|0|0|0|VIR|0|0|0|100|XEU|3378|6579|vetalmen|||0|76|0||Vistor hf|Virbac S.A|Hýdrókortisón aceponat||3378||3378|6579||1 088026|QG03DA0402|Prid delta|sk-innl|1,55|g|10|stk|1|pakki||QG03DA04|01.02.2012||R|0|0|0|0|0|0|CES|1|0|0|100|SEK|24018|41397|vetorma|||0|10|0||Icepharma hf|Ceva Sante Animale|Prógesterón||24018||24018|41397||2 088235|G03AA1204|Yasmin 28|filmhtfl|||84|stk|1|þpakki|3+0,03 mg|G03AA12|01.10.2013||R|0|0|0|0|0|0|BYP|0|0|0|100|DKK|2797|4972|lyfalmen|||1|84|0|84,0000|Icepharma hf|Bayer Pharma AG|Dróspírenón og ethinylestradíól||2797||2797|4972||2 088261|R01AD1201|Avamys|nefúði|27,5|mcg/sk|120|skammtar|1|glas||R01AD12|01.04.2008||R|0|0|0|0|G|0|RGO|0|0|1|100|GBP|1062|2584|lyfalmen|||1|120|0|30,0000|Vistor hf|Glaxo Group Limited|Flútíkasón fúróat||1062||1062|2584||1 088300|L01BA0110|Metojectpen|stl|17,5|mg|1|áf-penni|1|pakki||L01BA01|01.05.2016||R|0|0|0|1|G|0|WIL|0|0|0|100|XEU|2886|5094|lyfalmen|||1|1|0||Williams & Halls efh|medac Gesellschaft|Metótrexat||2886||2886|5094||2 088310|M01AX0101|Relifex|lausnart|1|g|20|stk|1|þpakki||M01AX01|01.04.1995||R|0|0|0|0|G|0|MAB|0|0|1|100|SEK|1289|2896|lyfalmen|||1|20|0|20,0000|Vistor hf|Meda AB|Nabúmeton||1289||1289|2896||1 088328|M01AX0101|Relifex|lausnart|1|g|100|stk|1|þpakki||M01AX01|01.04.1995||R|0|0|0|0|G|0|MAB|0|0|1|100|SEK|4009|6640|lyfalmen|||1|100|0|100,0000|Vistor hf|Meda AB|Nabúmeton||4009||4009|6640||1 088445|N05AX1205|Aripiprazol Krka|töflur|15|mg|56|stk|1|þpakki||N05AX12|01.03.2015||R|1|0|0|0|G|0|KRK|0|0|0|100|IKR|20454|22456|lyfalmen|V0684|21002|2|56|0|56,0000|LYFIS ehf|Krka Sverige AB|Aripiprazól||15500||15500|22456||2 088558|N06AX2601|Brintellix|filmhtfl|15|mg|28|stk|1|þpakki||N06AX26|01.10.2014||R|1|0|0|0|0|0|LBK|0|0|0|100|DKK|9959|14830|lyfalmen|||1|28|0|42,0000|Lundbeck Export A/S|H. Lundbeck A/S|Vortioxetín||9959||9959|14830||1 088612|N06DA0207|Donepezil Bluefish|filmhtfl|10|mg|98|stk|1|þpakki||N06DA02|01.04.2013||R|1|0|0|0|G|0|BLP|0|0|0|100|XEU|11732|7280|lyfalmen|||2|98|0|130,6700|LYFIS ehf|Bluefish Pharmaceuticals AB|Dónepezíl||4474||4474|7280|31.3.2016|2 088696|D05AX5201|Daivobet|hlaup|||30|g|1|fl|50 mcg/g+0,5 mg/g|D05AX52|01.04.2012||R|0|0|0|0|G|0|LEP|0|0|0|100|DKK|4340|7096|lyfalmen|||1|30|0||Vistor hf|LEO Pharma A/S|Kalcípótríól í blöndum||4340||4340|7096||1 088697|N06AX1611|Duofaxin|forðatfl|75|mg|98|stk|1|þpakki||N06AX16|01.07.2015||R|1|0|0|0|G|0|MEV|0|0|0|100|DKK|2611|4325|lyfalmen|V0334|3090|2|98|0|73,5000|Vistor hf|MediLink A/S|Venlafaxín||2327||2327|4325||1 088705|D05AX5201|Daivobet|hlaup|||60|g|1|túpa|50 mcg/g+0,5 mg/g|D05AX52|01.02.2011||R|0|0|0|0|G|0|LEP|0|0|0|100|DKK|7167|10987|lyfalmen|||1|60|0||Vistor hf|LEO Pharma A/S|Kalcípótríól í blöndum||7167||7167|10987||1 088714|D05AX5201|Daivobet|hlaup|||60|g|2|fl|50 mcg/g+0,5 mg/g|D05AX52|01.04.2012||R|0|0|0|0|G|0|LEP|0|0|0|100|DKK|13232|19335|lyfalmen|||1|120|0||Vistor hf|LEO Pharma A/S|Kalcípótríól í blöndum||13232||13232|19335||1 088882|QA02BX1202|Orbesealer vet.|spenalyf|2,6|g/dælu|60|dælur|1|pakki||QA02BX12|01.04.2015||R|0|0|0|0|0|0|ZOE|0|0|0|100|DKK|16667|31791|vetalmen|||0|60|0||Icepharma hf|Zoetis Finland OY|Bismuthi subnitras||16667||16667|31791||2 088917|B02BD0801|NovoSeven|sts|5|mg|1|hgl|1|pakki|+áfyllt sprauta, með leysi|B02BD08|01.10.2015||R|0|1|0|1|0|1|NAS|0|0|0|100|DKK|424006|532925|lyfsjukr|||1|1|0|0,1000|Vistor hf|Novo-Nordisk A/S|Eptacog alfa (virkjað)||424006||424006|532925||1 088975|G03AA1005|Harmonet|töflur|||63|stk|1|þpakki|20+75 mcg|G03AA10|01.10.2011||R|0|0|0|0|0|0|PER|0|0|0|100|DKK|1320|2939|lyfalmen|||1|63|0|84,0000|Icepharma hf|Pfizer ApS|Gestóden og ethinylestradíól||1320||1320|2939||1 089077|J07BD5204|M-M-RVAXPRO|sts|||10|hgl|1|pakki|+ lausn í áf.sp|J07BD52|01.02.2013||R|0|0|0|0|0|0|SPM|0|0|0|100|XEU|20926|29168|lyfalmen|||1|10|0||Icepharma hf|Sanofi Pasteur MSD|Mislingar í blöndum með hettusótt og rauðum hundum (veiklaða||20926||20926|29168||2 089094|A02BX1301|Gaviscon|tuggutfl|||120|stk|1|þpakki||A02BX13|01.01.1989||L|1|0|0|0|0|0|NDR|0|0|0|100|IKR|||lyfalmen|||0|120|0||Vistor hf|Nordic Drugs AB|Algínsýra|||||5846||1 089114|J05AX0901|Celsentri|filmhtfl|300|mg|60|stk|1|þpakki||J05AX09|01.04.2008||R|1|0|0|1|0|1|VIH|0|0|0|100|DKK|110502|143014|lyfsjukr|||1|60|0|30,0000|Vistor hf|ViiV Healthcare UK Ltd|Maravíroc||110502||110502|143014||1 089156|A03AA0406|Mebeverin dura|filmhtfl|135|mg|100|stk|1|þpakki||A03AA04|01.07.2010||R|1|0|0|0|G|0|MYL|0|0|0|100|SEK|3434|5849|lyfalmen|||2|100|0|45,0000|Icepharma hf|Mylan AB|Mebeverín||3434||3434|5849||2 089190|H01AC0101|Genotropin|sts|5|mg|1|áf-penni|1|pakki||H01AC01|01.02.2015||R|0|0|0|1|0|1|PER|0|1|0|100|DKK|19502|27965|lyfsjukr|||1|1|0|7,5000|Icepharma hf|Pfizer ApS|Sómatrópín||19502||19502|27965||1 089212|H01AC0101|Genotropin|sts|12|mg|1|áf-penni|1|pakki||H01AC01|01.02.2015||R|0|0|0|1|0|1|PER|0|1|0|100|DKK|46806|61901|lyfsjukr|||1|1|0|18,0000|Icepharma hf|Pfizer ApS|Sómatrópín||46806||46806|61901||1 089293|R06AX1305|Loratadin LYFIS|töflur|10|mg|30|stk|1|þpakki||R06AX13|01.05.2012||L|1|0|0|0|0|0|LYF|0|0|1|100|IKR|||lyflausa|||0|30|0|30,0000|LYFIS ehf|LYFIS ehf|Lóratadín||||||| 089304|R06AX1305|Loratadin LYFIS|töflur|10|mg|100|stk|1|þpakki||R06AX13|01.05.2012||L|1|0|0|0|G|0|LYF|0|0|1|100|XEU|||lyfalmen|V0362|2043|2|100|0|100,0000|LYFIS ehf|LYFIS ehf|Lóratadín|||||2043||2 089801|B03AC0001|Monofer|irl|100|mg/ml|1|ml|5|hgl||B03AC|01.10.2012||R|0|1|0|0|G|0|PAC|0|0|1|100|DKK|22126|30686|lyfalmen|||1|5|0|5,0000|Vistor hf|Pharmacosmos A/S|Járn, stungulyf||22126||22126|30686||1 089936|B03AC0001|Monofer|irl|100|mg/ml|10|ml|2|hgl||B03AC|01.10.2012||R|0|1|0|0|G|0|PAC|0|0|1|100|DKK|88502|114638|lyfalmen|||1|20|0|20,0000|Vistor hf|Pharmacosmos A/S|Járn, stungulyf||88502||88502|114638||1 090229|J01DB0101|Keflex|töflur|500|mg|20|stk|1|þpakki||J01DB01|01.07.2011||R|0|0|0|0|0|0|PAD|0|0|1|100|DKK|1444|3110|lyfalmen|||1|20|0|5,0000|Icepharma hf|PharmaCoDane ApS|Cefalexín||1444||1444|3110||2 090240|J01DB0101|Keflex|töflur|500|mg|40|stk|1|þpakki||J01DB01|01.05.2011||R|0|0|0|0|0|0|PAD|0|0|1|100|DKK|2888|5097|lyfalmen|||1|40|0|10,0000|Icepharma hf|PharmaCoDane ApS|Cefalexín||2888||2888|5097||2 090320|J01DB0101|Keflex|mixt.kyr|50|mg/ml|100|ml|1|fl|dreifa|J01DB01|01.03.2012||R|0|0|0|0|0|0|PAD|0|0|1|100|DKK|677|2054|lyfalmen|||1|100|0|2,5000|Icepharma hf|PharmaCoDane ApS|Cefalexín||677||677|2054||2 090354|J01DB0401|Kefzol|sts|1|g|10|stk|1|hgl||J01DB04|01.06.2011||R|0|0|0|0|0|1|PAD|0|0|0|100|DKK|5189|8264|lyfsjukr|||1|10|0|3,3333|Icepharma hf|PharmaCoDane ApS|Cefazólín||5189||5189|8264||2 090547|M09AB0201|Xiapex|sts|0,9|mg/hgl|1|hgl|1|stk|+ leysir|M09AB02|01.10.2014||R|0|1|0|1|G|0|BIO|0|0|0|100|DKK|116289|150211|lyfalmen|||1|1|0|1,0000|Swedish Orphan Biovitrum AB|Swedish Orphan Biovitrum AB|Clostridíum||116289||116289|150211||3 090662|R01AD1101|Nasacort|nefúði|55|mcg/sk|16,5|ml|1|stauk|120 sk|R01AD11|01.11.1998||R|0|0|0|0|G|0|SNO|0|0|1|100|NOK|1293|2902|lyfalmen|||1|16,5|0|30,0000|Vistor hf|Sanofi-aventis Norge AS|Tríamcínólón||1293||1293|2902||1 090784|N03AF0301|Inovelon|filmhtfl|100|mg|10|stk|1|þpakki||N03AF03|01.01.2015||R|0|0|0|1|G|0|EIS|0|0|0|100|SEK|807|2233|lyfalmen|||1|10|0|0,7100|Vistor hf|Eisai Ltd|Rúfínamíð||807||807|2233||1 090979|S01JA0101|Anatera|stl|100|mg/ml|5|ml|12|hgl|lausn|S01JA01|01.10.2011||R|0|0|0|1|0|1|CLA|0|0|0|100|USD|15554|22531|lyfsjukr|||1|60|0||Vistor hf|Alcon Nordic A/S|Flúorescein||||15554|22531||1 091266|V03AF0401|Isovorin|stl|10|mg/ml|2,5|ml|1|hgl||V03AF04|01.04.2012||R|0|0|0|0|0|1|PER|0|0|0|100|DKK|2333|4333|lyfsjukr|||1|2,5|0|0,8333|Icepharma hf|Pfizer ApS|Kalsíumlevófólínat||2333||2333|4333||1 091277|V03AF0401|Isovorin|stl|10|mg/ml|5|ml|1|hgl||V03AF04|01.04.2012||R|0|0|0|0|0|1|PER|0|0|0|100|DKK|4036|6677|lyfsjukr|||1|5|0|1,6667|Icepharma hf|Pfizer ApS|Kalsíumlevófólínat||4036||4036|6677||1 091289|V03AF0401|Isovorin|stl|10|mg/ml|17,5|ml|1|hgl||V03AF04|01.04.2012||R|0|0|0|0|0|1|PER|0|0|0|100|DKK|11847|17428|lyfsjukr|||1|17,5|0|5,8333|Icepharma hf|Pfizer ApS|Kalsíumlevófólínat||11847||11847|17428||1 091345|N06BA0403|Ritalin Uno|hylki|10|mg|30|stk|1|glas||N06BA04|01.03.2011||R|1|1|1|0|0|0|HES|0|0|0|100|DKK|3533|5985|lyfalmen|||1|30|0|10,0000|Vistor hf|Novartis Healthcare A/S|Metýlfenídat||3533||3533|5985||1 091493|A10BH0501|Trajenta|filmhtfl|5|mg|30|stk|1|þpakki||A10BH05|01.12.2012||R|1|0|0|0|G|0|BII|0|0|0|100|DKK|5853|9178|lyfalmen|||1|30|0|30,0000|Vistor hf|Boehringer Ingelheim International|Línaglíptín||5853||5853|9178||1 091627|J01CR0501|Piperacillin/Tazobactam Actavis|irs|2,5|g|1|hgl|1|pakki|2 g/ 0,5 g|J01CR05|01.08.2014||R|0|1|0|0|0|1|APC|0|0|0|100|SEK|1073|2599|lyfsjukr|||2|1|0|0,1400|Actavis Group PTC ehf|Actavis Group PTC ehf|Piperacillín og ensimblokkar||1073||1073|2599||1 091662|L01DB0105|Doxorubicin Actavis|sts|50|mg|1|stk|1|hgl|lausn|L01DB01|01.12.2011||R|0|0|0|1|0|1|APC|0|0|0|100|XEU|6550|10138|lyfsjukr|||2|1|0||Actavis Group PTC ehf|Actavis Group PTC ehf|Doxórúbicín||||6550|10138||1 091736|S01BA0102|Opnol|augndr|1|mg/ml|30|sk-hyl|1|pakki|lausn|S01BA01|01.05.2011||R|0|0|0|0|G|0|CHA|0|0|1|100|DKK|1382|3024|lyfalmen|||1|30|0||Vistor hf|CCS Healthcare AB|Dexametasón||1382||1382|3024||1 091751|A10BB1201|Amaryl|töflur|1|mg|90|stk|1|þpakki||A10BB12|01.09.1997||R|1|0|0|0|G|0|SNO|0|0|0|100|NOK|916|1714|lyfalmen|V0021|1397|1|90|0|45,0000|Vistor hf|Sanofi-aventis Norge AS|Glímepíríð||430||430|1714||1 091769|A10BB1201|Amaryl|töflur|2|mg|90|stk|1|þpakki||A10BB12|01.09.1997||R|1|0|0|0|G|0|SNO|0|0|0|100|NOK|1583|2015|lyfalmen|V0022|1535|1|90|0|90,0000|Vistor hf|Sanofi-aventis Norge AS|Glímepíríð||649||649|2015||1 091872|C07AA0512|Pranolol|töflur|80|mg|100|stk|1|glas||C07AA05|01.12.2011||R|1|0|0|0|G|0|AGT|0|0|0|100|XEU|1038|2551|lyfalmen|||2|100|0|50,0000|Actavis Group hf|Actavis Group hf|Própranólól||1038||1038|2551||1 092130|QJ01CA0401|Clamoxyl, vet.|töflur|200|mg|100|stk|1|þpakki||QJ01CA04|01.10.1987||R|0|0|0|0|0|0|ZOE|0|0|0|100|DKK|8168|15667|vetalmen|||0|100|0||Icepharma hf|Zoetis Finland OY|||8168||8168|15667||2 092176|A02BC0511|Esomeprazol Krka|sþ-hylki|20|mg|14|stk|1|þpakki||A02BC05|01.05.2016||L|1|0|0|0|0|0|KRK|0|0|0|100|IKR|||lyflausa|||2|14|0|9,3300|LYFIS ehf|Krka Sverige AB|Esómeprazól|||||||2 092361|B01AC0401|Plavix|töflur|75|mg|28|stk|1|þpakki||B01AC04|01.12.1999||R|1|0|0|0|G|0|SNC|0|0|0|100|NOK|4289|7026|lyfalmen|V0009|3387|1|28|0|28,0000|Vistor hf|Sanofi Clir SNC|Klópídógrel||4289||4289|7026||1 092553|N07BA0144|Nicorette Whitemint|tyggigúm|2|mg|30|stk|1|þpakki||N07BA01|01.08.2010||L|0|0|0|0|0|0|MCN|0|0|1|100|IKR|||lyflausa|||0|30|0|2,0000|Vistor hf|McNeil Denmark ApS|Nikótín|||||||1 092554|N06DX0105|Memantine Mylan|filmhtfl|20|mg|28|stk|1|þpakki||N06DX01|01.10.2013|31.03.2016|R|1|0|0|0|G|0|GEN|0|0|0|100|SEK|10489|5414|lyfalmen|||2|28|0|28,0000|Icepharma hf|Generics UK Ltd|Memantín||3118||3118|5414||2 092575|N07BA0144|Nicorette Whitemint|tyggigúm|2|mg|210|stk|1|þpakki||N07BA01|01.08.2010||L|0|0|0|0|0|0|MCN|0|0|1|100|IKR|||lyflausa|||0|210|0|14,0000|Vistor hf|McNeil Denmark ApS|Nikótín|||||||1 092655|G03CA0310|Vagifem|sk-tfl|10|mcg|18|stk|1|pakki||G03CA03|01.03.2011||R|0|0|0|0|G|0|NAS|0|0|0|100|DKK|2024|3908|lyfalmen|||1|18|0|7,2000|Vistor hf|Novo-Nordisk A/S|Estradíól||2024||2024|3908||1 092750|N05AH0203|Leponex (Lyf og heilsa)|töflur|100|mg|100|stk|1|glas||N05AH02|01.05.2007|30.04.2016|R|1|0|0|0|G|0|HOL|0|0|0|100|DKK|8286|7951|lyfalmen|||3|100|0|33,3333|Lyf og heilsa|Lyf og heilsa|Klózapín||4961||4961|7951||2 092879|M01AB0103|Indometacin Actavis|hylki|25|mg|28|stk|1|þpakki||M01AB01|01.03.2010||R|0|0|0|0|G|0|AUK|0|0|1|100|GBP|615|1969|lyfalmen|||2|28|0|7,0000|Actavis Group hf|Actavis UK Ltd.|Indómetacín||615||615|1969||1 092891|M01AB0103|Indometacin Actavis|hylki|50|mg|28|stk|1|þpakki||M01AB01|01.03.2010||R|0|0|0|0|G|0|AUK|0|0|1|100|GBP|1130|2678|lyfalmen|||2|28|0|14,0000|Actavis Group hf|Actavis UK Ltd.|Indómetacín||1130||1130|2678||1 092958|M05BA0408|Ostacid|töflur|70|mg|12|stk|1|þpakki||M05BA04|01.05.2010||R|1|0|0|0|G|0|WEH|0|0|0|100|XEU|2984|2755|lyfalmen|V0203|2755|2|12|0|84,0000|Williams & Halls efh|Williams & Halls ehf|Alendrónsýra||1186||1186|2755||2 092989|C03DA0403|Eplerenon Bluefish|filmhtfl|25|mg|30|stk|1|þpakki||C03DA04|01.10.2014||R|1|0|0|0|0|0|BLP|0|0|0|100|IKR|7800|4150|lyfalmen|V0107|4091|2|30|0|15,0000|LYFIS ehf|Bluefish Pharmaceuticals AB|Eplerenón||2200||2200|4150||2 093016|N02AA0504|OxyNorm Dispersa|munndr.t|5|mg|28|stk|1|þpakki||N02AA05|01.10.2011||R|0|0|1|0|0|0|NOP|0|0|0|100|DKK|888|2344|lyfalmen|||1|28|0|1,8700|Icepharma hf|Norpharma|Oxýcódon||888||888|2344||2 093027|N02AA0504|OxyNorm Dispersa|munndr.t|10|mg|28|stk|1|þpakki||N02AA05|01.10.2011||R|0|0|1|0|0|0|NOP|0|0|0|100|DKK|2038|3927|lyfalmen|||1|28|0|3,7300|Icepharma hf|Norpharma|Oxýcódon||2038||2038|3927||2 093038|N02AA0504|OxyNorm Dispersa|munndr.t|20|mg|28|stk|1|þpakki||N02AA05|01.10.2011||R|0|0|1|0|0|0|NOP|0|0|0|100|DKK|3962|6575|lyfalmen|||1|28|0|7,4700|Icepharma hf|Norpharma|Oxýcódon||3962||3962|6575||2 093260|N02CC0101|Imigran|stl|12|mg/ml|0,5|ml|2|spr|+ penni|N02CC01|01.10.1992||R|0|0|0|0|G|0|GPH|0|0|0|100|GBP|4882|7842|lyfalmen|||1|1|0|2,0000|Vistor hf|GlaxoSmithKline Pharma A/S|Súmatriptan||4882||4882|7842||1 093284|G04BD1201|Betmiga|forðatfl|50|mg|30|stk|1|þpakki||G04BD12|01.07.2013||R|1|0|0|0|G|0|APE|0|0|0|100|XEU|5259|8361|lyfalmen|||1|30|0|30,0000|Vistor hf|Astellas Phama Europe B.V.|Mírabegrón||5259||5259|8361||1 093306|M03AX0105|Xeomin|sts|100|ein/hgl|1|hgl|1|pakki||M03AX01|01.08.2015||R|0|1|0|1|0|1|ERZ|0|0|0|100|XEU|21945|29231|lyfsjukr|||1|1|0||Williams & Halls efh|Merz Pharmaceuticals GmbH|Clostridium botulinum toxín-A||20976||20976|29231||2 093343|C09CA0301|Diovan|mixtúra|3|mg/ml|160|ml|1|fl|lausn|C09CA03|01.03.2012||R|0|0|0|0|G|0|HES|0|0|0|100|DKK|1306|2920|lyfalmen|||1|160|0|6,0000|Vistor hf|Novartis Healthcare A/S|Valsartan||1306||1306|2920||1 093496|A07EC0204|Asacol|sþ-tfl|800|mg|60|stk|1|þpakki||A07EC02|01.03.2016||R|1|0|0|0|G|0|TIL|0|0|0|100|SEK|5559|8774|lyfalmen|V0724|8774|1|60|0|32,0000|Icepharma hf|Tillotts Pharma AB|Mesalazín (5-amínósalicýlsýra)||||5559|8774||2 093514|A07EC0204|Asacol|sþ-tfl|400|mg|100|stk|1|þpakki||A07EC02|01.03.2016||R|1|0|0|0|G|0|TIL|0|0|0|100|SEK|4116|6787|lyfalmen|V0723|6787|1|100|0|26,6667|Icepharma hf|Tillotts Pharma AB|Mesalazín (5-amínósalicýlsýra)||||4116|6787||2 093617|QG03DA0202|Veramix, vet.|sk-svamp|60|mg|1|stk|100|stk||QG03DA02|01.10.1991||R|0|0|0|0|0|0|ZOE|1|0|0|100|DKK|23539|40572|vetorma|||0|100|0||Icepharma hf|Zoetis Finland OY|Medroxyprogesteronum||23539||23539|40572||2 093668|N01BB0203|Xylocain|húðúði|100|mg/ml|50|ml|1|glas|+ sk-úðari|N01BB02|01.10.2014||R|0|0|0|0|0|0|AZD|0|0|1|100|SEK|2278|4258|lyfalmen|||1|50|0||Vistor hf|AstraZeneca A/S DK|Lídókaín||2278||2278|4258||1 093725|C03BA0802|Metolazon Abcur|töflur|5|mg|100|stk|1|þpakki||C03BA08|01.01.2014||R|0|0|0|0|G|0|ABC|0|0|0|100|SEK|33506|45079|lyfalmen|||2|100|0|100,0000|Icepharma hf|Abcur AB|Metólazón||33506||33506|45079||2 093757|N02AA0501|Oxycontin|forðatfl|80|mg|28|stk|1|þpakki||N02AA05|01.04.2003||R|1|0|1|0|G|0|NOP|0|0|0|100|DKK|7601|11584|lyfalmen|||1|28|0|29,8700|Icepharma hf|Norpharma |Oxýcódon||7601||7601|11584||2 093799|N02AA0501|Oxycontin|forðatfl|80|mg|98|stk|1|þpakki||N02AA05|01.04.2003||R|1|0|1|0|G|0|NOP|0|0|0|100|DKK|19676|28204|lyfalmen|V0588|20770|1|98|0|104,5300|Icepharma hf|Norpharma |Oxýcódon||19676||19676|28204||2 093827|L04AC0501|Stelara|stl|45|mg/spr|0,5|ml|1|áf.spr||L04AC05|01.04.2011||R|0|1|0|1|0|1|JCI|0|1|0|100|SEK|377979|475680|lyfsjukr|||1|0,5|0|83,3300|Vistor hf|Janssen-Cilag International N.V.|Ustekinumabi||377979||377979|475680||1 093838|L04AC0501|Stelara|stl|90|mg/spr|1|ml|1|áf.spr||L04AC05|01.05.2011||R|0|1|0|1|0|1|JCI|0|1|0|100|SEK|403026|506831|lyfsjukr|||1|1|0|166,6700|Vistor hf|Janssen-Cilag International N.V.|Ustekinumabi||403026||403026|506831||1 094111|N02CC0501|Almogran|filmhtfl|12,5|mg|6|stk|1|þpakki||N02CC05|01.07.2010||R|1|0|0|0|G|0|AAA|0|0|0|100|SEK|4193|6893|lyfalmen|V0236|6249|1|6|0|6,0000|Vistor hf|Almirall S.A.|Almótriptan||4193||4193|6893||1 094122|N02CC0501|Almogran|filmhtfl|12,5|mg|9|stk|1|þpakki||N02CC05|01.07.2010||R|1|0|0|0|G|0|AAA|0|0|0|100|SEK|5995|9374|lyfalmen|V0236|9374|1|9|0|9,0000|Vistor hf|Almirall S.A.|Almótriptan||5995||5995|9374||1 094132|QM01AC0604|Metacam fyrir ketti|mixtúra|0,5|mg/ml|15|ml|1|fl||QM01AC06|01.01.2009||R|0|0|0|0|0|0|BOI|0|0|0|100|DKK|1586|3117|vetalmen|||0|15|0||Vistor hf|Boehringer Ingelheim|||1586||1586|3117||1 094441|J05AB0103|Aclovir|töflur|200|mg|25|stk|1|þpakki||J05AB01|01.04.2013||R|1|0|0|0|G|0|RGM|0|0|1|100|XEU|941|2281|lyfalmen|V0044|2281|2|25|0|1,2500|Medical ehf|ratiopharm GmbH|Acíklóvír||842||842|2281||2 094495|N06AB1007|Escitalopram Bluefish|filmhtfl|5|mg|98|stk|1|þpakki||N06AB10|01.08.2015||R|1|0|0|0|G|0|BLP|0|0|0|100|IKR|2500|1948|lyfalmen|V0324|1948|2|98|0|49,0000|LYFIS ehf|Bluefish Pharmaceuticals AB|Escítalópram||600||600|1948||2 094652|B01AC0602|Hjarta-Aspirín|sþ-tfl|75|mg|500|stk|1|glas||B01AC06|01.02.2014||L|1|0|0|0|0|0|LYF|0|0|0|100|IKR|||lyflausa|||0|500|0|500,0000|LYFIS ehf|LYFIS ehf|Asetýlsalicýlsýra|||||||2 094757|N04BC0406|Ropinirole Portfarma|forðatfl|8|mg|84|stk|1|glas||N04BC04|01.12.2012||R|1|0|0|0|G|0|POF|0|0|0|100|XEU|15097|19617|lyfalmen|V0534|19617|2|84|0|112,0000|Alvogen|Alvogen|Rópíníról||13437||13437|19617||1 094801|J05AR0401|Trizivir|filmhtfl|750|mg|60|stk|1|þpakki|300+150+300 mg|J05AR04|01.08.2003||R|1|1|0|1|0|1|VII|0|0|0|100|GBP|75286|97922|lyfsjukr|||1|60|0|30,0000|GlaxoSmithKline ehf|ViiV Healthcare UK Ltd|Zídóvúdín, lamívúdín og abacavír||75286||75286|97922||1 094812|N01BX0403|Qutenza|plástur|179|mg|1|plástur|1|pakki||N01BX04|01.01.2011||R|0|1|0|0|0|0|APE|0|0|0|100|XEU|42143|56003|lyfalmen|||1|1|0||Vistor hf|Astellas Phama Europe B.V.|Capsaicin||||42143|56003||1 094834|QI09AB0801|Suiseng Vet|stl|||50|ml|1|hgl|dreifa|QI09AB08|01.05.2010||R|0|0|0|0|0|0|LHS|0|0|0|100|XEU|5750|9911|vetorma|||0|50|0||Dýraheilsa ehf|Laboratorios Hipra S.A.|Bakteríubólefni gegn Escherichia coli + Clostridium||5750||5750|9911||2 095005|B02BC3001|TachoSil|vefjal.n|5,5|mg|1|stk|1|pakki|+ 2,0 IU - 9,5x4,8 cm|B02BC30|01.01.2014||R|0|0|0|1|0|1|TAG|0|0|0|100|DKK|35930|48145|lyfsjukr|||2|1|0||Vistor hf|Takeda Austria GmbH|Blöndur||35930||35930|48145||1 095092|M03AX0101|Botox|sts|200|ae/hgl|1|hgl|1|pakki||M03AX01|01.04.2016||R|0|0|0|1|0|1|IRE|0|0|0|100|XEU|46283|61239|lyfsjukr|||1|1|0||Actavis ehf|Allergan Pharmaceuticals Ireland|Clostridium botulinum toxín-A||46283||46283|61239||1 095418|G04BE0305|Vizarsin (Lyfis)|filmhtfl|50|mg|8|stk|1|pakki||G04BE03|01.02.2011||R|1|0|0|0|0|0|LYF|0|0|0|100|IKR|4638|3195|lyfalmen|V0143|2914|3|8|0|8,0000|LYFIS ehf|LYFIS ehf|Síldenafíl||1506||1506|3195||2 095514|L04AX0501|Esbriet|hylki|267|mg|252|stk|1|þpakki|hart|L04AX05|01.02.2016||R|1|1|0|1|0|0|RRL|0|0|0|100|DKK|338240|426256|lyfalmen|||1|252|0|28,0300|Icepharma hf|Roche Registration Limited|Pírfenidon||||338240|426256||2 095588|N07BB0101|Antabus|freyðit|400|mg|50|stk|1|glas||N07BB01|01.12.1972||R|0|0|0|0|G|0|AGT|0|0|0|100|DKK|6951|10690|lyfalmen|||1|50|0|100,0000|Actavis Group hf|Actavis Group hf|Dísúlfíram||6951||6951|10690||1 095652|N05AX1301|Invega|forðatfl|3|mg|28|stk|1|þpakki||N05AX13|01.02.2008||R|0|0|0|0|0|0|JCI|0|0|0|100|SEK|15552|22528|lyfalmen|||1|28|0|14,0000|Vistor hf|Janssen-Cilag International N.V.|Paliperídón||15552||15552|22528||1 095680|N05AX1301|Invega|forðatfl|6|mg|28|stk|1|þpakki||N05AX13|01.02.2008||R|0|0|0|0|0|0|JCI|0|0|0|100|SEK|15784|22847|lyfalmen|||1|28|0|28,0000|Vistor hf|Janssen-Cilag International N.V.|Paliperídón||15784||15784|22847||1 095692|J01MA0204|Ciprofloxacin Portfarma|irl|2|mg/ml|100|ml|1|hgl||J01MA02|01.12.2010|30.04.2016|R|0|0|0|0|0|1|POF|0|0|0|100|XEU|1717|3485|lyfsjukr|||2|100|0|0,4000|Alvogen|Alvogen|Cíprófloxacín||1717||1717|3485||1 095704|J01MA0204|Ciprofloxacin Portfarma|irl|2|mg/ml|200|ml|1|hgl||J01MA02|01.12.2010||R|0|0|0|0|0|1|POF|0|0|0|100|XEU|2672|4800|lyfsjukr|||2|200|0|0,8000|Alvogen|Alvogen|Cíprófloxacín||2672||2672|4800||1 095707|N05AX1301|Invega|forðatfl|9|mg|28|stk|1|þpakki||N05AX13|01.02.2008||R|0|0|0|0|0|0|JCI|0|0|0|100|SEK|18376|26415|lyfalmen|||1|28|0|42,0000|Vistor hf|Janssen-Cilag International N.V.|Paliperídón||18376||18376|26415||1 095715|J02AC0103|Fluconazole Portfarma|irl|2|mg/ml|50|ml|1|hgl|lausn|J02AC01|01.10.2011||R|0|0|0|0|0|1|POF|0|0|0|100|XEU|1983|3852|lyfsjukr|||2|50|0|0,5000|Alvogen|Alvogen|Flúkónazól||||1983|3852||1 095726|J02AC0103|Fluconazole Portfarma|irl|2|mg/ml|100|ml|1|hgl||J02AC01|01.09.2011||R|0|0|0|0|0|1|POF|0|0|0|100|XEU|3099|5388|lyfsjukr|||2|100|0|1,0000|Alvogen|Alvogen|Flúkónazól||||3099|5388||1 095748|N02AX0212|Tramadol Actavis|hylki|50|mg|100|stk|1|glas||N02AX02|01.09.2011||R|1|0|1|0|G|0|AGP|0|0|1|100|XEU|874|1561|lyfalmen|V0225|1468|2|100|0|16,6700|Actavis Group hf|Actavis Group PTC ehf|Tramadól||319||319|1561||1 095767|R03BA0203|Budesonide Teva|innúðal|0,5|mg/ml|2|ml|20|lykjur||R03BA02|01.07.2015||R|0|0|0|0|G|0|TEV|0|0|0|100|IKR|4482|6628|lyfalmen|V0701|6628|2|40|0|13,3400|Medical ehf|Teva Pharma B.V.|Búdesóníð||4000||4000|6628||2 095924|QM01AE9102|Canidryl|töflur|20|mg|100|stk|1|pakki||QM01AE91|01.05.2007||R|0|0|0|0|0|0|CHD|0|0|0|100|IKR|4156|8055|vetalmen|||0|100|0||Dýraheilsa/Icevet ehf|Chanelle Pharmaceuticals (D)|||4156||4156|8055||2 095933|QM01AE9102|Canidryl|töflur|50|mg|100|stk|1|pakki||QM01AE91|01.05.2007||R|0|0|0|0|0|0|CHD|0|0|0|100|IKR|5733|11047|vetalmen|||0|100|0||Dýraheilsa/Icevet ehf|Chanelle Pharmaceuticals (D)|||5733||5733|11047||2 095942|QM01AE9102|Canidryl|töflur|100|mg|100|stk|1|pakki||QM01AE91|01.05.2007||R|0|0|0|0|0|0|CHD|0|0|0|100|IKR|9534|18258|vetalmen|||0|100|0||Dýraheilsa/Icevet ehf|Chanelle Pharmaceuticals (D)|||9534||9534|18258||2 096178|J06BA0103|Gammanorm|stl|165|mg/ml|10|ml|10|hgl||J06BA01|01.10.2008||R|0|0|0|1|0|1|OCT|0|1|0|100|DKK|94629|122387|lyfsjukr|||1|100|0||Vistor hf|Octapharma AB|Immúnóglóbúlín, normal, manna, sem ekki eru gefin í æð||94629||94629|122387||1 096203|C09DA0107|Losartan HCT Bluefish|filmhtfl|62,5|mg|98|stk|1|þpakki|50+12,5 mg|C09DA01|01.05.2012||R|1|0|0|0|G|0|BLP|0|0|0|100|XEU|2130|2365|lyfalmen|V0088|2365|2|98|0|98,0000|LYFIS ehf|Bluefish Pharmaceuticals AB|Lósartan og þvagræsilyf||903||903|2365||2 096227|C09DA0107|Losartan HCT Bluefish|filmhtfl|125|mg|98|stk|1|þpakki|100+25 mg|C09DA01|01.05.2012||R|1|0|0|0|G|0|BLP|0|0|0|100|XEU|2217|2650|lyfalmen|V0089|2650|2|98|0|98,0000|LYFIS ehf|Bluefish Pharmaceuticals AB|Lósartan og þvagræsilyf||1110||1110|2650||2 096251|D06AX1301|Altargo|smyrsli|1|%|5|g|1|túpa||D06AX13|01.11.2007||R|0|0|0|0|0|0|RGO|0|0|1|100|GBP|1682|3437|lyfalmen|||1|5|0||Vistor hf|Glaxo Group Limited|Retapamúlín||1682||1682|3437||1 096260|N06DA0301|Exelon|forðapl|4,6|mg/sólh|30|pokar|1|pakki||N06DA03|01.01.2008||R|0|1|0|0|G|0|NEL|0|0|0|100|DKK|13197|19287|lyfalmen|V0347|16922|1|30|0|14,5300|Vistor hf|Novartis Europharm Ltd|Rívastigmín||13197||13197|19287||1 096488|L04AX0401|Revlimid|hylki|5|mg|21|stk|1|þpakki|hart|L04AX04|01.03.2009||R|1|1|0|1|0|1|CEE|0|1|0|100|XEU|667273|835481|lyfsjukr|||1|21|0|10,5000|Celgene Europe ltd|Celgene Europe ltd|Lenalídómíd||667273||667273|835481||2 096497|L04AX0401|Revlimid|hylki|10|mg|21|stk|1|þpakki|hart|L04AX04|01.03.2009||R|1|1|0|1|0|1|CEE|0|1|0|100|XEU|618509|774832|lyfsjukr|||1|21|0|21,0000|Celgene Europe ltd|Celgene Europe ltd|Lenalídómíd||618509||618509|774832||2 096506|L04AX0401|Revlimid|hylki|15|mg|21|stk|1|þpakki|hart|L04AX04|01.03.2009||R|1|1|0|1|0|1|CEE|0|1|0|100|XEU|651062|815319|lyfsjukr|||1|21|0|31,5000|Celgene Europe ltd|Celgene Europe ltd|Lenalídómíd||651062||651062|815319||2 096515|L04AX0401|Revlimid|hylki|25|mg|21|stk|1|þpakki|hart|L04AX04|01.03.2009||R|1|1|0|1|0|1|CEE|0|1|0|100|XEU|713843|893401|lyfsjukr|||1|21|0|52,5000|Celgene Europe ltd|Celgene Europe ltd|Lenalídómíd||713843||713843|893401||2 096679|N06DA0301|Exelon|forðapl|9,5|mg/sólh|30|pokar|1|pakki||N06DA03|01.01.2008||R|0|1|0|0|G|0|NEL|0|0|0|100|DKK|13349|19496|lyfalmen|V0349|18342|1|30|0|30,0000|Vistor hf|Novartis Europharm Ltd|Rívastigmín||13349||13349|19496||1 096685|C03BA1102|Natrilix Retard|forðatfl|1,5|mg|30|stk|1|þpakki||C03BA11|01.03.1999||R|1|0|0|0|G|0|SEV|0|0|0|100|DKK|1167|2728|lyfalmen|||1|30|0|18,0000|Icepharma hf|Servier|Indapamíð||1167||1167|2728||2 096768|L02AE0102|Suprecur|nefúði|0,15|mg/sk|10|g|2|fl|lausn|L02AE01|01.01.2012||R|0|0|0|1|G|0|SNO|0|0|0|100|NOK|10908|16136|lyfalmen|||1|20|0|16,6700|Vistor hf|Sanofi-aventis Norge AS|Búserelín||10908||10908|16136||1 097061|QI09AB1301|Stellamune One|stl|||100|ml|10|glös|Fleyti|QI09AB13|01.10.2012||R|0|0|0|0|0|0|ELA|0|0|0|100|DKK|65226|112424|vetorma|||1|1000|0||Icepharma hf|Elanco Animal Health A/S|Óvirkar bakteríur í bóluefnum||65226||65226|112424||2 097092|QN02AF0102|Alvegesic vet.|stl|10|mg/ml|10|ml|1|hgl||QN02AF01|01.08.2010||R|0|0|0|0|0|0|AUW|1|0|0|100|XEU|7184|13800|vetalmen|||0|10|0||Icepharma hf|ALVETRA u. WERFFTt GmbH|Bútorfanóltartrat||||7184|13800||2 097269|J01FF0103|Dalacin (Lyf og heilsa)|hylki|300|mg|20|stk|1|þpakki||J01FF01|01.06.2007||R|1|0|0|0|0|0|DAC|0|0|1|100|DKK|1936|3787|lyfalmen|V0461|3787|3|20|0|5,0000|D.A.C. ehf|D.A.C. ehf|Klindamýcín||1936||1936|3787||2 097498|N06AX1602|Efexor Depot|forðahlk|37,5|mg|7|stk|1|þpakki||N06AX16|01.12.2012||R|1|0|0|0|0|0|PER|0|0|0|100|DKK|476|1777|lyfalmen|V0333|795|1|7|0|2,6300|Icepharma hf|Pfizer ApS|Venlafaxín||476||476|1777||1 097531|N06AX1602|Efexor Depot|forðahlk|75|mg|98|stk|1|þpakki||N06AX16|01.07.2012||R|1|0|0|0|0|0|PER|0|0|0|100|DKK|9864|14699|lyfalmen|V0334|3090|1|98|0|73,5000|Icepharma hf|Pfizer ApS|Venlafaxín||9864||9864|14699||1 097577|N06AX1602|Efexor Depot|forðahlk|150|mg|98|stk|1|þpakki||N06AX16|01.09.2011||R|1|0|0|0|0|0|PER|0|0|0|100|DKK|18352|26382|lyfalmen|V0335|3090|1|98|0|147,0000|Icepharma hf|Pfizer ApS|Venlafaxín||||18352|26382||1 097603|C10AX1301|Repatha|stl|140|mg|1|áf-penni|1|pakki||C10AX13|01.01.2016||R|0|0|0|0|0|0|AEB|0|0|0|100|DKK|32301|43555|lyfalmen|||1|1|0||Vistor hf|Amgen Europe B.V.|Evolocumab||32301||32301|43555||1 097662|QM01AH9201|Trocoxil|tuggutfl|95|mg|2|stk|1|þpakki||QM01AH92|01.11.2014||R|0|0|0|0|0|0|ZBE|0|0|0|100|DKK|5499|10603|vetalmen|||0|2|0||Icepharma hf|Zoetis Belgium S.A.|Mavakoxíb||5499||5499|10603||2 097881|A10BB1201|Amaryl|töflur|3|mg|90|stk|1|þpakki||A10BB12|01.09.1997||R|1|0|0|0|G|0|SNO|0|0|0|100|NOK|2273|2265|lyfalmen|V0023|1810|1|90|0|135,0000|Vistor hf|Sanofi-aventis Norge AS|Glímepíríð||830||830|2265||1 097889|J01MA0205|Ciprofloxacin Villerton|irl|2|mg/ml|200|ml|10|pokar||J01MA02|01.02.2016||R|0|0|0|0|0|1|VIN|0|0|0|100|DKK|2690|4825|lyfsjukr|||2|2000|0|8,0000|Icepharma hf|Villerton Invest SA|Cíprófloxacín||||2690|4825||2 097905|N06AX1104|Miron Smelt|munndr.t|15|mg|30|stk|1|þpakki||N06AX11|01.11.2007||R|0|0|0|0|G|0|AGP|0|0|0|100|XEU|976|1944|lyfalmen|V0329|1810|2|30|0|15,0000|Actavis Group hf|Actavis Group PTC ehf|Mirtazapín||597||597|1944||1 098059|C09CA0303|Valpress|filmhtfl|80|mg|98|stk|1|þpakki||C09CA03|01.12.2007||R|1|0|0|0|G|0|ACA|0|0|0|100|XEU|2978|3642|lyfalmen|V0678|3462|2|98|0|98,0000|Actavis Group hf|Actavis hf|Valsartan||1831||1831|3642||1 098068|C09CA0303|Valpress|filmhtfl|160|mg|98|stk|1|þpakki||C09CA03|01.12.2007||R|1|0|0|0|G|0|ACA|0|0|0|100|XEU|4961|3642|lyfalmen|V0679|3462|2|98|0|196,0000|Actavis Group hf|Actavis hf|Valsartan||1831||1831|3642||1 098074|QM01AE9001|Quadrisol|hlaup|100|mg/ml|30|ml|3|spr|f. hesta|QM01AE90|01.04.2015||R|0|0|0|0|0|0|ZBE|0|0|0|100|DKK|5063|9776|vetalmen|||0|90|0||Icepharma hf|Zoetis Belgium S.A.|Vedaprófen||5063||5063|9776||2 098233|D07AC0401|Synalar|krem|0,25|mg/g|30|g|1|túpa||D07AC04|01.04.1998||R|0|0|0|0|G|0|BIG|0|0|1|100|SEK|583|1925|lyfalmen|||1|30|0||Icepharma hf|Bioglan AB|Flúócínólón||583||583|1925||2 098245|D07AC0401|Synalar|smyrsli|0,25|mg/g|30|g|1|túpa||D07AC04|01.08.2011||R|0|0|0|0|G|0|BIG|0|0|1|100|SEK|583|1925|lyfalmen|||1|30|0||Icepharma hf|Bioglan AB|Flúócínólón||583||583|1925||2 098290|D08AC0202|Hibitane|sk-krem|10|mg/ml|250|ml|1|glas||D08AC02|01.06.2011||L|0|0|0|0|0|0|BIG|0|0|0|100|IKR|||lyflausa|||0|250|0||Icepharma hf|Bioglan AB|Klórhexidín|||||||2 098378|N03AX0904|Lamotrigin ratiopharm|dreifit.|25|mg|50|stk|1|þpakki||N03AX09|01.05.2012||R|0|0|0|0|G|0|RGM|0|0|0|100|IKR|1022|1673|lyfalmen|V0243|1673|2|50|0|4,1600|Medical ehf|ratiopharm GmbH|Lamótrigín||400||400|1673||2 098387|N03AX0904|Lamotrigin ratiopharm|dreifit.|50|mg|50|stk|1|þpakki||N03AX09|01.05.2012||R|0|0|0|0|G|0|RGM|0|0|0|100|IKR|1812|1948|lyfalmen|V0244|1828|2|50|0|8,3300|Medical ehf|ratiopharm GmbH|Lamótrigín||600||600|1948||2 098405|N03AX0904|Lamotrigin ratiopharm|dreifit.|100|mg|100|stk|1|þpakki||N03AX09|01.05.2012||R|0|0|0|0|G|0|RGM|0|0|0|100|IKR|5116|3600|lyfalmen|V0245|3600|2|100|0|33,3300|Medical ehf|ratiopharm GmbH|Lamótrigín||1800||1800|3600||2 098423|N03AX0904|Lamotrigin ratiopharm|dreifit.|200|mg|100|stk|1|þpakki||N03AX09|01.05.2012||R|0|0|0|0|G|0|RGM|0|0|0|100|IKR|9166|8004|lyfalmen|V0232|8004|2|100|0|66,6600|Medical ehf|ratiopharm GmbH|Lamótrigín||5000||5000|8004||2 098469|A04AA0107|Ondansetron Bluefish|filmhtfl|4|mg|10|stk|1|þpakki||A04AA01|01.09.2015||R|1|0|0|0|G|0|BLP|0|0|1|100|IKR|2815|3861|lyfalmen|V0381|3861|2|10|0|2,5000|LYFIS ehf|Bluefish Pharmaceuticals AB|Ondansetrón||1990||1990|3861||2 098713|V03AB2502|Flumazenil B. Braun|stl|0,1|mg/ml|5|ml|5|lykjur||V03AB25|01.04.2011|31.03.2016|R|0|0|0|0|0|1|BRA|0|0|0|100|XEU|5333|8463|lyfsjukr|||2|25|0||Actavis Group hf|Braun|Flúmazeníl||5333||5333|8463||1 098722|J07BM0101|Gardasil|stl|||0,5|ml|1|áf.spr|dreifa|J07BM01|01.08.2008||R|0|0|0|0|0|0|SPM|0|0|0|100|XEU|14344|20865|lyfalmen|||1|0,5|0||Icepharma hf|Sanofi Pasteur MSD|Papillomavírus (manna gerð 6, 11, 16, 18)||14344||14344|20865||2 099204|L02BA0301|Faslodex|stl|250|mg/spr|5|ml|2|spr||L02BA03|01.12.2010||R|0|0|0|0|0|1|ASZ|0|0|0|100|SEK|68046|88765|lyfsjukr|||1|10|0|60,2400|Vistor hf|AstraZeneca UK Ltd|Fulvestrant||68046||68046|88765||1 099476|N05AH0406|Quetiapin Mylan|filmhtfl|25|mg|100|stk|1|þpakki||N05AH04|01.03.2008||R|1|0|0|0|G|0|MYL|0|0|0|100|SEK|2419|2135|lyfalmen|V0284|2135|2|100|0|6,2500|Icepharma hf|Mylan AB|Quetíapín||736||736|2135||2 099485|N05AH0406|Quetiapin Mylan|filmhtfl|100|mg|100|stk|1|þpakki||N05AH04|01.03.2008||R|1|0|0|0|G|0|MYL|0|0|0|100|SEK|4521|4103|lyfalmen|V0285|4103|2|100|0|25,0000|Icepharma hf|Mylan AB|Quetíapín||2166||2166|4103||2 099494|N05AH0406|Quetiapin Mylan|filmhtfl|200|mg|100|stk|1|þpakki||N05AH04|01.03.2008||R|1|0|0|0|G|0|MYL|0|0|0|100|SEK|8091|7415|lyfalmen|V0286|7415|2|100|0|50,0000|Icepharma hf|Mylan AB|Quetíapín||4572||4572|7415||2 099705|D08AG0201|Betadine|húðlausn|100|mg/ml|500|ml|1|brusar|vatnslausn|D08AG02|01.04.1985||L|0|0|0|0|0|0|NOR|0|0|0|100|IKR|||lyflausa|||0|500|0||Icepharma hf|Norpharma a/s|Joð/pólývídón|||||||2 099707|N03AX1604|Brieka|hylki|25|mg|100|stk|1|glas||N03AX16|01.10.2015||R|1|0|0|0|0|0|AGP|0|0|0|100|XEU|3941|2456|lyfalmen|V0685|2456|2|100|0|8,3300|Actavis Group hf|Actavis Group PTC ehf|Pregabalín||969||969|2456||1 099721|D08AG0201|Betadine|lyf.sápa|75|mg/ml|500|ml|1|brusar||D08AG02|01.04.1985||L|0|0|0|0|0|0|NOR|0|0|0|100|IKR|||lyflausa|||0|500|0||Icepharma hf|Norpharma a/s|Joð/pólývídón|||||||2 099835|N03AX1107|Topiramat Actavis|filmhtfl|25|mg|60|stk|1|plglas||N03AX11|01.08.2010||R|1|0|0|0|G|0|AGP|0|0|0|100|XEU|1566|2009|lyfalmen|V0247|1765|2|60|0|5,0000|Actavis Group hf|Actavis Group PTC ehf|Tópíramat||644||644|2009||1 099847|N03AX1107|Topiramat Actavis|filmhtfl|50|mg|60|stk|1|plglas||N03AX11|01.09.2010||R|1|0|0|0|G|0|AGP|0|0|0|100|XEU|2828|3519|lyfalmen|V0248|3304|2|60|0|10,0000|Actavis Group hf|Actavis Group PTC ehf|Tópíramat||1741||1741|3519||1 099858|N03AX1107|Topiramat Actavis|filmhtfl|100|mg|60|stk|1|plglas||N03AX11|01.08.2010||R|1|0|0|0|G|0|AGP|0|0|0|100|XEU|5101|3945|lyfalmen|V0249|3688|2|60|0|20,0000|Actavis Group hf|Actavis Group PTC ehf|Tópíramat||2051||2051|3945||1 099863|L01XE0401|Sutent|hylki|12,5|mg|28|stk|1|þpakki||L01XE04|01.12.2012||R|1|0|0|1|0|1|IPI|0|1|0|100|DKK|155278|198702|lyfsjukr|||1|28|0||Icepharma hf|Pfizer Limited|Sunitíníb||155278||155278|198702||1 099872|L01XE0401|Sutent|hylki|25|mg|28|stk|1|þpakki||L01XE04|01.03.2014||R|1|0|0|1|0|1|IPI|0|1|0|100|DKK|299297|377822|lyfsjukr|||1|28|0||Icepharma hf|Pfizer Limited|Sunitíníb||299297||299297|377822||1 099881|L01XE0401|Sutent|hylki|50|mg|28|stk|1|þpakki||L01XE04|01.03.2014||R|1|0|0|1|0|1|IPI|0|1|0|100|DKK|598572|750036|lyfsjukr|||1|28|0||Icepharma hf|Pfizer Limited|Sunitíníb||598572||598572|750036||1 099902|H02AB0605|Prednisolone Actavis|töflur|5|mg|98|stk|1|þpakki||H02AB06|01.01.2011||R|1|0|0|0|G|0|AUK|0|0|1|100|GBP|592|1937|lyfalmen|V0414|1937|2|98|0|49,0000|Actavis Group hf|Actavis UK Ltd.|Prednisólón||592||592|1937||1 100211|QN01AX9301|Tricaine Pharmaq|duft|1000|mg/g|25|g|1|askja|lausn handa fiskum|QN01AX93|01.07.2013||R|0|0|0|0|0|0|PHL|0|0|0|100|GBP|5553|8951|veteldis|||0|25|0||PHARMAQ Ltd.|PHARMAQ Ltd|Tricaine Methane Sulfónat||5553||5553|8951||1 100300|G04BE0801|Cialis|filmhtfl|5|mg|28|stk|1|þpakki||G04BE08|01.11.2008||R|0|0|0|0|0|0|LIL|0|0|0|100|XEU|10300|15299|lyfalmen|||1|28|0|14,0000|Icepharma hf|Lilly ICOS Limited|Tadalafíl||||10300|15299||2 100428|N06AX1103|Miron|filmhtfl|15|mg|100|stk|1|plglas||N06AX11|01.01.2012||R|1|0|0|0|G|0|ACA|0|0|0|100|XEU|1783|3308|lyfalmen|V0672|3049|2|100|0|50,0000|Actavis Group hf|Actavis hf|Mirtazapín||1588||1588|3308||1 100807|N03AX1603|Pregabalin Krka|hylki|25|mg|56|stk|1|þpakki||N03AX16|01.03.2015||R|1|0|0|0|0|0|KNM|0|0|0|100|XEU|2111|1737|lyfalmen|V0685|1375|2|56|0|4,6667|LYFIS ehf|Krka d.d. Novo mesto|Pregabalín||447||447|1737||2 100884|J01AA0401|Lymecycline Actavis|hylki|300|mg|100|stk|1|þpakki||J01AA04|01.07.2015||R|0|0|0|0|0|0|AGP|0|0|1|100|XEU|4360|7123|lyfalmen|||2|100|0|50,0000|Actavis Group hf|Actavis Group PTC ehf|Lymecycline||4360||4360|7123||1 101106|N03AX1201|Neurontin|filmhtfl|600|mg|100|stk|1|þpakki||N03AX12|01.03.2009||R|1|0|0|0|G|0|PER|0|0|0|100|DKK|9728|12128|lyfalmen|V0254|10757|1|100|0|33,3300|Icepharma hf|Pfizer ApS|Gabapentín||7996||7996|12128||1 101115|N03AX1201|Neurontin|filmhtfl|800|mg|100|stk|1|þpakki||N03AX12|01.03.2009||R|1|0|0|0|G|0|PER|0|0|0|100|DKK|14231|20710|lyfalmen|V0256|19015|1|100|0|44,4400|Icepharma hf|Pfizer ApS|Gabapentín||14231||14231|20710||1 101148|QI10AB0301|Alpha Ject 5-3|stl|||500|ml|1|poki||QI10AB03|01.09.2013||R|0|0|0|0|0|0|PHA|0|0|0|100|NOK|59065|95213|veteldis|||0|500|0||Vistor hf|Pharmaq AS|Aeromónas + moritella + vibrio||59065||59065|95213||1 101195|N06DX0105|Memantine Mylan|filmhtfl|10|mg|28|stk|1|þpakki||N06DX01|01.10.2013|31.03.2016|R|1|0|0|0|G|0|GEN|0|0|0|100|SEK|5617|3016|lyfalmen|||2|28|0|14,0000|Icepharma hf|Generics UK Ltd|Memantín||1376||1376|3016||2 101742|N06AX1104|Miron Smelt|munndr.t|30|mg|30|stk|1|þpakki||N06AX11|01.11.2007||R|0|0|0|0|G|0|AGP|0|0|0|100|XEU|1202|2160|lyfalmen|V0330|1810|2|30|0|30,0000|Actavis Group hf|Actavis Group PTC ehf|Mirtazapín||754||754|2160||1 101751|N06AX1104|Miron Smelt|munndr.t|30|mg|96|stk|1|þpakki||N06AX11|01.11.2007||R|0|0|0|0|G|0|AGP|0|0|0|100|XEU|2470|2951|lyfalmen|V0331|2636|2|96|0|96,0000|Actavis Group hf|Actavis Group PTC ehf|Mirtazapín||1329||1329|2951||1 101756|C09DA0106|Lopress Comp|filmhtfl|62,5|mg|100|stk|1|glas|50+12,5 mg|C09DA01|01.11.2010||R|1|0|0|0|G|0|APC|0|0|0|100|XEU|2327|2452|lyfalmen|V0088|2413|2|100|0|100,0000|Actavis Group PTC ehf|Actavis Group PTC ehf|Lósartan og þvagræsilyf||966||966|2452||1 101767|C09DA0106|Lopress Comp|filmhtfl|125|mg|100|stk|1|glas|100+25 mg|C09DA01|01.11.2010||R|1|0|0|0|G|0|APC|0|0|0|100|XEU|2955|2756|lyfalmen|V0089|2704|2|100|0|100,0000|Actavis Group PTC ehf|Actavis Group PTC ehf|Lósartan og þvagræsilyf||1187||1187|2756||1 101823|QM01AC0602|Metacam fyrir hesta|mixtúra|15|mg/ml|250|ml|1|fl||QM01AC06|01.02.2009||R|0|0|0|0|0|0|BOI|0|0|0|100|DKK|11051|21136|vetalmen|||0|250|0||Vistor hf|Boehringer Ingelheim|||11051||11051|21136||1 101893|G03DB0801|Visanne|töflur|2|mg|28|stk|1|þpakki||G03DB08|01.05.2012||R|0|0|0|0|0|0|BAB|0|0|0|100|DKK|5477|8661|lyfalmen|||1|28|0|28,0000|Icepharma hf|Bayer AB|Díenógest||5477||5477|8661||2 101904|G03DB0801|Visanne|töflur|2|mg|84|stk|1|þpakki||G03DB08|01.05.2012||R|0|0|0|0|0|0|BAB|0|0|0|100|DKK|16249|23487|lyfalmen|||1|84|0|84,0000|Icepharma hf|Bayer AB|Díenógest||16249||16249|23487||2 102051|N05AF0103|Fluanxol Mite|filmhtfl|0,5|mg|100|stk|1|glas||N05AF01|01.03.2013||R|1|0|0|0|G|0|LBK|0|0|0|100|DKK|1013|2516|lyfalmen|||1|100|0|8,3333|Lundbeck Export A/S|H. Lundbeck A/S|Flúpentixól||1013||1013|2516||1 102062|N05AF0103|Fluanxol Mite|filmhtfl|1|mg|100|stk|1|glas||N05AF01|01.03.2013||R|1|0|0|0|G|0|LBK|0|0|0|100|DKK|1482|3162|lyfalmen|||1|100|0|16,6667|Lundbeck Export A/S|H. Lundbeck A/S|Flúpentixól||1482||1482|3162||1 102121|L01AA0101|Sendoxan|sts|1|g|1|stk|1|hgl||L01AA01|01.06.2014||R|0|0|0|1|0|1|BAM|0|0|0|100|SEK|5720|8995|lyfsjukr|||1|1|0||Icepharma hf|Baxter Medical AB|Cýklófosfamíð||5720||5720|8995||2 102173|N02BE0107|Paratabs|filmhtfl|500|mg|100|stk|1|þpakki||N02BE01|01.03.2013||R|1|0|0|0|0|0|APC|0|0|1|100|XEU|371|1633|lyfalmen|V0230|1626|2|100|0|16,6667|Actavis Group PTC ehf|Actavis Group PTC ehf|Paracetamól||371||371|1633||1 102353|N06AX2108|Aritavi|sþ-hylki|60|mg|28|stk|1|glas||N06AX21|01.12.2015||R|1|0|0|0|0|0|AGP|0|0|0|100|XEU|2791|4113|lyfalmen|V0693|4088|2|28|0|28,0000|Actavis Group hf|Actavis Group PTC ehf|Duloxetín||2173||2173|4113||1 102404|R03DX0701|Daxas|filmhtfl|500|mcg|30|stk|1|þpakki||R03DX07|01.10.2013||R|0|1|0|0|0|0|TAK|0|0|0|100|DKK|6450|10000|lyfalmen|||1|30|0|30,0000|Vistor hf|Takeda GmbH|Roflumílast||6450||6450|10000||1 102518|N05AX1208|Aripiprazol W&H|töflur|15|mg|56|stk|1|þpakki||N05AX12|01.01.2016||R|0|1|0|0|G|0|WEH|0|0|0|100|XEU|18330|21002|lyfalmen|V0684|21002|2|56|0|56,0000|Williams & Halls efh|Williams & Halls ehf|Aripiprazól||14443||14443|21002||2 102871|C01DA1401|Imdur|forðatfl|60|mg|98|stk|1|þpakki||C01DA14|01.07.1989||R|1|0|0|0|G|0|AZD|0|0|0|100|SEK|3183|5503|lyfalmen|V0041|2668|1|98|0|147,0000|Vistor hf|AstraZeneca A/S DK|Ísósorbíð mónónítrat||3183||3183|5503||1 102952|G04BD0803|Solifenacin Portfarma|filmhtfl|10|mg|90|stk|1|þpakki||G04BD08|01.06.2013||R|1|0|0|0|G|0|POF|0|0|0|100|XEU|14167|20622|lyfalmen|V0441|20622|2|90|0|180,0000|Alvogen|Alvogen|Sólífenacín||14167||14167|20622||1 103050|N05CF0205|Zovand|filmhtfl|10|mg|30|stk|1|þpakki||N05CF02|01.04.2015||R|1|0|0|0|0|0|WEH|0|0|1|100|IKR|321|1499|lyfalmen|V0060|1499|2|30|0|30,0000|Williams & Halls efh|Williams & Halls ehf|Zolpidem||274||274|1499||2 103114|L01BA0110|Metojectpen|stl|7,5|mg|1|áf-penni|1|pakki||L01BA01|01.05.2016||R|0|0|0|1|G|0|WIL|0|0|0|100|XEU|2342|4346|lyfalmen|||1|1|0||Williams & Halls efh|medac Gesellschaft|Metótrexat||2342||2342|4346||2 103379|L03AA1401|Lonquex|stl|6|mg|0,6|ml|1|áfspr||L03AA14|01.10.2015||R|0|0|0|1|0|1|UAB|0|0|0|100|NOK|95661|123693|lyfsjukr|||1|0,6|0|20,0000|Vistor hf|UAB Sicor Biotech|Lipegfilgrastim||95661||95661|123693||1 103610|L01DB0105|Doxorubicin Actavis|irþ|2|mg/ml|25|ml|1|hgl|lausn|L01DB01|01.03.2013||R|0|0|0|1|0|1|APC|0|0|0|100|XEU|3720|6242|lyfsjukr|||2|25|0||Actavis Group PTC ehf|Actavis Group PTC ehf|Doxórúbicín||3720||3720|6242||1 103633|C09DA0105|Presmin Combo|filmhtfl|62,5|mg|98|stk|1|þpakki|50+12,5 mg|C09DA01|01.02.2008||R|1|0|0|0|G|0|POF|0|0|0|100|IKR|2501|2785|lyfalmen|V0088|2365|2|98|0|98,0000|Alvogen|Alvogen|Lósartan og þvagræsilyf||1208||1208|2785||1 103642|C09DA0105|Presmin Combo|filmhtfl|125|mg|98|stk|1|þpakki|100+25 mg|C09DA01|01.02.2008||R|1|0|0|0|G|0|POF|0|0|0|100|IKR|3172|3371|lyfalmen|V0089|2650|2|98|0|98,0000|Alvogen|Alvogen|Lósartan og þvagræsilyf||1634||1634|3371||1 103651|C09CA0104|Presmin|filmhtfl|50|mg|98|stk|1|þpakki||C09CA01|01.02.2008||R|1|0|0|0|G|0|POF|0|0|0|100|IKR|2416|3558|lyfalmen|V0069|2988|2|98|0|98,0000|Alvogen|Alvogen|Lósartan||1770||1770|3558||1 103660|J05AB1103|Valaciklovir Portfarma|töflur|500|mg|10|stk|1|þpakki||J05AB11|01.02.2008||R|1|0|0|0|G|0|POF|0|0|1|100|GBP|1637|1926|lyfalmen|V0033|1926|2|10|0|1,6667|Alvogen|Alvogen|Valacíklóvír||584||584|1926||1 103669|J05AB1103|Valaciklovir Portfarma|töflur|500|mg|40|stk|1|þpakki||J05AB11|01.02.2008||R|1|0|0|0|G|0|POF|0|0|1|100|GBP|6824|4560|lyfalmen|V0182|4510|2|40|0|6,6700|Alvogen|Alvogen|Valacíklóvír||2498||2498|4560||1 103678|N06AX1604|Venlafaxin (Portfarma)|forðahlk|75|mg|100|stk|1|þpakki||N06AX16|01.12.2007||R|1|0|0|0|G|0|POF|0|0|0|100|IKR|3473|3600|lyfalmen|V0334|3153|2|100|0|75,0000|Alvogen|Alvogen|Venlafaxín||1800||1800|3600||1 103687|N06AX1604|Venlafaxin (Portfarma)|forðahlk|150|mg|100|stk|1|þpakki||N06AX16|01.12.2007||R|1|0|0|0|G|0|POF|0|0|0|100|IKR|6528|4494|lyfalmen|V0335|3153|2|100|0|150,0000|Alvogen|Alvogen|Venlafaxín||2450||2450|4494||1 103791|M01AE0115|Alvofen Express|hylki|400|mg|10|stk|1|þpakki||M01AE01|01.01.2015||L|1|0|0|0|0|0|IPC|0|0|1|100|IKR|||lyflausa|||0|10|0|3,3300|Alvogen|Alvogen IPco S.á.r.l.|Íbúprófen|||||||1 103806|N02AB0305|Fentanyl ratiopharm|forðapl|12|mcg/klst|5|stk|1|skpoki||N02AB03|01.12.2012||R|0|0|1|0|G|0|RGM|0|0|0|100|XEU|1614|3344|lyfalmen|||2|5|0|3,6000|Medical ehf|ratiopharm GmbH|Fentanýl||1614||1614|3344|30.4.2016|2 103813|B02BC3002|TISSEEL|vefjalím|||4|ml|10|áf.spr|+ Duo sett|B02BC30|01.01.2013||R|0|0|0|1|0|1|BAA|0|0|0|100|SEK|293788|370970|lyfsjukr|||1|40|0||Icepharma hf|Baxter AG|Blöndur||293788||293788|370970||2 103854|L01XE1701|INLYTA|filmhtfl|1|mg|56|stk|1|þpakki||L01XE17|01.05.2013||R|1|0|0|1|0|1|PZE|0|1|0|100|DKK|109336|141563|lyfsjukr|||1|56|0||Icepharma hf|Pfizer Ltd.|Axitinib||109336||109336|141563||1 103906|QD08AC5201|Malaseb vet.|hársápa|2|%|250|ml|1|glas|w/v|QD08AC52|01.10.2012||R|0|0|0|0|0|0|DEC|0|0|0|100|DKK|3532|6871|vetalmen|||1|250|0||Vistor hf|Dechra Veterinary Products A/S|Bígvaníð og amídín-Klórhexidín í blöndum||3532||3532|6871||1 103937|A06AG0201|Toilax|innhl|2|mg/ml|5|ml|5|túpa||A06AG02|01.12.1975||L|0|0|0|0|0|0|ERC|0|0|0|100|DKK|||lyfalmen|||0|25|0|5,0000|Vistor hf|Orion Pharma|Bisakódýl|||||1954||1 103952|A06AG0201|Toilax|innhl/tf|||1|stk|1|pakki|túpa+4 tfl|A06AG02|01.12.1972||L|1|0|0|0|0|0|ERC|0|0|0|100|IKR|||lyflausa|||0|1|0|1,0000|Vistor hf|Orion Pharma|Bisakódýl|||||||1 104026|V08AB0901|Visipaque|stl|270|mg J/ml|20|ml|10|glhgl||V08AB09|01.12.2009||R|0|0|0|0|0|1|GEH|0|0|0|100|NOK|8562|12907|lyfsjukr|||1|200|0||Icepharma hf|GE Healthcare AS|Jódixanól||8562||8562|12907||2 104471|H01BA0201|Minirin|nefdr|0,1|mg/ml|2,5|ml|1|glas|+2 slöngur|H01BA02|01.01.1988||R|0|0|0|0|G|0|FEL|0|0|0|100|DKK|2519|4589|lyfalmen|||1|2,5|0|10,0000|Vistor hf|Ferring Lægemidler A/S|Desmópressín||2519||2519|4589||1 104489|H01BA0201|Minirin|nefúði|0,1|mg/ml|5|ml|1|úðagl||H01BA02|01.09.2013||R|0|0|0|0|G|0|FEL|0|0|0|100|DKK|6039|9434|lyfalmen|||1|5|0|20,0000|Vistor hf|Ferring Lægemidler A/S|Desmópressín||6039||6039|9434||1 104675|C09DX0401|Entresto|filmhtfl|50|mg|28|stk|1|þpakki|24 + 26 mg|C09DX04|01.04.2016||R|0|0|0|0|0|0|NEL|0|0|0|100|DKK|9437|14111|lyfalmen|||1|28|0|14,0000|Vistor hf|Novartis Europharm Ltd|Valsartan og sacubitril||9437||9437|14111||1 104760|A07EC0202|Pentasa|eþ-stíll|1|g|28|stk|1|pakki||A07EC02|01.07.1991||R|0|0|0|0|G|0|FER|0|0|0|100|DKK|6963|10706|lyfalmen|||1|28|0|18,6667|Vistor hf|Ferring|Mesalazín (5-amínósalicýlsýra)||6963||6963|10706||1 104836|A07EC0202|Pentasa|innhl|10|mg/ml|100|ml|7|stk||A07EC02|01.01.1990||R|0|0|0|0|G|0|FER|0|0|0|100|DKK|3609|6090|lyfalmen|V0017|5547|1|700|0|4,6667|Vistor hf|Ferring|Mesalazín (5-amínósalicýlsýra)||3609||3609|6090||1 104851|A07EC0202|Pentasa|forðatfl|500|mg|100|stk|1|þpakki||A07EC02|01.04.1992||R|1|0|0|0|G|0|FER|0|0|0|100|DKK|4675|7557|lyfalmen|||1|100|0|33,3333|Vistor hf|Ferring|Mesalazín (5-amínósalicýlsýra)||4675||4675|7557||1 104856|R03AK1101|Flutiform|innúðal|55|mcg/sk|120|skammtar|1|pakki|50+5 mcg/sk|R03AK11|01.01.2014||R|0|0|0|0|G|0|HAR|0|0|0|100|DKK|4043|6687|lyfalmen|||1|120|0|30,0000|Icepharma hf|Norpharma a/s (N)|Formóteról og flútikasón||4043||4043|6687||2 104959|B03XA0201|Aranesp|stl|100|mcg/spr|0,5|ml|4|áf.spr|nálavörn|B03XA02|01.11.2010||R|0|0|0|1|0|1|RAG|0|0|0|100|DKK|98030|126689|lyfsjukr|||1|2|0|88,8900|Vistor hf|Amgen|Darbepóetín alfa||||98030|126689||1 105306|A02BC0505|Nexium (Lyf og heilsa)|sh-tfl|40|mg|100|stk|1|glas||A02BC05|23.09.2007||R|1|0|0|0|0|0|HOL|0|0|0|100|SEK|12248|17980|lyfalmen|V0012|5114|3|100|0|133,3300|Lyf og heilsa|Lyf og heilsa|Esómeprazól||12248||12248|17980|| 105315|G03AA0705|Microgynon (Lyf og heilsa)|töflur|||63|stk|1|þpakki||G03AA07|01.05.2009||R|0|0|0|0|0|0|HOL|0|0|0|100|DKK|1147|2701|lyfalmen|V0545|1905|3|63|0|84,0000|Lyf og heilsa|Lyf og heilsa|Levónorgestrel og ethinylestradíól||1147||1147|2701||2 105363|C03DA0403|Eplerenon Bluefish|filmhtfl|25|mg|30|stk|1|þpakki||C03DA04|01.05.2015||R|1|0|0|0|0|0|BLP|0|0|0|100|IKR|7800|4150|lyfalmen|V0107|4091|2|30|0|15,0000|LYFIS ehf|Bluefish Pharmaceuticals AB|Eplerenón||2200||2200|4150||2 105597|C09XA0201|Rasilez|filmhtfl|150|mg|98|stk|1|þpakki|2 x 49 töflur|C09XA02|01.01.2008||R|0|0|0|0|0|0|NEL|0|0|0|100|DKK|11973|17602|lyfalmen|||1|98|0|98,0000|Vistor hf|Novartis Europharm Ltd|Aliskiren||11973||11973|17602||1 105620|C09XA0201|Rasilez|filmhtfl|300|mg|98|stk|1|þpakki|2 x 49 töflur|C09XA02|01.01.2008||R|0|0|0|0|0|0|NEL|0|0|0|100|DKK|15051|21838|lyfalmen|||1|98|0|196,0000|Vistor hf|Novartis Europharm Ltd|Aliskiren||15051||15051|21838||1 105785|N01BB0301|Carbocain|stl|10|mg/ml|20|ml|5|hgl||N01BB03|01.02.2003||R|0|0|0|0|0|0|AZD|0|0|1|100|SEK|2070|3971|lyfalmen|||1|100|0||Vistor hf|AstraZeneca A/S DK|Mepívakaín||2070||2070|3971||1 105796|N01BB0301|Carbocain|stl|20|mg/ml|20|ml|5|hgl||N01BB03|01.02.2003||R|0|0|0|0|0|0|AZD|0|0|1|100|SEK|2447|4490|lyfalmen|||1|100|0||Vistor hf|AstraZeneca A/S DK|Mepívakaín||2447||2447|4490||1 106006|J05AH0201|Tamiflu|hylki|30|mg|10|stk|1|þpakki||J05AH02|01.11.2011||R|1|0|0|0|0|0|RRL|0|0|0|100|DKK|1637|3375|lyfalmen|||1|10|0|2,0000|Icepharma hf|Roche Registration Limited|Oseltamivír||1637||1637|3375||2 106017|J05AH0201|Tamiflu|hylki|45|mg|10|stk|1|þpakki||J05AH02|01.11.2011||R|1|0|0|0|0|0|RRL|0|0|0|100|DKK|3135|3375|lyfalmen|||1|10|0|3,0000|Icepharma hf|Roche Registration Limited|Oseltamivír||1637||1637|3375||2 106182|G03AA1203|Yasminelle|filmhtfl|||63|stk|1|þpakki|3+0,02 mg|G03AA12|01.04.2013||R|0|0|0|0|0|0|BGB|0|0|0|100|DKK|3132|5433|lyfalmen|V0191|4712|1|63|0|84,0000|Icepharma hf|Bayer Pharma AG|Dróspírenón og ethinylestradíól||3132||3132|5433||2 106390|L01XE1801|Jakavi|töflur|10|mg|56|stk|1|þpakki||L01XE18|01.03.2016||R|1|0|0|1|0|1|NEL|0|1|0|100|DKK|406194|510772|lyfsjukr|||1|56|0||Vistor hf|Novartis Europharm Ltd|Ruxolitinib||406194||406194|510772||1 106567|J05AB0102|Zovir|irs|500|mg/hgl|5|hgl|1|pakki||J05AB01|01.01.1995||R|0|0|0|0|0|1|GPH|0|0|0|100|GBP|17400|25072|lyfsjukr|||1|5|0|0,6250|Vistor hf|GlaxoSmithKline Pharma A/S|Acíklóvír||17400||17400|25072||1 106898|J05AB0102|Zovir|irs|250|mg/hgl|5|hgl|1|pakki||J05AB01|01.07.1989||R|0|0|0|0|0|1|GPH|0|0|0|100|GBP|9622|14366|lyfsjukr|||1|5|0|0,3125|Vistor hf|GlaxoSmithKline Pharma A/S|Acíklóvír||9622||9622|14366||1 106932|A10BG0303|Pioglitazone Teva Pharma|töflur|15|mg|98|stk|1|þpakki||A10BG03|01.11.2012||R|1|1|0|0|G|0|TEV|0|0|0|100|XEU|6381|5495|lyfalmen|V0572|5495|2|98|0|49,0000|Medical ehf|Teva Pharma B.V.|Píóglítazón||3177||3177|5495||2 106978|C03DA0404|Kalspar|filmhtfl|25|mg|30|stk|1|þpakki||C03DA04|01.08.2015||R|1|0|0|0|0|0|WEH|0|0|0|100|XEU|3219|4091|lyfalmen|V0107|4091|2|30|0|15,0000|Williams & Halls efh|Williams & Halls ehf|Eplerenón||2157||2157|4091||2 107002|R07AA0201|Curosurf|innö.guf|80|mg/ml|3|ml|1|hgl||R07AA02|01.01.2015||R|0|0|0|1|0|1|TPA|0|0|0|100|DKK|143724|184332|lyfsjukr|||1|3|0|1,5000|Vistor hf|Takeda Pharma A/S|Náttúrulegir fosfólípíðar||143724||143724|184332||1 107203|R06AX2201|Kestine|filmhtfl|10|mg|30|stk|1|þpakki||R06AX22|01.06.2012||L|1|0|0|0|0|0|APS|0|0|1|100|IKR|||lyflausa|||0|30|0|30,0000|Vistor hf|Almirall-Prodesfarma S.A.|Ebastín|||||||1 107219|A07EC0102|Salazopyrin EN|sh-tfl|500|mg|100|stk|1|glas||A07EC01|01.04.1987||R|1|0|0|0|G|0|PER|0|0|0|100|DKK|1397|3045|lyfalmen|||1|100|0|25,0000|Icepharma hf|Pfizer ApS|Súlfasalazín||1397||1397|3045||1 107265|C03DA0403|Eplerenon Bluefish|filmhtfl|50|mg|30|stk|1|þpakki||C03DA04|01.10.2014||R|1|0|0|0|0|0|BLP|0|0|0|100|IKR|9000|11858|lyfalmen|V0197|11858|2|30|0|30,0000|LYFIS ehf|Bluefish Pharmaceuticals AB|Eplerenón||7800||7800|11858||2 107464|G04BD0803|Solifenacin Portfarma|filmhtfl|5|mg|30|stk|1|þpakki||G04BD08|01.06.2013||R|1|0|0|0|G|0|POF|0|0|0|100|XEU|4138|6818|lyfalmen|V0438|6818|2|30|0|30,0000|Alvogen|Alvogen|Sólífenacín||4138||4138|6818||1 107575|N01AB0803|Sevoflurane Piramal|innö.guf|100|%|250|ml|1|fl||N01AB08|01.03.2015||R|0|0|0|0|0|1|PIR|0|0|0|100|XEU|19048|24207|lyfsjukr|||1|250|0||Williams & Halls efh|Piramal Healthcare UK Limited|Sevóflúran||16772||16772|24207||2 107607|A02BA0201|Asyran|töflur|150|mg|60|stk|1|þpakki||A02BA02|01.07.1986||R|1|0|0|0|G|0|ACA|0|0|0|100|XEU|821|2252|lyfalmen|||2|60|0|30,0000|Actavis Group hf|Actavis hf|Ranitidín||821||821|2252||1 107657|N05AX1205|Aripiprazol Krka|töflur|10|mg|56|stk|1|þpakki||N05AX12|01.03.2015||R|1|0|0|0|G|0|KRK|0|0|0|100|IKR|20582|22456|lyfalmen|V0683|21002|2|56|0|37,3300|LYFIS ehf|Krka Sverige AB|Aripiprazól||15500||15500|22456||2 107935|QN01AX0304|Aniketam vet.|stl|100|mg/ml|50|ml|1|hgl|lausn|QN01AX03|01.04.2015||R|0|0|1|0|0|0|VEB|1|0|0|100|IKR|8574|16437|vetalmen|||0|50|0||Dýraheilsa ehf|Le Vet Beheer B.V.|Ketaminum||||8574|16437||2 108103|M05BA0804|Zoledronic acid medac|irl|4|mg/glasi|100|ml|1|glas|lausn|M05BA08|01.12.2013|30.04.2016|R|0|1|0|1|0|1|WIL|0|0|0|100|XEU|13017|19039|lyfsjukr|||2|100|0|1,0000|Williams & Halls efh|medac Gesellschaft|Zoledronsýra||13017||13017|19039||2 108126|G04BD0402|Oxybutynin Mylan|töflur|5|mg|100|stk|1|þpakki||G04BD04|01.05.2013||R|0|0|0|0|G|0|MYL|0|0|0|100|SEK|2199|4149|lyfalmen|||2|100|0|33,3300|Icepharma hf|Mylan AB|Oxýbútýnín||2199||2199|4149||2 108347|J05AX1401|Daklinza|filmhtfl|30|mg|28|stk|1|þpakki||J05AX14|01.10.2015||R|1|0|0|1|0|1|BMS|0|1|0|100|DKK|1297289|1619044|lyfsjukr|||1|28|0|14,0000|Vistor hf|Bristol-Myers Squibb Pharma EEIG|Daclatasvír||1297289||1297289|1619044||1 108413|C10A00001|Praluent|stl|75|mg/ml|1|ml|2|áfpen|lausn í áf.lyfjapenna|C10A000|01.02.2016||R|0|0|0|0|0|0|SGA|0|0|0|100|NOK|64557|84352|lyfalmen|||1|2|0||Vistor hf|Sanofi-aventis groupe|Alirocumab||||64557|84352||1 108433|L03AB1001|PegIntron|sts|50|mcg|4|stk|1|pakki|fjölskammta pennar|L03AB10|01.10.2013||R|0|0|0|1|0|1|MLD|0|0|0|100|DKK|48644|64226|lyfsjukr|||1|4|0|26,6700|Vistor hf|Merck Sharp & Dohme Limited|Peginterferón alfa 2b||48644||48644|64226||1 108455|N04BD0203|Rasagilin WH|töflur|1|mg|30|stk|1|þpakki||N04BD02|01.04.2016||R|0|0|0|0|G|0|WEH|0|0|0|100|XEU|14796|21487|lyfalmen|V0726|21487|2|30|0|30,0000|Williams & Halls efh|Williams & Halls ehf|Rasagilín||14796||14796|21487||2 108540|A10BH0201|Galvus|töflur|50|mg|30|stk|1|þpakki||A10BH02|01.09.2008||R|0|0|0|0|G|0|NEL|0|0|0|100|DKK|2929|5154|lyfalmen|||1|30|0|15,0000|Vistor hf|Novartis Europharm Ltd|Vildagliptín||2929||2929|5154||1 108562|A10BH0201|Galvus|töflur|50|mg|90|stk|1|þpakki||A10BH02|01.09.2008||R|0|0|0|0|G|0|NEL|0|0|0|100|DKK|8694|13089|lyfalmen|||1|90|0|45,0000|Vistor hf|Novartis Europharm Ltd|Vildagliptín||8694||8694|13089||1 108697|A16AA0601|Cystadane|duft|1|g|180|g|1|glas||A16AA06|01.07.2013||R|0|0|0|1|0|0|OEU|0|0|0|100|XEU|66107|86313|lyfalmen|||1|180|0|30,0000|Orphan Europe S.a.r.l.|Orphan Europe S.a.r.l.|Betain anhydrous||66107||66107|86313||3 108852|R01AD0501|Rhinocort Aqua|nefúði|64|mcg/sk|120|skammtar|1|fl||R01AD05|01.10.1988||R|0|0|0|0|G|0|AZD|0|0|1|100|SEK|1327|2949|lyfalmen|||1|120|0|38,4000|Vistor hf|AstraZeneca A/S DK|Búdesóníð||1327||1327|2949||1 109421|V01AA0303|Alutard SQ, derm.farinae|stl|||5|ml|4|hgl|byrjunarsett|V01AA03|01.07.1999||R|0|0|0|1|G|0|ALK|0|0|0|100|DKK|21552|29960|lyfalmen|||1|20|0||Vistor hf|ALK-Abello A/S|rykmaurar||21552||21552|29960||1 109439|V01AA0303|Alutard SQ, derm.farinae|stl|0,1|mi.SQ/ml|5|ml|1|hgl|framhaldssett|V01AA03|01.07.1999||R|0|0|0|1|G|0|ALK|0|0|0|100|DKK|17255|24872|lyfalmen|||1|5|0||Vistor hf|ALK-Abello A/S|rykmaurar||17255||17255|24872||1 109569|N02AA0505|Oxycodone ratiopharm|forðatfl|20|mg|28|stk|1|þpakki||N02AA05|01.01.2013||R|1|0|1|0|G|0|RAT|0|0|0|100|XEU|1473|3150|lyfalmen|||2|28|0|7,4700|LYFIS ehf|ratiopharm GmbH|Oxýcódon||1473||1473|3150|30.4.2016|2 109578|N02AA0505|Oxycodone ratiopharm|forðatfl|20|mg|98|stk|1|þpakki||N02AA05|01.01.2013||R|1|0|1|0|G|0|RAT|0|0|0|100|XEU|5117|7952|lyfalmen|V0585|7951|2|98|0|26,1300|LYFIS ehf|ratiopharm GmbH|Oxýcódon||4962||4962|7952||2 109588|N02AA0505|Oxycodone ratiopharm|forðatfl|40|mg|28|stk|1|þpakki||N02AA05|01.01.2013||R|1|0|1|0|G|0|RAT|0|0|0|100|XEU|2692|4827|lyfalmen|||2|28|0|14,9300|LYFIS ehf|ratiopharm GmbH|Oxýcódon||2692||2692|4827|30.4.2016|2 109597|N02AA0505|Oxycodone ratiopharm|forðatfl|40|mg|98|stk|1|þpakki||N02AA05|01.01.2013||R|1|0|1|0|G|0|RAT|0|0|0|100|XEU|8676|13064|lyfalmen|V0587|13064|2|98|0|52,2700|LYFIS ehf|ratiopharm GmbH|Oxýcódon||8676||8676|13064||2 109615|N02AA0505|Oxycodone ratiopharm|forðatfl|80|mg|98|stk|1|þpakki||N02AA05|01.01.2013||R|1|0|1|0|G|0|RAT|0|0|0|100|XEU|15367|20772|lyfalmen|V0588|20770|2|98|0|104,5300|LYFIS ehf|ratiopharm GmbH|Oxýcódon||14276||14276|20772||2 110033|R06AE0705|Cetirizin ratiopharm|filmhtfl|10|mg|30|stk|1|þpakki||R06AE07|01.09.2012||L|1|0|0|0|0|0|RGM|0|0|1|100|IKR|||lyflausa|||0|30|0|30,0000|Medical ehf|ratiopharm GmbH|Cetirizín|||||||2 110080|S01ED0105|Optimol|augndr|5|mg/ml|5|ml|1|glas||S01ED01|01.01.1987||R|0|0|0|0|G|0|SAO|0|0|0|100|XEU|401|1674|lyfalmen|||1|5|0|25,0000|Icepharma hf|Santen Oy|Tímólól||401||401|1674||2 110177|N06AX2108|Aritavi|sþ-hylki|60|mg|90|stk|1|glas||N06AX21|01.12.2015||R|1|0|0|0|0|0|AGP|0|0|0|100|XEU|8121|10657|lyfalmen|V0694|10565|2|90|0|90,0000|Actavis Group hf|Actavis Group PTC ehf|Duloxetín||6927||6927|10657||1 110242|V03AN0101|Conoxia|lyfjagas|100|%|3|l|1|hylki|undir þrýstingi/LIV|V03AN01|01.04.2008||L|0|0|0|0|0|0|AGA|0|0|0|100|IKR|||lyflausa|||0|3|0||Ísaga ehf|AGA AB|Súrefni|||||||5 110287|N05AX0806|Risperidon Krka|filmhtfl|1|mg|60|stk|1|þpakki||N05AX08|01.05.2014||R|1|0|0|0|G|0|KRK|0|0|0|100|IKR|1500|2361|lyfalmen|V0291|2361|2|60|0|12,0000|LYFIS ehf|Krka Sverige AB|Risperídón||900||900|2361||2 110306|N05AX0806|Risperidon Krka|filmhtfl|2|mg|60|stk|1|þpakki||N05AX08|01.05.2014||R|1|0|0|0|G|0|KRK|0|0|0|100|IKR|2700|3806|lyfalmen|V0292|3806|2|60|0|24,0000|LYFIS ehf|Krka Sverige AB|Risperídón||1950||1950|3806||2 110324|N05AX0806|Risperidon Krka|filmhtfl|3|mg|60|stk|1|þpakki||N05AX08|01.05.2014||R|1|0|0|0|G|0|KRK|0|0|0|100|IKR|4210|5389|lyfalmen|V0296|5389|2|60|0|36,0000|LYFIS ehf|Krka Sverige AB|Risperídón||3100||3100|5389||2 110342|N05AX0806|Risperidon Krka|filmhtfl|4|mg|60|stk|1|þpakki||N05AX08|01.05.2014||R|1|0|0|0|G|0|KRK|0|0|0|100|IKR|5000|6765|lyfalmen|V0297|6765|2|60|0|48,0000|LYFIS ehf|Krka Sverige AB|Risperídón||4100||4100|6765||2 110395|G03AA0902|Mercilon|töflur|||63|stk|1|þpakki|150/20 mcg|G03AA09|01.07.1990||R|0|0|0|0|0|0|ORG|0|0|0|100|DKK|1367|3004|lyfalmen|V0065|2351|1|63|0|84,0000|Vistor hf|N.V. Organon|Desógestrel og ethinylestradíól||1367||1367|3004||1 110397|V03AN0101|Conoxia|lyfjagas|100|%|5|l|1|hylki|undir þrýstingi/LIV|V03AN01|01.01.2013||L|0|0|0|0|0|0|AGA|0|0|0|100|IKR|||lyflausa|||0|5|0||Ísaga ehf|AGA AB|Súrefni|||||||5 110421|H01CC0101|Orgalutran|stl|0,5|mg/ml|0,5|ml|5|áf.spr||H01CC01|01.12.2015||R|0|0|0|1|0|1|MLD|0|0|0|100|DKK|23663|32630|lyfsjukr|||1|2,5|0|5,0000|Vistor hf|Merck Sharp & Dohme Limited|Ganirelix||23663||23663|32630||1 110635|C08DA0104|Veraloc Retard|forðatfl|200|mg|100|stk|1|glas||C08DA01|01.10.1988||R|1|0|0|0|G|0|ORC|0|0|0|100|DKK|3495|5933|lyfalmen|||1|100|0|83,3333|Vistor hf|Orion Corporation|Verapamíl||3495||3495|5933||1 110750|J05AX0801|Isentress|filmhtfl|400|mg|60|stk|1|glas||J05AX08|01.04.2012||R|1|0|0|1|0|1|MLD|0|0|0|100|DKK|81884|106268|lyfsjukr|||1|60|0|30,0000|Vistor hf|Merck Sharp & Dohme Limited|Raltegravír||81884||81884|106268||1 111295|G02BA0304|Levosert|leginnle|20|mcg/sólh|1|stk|1|poki||G02BA03|01.09.2015||R|0|0|0|0|0|0|EHF|0|0|0|100|XEU|15002|17679|lyfalmen|||2|1|0||Actavis Group PTC hf|Actavis ehf|Plast lyfjalykkja (IUD) með prógestógen||12029||12029|17679||1 111479|S01ED5113|Dorzolamide/Timolol Portfarma|augndr|5|mg/ml|5|ml|3|glas|+ dorzólamid 20 mg/ml|S01ED51|01.11.2011||R|0|0|0|0|G|0|POF|0|0|0|100|XEU|2622|4500|lyfalmen|V0373|4500|2|15|0|75,0000|Alvogen|Alvogen|Tímólól í blöndum||2454||2454|4500||1 111678|A06AB5802|CitraFleet|mixtduft|||2|pokar|1|pakki|lausn|A06AB58|01.12.2013||L|0|0|0|0|0|0|CAS|0|0|0|100|IKR|||lyflausa|||0|2|0||Vistor hf|Casen Recordati S.L.|Natríumpicosúlfat|||||||1 111795|R06AX1301|Clarityn|töflur|10|mg|10|stk|1|þpakki||R06AX13|01.09.2014||L|1|0|0|0|0|0|BAB|0|0|1|100|IKR|||lyflausa|||1|10|0|10,0000|Icepharma hf|Bayer AB|Lóratadín|||||||2 111863|V03AF0101|Uromitexan|stl|100|mg/ml|10|ml|10|lykjur||V03AF01|01.04.2015||R|0|0|0|0|0|1|BAM|0|0|0|100|SEK|3389|5787|lyfsjukr|||1|100|0||Icepharma hf|Baxter Medical AB|Mesna||3389||3389|5787||2 111955|N02BE0101|Panodil|filmhtfl|1|g|100|stk|1|glas||N02BE01|01.05.2003||R|1|0|0|0|0|0|HCA|0|0|1|100|DKK|645|2010|lyfalmen|V0229|1945|1|100|0|33,3300|Artasan ehf|GlaxoSmithKline CH A/S|Paracetamól||645||645|2010||1 112022|G03AC0802|Implanon NXT|vefjalyf|68|mg|1|stk|1|pakki||G03AC08|01.02.2011||R|0|0|0|0|0|0|ORG|0|0|0|100|DKK|19311|27702|lyfalmen|||1|1|0|1000,0000|Vistor hf|N.V. Organon|Etónógestrel||19311||19311|27702||1 112056|R03BB0501|Eklira Genuair|innönddu|322|mcg|60|skammtar|3|innö.t||R03BB05|01.01.2013|31.03.2016|R|0|0|0|0|G|0|ZEN|0|0|0|100|SEK|14912|21647|lyfalmen|||1|180|0|90,0000|Vistor hf|AstraZeneca AB|Aclídínumbrómíð||14912||14912|21647||1 112191|C02KX0501|Adempas|filmhtfl|1|mg|42|stk|1|þpakki||C02KX05|01.12.2014||R|1|0|0|1|0|1|BYE|0|1|0|100|DKK|180636|230241|lyfsjukr|||1|42|0|9,3300|Vistor hf|Bayer Pharma AG|Riociguatum||180636||180636|230241||1 112873|J01CA0413|Amoxin|mixtduft|50|mg/ml|100|ml|1|glas||J01CA04|01.12.2015||R|0|0|0|0|0|0|RAT|0|0|1|100|IKR|1700|3462|lyfalmen|||2|100|0|5,0000|LYFIS ehf|ratiopharm GmbH|Amoxicillín||1700||1700|3462||2 113058|N07BA0148|Nicovel Fruit|tyggigúm|2|mg|24|stk|1|þpakki||N07BA01|01.02.2013||L|0|0|0|0|0|0|ORI|0|0|1|100|IKR|||lyflausa|||0|24|0|1,6000|Artasan ehf|Orifarm Generics A/S|Nikótín|||||||1 113143|N05AX1205|Aripiprazol Krka|töflur|30|mg|56|stk|1|þpakki||N05AX12|01.03.2015||R|1|0|0|0|G|0|KRK|0|0|0|100|IKR|40598|33688|lyfalmen|V0717|33688|2|56|0|112,0000|LYFIS ehf|Krka Sverige AB|Aripiprazól||24500||24500|33688||2 113251|D01AE1602|Amorolfin ratiopharm|lakk|5|%|5|ml|1|glas||D01AE16|01.09.2014||L|0|0|0|0|0|0|RPO|0|0|1|100|IKR|||lyfalmen|V0655|4701|2|5|0||LYFIS ehf|ratiopharm Oy|Amorolfín|||||4701||2 113331|H02AB0205|Dexametason Abcur|töflur|1|mg|20|stk|1|þpakki||H02AB02|01.11.2013||R|1|0|0|0|G|0|ABC|0|0|1|100|SEK|1676|3429|lyfalmen|||2|20|0|13,3300|Icepharma hf|Abcur AB|Dexametasón||1676||1676|3429||2 113394|A10BD0801|Eucreas|filmhtfl|900|mg|60|stk|1|þpakki|50mg/850mg|A10BD08|01.11.2008||R|0|0|0|0|G|0|NEL|0|0|0|100|DKK|6883|10596|lyfalmen|V0024|9093|1|60|0|30,0000|Vistor hf|Novartis Europharm Ltd|Metforminum og vildagliptinum||6883||6883|10596||1 113403|A10BD0801|Eucreas|filmhtfl|900|mg|180|stk|1|þpakki|50mg/850mg|A10BD08|01.11.2008||R|0|0|0|0|G|0|NEL|0|0|0|100|DKK|19004|27279|lyfalmen|V0024|27279|1|180|0|90,0000|Vistor hf|Novartis Europharm Ltd|Metforminum og vildagliptinum||19004||19004|27279||1 113412|A10BD0801|Eucreas|filmhtfl|1050|mg|60|stk|1|þpakki|50mg/1000mg|A10BD08|01.11.2008||R|0|0|0|0|G|0|NEL|0|0|0|100|DKK|6200|9656|lyfalmen|V0025|7910|1|60|0|30,0000|Vistor hf|Novartis Europharm Ltd|Metforminum og vildagliptinum||6200||6200|9656||1 113414|B05AA0114|Albuman|irl|40|g/líter|100|ml|1|hgl|lausn|B05AA01|01.03.2013||R|0|0|0|0|0|1|SPP|0|0|0|100|XEU|2057|3953|lyfsjukr|||1|100|0||Williams & Halls efh|Sanquin Plasma Product|Albúmín||2057||2057|3953||2 113415|B01AB0501|Klexane|stl|100|mg/ml|0,2|ml|10|áf.spr|einnota dæla|B01AB05|01.10.1995||R|0|0|0|0|G|0|SNO|0|0|1|100|NOK|2547|4628|lyfalmen|||1|2|0|10,0000|Vistor hf|Sanofi-aventis Norge AS|Enoxaparín||2547||2547|4628||1 113421|A10BD0801|Eucreas|filmhtfl|1050|mg|180|stk|1|þpakki|50mg/1000mg|A10BD08|01.11.2008||R|0|0|0|0|G|0|NEL|0|0|0|100|DKK|16425|23730|lyfalmen|V0025|23730|1|180|0|90,0000|Vistor hf|Novartis Europharm Ltd|Metforminum og vildagliptinum||16425||16425|23730||1 113648|N06BA0404|Methylphenidate Sandoz|forðatfl|27|mg|30|stk|1|glas||N06BA04|01.03.2015||R|1|1|1|0|0|0|SHS|0|0|0|100|DKK|5223|6602|lyfalmen|V0681|6602|2|30|0|27,0000|Artasan ehf|Sandoz A/S|Metýlfenídat||3981||3981|6602||1 113704|B01AB0501|Klexane|stl|100|mg/ml|0,4|ml|10|áf.spr|einnota dæla|B01AB05|01.10.1995||R|0|0|0|0|G|0|SNO|0|0|1|100|NOK|4375|7144|lyfalmen|||1|4|0|20,0000|Vistor hf|Sanofi-aventis Norge AS|Enoxaparín||4375||4375|7144||1 113818|L01XE0801|Tasigna|hylki|200|mg|112|stk|1|þpakki||L01XE08|01.06.2008||R|0|1|0|1|0|1|NEL|0|1|0|100|DKK|444444|558344|lyfsjukr|||1|112|0||Vistor hf|Novartis Europharm Ltd|Nilotiníb||444444||444444|558344||1 113894|J01CE0204|Kaavepenin|töflur|1|g|20|stk|1|þpakki||J01CE02|01.10.1985||R|0|0|0|0|0|0|REP|0|0|1|100|SEK|569|1905|lyfalmen|||1|20|0|10,0000|Vistor hf|Recip AB|Fenoxýmetýlpenicillín||569||569|1905||1 113902|J01CE0204|Kaavepenin|töflur|1|g|30|stk|1|þpakki||J01CE02|01.10.1985||R|0|0|0|0|0|0|REP|0|0|1|100|SEK|721|2115|lyfalmen|||1|30|0|15,0000|Vistor hf|Recip AB|Fenoxýmetýlpenicillín||721||721|2115||1 113910|J01CE0204|Kaavepenin|töflur|1|g|40|stk|1|þpakki||J01CE02|01.10.1985||R|0|0|0|0|0|0|REP|0|0|1|100|SEK|1097|2632|lyfalmen|||1|40|0|20,0000|Vistor hf|Recip AB|Fenoxýmetýlpenicillín||1097||1097|2632||1 114033|R03AC0210|Ventolin Diskus|innönddu|200|mcg/sk|60|skammtar|1|stk|Diskus tæki|R03AC02|01.03.1999||R|0|0|0|0|G|0|GPH|0|0|1|100|IKR|732|2130|lyfalmen|||1|60|0|15,0000|Vistor hf|GlaxoSmithKline Pharma A/S|Salbútamól||732||732|2130||1 114072|A07DA0301|Imodium|filmhtfl|2|mg|16|stk|1|þpakki||A07DA03|01.02.2014||L|1|0|0|0|0|0|MCS|0|0|0|100|IKR|||lyflausa|||0|16|0|3,2000|Vistor hf|McNeil Sweden AB|Lóperamíð|||||||1 114134|B02BD0204|Helixate NexGen|sts|250|ae/hgl|1|hgl|1|pakki|+leysir og bl.sett|B02BD02|01.11.2013||R|0|0|0|1|0|1|BAY|0|1|0|100|SEK|20774|28976|lyfsjukr|||1|1|0|0,5000|Icepharma hf|Bayer AB "Bayer Schering Pharma"|Storkuþáttur VIII||||20774|28976||2 114328|L01AX0303|Temomedac|hylki|100|mg|5|stk|1|glas||L01AX03|01.04.2011||R|0|0|0|1|0|1|WIL|0|1|0|100|XEU|31379|42389|lyfsjukr|||2|5|0||Williams & Halls efh|medac Gesellschaft|Temozolomid||||31379|42389||2 114440|M01AH0501|Arcoxia|filmhtfl|30|mg|28|stk|1|þpakki||M01AH05|01.01.2010||R|1|0|0|0|G|0|MSD|0|0|1|100|DKK|3668|6171|lyfalmen|||1|28|0|14,0000|Vistor hf|M.S.D.|Etoríkoxíb||3668||3668|6171||1 114512|D06BB0401|Condyline|húðlausn|5|mg/ml|3,5|ml|1|glas|til penslunar|D06BB04|01.11.2010||R|0|0|0|0|0|0|GAN|0|0|1|100|XEU|1965|3827|lyfalmen|||1|3,5|0||Icepharma hf|Galderma Nordic AB|Pódófýllótoxín||1965||1965|3827||2 114531|L01AA0201|Leukeran|filmhtfl|2|mg|25|stk|1|glas||L01AA02|01.04.2013||R|0|0|0|0|G|0|APP|0|0|0|100|XEU|9818|14636|lyfalmen|||1|25|0||Artasan ehf|Aspen Pharma Trading Limited|Chlorambucíl||9818||9818|14636||1 114675|D10AD5301|Epiduo|hlaup|||60|g|1|túpa|0,1% / 2,5%|D10AD53|01.12.2011||R|0|0|0|0|0|0|GAN|0|0|0|100|SEK|5304|8423|lyfalmen|||1|60|0||Icepharma hf|Galderma Nordic AB|Adapalen og benzóýl peroxíð||5304||5304|8423||2 114755|L02BB0307|Bicalutamid Medical|filmhtfl|50|mg|90|stk|1|þpakki||L02BB03|01.11.2014||R|0|0|0|0|G|0|MED|0|0|0|100|IKR|14000|14886|lyfalmen|V0420|14784|2|90|0|90,0000|Medical ehf|Medical ehf|Bíkalútamíð||10000||10000|14886||2 114912|QP54AA0501|Stronghold|bl.lausn|120|mg|1|ml|3|túpa||QP54AA05|01.12.2014||R|0|0|0|0|0|0|ZBE|1|0|0|100|XEU|5385|9282|vetorma|||0|3|0||Icepharma hf|Zoetis Belgium S.A.|Selamectinum||5385||5385|9282||2 114941|N05AH0312|Zalasta|töflur|2,5|mg|28|stk|1|þpakki||N05AH03|01.01.2013||R|1|0|0|0|G|0|KNM|0|0|0|100|XEU|2189|2563|lyfalmen|V0278|2563|2|28|0|7,0000|LYFIS ehf|Krka d.d. Novo mesto|Olanzapín||1047||1047|2563||2 114952|N05AH0312|Zalasta|töflur|5|mg|28|stk|1|þpakki||N05AH03|01.01.2013||R|1|0|0|0|G|0|KNM|0|0|0|100|XEU|2886|2631|lyfalmen|V0279|2631|2|28|0|14,0000|LYFIS ehf|Krka d.d. Novo mesto|Olanzapín||1096||1096|2631||2 114963|N05AH0312|Zalasta|töflur|7,5|mg|56|stk|1|þpakki||N05AH03|01.01.2013||R|1|0|0|0|G|0|KNM|0|0|0|100|XEU|8394|4141|lyfalmen|V0280|4141|2|56|0|42,0000|LYFIS ehf|Krka d.d. Novo mesto|Olanzapín||2193||2193|4141||2 114985|N05AH0312|Zalasta|töflur|10|mg|56|stk|1|þpakki||N05AH03|01.01.2013||R|1|0|0|0|G|0|KNM|0|0|0|100|XEU|10348|15365|lyfalmen|V0282|2991|2|56|0|56,0000|LYFIS ehf|Krka d.d. Novo mesto|Olanzapín||10348||10348|15365||2 114996|N05AH0312|Zalasta|munndr.t|5|mg|28|stk|1|þpakki||N05AH03|01.01.2013||R|0|0|0|0|G|0|KNM|0|0|0|100|IKR|5276|6628|lyfalmen|V0457|6628|2|28|0|14,0000|LYFIS ehf|Krka d.d. Novo mesto|Olanzapín||4000||4000|6628||2 115007|N05AH0312|Zalasta|munndr.t|10|mg|28|stk|1|þpakki||N05AH03|01.01.2013||R|0|0|0|0|G|0|KNM|0|0|0|100|IKR|8022|10457|lyfalmen|||2|28|0|28,0000|LYFIS ehf|Krka d.d. Novo mesto|Olanzapín||6782||6782|10457||2 115018|N05AH0312|Zalasta|munndr.t|15|mg|28|stk|1|þpakki||N05AH03|01.01.2013||R|0|0|0|0|G|0|KNM|0|0|0|100|IKR|17396|13785|lyfalmen|V0475|13785|2|28|0|42,0000|LYFIS ehf|Krka d.d. Novo mesto|Olanzapín||9200||9200|13785||2 115029|N05AH0312|Zalasta|munndr.t|20|mg|28|stk|1|þpakki||N05AH03|01.01.2013||R|0|0|0|0|G|0|KNM|0|0|0|100|IKR|13896|20024|lyfalmen|V0540|20024|2|28|0|56,0000|LYFIS ehf|Krka d.d. Novo mesto|Olanzapín||13733||13733|20024||2 115126|B02BD0801|NovoSeven|sts|1|mg|1|hgl|1|pakki|+áfyllt sprauta, með leysi|B02BD08|01.10.2015||R|0|1|0|1|0|1|NAS|0|0|0|100|DKK|84801|109957|lyfsjukr|||1|1|0|0,0200|Vistor hf|Novo-Nordisk A/S|Eptacog alfa (virkjað)||84801||84801|109957||1 115163|B01AE0701|Pradaxa|hylki|75|mg|10|stk|1|þpakki|hart|B01AE07|01.01.2009||R|0|1|0|0|G|0|BII|0|0|0|100|DKK|1691|3450|lyfalmen|||1|10|0|2,5000|Vistor hf|Boehringer Ingelheim International|Dabigatran etexílat||1691||1691|3450||1 115241|V03AB1504|Naloxon B. Braun|stl|0,4|mg/ml|1|ml|10|lykjur||V03AB15|01.09.2010||R|0|0|0|0|0|1|BRA|0|0|0|100|XEU|7864|11946|lyfsjukr|||2|10|0||Actavis Group hf|Braun|Naloxón||7864||7864|11946||1 115285|J01CA0411|Amoxicillin Mylan|töflur|750|mg|20|stk|1|þpakki||J01CA04|01.10.1998||R|0|0|0|0|0|0|MYL|0|0|1|100|SEK|1139|2600|lyfalmen|V0158|2361|2|20|0|15,0000|Icepharma hf|Mylan AB|Amoxicillín||1074||1074|2600||2 115309|N05AH0206|Clozapin Medical|töflur|25|mg|100|stk|1|þpakki||N05AH02|01.06.2015||R|1|0|0|0|G|0|MED|0|0|0|100|IKR|1955|2567|lyfalmen|V0276|2567|2|100|0|8,3300|Medical ehf|Medical ehf|Klózapín||1050||1050|2567||2 115330|B01AE0701|Pradaxa|hylki|75|mg|60|stk|1|þpakki|hart|B01AE07|01.01.2009||R|0|1|0|0|G|0|BII|0|0|0|100|DKK|10143|15083|lyfalmen|||1|60|0|15,0000|Vistor hf|Boehringer Ingelheim International|Dabigatran etexílat||10143||10143|15083||1 115341|B01AE0701|Pradaxa|hylki|110|mg|10|stk|1|þpakki|hart|B01AE07|01.01.2009||R|0|1|0|0|G|0|BII|0|0|0|100|DKK|1691|3450|lyfalmen|||1|10|0|3,6700|Vistor hf|Boehringer Ingelheim International|Dabigatran etexílat||1691||1691|3450||1 115364|B01AE0701|Pradaxa|hylki|110|mg|60|stk|1|þpakki|hart|B01AE07|01.01.2009||R|0|1|0|0|G|0|BII|0|0|0|100|DKK|9266|13876|lyfalmen|||1|60|0|22,0000|Vistor hf|Boehringer Ingelheim International|Dabigatran etexílat||9266||9266|13876||1 115554|B03AC0001|Monofer|irl|100|mg/ml|10|ml|1|hgl||B03AC|01.07.2013||R|0|1|0|0|G|0|PAC|0|0|1|100|DKK|46058|60955|lyfalmen|||1|10|0|10,0000|Vistor hf|Pharmacosmos A/S|Járn, stungulyf||46058||46058|60955||1 115931|R03AC1202|Serevent Diskus|innönddu|50|mcg/sk|60|skammtar|1|pakki||R03AC12|01.01.1995||R|0|0|0|0|G|0|GPH|0|0|1|100|GBP|3433|5847|lyfalmen|||1|60|0|30,0000|Vistor hf|GlaxoSmithKline Pharma A/S|Salmeteról||3433||3433|5847||1 116004|J01DC0202|Zinacef|sts|1,5|g|5|hgl|1|pakki||J01DC02|01.06.2005||R|0|0|0|0|0|1|GPH|0|0|0|100|GBP|3471|5900|lyfsjukr|||1|5|0|2,5000|Vistor hf|GlaxoSmithKline Pharma A/S|Cefúroxím||3471||3471|5900||1 116046|J01DC0202|Zinacef|sts|750|mg|5|hgl|1|pakki||J01DC02|01.09.1983||R|0|0|0|0|0|1|GPH|0|0|0|100|GBP|1814|3619|lyfsjukr|||1|5|0|1,2500|Vistor hf|GlaxoSmithKline Pharma A/S|Cefúroxím||1814||1814|3619||1 116198|C08CA0105|Amlodipin Bluefish|töflur|5|mg|100|stk|1|þpakki||C08CA01|01.03.2012||R|1|0|0|0|G|0|BLP|0|0|0|100|IKR|1153|2038|lyfalmen|V0056|1995|2|100|0|100,0000|LYFIS ehf|Bluefish Pharmaceuticals AB|Amlódipín||665||665|2038||2 116220|C08CA0105|Amlodipin Bluefish|töflur|10|mg|100|stk|1|þpakki||C08CA01|01.03.2012||R|1|0|0|0|G|0|BLP|0|0|0|100|IKR|1826|2038|lyfalmen|V0057|2038|2|100|0|200,0000|LYFIS ehf|Bluefish Pharmaceuticals AB|Amlódipín||665||665|2038||2 116244|D11AF01|Verucid|áburður|||10|ml|1|glas||D11AF|01.11.1981||L|0|0|0|0|0|0|GAN|0|0|0|100|IKR|||lyflausa|||0|10|0||Icepharma hf|Galderma Nordic AB|Lyf við vörtum og líkþornum|||||||2 116449|N05AH0313|Olanzapin Sandoz|filmhtfl|5|mg|250|stk|1|glas||N05AH03|01.05.2013||R|2|0|0|0|G|0|SHS|0|0|0|100|DKK|17536|12424|lyfalmen|||2|250|0|125,0000|Artasan ehf|Sandoz A/S|Olanzapín||8211||8211|12424||1 116551|M01AE0102|Ibufen|töflur|200|mg|20|stk|1|þpakki||M01AE01|01.12.2008||L|1|0|0|0|0|0|ACA|0|0|1|100|IKR|||lyflausa|||0|20|0|3,3333|Actavis Group hf|Actavis hf|Íbúprófen|||||||1 116573|M01AE0102|Ibufen|töflur|400|mg|30|stk|1|þpakki||M01AE01|01.05.2008||L|1|0|0|0|0|0|ACA|0|0|1|100|IKR|||lyflausa|||0|30|0|10,0000|Actavis Group hf|Actavis hf|Íbúprófen|||||||1 116584|M01AE0102|Ibufen|töflur|400|mg|100|stk|1|glas||M01AE01|01.08.2008||R|1|0|0|0|G|0|ACA|0|0|1|100|XEU|673|1934|lyfalmen|V0562|1641|2|100|0|33,3333|Actavis Group hf|Actavis hf|Íbúprófen||590||590|1934|| 116595|M01AE0102|Ibufen|töflur|600|mg|30|stk|1|þpakki||M01AE01|01.07.2008||R|1|0|0|0|G|0|ACA|0|0|1|100|XEU|335|1565|lyfalmen|V0563|1565|2|30|0|15,0000|Actavis Group hf|Actavis hf|Íbúprófen||322||322|1565||1 116606|M01AE0102|Ibufen|töflur|600|mg|100|stk|1|glas||M01AE01|01.05.2008||R|1|0|0|0|G|0|ACA|0|0|1|100|XEU|806|2212|lyfalmen|V0564|2004|2|100|0|50,0000|Actavis Group hf|Actavis hf|Íbúprófen||792||792|2212||1 116694|G04BD1101|Toviaz|forðatfl|4|mg|84|stk|1|þpakki||G04BD11|01.11.2008||R|1|0|0|0|G|0|IPI|0|0|0|100|DKK|14048|20458|lyfalmen|||1|84|0|84,0000|Icepharma hf|Pfizer Limited|Fesóteródín||14048||14048|20458||1 116697|C09CA0602|Candpress|töflur|8|mg|100|stk|1|þpakki||C09CA06|01.01.2012||R|1|0|0|0|0|0|AGP|0|0|0|100|XEU|4745|5735|lyfalmen|V0081|5735|2|100|0|100,0000|Actavis Group hf|Actavis Group PTC ehf|Candesartan||3351||3351|5735||1 116705|G04BD1101|Toviaz|forðatfl|4|mg|28|stk|1|þpakki||G04BD11|01.11.2008||R|1|0|0|0|G|0|IPI|0|0|0|100|DKK|5475|8658|lyfalmen|||1|28|0|28,0000|Icepharma hf|Pfizer Limited|Fesóteródín||5475||5475|8658||1 116716|G04BD1101|Toviaz|forðatfl|8|mg|28|stk|1|þpakki||G04BD11|01.11.2008||R|1|0|0|0|G|0|IPI|0|0|0|100|DKK|5867|9198|lyfalmen|||1|28|0|56,0000|Icepharma hf|Pfizer Limited|Fesóteródín||5867||5867|9198||1 116727|G04BD1101|Toviaz|forðatfl|8|mg|84|stk|1|þpakki||G04BD11|01.11.2008||R|1|0|0|0|G|0|IPI|0|0|0|100|DKK|15060|21851|lyfalmen|||1|84|0|168,0000|Icepharma hf|Pfizer Limited|Fesóteródín||15060||15060|21851||1 116769|N06DX0108|Memantine Alvogen|munndr.t|20|mg|56|stk|1|þpakki||N06DX01|01.05.2014||R|0|0|0|0|G|0|IPC|0|0|0|100|DKK|10986|8666|lyfalmen|||2|56|0|56,0000|Alvogen|Alvogen IPco S.á.r.l.|Memantín||5481||5481|8666||1 116841|D07AC1302|Ovixan|húðlausn|0,1|%|30|ml|1|dropaí||D07AC13|01.08.2013||R|0|0|0|0|G|0|GAB|0|0|1|100|SEK|643|2007|lyfalmen|||2|30|0||Vistor hf|Galenica AB|Mómetasón||||643|2007||1 117408|QA12AX0001|Calcimag vet. Kela|irl|||500|ml|12|plastf||QA12AX|01.04.2004||R|0|0|0|0|0|0|KEL|1|0|0|100|XEU|8681|16640|vetalmen|||0|6000|0||Icepharma hf|Kela Laboratoria NV|Kalsíum í blöndum með D-vítamíni/eða öðrum efnum||8681||8681|16640||2 117424|M01AE0303|Orudis|forðahlk|100|mg|100|stk|1|glas||M01AE03|01.12.2014||R|1|0|0|0|G|0|SNO|0|0|1|100|NOK|1379|3020|lyfalmen|||1|100|0|66,6700|Vistor hf|Sanofi-aventis Norge AS|Ketóprófen||1379||1379|3020||1 117531|N04BA0201|Madopar|hylki|250|mg|100|stk|1|glas|200+50 mg|N04BA02|01.07.1974||R|1|0|0|0|G|0|ROC|0|0|0|100|DKK|3916|6512|lyfalmen|V0435|6397|1|100|0|33,3333|Icepharma hf|Roche|Levódópa og dópadekarboxýl­asa­hemill||3916||3916|6512||2 117550|N05AH0405|Seroquel Prolong|forðatfl|50|mg|100|stk|1|þpakki||N05AH04|01.12.2008||R|1|1|0|0|0|0|ASZ|0|0|0|100|SEK|12611|16223|lyfalmen|V0275|13235|1|100|0|12,5000|Vistor hf|AstraZeneca UK Ltd|Quetíapín||10971||10971|16223||1 117561|N05AH0405|Seroquel Prolong|forðatfl|200|mg|100|stk|1|þpakki||N05AH04|01.12.2008||R|1|1|0|0|G|0|ASZ|0|0|0|100|SEK|22288|27813|lyfalmen|V0273|23842|1|100|0|50,0000|Vistor hf|AstraZeneca UK Ltd|Quetíapín||19392||19392|27813||1 117564|N04BA0201|Madopar|hylki|62,5|mg|100|stk|1|glas|50+12.5 mg|N04BA02|01.06.1981||R|1|0|0|0|G|0|ROC|0|0|0|100|DKK|1314|2931|lyfalmen|||1|100|0|8,3333|Icepharma hf|Roche|Levódópa og dópadekarboxýl­asa­hemill||1314||1314|2931||2 117584|N05AH0405|Seroquel Prolong|forðatfl|300|mg|100|stk|1|þpakki||N05AH04|01.12.2008||R|1|1|0|0|G|0|ASZ|0|0|0|100|SEK|35338|42060|lyfalmen|V0272|33688|1|100|0|75,0000|Vistor hf|AstraZeneca UK Ltd|Quetíapín||31119||31119|42060||1 117595|N05AH0405|Seroquel Prolong|forðatfl|400|mg|100|stk|1|þpakki||N05AH04|01.12.2008||R|1|1|0|0|G|0|ASZ|0|0|0|100|SEK|44577|59082|lyfalmen|V0261|43174|1|100|0|100,0000|Vistor hf|AstraZeneca UK Ltd|Quetíapín||||44577|59082||1 117676|L01DB0103|Caelyx|irþ|2|mg/ml|10|ml|1|hgl||L01DB01|01.01.2011||R|0|0|0|1|0|1|JCI|0|1|0|100|SEK|50773|66918|lyfsjukr|||1|10|0||Vistor hf|Janssen-Cilag International N.V.|Doxórúbicín||50773||50773|66918||1 117770|QP51AJ0101|Baycox Vet.|mixtúra|50|mg/ml|250|ml|1|fl||QP51AJ01|01.12.2005||R|0|0|0|0|0|0|BAN|0|0|0|100|DKK|8630|14875|vetorma|||0|250|0||Icepharma hf|Bayer Animal Health GmbH|||8630||8630|14875||2 117929|QA12AA0301|Calci-kel vet. Kela|irl|20,8|mg/ml|100|ml|12|fl||QA12AA03|01.04.2004||R|0|0|0|0|0|0|KEL|0|0|0|100|NOK|5329|10281|vetalmen|||0|1200|0||Icepharma hf|Kela Laboratoria NV|Kalsíum glúkónat||5329||5329|10281||2 117937|QA12AA0301|Calci-kel vet. Kela|irl|20,8|mg/ml|500|ml|12|plastf||QA12AA03|01.04.2004||R|0|0|0|0|0|0|KEL|0|0|0|100|XEU|10280|19674|vetalmen|||0|6000|0||Icepharma hf|Kela Laboratoria NV|Kalsíum glúkónat||10280||10280|19674||2 118020|N05AH0306|Olanzapin Actavis|filmhtfl|2,5|mg|28|stk|1|þpakki||N05AH03|01.05.2008||R|1|0|0|0|G|0|AGP|0|0|0|100|XEU|1607|3334|lyfalmen|V0278|2563|2|28|0|7,0000|Actavis Group hf|Actavis Group PTC ehf|Olanzapín||1607||1607|3334||1 118043|N05AH0306|Olanzapin Actavis|filmhtfl|5|mg|28|stk|1|þpakki||N05AH03|01.04.2008||R|1|0|0|0|G|0|AGP|0|0|0|100|XEU|2635|4009|lyfalmen|V0279|2631|2|28|0|14,0000|Actavis Group hf|Actavis Group PTC ehf|Olanzapín||2097||2097|4009||1 118076|N05AH0306|Olanzapin Actavis|filmhtfl|10|mg|56|stk|1|þpakki||N05AH03|01.03.2008||R|1|0|0|0|G|0|AGP|0|0|0|100|XEU|8998|2991|lyfalmen|V0282|2991|2|56|0|56,0000|Actavis Group hf|Actavis Group PTC ehf|Olanzapín||1358||1358|2991||1 118087|N05AH0306|Olanzapin Actavis|filmhtfl|15|mg|28|stk|1|þpakki||N05AH03|01.04.2008||R|1|0|0|0|G|0|AGP|0|0|0|100|XEU|1553|3260|lyfalmen|V0283|2767|2|28|0|42,0000|Actavis Group hf|Actavis Group PTC ehf|Olanzapín||1553||1553|3260||1 118231|N01AX1301|Niontix|lyfjagas|100|%|4|l|1|hylki||N01AX13|01.06.2008||R|0|0|0|0|0|1|AGA|0|0|0|100|IKR|9512|14215|lyfsjukr|||1|4|0||Ísaga ehf|AGA AB|di-Nitrogen oxíð||9512||9512|14215||5 118307|A02BA0201|Asyran|töflur|150|mg|30|stk|1|þpakki||A02BA02|01.04.1994||L|1|0|0|0|0|0|ACA|0|0|0|100|IKR|||lyflausa|||0|30|0|15,0000|Actavis Group hf|Actavis hf|Ranitidín|||||||1 118484|N05AH0306|Olanzapin Actavis|filmhtfl|7,5|mg|56|stk|1|þpakki||N05AH03|01.04.2008||R|1|0|0|0|G|0|AGP|0|0|0|100|XEU|8394|5224|lyfalmen|V0280|4141|2|56|0|42,0000|Actavis Group hf|Actavis Group PTC ehf|Olanzapín||2980||2980|5224||1 118575|QM01AH9201|Trocoxil|tuggutfl|75|mg|2|stk|1|þpakki||QM01AH92|01.11.2014||R|0|0|0|0|0|0|ZBE|0|0|0|100|DKK|4782|9243|vetalmen|||0|2|0||Icepharma hf|Zoetis Belgium S.A.|Mavakoxíb||4782||4782|9243||2 118612|A07EC0203|Pentasa Sachets|forðakyr|1|g|150|stk|1|pakki|3 x 50 stk|A07EC02|01.04.1998||R|0|0|0|0|G|0|FER|0|0|0|100|DKK|19464|27912|lyfalmen|||1|150|0|100,0000|Vistor hf|Ferring|Mesalazín (5-amínósalicýlsýra)||19464||19464|27912||1 118658|L01AA0101|Sendoxan|sts|500|mg|1|stk|1|hgl||L01AA01|01.06.2014||R|0|0|0|1|0|1|BAM|0|0|0|100|SEK|2867|5068|lyfsjukr|||1|1|0||Icepharma hf|Baxter Medical AB|Cýklófosfamíð||2867||2867|5068||2 118793|C01AA0504|Lanoxin mite|töflur|62,5|mcg|120|stk|1|þpakki||C01AA05|01.12.2010||R|1|0|0|0|G|0|APP|0|0|0|100|XEU|434|1720|lyfalmen|||1|120|0|30,0000|Artasan ehf|Aspen Pharma Trading Limited|Digoxín||434||434|1720||1 118967|C03DA0405|Eplerenon Actavis|filmhtfl|25|mg|30|stk|1|þpakki||C03DA04|01.09.2015||R|1|0|0|0|0|0|AGP|0|0|0|100|XEU|6488|4183|lyfalmen|V0107|4091|2|30|0|15,0000|Actavis Group hf|Actavis Group PTC ehf|Eplerenón||2224||2224|4183||1 119394|C07AG0101|Trandate|filmhtfl|100|mg|50|stk|1|glas||C07AG01|01.04.2013||R|1|0|0|0|G|0|APP|0|0|0|100|GBP|1269|2869|lyfalmen|||1|50|0|8,3333|Artasan ehf|Aspen Pharma Trading Limited|Labetalól||1269||1269|2869||1 119825|N05BA1206|Alprazolam Krka|forðatfl|1|mg|30|stk|1|þpakki||N05BA12|01.08.2012||R|1|0|0|0|0|0|KRK|0|0|1|100|XEU|855|1956|lyfalmen|V0309|1956|2|30|0|30,0000|LYFIS ehf|Krka Sverige AB|Alprazólam||606||606|1956||2 119984|C02KX0201|Volibris|filmhtfl|5|mg|30|stk|1|þpakki||C02KX02|01.12.2008||R|1|1|0|1|0|1|RGO|0|1|0|100|GBP|347160|437350|lyfsjukr|||1|30|0|20,0000|Vistor hf|Glaxo Group Limited|Ambrisentanum||347160||347160|437350||1 120007|C02KX0201|Volibris|filmhtfl|10|mg|30|stk|1|þpakki||C02KX02|01.12.2008||R|1|1|0|1|0|1|RGO|0|1|0|100|GBP|310529|391791|lyfsjukr|||1|30|0|40,0000|Vistor hf|Glaxo Group Limited|Ambrisentanum||310529||310529|391791||1 120022|S01FA0401|Cyclogyl 1 %|augndr|10|mg/ml|10|ml|1|glas||S01FA04|01.10.2003||R|0|0|0|0|G|0|SAC|0|0|0|100|USD|998|2496|lyfalmen|||1|10|0||Vistor hf|S.A. Alcon - Couvreur N.V.|Cýklópentólat||998||998|2496||1 120062|L01BA0401|Alimta|irþ|100|mg/hgl|1|hgl|1|pakki||L01BA04|01.11.2008||R|0|0|0|1|0|1|LIL|0|1|0|100|XEU|38130|50928|lyfsjukr|||1|1|0||Icepharma hf|Lilly ICOS Limited|Pemetrexed||38130||38130|50928||2 120596|QJ01CA0401|Clamoxyl, vet.|töflur|200|mg|10|stk|1|þpakki||QJ01CA04|01.02.2016||R|0|0|0|0|0|0|ZOE|0|0|0|100|DKK|888|1745|vetalmen|||0|10|0||Icepharma hf|Zoetis Finland OY|||||888|1745||2 120768|C10AA0703|Rosuvastatin Krka|filmhtfl|20|mg|100|stk|1|þpakki||C10AA07|01.03.2015||R|1|0|0|0|0|0|KRK|0|0|0|100|IKR|10373|11308|lyfalmen|V0118|11308|2|100|0|200,0000|LYFIS ehf|Krka Sverige AB|Rósuvastatín||7400||7400|11308||2 120798|H01AC0111|Omnitrope|stl|6,7|mg/ml|1,5|ml|1|rörlyk|lausn|H01AC01|01.04.2012||R|0|0|0|1|0|1|SDG|0|1|0|100|DKK|26031|35625|lyfsjukr|||1|1,5|0|15,0000|Artasan ehf|Sandoz GmbH (Kundl)|Sómatrópín||26031||26031|35625||1 121104|L01XC1401|Kadcyla|irþ|160|mg|1|hgl|1|pakki||L01XC14|01.06.2014||R|0|1|0|1|0|1|RRL|0|1|0|100|DKK|402232|505844|lyfsjukr|||1|1|0||Icepharma hf|Roche Registration Limited|Trastuzumab emtansine||402232||402232|505844||2 121164|A02BC0501|Nexium|mixt.kyr|10|mg|28|sk-pokar|1|pakki|dreifa|A02BC05|01.04.2009||R|0|0|0|0|0|0|AZD|0|0|0|100|SEK|4367|7133|lyfalmen|||1|28|0|9,3300|Vistor hf|AstraZeneca A/S DK|Esómeprazól||4367||4367|7133||1 121286|M03AC0901|Esmeron|stl|10|mg/ml|5|ml|10|hgl||M03AC09|01.04.2009||R|0|0|0|0|0|1|ORG|0|0|0|100|DKK|6819|10508|lyfsjukr|||1|50|0||Vistor hf|N.V. Organon|Rókúrón, brómíð||6819||6819|10508||1 121302|N02BA5102|Treo|freyðit|||60|stk|1|glas||N02BA51|01.12.2012||L|0|0|0|0|0|0|MAB|0|0|1|100|IKR|||lyflausa|||0|60|0|10,0000|Vistor hf|Meda AB|Acetýlsalicýlsýra í blöndum, þó ekki með geðlyfjum (psychole|||||||1 121327|R03AC0204|Ventolin|innúðal|0,1|mg/sk|200|skammtar|1|stauk|dreifa|R03AC02|01.12.1972||R|0|0|0|0|G|0|GPH|0|0|1|100|IKR|432|1717|lyfalmen|||1|200|0|25,0000|Vistor hf|GlaxoSmithKline Pharma A/S|Salbútamól||432||432|1717||1 121562|B03BB0104|Folic Acid|töflur|5|mg|28|stk|1|þpakki||B03BB01|01.01.2008||R|1|0|0|0|G|0|AUK|0|0|1|100|GBP|437|1724|lyfalmen|||2|28|0|350,0000|Actavis Group hf|Actavis UK Ltd.|Fólínsýra||437||437|1724||1 121582|N06AA0401|Anafranil|töflur|25|mg|100|stk|1|þpakki||N06AA04|01.03.1977||R|1|0|0|0|G|0|HES|0|0|0|100|DKK|1515|3207|lyfalmen|||1|100|0|25,0000|Vistor hf|Novartis Healthcare A/S|Klómípramín||1515||1515|3207||1 121691|H02AB0605|Prednisolone Actavis|töflur|1|mg|28|stk|1|þpakki||H02AB06|01.01.2011||R|1|0|0|0|G|0|AUK|0|0|1|100|GBP|292|1524|lyfalmen|||2|28|0|2,8000|Actavis Group hf|Actavis UK Ltd.|Prednisólón||292||292|1524||1 121912|L01BA0110|Metojectpen|stl|25|mg|1|áf-penni|1|pakki||L01BA01|01.05.2016||R|0|0|0|1|G|0|WIL|0|0|0|100|XEU|3295|5657|lyfalmen|||1|1|0||Williams & Halls efh|medac Gesellschaft|Metótrexat||3295||3295|5657||2 122301|R01AD0802|Nasofan|nefúði|50|mcg/sk|60|skammtar|1|glas||R01AD08|01.05.2014||L|0|0|0|0|0|0|TSB|0|0|1|100|IKR|||lyflausa|||2|60|0|15,0000|Medical ehf|Teva Sweden AB|Flútíkasón||||||29.2.2016|2 122354|N05AX1209|Aripiprazole Sandoz|töflur|5|mg|56|stk|1|þpakki||N05AX12|01.04.2016||R|1|1|0|0|0|0|HSS|0|0|0|100|DKK|15340|20806|lyfalmen|V0682|20512|2|56|0|18,6600|Artasan ehf|Sandoz GmbH|Aripiprazól||14301||14301|20806||1 122411|QI09AA0701|Ingelvac CircoFLEX|stl|||50|ml|1|hgl|dreifa|QI09AA07|01.12.2010||R|0|0|0|0|0|0|BIV|0|0|0|100|DKK|9016|15540|vetorma|||0|50|0||Vistor hf|Boehringer Ingelheim Vetmedica GmbH|Porcine circovirus Type ORF-2 protein||9016||9016|15540||1 122471|L01XE1301|Giotrif|filmhtfl|30|mg|28|stk|1|þpakki||L01XE13|01.05.2016||R|0|0|0|1|0|1|BOE|0|0|0|100|DKK|263689|333535|lyfsjukr|||1|28|0||Vistor hf|Boehringer Ingelheim International GmbH|Afatiníb||263689||263689|333535||1 122547|N07BC0202|Metadon Abcur|töflur|5|mg|20|stk|1|þpakki||N07BC02|01.10.2013||R|1|0|1|0|G|0|ABC|0|0|0|100|SEK|558|1890|lyfalmen|||1|20|0|5,0000|Icepharma hf|Abcur AB|Metadón||558||558|1890||2 123216|N05BA0105|Stesolid|eþ-stíll|5|mg|10|stk|1|pakki||N05BA01|01.07.2005||R|0|0|0|0|0|0|AGT|0|0|1|100|DKK|763|2172|lyfalmen|||2|10|0|5,0000|Actavis Group hf|Actavis Group hf|Díazepam||763||763|2172||1 123224|N05BA0105|Stesolid|eþ-stíll|10|mg|10|stk|1|pakki||N05BA01|01.07.2005||R|0|0|0|0|0|0|AGT|0|0|1|100|DKK|1260|2856|lyfalmen|||2|10|0|10,0000|Actavis Group hf|Actavis Group hf|Díazepam||1260||1260|2856||1 123256|QP52AA5104|Zantel|töflur|550|mg|100|stk|1|þpakki|50+500 mg|QP52AA51|01.07.2011||R|0|0|0|0|0|0|ICE|0|0|0|100|USD|27392|47213|vetorma|||0|100|0||Icepharma hf|Icepharma hf|||27392||27392|47213||2 123456|R03DX0701|Daxas|filmhtfl|500|mcg|90|stk|1|þpakki||R03DX07|01.10.2013||R|0|1|0|0|0|0|TAK|0|0|0|100|DKK|18992|27263|lyfalmen|||1|90|0|90,0000|Vistor hf|Takeda GmbH|Roflumílast||18992||18992|27263||1 123493|C10AA0506|Atorvaratio|filmhtfl|80|mg|100|stk|1|þpakki||C10AA05|01.07.2014||R|1|0|0|0|0|0|TSB|0|0|0|100|IKR|7844|11919|lyfalmen|V0115|11919|2|100|0|400,0000|Medical ehf|Teva Sweden AB|Atorvastatín||7844||7844|11919||2 123641|QP51AJ0102|Baycox Sheep vet.|mixtúra|50|mg/ml|1000|ml|1|glas||QP51AJ01|01.03.2014||R|0|0|0|0|0|0|BAN|0|0|0|100|DKK|28309|48793|vetorma|||0|1000|0||Icepharma hf|Bayer Animal Health GmbH|||28309||28309|48793||2 123806|C07AA0512|Pranolol|töflur|20|mg|100|stk|1|glas||C07AA05|01.09.2011||R|1|0|0|0|G|0|AGT|0|0|0|100|XEU|261|1481|lyfalmen|||2|100|0|12,5000|Actavis Group hf|Actavis Group hf|Própranólól||||261|1481||1 123992|N07XX0201|Rilutek|töflur|50|mg|56|stk|1|þpakki||N07XX02|01.05.1998||R|1|0|0|1|G|0|AVS|0|0|0|100|NOK|20835|29053|lyfalmen|V0579|27025|1|56|0|28,0000|Vistor hf|Aventis Pharma SA|Rílúzól||20835||20835|29053||1 124020|QM01AC0603|Rheumocam|mixtúra|1,5|mg/ml|42|ml|1|plastf||QM01AC06|01.08.2009||R|0|0|0|0|0|0|CHP|0|0|0|100|XEU|1617|3178|vetalmen|||0|42|0||Icepharma hf|Chanelle Pharmaceuticals|||||1617|3178||2 124119|B01AC0401|Plavix|töflur|300|mg|30|stk|1|þpakki||B01AC04|01.09.2009||R|1|0|0|0|0|0|SNC|0|0|0|100|NOK|27613|37626|lyfalmen|||1|30|0|120,0000|Vistor hf|Sanofi Clir SNC|Klópídógrel||||27613|37626||1 124168|N07BC0202|Metadon Abcur|töflur|20|mg|100|stk|1|þpakki||N07BC02|01.10.2013||R|1|0|1|0|G|0|ABC|0|0|0|100|SEK|8860|13317|lyfalmen|||1|100|0|100,0000|Icepharma hf|Abcur AB|Metadón||8860||8860|13317||2 124207|N02CC0105|Sumatriptan Bluefish|töflur|100|mg|6|stk|1|þpakki||N02CC01|01.04.2012|31.03.2016|R|1|0|0|0|G|0|BLP|0|0|0|100|XEU|1716|1929|lyfalmen|||2|6|0|12,0000|LYFIS ehf|Bluefish Pharmaceuticals AB|Súmatriptan||586||586|1929||2 124251|N02CC0105|Sumatriptan Bluefish|töflur|50|mg|12|stk|1|þpakki||N02CC01|01.04.2012|31.03.2016|R|1|0|0|0|G|0|BLP|0|0|0|100|XEU|2450|2194|lyfalmen|||2|12|0|12,0000|LYFIS ehf|Bluefish Pharmaceuticals AB|Súmatriptan||779||779|2194||2 124354|G02AB0101|Methergin|töflur|0,125|mg|30|stk|1|þpakki||G02AB01|01.03.1980||R|1|0|0|0|G|0|HES|0|0|0|100|DKK|888|2344|lyfalmen|||1|30|0|18,7500|Vistor hf|Novartis Healthcare A/S|Metýlergómetrín||888||888|2344||1 124727|C09AA0201|Daren|töflur|10|mg|30|stk|1|þpakki||C09AA02|01.01.1994||R|1|0|0|0|G|0|ACA|0|0|0|100|XEU|415|1693|lyfalmen|||2|30|0|30,0000|Actavis Group hf|Actavis hf|Enalapríl||415||415|1693||1 124870|S01ED5110|Duotrav|augndr|||2,5|ml|3|glas|40 mcg/ml+5 mg/ml|S01ED51|01.10.2011||R|0|0|0|0|G|0|ALA|0|0|0|100|USD|9764|14561|lyfalmen|V0464|14561|1|7,5|0|75,0000|Vistor hf|Alcon Laboratories Ltd.|Tímólól í blöndum||9764||9764|14561||1 125054|C09AA0201|Daren|töflur|10|mg|100|stk|1|þpakki||C09AA02|01.01.1994||R|1|0|0|0|G|0|ACA|0|0|0|100|XEU|908|2372|lyfalmen|V0066|2361|2|100|0|100,0000|Actavis Group hf|Actavis hf|Enalapríl||908||908|2372||1 125125|L01AA0301|Alkeran|töflur|2|mg|25|stk|1|glas||L01AA03|01.06.2013||R|0|0|0|1|G|0|APP|0|0|0|100|XEU|11273|16638|lyfalmen|||1|25|0||Artasan ehf|Aspen Pharma Trading Limited|Melphalan||11273||11273|16638||1 125457|N05AH0411|Quetiapine Teva|filmhtfl|100|mg|100|stk|1|þpakki||N05AH04|01.09.2014||R|1|0|0|0|G|0|TSB|0|0|0|100|IKR|4400|4150|lyfalmen|V0285|4103|2|100|0|25,0000|Medical ehf|Teva Sweden AB|Quetíapín||2200||2200|4150||2 126540|J01GB0303|Gentacoll|vefjasv|1,3|mg/fercm|1|stk|1|pakki|10X10 cm|J01GB03|01.10.1995||R|0|0|0|0|0|1|EUS|0|0|0|100|XEU|22509|31170|lyfsjukr|||1|1|0|0,5417|EUSA Pharma (Europe) Ltd.|EUSA Pharma (Europe) Ltd|Gentamícín||22509||22509|31170||2 126649|J01GB0303|Gentacoll|vefjasv|1,3|mg/fercm|1|stk|1|pakki|5X5 cm|J01GB03|01.10.1995||R|0|0|0|0|0|1|EUS|0|0|0|100|XEU|7503|11449|lyfsjukr|||1|1|0|0,1354|EUSA Pharma (Europe) Ltd.|EUSA Pharma (Europe) Ltd|Gentamícín||7503||7503|11449||2 126684|J06BA0208|Privigen|irl|100|mg/ml|50|ml|1|hgl||J06BA02|01.10.2009||R|0|0|0|0|0|1|CSB|0|1|0|100|SEK|31893|43039|lyfsjukr|||1|50|0||Icepharma hf|CSL Behring GmbH|Immúnóglóbúlín, normal, manna, gefin í æð||31893||31893|43039||2 126695|J06BA0208|Privigen|irl|100|mg/ml|100|ml|1|hgl||J06BA02|01.10.2009||R|0|0|0|0|0|1|CSB|0|1|0|100|SEK|63786|83377|lyfsjukr|||1|100|0||Icepharma hf|CSL Behring GmbH|Immúnóglóbúlín, normal, manna, gefin í æð||63786||63786|83377||2 126707|J06BA0208|Privigen|irl|100|mg/ml|200|ml|1|hgl||J06BA02|01.10.2009||R|0|0|0|0|0|1|CSB|0|1|0|100|SEK|127573|164245|lyfsjukr|||1|200|0||Icepharma hf|CSL Behring GmbH|Immúnóglóbúlín, normal, manna, gefin í æð||127573||127573|164245||2 126803|S01LA0501|Eylea|stl|40|mg/ml|1|hgl|1|pakki|lausn|S01LA05|01.10.2013||R|0|1|0|1|0|1|BGB|0|1|0|100|DKK|120471|155412|lyfsjukr|||1|1|0||Icepharma hf|Bayer Pharma AG|Aflibercept||120471||120471|155412||2 126926|B01AF0101|Xarelto|filmhtfl|15|mg|100|stk|1|þpakki||B01AF01|01.05.2012||R|1|1|0|0|G|0|BAP|0|0|0|100|DKK|30482|41254|lyfalmen|||1|100|0|75,0000|Icepharma hf|Bayer Schering Pharma AG|Rivaoxaban||||30482|41254||2 126949|S01BC1001|Nevanac|augndr|3|mg/ml|3|ml|1|glas||S01BC10|01.02.2014||R|0|0|0|0|G|0|ALA|0|0|1|100|USD|3227|5564|lyfalmen|||1|3|0||Vistor hf|Alcon Laboratories Ltd.|Nepafenak||||3227|5564||1 127362|A02BC0508|Esomeprazol Actavis|sþ-tfl|20|mg|100|stk|1|glas||A02BC05|01.02.2015||R|1|0|0|0|G|0|APC|0|0|0|100|XEU|3694|5393|lyfalmen|V0011|5393|2|100|0|66,6700|Actavis Group PTC ehf|Actavis Group PTC ehf|Esómeprazól||3103||3103|5393||1 127383|R02AA0302|Strepsils med honning og citron|sogtfl|||36|stk|1|þpakki||R02AA03|01.01.2009||L|0|0|0|0|0|0|RBH|0|0|1|100|IKR|||lyflausa|||0|36|0|6,0000|Artasan ehf|Reckitt Benckiser Healthcare Ltd.-A|Díklórbenzýlalkóhól|||||||1 127542|G04BE0307|Sildenafil Mylan|filmhtfl|100|mg|4|stk|1|þpakki||G04BE03|01.08.2013|31.03.2016|R|1|0|0|0|0|0|MYL|0|0|0|100|SEK|1591|2355|lyfalmen|||2|4|0|8,0000|Icepharma hf|Mylan AB|Síldenafíl||896||896|2355||2 127881|N07BA0149|Nicovel Mint|tyggigúm|2|mg|24|stk|1|þpakki||N07BA01|01.02.2013||L|0|0|0|0|0|0|ORI|0|0|1|100|IKR|||lyflausa|||0|24|0|1,6000|Artasan ehf|Orifarm Generics A/S|Nikótín|||||||1 128003|N05CF0205|Zovand|töflur|10|mg|100|stk|1|þpakki||N05CF02|01.04.2015||R|1|0|0|0|0|0|WEH|0|0|0|100|IKR|1644|2595|lyfalmen|V0313|2595|2|100|0|100,0000|Williams & Halls efh|Williams & Halls ehf|Zolpidem||1070||1070|2595||2 128034|N02AA5908|Paracetamol/Kodein Actavis|filmhtfl|1060|mg|10|stk|1|þpakki|60+1000 mg|N02AA59|01.10.2015||R|1|0|0|0|0|0|AGP|0|0|1|100|XEU|593|1938|lyfalmen|V0206|1377|2|10|0|6,6700|Actavis Group hf|Actavis Group PTC ehf|Kódein í blöndum nema með geðlyfjum||593||593|1938||1 128058|N05AH0301|Zyprexa|húðuðtfl|5|mg|28|stk|1|þpakki||N05AH03|01.03.1998||R|1|0|0|0|G|0|ELD|0|0|0|100|XEU|6544|5785|lyfalmen|V0279|2631|1|28|0|14,0000|Icepharma hf|Eli Lilly Nederland B.V.|Olanzapín||3388||3388|5785||2 128131|QG51AG0101|Sulfa-Streptocillin vet.|legstíl|||30|stk|1|þpakki||QG51AG01|01.03.2009||R|0|0|0|0|0|0|BID|1|0|0|100|DKK|12834|24519|vetalmen|||0|30|0||Vistor hf|Boehringer Ingelheim Danmark|Súlfónamíðar í blöndu með öðrum lyfjum||12834||12834|24519||1 128146|N06DX0108|Memantine Alvogen|munndr.t|10|mg|56|stk|1|þpakki||N06DX01|01.05.2014||R|0|0|0|0|G|0|IPC|0|0|0|100|DKK|4439|4368|lyfalmen|||2|56|0|28,0000|Alvogen|Alvogen IPco S.á.r.l.|Memantín||2358||2358|4368||1 128348|C03AB0102|Centyl mite med kaliumklorid|töflur|||100|stk|1|glas||C03AB01|01.05.1999||R|1|0|0|0|G|0|LEP|0|0|0|100|DKK|1094|2628|lyfalmen|||1|100|0|50,0000|Vistor hf|LEO Pharma A/S|Bendróflúmetíazíð og kalíum||1094||1094|2628||1 128625|J07BA0102|FSME-Immun Vuxen|stl|2,4|mcg/sk|0,5|ml|1|spr|bóluefni|J07BA01|01.06.2015||R|0|0|0|0|0|0|PIS|0|0|0|100|SEK|3685|6194|lyfalmen|||1|0,5|0||Icepharma hf|Pfizer ApS|Heilabólguveira óvirk, borin með blóðmaur||3685||3685|6194||2 129024|A02BC0403|Rabeprazol Krka|sþ-tfl|20|mg|28|stk|1|þpakki||A02BC04|01.03.2014||R|0|0|0|0|0|0|KRK|0|0|0|100|IKR|2500|2223|lyfalmen|V0003|1662|2|28|0|28,0000|LYFIS ehf|Krka Sverige AB|Rabeprazól||800||800|2223||2 129106|N05AH0301|Zyprexa|húðuðtfl|10|mg|56|stk|1|þpakki||N05AH03|01.03.1998||R|1|0|0|0|G|0|ELD|0|0|0|100|XEU|25748|21211|lyfalmen|V0282|2991|1|56|0|56,0000|Icepharma hf|Eli Lilly Nederland B.V.|Olanzapín||14595||14595|21211||2 129158|H02AB0605|Prednisolone Actavis|töflur|5|mg|28|stk|1|þpakki||H02AB06|01.02.2011||R|1|0|0|0|G|0|AUK|0|0|1|100|GBP|213|1415|lyfalmen|||2|28|0|14,0000|Actavis Group hf|Actavis UK Ltd.|Prednisólón||213||213|1415||1 129188|V03AE0204|Sevelamerkarbonat WH|filmhtfl|800|mg|180|stk|1|glas||V03AE02|01.03.2016||R|1|1|0|0|0|0|WEH|0|0|0|100|XEU|20090|25734|lyfalmen|V0680|25734|2|180|0|22,5000|Williams & Halls efh|Williams & Halls ehf|Sevelamer||17881||17881|25734||2 129291|A02BC0113|Omeprazol Sandoz|sþ-hylki|40|mg|100|stk|1|glas||A02BC01|01.10.2015||R|1|0|0|0|G|0|SHS|0|0|0|100|DKK|4784|2643|lyfalmen|V0001|2643|2|100|0|200,0000|Artasan ehf|Sandoz A/S|Ómeprazól||1105||1105|2643||1 129668|A02AH0002|Natriumbikarbonat|töflur|1|g|100|stk|1|glas||A02AH|01.08.2005||L|1|0|0|0|0|0|REP|0|0|0|100|SEK|||lyfalmen|||0|100|0||Vistor hf|Recip AB|Natríumhýdrógenkarbonat|||||3034||1 129817|R03BB0101|Atrovent|innúðal|0,25|mg/ml|60|plastl|1|pakki|í vél|R03BB01|01.04.1989||R|0|0|0|0|G|0|BOI|0|0|0|100|DKK|2972|5213|lyfalmen|||1|60|0|100,0000|Vistor hf|Boehringer Ingelheim|Ípratrópíumbrómíð||2972||2972|5213||1 129936|N06BA0406|Medikinet CR|hylki|50|mg|30|stk|1|þpakki|með breyttan losunarhraða|N06BA04|01.01.2015||R|1|1|1|0|0|0|PUT|0|0|0|100|IKR|9929|14788|lyfalmen|||2|30|0|50,0000|LYFIS ehf|Medice Arzneimittel Putter GmbH|Metýlfenídat||9929||9929|14788||2 130286|C01CA2406|Adrenalin Mylan|stl|1|mg/ml|1|ml|10|gl-lyk||C01CA24|01.06.2009||R|0|0|0|0|0|0|MYL|0|0|1|100|SEK|1983|3852|lyfalmen|||2|10|0|20,0000|Icepharma hf|Mylan AB|Adrenalín tartrat||1983||1983|3852||2 130397|QH01CA9301|Suprelorin|vefjalyf|4,7|mg|2|stk|1|pakki|fyrir hunda|QH01CA93|01.05.2012||R|0|0|0|0|0|0|VIR|1|0|0|100|XEU|15360|29311|vetalmen|||0|2|0||Vistor hf|Virbac S.A|Deslorelín||15360||15360|29311||1 130591|A03BA0103|Atropin Mylan|stl|0,5|mg/ml|1|ml|10|gl-lyk||A03BA01|01.06.2009||R|0|0|0|0|0|0|MYL|0|0|1|100|SEK|1550|3256|lyfalmen|||2|10|0|3,3400|Icepharma hf|Mylan AB|Atrópínsúlfat||1550||1550|3256||2 130596|N07BA0301|Champix|filmhtfl|||53|stk|1|þpakki|0,5 mg og 1 mg|N07BA03|01.02.2009||R|0|0|0|0|0|0|IPI|0|0|1|100|DKK|10098|15021|lyfalmen|||1|53|0|23,7500|Icepharma hf|Pfizer Limited|Vareniclin||||10098|15021||1 130772|QI10AB0201|Alpha Ject 3000|stl|||500|ml|1|plpoki||QI10AB02|01.05.2009||R|0|0|0|0|0|0|PHA|0|0|0|100|NOK|46707|75292|veteldis|||0|500|0||Vistor hf|PHARMAQ AS|Aeromónas+Vibrio||||46707|75292||1 131136|C01CA2601|Efedrin Mylan|stl|50|mg/ml|1|ml|10|gl-lyk||C01CA26|01.06.2009||R|0|0|0|0|0|0|MYL|0|0|0|100|SEK|2842|5034|lyfalmen|||2|10|0|10,0000|Icepharma hf|Mylan AB|Efedrínhýdróklóríð||||2842|5034||2 131334|N03AB0205|Fenantoin Recip|töflur|100|mg|100|stk|1|glas||N03AB02|01.06.2004||R|1|0|0|0|G|0|REP|0|0|0|100|SEK|401|1674|lyfalmen|||2|100|0|33,3333|Vistor hf|Recip AB|Fenýtóín||401||401|1674||1 131383|N03AA0204|Fenemal Recip|töflur|15|mg|100|stk|1|glas||N03AA02|01.06.2004||R|1|0|0|0|G|0|REP|0|0|0|100|SEK|631|1991|lyfalmen|||2|100|0|15,0000|Vistor hf|Recip AB|Fenemal||631||631|1991||1 131417|N03AA0204|Fenemal Recip|töflur|50|mg|100|stk|1|glas||N03AA02|01.06.2004||R|1|0|0|0|G|0|REP|0|0|0|100|SEK|841|2280|lyfalmen|||2|100|0|50,0000|Vistor hf|Recip AB|Fenemal||841||841|2280||1 131441|N03AA0204|Fenemal Recip|töflur|100|mg|100|stk|1|glas||N03AA02|01.06.2004||R|1|0|0|0|G|0|REP|0|0|0|100|SEK|931|2404|lyfalmen|||2|100|0|100,0000|Vistor hf|Recip AB|Fenemal||931||931|2404||1 131740|N07BA0132|Nicorette Microtab Lemon|tungur.t|2|mg|90|stk|1|þpakki||N07BA01|01.10.2008||L|0|0|0|0|0|0|MCN|0|0|1|100|IKR|||lyflausa|||0|90|0|6,0000|Vistor hf|McNeil Denmark ApS|Nikótín|||||||1 132260|N06DA0404|Galantamine Portfarma|forðahlk|8|mg|28|stk|1|þpakki||N06DA04|01.12.2011||R|1|0|0|0|G|0|POF|0|0|0|100|SEK|3783|6329|lyfalmen|||2|28|0|14,0000|Alvogen|Alvogen|Galantamín||3783||3783|6329||1 132361|C09DA0309|Valpress Comp|filmhtfl|172,5|mg|98|stk|1|þpakki||C09DA03|01.10.2008||R|1|0|0|0|G|0|AGP|0|0|0|100|XEU|4689|2932|lyfalmen|V0581|2774|2|98|0|98,0000|Actavis Group hf|Actavis Group PTC ehf|Valsartan og þvagræsilyf||1315||1315|2932||1 132372|C09DA0309|Valpress Comp|filmhtfl|92,5|mg|98|stk|1|þpakki||C09DA03|01.10.2008||R|1|0|0|0|G|0|AGP|0|0|0|100|XEU|2915|2932|lyfalmen|V0580|2774|2|98|0|98,0000|Actavis Group hf|Actavis Group PTC ehf|Valsartan og þvagræsilyf||1315||1315|2932||1 132494|M01AX0503|Glucosamin LYFIS|mixtduft|1178|mg|30|skpokar|1|pakki||M01AX05|01.05.2016||L|0|0|0|0|0|0|LYF|0|0|1|100|IKR|||lyflausa|||0|30|0|30,0000|LYFIS ehf|LYFIS ehf|Glúkósamín|||||||2 132546|A06AX0401|Constella|hylki|290|mcg|28|stk|1|glas||A06AX04|01.05.2013||R|0|0|0|0|G|0|AIP|0|0|0|100|DKK|8939|13426|lyfalmen|||1|28|0|28,0000|Actavis ehf|Allergan Pharmaceuticals Ltd.|Linaclotídum||8939||8939|13426||1 132662|R05DA0403|Kodein Recip|töflur|25|mg|100|stk|1|glas||R05DA04|01.08.2005||R|1|0|1|0|G|0|REP|0|0|1|100|SEK|1260|2856|lyfalmen|||2|100|0|25,0000|Vistor hf|Recip AB|Kódein||1260||1260|2856||1 132663|N06BA0402|Concerta|forðatfl|27|mg|30|stk|1|glas||N06BA04|01.02.2009||R|1|1|1|0|0|0|JAS|0|0|0|100|SEK|5917|9266|lyfalmen|V0681|6602|1|30|0|27,0000|Vistor hf|Janssen-Cilag AB|Metýlfenídat||5917||5917|9266||1 132717|QN05CM9204|Nerfasin vet.|stl|100|mg/ml|50|ml|1|hgl|fyrir nautgripi og hesta|QN05CM92|01.07.2013||R|0|0|0|0|0|0|BVL|1|0|0|100|XEU|5856|11281|vetalmen|||0|50|0||Dýraheilsa ehf|Le Vet B.V.|||||5856|11281||2 132748|N06AX1610|Venlafaxine Bluefish|forðahlk|150|mg|100|stk|1|þpakki|hart|N06AX16|01.05.2015||R|1|0|0|0|G|0|BLP|0|0|0|100|IKR|3700|3187|lyfalmen|V0335|3153|2|100|0|150,0000|LYFIS ehf|Bluefish Pharmaceuticals AB|Venlafaxín||1500||1500|3187||2 132761|D08AG0201|Betadine|húðlausn|100|mg/ml|8|ml|1|glas||D08AG02|01.01.1986||L|0|0|0|0|0|0|NOR|0|0|0|100|IKR|||lyflausa|||0|8|0||Icepharma hf|Norpharma a/s|Joð/pólývídón|||||||2 132845|S01HA0401|Alcaine|augndr|5|mg/ml|15|ml|1|glas||S01HA04|01.09.2003||R|0|0|0|0|0|0|SAC|0|0|0|100|USD|514|1830|lyfalmen|||1|15|0||Vistor hf|S.A. Alcon - Couvreur N.V.|Proxýmetakaín||514||514|1830||1 132852|A07BA0104|Kolsuspension|mixtúra|150|mg/ml|100|ml|1|fl|dreifa|A07BA01|01.08.2005||L|0|0|0|0|0|0|ABI|0|0|0|100|IKR|||lyflausa|||0|100|0|3,0000|Vistor hf|Abigo Medical AB|Lyfjakol|||||||1 132902|G03AB0402|Trinovum 28|töflur|||84|stk|1|þpakki||G03AB04|01.01.1993||R|0|0|0|0|0|0|JAS|0|0|0|100|SEK|1084|2614|lyfalmen|||1|84|0|84,0000|Vistor hf|Janssen-Cilag AB|Noretísterón og ethinylestradíól||1084||1084|2614||1 133097|M03AX0104|NeuroBloc|stl|5000|ein/ml|0,5|ml|1|hgl||M03AX01|01.02.2009||R|0|1|0|1|0|1|EIS|0|0|0|100|SEK|23052|31857|lyfsjukr|||1|0,5|0||Vistor hf|Eisai Ltd|Clostridium botulinum toxín-A||23052||23052|31857||1 133109|M03AX0104|NeuroBloc|stl|5000|ein/ml|1|ml|1|hgl||M03AX01|01.02.2009||R|0|1|0|1|0|1|EIS|0|0|0|100|SEK|30651|41468|lyfsjukr|||1|1|0||Vistor hf|Eisai Ltd|Clostridium botulinum toxín-A||30651||30651|41468||1 133120|M03AX0104|NeuroBloc|stl|5000|ein/ml|2|ml|1|hgl||M03AX01|01.02.2009||R|0|1|0|1|0|1|EIS|0|0|0|100|SEK|41678|55415|lyfsjukr|||1|2|0||Vistor hf|Eisai Ltd|Clostridium botulinum toxín-A||||41678|55415||1 133411|B06AC0101|Cinryze|sts|500|ae|2|hgl|1|pakki|+ leysir, lausn|B06AC01|01.03.2013||R|0|1|0|1|0|1|SPR|0|0|0|100|DKK|242858|307627|lyfsjukr|||1|2|0||Lyfjaver ehf|ViroPharma SPRL|C1 hemill||242858||242858|307627||3 133508|A06AD6501|Moxalole|mixtduft|13,8|g|8|pokar|1|pakki||A06AD65|01.05.2011||L|0|0|0|0|0|0|MEB|0|0|0|100|IKR|||lyflausa|||0|8|0||Vistor hf|Meda AB (V)|Makrógól 3350|||||||1 133530|A06AD6501|Moxalole|mixtduft|13,8|g|20|pokar|1|pakki||A06AD65|01.05.2011||L|0|0|0|0|0|0|MEB|0|0|0|100|IKR|||lyflausa|||0|20|0|10,0000|Vistor hf|Meda AB (V)|Makrógól 3350|||||||1 133551|J05AG0101|Viramune|töflur|200|mg|14|stk|1|þpakki||J05AG01|01.03.2013||R|1|0|0|1|0|1|BII|0|0|0|100|DKK|7571|11543|lyfsjukr|||1|14|0|7,0000|Vistor hf|Boehringer Ingelheim International|Nevírapín||7571||7571|11543||1 133552|A06AD6501|Moxalole|mixtduft|13,8|g|50|pokar|1|pakki||A06AD65|01.05.2011||L|0|0|0|0|0|0|MEB|0|0|0|100|SEK|||lyfalmen|V0592|6007|0|50|0|25,0000|Vistor hf|Meda AB (V)|Makrógól 3350|||||6007||1 133919|N06AX1105|Mirtazapine Bluefish|munndr.t|15|mg|30|stk|1|þpakki||N06AX11|01.04.2014||R|0|0|0|0|G|0|BLP|0|0|0|100|IKR|998|1810|lyfalmen|V0329|1810|2|30|0|15,0000|LYFIS ehf|Bluefish Pharmaceuticals AB|Mirtazapín||500||500|1810||2 133949|H01BB0201|Syntocinon|nefúði|6,7|mcg/sk|5|ml|1|stauk||H01BB02|01.02.2015||R|0|0|0|0|G|0|STI|0|0|0|100|NOK|2687|4821|lyfalmen|||1|5|0|13,3333|Lyfjaver ehf|Sigma-Tau Industrie Farmaceutiche|Oxýtócín||2687||2687|4821||3 133974|N06AX1610|Venlafaxine Bluefish|forðahlk|37,5|mg|30|stk|1|þpakki|hart|N06AX16|01.04.2014||R|1|0|0|0|0|0|BLP|0|0|0|100|IKR|1661|3408|lyfalmen|V0333|3408|2|30|0|11,2500|LYFIS ehf|Bluefish Pharmaceuticals AB|Venlafaxín||1661||1661|3408||2 134019|N06AX1610|Venlafaxine Bluefish|forðahlk|75|mg|100|stk|1|þpakki|hart|N06AX16|01.04.2014||R|1|0|0|0|G|0|BLP|0|0|0|100|IKR|3700|3187|lyfalmen|V0334|3153|2|100|0|75,0000|LYFIS ehf|Bluefish Pharmaceuticals AB|Venlafaxín||1500||1500|3187||2 134085|N06AX1610|Venlafaxine Bluefish|forðahlk|150|mg|100|stk|1|þpakki|hart|N06AX16|01.04.2014||R|1|0|0|0|G|0|BLP|0|0|0|100|IKR|3700|3187|lyfalmen|V0335|3153|2|100|0|150,0000|LYFIS ehf|Bluefish Pharmaceuticals AB|Venlafaxín||1500||1500|3187||2 134352|S01EE0501|Taflotan|augndr|15|mcg/ml|0,3|ml|30|sk-hyl||S01EE05|01.03.2010||R|0|0|0|0|G|0|SAO|0|0|0|100|XEU|2915|5134|lyfalmen|V0378|3977|1|9|0|30,0000|Icepharma hf|Santen Oy|Taflúprost||2915||2915|5134||2 134374|S01EE0501|Taflotan|augndr|15|mcg/ml|0,3|ml|90|sk-hyl||S01EE05|01.06.2010||R|0|0|0|0|G|0|SAO|0|0|0|100|XEU|7852|11930|lyfalmen|V0378|11930|1|27|0|90,0000|Icepharma hf|Santen Oy|Taflúprost||7852||7852|11930||2 134520|L01DB0302 |Epirubicin Actavis|stl|2|mg/ml|25|ml|1|hgl||L01DB03|01.04.2009||R|0|0|0|1|0|1|AGT|0|0|0|100|XEU|2408|4437|lyfsjukr|||2|25|0||Actavis Group hf|Actavis Group hf|Epírúbicín||2408||2408|4437||1 134642|J05AE0801|Reyataz|hylki|300|mg|30|stk|1|plglas||J05AE08|01.01.2010||R|1|0|0|1|0|1|BRS|0|0|0|100|DKK|53231|70027|lyfsjukr|||1|30|0|30,0000|Vistor hf|Bristol-Myers Squibb|Atazanavír||53231||53231|70027||1 134844|R06AX1301|Clarityn|töflur|10|mg|100|stk|1|þpakki||R06AX13|01.04.2014||L|1|0|0|0|G|0|BAB|0|0|1|100|DKK|||lyfalmen|V0362|2043|1|100|0|100,0000|Icepharma hf|Bayer AB|Lóratadín|||||8363||2 134862|J05AR0601|Atripla|filmhtfl|||30|stk|1|glas|600+200+245 mg|J05AR06|01.07.2008||R|0|1|0|1|0|1|GSL|0|0|0|100|DKK|106852|138474|lyfsjukr|||1|30|0|30,0000|Gilead Nordic|Gilead Science International Ltd|Emtrícítabín, tenófóvír dísóproxíl og efavírenz||106852||106852|138474||2 134906|A02BC0307|Gasterix|sþ-hylki|30|mg|100|stk|1|glas||A02BC03|01.02.2014||R|1|0|0|0|G|0|RGM|0|0|0|100|IKR|4200|3462|lyfalmen|V0007|3462|2|100|0|100,0000|Medical ehf|ratiopharm GmbH|Lansóprazól||1700||1700|3462||2 134939|A02BC0307|Gasterix|sþ-hylki|15|mg|100|stk|1|glas||A02BC03|01.02.2014||R|1|0|0|0|G|0|RGM|0|0|0|100|IKR|2560|3875|lyfalmen|||2|100|0|50,0000|Medical ehf|ratiopharm GmbH|Lansóprazól||2000||2000|3875||2 135090|C02KX0501|Adempas|filmhtfl|1,5|mg|84|stk|1|þpakki||C02KX05|01.12.2014||R|1|0|0|1|0|1|BYE|0|1|0|100|DKK|363877|458141|lyfsjukr|||1|84|0|28,0000|Vistor hf|Bayer Pharma AG|Riociguatum||363877||363877|458141||1 135216|A10AE0406|Toujeo [SoloStar]|stl|300|ein/ml|1,5|ml|5|pennar|áfylltir lyfjapennar|A10AE04|01.10.2015||R|0|1|0|0|G|0|SDE|0|0|0|100|NOK|9275|13888|lyfalmen|||1|7,5|0|56,2500|Vistor hf|Sanofi - aventis Deutschland GmbH|Insulín glargín||9275||9275|13888||1 135319|C08DA0108|Verapamil Mylan|töflur|80|mg|100|stk|1|glas||C08DA01|01.01.1990||R|1|0|0|0|G|0|MYL|0|0|0|100|SEK|857|2302|lyfalmen|||2|100|0|33,3333|Icepharma hf|Mylan AB|Verapamíl||857||857|2302||2 135434|R03BA0502|Flixotide Diskus|innönddu|100|mcg/sk|60|skammtar|1|pakki|í diskus-t|R03BA05|01.07.1995||R|0|0|0|0|G|0|GPH|0|0|0|100|GBP|1262|2859|lyfalmen|||1|60|0|10,0000|Vistor hf|GlaxoSmithKline Pharma A/S|Flútíkasón||1262||1262|2859||1 135907|M01AH0107|Celecoxib LYFIS|hylki|200|mg|30|stk|1|þpakki||M01AH01|01.10.2015||R|1|0|0|0|G|0|LYF|0|0|1|100|IKR|3000|3187|lyfalmen|V0037|3187|2|30|0|30,0000|LYFIS ehf|LYFIS ehf|Celekoxíb||1500||1500|3187||2 136168|G03AB0401|Trinovum|töflur|||63|stk|1|þpakki||G03AB04|01.10.1988||R|0|0|0|0|0|0|JAS|0|0|0|100|SEK|1084|2614|lyfalmen|||1|63|0|84,0000|Vistor hf|Janssen-Cilag AB|Noretísterón og ethinylestradíól||1084||1084|2614||1 136181|L04AA1001|Rapamune|mixtúra|1|mg/ml|60|ml|1|fl||L04AA10|01.01.2013||R|0|0|0|1|G|0|IPI|0|0|0|100|DKK|35899|48106|lyfalmen|||1|60|0|20,0000|Icepharma hf|Pfizer Limited|Sirolimus||35899||35899|48106|| 136200|J04AC0102|Tibinide|töflur|300|mg|100|stk|1|glas||J04AC01|01.07.2005||R|1|0|0|0|0|0|REP|0|0|0|100|SEK|5882|9218|lyfalmen|||1|100|0|100,0000|Vistor hf|Recip AB|Ísóníazíð||5882||5882|9218||1 136281|L04AB0101|Enbrel|sts|25|mg|4|hgl|1|pakki|+ leysir|L04AB01|01.03.2012||R|0|1|0|1|0|1|IPI|0|1|0|100|DKK|61644|80668|lyfsjukr|||1|4|0|14,2900|Icepharma hf|Pfizer Limited|Etanercept||61644||61644|80668||1 136653|N06AX2601|Brintellix|filmhtfl|5|mg|28|stk|1|þpakki||N06AX26|01.10.2014||R|1|0|0|0|0|0|LBK|0|0|0|100|DKK|2865|5066|lyfalmen|||1|28|0|14,0000|Lundbeck Export A/S|H. Lundbeck A/S|Vortioxetín||2865||2865|5066||1 136658|N05BA1206|Alprazolam Krka|forðatfl|0,5|mg|30|stk|1|þpakki||N05BA12|01.08.2012||R|1|0|0|0|0|0|KRK|0|0|1|100|XEU|406|1563|lyfalmen|V0307|1563|2|30|0|15,0000|LYFIS ehf|Krka Sverige AB|Alprazólam||320||320|1563||2 136953|D06BX0106|Rosazol|krem|10|mg/g|25|g|1|túpa||D06BX01|01.04.2016||L|0|0|0|0|0|0|AGT|0|0|1|100|IKR|||lyflausa|||2|25|0||Actavis Group hf|Actavis Group hf|Metrónídazól|||||||1 137110|L01XA0302|Oxaliplatin Hospira|irþ|5|mg/ml|20|ml|1|hgl||L01XA03|01.06.2011||R|0|0|0|1|0|1|VOG|0|0|0|100|XEU|5253|8352|lyfsjukr|||2|20|0||Alvogen HS|Hospira UK Ltd.|Oxalíplatín||5253||5253|8352||1 137635|N05AH0413|Quetiapin ratiopharm|forðatfl|400|mg|100|stk|1|þpakki||N05AH04|01.05.2015||R|1|0|0|0|G|0|TEV|0|0|0|100|IKR|39000|43174|lyfalmen|V0261|43174|2|100|0|100,0000|Medical ehf|Teva Pharma B.V.|Quetíapín||32000||32000|43174||2 137809|M05BA0302|Pamidronatdinatrium Hospira|irþ|3|mg/ml|5|ml|5|hgl|lausn|M05BA03|01.05.2005||R|0|0|0|0|0|1|VOG|0|0|0|100|XEU|19115|27432|lyfsjukr|||2|25|0|1,2500|Alvogen HS|Hospira UK Ltd.|Pamídrónsýra||19115||19115|27432||1 137820|M05BA0302|Pamidronatdinatrium Hospira|irþ|3|mg/ml|10|ml|1|hgl|lausn |M05BA03|01.05.2005||R|0|0|0|0|0|1|VOG|0|0|0|100|XEU|5557|8771|lyfsjukr|||2|10|0|0,5000|Alvogen HS|Hospira UK Ltd.|Pamídrónsýra||5557||5557|8771||1 137831|M05BA0302|Pamidronatdinatrium Hospira|irþ|6|mg/ml|10|ml|1|hgl|lausn|M05BA03|01.05.2005||R|0|0|0|0|0|1|VOG|0|0|0|100|XEU|4853|7802|lyfsjukr|||2|10|0|1,0000|Alvogen HS|Hospira UK Ltd.|Pamídrónsýra||4853||4853|7802||1 137842|M05BA0302|Pamidronatdinatrium Hospira|irþ|9|mg/ml|10|ml|1|hgl|lausn|M05BA03|01.05.2005||R|0|0|0|0|0|1|VOG|0|0|0|100|XEU|5485|8672|lyfsjukr|||2|10|0|1,5000|Alvogen HS|Hospira UK Ltd.|Pamídrónsýra||5485||5485|8672||1 138302|N03AX1603|Pregabalin Krka|hylki|300|mg|56|stk|1|þpakki||N03AX16|01.04.2015||R|1|0|0|0|0|0|KNM|0|0|0|100|XEU|12872|7070|lyfalmen|V0689|6672|2|56|0|56,0000|LYFIS ehf|Krka d.d. Novo mesto|Pregabalín||4321||4321|7070||2 138318|L01BA0109|Metoject|stl|50|mg/ml|0,35|ml|1|áfspr||L01BA01|01.12.2012||R|0|0|0|1|G|0|WIL|0|0|0|100|SEK|2756|4916|lyfalmen|||1|0,35|0||Williams & Halls efh|medac Gesellschaft|Metótrexat||2756||2756|4916||2 138594|S01ED0105|Optimol|augndr|5|mg/ml|0,25|ml|60|sk-hyl|án rotvarnar|S01ED01|01.01.1995||R|0|0|0|0|G|0|SAO|0|0|0|100|XEU|1475|3152|lyfalmen|||1|15|0|60,0000|Icepharma hf|Santen Oy|Tímólól||1475||1475|3152||2 138603|N07BB0501|Selincro|filmhtfl|18|mg|28|stk|1|þpakki||N07BB05|01.06.2013||R|1|0|0|0|0|0|LBK|0|0|0|100|DKK|15210|22057|lyfalmen|||1|28|0|28,0000|Lundbeck Export A/S|H. Lundbeck A/S|Nalmefenum||15210||15210|22057||1 138619|L01BA0110|Metojectpen|stl|22,5|mg|1|áf-penni|1|pakki||L01BA01|01.05.2016||R|0|0|0|1|G|0|WIL|0|0|0|100|XEU|3240|5582|lyfalmen|||1|1|0||Williams & Halls efh|medac Gesellschaft|Metótrexat||3240||3240|5582||2 139050|S01ED5115|Arzotilol|augndr|5|mg/ml|5|ml|3|glös|+ dorzólamíð 20 mg|S01ED51|01.01.2012||R|0|0|0|0|G|0|APC|0|0|0|100|XEU|2463|4512|lyfalmen|V0373|4500|2|15|0|75,0000|Actavis Group PTC ehf|Actavis Group PTC ehf|Tímólól í blöndum||2463||2463|4512||1 139604|L04AA3201|Otezla|filmhtfl|30|mg|56|stk|1|þpakki||L04AA32|01.05.2016||R|1|0|0|1|0|1|CLC|0|0|0|100|XEU|109071|141234|lyfsjukr|||1|56|0||Celgene AB|Celgene Europe Limited|Apremilast||109071||109071|141234||2 139840|R06AA0401|Tavegyl|töflur|1|mg|100|stk|1|þpakki||R06AA04|01.08.1981||L|1|0|0|0|0|0|NEH|0|0|1|100|DKK|||lyfalmen|||0|100|0|50,0000|Artasan ehf|Novartis Healthcare A/S|Klemastín|||||4761||1 140327|N04BC0502|Sifrol|töflur|0,088|mg|30|stk|1|þpakki||N04BC05|01.05.2005||R|0|0|0|0|G|0|BII|0|0|0|100|DKK|1094|2628|lyfalmen|V0266|2093|1|30|0|1,0600|Vistor hf|Boehringer Ingelheim International |Pramipexól||1094||1094|2628||1 140330|N02AA0506|Oxikodon Depot Actavis|forðatfl|80|mg|98|stk|1|glas||N02AA05|01.08.2015||R|1|0|1|0|G|0|APC|0|0|0|100|XEU|14275|20770|lyfalmen|V0588|20770|2|98|0|104,5300|Actavis Group PTC ehf|Actavis Group PTC ehf|Oxýcódon||14275||14275|20770||1 140442|N05AF0503|Cisordinol-Acutard|stl|50|mg/ml|1|ml|10|lykjur||N05AF05|01.01.1991||R|0|0|0|0|0|1|LBK|0|0|0|100|DKK|9850|14680|lyfsjukr|||1|10|0|16,6700|Lundbeck Export A/S|H. Lundbeck A/S|Zúklópentixól||9850||9850|14680||1 140500|N07BC0202|Metadon Abcur|töflur|40|mg|25|stk|1|glas||N07BC02|01.03.2016||R|1|0|1|0|G|0|ABC|0|0|0|100|SEK|5349|8485|lyfalmen|||1|25|0|40,0000|Icepharma hf|Abcur AB|Metadón||5349||5349|8485||2 140729|QN01AX0001|Finquel, vet|duft|100|%|1000|g|1|fl|baðlausn handa fiskum|QN01AX|01.01.2012||R|0|0|0|0|0|0|SRR|0|0|0|100|NOK|67661|128537|vetalmen|||0|1000|0||Scan Aqua AS|Scan Aqua AS|Tricaine mesylate||67661||67661|128537||1 140954|N07BA0103|Nicorette|nefúði|10|mg/ml|10|ml|1|glas||N07BA01|01.04.1994||L|0|0|0|0|0|0|MCN|0|0|1|100|IKR|||lyflausa|||0|10|0|3,3300|Vistor hf|McNeil Denmark ApS|Nikótín|||||||1 141015|J05AR1401|REZOLSTA|filmhtfl|950|mg|30|stk|1|glas|800+150 mg|J05AR14|01.01.2016||R|0|0|0|1|0|1|JAS|0|0|0|100|SEK|52732|69396|lyfsjukr|||1|30|0||Vistor hf|Janssen-Cilag AB|Darunavir og cobicistat||52732||52732|69396||1 141044|H02AB0401|Depo-Medrol|stl|40|mg/ml|2|ml|1|áfspr||H02AB04|01.04.1994||R|0|0|0|0|G|0|PER|0|0|1|100|DKK|1074|2600|lyfalmen|V0413|2380|1|2|0|4,0000|Icepharma hf|Pfizer ApS|Metýlprednisólón||1074||1074|2600||1 141063|S01BC1001|Nevanac|augndr|1|mg/ml|5|ml|1|dropaí||S01BC10|01.08.2013||R|0|0|0|0|G|0|ALA|0|0|1|100|USD|3227|5564|lyfalmen|||1|5|0||Vistor hf|Alcon Laboratories Ltd.|Nepafenak||||3227|5564||1 141129|L01AA0101|Sendoxan|sts|200|mg|1|stk|1|hgl||L01AA01|01.06.2014|29.02.2016|R|0|0|0|1|0|1|BAM|0|0|0|100|SEK|1151|2706|lyfsjukr|||1|1|0||Icepharma hf|Baxter Medical AB|Cýklófosfamíð||1151||1151|2706||2 141153|R01AB0601|Otrivin Comp|nefúði|1,1|mg/ml|10|ml|1|glas|0,5+0,6 mg/ml|R01AB06|01.05.2013||L|0|0|0|0|0|0|NAA|0|0|1|100|IKR|||lyflausa|||0|10|0|12,5000|Artasan ehf|Novartis Healthcare A/S|Xýlómetazóín og Ípratrópíum|||||||1 141388|B05BB0114|Natriumklorid Fresenius Kabi|irl|9|mg/ml|500|ml|20|pokar|Freeflex umbúðir|B05BB01|01.12.2011||R|0|0|0|0|0|1|FKA|0|0|0|100|DKK|3471|5900|lyfsjukr|||1|10000|0||Vistor hf|Fresenius Kabi AB|Elektrólýtar||3471||3471|5900||1 141438|G03GA0502|Gonal-f|stl|300|ae/penna|0,5|ml|1|penni|(22 mcg) áfylltur penni|G03GA05|01.01.2012||R|0|0|0|1|G|0|MSE|0|0|0|100|SEK|14745|21417|lyfalmen|||1|0,5|0|4,0000|Icepharma hf|Merck Serono Europe Ltd|Follitrópín alfa||||14745|21417||2 141569|H02AB0908|Plenadren|töflur|5|mg|50|stk|1|glas|með breyttan losunarhraða|H02AB09|01.01.2013||R|1|0|0|0|G|0|SPR|0|0|1|100|DKK|38632|51562|lyfalmen|||1|50|0|8,3300|Lyfjaver ehf|ViroPharma SPRL|Hýdrókortisón||38632||38632|51562||3 141684|G03AA1205|Yaz|filmhtfl|||84|stk|1|þpakki|0,02mg/3mg|G03AA12|01.02.2009||R|0|0|0|0|0|0|BAB|0|0|0|100|DKK|3571|6037|lyfalmen|V0193|4881|1|84|0|84,0000|Icepharma hf|Bayer AB|Dróspírenón og ethinylestradíól||||3571|6037||2 141751|J01EE0106|Co-Trimoxazole|töflur|480|mg|28|stk|1|glas|80+400 mg|J01EE01|01.02.2009||R|0|0|0|0|0|0|AEA|0|0|1|100|XEU|573|1911|lyfalmen|||2|28|0|7,0000|Actavis hf|Actavis EAD|Súlfametoxazól og trímetóprím||573||573|1911||1 141856|V07AB0014|Natriumklorid Fresenius Kabi|leysir|9|mg/ml|10|ml|20|lykjur|fyrir stl|V07AB|01.06.2015||L|0|0|0|0|0|0|FKA|0|0|0|100|DKK|||lyfalmen|||0|200|0||Vistor hf|Fresenius Kabi AB|Leysi- og þynningarvökvar, þ.m.t. skolvökvar|||||3096||1 141872|R03DC0304|Montelukast Teva|tuggutfl|4|mg|98|stk|1|þpakki||R03DC03|01.02.2013||R|1|0|0|0|G|0|TEV|0|0|0|100|XEU|5339|8471|lyfalmen|V0492|8471|2|98|0|39,2000|Medical ehf|Teva Pharma B.V.|Montelúkast||5339||5339|8471||2 141945|N04BC0502|Sifrol|töflur|0,18|mg|100|stk|1|þpakki||N04BC05|01.05.2005||R|0|0|0|0|G|0|BII|0|0|0|100|DKK|5876|9210|lyfalmen|V0267|4197|1|100|0|7,2000|Vistor hf|Boehringer Ingelheim International|Pramipexól||5876||5876|9210||1 142034|M01AE0218|Naproxen Mylan|töflur|500|mg|100|stk|1|glas||M01AE02|01.07.2012||R|1|0|0|0|G|0|MYL|0|0|1|100|SEK|1672|3340|lyfalmen|V0127|3117|2|100|0|100,0000|Icepharma hf|Mylan AB|Naproxen||1611||1611|3340||2 142123|R07AX0101|INOmax|innö.gas|800|ppm|2|l|1|gashyl||R07AX01|01.09.2014||R|0|1|0|1|0|1|LIN|0|0|0|100|XEU|20575|28724|lyfsjukr|||1|2|0||Ísaga ehf - Linde Heathcare|Linde Healthcare AB|Nituroxíð||||20575|28724||5 142266|A04AA0107|Ondansetron Bluefish|filmhtfl|8|mg|10|stk|1|þpakki||A04AA01|01.09.2015||R|1|0|0|0|G|0|BLP|0|0|1|100|IKR|3320|3758|lyfalmen|V0384|2897|2|10|0|5,0000|LYFIS ehf|Bluefish Pharmaceuticals AB|Ondansetrón||1915||1915|3758||2 142307|C01BD0101|Cordarone|töflur|200|mg|30|stk|1|þpakki||C01BD01|01.04.1987||R|1|0|0|0|G|0|SNO|0|0|0|100|NOK|715|2106|lyfalmen|||1|30|0|30,0000|Vistor hf|Sanofi-aventis Norge AS|Amíódarón||715||715|2106||1 142323|J01XX0501|Haiprex|töflur|1|g|100|stk|1|glas||J01XX05|01.10.1995||R|1|0|0|0|0|0|MEB|0|0|1|100|SEK|2443|4485|lyfalmen|||1|100|0|50,0000|Vistor hf|Meda AB (V)|Metenamín||2443||2443|4485||1 142615|C07AG0205|Carveratio|töflur|6,25|mg|100|stk|1|þpakki||C07AG02|01.06.2015||R|0|0|0|0|G|0|RGM|0|0|0|100|IKR|1750|3531|lyfalmen|||2|100|0|16,6700|Medical ehf|ratiopharm GmbH|Carvedílól||1750||1750|3531||2 143139|V07AB0013|Sterilt vatten/vann/vand Fresenius Kabi|leysir|||100|ml|50|hgl|fyrir stungulyf|V07AB|01.11.2012||L|0|0|0|0|0|0|FKA|0|0|0|100|IKR|||lyfalmen|||0|5000|0||Vistor hf|Fresenius Kabi AB|Leysi- og þynningarvökvar, þ.m.t. skolvökvar|||||16444||1 143339|H02AB0403|Solu-Medrol|sts|125|mg|1|stk|1|hgl|Act-O-Vial|H02AB04|01.07.1974||R|0|0|0|0|G|0|PER|0|0|1|100|DKK|1482|3162|lyfalmen|||1|1|0|6,2500|Icepharma hf|Pfizer ApS|Metýlprednisólón||1482||1482|3162||1 143347|H02AB0403|Solu-Medrol|sts|500|mg|1|stk|1|hgl|+ leysir|H02AB04|01.07.1974||R|0|0|0|0|0|1|PER|0|0|0|100|DKK|2003|3879|lyfsjukr|||1|1|0|25,0000|Icepharma hf|Pfizer ApS|Metýlprednisólón||2003||2003|3879||1 143410|N03AX1604|Brieka|hylki|150|mg|100|stk|1|glas||N03AX16|01.10.2015||R|1|0|0|0|0|0|AGP|0|0|0|100|XEU|14648|10709|lyfalmen|V0687|10629|2|100|0|50,0000|Actavis Group hf|Actavis Group PTC ehf|Pregabalín||6965||6965|10709||1 143511|J07BC2002|Twinrix Paediatric|stl|||0,5|ml|1|dæla|einnota dæla|J07BC20|01.01.1999||R|0|0|0|0|0|0|GBI|0|0|0|100|GBP|3547|6004|lyfalmen|||1|0,5|0||Vistor hf|GlaxoSmithKline Biologicals SA|Lifrarbólgubóluefni (hepatitis)-Blöndur||3547||3547|6004|| 143526|C07AB0309|Atenolol Actavis|filmhtfl|50|mg|100|stk|1|þpakki||C07AB03|01.10.2012||R|1|0|0|0|G|0|AGP|0|0|0|100|XEU|518|1637|lyfalmen|V0542|1637|2|100|0|66,6700|Actavis Group hf|Actavis Group PTC ehf|Atenólól||374||374|1637||1 143586|S01FA0601|Mydriacyl 1 %|augndr|10|mg/ml|15|ml|1|glas||S01FA06|01.09.2003||R|0|0|0|0|0|0|SAC|0|0|0|100|USD|940|2416|lyfalmen|||1|15|0||Vistor hf|S.A. Alcon - Couvreur N.V.|Trópíkamíð||940||940|2416||1 143602|J01FA1001|Zitromax|töflur|500|mg|2|stk|1|þpakki||J01FA10|01.11.1998||R|1|0|0|0|0|0|PER|0|0|1|100|DKK|1207|2784|lyfalmen|V0173|2336|1|2|0|3,3333|Icepharma hf|Pfizer ApS|Azitrómýcín||1207||1207|2784||1 143609|A10BD0701|Janumet|filmhtfl|900|mg|56|stk|1|þpakki|50/850 mg|A10BD07|01.03.2013||R|1|0|0|0|G|0|MLD|0|0|0|100|DKK|5837|9156|lyfalmen|V0387|8095|1|56|0|28,0000|Vistor hf|Merck Sharp & Dohme Limited|Metforminum og sitagliptinum||5837||5837|9156||1 143610|N02CX0201|Catapresan|töflur|25|mcg|100|stk|1|þpakki||N02CX02|01.04.1974|31.03.2016|R|1|0|0|0|G|0|BOI|0|0|0|100|DKK|990|2485|lyfalmen|||1|100|0|25,0000|Vistor hf|Boehringer Ingelheim|Klónidín||990||990|2485||1 143631|A10BD0701|Janumet|filmhtfl|1050|mg|56|stk|1|þpakki|50/1000mg|A10BD07|01.03.2009||R|1|0|0|0|G|0|MLD|0|0|0|100|DKK|5902|9246|lyfalmen|V0386|7443|1|56|0|28,0000|Vistor hf|Merck Sharp & Dohme Limited|Metforminum og sitagliptinum||5902||5902|9246||1 143727|D07AB0201|Locoid|smyrsli|1|mg/g|30|g|1|túpa||D07AB02|01.07.1985||R|0|0|0|0|G|0|ASP|0|0|1|100|XEU|518|1835|lyfalmen|||1|30|0||Vistor hf|Astellas Pharma A/S|Hýdrókortisón bútýrat||518||518|1835||1 143787|N06AX1611|Duofaxin|forðatfl|225|mg|28|stk|1|þpakki||N06AX16|01.07.2015||R|1|0|0|0|0|0|MEV|0|0|0|100|DKK|1437|2964|lyfalmen|||2|28|0|63,0000|Vistor hf|MediLink A/S|Venlafaxín||1338||1338|2964||1 143800|N05AN0101|Litarex|forðatfl|6|mmól|100|stk|1|glas||N05AN01|01.04.1974||R|1|0|0|0|G|0|AGT|0|0|0|100|DKK|2403|4430|lyfalmen|||2|100|0|25,0000|Actavis Group hf|Actavis Group hf|Litíum||2403||2403|4430||1 143891|J01FA1001|Zitromax|töflur|500|mg|3|stk|1|þpakki||J01FA10|01.11.1998||R|1|0|0|0|0|0|PER|0|0|1|100|DKK|1524|3220|lyfalmen|V0174|2654|1|3|0|5,0000|Icepharma hf|Pfizer ApS|Azitrómýcín||1524||1524|3220||1 144030|N04BA0207|Sinemet depot mite|forðatfl|125|mg|100|stk|1|glas|25+100 mg|N04BA02|01.04.1992||R|1|0|0|0|G|0|MSD|0|0|0|100|DKK|1845|3662|lyfalmen|||1|100|0|16,6667|Vistor hf|M.S.D.|Levódópa og dópadekarboxýl­asa­hemill||1845||1845|3662||1 144035|N05AH0501|Sycrest|tungur.t|10|mg|60|stk|1|þpakki||N05AH05|01.10.2011||R|0|0|0|0|0|0|ORR|0|0|0|100|DKK|24560|33764|lyfalmen|||1|60|0|30,0000|Lundbeck Export A/S|N.V. Organon|Asenapíne||24560||24560|33764||1 144139|H01AC0106|Norditropin Simplexx|stl|10|mg/ml|1,5|ml|1|rörlyk||H01AC01|01.02.2000||R|0|0|0|1|0|1|NAS|0|1|0|100|DKK|61557|80558|lyfsjukr|||1|1,5|0|22,5000|Vistor hf|Novo-Nordisk A/S|Sómatrópín||61557||61557|80558||1 144419|R03AC1302|Oxis Turbuhaler|innönddu|9|mcg/sk|60|skammtar|1|stauk||R03AC13|01.01.2016||R|0|0|0|0|G|0|AZD|0|0|1|100|SEK|3401|5803|lyfalmen|||1|60|0|22,5000|Vistor hf|AstraZeneca A/S DK|Formóteról||3401||3401|5803||1 144436|H01AC0106|Norditropin Simplexx|stl|6,7|mg/ml|1,5|ml|1|rörlyk||H01AC01|01.02.2000||R|0|0|0|1|0|1|NAS|0|1|0|100|DKK|41044|54613|lyfsjukr|||1|1,5|0|15,0000|Vistor hf|Novo-Nordisk A/S|Sómatrópín||41044||41044|54613||1 144498|N02AA0506|Oxikodon Depot Actavis|forðatfl|40|mg|98|stk|1|glas||N02AA05|01.08.2015||R|1|0|1|0|G|0|APC|0|0|0|100|XEU|9041|13064|lyfalmen|V0587|13064|2|98|0|52,2700|Actavis Group PTC ehf|Actavis Group PTC ehf|Oxýcódon||8676||8676|13064||1 144725|H01AC0106|Norditropin Simplexx|stl|3,3|mg/ml|1,5|ml|1|rörlyk||H01AC01|01.02.2000||R|0|0|0|1|0|1|NAS|0|1|0|100|DKK|20522|28657|lyfsjukr|||1|1,5|0|7,5000|Vistor hf|Novo-Nordisk A/S|Sómatrópín||20522||20522|28657||1 144808|D07AB0201|Locoid|húðlausn|1|mg/ml|30|ml|1|glas||D07AB02|01.10.1986||R|0|0|0|0|G|0|ASP|0|0|1|100|XEU|542|1868|lyfalmen|||1|30|0||Vistor hf|Astellas Pharma A/S|Hýdrókortisón bútýrat||542||542|1868||1 145077|L04AB0201|Remicade|irs|100|mg|1|hgl|1|pakki||L04AB02|01.06.2011||R|0|1|0|1|0|1|CEO|0|1|0|100|DKK|69361|90429|lyfsjukr|||1|1|0|26,6700|Vistor hf|Centocor B.V.|Infliximab||69361||69361|90429||1 145440|QG04CX9001|Ypozane|töflur|1,875|mg|7|stk|1|þpakki|handa hundum|QG04CX90|01.05.2014||R|0|0|0|0|0|0|VIR|0|0|0|100|XEU|1586|3117|vetalmen|||0|7|0||Vistor hf|Virbac S.A|Osasterón||1586||1586|3117||1 145451|QG04CX9001|Ypozane|töflur|3,75|mg|7|stk|1|þpakki|handa hundum|QG04CX90|01.05.2014||R|0|0|0|0|0|0|VIR|0|0|0|100|XEU|2406|4729|vetalmen|||0|7|0||Vistor hf|Virbac S.A|Osasterón||2406||2406|4729||1 145607|P02CX0101|Vanquin|töflur|50|mg|8|stk|1|þpakki||P02CX01|01.12.1972||L|1|0|0|0|0|0|REP|0|0|0|100|IKR|||lyflausa|||0|8|0|1,1400|Vistor hf|Recip AB|Pýrvín|||||||1 145616|QG04CX9001|Ypozane|töflur|7,5|mg|7|stk|1|þpakki|handa hundum|QG04CX90|01.05.2014||R|0|0|0|0|0|0|VIR|0|0|0|100|XEU|3702|7194|vetalmen|||0|7|0||Vistor hf|Virbac S.A|Osasterón||3702||3702|7194||1 145627|QG04CX9001|Ypozane|töflur|15|mg|7|stk|1|þpakki|handa hundum|QG04CX90|01.05.2014||R|0|0|0|0|0|0|VIR|0|0|0|100|XEU|5162|9964|vetalmen|||0|7|0||Vistor hf|Virbac S.A|Osasterón||5162||5162|9964||1 145648|B05BB0121|Plasmalyte|irl|||500|ml|20|pokar|lausn|B05BB01|01.09.2015||R|0|0|0|0|0|1|BAM|0|0|0|100|SEK|9465|14150|lyfsjukr|||1|10000|0||Icepharma hf|Baxter Medical AB|Elektrólýtar||9465||9465|14150||2 145784|B03AC0005|Ferinject|irl|50|mg/ml|2|ml|1|hgl||B03AC|01.06.2014||R|0|1|0|0|G|0|VIF|0|0|1|100|CHF|5094|8134|lyfalmen|||1|2|0|1,0000|Vistor hf|Vifor France SA|Járn, stungulyf||5094||5094|8134||1 145806|B03AC0005|Ferinject|irl|50|mg/ml|10|ml|1|hgl||B03AC|01.06.2014||R|0|1|0|0|G|0|VIF|0|0|1|100|CHF|26912|36739|lyfalmen|||1|10|0|5,0000|Vistor hf|Vifor France SA|Járn, stungulyf||26912||26912|36739||1 146082|L04AA2601|Benlysta|irs|120|mg/hgl|1|hgl|1|pakki|lausn|L04AA26|01.12.2011||R|0|0|0|1|0|1|GGL|0|1|0|100|GBP|28350|38558|lyfsjukr|||1|1|0|4,8000|GlaxoSmithKline ehf|Glaxo Group Limited|Belimumab||||28350|38558||1 146229|L01XX1903|Irinotecan Hospira|irþ|20|mg/ml|25|ml|1|hgl|lausn|L01XX19|01.12.2015||R|0|0|0|1|0|1|VOG|0|0|0|100|XEU|7601|11584|lyfsjukr|||2|25|0||Alvogen HS|Hospira UK Ltd.|Írinótekan||7601||7601|11584||1 146473|N06BA0901|Strattera|hylki|80|mg|28|stk|1|þpakki|hart|N06BA09|01.01.2010||R|1|0|0|1|0|0|ELI|0|0|0|100|XEU|15775|22835|lyfalmen|||1|28|0|28,0000|Icepharma hf|Eli Lilly Danmark A/S|Atomoxetín||15775||15775|22835||2 146530|P01AB0102|Flagyl|töflur|400|mg|10|stk|1|þpakki||P01AB01|01.10.1995||R|1|0|0|0|0|0|SNO|0|0|1|100|NOK|293|1525|lyfalmen|||1|10|0|2,0000|Vistor hf|Sanofi-aventis Norge AS|Metrónídazól||293||293|1525||1 147263|L01BC0102|Arabine|stl/irl|100|mg/ml|20|ml|1|hgl||L01BC01|01.09.2015||R|0|0|0|1|0|1|ALV|0|0|0|100|XEU|2833|5022|lyfsjukr|||2|20|0||Alvogen|Hospira Nordic AB|Cýtarabín||||2833|5022||1 147426|N06BA0404|Methylphenidate Sandoz|forðatfl|18|mg|30|stk|1|glas||N06BA04|01.04.2015||R|1|1|1|0|0|0|SHS|0|0|0|100|DKK|4682|5876|lyfalmen|V0691|5876|2|30|0|18,0000|Artasan ehf|Sandoz A/S|Metýlfenídat||3454||3454|5876||1 147578|V07AB0013|Sterilt vatten/vann/vand Fresenius Kabi|leysir|||20|ml|20|plastl|fyrir stungulyf|V07AB|01.06.2015||L|0|0|0|0|0|0|FKA|0|0|0|100|IKR|||lyfalmen|||0|400|0||Vistor hf|Fresenius Kabi AB|Leysi- og þynningarvökvar, þ.m.t. skolvökvar|||||2994||1 148213|R05CB1301|Pulmozyme|innúðal|1|mg/ml|2,5|ml|30|lykjur||R05CB13|01.01.1997||R|0|0|0|1|0|0|ROA|0|0|0|100|DKK|99507|128557|lyfalmen|||1|75|0|30,0000|Icepharma hf|Roche A.S.|Dornase alfa||99507||99507|128557||2 148238|M01AH0107|Celecoxib LYFIS|hylki|200|mg|100|stk|1|þpakki||M01AH01|01.10.2015||R|1|0|0|0|G|0|LYF|0|0|1|100|IKR|9436|7316|lyfalmen|V0196|7316|2|100|0|100,0000|LYFIS ehf|LYFIS ehf|Celekoxíb||4500||4500|7316||2 148263|J01CA0802|Penomax|filmhtfl|200|mg|20|stk|1|þpakki||J01CA08|01.09.2012||R|0|0|0|0|0|0|OPF|0|0|1|100|DKK|1068|2336|lyfalmen|V0577|2336|2|20|0|6,6667|Alvogen|Orion Corporation|Pívmecillínam||882||882|2336||1 148274|J01CA0802|Penomax|filmhtfl|200|mg|30|stk|1|þpakki||J01CA08|01.09.2012||R|0|0|0|0|0|0|OPF|0|0|1|100|DKK|1589|3309|lyfalmen|||2|30|0|10,0000|Alvogen|Orion Corporation|Pívmecillínam||1589||1589|3309||1 148285|J01CA0802|Penomax|filmhtfl|200|mg|100|stk|1|glas||J01CA08|01.09.2012||R|0|0|0|0|0|0|OPF|0|0|1|100|DKK|5462|8277|lyfalmen|||2|100|0|33,3300|Alvogen|Orion Corporation|Pívmecillínam||5198||5198|8277||1 148363|D11AH0401|Toctino|hylki|10|mg|30|stk|1|þpakki|mjúk|D11AH04|01.03.2012||R|0|1|0|1|0|0|SLA|0|0|0|100|GBP|60910|79740|lyfalmen|||1|30|0|15,0000|Vistor hf|Stiefel Laboratories Ireland Ltd.|Alítretínóín||60910||60910|79740||1 148374|D11AH0401|Toctino|hylki|30|mg|30|stk|1|þpakki|mjúk|D11AH04|01.03.2012||R|0|1|0|1|0|0|SLA|0|0|0|100|GBP|60910|79740|lyfalmen|||1|30|0|45,0000|Vistor hf|Stiefel Laboratories Ireland Ltd.|Alítretínóín||60910||60910|79740||1 148411|C03CA0110|Impugan|töflur|40|mg|100|stk|1|glas||C03CA01|01.08.2013||R|1|0|0|0|G|0|AGT|0|0|0|100|SEK|391|1567|lyfalmen|V0601|1567|2|100|0|100,0000|Actavis Group hf|Actavis Group hf|Fúrósemíð||323||323|1567||1 148452|N04AA0201|Akineton|töflur|2|mg|100|stk|1|þpakki||N04AA02|01.11.2005||R|1|0|0|0|G|0|LFS|0|0|0|100|DKK|755|2161|lyfalmen|||1|100|0|20,0000|Vistor hf|Laboratorio Farmaceutico (S.I.T.)|Bíperíden||755||755|2161||1 148642|N01AX6301|Livopan|lyfjagas|||5|l|1|hylki|50% + 50%|N01AX63|01.05.2012||R|0|0|0|0|0|1|AGA|0|0|0|100|IKR|62097|81241|lyfsjukr|||1|5|0||Ísaga ehf|AGA AB|Tvínituroxíð og súrefni||62097||62097|81241||5 148752|L01CA0207|Vincristine Hospira|stl|1|mg/ml|2|ml|5|hgl||L01CA02|01.07.2004||R|0|0|0|1|0|1|ALV|0|0|0|100|XEU|12136|17826|lyfsjukr|||2|10|0||Alvogen|Hospira Nordic AB|Vínkristín||12136||12136|17826||1 148917|L01BA0301|Tomudex|irs|2|mg/hgl|1|hgl|1|pakki||L01BA03|01.03.1998||R|0|0|0|1|0|1|ALV|0|0|0|100|XEU|25961|35536|lyfsjukr|||1|1|0||Alvogen|Hospira Nordic AB|Raltítrexed||25961||25961|35536||1 148999|QN05CM9201|Rompun, vet.|stl|20|mg/ml|25|ml|1|hgl||QN05CM92|01.12.1972||R|0|0|0|0|0|0|BAN|1|0|0|100|DKK|3216|6272|vetalmen|||0|25|0||Icepharma hf|Bayer Animal Health GmbH|||3216||3216|6272||2 149525|QA04AD9001|Cerenia|töflur|60|mg|4|stk|1|þpakki||QA04AD90|01.04.2015||R|0|0|0|0|0|0|ZBE|0|0|0|100|DKK|2483|4880|vetalmen|||0|4|0||Icepharma hf|Zoetis Belgium S.A.|||||2483|4880||2 149624|B05BB0114|Natriumklorid Fresenius Kabi|irl|9|mg/ml|500|ml|20|pokar|Kabipac|B05BB01|01.11.2015||R|0|0|0|0|0|1|FKA|0|0|0|100|DKK|2175|4116|lyfsjukr|||1|10000|0||Vistor hf|Fresenius Kabi AB|Elektrólýtar||2175||2175|4116||1 150162|S01GX0801|Zaditen|augndr|0,25|mg/ml|0,4|ml|60|sk-hyl||S01GX08|01.01.2013||R|0|0|0|0|G|0|TEA|0|0|0|100|SEK|4475|7282|lyfalmen|||1|24|0||Vistor hf|Laboratories THEA|Ketotifen||4475||4475|7282||1 150521|B03XA0201|Aranesp|stl|40|mcg/spr|0,4|ml|4|áf.spr|nálavörn|B03XA02|01.11.2010||R|0|0|0|1|0|1|RAG|0|0|0|100|DKK|39211|52295|lyfsjukr|||1|1,6|0|35,5600|Vistor hf|Amgen|Darbepóetín alfa||||39211|52295||1 151191|N05AF0102|Fluanxol Depot|stl|20|mg/ml|1|ml|10|lykjur||N05AF01|01.03.1977||R|0|0|0|0|G|0|LBK|0|0|0|100|DKK|5663|8917|lyfalmen|||1|10|0|50,0000|Lundbeck Export A/S|H. Lundbeck A/S|Flúpentixól||5663||5663|8917||1 151217|G01AF0102|Flagyl|sk-stíll|500|mg|10|stk|1|pakki|+ hanskar|G01AF01|01.10.1995||R|0|0|0|0|G|0|SNO|0|0|0|100|NOK|853|2296|lyfalmen|||1|10|0|10,0000|Vistor hf|Sanofi-aventis Norge AS|Metrónídazól||853||853|2296||1 151250|J05AX6701|Viekirax|filmhtfl|137,5|mg|56|stk|1|þpakki|12,5mg/75mg/50mg|J05AX67|01.10.2015||R|0|0|0|1|0|1|ABV|0|1|0|100|DKK|1750219|2182362|lyfsjukr|||1|56|0||Vistor hf|AbbVie Ltd.|Ombitasvir, paritaprevir og ritonavir||1750219||1750219|2182362||1 151518|N06DX0101|Ebixa|filmhtfl|20|mg|28|stk|1|þpakki||N06DX01|01.11.2008||R|1|0|0|0|G|0|LBK|0|0|0|100|DKK|11249|16605|lyfalmen|V0606|4972|1|28|0|28,0000|Lundbeck Export A/S|H. Lundbeck A/S|Memantín||||11249|16605||1 151529|N06DX0101|Ebixa|filmhtfl|20|mg|98|stk|1|þpakki||N06DX01|01.11.2008||R|1|0|0|0|G|0|LBK|0|0|0|100|DKK|37036|49544|lyfalmen|V0607|10877|1|98|0|98,0000|Lundbeck Export A/S|H. Lundbeck A/S|Memantín||37036||37036|49544||1 151532|C03CA0101|Furix|töflur|20|mg|100|stk|1|glas||C03CA01|01.04.2014||R|1|0|0|0|G|0|TPA|0|0|0|100|DKK|375|1638|lyfalmen|V0633|1575|2|100|0|50,0000|Vistor hf|Takeda Pharma A/S|Fúrósemíð||375||375|1638||1 151627|G03GA0801|Ovitrelle|stl|250|mcg/spr|0,5|ml|1|pakki|lausn,áf.lyfjap.+ spr.nál|G03GA08|01.04.2012||R|0|0|0|1|G|0|MSE|0|0|0|100|SEK|4261|6987|lyfalmen|||1|0,5|0|1,0000|Icepharma hf|Merck Serono Europe Ltd|Chóríógónadótrópín alfa||||4261|6987||2 151640|G04CA0204|Tamsulogen|hylki|0,4|mg|90|stk|1|þpakki|með br. losunarhraða|G04CA02|01.05.2006||R|1|0|0|0|G|0|MYL|0|0|0|100|SEK|4559|3399|lyfalmen|V0148|3141|2|90|0|90,0000|Icepharma hf|Mylan AB|Tamsúlósín||1654||1654|3399||2 151737|S01AA2601|Azyter|augndr|15|mg/g|0,25|g|6|sk-ílá||S01AA26|01.04.2016||R|0|0|0|0|0|0|LTH|0|0|1|100|SEK|1116|2658|lyfalmen|||1|1,5|0||Vistor hf|Laboratoires THEA|azithromycin||1116||1116|2658||1 151810|QJ01CE9003|Penethaone vet.|sts|10|m.ae/hgl|1|hgl|1|pakki|+leysir|QJ01CE90|01.03.2016||R|0|0|0|0|0|0|DIV|0|0|0|100|IKR|1768|3475|vetalmen|||0|1|0||Dýraheilsa ehf|Divasa-Farmavic S.A.|||||1768|3475||2 151928|N06AA1201|Sinquan|hylki|25|mg|100|stk|1|þpakki||N06AA12|01.12.1972||R|1|0|0|0|G|0|PER|0|0|0|100|DKK|1388|3033|lyfalmen|||1|100|0|25,0000|Icepharma hf|Pfizer ApS|Doxepín||1388||1388|3033||1 151975|A02BC0110|Omeprazol ratiopharm|sþ-hylki|20|mg|100|stk|1|glas|hart|A02BC01|01.02.2012||R|1|0|0|0|G|0|RAT|0|0|0|100|IKR|4359|3035|lyfalmen|V0006|2825|2|100|0|100,0000|LYFIS ehf|ratiopharm GmbH|Ómeprazól||1390||1390|3035||2 152197|C07AB0213|Metoprololsuccinat Hexal|forðatfl|25|mg|100|stk|1|plglas|23,75 mg metoprololsuccinat|C07AB02|01.04.2015||R|1|0|0|0|G|0|SSA|0|0|0|100|DKK|1034|1875|lyfalmen|V0050|1875|2|100|0|15,8300|Artasan ehf|Hexal A/S|Metóprólól||547||547|1875||1 152223|M03BX0103|Lioresal|stl|50|mcg/ml|1|ml|5|lykjur|stl.intrathecal.|M03BX01|01.10.1995||R|0|0|0|1|0|1|HES|0|0|0|100|DKK|1690|3448|lyfsjukr|||1|5|0|0,4500|Vistor hf|Novartis Healthcare A/S|Baklófen||1690||1690|3448||1 152318|D01BA0204|Terbinafine (Lyf og heilsa)|töflur|250|mg|28|stk|1|þpakki||D01BA02|01.12.2010||R|1|0|0|0|0|0|HOL|0|0|0|100|XEU|1963|3798|lyfalmen|V0123|3798|3|28|0|28,0000|Lyf og heilsa|Lyf og heilsa|Terbínafín||1944||1944|3798||2 152348|M02AA0701|Felden gel|hlaup|5|mg/g|25|g|1|túpa||M02AA07|01.04.1996||L|0|0|0|0|0|0|PER|0|0|1|100|IKR|||lyflausa|||0|25|0||Icepharma hf|Pfizer ApS|Píroxíkam|||||||1 152397|R03BA0202|Pulmicort Turbuhaler|innönddu|100|mcg/sk|200|skammtar|1|stauk||R03BA02|01.04.1991||R|0|0|0|0|G|0|AZD|0|0|0|100|SEK|2764|4927|lyfalmen|||1|200|0|25,0000|Vistor hf|AstraZeneca A/S DK|Búdesóníð||2764||2764|4927||1 152413|R03BA0202|Pulmicort Turbuhaler|innönddu|200|mcg/sk|200|skammtar|1|stauk||R03BA02|01.10.1989||R|0|0|0|0|G|0|AZD|0|0|0|100|SEK|4435|7227|lyfalmen|||1|200|0|50,0000|Vistor hf|AstraZeneca A/S DK|Búdesóníð||4435||4435|7227||1 152421|R03BA0202|Pulmicort Turbuhaler|innönddu|400|mcg/sk|200|skammtar|1|stauk||R03BA02|01.10.1989||R|0|0|0|0|G|0|ASZ|0|0|0|100|SEK|8110|12285|lyfalmen|||1|200|0|100,0000|Vistor hf|AstraZeneca UK Ltd|Búdesóníð||8110||8110|12285||1 152635|B01AC0601|Hjartamagnyl|sþ-tfl|75|mg|100|stk|1|glas||B01AC06|01.06.2012||L|1|0|0|0|0|0|AGP|0|0|0|100|IKR|||lyflausa|||0|100|0|100,0000|Actavis Group hf|Actavis Group PTC ehf|Asetýlsalicýlsýra|||||||1 152636|A02BC0113|Omeprazol Sandoz|sþ-hylki|10|mg|100|stk|1|glas||A02BC01|01.10.2015||R|1|0|0|0|G|0|SHS|0|0|0|100|DKK|3159|4639|lyfalmen|V0002|4639|2|100|0|50,0000|Artasan ehf|Sandoz A/S|Ómeprazól||2555||2555|4639||1 152653|J05AB1105|Valaciclovir Bluefish|filmhtfl|500|mg|10|stk|1|þpakki||J05AB11|01.06.2014||R|1|0|0|0|G|0|BLP|0|0|1|100|IKR|1427|2086|lyfalmen|V0033|1926|2|10|0|1,6667|LYFIS ehf|Bluefish Pharmaceuticals AB|Valacíklóvír||700||700|2086||2 152663|N04BC0504|Oprymea (Lyfis)|töflur|0,7|mg|100|stk|1|þpakki||N04BC05|01.07.2010||R|0|0|0|0|G|0|LYF|0|0|0|100|XEU|16676|24075|lyfalmen|||3|100|0|28,0000|LYFIS ehf|LYFIS ehf|Pramipexól||16676||16676|24075||2 152675|J05AB1105|Valaciclovir Bluefish|filmhtfl|500|mg|42|stk|1|þpakki||J05AB11|01.06.2014||R|1|0|0|0|G|0|BLP|0|0|1|100|IKR|5140|4838|lyfalmen|V0182|4735|2|42|0|7,0000|LYFIS ehf|Bluefish Pharmaceuticals AB|Valacíklóvír||2700||2700|4838||2 152687|J05AB1105|Valaciclovir Bluefish|filmhtfl|500|mg|90|stk|1|þpakki||J05AB11|01.06.2014||R|1|0|0|0|G|0|BLP|0|0|1|100|IKR|12712|10757|lyfalmen|||2|90|0|15,0000|LYFIS ehf|Bluefish Pharmaceuticals AB|Valacíklóvír||7000||7000|10757||2 152991|J02AC0201|Sporanox|hylki|100|mg|4|stk|1|þpakki|hart|J02AC02|01.01.1995||R|1|0|0|0|0|0|JAS|0|0|1|100|SEK|1038|2551|lyfalmen|||1|4|0|2,0000|Vistor hf|Janssen-Cilag AB|Ítracónazól||1038||1038|2551||1 153080|R06AE0704|Histasin|töflur|10|mg|10|stk|1|þpakki||R06AE07|01.01.1998||L|1|0|0|0|0|0|ACA|0|0|1|100|IKR|||lyflausa|||0|10|0|10,0000|Actavis Group hf|Actavis hf|Cetirizín|||||||1 153122|N01BB5203|Xylocain adrenalin|stl|10|mg/ml|20|ml|5|hgl|(10mg+5míkróg)/ml|N01BB52|01.10.1995||R|0|0|0|0|0|0|AZD|0|0|1|100|SEK|1521|3216|lyfalmen|||1|100|0||Vistor hf|AstraZeneca A/S DK|Lídókaín í blöndum||1521||1521|3216||1 153190|S01EC0402|Brinzolamide ratiopharm|augndr|10|mg/ml|5|ml|1|glas||S01EC04|01.04.2016||R|0|0|0|0|G|0|RAT|0|0|0|100|IKR|1176|2354|lyfalmen|V0444|2293|2|5|0|25,0000|LYFIS ehf|ratiopharm GmbH|Brinzólamíð||895||895|2354||2 153197|R06AE0704|Histasin|töflur|10|mg|30|stk|1|þpakki||R06AE07|01.01.1998||L|1|0|0|0|0|0|ACA|0|0|1|100|IKR|||lyflausa|||0|30|0|30,0000|Actavis Group hf|Actavis hf|Cetirizín|||||||1 153222|B03XA0201|Aranesp|stl|30|mcg/spr|0,3|ml|4|áf.spr|nálavörn|B03XA02|01.11.2010||R|0|0|0|1|0|1|RAG|0|0|0|100|DKK|29409|39897|lyfsjukr|||1|1,2|0|26,6700|Vistor hf|Amgen|Darbepóetín alfa||||29409|39897||1 153254|N01BB0203|Xylocain|stl|20|mg/ml|20|ml|5|hgl|með rotvörn|N01BB02|01.03.2003||R|0|0|0|0|0|0|AZD|0|0|1|100|SEK|1921|3766|lyfalmen|V0561|3056|1|100|0||Vistor hf|AstraZeneca A/S DK|Lídókaín||1921||1921|3766||1 153270|N01BB0203|Xylocain|stl|10|mg/ml|20|ml|5|hgl|með rotvörn|N01BB02|01.03.2003||R|0|0|0|0|0|0|AZD|0|0|1|100|SEK|1343|2971|lyfalmen|V0560|2851|1|100|0||Vistor hf|AstraZeneca A/S DK|Lídókaín||1343||1343|2971||1 153288|R06AE0704|Histasin|filmhtfl|10|mg|100|stk|1|þpakki||R06AE07|01.01.1998||L|1|0|0|0|G|0|ACA|0|0|1|100|XEU|||lyfalmen|V0575|2227|2|100|0|100,0000|Actavis Group hf|Actavis hf|Cetirizín|||||3637||1 153379|J02AA0104|AmBisome|irs|50|mg/hgl|10|hgl|1|pakki||J02AA01|01.07.2001||R|0|0|0|0|0|1|GSL|0|0|0|100|DKK|190169|242097|lyfsjukr|||1|10|0|14,2857|Gilead Nordic|Gilead Science International Ltd|Amfóterícín||190169||190169|242097||2 153417|C07AA0512|Pranolol|töflur|40|mg|100|stk|1|glas||C07AA05|01.10.2011||R|1|0|0|0|G|0|AGT|0|0|0|100|XEU|639|2002|lyfalmen|||2|100|0|25,0000|Actavis Group hf|Actavis Group hf|Própranólól||||639|2002||1 153507|L02BG0602|Exemestan- Actavis|filmhtfl|25|mg|100|stk|1|þpakki||L02BG06|01.08.2011||R|0|0|0|0|G|0|APC|0|0|0|100|XEU|26901|36725|lyfalmen|V0452|36725|2|100|0|100,0000|Actavis Group PTC ehf|Actavis Group PTC ehf|Exemestan||26901||26901|36725||1 153536|J02AC0201|Sporanox|hylki|100|mg|15|stk|1|þpakki|hart|J02AC02|01.04.1995||R|1|0|0|0|0|0|JAS|0|0|1|100|SEK|3652|6149|lyfalmen|||1|15|0|7,5000|Vistor hf|Janssen-Cilag AB|Ítracónazól||3652||3652|6149||1 153553|N05BA0205|Risolid|filmhtfl|10|mg|24|stk|1|glas||N05BA02|01.07.2012||R|1|0|0|0|0|0|AGT|0|0|1|100|XEU|571|1908|lyfalmen|||2|24|0|8,0000|Actavis Group hf|Actavis Group hf|Klórdíazepoxíð||571||571|1908||1 153564|N05BA0205|Risolid|filmhtfl|25|mg|24|stk|1|glas||N05BA02|01.07.2012||R|1|0|0|0|0|0|AGT|0|0|1|100|XEU|969|2456|lyfalmen|||2|24|0|20,0000|Actavis Group hf|Actavis Group hf|Klórdíazepoxíð||969||969|2456||1 153903|N03AX1108|Topiramat Bluefish|filmhtfl|100|mg|60|stk|1|þpakki||N03AX11|01.09.2015||R|1|0|0|0|G|0|BLP|0|0|0|100|XEU|5695|3718|lyfalmen|||2|60|0|20,0000|LYFIS ehf|Bluefish Pharmaceuticals AB|Tópíramat||1886||1886|3718|31.3.2016|2 154014|R06AX2705|Desloratadine Teva|filmhtfl|5|mg|30|stk|1|þpakki||R06AX27|01.09.2013||R|1|0|0|0|G|0|TEV|0|0|1|100|XEU|565|1900|lyfalmen|V0366|1900|2|30|0|30,0000|Medical ehf|Teva Pharma B.V.|Deslóratadín||565||565|1900||2 154048|L02AE0307|Reseligo|vefjalyf|3,6|mg|1|áf.spr|1|pakki||L02AE03|01.05.2016||R|0|0|0|1|G|0|IPC|0|0|0|100|SEK|21838|24729|lyfalmen|V0183|24729|2|1|0|27,9070|Alvogen|Alvogen IPco S.á.r.l.|Góserelín||17151||17151|24729||1 154480|R06AX2201|Kestine|filmhtfl|20|mg|100|stk|1|þpakki||R06AX22|01.06.2012||R|1|0|0|0|G|0|APS|0|0|1|100|DKK|8352|12618|lyfalmen|||1|100|0|200,0000|Vistor hf|Almirall-Prodesfarma S.A.|Ebastín||8352||8352|12618||1 154591|M01AB5501|Arthrotec|töflur|50,2|mg|20|stk|1|þpakki|0,2+50 mg|M01AB55|01.04.1993||R|1|0|0|0|G|0|PER|0|0|1|100|DKK|937|2412|lyfalmen|||1|20|0|10,0000|Icepharma hf|Pfizer ApS|Díklófenaknatríum í blöndum||937||937|2412||1 154618|B05BA1021|SmofKabiven|irl|1100|kcal|986|ml|4|pokar|fleyti|B05BA10|01.08.2011||R|0|0|0|0|0|1|FKA|0|0|0|100|DKK|18001|25899|lyfsjukr|||1|3944|0||Vistor hf|Fresenius Kabi AB|Blöndur||18001||18001|25899||1 154629|B05BA1021|SmofKabiven|irl|1600|kcal|1477|ml|4|pokar|fleyti|B05BA10|01.08.2011||R|0|0|0|0|0|1|FKA|0|0|0|100|DKK|20568|28715|lyfsjukr|||1|5908|0||Vistor hf|Fresenius Kabi AB|Blöndur||20568||20568|28715||1 154640|B05BA1021|SmofKabiven|irl|2200|kcal|1970|ml|4|pokar|fleyti|B05BA10|01.08.2011||R|0|0|0|0|0|1|FKA|0|0|0|100|DKK|25730|35244|lyfsjukr|||1|7880|0||Vistor hf|Fresenius Kabi AB|Blöndur||25730||25730|35244||1 154651|B05BA1021|SmofKabiven|irl|2700|kcal|2463|ml|3|pokar|fleyti|B05BA10|01.03.2014||R|0|0|0|0|0|1|FKA|0|0|0|100|DKK|23474|32391|lyfsjukr|||1|7389|0||Vistor hf|Fresenius Kabi AB|Blöndur||23474||23474|32391||1 154662|B05BA1022|SmofKabiven Elektrolytfri|irl|1100|kcal|986|ml|4|pokar|fleyti|B05BA10|01.08.2011||R|0|0|0|0|0|1|FKA|0|0|0|100|DKK|23795|32797|lyfsjukr|||1|3944|0||Vistor hf|Fresenius Kabi AB|Blöndur||23795||23795|32797||1 154673|B05BA1022|SmofKabiven Elektrolytfri|irl|1600|kcal|1477|ml|4|pokar|fleyti|B05BA10|01.08.2011||R|0|0|0|0|0|1|FKA|0|0|0|100|DKK|28839|39176|lyfsjukr|||1|5908|0||Vistor hf|Fresenius Kabi AB|Blöndur||28839||28839|39176||1 154706|B05BA1023|SmofKabiven Perifer|irl|800|kcal|1206|ml|4|pokar|fleyti|B05BA10|01.08.2011||R|0|0|0|0|0|1|FKA|0|0|0|100|DKK|15347|22246|lyfsjukr|||1|4824|0||Vistor hf|Fresenius Kabi AB|Blöndur||15347||15347|22246||1 154708|M01AB5501|Arthrotec|töflur|50,2|mg|100|stk|1|þpakki|0,2+50 mg|M01AB55|01.04.1993||R|1|0|0|0|G|0|PER|0|0|1|100|DKK|2922|5144|lyfalmen|||1|100|0|50,0000|Icepharma hf|Pfizer ApS|Díklófenaknatríum í blöndum||2922||2922|5144||1 154717|B05BA1023|SmofKabiven Perifer|irl|1300|kcal|1904|ml|4|pokar|fleyti|B05BA10|01.08.2011||R|0|0|0|0|0|1|FKA|0|0|0|100|DKK|22679|31385|lyfsjukr|||1|7616|0||Vistor hf|Fresenius Kabi AB|Blöndur||22679||22679|31385||1 154728|N06AX1608|Venlafaxin Actavis|forðahlk|75|mg|28|stk|1|þpakki|hart|N06AX16|01.08.2009||R|1|0|0|0|0|0|AGP|0|0|0|100|XEU|1351|2982|lyfalmen|V0336|2324|2|28|0|21,0000|Actavis Group hf|Actavis Group PTC ehf|Venlafaxín||1351||1351|2982||1 154739|N06AX1608|Venlafaxin Actavis|forðahlk|75|mg|98|stk|1|þpakki|hart|N06AX16|01.08.2009||R|1|0|0|0|G|0|AGP|0|0|0|100|XEU|3108|3090|lyfalmen|V0334|3090|2|98|0|73,5000|Actavis Group hf|Actavis Group PTC ehf|Venlafaxín||1430||1430|3090||1 154761|N06AX1608|Venlafaxin Actavis|forðahlk|150|mg|98|stk|1|þpakki|hart|N06AX16|01.08.2009||R|1|0|0|0|G|0|AGP|0|0|0|100|XEU|6163|3090|lyfalmen|V0335|3090|2|98|0|147,0000|Actavis Group hf|Actavis Group PTC ehf|Venlafaxín||1430||1430|3090||1 154952|L04AX0501|Esbriet|hylki|267|mg|252|stk|1|þpakki|hart|L04AX05|01.07.2012|31.03.2016|R|1|1|0|1|0|0|RRL|0|0|0|100|DKK|341415|430205|lyfalmen|||1|252|0|28,0300|Icepharma hf|Roche Registration Limited|Pírfenidon||341415||341415|430205||2 155033|N06DX0106|Memantine ratiopharm|filmhtfl|10|mg|30|stk|1|þpakki||N06DX01|01.10.2013||R|1|0|0|0|G|0|RGM|0|0|0|100|XEU|2632|2958|lyfalmen|V0604|2958|2|30|0|15,0000|Medical ehf|ratiopharm GmbH|Memantín||1334||1334|2958||2 155219|N03AX1106|Topiramate Portfarma|filmhtfl|25|mg|60|stk|1|þpakki||N03AX11|01.04.2010||R|1|0|0|0|G|0|POF|0|0|0|100|XEU|1566|2009|lyfalmen|V0247|1765|2|60|0|5,0000|Alvogen|Alvogen|Tópíramat||644||644|2009||1 155230|N03AX1106|Topiramate Portfarma|filmhtfl|50|mg|60|stk|1|þpakki||N03AX11|01.04.2010||R|1|0|0|0|G|0|POF|0|0|0|100|XEU|2828|3519|lyfalmen|V0248|3304|2|60|0|10,0000|Alvogen|Alvogen|Tópíramat||1741||1741|3519||1 155241|N03AX1106|Topiramate Portfarma|filmhtfl|100|mg|60|stk|1|þpakki||N03AX11|01.04.2010||R|1|0|0|0|G|0|POF|0|0|0|100|XEU|5101|3945|lyfalmen|V0249|3688|2|60|0|20,0000|Alvogen|Alvogen|Tópíramat||2051||2051|3945||1 155246|C10BA0501|Atozet|filmhtfl|30|mg|90|stk|1|þpakki|10 mg + 20 mg|C10BA05|01.03.2015||R|0|0|0|0|0|0|MLD|0|0|0|100|DKK|15697|22728|lyfalmen|||1|90|0||Vistor hf|Merck Sharp & Dohme Limited|Atorvastin og ezetimibe||15697||15697|22728||1 155390|N05AF0301|Truxal|töflur|50|mg|100|stk|1|glas||N05AF03|01.12.1972||R|1|0|0|0|G|0|LBK|0|0|0|100|DKK|1377|3018|lyfalmen|||1|100|0|16,6667|Lundbeck Export A/S|H. Lundbeck A/S|Klórprótixen||1377||1377|3018||1 155410|A02BC0403|Rabeprazol Krka|sþ-tfl|10|mg|28|stk|1|þpakki||A02BC04|01.03.2014||R|0|0|0|0|0|0|KRK|0|0|0|100|IKR|1500|2223|lyfalmen|V0466|1795|2|28|0|14,0000|LYFIS ehf|Krka Sverige AB|Rabeprazól||800||800|2223||2 155415|N03AX1404|Levetiracetam Actavis|filmhtfl|500|mg|100|stk|1|glas||N03AX14|01.04.2015||R|1|0|0|0|0|0|APC|0|0|0|100|XEU|10743|6760|lyfalmen|V0253|6065|2|100|0|33,3300|Actavis Group PTC ehf|Actavis Group PTC ehf|Levetíracetam||4096||4096|6760||1 155432|N05AF0301|Truxal|töflur|15|mg|100|stk|1|glas||N05AF03|01.12.1972||R|1|0|0|0|G|0|LBK|0|0|0|100|DKK|593|1938|lyfalmen|||1|100|0|5,0000|Lundbeck Export A/S|H. Lundbeck A/S|Klórprótixen||593||593|1938||1 155478|G03AC0902|Gestrina|filmhtfl|75|mcg|84|stk|1|þpakki|3x28 stk|G03AC09|01.01.2013||R|0|0|0|0|0|0|APC|0|0|0|100|XEU|1484|2625|lyfalmen|V0590|2625|2|84|0|84,0000|Actavis Group PTC ehf|Actavis Group PTC ehf|Desógestrel||1092||1092|2625||1 155494|M01AE0113|Ibuxin|filmhtfl|400|mg|30|stk|1|þpakki||M01AE01|01.09.2014||L|1|0|0|0|0|0|ROY|0|0|1|100|IKR|||lyflausa|||2|30|0|10,0000|Medical ehf|ratiopharm Oy|Íbúprófen|||||||2 155648|J02AC0201|Sporanox|hylki|100|mg|28|stk|1|þpakki|hart|J02AC02|01.04.1995||R|1|0|0|0|0|0|JAS|0|0|1|100|SEK|5563|8779|lyfalmen|||1|28|0|14,0000|Vistor hf|Janssen-Cilag AB|Ítracónazól||5563||5563|8779||1 156195|A04AA0107|Ondansetron Bluefish|filmhtfl|4|mg|100|stk|1|þpakki||A04AA01|01.09.2015||R|1|0|0|0|G|0|BLP|0|0|1|100|IKR|16000|20392|lyfalmen|V0383|20392|2|100|0|25,0000|LYFIS ehf|Bluefish Pharmaceuticals AB|Ondansetrón||14000||14000|20392||2 156439|L04AC1001|Cosentyx|stl|150|mg|2|áf.spr|1|þpakki||L04AC10|01.07.2015||R|0|0|0|1|0|1|NEL|0|1|0|100|DKK|145216|160040|lyfsjukr|||1|2|0||Vistor hf|Novartis Europharm Ltd|Secukinumab||124192||124192|160040||1 156506|A10AB0405|Humalog KwikPen|stl|100|ae/ml|3|ml|5|rörlyk||A10AB04|01.05.2011||R|0|0|0|0|G|0|ELD|0|0|0|100|XEU|4784|7707|lyfalmen|||1|15|0|37,5000|Icepharma hf|Eli Lilly Nederland B.V.|Insúlín lispró||4784||4784|7707||2 156517|A10AD0403|Humalog Mix25 KwikPen|stl|100|ae/ml|3|ml|5|rörlyk||A10AD04|01.05.2011||R|0|0|0|0|G|0|ELD|0|0|0|100|XEU|5356|8494|lyfalmen|||1|15|0|37,5000|Icepharma hf|Eli Lilly Nederland B.V.|Insulín lispro||5356||5356|8494||2 156528|J01XE0101|Furadantin|töflur|50|mg|15|stk|1|þpakki||J01XE01|01.08.2010||R|1|0|0|0|0|0|REP|0|0|1|100|SEK|368|1629|lyfalmen|||2|15|0|3,7500|Vistor hf|Recip AB|Nítrófúrantóín||368||368|1629||1 156596|A08AB0101|Xenical|hylki|120|mg|84|stk|1|þpakki||A08AB01|01.07.1999||R|1|0|0|0|0|0|ROC|0|0|0|100|DKK|8696|13091|lyfalmen|||1|84|0|28,0000|Icepharma hf|Roche|Orlístat||8696||8696|13091||2 156661|P02CA0101|Vermox|töflur|100|mg|6|stk|1|þpakki||P02CA01|01.12.1982||R|1|0|0|0|0|0|JAS|0|0|0|100|SEK|636|1998|lyfalmen|||1|6|0|3,0000|Vistor hf|Janssen-Cilag AB|Mebendazól||636||636|1998||1 156723|QN01AX0303|Ketador vet.|stl|100|mg/ml|50|ml|1|hgl|lausn|QN01AX03|01.04.2013||R|0|0|1|0|0|0|RPG|1|0|0|100|XEU|10427|19953|vetalmen|||0|50|0||Icepharma hf|Richter Pharma AG|Ketaminum||10427||10427|19953||2 157015|QP54AB5207|Equest Pramox vet|hlaup|||14,4|g|1|sk-dæl|19,5mg/g+121,7mg/g|QP54AB52|01.08.2014||R|0|0|0|0|0|0|ZOE|0|0|0|100|DKK|2524|4350|vetorma|||0|14,4|0||Icepharma hf|Zoetis Finland OY|||2524||2524|4350||2 157047|N07BA0146|Nicotinell Tropical Fruit|tyggigúm|2|mg|24|stk|1|þpakki||N07BA01|01.11.2011||L|0|0|0|0|0|0|SDF|0|0|1|100|IKR|||lyflausa|||0|24|0|1,6000|Artasan ehf|GlaxoSmithKline Consumer Healthcare A/S|Nikótín|||||||1 157331|QN03AA0201|Phenoleptil|töflur|100|mg|100|stk|1|þpakki|handa hundum|QN03AA02|01.05.2016||R|0|0|0|0|0|0|BVL|0|0|0|100|IKR|2895|5663|vetalmen|||1|100|0||Dýraheilsa ehf|Le Vet B.V.|Phenobarbitalum||2895||2895|5663||2 157756|L03AA0202|Zarzio|stl/irl|48|millj ae|0,5|ml|5|áf.spr|lausn|L03AA02|01.12.2015||R|0|0|0|1|0|1|SAR|0|0|0|100|DKK|37843|50565|lyfsjukr|||1|2,5|0|6,8600|Artasan ehf|Sandoz GmbH (A)|Fílgrastím||||37843|50565||1 157863|N03AF0104|Tegretol|töflur|200|mg|100|stk|1|þpakki||N03AF01|01.01.2010||R|1|0|0|0|G|0|HES|0|0|0|100|DKK|1352|2983|lyfalmen|V0239|2983|1|100|0|20,0000|Vistor hf|Novartis Healthcare A/S|Karbamazepín||1352||1352|2983||1 157869|D11AX1601|Vaniqa|krem|11,5|%|30|g|1|túpa||D11AX16|01.01.2013||R|0|0|0|0|0|0|ALM|0|0|0|100|DKK|5955|9319|lyfalmen|||1|30|0||Vistor hf|Almirall S.A.|Eflórníthin||5955||5955|9319||1 158098|C01BD0101|Cordarone|stl|50|mg/ml|3|ml|6|lykjur||C01BD01|01.08.2013||R|0|0|0|0|0|1|SNO|0|0|0|100|NOK|900|2361|lyfsjukr|||1|18|0|4,5000|Vistor hf|Sanofi-aventis Norge AS|Amíódarón||||900|2361||1 158163|N05AH0405|Seroquel Prolong|forðatfl|50|mg|10|stk|1|þpakki||N05AH04|01.10.2011|31.03.2016|R|1|1|0|0|0|0|ASA|0|0|0|100|SEK|1336|2961|lyfalmen|||1|10|0|1,2500|Vistor hf|Astra Zeneca A/S|Quetíapín||||1336|2961||1 158185|N05AH0405|Seroquel Prolong|forðatfl|150|mg|100|stk|1|þpakki||N05AH04|01.10.2011||R|1|1|0|0|0|0|ASA|0|0|0|100|SEK|24705|33948|lyfalmen|||1|100|0|37,5000|Vistor hf|Astra Zeneca A/S|Quetíapín||||24705|33948||1 158287|N03AF0104|Tegretol|töflur|200|mg|50|stk|1|þpakki||N03AF01|01.12.1972||R|1|0|0|0|G|0|HES|0|0|0|100|DKK|843|2283|lyfalmen|V0239|1492|1|50|0|10,0000|Vistor hf|Novartis Healthcare A/S|Karbamazepín||843||843|2283||1 158608|J02AX0501|Mycamine|irs|50|mg|1|hgl|1|pakki||J02AX05|01.03.2009||R|0|1|0|1|0|1|APG|0|0|0|100|XEU|40374|53766|lyfsjukr|||1|1|0|0,5000|Vistor hf|Astellas Pharma GmbH|Micafungin||||40374|53766||1 158619|J02AX0501|Mycamine|irs|100|mg|1|hgl|1|pakki||J02AX05|01.03.2009||R|0|1|0|1|0|1|APG|0|0|0|100|XEU|53141|69913|lyfsjukr|||1|1|0|1,0000|Vistor hf|Astellas Pharma GmbH|Micafungin||53141||53141|69913||1 158725|M01AB0516|Diklofenak Mylan|sþ-tfl|50|mg|100|stk|1|þpakki||M01AB05|01.12.2008||R|1|0|0|0|G|0|MYL|0|0|1|100|SEK|876|1984|lyfalmen|V0469|1948|2|100|0|50,0000|Icepharma hf|Mylan AB|Díklófenak||626||626|1984||2 159107|N02AB0303|Fentanyl Actavis|forðapl|25|mcg/klst|5|stk|1|þpakki||N02AB03|01.12.2008||R|0|0|1|0|G|0|AGP|0|0|0|100|XEU|1870|3296|lyfalmen|V0219|3296|2|5|0|7,5000|Actavis Group hf|Actavis Group PTC ehf|Fentanýl||1579||1579|3296||1 159118|N02AB0303|Fentanyl Actavis|forðapl|50|mcg/klst|5|stk|1|þpakki||N02AB03|01.12.2008||R|0|0|1|0|G|0|AGP|0|0|0|100|XEU|3207|5485|lyfalmen|V0220|5485|2|5|0|15,0000|Actavis Group hf|Actavis Group PTC ehf|Fentanýl||3170||3170|5485||1 159130|N02AB0303|Fentanyl Actavis|forðapl|75|mcg/klst|5|stk|1|þpakki||N02AB03|01.12.2008||R|0|0|1|0|G|0|AGP|0|0|0|100|XEU|4605|7021|lyfalmen|V0221|7019|2|5|0|22,5000|Actavis Group hf|Actavis Group PTC ehf|Fentanýl||4286||4286|7021||1 159141|N02AB0303|Fentanyl Actavis|forðapl|100|mcg/klst|5|stk|1|þpakki||N02AB03|01.12.2008||R|0|0|1|0|G|0|AGP|0|0|0|100|XEU|4992|7612|lyfalmen|V0223|7612|2|5|0|30,0000|Actavis Group hf|Actavis Group PTC ehf|Fentanýl||4715||4715|7612||1 159295|C09DA0310|Valsartan/Hydrochlorothiazide ratiopharm|filmhtfl|172,5|mg|98|stk|1|þpakki|160/12,5 mg|C09DA03|01.11.2012||R|1|0|0|0|G|0|RGM|0|0|0|100|IKR|3218|2774|lyfalmen|V0581|2774|2|98|0|98,0000|Medical ehf|ratiopharm GmbH|Valsartan og þvagræsilyf||1200||1200|2774||2 159341|L02BB0306|Bicalutamid LYFIS|filmhtfl|150|mg|90|stk|1|þpakki||L02BB03|01.06.2015||R|0|0|0|0|G|0|LYF|0|0|0|100|IKR|27000|21493|lyfalmen|V0421|21493|2|90|0|270,0000|LYFIS ehf|LYFIS ehf|Bíkalútamíð||14800||14800|21493||2 159454|L01XX3202|VORTEMYEL|sts|3,5|mg/hgl|1|hgl|1|pakki|lausn|L01XX32|01.12.2015||R|0|1|0|1|0|1|IPC|0|1|0|100|SEK|129039|166068|lyfsjukr|||2|1|0||Alvogen|Alvogen IPco S.á.r.l.|Bortezomíb||129039||129039|166068||1 159672|R05CB0105|Acetylcystein Mylan|freyðit|200|mg|25|stk|1|pakki||R05CB01|01.03.2010||R|0|0|0|0|G|0|MYL|0|0|1|100|SEK|449|1740|lyfalmen|||2|25|0|10,0000|Icepharma hf|Mylan AB|Acetýlcýstein||449||449|1740||2 159683|R05CB0105|Acetylcystein Mylan|freyðit|200|mg|100|stk|1|pakki||R05CB01|01.03.2010||R|0|0|0|0|G|0|MYL|0|0|1|100|SEK|1362|2997|lyfalmen|||2|100|0|40,0000|Icepharma hf|Mylan AB|Acetýlcýstein||1362||1362|2997||2 159772|B01AD0701|Rapilysin|sts|10|ae/hgl|2|hgl|1|pakki|+ leysir|B01AD07|01.02.2002||R|0|0|0|0|0|1|APC|0|0|0|100|DKK|121660|156891|lyfsjukr|||1|2|0|1,0000|Actavis Group PTC ehf|Actavis Group PTC ehf|Reteplasi||121660||121660|156891||1 159845|A02BC0509|Esomeprazole Alvogen|sþ-tfl|40|mg|100|stk|1|þpakki||A02BC05|01.10.2015||R|1|0|0|0|G|0|IPC|0|0|0|100|IKR|8980|5114|lyfalmen|V0012|5114|2|100|0|133,3300|Alvogen|Alvogen IPco S.á.r.l.|Esómeprazól||2900||2900|5114||1 159973|QM01AG9002|Flunixin|stl|50|mg/ml|50|ml|1|hgl|nautg,hesta og svín|QM01AG90|01.11.2011||R|0|0|0|0|0|0|NOB|1|0|0|100|XEU|3730|7247|vetalmen|||0|50|0||Norbrook Laboratories Limited|Norbrook Laboratories Limited|||3730||3730|7247||2 160164|M01AE0219|Alpoxen|töflur|250|mg|20|stk|1|þpakki||M01AE02|01.05.2014|31.03.2016|L|0|0|0|0|0|0|AGP|0|0|1|100|IKR|||lyflausa|||2|20|0|10,0000|Actavis Group hf|Actavis Group PTC ehf|Naproxen|||||||1 160279|A02BC0402|Rabeprazol Actavis|sh-tfl|20|mg|56|stk|1|þpakki||A02BC04|01.05.2011||R|0|0|0|0|G|0|APC|0|0|0|100|IKR|5300|2499|lyfalmen|V0010|2057|2|56|0|56,0000|Actavis Group PTC ehf|Actavis Group PTC ehf|Rabeprazól||1000||1000|2499||1 160325|N05BA0105|Stesolid|stl|5|mg/ml|2|ml|25|lykjur||N05BA01|01.04.1974||R|0|0|0|0|0|1|AGT|0|0|0|100|DKK|6686|5009|lyfsjukr|||2|50|0|25,0000|Actavis Group hf|Actavis Group hf|Díazepam||2824||2824|5009||1 160343|G03AA1206|Cleodette|filmhtfl|||63|stk|1|þpakki|3+0,02 mg|G03AA12|01.07.2014||R|0|0|0|0|0|0|AGP|0|0|0|100|XEU|2608|4712|lyfalmen|V0191|4712|2|63|0|84,0000|Actavis Group hf|Actavis Group PTC ehf|Dróspírenón og ethinylestradíól||2608||2608|4712||1 160523|N05AB0401|Stemetil|töflur|5|mg|100|stk|1|þpakki||N05AB04|01.06.1981||R|1|0|0|0|G|0|SNO|0|0|0|100|NOK|722|2116|lyfalmen|||1|100|0|5,0000|Vistor hf|Sanofi-aventis Norge AS|Próklórperazín||722||722|2116||1 160531|C10AC0101|Questran|mixtduft|4|g|50|skammtar|1|skpoki||C10AC01|01.05.2016||R|0|0|0|0|0|0|BRS|0|0|0|100|DKK|3295|5657|lyfalmen|||1|50|0|14,2800|Vistor hf|Bristol-Myers Squibb|Kólestýramín||3295||3295|5657||1 160692|N03AX1607|Pregabalin Alvogen|hylki|75|mg|56|stk|1|þpakki||N03AX16|01.02.2016||R|1|0|0|0|0|0|IPC|0|0|0|100|XEU|4128|6804|lyfalmen|V0686|3744|2|56|0|14,0000|Alvogen|Alvogen IPco S.á.r.l.|Pregabalín||||4128|6804||1 160852|R01AX0301|Atrovent|nefúði|21|mcg/sk|15|ml|1|glas|180 sk, lausn|R01AX03|01.09.2009||R|0|0|0|0|G|0|BOI|0|0|1|100|DKK|1067|2591|lyfalmen|||1|15|0|15,7500|Vistor hf|Boehringer Ingelheim|Ípratrópínbrómíð||1067||1067|2591||1 161075|H02AB0403|Solu-Medrol|sts|40|mg|1|stk|1|hgl|Act-O-Vial|H02AB04|01.08.1980||R|0|0|0|0|G|0|PER|0|0|1|100|DKK|606|1956|lyfalmen|||1|1|0|2,0000|Icepharma hf|Pfizer ApS|Metýlprednisólón||606||606|1956||1 161091|H02AB0901|Solu-Cortef|sts|250|mg|1|stk|1|hgl|Act-O-Vial|H02AB09|01.12.1972||R|0|0|0|0|0|1|PER|0|0|0|100|DKK|818|2248|lyfsjukr|||1|1|0|8,3333|Icepharma hf|Pfizer ApS|Hýdrókortisón||818||818|2248||1 161113|J01CR0202|Augmentin|töflur|1|g|14|stk|1|þpakki|875+125 mg|J01CR02|01.11.2015||R|0|0|0|0|0|0|GPH|0|0|1|100|IKR|1115|2657|lyfalmen|V0169|2014|1|14|0|12,2500|Vistor hf|GlaxoSmithKline Pharma A/S|Amoxicillín og ensímblokkar||1115||1115|2657||1 161117|H02AB0901|Solu-Cortef|sts|100|mg|1|stk|5|hgl|Act-O-Vial |H02AB09|01.08.1998||R|0|0|0|0|G|0|PER|0|0|1|100|DKK|2254|4225|lyfalmen|||1|5|0|16,6667|Icepharma hf|Pfizer ApS|Hýdrókortisón||2254||2254|4225||1 161125|H02AB0901|Solu-Cortef|sts|100|mg|1|stk|1|hgl|Act-O-Vial|H02AB09|01.12.1972||R|0|0|0|0|G|0|PER|0|0|1|100|DKK|539|1864|lyfalmen|||1|1|0|3,3333|Icepharma hf|Pfizer ApS|Hýdrókortisón||539||539|1864||1 161547|L02BG0601|Aromasin|töflur|25|mg|100|stk|1|þpakki||L02BG06|01.06.2001||R|0|0|0|0|G|0|PER|0|0|0|100|DKK|54735|71930|lyfalmen|V0452|36725|1|100|0|100,0000|Icepharma hf|Pfizer ApS|Exemestan||54735||54735|71930||1 161592|J01DD0101|Cefotaxim Villerton|sts|1|g|10|ml|10|hgl|lausn|J01DD01|01.02.2016||R|0|0|0|0|0|1|VIN|0|0|0|100|DKK|5778|9075|lyfsjukr|||2|100|0|2,5000|Icepharma hf|Villerton Invest SA|Cefotaximum||||5778|9075||2 161870|N07BC5101|Suboxone|tungur.t|10|mg|28|stk|1|þpakki|8+2 mg|N07BC51|01.08.2011||R|0|0|1|1|0|1|RBP|0|0|0|100|DKK|10913|16143|lyfsjukr|||1|28|0|28,0000|Vistor hf|RB Pharmaceuticals Limited|Búprenorfín í blöndum||10913||10913|16143||1 162080|H01AC0111|Omnitrope|stl|6,7|mg/ml|1,5|ml|5|rörlyk|lausn|H01AC01|01.04.2012||R|0|0|0|1|0|1|SDG|0|1|0|100|DKK|130155|167456|lyfsjukr|||1|7,5|0|75,0000|Artasan ehf|Sandoz GmbH (Kundl)|Sómatrópín||130155||130155|167456||1 162261|H01CB0501|Signifor|stl|0,6|mg|1|ml|60|lykjur||H01CB05|01.11.2012||R|0|0|0|0|0|0|NEL|0|0|0|100|DKK|484767|608494|lyfalmen|||1|60|0|30,0000|Vistor hf|Novartis Europharm Ltd|PAsireótið disapartate||484767||484767|608494||1 162276|A10BB0904|Zodediab|töflur|30|mg|180|stk|1|þpakki||A10BB09|01.03.2015||R|1|0|0|0|G|0|IPC|0|0|0|100|IKR|2658|4687|lyfalmen|V0020|4687|2|180|0|90,0000|Alvogen|Alvogen IPco S.á.r.l.|Glíklazíð||2590||2590|4687||1 162354|A07EC0101|Salazopyrin|töflur|500|mg|100|stk|1|glas||A07EC01|01.12.1972||R|1|0|0|0|G|0|PER|0|0|0|100|DKK|1796|3594|lyfalmen|||1|100|0|25,0000|Icepharma hf|Pfizer ApS|Súlfasalazín||1796||1796|3594||1 162778|QN05CM9002|Detonervin, vet.|stl|10|mg/ml|5|ml|1|hgl|f.hesta og nautgr.|QN05CM90|01.12.2011||R|0|0|0|0|0|0|LEV|1|0|0|100|XEU|5023|9700|vetalmen|||0|5|0||Le Vet B.V.|Le Vet B.V.|||5023||5023|9700||2 162808|C01DA1404|Fem-Mono Retard|forðatfl|60|mg|100|stk|1|þpakki||C01DA14|01.10.2013||R|1|0|0|0|G|0|MYL|0|0|0|100|SEK|2452|2722|lyfalmen|V0041|2722|2|100|0|150,0000|Icepharma hf|Mylan AB|Ísósorbíð mónónítrat||1162||1162|2722||2 162841|A10BA0203|Metformin Bluefish|filmhtfl|500|mg|100|stk|1|þpakki||A10BA02|01.09.2012||R|1|0|0|0|G|0|BLP|0|0|0|100|IKR|445|1728|lyfalmen|V0500|1600|2|100|0|25,0000|LYFIS ehf|Bluefish Pharmaceuticals AB|Metformín||440||440|1728||2 162852|A10BA0203|Metformin Bluefish|filmhtfl|850|mg|100|stk|1|þpakki||A10BA02|01.09.2012||R|1|0|0|0|G|0|BLP|0|0|0|100|IKR|745|2148|lyfalmen|||2|100|0|42,5000|LYFIS ehf|Bluefish Pharmaceuticals AB|Metformín||745||745|2148||2 162863|A10BA0203|Metformin Bluefish|filmhtfl|1000|mg|60|stk|1|þpakki||A10BA02|01.09.2012||R|1|0|0|0|G|0|BLP|0|0|0|100|IKR|918|1948|lyfalmen|V0502|1722|2|60|0|30,0000|LYFIS ehf|Bluefish Pharmaceuticals AB|Metformín||600||600|1948||2 162874|C10AA0106|Simvastatin Bluefish|filmhtfl|10|mg|100|stk|1|þpakki||C10AA01|01.08.2012||R|1|0|0|0|G|0|BLP|0|0|0|100|IKR|743|1711|lyfalmen|V0108|1711|2|100|0|33,3400|LYFIS ehf|Bluefish Pharmaceuticals AB|Simvastatín||428||428|1711||2 162885|C10AA0106|Simvastatin Bluefish|filmhtfl|20|mg|100|stk|1|þpakki||C10AA01|01.08.2012||R|1|0|0|0|G|0|BLP|0|0|0|100|IKR|836|1841|lyfalmen|V0109|1841|2|100|0|66,6700|LYFIS ehf|Bluefish Pharmaceuticals AB|Simvastatín||522||522|1841||2 162896|C10AA0106|Simvastatin Bluefish|filmhtfl|40|mg|100|stk|1|þpakki||C10AA01|01.08.2012||R|1|0|0|0|G|0|BLP|0|0|0|100|IKR|1347|2174|lyfalmen|V0110|2174|2|100|0|133,3333|LYFIS ehf|Bluefish Pharmaceuticals AB|Simvastatín||764||764|2174||2 162933|R03BA0501|Flixotide|innúðal|50|mcg/sk|120|skammtar|1|stauk||R03BA05|01.07.1994||R|0|0|0|0|G|0|GPH|0|0|0|100|GBP|1376|3016|lyfalmen|||1|120|0|20,0000|Vistor hf|GlaxoSmithKline Pharma A/S|Flútíkasón||1376||1376|3016||1 163036|N03AF0301|Inovelon|filmhtfl|200|mg|60|stk|1|þpakki||N03AF03|01.01.2015||R|0|0|0|1|G|0|EIS|0|0|0|100|SEK|9578|14305|lyfalmen|||1|60|0|8,5700|Vistor hf|Eisai Ltd|Rúfínamíð||9578||9578|14305||1 163089|N06BA0401|Ritalin|töflur|10|mg|30|stk|1|þpakki||N06BA04|01.12.1972||R|1|1|1|0|0|0|HES|0|0|0|100|DKK|1090|2622|lyfalmen|V0671|2325|1|30|0|10,0000|Vistor hf|Novartis Healthcare A/S|Metýlfenídat||1090||1090|2622||1 163239|L01BA0110|Metojectpen|stl|30|mg|1|áf-penni|1|pakki||L01BA01|01.05.2016||R|0|0|0|1|G|0|WIL|0|0|0|100|XEU|3698|6212|lyfalmen|||1|1|0||Williams & Halls efh|medac Gesellschaft|Metótrexat||3698||3698|6212||2 163246|P01AB0102|Flagyl|töflur|400|mg|30|stk|1|þpakki||P01AB01|01.10.1995||R|1|0|0|0|0|0|SNO|0|0|1|100|NOK|1216|2796|lyfalmen|||1|30|0|6,0000|Vistor hf|Sanofi-aventis Norge AS|Metrónídazól||1216||1216|2796||1 163354|C10BA0501|Atozet|filmhtfl|30|mg|30|stk|1|þpakki|10 mg + 20 mg|C10BA05|01.03.2015||R|0|0|0|0|0|0|MLD|0|0|0|100|DKK|5611|8845|lyfalmen|||1|30|0||Vistor hf|Merck Sharp & Dohme Limited|Atorvastin og ezetimibe||5611||5611|8845||1 163389|G03AD0102|Postinor|töflur|1500|mcg|1|stk|1|þpakki||G03AD01|01.09.2015||L|0|0|0|0|0|0|MEI|0|0|0|100|IKR|||lyflausa|||0|1|0|1,0000|Icepharma hf|Medimpex UK Limited|Levonorgestrel|||||||2 163429|C01CA0601|Fenylefrin Abcur|stl|0,1|mg/ml|5|ml|10|lykjur||C01CA06|01.09.2013||R|0|0|0|0|0|1|ABC|0|0|0|100|SEK|11370|16772|lyfsjukr|||2|50|0|1,2500|Icepharma hf|Abcur AB|Phenylephrin||11370||11370|16772||2 163493|R03BA0501|Flixotide|innúðal|125|mcg/sk|120|skammtar|1|stauk||R03BA05|01.07.1994||R|0|0|0|0|G|0|GPH|0|0|0|100|GBP|2402|4428|lyfalmen|||1|120|0|25,0000|Vistor hf|GlaxoSmithKline Pharma A/S|Flútíkasón||2402||2402|4428||1 163494|L01XE0501|Nexavar|filmhtfl|200|mg|112|stk|1|þpakki||L01XE05|01.06.2013||R|0|0|0|1|0|1|BYP|0|1|0|100|DKK|465983|585132|lyfsjukr|||1|112|0||Icepharma hf|Bayer Pharma AG|Sorafeníb||465983||465983|585132||2 163667|M01AE0113|Ibuxin|filmhtfl|800|mg|30|stk|1|þpakki||M01AE01|01.03.2013||R|1|0|0|0|G|0|ROY|0|0|1|100|XEU|541|1731|lyfalmen|||2|30|0|20,0000|Medical ehf|ratiopharm Oy|Íbúprófen||442||442|1731||2 163675|M01AE0113|Ibuxin|filmhtfl|800|mg|100|stk|1|þpakki||M01AE01|01.03.2013||R|1|0|0|0|G|0|ROY|0|0|1|100|XEU|1491|2585|lyfalmen|||2|100|0|66,6700|Medical ehf|ratiopharm Oy|Íbúprófen||1063||1063|2585||2 164125|R01AA0707|Otrivin Junior ukonserveret|nefúði|0,5|mg/ml|10|ml|1|glas||R01AA07|01.02.2014||L|0|0|0|0|0|0|NHE|0|0|1|100|IKR|||lyflausa|||0|10|0|6,2500|Artasan ehf|Novartis Healthcare A/S-A|Xýlómetazólín|||||||1 164256|B05BA0311|Glucos Fresenius Kabi|irl|50|mg/ml|500|ml|20|pokar|Freeflex umbúðir|B05BA03|01.12.2011||R|0|0|0|0|0|1|FKA|0|0|0|100|DKK|3521|5969|lyfsjukr|||1|10000|0||Vistor hf|Fresenius Kabi AB|Kolvetni||3521||3521|5969||1 164324|L01BB0202|Xaluprine|mixtúra|20|mg/ml|100|ml|1|glas||L01BB02|01.05.2015||R|0|0|0|1|0|1|VON|0|0|0|100|DKK|35102|47098|lyfsjukr|||1|100|0||Williams & Halls efh|Nova Laboratories Limited|Merkaptópúrín||35102||35102|47098||2 164592|QN03AX9001|Pexion|töflur|400|mg|100|stk|1|glas|handa hundum|QN03AX90|01.05.2014||R|0|0|0|0|0|0|BIV|0|0|0|100|DKK|8541|16374|vetalmen|||0|100|0||Vistor hf|Boehringer Ingelheim Vetmedica GmbH|Imepitoin||8541||8541|16374||1 164724|QA07XA9101|VetZin|forbl|1000|mg/g|25|kg|1|poki|forblanda f, lyfjabl. fóður|QA07XA91|01.03.2014||R|0|0|0|0|0|0|VEP|0|0|0|100|DKK|39141|74429|vetalmen|||0|25|0||Orion Pharma A/S Animal Health|Vepidan Aps|Zink Oxide||39141||39141|74429||2 164807|N04BD0105|Selegilin Mylan|töflur|5|mg|100|stk|1|glas||N04BD01|01.10.1995||R|1|0|0|0|G|0|MYL|0|0|0|100|SEK|2556|4640|lyfalmen|||2|100|0|100,0000|Icepharma hf|Mylan AB|Selegilín||||2556|4640||2 164818|N04BD0105|Selegilin Mylan|töflur|10|mg|100|stk|1|glas||N04BD01|01.05.2010||R|1|0|0|0|G|0|MYL|0|0|0|100|SEK|8427|12721|lyfalmen|||2|100|0|200,0000|Icepharma hf|Mylan AB|Selegilín||8427||8427|12721||2 164827|C02KX0501|Adempas|filmhtfl|2,5|mg|84|stk|1|þpakki||C02KX05|01.12.2014||R|1|0|0|1|0|1|BYE|0|1|0|100|DKK|363877|458141|lyfsjukr|||1|84|0|46,6700|Vistor hf|Bayer Pharma AG|Riociguatum||363877||363877|458141||1 164829|N06AA0406|Klomipramin Mylan|töflur|10|mg|100|stk|1|glas||N06AA04|01.10.2010||R|1|0|0|0|G|0|MYL|0|0|0|100|SEK|1000|2499|lyfalmen|||2|100|0|10,0000|Icepharma hf|Mylan AB|Klómípramín||1000||1000|2499||2 164840|N06AA0406|Klomipramin Mylan|töflur|25|mg|100|stk|1|glas||N06AA04|01.10.1992||R|1|0|0|0|G|0|MYL|0|0|0|100|SEK|1224|2807|lyfalmen|||2|100|0|25,0000|Icepharma hf|Mylan AB|Klómípramín||1224||1224|2807|31.3.2016|2 164871|A07EC0204|Asacol|eþ-stíll|500|mg|60|stk|1|pakki||A07EC02|01.01.2000||R|0|0|0|0|G|0|TIL|0|0|0|100|SEK|5360|8500|lyfalmen|V0014|8489|1|60|0|20,0000|Icepharma hf|Tillotts Pharma AB|Mesalazín (5-amínósalicýlsýra)||||5360|8500||2 165019|C05AA0102|Proctosedyl|eþ-smyr|||30|g|1|túpa||C05AA01|01.03.1981||L|0|0|0|0|0|0|SNO|0|0|0|100|IKR|||lyflausa|||0|30|0||Vistor hf|Sanofi-aventis Norge AS|Hýdrókortisón|||||||1 165175|N05BA0205|Risolid|filmhtfl|10|mg|100|stk|1|glas||N05BA02|01.03.2012||R|1|0|0|0|0|0|AGT|0|0|0|100|XEU|1353|2984|lyfalmen|||2|100|0|33,3300|Actavis Group hf|Actavis Group hf|Klórdíazepoxíð||1353||1353|2984||1 165306|QN05CM9101|Dorbene vet.|stl|1|mg/ml|10|mg|1|hgl||QN05CM91|01.05.2009||R|0|0|0|0|0|0|LAS|1|0|0|100|XEU|6146|11831|vetalmen|||0|10|0||Dýraheilsa ehf|Laboratorios SYVA S.A.|Metetomidinum||6146||6146|11831||2 165507|L01XX1904|Irinotecan Actavis|irþ|20|mg/ml|25|ml|1|hgl|lausn|L01XX19|01.04.2013|31.03.2016|R|0|0|0|1|0|1|AGT|0|0|0|100|XEU|6702|10347|lyfsjukr|||2|25|0||Actavis Group hf|Actavis Group hf|Írinótekan||6702||6702|10347||1 165603|H01AC0104|Saizen|sts|8|mg/ml|1,5|ml|5|rörlyk||H01AC01|01.05.2011||R|0|0|0|1|0|1|EMA|0|1|0|100|SEK|164589|210283|lyfsjukr|||1|7,5|0|90,0000|Icepharma hf|E. Merck AB|Sómatrópín||164589||164589|210283||2 165662|V08CA0301|Omniscan|stl|0,5|mmol/ml|10|ml|10|gl-hgl|röntgenskuggaefni fyrir MRT|V08CA03|01.12.2010||R|0|0|0|0|0|1|GEH|0|0|0|100|NOK|26304|35970|lyfsjukr|||1|100|0||Icepharma hf|GE Healthcare AS|Gadódíamíð||26304||26304|35970||2 165670|V08CA0301|Omniscan|stl|0,5|mmol/ml|15|ml|10|gl-hgl|röntgenskuggaefni fyrir MRT|V08CA03|01.12.2010||R|0|0|0|0|0|1|GEH|0|0|0|100|NOK|38299|51141|lyfsjukr|||1|150|0||Icepharma hf|GE Healthcare AS|Gadódíamíð||38299||38299|51141||2 165761|R06AE0501|Postafen|töflur|25|mg|100|stk|1|þpakki||R06AE05|01.12.1972||R|1|0|0|0|G|0|UCN|0|0|1|100|SEK|598|1945|lyfalmen|||1|100|0|50,0000|Vistor hf|UCB Nordic A/S|Meklózín||598||598|1945||1 165779|R06AE0501|Postafen|töflur|25|mg|25|stk|1|þpakki||R06AE05|01.12.1972||R|1|0|0|0|G|0|UCN|0|0|1|100|SEK|173|1360|lyfalmen|||1|25|0|12,5000|Vistor hf|UCB Nordic A/S|Meklózín||173||173|1360||1 165787|R06AE0501|Postafen|töflur|25|mg|10|stk|1|þpakki||R06AE05|01.12.1972||L|1|0|0|0|0|0|UCN|0|0|1|100|IKR|||lyflausa|||0|10|0|5,0000|Vistor hf|UCB Nordic A/S|Meklózín|||||||1 165799|C02KX0501|Adempas|filmhtfl|2|mg|42|stk|1|þpakki||C02KX05|01.12.2014||R|1|0|0|1|0|1|BYE|0|1|0|100|DKK|180636|230241|lyfsjukr|||1|42|0|18,6700|Vistor hf|Bayer Pharma AG|Riociguatum||180636||180636|230241||1 165859|B05BA0311|Glucos Fresenius Kabi|irl|100|mg/ml|500|ml|20|pokar|Freeflex umbúðir|B05BA03|01.12.2011||R|0|0|0|0|0|1|FKA|0|0|0|100|DKK|3720|6242|lyfsjukr|||1|10000|0||Vistor hf|Fresenius Kabi AB|Kolvetni||3720||3720|6242||1 165878|V08CA0301|Omniscan|stl|0,5|mmol/ml|20|ml|10|gl-hgl|röntgenskuggaefni fyrir MRT|V08CA03|01.12.2010||R|0|0|0|0|0|1|GEH|0|0|0|100|NOK|51093|67323|lyfsjukr|||1|200|0||Icepharma hf|GE Healthcare AS|Gadódíamíð||51093||51093|67323||2 165903|QA03DB0401|Spasmium vet.|stl|504|mg/ml|100|ml|1|hgl|500 mg/ml+4 mg/ml, lausn|QA03DB04|01.02.2016||R|0|0|0|0|0|0|RPG|1|0|0|100|XEU|5317|10258|vetalmen|||0|100|0||Icepharma hf|Richter Pharma AG|Butylscopolamine og metamizolum||||5317|10258||2 166008|QJ51RC2202|Nafpenzal vet.|spenalyf|||3|g|20|spr||QJ51RC22|01.02.2010||R|0|0|0|0|0|0|IBV|0|0|0|100|DKK|4162|8067|vetalmen|||0|60|0||Vistor hf|Intervet International BV|||||4162|8067||1 166120|A16AX0701|Kuvan|lausnart|100|mg|120|stk|1|glas||A16AX07|01.04.2013||R|0|0|0|1|0|0|MSE|0|0|0|100|SEK|396937|499258|lyfalmen|||1|120|0||Icepharma hf|Merck Serono Europe Ltd|Saprópterín||396937||396937|499258||2 166157|P01BA0201|Plaquenil|töflur|200|mg|100|stk|1|þpakki||P01BA02|01.12.1972||R|1|0|0|0|G|0|SNO|0|0|0|100|NOK|1341|2968|lyfalmen|||1|100|0|38,7597|Vistor hf|Sanofi-aventis Norge AS|Hydroxýklórókín||1341||1341|2968||1 166165|H01CA0201|Synarela|nefúði|200|mcg/sk|8|ml|1|stauk|60 sk|H01CA02|01.04.1992||R|0|0|0|1|G|0|PER|0|0|0|100|DKK|13877|20223|lyfalmen|||1|8|0|30,0000|Icepharma hf|Pfizer ApS|Nafarelín||13877||13877|20223||1 166351|M01AE0217|Naproxen-E Mylan|sh-tfl|250|mg|100|stk|1|glas||M01AE02|01.07.1993||R|1|0|0|0|G|0|MYL|0|0|1|100|SEK|1894|2627|lyfalmen|||2|100|0|50,0000|Icepharma hf|Mylan AB|Naproxen||1093||1093|2627||2 166362|M01AE0217|Naproxen-E Mylan|sh-tfl|500|mg|100|stk|1|glas||M01AE02|01.07.1993||R|1|0|0|0|G|0|MYL|0|0|1|100|SEK|3586|6058|lyfalmen|V0428|6058|2|100|0|100,0000|Icepharma hf|Mylan AB|Naproxen||3586||3586|6058||2 166869|N02BA0110|Aspirin Actavis|töflur|300|mg|100|stk|1|glas||N02BA01|01.11.2010||L|0|0|0|0|0|0|AUK|0|0|1|100|IKR|||lyflausa|||0|100|0|10,0000|Actavis Group hf|Actavis UK Ltd.|Acetýlsalicýlsýra|||||||1 167319|N06AX1608|Venlafaxin Actavis|forðahlk|37,5|mg|7|stk|1|þpakki|hart|N06AX16|01.08.2009||R|1|0|0|0|0|0|AGP|0|0|0|100|XEU|399|1671|lyfalmen|V0333|795|2|7|0|2,6300|Actavis Group hf|Actavis Group PTC ehf|Venlafaxín||399||399|1671||1 167905|A02BC0508|Esomeprazol Actavis|sþ-tfl|40|mg|28|stk|1|þpakki||A02BC05|01.01.2015||R|1|0|0|0|0|0|APC|0|0|0|100|XEU|1594|2490|lyfalmen|V0005|2344|2|28|0|37,3300|Actavis Group PTC ehf|Actavis Group PTC ehf|Esómeprazól||994||994|2490||1 168038|J05AR0901|Stribild|filmhtfl|745|mg|30|stk|1|glas|150+150+200+245 mg|J05AR09|01.11.2013||R|0|1|0|1|0|1|GSL|0|0|0|100|DKK|157566|201548|lyfsjukr|||1|30|0||Gilead Nordic|Gilead Science International Ltd|Emtrícítabín,tenófóvír disóproxíl,elvítegravír og cobícístat||157566||157566|201548||2 168275|M04AA0104|Allopurinol|töflur|100|mg|100|stk|1|þpakki||M04AA01|01.06.2009||R|1|0|0|0|G|0|AUK|0|0|0|100|GBP|444|1733|lyfalmen|V0119|1673|2|100|0|25,0000|Actavis Group hf|Actavis UK Ltd.|Allópúrinol||||444|1733||1 168309|A02BC0306|Lanser|sþ-hylki|30|mg|98|stk|1|þpakki||A02BC03|01.08.2009||R|1|0|0|0|G|0|AGP|0|0|0|100|IKR|4452|3696|lyfalmen|V0007|3393|2|98|0|98,0000|Actavis Group hf|Actavis Group PTC ehf|Lansóprazól||1870||1870|3696||1 168423|R06AX2701|Aerius|filmhtfl|5|mg|90|stk|1|þpakki||R06AX27|01.10.2015||R|1|0|0|0|G|0|MLD|0|0|1|100|DKK|3050|5320|lyfalmen|V0458|3137|1|90|0|90,0000|Vistor hf|Merck Sharp & Dohme Limited|Deslóratadín||3050||3050|5320||1 168589|N02CC0402|Maxalt Smelt|frþ.tfl|10|mg|6|stk|1|þpakki||N02CC04|01.11.2013||R|0|0|0|0|G|0|MSD|0|0|0|100|DKK|2481|4537|lyfalmen|V0621|1263|1|6|0|6,0000|Vistor hf|M.S.D.|Rizatriptan||2481||2481|4537||1 168618|L01BA0109|Metoject|stl|50|mg/ml|0,15|ml|1|áfspr||L01BA01|01.12.2012||R|0|0|0|1|G|0|WIL|0|0|0|100|SEK|2110|4026|lyfalmen|||1|0,15|0||Williams & Halls efh|medac Gesellschaft|Metótrexat||2110||2110|4026||2 168629|L01BA0109|Metoject|stl|50|mg/ml|0,2|ml|1|áfspr||L01BA01|01.12.2012||R|0|0|0|1|G|0|WIL|0|0|0|100|SEK|2260|4233|lyfalmen|||1|0,2|0||Williams & Halls efh|medac Gesellschaft|Metótrexat||2260||2260|4233||2 168640|L01BA0109|Metoject|stl|50|mg/ml|0,3|ml|1|áfspr||L01BA01|01.12.2012||R|0|0|0|1|G|0|WIL|0|0|0|100|SEK|2483|4540|lyfalmen|||1|0,3|0||Williams & Halls efh|medac Gesellschaft|Metótrexat||2483||2483|4540||2 168651|L01BA0109|Metoject|stl|50|mg/ml|0,4|ml|1|áfspr||L01BA01|01.12.2012||R|0|0|0|1|G|0|WIL|0|0|0|100|SEK|2807|4986|lyfalmen|||1|0,4|0||Williams & Halls efh|medac Gesellschaft|Metótrexat||2807||2807|4986||2 168662|L01BA0109|Metoject|stl|50|mg/ml|0,5|ml|1|áfspr||L01BA01|01.12.2012||R|0|0|0|1|G|0|WIL|0|0|0|100|SEK|2956|5191|lyfalmen|||1|0,5|0||Williams & Halls efh|medac Gesellschaft|Metótrexat||2956||2956|5191||2 168740|N03AF0105|Tegretol Retard|forðatfl|200|mg|200|stk|1|þpakki||N03AF01|01.07.1988||R|1|0|0|0|G|0|HES|0|0|0|100|DKK|2715|4859|lyfalmen|V0240|4858|1|200|0|40,0000|Vistor hf|Novartis Healthcare A/S|Karbamazepín||2715||2715|4859||1 168971|N03AF0105|Tegretol Retard|forðatfl|400|mg|200|stk|1|þpakki||N03AF01|01.07.1988||R|1|0|0|0|G|0|HES|0|0|0|100|DKK|5011|8019|lyfalmen|V0433|8017|1|200|0|80,0000|Vistor hf|Novartis Healthcare A/S|Karbamazepín||5011||5011|8019||1 168997|L01CA0401|Navelbine|irþ|10|mg/ml|1|ml|10|hgl||L01CA04|01.03.1998||R|0|0|0|1|0|1|PFP|0|0|0|100|SEK|26427|36126|lyfsjukr|||1|10|0||Vistor hf|Pierre Fabre Pharma|Vínorelbín||26427||26427|36126||1 169175|N03AX1603|Pregabalin Krka|hylki|225|mg|56|stk|1|þpakki||N03AX16|01.04.2015||R|1|0|0|0|0|0|KNM|0|0|0|100|XEU|11332|7412|lyfalmen|V0688|6779|2|56|0|42,0000|LYFIS ehf|Krka d.d. Novo mesto|Pregabalín||4570||4570|7412||2 169433|L01CA0401|Navelbine|irþ|10|mg/ml|5|ml|10|hgl||L01CA04|01.03.1998||R|0|0|0|1|0|1|PFP|0|0|0|100|SEK|132134|169918|lyfsjukr|||1|50|0||Vistor hf|Pierre Fabre Pharma|Vínorelbín||132134||132134|169918||1 169557|J05AB0601|Cymevene|irs|500|mg|5|hgl|1|pakki|+innr.sía|J05AB06|01.10.1995||R|0|0|0|0|0|1|ROA|0|0|0|100|DKK|18348|26376|lyfsjukr|||1|5|0|5,0000|Icepharma hf|Roche A.S.|Gancíklóvír||18348||18348|26376||2 169664|J07BK0101|Varilrix|sts|||0,5|ml|1|hgl|þurrefni + 0.5 ml leysir|J07BK01|01.10.1995||R|0|0|0|0|0|0|GPH|0|0|0|100|GBP|4977|7973|lyfalmen|||1|0,5|0||Vistor hf|GlaxoSmithKline Pharma A/S|Hlaupabóla, veikluð veira||4977||4977|7973||1 169751|J01MA0204|Ciprofloxacin Portfarma|filmhtfl|500|mg|20|stk|1|þpakki||J01MA02|01.06.2009||R|1|0|0|0|0|0|POF|0|0|1|100|IKR|1168|2730|lyfalmen|V0411|2730|2|20|0|10,0000|Alvogen|Alvogen|Cíprófloxacín||1168||1168|2730||1 169762|J01MA0204|Ciprofloxacin Portfarma|filmhtfl|500|mg|10|stk|1|þpakki||J01MA02|01.06.2009||R|1|0|0|0|0|0|POF|0|0|1|100|IKR|647|2013|lyfalmen|V0177|2013|2|10|0|5,0000|Alvogen|Alvogen|Cíprófloxacín||647||647|2013||1 169773|J01MA0204|Ciprofloxacin Portfarma|filmhtfl|250|mg|20|stk|1|þpakki||J01MA02|01.06.2009||R|1|0|0|0|0|0|POF|0|0|1|100|IKR|638|2000|lyfalmen|V0418|2000|2|20|0|5,0000|Alvogen|Alvogen|Cíprófloxacín||638||638|2000||1 169784|J01MA0204|Ciprofloxacin Portfarma|filmhtfl|250|mg|10|stk|1|þpakki||J01MA02|01.06.2009||R|1|0|0|0|0|0|POF|0|0|1|100|IKR|393|1663|lyfalmen|V0176|1663|2|10|0|2,5000|Alvogen|Alvogen|Cíprófloxacín||393||393|1663||1 169912|N01BB0102|Marcain|stl|2,5|mg/ml|20|ml|5|gl-hgl|án rotv|N01BB01|01.03.2003||R|0|0|0|0|0|0|AZD|0|0|1|100|SEK|2519|4589|lyfalmen|||1|100|0||Vistor hf|AstraZeneca A/S DK|Búpívakaín||2519||2519|4589||1 169920|N01BB0102|Marcain|stl|5|mg/ml|20|ml|5|gl-hgl|án rotv|N01BB01|01.03.2003||R|0|0|0|0|0|0|AZD|0|0|1|100|SEK|2712|4855|lyfalmen|||1|100|0||Vistor hf|AstraZeneca A/S DK|Búpívakaín||2712||2712|4855||1 170062|L04AC0701|RoActemra|irþ|20|mg/ml|4|ml|1|hgl||L04AC07|01.07.2009||R|0|1|0|1|0|1|RRL|0|1|0|100|DKK|17648|25413|lyfsjukr|||1|4|0|4,0000|Icepharma hf|Roche Registration Limited|Tocilizúmabi||||17648|25413||2 170085|L04AC0701|RoActemra|irþ|20|mg/ml|10|ml|1|hgl||L04AC07|01.07.2009||R|0|1|0|1|0|1|RRL|0|1|0|100|DKK|43700|57972|lyfsjukr|||1|10|0|10,0000|Icepharma hf|Roche Registration Limited|Tocilizúmabi||||43700|57972||2 170092|J07BC2001|Twinrix Adult|stl|||1|ml|1|dæla|einnota dæla|J07BC20|01.01.1999||R|0|0|0|0|0|0|GBI|0|0|0|100|GBP|5226|8315|lyfalmen|||1|1|0||Vistor hf|GlaxoSmithKline Biologicals SA|Lifrarbólgubóluefni (hepatitis)-Blöndur||5226||5226|8315||1 170107|L04AC0701|RoActemra|irþ|20|mg/ml|20|ml|1|hgl||L04AC07|01.07.2009||R|0|1|0|1|0|1|RRL|0|1|0|100|DKK|87400|113244|lyfsjukr|||1|20|0|20,0000|Icepharma hf|Roche Registration Limited|Tocilizúmabi||87400||87400|113244||2 170486|C10A00001|Praluent|stl|75|mg/ml|1|ml|6|áfpen|lausn í áf.lyfjapenna|C10A000|01.02.2016||R|0|0|0|0|0|0|SGA|0|0|0|100|NOK|185918|236810|lyfalmen|||1|6|0||Vistor hf|Sanofi-aventis groupe|Alirocumab||||185918|236810||1 170489|G04BD0705|Tolterodine Sandoz|forðahlk|4|mg|28|stk|1|plglas||G04BD07|01.08.2013||R|1|0|0|0|G|0|SHS|0|0|0|100|DKK|3074|5353|lyfalmen|V0618|5353|1|28|0|28,0000|Artasan ehf|Sandoz A/S|Tólteródín||||3074|5353||1 170505|J04AB0201|Rimactan|hylki|300|mg|100|stk|1|þpakki||J04AB02|01.07.2012||R|1|0|0|0|G|0|SAD|0|0|0|100|DKK|12015|17660|lyfalmen|||1|100|0|50,0000|Icepharma hf|Sandoz GmbH|Rífampicín||12015||12015|17660||2 170555|N01BB5301|Carbocain adrenalin|stl|10|mg/ml|20|ml|5|hgl|10 mg+5 míkróg/ml|N01BB53|01.12.1982||R|0|0|0|0|0|0|AZD|0|0|1|100|SEK|2061|3959|lyfalmen|||1|100|0||Vistor hf|AstraZeneca A/S DK|Mepívakaín í blöndum||2061||2061|3959||1 170628|J01GB0304|Gentamicin B. Braun|irl|1|mg/ml|80|ml|20|fl||J01GB03|01.04.2011||R|0|0|0|0|0|1|BRA|0|0|0|100|XEU|10163|15111|lyfsjukr|||2|1600|0|6,6700|Actavis Group hf|Braun|Gentamícín||10163||10163|15111||1 170640|J01GB0304|Gentamicin B. Braun|irl|3|mg/ml|80|ml|20|fl||J01GB03|01.04.2011||R|0|0|0|0|0|1|BRA|0|0|0|100|XEU|24448|33623|lyfsjukr|||2|1600|0|20,0000|Actavis Group hf|Braun|Gentamícín||24448||24448|33623||1 170651|J01GB0304|Gentamicin B. Braun|irl|3|mg/ml|120|ml|20|fl||J01GB03|01.04.2011||R|0|0|0|0|0|1|BRA|0|0|0|100|XEU|36672|49083|lyfsjukr|||2|2400|0|30,0000|Actavis Group hf|Braun|Gentamícín||36672||36672|49083||1 170672|L03AA0202|Zarzio|stl/irl|30|millj ae|0,5|ml|5|áf.spr|lausn|L03AA02|01.12.2015||R|0|0|0|1|0|1|SAR|0|0|0|100|DKK|31825|42953|lyfsjukr|||1|2,5|0|4,2900|Artasan ehf|Sandoz GmbH (A)|Fílgrastím||||31825|42953||1 170697|M05BA0406|Alendronat Actavis|töflur|70|mg|12|stk|1|þpakki||M05BA04|01.06.2009||R|1|0|0|0|G|0|AGP|0|0|0|100|XEU|2984|2755|lyfalmen|V0203|2755|2|12|0|84,0000|Actavis Group hf|Actavis Group PTC ehf|Alendrónsýra||1186||1186|2755||1 170997|L01BC0701|Vidaza|sts|25|mg/ml|4|ml|1|hgl|dreifa|L01BC07|01.09.2009||R|0|0|0|1|0|1|CEE|0|1|0|100|XEU|51151|67397|lyfsjukr|||1|4|0||Celgene Europe ltd|Celgene Europe ltd|Azasitidín||51151||51151|67397||2 171404|QS02CA0102|Canaural|eyrnadr|||25|ml|1|glas|handa hundum|QS02CA01|01.01.2012||R|0|0|0|0|0|0|DEC|0|0|0|100|DKK|2436|4788|vetalmen|||0|25|0||Vistor hf|Dechra Veterinary Products A/S|||2436||2436|4788||1 171603|N01BB5101|Marcain adrenalin|stl|2,5|mg/ml|20|ml|5|hgl||N01BB51|01.12.1982||R|0|0|0|0|0|0|AZD|0|0|1|100|SEK|3123|5421|lyfalmen|||1|100|0||Vistor hf|AstraZeneca A/S DK|Búpívakaín í blöndum||3123||3123|5421||1 171611|N01BB5101|Marcain adrenalin|stl|5|mg/ml|20|ml|5|hgl||N01BB51|01.12.1982||R|0|0|0|0|0|0|AZD|0|0|1|100|SEK|3153|5462|lyfalmen|||1|100|0||Vistor hf|AstraZeneca A/S DK|Búpívakaín í blöndum||3153||3153|5462||1 171765|QA04AD9001|Cerenia|töflur|24|mg|4|stk|1|þpakki||QA04AD90|01.04.2015||R|0|0|0|0|0|0|ZBE|0|0|0|100|DKK|1301|2557|vetalmen|||0|4|0||Icepharma hf|Zoetis Belgium S.A.|||||1301|2557||2 171793|N03AX1101|Topimax|töflur|25|mg|60|stk|1|þpakki||N03AX11|01.01.2003||R|1|0|0|0|G|0|JAS|0|0|0|100|SEK|2676|4805|lyfalmen|V0247|1765|1|60|0|5,0000|Vistor hf|Janssen-Cilag AB|Tópíramat||2676||2676|4805||1 171876|N03AX1101|Topimax|töflur|50|mg|60|stk|1|þpakki||N03AX11|01.01.2003||R|1|0|0|0|G|0|JAS|0|0|0|100|SEK|4651|7524|lyfalmen|V0248|3304|1|60|0|10,0000|Vistor hf|Janssen-Cilag AB|Tópíramat||4651||4651|7524||1 171991|V08CA0101|Magnevist|stl|469|mg/ml|15|ml|5|spr|röntgenskuggaefni|V08CA01|01.04.2007||R|0|0|0|0|0|1|BGB|0|0|0|100|DKK|39843|53094|lyfsjukr|||1|75|0||Icepharma hf|Bayer Pharma AG|Gadópentetat||39843||39843|53094||2 172049|V08CA0101|Magnevist|stl|469|mg/ml|10|ml|5|spr|röntgenskuggaefni|V08CA01|01.04.2007||R|0|0|0|0|0|1|BGB|0|0|0|100|DKK|26562|36296|lyfsjukr|||1|50|0||Icepharma hf|Bayer Pharma AG|Gadópentetat||26562||26562|36296||2 172289|L04AX0501|Esbriet|hylki|267|mg|63|stk|1|þpakki|hart|L04AX05|01.02.2016||R|1|1|0|1|0|0|RRL|0|0|0|100|DKK|100721|130849|lyfalmen|V0484|130849|1|63|0|7,0000|Icepharma hf|Roche Registration Limited|Pírfenidon||||100721|130849||2 172353|N03AX1101|Topimax|töflur|100|mg|60|stk|1|þpakki||N03AX11|01.01.2003||R|1|0|0|0|G|0|JAS|0|0|0|100|SEK|8609|12972|lyfalmen|V0249|3688|1|60|0|20,0000|Vistor hf|Janssen-Cilag AB|Tópíramat||8609||8609|12972||1 172395|N03AX1101|Topimax|töflur|200|mg|60|stk|1|þpakki||N03AX11|01.01.2003||R|1|0|0|0|G|0|JAS|0|0|0|100|SEK|15668|22688|lyfalmen|V0252|13555|1|60|0|40,0000|Vistor hf|Janssen-Cilag AB|Tópíramat||15668||15668|22688||1 172411|V08CA0101|Magnevist|stl|469|mg/ml|20|ml|5|spr|röntgenskuggaefni|V08CA01|01.04.2007||R|0|0|0|0|0|1|BGB|0|0|0|100|DKK|61093|79971|lyfsjukr|||1|100|0||Icepharma hf|Bayer Pharma AG|Gadópentetat||61093||61093|79971||2 172482|N06DA0303|Nimvastid (Lyfis)|hylki|6|mg|112|stk|1|þpakki||N06DA03|01.04.2011||R|1|0|0|0|G|0|LYF|0|0|0|100|IKR|27510|33649|lyfalmen|V0346|33649|3|112|0|74,6700|LYFIS ehf|LYFIS ehf|Rívastigmín||24469||24469|33649||2 172567|QP54AA0301|Dectomax vet.|stl|10|mg/ml|200|ml|1|hgl||QP54AA03|01.04.2015||R|0|0|0|0|0|0|ZOE|1|0|0|100|DKK|16956|29225|vetorma|||0|200|0||Icepharma hf|Zoetis Finland OY|Doramectinum||16956||16956|29225||2 172592|N06AX2601|Brintellix|filmhtfl|10|mg|98|stk|1|þpakki||N06AX26|01.10.2014||R|1|0|0|0|0|0|LBK|0|0|0|100|DKK|20005|28003|lyfalmen|||1|98|0|98,0000|Lundbeck Export A/S|H. Lundbeck A/S|Vortioxetín||20005||20005|28003||1 172627|C07FB0202|Logimax forte|forðatfl|105|mg|98|stk|1|pakki|þp 10 + 95 mg|C07FB02|01.07.1999||R|1|0|0|0|G|0|AZD|0|0|0|100|SEK|9473|14161|lyfalmen|||1|98|0|98,0000|Vistor hf|AstraZeneca A/S DK|Metóprólól og önnur blóðþrýstingslækkandi lyf||9473||9473|14161||1 172684|N02AA0303|Palladon|forðahlk|4|mg|56|stk|1|þpakki||N02AA03|01.09.2000||R|1|0|1|0|G|0|NOP|0|0|0|100|DKK|5444|8615|lyfalmen|||1|56|0|11,2000|Icepharma hf|Norpharma |Hýdrómorphón||5444||5444|8615||2 172692|N02AA0303|Palladon|forðahlk|8|mg|56|stk|1|þpakki||N02AA03|01.09.2000||R|1|0|1|0|G|0|NOP|0|0|0|100|DKK|10124|15057|lyfalmen|||1|56|0|22,4000|Icepharma hf|Norpharma |Hýdrómorphón||10124||10124|15057||2 172723|N05AH0410|Quetiapin Actavis|filmhtfl|25|mg|100|stk|1|þpakki||N05AH04|01.07.2013||R|1|0|0|0|G|0|AGP|0|0|0|100|XEU|2419|2148|lyfalmen|V0284|2135|2|100|0|6,2500|Actavis Group hf|Actavis Group PTC ehf|Quetíapín||745||745|2148||1 172759|N02AA0303|Palladon|forðahlk|16|mg|56|stk|1|þpakki||N02AA03|01.09.2000||R|1|0|1|0|G|0|NOP|0|0|0|100|DKK|17548|25275|lyfalmen|||1|56|0|44,8000|Icepharma hf|Norpharma |Hýdrómorphón||17548||17548|25275||2 172895|H01CB0501|Signifor|stl|0,9|mg|1|ml|60|lykjur||H01CB05|01.11.2012||R|0|0|0|0|0|0|NEL|0|0|0|100|DKK|544527|682819|lyfalmen|||1|60|0|45,0000|Vistor hf|Novartis Europharm Ltd|PAsireótið disapartate||544527||544527|682819||1 172916|N02AA0303|Palladon|forðahlk|24|mg|56|stk|1|þpakki||N02AA03|01.09.2000||R|1|0|1|0|G|0|NOP|0|0|0|100|DKK|22592|31275|lyfalmen|||1|56|0|67,2000|Icepharma hf|Norpharma |Hýdrómorphón||22592||22592|31275||2 173088|N05CD0202|Mogadon|töflur|5|mg|50|stk|1|þpakki||N05CD02|01.12.1972||R|1|0|0|0|0|0|MAB|0|0|1|100|SEK|357|1614|lyfalmen|||1|50|0|50,0000|Vistor hf|Meda AB|Nítrazepam||357||357|1614||1 173284|C10AA0702|Rosuvastatin Actavis|filmhtfl|20|mg|98|stk|1|þpakki||C10AA07|01.12.2012||R|1|0|0|0|0|0|APC|0|0|0|100|XEU|9461|11299|lyfalmen|V0118|11082|2|98|0|196,0000|Actavis Group PTC ehf|Actavis Group PTC ehf|Rósuvastatín||7394||7394|11299||1 173310|N05BE0108|Buspiron Mylan|töflur|5|mg|100|stk|1|þpakki||N05BE01|01.04.1995||R|1|0|0|0|G|0|MYL|0|0|1|100|SEK|2924|5147|lyfalmen|||2|100|0|16,6667|Icepharma hf|Mylan AB|Búspírón hýdróklóríð||2924||2924|5147||2 173344|A06AG1101|Microlax|innhl|||5|ml|12|túpa||A06AG11|01.12.1972||L|0|0|0|0|0|0|MCN|0|0|0|100|DKK|||lyfalmen|||0|60|0|12,0000|Vistor hf|McNeil Denmark ApS|Lárýlsúlfat, þ.m.t. í blöndum|||||3446||1 173518|N05BE0108|Buspiron Mylan|töflur|10|mg|100|stk|1|þpakki||N05BE01|01.04.1995||R|1|0|0|0|G|0|MYL|0|0|1|100|SEK|5008|8015|lyfalmen|||2|100|0|33,3333|Icepharma hf|Mylan AB|Búspírón hýdróklóríð||5008||5008|8015||2 173750|B03XA0201|Aranesp|stl|10|mcg/spr|0,4|ml|4|áf.spr|nálarvörn|B03XA02|01.08.2011||R|0|0|0|1|0|1|RAG|0|0|0|100|DKK|11772|17325|lyfsjukr|||1|1,6|0|8,8900|Vistor hf|Amgen|Darbepóetín alfa||11772||11772|17325||1 173895|N05AX1207|Lemilvo|töflur|15|mg|100|stk|1|glas||N05AX12|01.03.2016||R|1|1|0|0|G|0|AGP|0|0|0|100|XEU|37062|38159|lyfalmen|V0684|37504|2|100|0|100,0000|Actavis Group hf|Actavis Group PTC ehf|Aripiprazól||28035||28035|38159||1 173942|H01AC0111|Omnitrope|stl|3,3|mg/ml|1,5|ml|1|rörlyk|lausn|H01AC01|01.04.2012||R|0|0|0|1|0|1|SDG|0|1|0|100|DKK|12850|18809|lyfsjukr|||1|1,5|0|7,5000|Artasan ehf|Sandoz GmbH (Kundl)|Sómatrópín||12850||12850|18809||1 173955|N05BA0106|Stesolid Novum|stl|5|mg/ml|2|ml|10|lykjur||N05BA01|01.07.1985||R|0|0|0|0|0|1|AGT|0|0|0|100|DKK|1743|3521|lyfsjukr|||2|20|0|10,0000|Actavis Group hf|Actavis Group hf|Díazepam||1743||1743|3521||1 174300|J01CE0204|Kaavepenin|töflur|800|mg|14|stk|1|þpakki||J01CE02|01.01.1989||R|0|0|0|0|0|0|REP|0|0|1|100|SEK|534|1857|lyfalmen|||1|14|0|5,6000|Vistor hf|Recip AB|Fenoxýmetýlpenicillín||534||534|1857||1 174354|J01CA0414|Amoxicilline Actavis Disper|töflur|500|mg|20|stk|1|þpakki|hræra vel í vatni og drekka|J01CA04|01.03.2013|29.02.2016|R|0|0|0|0|0|0|AVB|0|0|1|100|XEU|1170|2733|lyfalmen|||2|20|0|10,0000|Actavis Group PTC ehf|Actavis BV|Amoxicillín||1170||1170|2733||1 174359|J01CE0204|Kaavepenin|töflur|1|g|14|stk|1|þpakki||J01CE02|01.01.1989||R|0|0|0|0|0|0|REP|0|0|1|100|SEK|545|1872|lyfalmen|||1|14|0|7,0000|Vistor hf|Recip AB|Fenoxýmetýlpenicillín||545||545|1872||1 174433|S01EA0501|Alphagan|augndr|2|mg/ml|5|ml|1|glas||S01EA05|01.04.2009||R|0|0|0|0|G|0|IRE|0|0|0|100|XEU|1276|2878|lyfalmen|V0368|2314|1|5|0|25,0000|Actavis ehf|Allergan Pharmaceuticals Ireland|Brímónidín||1276||1276|2878||1 174522|N04BC0505|Oprymea|forðatfl|0,26|mg|30|stk|1|þpakki||N04BC05|01.02.2014||R|0|0|0|0|G|0|KNM|0|0|0|100|IKR|2900|5114|lyfalmen|||2|30|0|3,1200|LYFIS ehf|Krka d.d. Novo mesto|Pramipexól||2900||2900|5114|| 174664|S01EA0501|Alphagan|augndr|2|mg/ml|5|ml|3|glös||S01EA05|01.04.2009||R|0|0|0|0|G|0|IRE|0|0|0|100|XEU|4229|6943|lyfalmen|V0368|6943|1|15|0|75,0000|Actavis ehf|Allergan Pharmaceuticals Ireland|Brímónidín||4229||4229|6943||1 174935|L01XE1301|Giotrif|filmhtfl|20|mg|28|stk|1|þpakki||L01XE13|01.05.2016||R|0|0|0|1|0|1|BOE|0|0|0|100|DKK|263689|333535|lyfsjukr|||1|28|0||Vistor hf|Boehringer Ingelheim International GmbH|Afatiníb||263689||263689|333535||1 175058|N05AH0413|Quetiapin ratiopharm|forðatfl|50|mg|10|stk|1|þpakki||N05AH04|01.05.2015||R|1|0|0|0|0|0|TEV|0|0|0|100|IKR|1262|2859|lyfalmen|||2|10|0|1,2500|Medical ehf|Teva Pharma B.V.|Quetíapín||1262||1262|2859||2 175333|QM01AC0603|Rheumocam|mixtúra|15|mg/ml|100|ml|1|glas|handa hestum|QM01AC06|01.09.2013||R|0|0|0|0|0|0|CHP|0|0|0|100|XEU|4750|9182|vetalmen|||0|100|0||Icepharma hf|Chanelle Pharmaceuticals|||4750||4750|9182||2 175370|G03GA0601|Puregon|stl|300|ae/rörly|0,36|ml|1|pakki||G03GA06|01.08.2015||R|0|0|0|1|G|0|MLD|0|0|0|100|DKK|14122|20560|lyfalmen|||1|0,36|0|4,0000|Vistor hf|Merck Sharp & Dohme Limited|Follitrópín beta||||14122|20560||1 175600|G03AA0904|Denise|töflur|||63|stk|1|þpakki|150/20 mcg|G03AA09|01.04.2014||R|0|0|0|0|0|0|RGM|0|0|0|100|IKR|1477|2361|lyfalmen|V0065|2351|2|63|0|84,0000|Medical ehf|ratiopharm GmbH|Desógestrel og ethinylestradíól||900||900|2361||2 175612|J05AB1101|Valtrex|töflur|500|mg|10|stk|1|þpakki||J05AB11|01.10.1996||R|1|0|0|0|G|0|GPH|0|0|1|100|GBP|2367|2283|lyfalmen|V0033|1926|1|10|0|1,6667|Vistor hf|GlaxoSmithKline Pharma A/S|Valacíklóvír||843||843|2283||1 175868|V03AN0101|Conoxia|lyfjagas|100|%|37|l|1|gashyl|kælt|V03AN01|01.10.2012||L|0|0|0|0|0|0|AGA|0|0|0|100|IKR|||lyflausa|||0|37|0||Ísaga ehf|AGA AB|Súrefni|||||||5 176214|N05AH0301|Zyprexa|húðuðtfl|2,5|mg|28|stk|1|þpakki||N05AH03|01.01.1999||R|1|0|0|0|0|0|ELD|0|0|0|100|XEU|4433|4686|lyfalmen|V0278|2563|1|28|0|7,0000|Icepharma hf|Eli Lilly Nederland B.V.|Olanzapín||2589||2589|4686||2 176520|M01AH0105|Cloxabix|hylki|100|mg|100|stk|1|þpakki||M01AH01|01.03.2013||R|1|0|0|0|G|0|WEH|0|0|1|100|XEU|3708|6226|lyfalmen|V0429|6226|2|100|0|50,0000|Williams & Halls efh|Williams & Halls ehf|Celekoxíb||3708||3708|6226||2 176616|N05CH0101|Circadin|forðatfl|2|mg|30|stk|1|þpakki||N05CH01|01.10.2012||R|0|0|0|0|0|0|RAD|0|0|1|100|DKK|2454|4500|lyfalmen|||2|30|0|30,0000|Vistor hf|RAD Neurim Pharmaceuticals EEC Ltd.|Melatonin||2454||2454|4500||1 177176|B05BA0312|Glucos Baxter Viaflo 50 mg/ml|irl|50|mg/ml|100|ml|50|pokar|lausn|B05BA03|01.07.2013||R|0|0|0|0|0|1|BAM|0|0|0|100|SEK|7740|11776|lyfsjukr|||1|5000|0||Icepharma hf|Baxter Medical AB|Kolvetni||7740||7740|11776||2 177454|N02BE0107|Paratabs|filmhtfl|500|mg|300|stk|1|glas||N02BE01|01.05.2013||R|1|0|0|0|0|0|ACA|0|0|1|100|XEU|735|2134|lyfalmen|V0231|2039|2|300|0|50,0000|Actavis Group hf|Actavis hf|Paracetamól||735||735|2134||1 177627|QH02AB0201|Dexaject|stl|2|mg/ml|100|ml|1|hgl||QH02AB02|01.06.2013||R|0|0|0|0|0|0|DOR|1|0|0|100|XEU|4078|7907|vetalmen|||0|100|0||Icepharma hf|Dopharma Reserch B.V|Dexamethasón||4078||4078|7907||2 177937|M04AC0102|Colrefuz|töflur|500|mcg|100|stk|1|þpakki||M04AC01|01.10.2015||R|0|0|0|0|G|0|AGP|0|0|0|100|XEU|6717|10367|lyfalmen|||2|100|0|50,0000|Actavis Group hf|Actavis Group PTC ehf|Kolkisín||6717||6717|10367||1 178223|B01AF0101|Xarelto|filmhtfl|10|mg|100|stk|1|þpakki||B01AF01|01.01.2014||R|1|1|0|0|G|0|BYP|0|0|0|100|DKK|30482|41254|lyfalmen|||1|100|0|50,0000|Icepharma hf|Bayer Pharma AG|Rivaoxaban||30482||30482|41254||2 178273|L01XE2501|Mekinist|filmhtfl|2|mg|30|stk|1|glas||L01XE25|01.01.2016||R|0|0|0|1|0|1|NEL|0|0|0|100|DKK|879151|1098998|lyfsjukr|||1|30|0||Vistor hf|Novartis Europharm Ltd|Trametinib||879151||879151|1098998||1 178722|N06AB0404|Citalopram Bluefish|filmhtfl|40|mg|100|stk|1|þpakki||N06AB04|01.09.2012||R|1|0|0|0|G|0|BLP|0|0|0|100|IKR|4998|3669|lyfalmen|V0320|3669|2|100|0|200,0000|LYFIS ehf|Bluefish Pharmaceuticals AB|Cítalópram||1850||1850|3669||2 179157|L04AB0601|Simponi|stl|50|mg|1|spr|1|spr|áfyllt sprauta|L04AB06|01.06.2011||R|0|1|0|1|0|1|JAN|0|1|0|100|DKK|126142|162465|lyfsjukr|||1|1|0|30,1200|Vistor hf|Janssen Biologics B.V.|Golimumab||126142||126142|162465||1 179552|B01AF0101|Xarelto|filmhtfl|15|mg|28|stk|1|þpakki||B01AF01|01.05.2012||R|1|1|0|0|G|0|BAP|0|0|0|100|DKK|8605|12966|lyfalmen|||1|28|0|21,0000|Icepharma hf|Bayer Schering Pharma AG|Rivaoxaban||||8605|12966||2 179557|C10BA0501|Atozet|filmhtfl|50|mg|90|stk|1|þpakki|10 mg + 40 mg|C10BA05|01.03.2015||R|0|0|0|0|0|0|MLD|0|0|0|100|DKK|15915|23028|lyfalmen|||1|90|0||Vistor hf|Merck Sharp & Dohme Limited|Atorvastin og ezetimibe||15915||15915|23028||1 180130|L01AX0303|Temomedac|hylki|250|mg|5|stk|1|glas||L01AX03|01.04.2011||R|0|0|0|1|0|1|WIL|0|1|0|100|XEU|103957|134873|lyfsjukr|||2|5|0||Williams & Halls efh|medac Gesellschaft|Temozolomid||103957||103957|134873||2 180166|A07EC0301|Dipentum|hylki|250|mg|100|stk|1|glas||A07EC03|01.01.1990||R|1|0|0|0|G|0|ATN|0|0|0|100|DKK|4411|7194|lyfalmen|||1|100|0|25,0000|Pharmanovia A/S|Atnahs Pharma UK Ltd|Olsalazín||4411||4411|7194||1 180500|G04CA0207|Tamsulosin Medical|hylki|0,4|mg|100|stk|1|þpakki|með br. losunarhraða|G04CA02|01.12.2012||R|1|0|0|0|G|0|MED|0|0|0|100|XEU|2314|3490|lyfalmen|V0148|3490|2|100|0|100,0000|Medical ehf|Medical ehf|Tamsúlósín||1720||1720|3490||2 180539|R01AA0705|Otrivin Menthol ukonserveret|nefúði|1|mg/ml|10|ml|1|glas|sk-úðari|R01AA07|01.05.2001||L|0|0|0|0|0|0|NHE|0|0|1|100|IKR|||lyflausa|||0|10|0|12,5000|Artasan ehf|Novartis Healthcare A/S-A|Xýlómetazólín|||||||1 180729|S03CA0401|Hydrocortison m.Terram.|aug.eydr|||5|ml|1|túpa|+ Polymyxin B|S03CA04|01.11.1981||R|0|0|0|0|G|0|PER|0|0|1|100|DKK|709|2098|lyfalmen|||1|5|0||Icepharma hf|Pfizer ApS|Hýdrókortisón og sýkingalyf||709||709|2098||1 181255|G01AF0201|Canesten|sk-krem|10|mg/g|50|g|1|sett|+stjaka|G01AF02|01.12.1982||L|0|0|0|0|0|0|BAE|0|0|0|100|IKR|||lyflausa|||0|50|0|5,0000|Icepharma hf|Bayer AB|Klótrímazól|||||||2 181552|QJ51DD1201|Pathozone vet.|spenalyf|250|mg/dælu|10|ml|10|dælur|dæla + rýja|QJ51DD12|01.10.1995|29.02.2016|R|0|0|0|0|0|0|ZOE|0|0|0|100|DKK|7196|13823|vetalmen|||0|100|0||Icepharma hf|Zoetis Finland OY|Cefoperazone||7196||7196|13823||2 181750|L01BA0108|Methotrexate Pfizer|irþ|100|mg/ml|10|ml|1|hgl||L01BA01|01.04.1991||R|0|0|0|1|0|1|PER|0|0|0|100|DKK|8703|13101|lyfsjukr|||1|10|0||Icepharma hf|Pfizer ApS|Metótrexat||8703||8703|13101||1 181980|C10BA0201|Inegy|töflur|30|mg|28|stk|1|þpakki|10 mg + 20 mg|C10BA02|01.07.2013||R|1|0|0|0|0|0|MLD|0|0|0|100|DKK|5447|8619|lyfalmen|||1|28|0|28,0000|Vistor hf|Merck Sharp & Dohme Limited|Ezetimíb og simvastatín||5447||5447|8619||1 182086|S01XA2020|Hyprosan|augndr|3,2|mg|10|ml|3|dropaí||S01XA20|01.09.2014||L|0|0|0|0|G|0|SAO|0|0|0|100|XEU|||lyfalmen|||0|30|0||Icepharma hf|Santen Oy|Gervitár og aðrar óvirkar samsetningar|||||5777||2 182307|L04AD0201|Advagraf|forðahlk|0,5|mg|50|stk|1|þpakki||L04AD02|01.11.2012||R|0|0|0|1|G|0|APE|0|0|0|100|XEU|10708|15861|lyfalmen|||1|50|0|5,0000|Vistor hf|Astellas Phama Europe B.V.|Tacrolimus||10708||10708|15861||1 182435|A10BB0903|Gliclazide LYFIS|töflur|30|mg|180|stk|1|þpakki||A10BB09|01.10.2014||R|1|0|0|0|G|0|LYF|0|0|0|100|IKR|8700|4701|lyfalmen|V0020|4687|2|180|0|90,0000|LYFIS ehf|LYFIS ehf|Glíklazíð||2600||2600|4701||2 182502|C01CA0302|Noradrenalin Abcur|irþ|1|mg/ml|5|ml|10|lykjur||C01CA03|01.05.2013||R|0|0|0|0|0|1|ABC|0|0|0|100|SEK|15327|22218|lyfsjukr|||2|50|0|8,3300|Icepharma hf|Abcur AB|Noradrenalín||15327||15327|22218||2 182707|QP54AA0301|Dectomax vet.|stl|10|mg/ml|50|ml|1|hgl||QP54AA03|01.02.2016||R|0|0|0|0|0|0|ZOE|1|0|0|100|DKK|4770|8222|vetorma|||0|50|0||Icepharma hf|Zoetis Finland OY|Doramectinum||||4770|8222||2 182831|QN51AA0102|Exagon vet.|stl|400|mg/ml|100|ml|5|hgl||QN51AA01|01.09.2014||R|0|0|1|0|0|0|RPG|1|0|0|100|XEU|18378|35037|vetalmen|||0|500|0||Icepharma hf|Richter Pharma AG|Pentobarbital||||18378|35037||2 182862|N04BC0507|Pramipexole Sandoz|forðatfl|2,1|mg|100|stk|1|þpakki||N04BC05|01.02.2015||R|1|0|0|0|G|0|SHS|0|0|0|100|DKK|30767|32660|lyfalmen|V0636|32660|2|100|0|84,0000|Artasan ehf|Sandoz A/S|Pramipexól||23687||23687|32660||1 183093|J07BA0101|FSME-Immun Junior|stl|1,2|mcg/sk|0,25|ml|1|spr|bóluefni|J07BA01|01.06.2015||R|0|0|0|0|0|0|PIS|0|0|0|100|SEK|3421|5831|lyfalmen|||1|0,25|0||Icepharma hf|Pfizer ApS|Heilabólguveira óvirk, borin með blóðmaur||3421||3421|5831||2 183327|QM01AG9001|Finadyne, vet.|stl|50|mg/ml|50|ml|1|hgl||QM01AG90|01.07.1992||R|0|0|0|0|0|0|IBV|1|0|0|100|DKK|4799|9275|vetalmen|||0|50|0||Vistor hf|Intervet International BV|||4799||4799|9275||1 183516|N02CC0105|Sumatriptan Bluefish|töflur|100|mg|6|stk|1|þpakki||N02CC01|01.03.2013||R|1|0|0|0|G|0|BLP|0|0|0|100|XEU|1696|1919|lyfalmen|V0234|1383|2|6|0|12,0000|LYFIS ehf|Bluefish Pharmaceuticals AB|Súmatriptan||579||579|1919||2 183660|C01CA2407|Jext|stl|300|mcg|1|stk|1|pakki|áfylltur penni|C01CA24|01.10.2011||R|0|0|0|0|G|0|ALK|0|0|1|100|DKK|5153|8215|lyfalmen|||1|1|0|0,6000|Vistor hf|ALK-Abello A/S|Adrenalín tartrat||||5153|8215||1 183871|H02AA0201|Florinef|töflur|0,1|mg|100|stk|1|glas||H02AA02|01.12.1972||R|0|0|0|0|G|0|APP|0|0|0|100|DKK|1058|2578|lyfalmen|||1|100|0|100,0000|Artasan ehf|Aspen Pharma Trading Limited|Flúdrókortisón||1058||1058|2578||1 184046|L01XE2701|IMBRUVICA|filmhtfl|140|mg|90|stk|1|glas||L01XE27|01.02.2016||R|1|0|0|1|0|1|JCI|0|1|0|100|SEK|784393|981145|lyfsjukr|||1|90|0||Vistor hf|Janssen-Cilag International N.V.|Ibrutinib||||784393|981145||1 184176|J01CR0201|Amoksiklav|mixtúrud|31,25|mg/ml|100|ml|1|glas|25+6.25 mg/ml|J01CR02|01.01.1996||R|0|0|0|0|0|0|LPM|0|0|1|100|XEU|522|1841|lyfalmen|||2|100|0|2,5000|Actavis Group hf|LEK Pharmaceuticals d.d.|Amoxicillín og ensímblokkar||522||522|1841||1 184192|J01CR0201|Amoksiklav|mixtúrud|62,5|mg/ml|100|ml|1|glas|50+12.5 mg/ml|J01CR02|01.01.1996||R|0|0|0|0|0|0|LPM|0|0|1|100|IKR|1517|2358|lyfalmen|||2|100|0|5,0000|Actavis Group hf|LEK Pharmaceuticals d.d.|Amoxicillín og ensímblokkar||898||898|2358||1 184234|A07EC0204|Asacol|innhl|10|mg/ml|100|ml|7|stk||A07EC02|01.02.2000||R|0|0|0|0|G|0|TIL|0|0|0|100|SEK|3215|5547|lyfalmen|V0017|5547|1|700|0|4,6667|Icepharma hf|Tillotts Pharma AB|Mesalazín (5-amínósalicýlsýra)||||3215|5547||2 184275|L02BG0401|Femar|töflur|2,5|mg|100|stk|1|þpakki||L02BG04|01.03.1998||R|0|0|0|0|G|0|HES|0|0|0|100|DKK|47705|63038|lyfalmen|V0185|13309|1|100|0|100,0000|Vistor hf|Novartis Healthcare A/S|Letrózól||47705||47705|63038||1 184341|J01CR0201|Amoksiklav|filmhtfl|625|mg|16|stk|1|þpakki|500+125 mg|J01CR02|01.01.1996||R|0|0|0|0|0|0|LPM|0|0|1|100|XEU|1207|2784|lyfalmen|||2|16|0|8,0000|Actavis Group hf|LEK Pharmaceuticals d.d.|Amoxicillín og ensímblokkar||1207||1207|2784||1 185025|R01AC0102|Glinor|nefúði|5,2|mg/sk|15|ml|1|glas||R01AC01|01.03.2015||L|0|0|0|0|0|0|RGM|0|0|1|100|IKR|||lyflausa|||0|15|0|1,9500|Medical ehf|ratiopharm GmbH|Krómóglíkatsýra|||||||2 186052|N02AA5908|Paracetamol/Kodein Actavis|filmhtfl|1060|mg|20|stk|1|þpakki|60+1000 mg|N02AA59|01.10.2015||R|1|0|0|0|0|0|AGP|0|0|1|100|XEU|1185|2753|lyfalmen|V0206|2753|2|20|0|13,3400|Actavis Group hf|Actavis Group PTC ehf|Kódein í blöndum nema með geðlyfjum||1185||1185|2753||1 186259|J02AC0102|Candizol|hylki|200|mg|30|stk|1|glas||J02AC01|01.02.2016||R|1|0|0|0|0|0|ACA|0|0|1|100|IKR|14199|12822|lyfalmen|V0419|12822|2|30|0|30,0000|Actavis Group hf|Actavis hf|Flúkónazól||8500||8500|12822||1 186713|N02AA0506|Oxikodon Depot Actavis|forðatfl|10|mg|28|stk|1|þpakki||N02AA05|01.10.2014||R|1|0|1|0|G|0|APC|0|0|0|100|XEU|857|2302|lyfalmen|V0597|2302|2|28|0|3,7300|Actavis Group PTC ehf|Actavis Group PTC ehf|Oxýcódon||857||857|2302||1 186790|N06DX0106|Memantine ratiopharm|filmhtfl|20|mg|100|stk|1|glas||N06DX01|01.10.2013||R|1|0|0|0|G|0|RGM|0|0|0|100|XEU|11693|12297|lyfalmen|V0607|11099|2|100|0|100,0000|Medical ehf|ratiopharm GmbH|Memantín||8119||8119|12297||2 186867|C10BA0501|Atozet|filmhtfl|20|mg|30|stk|1|þpakki|10 mg + 10 mg|C10BA05|01.03.2015||R|0|0|0|0|0|0|MLD|0|0|0|100|DKK|5546|8756|lyfalmen|||1|30|0||Vistor hf|Merck Sharp & Dohme Limited|Atorvastin og ezetimibe||5546||5546|8756||1 187032|N02AA5908|Paracetamol/Kodein Actavis|filmhtfl|1060|mg|100|stk|1|þpakki|60+1000 mg|N02AA59|01.10.2015||R|1|0|1|0|0|0|AGP|0|0|1|100|XEU|3541|5996|lyfalmen|V0210|5996|2|100|0|66,6600|Actavis Group hf|Actavis Group PTC ehf|Kódein í blöndum nema með geðlyfjum||3541||3541|5996||1 187154|N06AX1611|Duofaxin|forðatfl|225|mg|98|stk|1|þpakki||N06AX16|01.07.2015||R|1|0|0|0|G|0|MEV|0|0|0|100|DKK|4041|6307|lyfalmen|||2|98|0|220,5000|Vistor hf|MediLink A/S|Venlafaxín||3767||3767|6307||1 187191|A10BX0204|Repaglinide Krka|töflur|0,5|mg|120|stk|1|þpakki||A10BX02|01.11.2013||R|1|0|0|0|G|0|KNM|0|0|0|100|IKR|2459|4507|lyfalmen|V0462|4507|2|120|0|15,0000|LYFIS ehf|Krka d.d. Novo mesto|Repaglíníð||2459||2459|4507||2 187399|QP54AA0501|Stronghold|bl.lausn|240|mg|2|ml|3|túpa||QP54AA05|01.12.2014||R|0|0|0|0|0|0|ZBE|1|0|0|100|XEU|5196|8956|vetorma|||0|6|0||Icepharma hf|Zoetis Belgium S.A.|Selamectinum||5196||5196|8956||2 187595|D11AH0201|Elidel|krem|1|%|30|g|1|túpa||D11AH02|01.09.2012||R|0|0|0|0|G|0|MAB|0|0|1|100|SEK|3922|6520|lyfalmen|||1|30|0||Vistor hf|Meda AB|Pímekrólímus||3922||3922|6520||1 188338|S01XA2020|Hyprosan|augndr|3,2|mg|10|ml|1|dropaí||S01XA20|01.09.2014||L|0|0|0|0|G|0|SAO|0|0|0|100|XEU|||lyfalmen|||0|10|0||Icepharma hf|Santen Oy|Gervitár og aðrar óvirkar samsetningar|||||2673||2 188364|J01AA1201|Tygacil|irs|50|mg|10|hgl|1|pakki||J01AA12|01.08.2012||R|0|0|0|0|0|1|IPI|0|0|0|100|DKK|68699|89591|lyfsjukr|||1|10|0|5,0000|Icepharma hf|Pfizer Limited|Tigecýklín||68699||68699|89591||2 188405|N02CC0403|Rizatriptan Portfarma|munndr.t|10|mg|6|stk|1|þpakki||N02CC04|01.09.2013||R|0|0|0|0|G|0|POF|0|0|0|100|XEU|1400|1941|lyfalmen|V0621|1263|2|6|0|6,0000|Alvogen|Alvogen|Rizatriptan||595||595|1941||1 188631|N03AG0102|Orfiril|mixtúra|60|mg/ml|250|ml|1|glas||N03AG01|01.10.1995||R|0|1|0|0|G|0|DEA|0|0|0|100|XEU|2607|4710|lyfalmen|||1|250|0|10,0000|Vistor hf|Desitin Artzneimittel|Valpróínsýra||2607||2607|4710||1 188988|H02AB0205|Dexametason Abcur|töflur|4|mg|20|stk|1|þpakki|stakskammtaþynna|H02AB02|01.02.2016||R|1|0|0|0|G|0|ABC|0|0|1|100|SEK|3756|6292|lyfalmen|||2|20|0|53,3300|Icepharma hf|Abcur AB|Dexametasón||||3756|6292||2 189052|M05BA0604|Iasibon|irþ|1|mg/ml|2|ml|1|lykja||M05BA06|01.10.2012||R|0|0|0|1|0|1|PSA|0|0|0|100|DKK|8592|12948|lyfsjukr|||2|2|0|0,3400|Alvogen|Pharmathen S.A.|Íbandrónsýra||8592||8592|12948||1 189148|J05AG0501|EDURANT|filmhtfl|25|mg|30|stk|1|glas||J05AG05|01.04.2013||R|0|0|0|1|0|1|JCI|0|0|0|100|SEK|41198|54808|lyfsjukr|||1|30|0|30,0000|Vistor hf|Janssen-Cilag International N.V.|Rilpívírin||41198||41198|54808||1 189175|V03AC0101|Desferal|irs|500|mg|10|hgl|1|pakki|lausn|V03AC01|01.04.2007||R|0|0|0|0|0|1|HES|0|0|0|100|DKK|6373|9894|lyfsjukr|||1|10|0||Vistor hf|Novartis Healthcare A/S|Deferoxamín||6373||6373|9894||1 189235|H01CC0101|Orgalutran|stl|0,5|mg/ml|0,5|ml|1|áfspr||H01CC01|01.12.2015||R|0|0|0|1|0|1|MLD|0|0|0|100|DKK|4732|7635|lyfsjukr|||1|0,5|0|1,0000|Vistor hf|Merck Sharp & Dohme Limited|Ganirelix||4732||4732|7635||1 189506|H02AB0401|Depo-Medrol|stl|40|mg/ml|5|ml|1|hgl||H02AB04|01.12.1972||R|0|0|0|0|G|0|PER|0|0|1|100|DKK|2517|4587|lyfalmen|||1|5|0|10,0000|Icepharma hf|Pfizer ApS|Metýlprednisólón||2517||2517|4587||1 189514|H02AB0401|Depo-Medrol|stl|40|mg/ml|2|ml|1|hgl||H02AB04|01.12.1972||R|0|0|0|0|G|0|PER|0|0|1|100|DKK|914|2380|lyfalmen|V0413|2380|1|2|0|4,0000|Icepharma hf|Pfizer ApS|Metýlprednisólón||914||914|2380||1 189522|H02AB0401|Depo-Medrol|stl|40|mg/ml|1|ml|1|hgl||H02AB04|01.12.1972||R|0|0|0|0|G|0|PER|0|0|1|100|DKK|442|1731|lyfalmen|||1|1|0|2,0000|Icepharma hf|Pfizer ApS|Metýlprednisólón||442||442|1731||1 189627|L01BA0108|Methotrexate Pfizer|stl/irl|25|mg/ml|1|ml|1|hgl||L01BA01|01.11.2011||R|0|0|0|1|0|1|PER|0|0|0|100|DKK|410|1687|lyfsjukr|||1|1|0||Icepharma hf|Pfizer ApS|Metótrexat||410||410|1687||1 190000|N06AX2106|Duloxetin W&H|sþ-hylki|60|mg|28|stk|1|þpakki||N06AX21|01.08.2015||R|1|0|0|0|0|0|WEH|0|0|0|100|XEU|3910|4113|lyfalmen|V0693|4088|2|28|0|28,0000|Williams & Halls efh|Williams & Halls ehf|Duloxetín||2173||2173|4113||2 190042|G03CA0401|Ovestin|töflur|1|mg|90|stk|1|þpakki||G03CA04|01.11.2015||R|0|0|0|0|G|0|APP|0|0|0|100|DKK|1520|3214|lyfalmen|V0704|3214|1|90|0|45,0000|Artasan ehf|Aspen Pharma Trading Limited|Estríól||1520||1520|3214||1 190320|C03CA0101|Furix|stl|10|mg/ml|2|ml|5|lykjur||C03CA01|01.05.2014||R|0|0|0|0|G|0|TPA|0|0|0|100|DKK|241|1454|lyfalmen|||2|10|0|2,5000|Vistor hf|Takeda Pharma A/S|Fúrósemíð||241||241|1454||1 190425|C08CA0502|Adalat Oros|forðatfl|60|mg|98|stk|1|þpakki||C08CA05|01.03.2013||R|1|0|0|0|G|0|BYP|0|0|0|100|DKK|6873|10582|lyfalmen|||1|98|0|196,0000|Icepharma hf|Bayer Pharma AG|Nífedipín||||6873|10582||2 190702|M01AB0101|Confortid|eþ-stíll|100|mg|10|stk|1|pakki||M01AB01|01.01.2012||R|0|0|0|0|G|0|AGT|0|0|1|100|DKK|2091|4000|lyfalmen|||2|10|0|10,0000|Actavis Group hf|Actavis Group hf|Indómetacín||2091||2091|4000||1 190728|M01AB0101|Confortid|eþ-stíll|50|mg|10|stk|1|þpakki||M01AB01|01.08.2012||R|0|0|0|0|G|0|AGT|0|0|1|100|DKK|1353|2984|lyfalmen|||2|10|0|5,0000|Actavis Group hf|Actavis Group hf|Indómetacín||1353||1353|2984||1 190809|G03XB0201|Esmya|töflur|5|mg|28|stk|1|þpakki||G03XB02|01.05.2016||R|0|1|0|1|G|0|CLP|0|0|0|100|XEU|21079|29361|lyfalmen|||1|28|0|28,0000|Vistor hf|Gedeon Ricther Plc.|Ulipristal||21079||21079|29361||1 190894|N04BC0507|Pramipexole Sandoz|forðatfl|0,52|mg|100|stk|1|þpakki||N04BC05|01.09.2015||R|1|0|0|0|G|0|SHS|0|0|0|100|DKK|11743|15368|lyfalmen|V0635|15368|2|100|0|20,8000|Artasan ehf|Sandoz A/S|Pramipexól||10350||10350|15368||1 191045|C01DA0205|Nitroglyserin DAK|tungur.t|0,25|mg|100|stk|1|glas||C01DA02|01.06.2014||L|0|0|0|0|G|0|TPA|0|0|0|100|DKK|||lyfalmen|||0|100|0|10,0000|Vistor hf|Takeda Pharma A/S|Glýcerýltrínítrat|||||3496||1 191064|B05XC03|Vitalipid Infant|irþ|||10|ml|10|lykjur||B05XC|01.10.1985||R|0|0|0|0|0|1|FKA|0|0|0|100|DKK|3438|5854|lyfsjukr|||1|100|0||Vistor hf|Fresenius Kabi AB|Vítamín||3438||3438|5854||1 191079|C10AA0702|Rosuvastatin Actavis|filmhtfl|10|mg|98|stk|1|þpakki||C10AA07|01.12.2012||R|1|0|0|0|0|0|APC|0|0|0|100|XEU|6228|6880|lyfalmen|V0117|6880|2|98|0|98,0000|Actavis Group PTC ehf|Actavis Group PTC ehf|Rósuvastatín||4183||4183|6880||1 191247|B05XC02|Vitalipid Adult|irþ|||10|ml|10|lykjur||B05XC|01.10.1985||R|0|0|0|0|0|1|FKA|0|0|0|100|DKK|3239|5580|lyfsjukr|||1|100|0||Vistor hf|Fresenius Kabi AB|Vítamín||3239||3239|5580||1 191254|B05XC01|Soluvit|irs|||10|ml|10|hgl||B05XC|01.10.1985||R|0|0|0|0|0|1|FKA|0|0|0|100|DKK|3379|5773|lyfsjukr|||1|100|0||Vistor hf|Fresenius Kabi AB|Vítamín||3379||3379|5773||1 191403|R01AA0503|Nezeril|nefúði|0,25|mg/ml|7,5|ml|1|glas|sk-úðari|R01AA05|01.10.1994||L|0|0|0|0|0|0|OME|0|0|1|100|IKR|||lyflausa|||0|7,5|0|4,6875|Vistor hf|Omega Pharma Nordic AB|Oxýmetazólín|||||||1 191916|S01AA0101|Chloromycetin|augnsm|10|mg/g|4|g|1|túpa||S01AA01|01.12.1972||R|0|0|0|0|G|0|PER|0|0|1|100|DKK|464|1761|lyfalmen|||1|4|0||Icepharma hf|Pfizer ApS|Klóramfeníkól||464||464|1761||2 191986|N03AX1604|Brieka|hylki|300|mg|100|stk|1|glas||N03AX16|01.10.2015||R|1|0|0|0|0|0|AGP|0|0|0|100|XEU|21124|11915|lyfalmen|V0689|11915|2|100|0|100,0000|Actavis Group hf|Actavis Group PTC ehf|Pregabalín||7841||7841|11915||1 192296|H05BX0103|Cinacalcet Sandoz|filmhtfl|60|mg|28|stk|1|þpakki||H05BX01|01.05.2016||R|1|0|0|0|0|0|SHS|0|0|0|100|DKK|37673|50118|lyfalmen|V0721|50118|2|28|0|28,0000|Artasan ehf|Sandoz A/S|Cinacalcet||37490||37490|50118||1 192456|N06AX1104|Miron Smelt|munndr.t|15|mg|96|stk|1|þpakki||N06AX11|01.12.2011||R|0|0|0|0|G|0|AGP|0|0|0|100|XEU|3407|5812|lyfalmen|||2|96|0|48,0000|Actavis Group hf|Actavis Group PTC ehf|Mirtazapín||3407||3407|5812||1 192514|M01AH0106|Celecoxib Actavis|hylki|100|mg|100|stk|1|þpakki||M01AH01|01.12.2014||R|1|0|0|0|G|0|AGP|0|0|1|100|XEU|4264|6226|lyfalmen|V0429|6226|2|100|0|50,0000|Actavis Group hf|Actavis Group PTC ehf|Celekoxíb||3708||3708|6226||1 192617|C03AB0101|Centyl med kaliumklorid|sh-tfl|||100|stk|1|glas||C03AB01|01.12.1972||R|1|0|0|0|G|0|LEP|0|0|0|100|DKK|1430|3090|lyfalmen|||1|100|0|100,0000|Vistor hf|LEO Pharma A/S|Bendróflúmetíazíð og kalíum||1430||1430|3090||1 192644|C10BA0501|Atozet|filmhtfl|90|mg|30|stk|1|þpakki|10 mg + 80 mg|C10BA05|01.03.2015||R|0|0|0|0|0|0|MLD|0|0|0|100|DKK|5814|9125|lyfalmen|||1|30|0||Vistor hf|Merck Sharp & Dohme Limited|Atorvastin og ezetimibe||5814||5814|9125||1 192699|B05BB0117|Natriumklorid Baxter Viaflo 9 mg/ml|irl|9|mg/ml|100|ml|50|pokar|lausn|B05BB01|01.07.2013||R|0|0|0|0|0|1|BAM|0|0|0|100|SEK|6775|10447|lyfsjukr|||1|5000|0||Icepharma hf|Baxter Medical AB|Elektrólýtar||6775||6775|10447||2 192867|S01BA0103|Ozurdex|vefjalyf|700|mcg|1|stk|1|pakki|til ísetningar, vefjalyf|S01BA01|01.10.2012||R|0|1|0|1|0|1|IRE|0|1|0|100|XEU|156850|200657|lyfsjukr|||2|1|0||Actavis ehf|Allergan Pharmaceuticals Ireland|Dexametasón||156850||156850|200657||1 193122|N02CC0105|Sumatriptan Bluefish|töflur|50|mg|12|stk|1|þpakki||N02CC01|01.07.2014||R|1|0|0|0|G|0|BLP|0|0|0|100|XEU|2422|2182|lyfalmen|V0233|1757|2|12|0|12,0000|LYFIS ehf|Bluefish Pharmaceuticals AB|Súmatriptan||770||770|2182||2 193242|A07DA0301|Imodium|filmhtfl|2|mg|100|stk|1|þpakki||A07DA03|01.02.2014||R|1|0|0|0|G|0|MCS|0|0|0|100|SEK|880|2333|lyfalmen|V0447|2024|1|100|0|20,0000|Vistor hf|McNeil Sweden AB|Lóperamíð||880||880|2333||1 193432|N03AX2201|Fycompa|filmhtfl|10|mg|28|stk|1|þpakki||N03AX22|01.01.2015||R|1|0|0|0|G|0|EUR|0|0|0|100|SEK|21138|29436|lyfalmen|||1|28|0|35,0000|Vistor hf|Eisai Europe Ltd.|Perampanel||21138||21138|29436||1 193821|A12AA0601|Calcium-Sandoz|freyðit|500|mg|20|stk|1|glas||A12AA06|01.12.1972||L|0|0|0|0|0|0|SHS|0|0|0|100|IKR|||lyfalmen|||0|20|0|7,5500|Artasan ehf|Sandoz A/S|Kalsíumlaktóglúkónat|||||2384||1 193999|QN01AX9301|Tricaine Pharmaq|duft|1000|mg/g|250|g|1|askja|lausn handa fiskum|QN01AX93|01.07.2013||R|0|0|0|0|0|0|PHL|0|0|0|100|GBP|40500|65286|veteldis|||0|250|0||PHARMAQ Ltd.|PHARMAQ Ltd|Tricaine Methane Sulfónat||40500||40500|65286||1 194356|J02AC0102|Candizol|hylki|150|mg|4|stk|1|þpakki||J02AC01|01.08.2014||R|1|0|0|0|0|0|ACA|0|0|1|100|IKR|2031|1948|lyfalmen|V0556|1907|2|4|0|3,0000|Actavis Group hf|Actavis hf|Flúkónazól||600||600|1948||1 194404|QM01AC0606|Meloxidolor|stl|20|mg/ml|50|ml|1|hgl||QM01AC06|01.07.2014||R|0|0|0|0|0|0|VEB|1|0|0|100|XEU|4867|9404|vetalmen|||0|50|0||Dýraheilsa ehf|Le Vet Beheer B.V.|||4867||4867|9404||2 194545|N03AX1609|Pregabalin Sandoz GmbH|hylki|300|mg|56|stk|1|þpakki||N03AX16|01.02.2016||R|1|0|0|0|0|0|SDG|0|0|0|100|DKK|8707|7367|lyfalmen|V0689|6672|2|56|0|56,0000|Artasan ehf|Sandoz GmbH (Kundl)|Pregabalín||4537||4537|7367||1 194672|A02BC0508|Esomeprazol Actavis|sþ-tfl|40|mg|100|stk|1|glas||A02BC05|01.02.2015||R|1|0|0|0|G|0|APC|0|0|0|100|XEU|5777|5393|lyfalmen|V0012|5114|2|100|0|133,3300|Actavis Group PTC ehf|Actavis Group PTC ehf|Esómeprazól||3103||3103|5393||1 195040|C07AB0311|Atenolol Mylan|töflur|25|mg|250|stk|1|glas||C07AB03|01.07.2009||R|2|0|0|0|G|0|MYL|0|0|0|100|SEK|1565|3276|lyfalmen|||2|250|0|83,3300|Icepharma hf|Mylan AB|Atenólól||1565||1565|3276||2 195455|V07AB0002|Sterilt Vand "Baxter" Viaflo|leysir|||100|ml|50|pokar|leysir f.stungulyf|V07AB|01.07.2013||L|0|0|0|0|0|0|BAM|0|0|0|100|IKR|||lyfalmen|||0|5000|0||Icepharma hf|Baxter Medical AB|Leysi- og þynningarvökvar, þ.m.t. skolvökvar|||||12944||2 195583|H01AC0104|Saizen|sts|8|mg/ml|2,5|ml|1|rörlyk||H01AC01|01.05.2011||R|0|0|0|1|0|1|EMA|0|1|0|100|SEK|54863|72091|lyfsjukr|||1|2,5|0|30,0000|Icepharma hf|E. Merck AB|Sómatrópín||54863||54863|72091||2 195587|L04AB0601|Simponi|stl|50|mg|1|áf-penni|1|penni|áfylltur penni|L04AB06|01.06.2011||R|0|1|0|1|0|1|JAN|0|1|0|100|DKK|125115|161188|lyfsjukr|||1|1|0|30,1200|Vistor hf|Janssen Biologics B.V.|Golimumab||125115||125115|161188||1 195618|D07AC1301|Elocon|smyrsli|0,1|%|30|g|1|túpa||D07AC13|01.02.2014||R|0|0|0|0|G|0|MBV|0|0|1|100|DKK|897|2357|lyfalmen|||1|30|0||Vistor hf|Merck Sharp & Dohme B.V.|Mómetasón||897||897|2357||1 195669|D01AC2002|Pevisone|krem|||15|g|1|túpa||D01AC20|01.10.1988||R|0|0|0|0|0|0|JAS|0|0|1|100|SEK|621|1977|lyfalmen|||1|15|0||Vistor hf|Janssen-Cilag AB|Blöndur||621||621|1977||1 195768|R01BA0101|Rinexin|forðatfl|50|mg|30|stk|1|þpakki||R01BA01|01.03.1981||R|1|0|0|0|G|0|REP|0|0|1|100|SEK|330|1576|lyfalmen|||1|30|0|15,0000|Vistor hf|Recip AB|Fenýlprópanólamín||330||330|1576||1 195776|R01BA0101|Rinexin|forðatfl|50|mg|100|stk|1|glas||R01BA01|01.03.1981||R|1|0|0|0|G|0|REP|0|0|1|100|SEK|700|2086|lyfalmen|||1|100|0|50,0000|Vistor hf|Recip AB|Fenýlprópanólamín||700||700|2086||1 196022|C07AB0311|Atenolol Mylan|töflur|50|mg|250|stk|1|glas||C07AB03|01.07.2009||R|2|0|0|0|G|0|MYL|0|0|0|100|SEK|2000|3875|lyfalmen|||2|250|0|166,6700|Icepharma hf|Mylan AB|Atenólól||2000||2000|3875||2 196444|M04AA0105|Allonol|töflur|300|mg|100|stk|1|þpakki||M04AA01|01.06.2014||R|1|0|0|0|G|0|RGM|0|0|0|100|IKR|1681|3436|lyfalmen|||2|100|0|75,0000|Medical ehf|ratiopharm GmbH|Allópúrinol||1681||1681|3436||2 196551|N02BE0114|Pinex|mixtúra|24|mg/ml|100|ml|1|fl||N02BE01|01.07.2012||L|0|0|0|0|0|0|APC|0|0|1|100|IKR|||lyflausa|||0|100|0|0,8000|Actavis Group PTC ehf|Actavis Group PTC ehf|Paracetamól|||||||1 196851|C07AG0101|Trandate|stl|5|mg/ml|20|ml|5|lykjur||C07AG01|01.05.2012||R|0|0|0|0|G|0|APP|0|0|0|100|GBP|6974|10721|lyfalmen|||1|100|0|0,8333|Artasan ehf|Aspen Pharma Trading Limited|Labetalól||6974||6974|10721||1 196913|B03XA0201|Aranesp|stl|20|mcg/spr|0,5|ml|4|áf.spr|nálavörn|B03XA02|01.11.2010||R|0|0|0|1|0|1|RAG|0|0|0|100|DKK|19605|28107|lyfsjukr|||1|2|0|17,7800|Vistor hf|Amgen|Darbepóetín alfa||||19605|28107||1 197160|M04AA0105|Allonol|töflur|100|mg|100|stk|1|þpakki||M04AA01|01.05.2014||R|1|0|0|0|G|0|RGM|0|0|0|100|IKR|564|1673|lyfalmen|V0119|1673|2|100|0|25,0000|Medical ehf|ratiopharm GmbH|Allópúrinol||400||400|1673||2 197272|N03AX1607|Pregabalin Alvogen|hylki|150|mg|56|stk|1|þpakki||N03AX16|01.02.2016||R|1|0|0|0|0|0|IPC|0|0|0|100|XEU|6419|9957|lyfalmen|V0687|5952|2|56|0|28,0000|Alvogen|Alvogen IPco S.á.r.l.|Pregabalín||||6419|9957||1 197320|L04AB0204|Inflectra|irþ|100|mg|1|hgl|1|pakki||L04AB02|01.01.2015||R|0|1|0|1|0|1|SCO|0|1|0|100|XEU|56376|74005|lyfsjukr|||2|1|0|26,6700|Scope Pharma ehf|Hospira UK Limited|Infliximab||56376||56376|74005||1 197554|N07BA0147|Nicorette QuickMist|munnhúði|1|mg/sk|150|skammtar|1|fl|1 x 150 úðaskammtar|N07BA01|01.01.2013||L|0|0|0|0|0|0|MCN|0|0|1|100|IKR|||lyflausa|||0|150|0|0,4400|Vistor hf|McNeil Denmark ApS|Nikótín|||||||1 197657|N05BA1203|Tafil|töflur|1|mg|20|stk|1|þpakki||N05BA12|01.10.1990||R|1|0|0|0|0|0|PER|0|0|1|100|DKK|758|2166|lyfalmen|||1|20|0|20,0000|Icepharma hf|Pfizer ApS|Alprazólam||758||758|2166||1 197673|N05BA1203|Tafil|töflur|1|mg|100|stk|1|þpakki||N05BA12|01.10.1990||R|1|0|0|0|0|0|PER|0|0|0|100|DKK|2480|4536|lyfalmen|||1|100|0|100,0000|Icepharma hf|Pfizer ApS|Alprazólam||2480||2480|4536||1 197848|N01BB0203|Xylocain|hlaup|20|mg/ml|10|g|10|plspr|án rotvarnarefnis|N01BB02|01.10.2003||R|0|0|0|0|0|0|AZD|0|0|1|100|SEK|1561|3271|lyfalmen|||1|100|0||Vistor hf|AstraZeneca A/S DK|Lídókaín||1561||1561|3271||1 198220|QJ51DD1201|Pathozone vet.|spenalyf|250|mg/dælu|10|ml|10|dælur|dæla + rýja|QJ51DD12|01.04.2015||R|0|0|0|0|0|0|ZOE|0|0|0|100|DKK|7159|13753|vetalmen|||0|100|0||Icepharma hf|Zoetis Finland OY|Cefoperazone||7159||7159|13753||2 198334|M02AA1502|Voltaren|hlaup|11,6|mg/g|150|g|1|túpa||M02AA15|01.02.2015||L|0|0|0|0|0|0|NHE|0|0|1|100|IKR|||lyflausa|||0|150|0||Artasan ehf|Novartis Healthcare A/S-A|Díklófenak|||||||1 198582|C09CA0106|Losatrix|filmhtfl|50|mg|100|stk|1|þpakki||C09CA01|01.01.2014||R|1|0|0|0|G|0|RGM|0|0|0|100|IKR|2212|3049|lyfalmen|V0069|3049|2|100|0|100,0000|Medical ehf|ratiopharm GmbH|Lósartan||1400||1400|3049||2 198648|L01BC0203|Flurablastin|stl|50|mg/ml|20|ml|10|hgl||L01BC02|01.04.1991||R|0|0|0|1|0|1|PER|0|0|0|100|DKK|6347|9858|lyfsjukr|||1|200|0||Icepharma hf|Pfizer ApS|Flúóróúracíl||6347||6347|9858||1 199091|L01XX1101|Estracyt|hylki|140|mg|100|stk|1|glas||L01XX11|01.12.1978||R|0|0|0|0|G|0|PER|0|0|0|100|DKK|32026|43207|lyfalmen|||1|100|0||Icepharma hf|Pfizer ApS|Estramústín||32026||32026|43207||1 199539|N05CD0503|Halcion|töflur|0,25|mg|30|stk|1|þpakki||N05CD05|01.11.1981||R|1|0|0|0|0|0|PER|0|0|1|100|DKK|560|1893|lyfalmen|||1|30|0|30,0000|Icepharma hf|Pfizer ApS|Tríazólam||560||560|1893||1 199692|B03XA0201|Aranesp|stl|300|mcg/spr|0,6|ml|1|áf.spr|nálavörn|B03XA02|01.11.2010||R|0|0|0|1|0|1|RAG|0|0|0|100|DKK|83300|108059|lyfsjukr|||1|0,6|0|66,6700|Vistor hf|Amgen|Darbepóetín alfa||||83300|108059||1 199737|G02CB0301|Dostinex|töflur|0,5|mg|8|stk|1|glas||G02CB03|01.07.1993||R|1|0|0|0|G|0|PER|0|0|0|100|DKK|4130|6807|lyfalmen|V0126|6807|1|8|0|8,0000|Icepharma hf|Pfizer ApS|Kabególín||4130||4130|6807||1 199836|B01AC1301|ReoPro|stl|2|mg/ml|5|ml|1|hgl||B01AC13|01.09.1997||R|0|0|0|0|0|1|JAB|0|0|0|100|XEU|47279|62499|lyfsjukr|||1|5|0|0,4000|Janssen Biologics B.V.|Janssen Biologics B.V.|Abciximab||47279||47279|62499||2 199915|QP52AF0201|Banminth, vet.|pasta|115,3|mg/g|3|g|1|áfspr||QP52AF02|01.04.2016||R|0|0|0|0|0|0|ZOE|0|0|0|100|DKK|1091|1880|vetorma|||0|3|0||Icepharma hf|Zoetis Finland OY|||1091||1091|1880||2 199940|L01XC1101|Yervoy|stþ|5|mg/ml|40|ml|1|hgl|lausn|L01XC11|01.05.2012||R|0|1|0|1|0|1|BMS|0|1|0|100|DKK|2283686|2845846|lyfsjukr|||1|40|0||Vistor hf|Bristol-Myers Squibb Pharma EEIG|Ipilimumab||2283686||2283686|2845846||1 370007|B02BA0102|Konakion Novum|stl|10|mg/ml|0,2|ml|5|lykjur||B02BA01|01.10.1995||R|0|0|0|0|0|1|ROC|0|0|0|100|DKK|553|1883|lyfsjukr|||1|1|0|0,5000|Icepharma hf|Roche|Fýtómenadíón||553||553|1883||2 370173|QH01CA9301|Suprelorin|vefjalyf|9,4|mg|2|stk|1|pakki|fyrir hunda|QH01CA93|01.05.2012||R|0|0|0|0|0|0|VIR|1|0|0|100|XEU|29352|55857|vetalmen|||0|2|0||Vistor hf|Virbac S.A|Deslorelín||29352||29352|55857||1 370395|J01CA0413|Amoxin|filmhtfl|375|mg|20|stk|1|þpakki||J01CA04|01.03.2013||R|0|0|0|0|0|0|RGM|0|0|1|100|IKR|1425|2789|lyfalmen|||2|20|0|7,5000|Medical ehf|ratiopharm GmbH|Amoxicillín||1211||1211|2789||2 371284|D11AH0201|Elidel|krem|1|%|60|g|1|túpa||D11AH02|01.09.2012||R|0|0|0|0|G|0|MAB|0|0|1|100|SEK|8516|12844|lyfalmen|||1|60|0||Vistor hf|Meda AB|Pímekrólímus||8516||8516|12844||1 371583|A06AG1001|Klyx|innhl|||240|ml|1|fl||A06AG10|01.12.1978||L|0|0|0|0|0|0|FEL|0|0|0|100|IKR|||lyflausa|||0|240|0|1,0000|Vistor hf|Ferring Lægemidler A/S|Dókúsatnatríum, þ.m.t. í blöndum|||||||1 371609|A06AG1001|Klyx|innhl|||120|ml|1|fl||A06AG10|01.12.1978||L|0|0|0|0|0|0|FEL|0|0|0|100|IKR|||lyflausa|||0|120|0|1,0000|Vistor hf|Ferring Lægemidler A/S|Dókúsatnatríum, þ.m.t. í blöndum|||||||1 371617|A06AG1001|Klyx|innhl|||120|ml|10|fl||A06AG10|01.12.1978||L|0|0|0|0|0|0|FEL|0|0|0|100|DKK|||lyfalmen|||0|1200|0|10,0000|Vistor hf|Ferring Lægemidler A/S|Dókúsatnatríum, þ.m.t. í blöndum|||||9078||1 371658|A02BA0201|Asyran|töflur|150|mg|10|stk|1|þpakki||A02BA02|01.10.1995||L|1|0|0|0|0|0|ACA|0|0|0|100|IKR|||lyflausa|||0|10|0|5,0000|Actavis Group hf|Actavis hf|Ranitidín|||||||1 372045|N05AL0501|Solian|töflur|50|mg|90|stk|1|þpakki||N05AL05|01.01.2005||R|1|0|0|0|G|0|SNO|0|0|0|100|NOK|3405|5809|lyfalmen|||1|90|0|11,2500|Vistor hf|Sanofi-aventis Norge AS|Amísúlpríð||3405||3405|5809||1 372151|N04BA0209|Madopar Quick "125"|lausnart|125|mg|100|stk|1|glas|100+25 mg|N04BA02|01.11.2000||R|0|0|0|0|G|0|ROC|0|0|0|100|DKK|3082|5364|lyfalmen|||1|100|0|16,6667|Icepharma hf|Roche|Levódópa og dópadekarboxýl­asa­hemill||3082||3082|5364||2 372177|N07BA0103|Nicorette|innsogsl|10|mg|42|rör|1|pakki|þp+munnstk|N07BA01|01.09.1977||L|0|0|0|0|0|0|MCN|0|0|1|100|IKR|||lyflausa|||0|42|0|7,0000|Vistor hf|McNeil Denmark ApS|Nikótín|||||||1 372185|N07BA0103|Nicorette|innsogsl|10|mg|18|rör|1|pakki|þp+munnstk|N07BA01|01.09.1977||L|0|0|0|0|0|0|MCN|0|0|1|100|IKR|||lyflausa|||0|18|0|3,0000|Vistor hf|McNeil Denmark ApS|Nikótín|||||||1 372571|G03CA0401|Ovestin|sk-stíll|0,5|mg|15|stk|1|þpakki||G03CA04|01.08.2015||L|0|0|0|0|G|0|APP|0|0|0|100|DKK|||lyfalmen|||0|15|0|37,5000|Artasan ehf|Aspen Pharma Trading Limited|Estríól|||||2401||1 373234|C09AA0211|Enalapril Krka|töflur|10|mg|250|stk|1|glas||C09AA02|01.02.2016||R|1|0|0|0|G|0|KRK|0|0|0|100|IKR|2770|4935|lyfalmen|V0482|4935|2|250|0|250,0000|LYFIS ehf|Krka Sverige AB|Enalapríl||2770||2770|4935||2 373241|N05AL0501|Solian|töflur|200|mg|90|stk|1|þpakki||N05AL05|01.01.2005||R|1|0|0|0|G|0|SNO|0|0|0|100|NOK|7681|11694|lyfalmen|||1|90|0|45,0000|Vistor hf|Sanofi-aventis Norge AS|Amísúlpríð||7681||7681|11694||1 373251|L03AB1301|Plegridy|stl|||2|áf-penni|1|pakki|63 og 94 mcg|L03AB13|01.07.2015||R|0|0|0|1|0|1|BIB|0|0|0|100|XEU|114386|147844|lyfsjukr|||1|2|0|17,6400|Icepharma hf|Biogen Idec Ltd|Peginterferón beta-1a||114386||114386|147844||2 373324|R03AK0602|Seretide Diskus|innönddu|150|mcg/sk|60|skammtar|1|pakki|50+100 mcg, discus|R03AK06|01.05.2000||R|0|0|0|0|G|0|GPH|0|0|0|100|GBP|3825|6387|lyfalmen|||1|60|0|30,0000|Vistor hf|GlaxoSmithKline Pharma A/S|Salmeteról og fluticason||3825||3825|6387||1 373340|R03AK0602|Seretide Diskus|innönddu|300|mcg/sk|60|skammtar|1|pakki|50+250 mcg, discus|R03AK06|01.05.2000||R|0|0|0|0|G|0|GPH|0|0|0|100|GBP|4595|7447|lyfalmen|V0436|7447|1|60|0|30,0000|Vistor hf|GlaxoSmithKline Pharma A/S|Salmeteról og fluticason||4595||4595|7447||1 373365|R03AK0602|Seretide Diskus|innönddu|550|mcg/sk|60|skammtar|1|pakki|50+500 mcg, discus|R03AK06|01.05.2000||R|0|0|0|0|G|0|GPH|0|0|0|100|GBP|5877|9211|lyfalmen|V0437|9211|1|60|0|30,0000|Vistor hf|GlaxoSmithKline Pharma A/S|Salmeteról og fluticason||5877||5877|9211||1 373853|L02BB0307|Bicalutamid Medical|filmhtfl|50|mg|30|stk|1|þpakki||L02BB03|01.06.2012||R|0|0|0|0|G|0|MED|0|0|0|100|XEU|5602|8336|lyfalmen|V0420|4928|2|30|0|30,0000|Medical ehf|Medical ehf|Bíkalútamíð||5241||5241|8336||2 373857|C07AB0309|Atenolol Actavis|töflur|25|mg|100|stk|1|þpakki||C07AB03|01.10.2012||R|1|0|0|0|G|0|APC|0|0|0|100|XEU|393|1495|lyfalmen|V0541|1495|2|100|0|33,3300|Actavis Group PTC ehf|Actavis Group PTC ehf|Atenólól||271||271|1495||1 373951|G02CB0301|Dostinex|töflur|0,5|mg|2|stk|1|glas||G02CB03|01.04.1998||R|1|0|0|0|G|0|PER|0|0|0|100|DKK|1398|3046|lyfalmen|V0126|1702|1|2|0|2,0000|Icepharma hf|Pfizer ApS|Kabególín||1398||1398|3046||1 374143|L01XE1201|Caprelsa|filmhtfl|100|mg|30|stk|1|þpakki||L01XE12|01.07.2012||R|1|1|0|1|0|1|AZA|0|0|0|100|SEK|331500|417873|lyfsjukr|||1|30|0||Vistor hf|AstraZeneca AB|Vandetaníb||331500||331500|417873||1 374194|L01XE2501|Mekinist|filmhtfl|0,5|mg|30|stk|1|glas||L01XE25|01.01.2016||R|0|0|0|1|0|1|NEL|0|0|0|100|DKK|219788|278935|lyfsjukr|||1|30|0||Vistor hf|Novartis Europharm Ltd|Trametinib||219788||219788|278935||1 374231|A10BA0201|Glucophage|töflur|500|mg|100|stk|1|þpakki||A10BA02|01.01.1987||R|1|0|0|0|G|0|MCK|0|0|0|100|SEK|482|1786|lyfalmen|V0500|1600|1|100|0|25,0000|Icepharma hf|Merck Santé s.a.s.|Metformín||482||482|1786||2 374251|B05BA0311|Glucos Fresenius Kabi|irl|50|mg/ml|250|ml|30|pokar|Freeflex umbúðir|B05BA03|01.12.2011||R|0|0|0|0|0|1|FKA|0|0|0|100|DKK|5174|8244|lyfsjukr|||1|7500|0||Vistor hf|Fresenius Kabi AB|Kolvetni||5174||5174|8244||1 374279|L04AD0104|Ciqorin|hylki|25|mg|50|stk|1|þpakki||L04AD01|01.04.2014||R|0|0|0|0|G|0|TEV|0|0|0|100|IKR|6800|6903|lyfalmen|||2|50|0|5,0000|Medical ehf|Teva Pharma B.V.|Ciklospórín||4200||4200|6903||2 374319|H02AB0205|Dexametason Abcur|töflur|4|mg|100|stk|1|þpakki||H02AB02|01.11.2013||R|1|0|0|0|G|0|ABC|0|0|1|100|SEK|18785|26978|lyfalmen|||2|100|0|266,6600|Icepharma hf|Abcur AB|Dexametasón||18785||18785|26978||2 374348|G04CA0201|Omnic|forðahlk|0,4|mg|30|stk|1|þpakki||G04CA02|01.08.1998||R|1|0|0|0|G|0|ASP|0|0|0|100|XEU|3391|5790|lyfalmen|||1|30|0|30,0000|Vistor hf|Astellas Pharma A/S|Tamsúlósín||3391||3391|5790||1 374397|J05AB1101|Valtrex|töflur|250|mg|60|stk|1|þpakki||J05AB11|01.01.2003||R|1|0|0|0|G|0|GPH|0|0|1|100|GBP|10670|15808|lyfalmen|||1|60|0|5,0000|Vistor hf|GlaxoSmithKline Pharma A/S|Valacíklóvír||10670||10670|15808||1 374504|G01AF0502|Pevaryl Depot|krem/sti|||15|g|1|sett|kr.+1sk-stíll m.forðaverkun|G01AF05|01.01.1997||L|0|0|0|0|0|0|MCS|0|0|0|100|IKR|||lyflausa|||0|15|0|1,5000|Vistor hf|McNeil Sweden AB|Ekónazól|||||||1 374527|J07CA0602|Pentavac|sts|||0,5|ml|1|hgl|leysir, dreifa|J07CA06|01.04.2015||R|0|0|0|0|0|0|SPM|0|0|0|100|XEU|4025|6662|lyfalmen|||1|0,5|0||Icepharma hf|Sanofi Pasteur MSD|Barnaveiki, haemophilus influenza B, kíghósti, mænusótt, stí||4025||4025|6662||2 374587|B01AB0501|Klexane|stl|100|mg/ml|0,6|ml|10|áf.spr|einnota dæla|B01AB05|01.01.1993||R|0|0|0|0|G|0|SNO|0|0|1|100|NOK|6132|9562|lyfalmen|||1|6|0|30,0000|Vistor hf|Sanofi-aventis Norge AS|Enoxaparín||6132||6132|9562||1 374595|B01AB0501|Klexane|stl|100|mg/ml|0,8|ml|10|áf.spr|einnota dæla|B01AB05|01.01.1993||R|0|0|0|0|G|0|SNO|0|0|1|100|NOK|7237|11083|lyfalmen|||1|8|0|40,0000|Vistor hf|Sanofi-aventis Norge AS|Enoxaparín||7237||7237|11083||1 374603|B01AB0501|Klexane|stl|100|mg/ml|1|ml|10|lykjur|einnota dæla|B01AB05|01.01.1993||R|0|0|0|0|G|0|SNO|0|0|1|100|NOK|8476|12789|lyfalmen|||1|10|0|50,0000|Vistor hf|Sanofi-aventis Norge AS|Enoxaparín||8476||8476|12789||1 374672|A04AA0107|Ondansetron Bluefish|filmhtfl|4|mg|50|stk|1|þpakki||A04AA01|01.09.2015||R|1|0|0|0|G|0|BLP|0|0|1|100|IKR|9198|12111|lyfalmen|V0383|10196|2|50|0|12,5000|LYFIS ehf|Bluefish Pharmaceuticals AB|Ondansetrón||7984||7984|12111||2 376246|B01AC2401|Brilique|filmhtfl|90|mg|168|stk|1|þpakki||B01AC24|01.06.2011||R|1|0|0|0|G|0|AZA|0|0|0|100|SEK|26435|36136|lyfalmen|V0459|36136|1|168|0|84,0000|Vistor hf|AstraZeneca AB|Ticagrelor||26435||26435|36136||1 376387|R03AK1001|Relvar Ellipta|innönddu|206|mcg/sk|30|skammtar|1|pakki|184+22 mcg|R03AK10|01.04.2014||R|0|0|0|0|G|0|RGO|0|0|0|100|GBP|6198|9653|lyfalmen|||1|30|0||Vistor hf|Glaxo Group Limited|Vilanterol og flútícason||6198||6198|9653||1 376509|L04AD0202|Prograf|hylki|1|mg|50|stk|1|þpakki||L04AD02|01.06.2010||R|0|0|0|1|G|0|ASP|0|0|0|100|XEU|16038|23197|lyfalmen|||1|50|0|10,0000|Vistor hf|Astellas Pharma A/S|Tacrolimus||16038||16038|23197||1 376533|L04AD0202|Prograf|hylki|5|mg|50|stk|1|þpakki||L04AD02|01.06.2010||R|0|0|0|1|G|0|ASP|0|0|0|100|XEU|82394|106913|lyfalmen|||1|50|0|50,0000|Vistor hf|Astellas Pharma A/S|Tacrolimus||82394||82394|106913||1 376974|L01XX4301|Erivedge|hylki|150|mg|28|stk|1|glas||L01XX43|01.10.2014||R|1|1|0|1|0|1|RRL|0|0|0|100|DKK|771109|964624|lyfsjukr|||1|28|0||Icepharma hf|Roche Registration Limited|Vismodegibum||771109||771109|964624||2 377134|QP54AA0105|Noromectin|stl|1|% w/v|250|ml|1|hgl|lausn|QP54AA01|01.03.2014||R|0|0|0|0|0|0|NOB|1|0|0|100|XEU|11267|19420|vetorma|||0|250|0||Norbrook Laboratories Limited|Norbrook Laboratories Limited|Ivermectinum||11267||11267|19420||2 377242|J01FA0901|Klacid|töflur|500|mg|14|stk|1|þpakki||J01FA09|01.04.1992||R|1|0|0|0|0|0|ABS|0|0|1|100|DKK|3829|6392|lyfalmen|||1|14|0|14,0000|Vistor hf|Abbott Scandinavia AB|Klaritrómýcín||3829||3829|6392|31.3.2016|1 377333|J05AB1101|Valtrex|töflur|500|mg|42|stk|1|þpakki||J05AB11|01.10.1996||R|1|0|0|0|G|0|GPH|0|0|1|100|GBP|10335|7595|lyfalmen|V0182|4735|1|42|0|7,0000|Vistor hf|GlaxoSmithKline Pharma A/S|Valacíklóvír||4703||4703|7595||1 378535|D07AC1301|Elocon|krem|0,1|%|100|g|1|túpa||D07AC13|01.02.2014||R|0|0|0|0|G|0|MBV|0|0|1|100|DKK|1750|3531|lyfalmen|||1|100|0||Vistor hf|Merck Sharp & Dohme B.V.|Mómetasón||1750||1750|3531||1 378543|N03AX1606|Pregabalin Mylan|hylki|150|mg|56|stk|1|þpakki||N03AX16|01.11.2015||R|0|0|0|0|0|0|GGE|0|0|0|100|SEK|6357|5952|lyfalmen|V0687|5952|2|56|0|28,0000|Mylan AB|Generics (UK) Ltd.|Pregabalín||3509||3509|5952||2 378686|D11AX1801|Solaraze|hlaup|3|%|100|g|1|túpa||D11AX18|01.08.2012||R|0|0|0|0|0|0|ALM|0|0|0|100|XEU|14482|21055|lyfalmen|||1|100|0||Vistor hf|Almirall S.A.|Önnur húðlyf-Diclofenacum||14482||14482|21055|| 379158|R01AD0901|Nasonex|nefúði|50|mcg/sk|140|skammtar|1|úðagl|18 g í pakkn.|R01AD09|01.02.2015||R|0|0|0|0|G|0|MBV|0|0|1|100|DKK|1567|3279|lyfalmen|V0677|2748|1|140|0|35,0000|Vistor hf|Merck Sharp & Dohme B.V.|Mómetasón||1567||1567|3279||1 379521|QP54AB5208|Cydectin TriclaMox|mixtúra|51|mg/ml|1|l|1|glas|1 mg/ml + 50 mg/ml|QP54AB52|01.03.2014||R|0|0|0|0|0|0|ZOE|0|0|0|100|DKK|7371|12705|vetorma|||0|1|0||Icepharma hf|Zoetis Finland OY|||7371||7371|12705||2 379570|L04AB0101|Enbrel|stl|50|mg|4|pennar|1|pakki|lausn|L04AB01|01.03.2012||R|0|1|0|1|0|1|IPI|0|1|0|100|DKK|138393|177702|lyfsjukr|||1|4|0|28,5800|Icepharma hf|Pfizer Limited|Etanercept||||138393|177702||1 379669|H01CB0202|Sandostatin Lar|sts|10|mg|2|ml|1|hgl|+ leysir|H01CB02|01.01.1999||R|0|0|0|0|0|1|HES|0|0|0|100|DKK|88699|114887|lyfsjukr|||1|2|0|14,2900|Vistor hf|Novartis Healthcare A/S|Oktreótíð||88699||88699|114887||1 379677|H01CB0202|Sandostatin Lar|sts|20|mg|2|ml|1|hgl|+ leysir|H01CB02|01.01.1999||R|0|0|0|0|0|1|HES|0|0|0|100|DKK|116672|150687|lyfsjukr|||1|2|0|28,5700|Vistor hf|Novartis Healthcare A/S|Oktreótíð||116672||116672|150687||1 379685|H01CB0202|Sandostatin Lar|sts|30|mg|2|ml|1|hgl|+ leysir|H01CB02|01.01.1999||R|0|0|0|0|0|1|HES|0|0|0|100|DKK|150675|192978|lyfsjukr|||1|2|0|42,8600|Vistor hf|Novartis Healthcare A/S|Oktreótíð||150675||150675|192978||1 379760|L03AB1001|PegIntron|sts|150|mcg|4|áf-penni|1|pakki|fjölskammta pennar|L03AB10|01.11.2013||R|0|0|0|1|0|1|MLD|0|0|0|100|DKK|127818|164550|lyfsjukr|||1|4|0|80,0000|Vistor hf|Merck Sharp & Dohme Limited|Peginterferón alfa 2b||127818||127818|164550||1 379796|N04BC0406|Ropinirole Portfarma|forðatfl|2|mg|84|stk|1|glas||N04BC04|01.12.2012||R|1|0|0|0|G|0|POF|0|0|0|100|XEU|5162|6441|lyfalmen|V0532|6441|2|84|0|28,0000|Alvogen|Alvogen|Rópíníról||3864||3864|6441||1 379875|N05BA0105|Stesolid|innhl|5|mg/2.5ml|2,5|ml|5|túpa||N05BA01|01.10.1995||R|0|0|0|0|0|0|AGT|0|0|1|100|DKK|1836|3649|lyfalmen|||2|12,5|0|2,5000|Actavis Group hf|Actavis Group hf|Díazepam||1836||1836|3649||1 379883|N05BA0105|Stesolid|innhl|10|mg/2.5ml|2,5|ml|5|túpa||N05BA01|01.10.1995||R|0|0|0|0|0|0|AGT|0|0|1|100|DKK|2385|4405|lyfalmen|||2|12,5|0|5,0000|Actavis Group hf|Actavis Group hf|Díazepam||2385||2385|4405||1 380141|QN03AA0201|Phenoleptil|töflur|25|mg|100|stk|1|þpakki|handa hundum|QN03AA02|01.05.2016||R|0|0|0|0|0|0|BVL|0|0|0|100|IKR|2057|4043|vetalmen|||1|100|0||Dýraheilsa ehf|Le Vet B.V.|Phenobarbitalum||2057||2057|4043||2 380162|H01BA0201|Minirin|nefúði|0,1|mg/ml|5|ml|3|úðagl||H01BA02|01.09.2013||R|0|0|0|0|G|0|FEL|0|0|0|100|DKK|18497|26581|lyfalmen|||1|15|0|60,0000|Vistor hf|Ferring Lægemidler A/S|Desmópressín||18497||18497|26581|| 380374|D10AX0302|Finacea|hlaup|15|%|30|g|1|túpa||D10AX03|01.02.2015||R|0|0|0|0|0|0|BAB|0|0|0|100|DKK|1438|3101|lyfalmen|||1|30|0||Icepharma hf|Bayer AB|Azelainsýra||1438||1438|3101||2 380466|B01AF0201|Eliquis|filmhtfl|2,5|mg|168|stk|1|þpakki||B01AF02|01.09.2014||R|1|1|0|0|G|0|BRP|0|0|0|100|DKK|26151|35777|lyfalmen|V0653|35777|1|168|0|42,0000|Icepharma hf|Bristol-Myers Squibb/Pfizer EEIG|Apixaban ||||26151|35777||1 380486|N06AB0606|Sertralin Hexal|filmhtfl|50|mg|100|stk|1|þpakki||N06AB06|01.03.2016||R|1|0|0|0|G|0|SSA|0|0|0|100|DKK|1754|1996|lyfalmen|V0322|1996|2|100|0|100,0000|Artasan ehf|Hexal A/S|Sertralín||635||635|1996||1 380732|C10AA0703|Rosuvastatin Krka|filmhtfl|40|mg|100|stk|1|þpakki||C10AA07|01.07.2014||R|1|0|0|0|0|0|KRK|0|0|0|100|IKR|20000|25897|lyfalmen|V0195|25897|2|100|0|400,0000|LYFIS ehf|Krka Sverige AB|Rósuvastatín||18000||18000|25897||2 380833|N06DX0106|Memantine ratiopharm|filmhtfl|20|mg|30|stk|1|þpakki||N06DX01|01.10.2013||R|1|0|0|0|G|0|RGM|0|0|0|100|XEU|4866|5327|lyfalmen|V0606|5327|2|30|0|30,0000|Medical ehf|ratiopharm GmbH|Memantín||3055||3055|5327||2 381005|N07BA0146|Nicotinell Tropical Fruit|tyggigúm|2|mg|204|stk|1|þpakki||N07BA01|01.11.2011||L|0|0|0|0|0|0|SDF|0|0|1|100|IKR|||lyflausa|||0|204|0|13,6000|Artasan ehf|GlaxoSmithKline Consumer Healthcare A/S|Nikótín|||||||1 381231|QP54AA0501|Stronghold|bl.lausn|30|mg|0,25|ml|3|túpa||QP54AA05|01.12.2014||R|0|0|0|0|0|0|ZBE|1|0|0|100|XEU|2806|4836|vetorma|||0|0,75|0||Icepharma hf|Zoetis Belgium S.A.|Selamectinum||2806||2806|4836||2 381505|G04BE0305|Vizarsin (Lyfis)|filmhtfl|50|mg|12|stk|1|pakki||G04BE03|01.08.2010||R|1|0|0|0|0|0|LYF|0|0|0|100|IKR|6958|4394|lyfalmen|V0143|4371|3|12|0|12,0000|LYFIS ehf|LYFIS ehf|Síldenafíl||2377||2377|4394||2 381589|G03GA0601|Puregon|stl|900|ae/rörly|1,08|ml|1|lykja||G03GA06|01.06.2015||R|0|0|0|1|G|0|MLD|0|0|0|100|DKK|39787|53023|lyfalmen|||1|1,08|0|12,0000|Vistor hf|Merck Sharp & Dohme Limited|Follitrópín beta||||39787|53023||1 382162|N04BC0406|Ropinirole Portfarma|forðatfl|4|mg|84|stk|1|glas||N04BC04|01.12.2012||R|1|0|0|0|G|0|POF|0|0|0|100|XEU|7078|9919|lyfalmen|V0533|9919|2|84|0|56,0000|Alvogen|Alvogen|Rópíníról||6391||6391|9919||1 382190|G04BE0307|Sildenafil Mylan|filmhtfl|25|mg|4|stk|1|þpakki||G04BE03|01.03.2014|31.03.2016|R|1|0|0|0|0|0|MYL|0|0|0|100|SEK|3508|4112|lyfalmen|||2|4|0|2,0000|Icepharma hf|Mylan AB|Síldenafíl||2172||2172|4112||2 382383|V03AN0101|Conoxia|lyfjagas|100|%|10|l|1|hylki|kælt|V03AN01|01.10.2012||L|0|0|0|0|0|0|AGA|0|0|0|100|IKR|||lyflausa|||0|10|0||Ísaga ehf|AGA AB|Súrefni|||||||5 382474|V03AN0501|Lyfjaloft AGA 100%|lyfjagas|100|%|20|l|1|hylki|undir þrýstingi|V03AN05|01.10.2013||L|0|0|0|0|0|0|AGA|0|0|0|100|IKR|||lyflausa|||2|20|0||Ísaga ehf|AGA AB|Lyfjagös|||||||5 382764|R03AK0705|Bufomix Easyhaler|innönddu|164,5|mcg/sk|120|skammtar|1|pakki|160+4,5 mcg/sk|R03AK07|01.11.2014||R|0|0|0|0|G|0|COR|0|0|0|100|DKK|4465|7268|lyfalmen|||2|120|0|30,0000|Vistor hf|Orion Corporation|Formóteról og budesonide||4465||4465|7268||1 383000|R03CC1201|Bambec|töflur|10|mg|100|stk|1|glas||R03CC12|01.10.1991||R|1|0|0|0|G|0|AZD|0|0|0|100|SEK|5816|9127|lyfalmen|||1|100|0|50,0000|Vistor hf|AstraZeneca A/S DK|Bambúteról||5816||5816|9127||1 383117|QP52AA5103|Drontal Vet.|töflur|250|mg|2|stk|1|þpakki|230+20 mg|QP52AA51|01.06.2000||R|0|0|0|0|0|0|BAN|0|0|0|100|DKK|1138|1961|vetorma|||0|2|0||Icepharma hf|Bayer Animal Health GmbH|||1138||1138|1961||2 383257|D01AC0802|Dermatin|sápa|20|mg/ml|60|ml|1|glas||D01AC08|01.07.1998||L|0|0|0|0|0|0|ACA|0|0|1|100|IKR|||lyflausa|||0|60|0||Actavis Group hf|Actavis hf|Ketókónazól|||||||1 383265|D01AC0802|Dermatin|sápa|20|mg/ml|120|ml|1|glas||D01AC08|01.07.1998||L|0|0|0|0|0|0|ACA|0|0|1|100|IKR|||lyflausa|||0|120|0||Actavis Group hf|Actavis hf|Ketókónazól|||||||1 383428|D07AC0104|Diproderm|krem|0,5|mg/g|100|g|1|túpa||D07AC01|01.04.2014||R|0|0|0|0|G|0|MBV|0|0|1|100|DKK|1443|3108|lyfalmen|||1|100|0||Vistor hf|Merck Sharp & Dohme B.V.|Betametasón||1443||1443|3108||1 383445|J05AG0101|Viramune|forðatfl|400|mg|30|stk|1|þpakki||J05AG01|01.03.2013||R|1|0|0|1|0|1|BII|0|0|0|100|DKK|35078|47067|lyfsjukr|||1|30|0|30,0000|Vistor hf|Boehringer Ingelheim International|Nevírapín||35078||35078|47067||1 384064|A02BC0110|Omeprazol ratiopharm|sþ-hylki|20|mg|56|stk|1|þpakki|hart|A02BC01|01.06.2015||R|1|0|0|0|G|0|RAT|0|0|0|100|IKR|2373|2499|lyfalmen|V0006|1582|2|56|0|56,0000|LYFIS ehf|ratiopharm GmbH|Ómeprazól||1000||1000|2499||2 384125|A10BX1201|Jardiance|filmhtfl|10|mg|30|stk|1|þpakki||A10BX12|01.07.2015||R|1|0|0|0|G|0|BOE|0|0|0|100|DKK|6215|9677|lyfalmen|||1|30|0|17,1400|Vistor hf|Boehringer Ingelheim International GmbH|Empagliflozin||6215||6215|9677||1 384716|D01AE1504|Terbinafin Actavis|krem|10|mg/g|15|g|1|túpa||D01AE15|01.09.2015||L|0|0|0|0|0|0|APC|0|0|1|100|IKR|||lyflausa|||0|15|0||Actavis Group PTC ehf|Actavis Group PTC ehf|Terbínafín|||||||1 385238|C10BA0201|Inegy|töflur|50|mg|28|stk|1|þpakki|10 mg + 40 mg|C10BA02|01.07.2013||R|1|0|0|0|0|0|MLD|0|0|0|100|DKK|6716|10366|lyfalmen|||1|28|0|28,0000|Vistor hf|Merck Sharp & Dohme Limited|Ezetimíb og simvastatín||6716||6716|10366||1 386133|H01CB0501|Signifor|sts|60|mg|1|hgl|1|pakki||H01CB05|01.10.2015||R|0|0|0|0|0|1|NEL|0|0|0|100|DKK|374681|471578|lyfsjukr|||1|1|0|50,0000|Vistor hf|Novartis Europharm Ltd|PAsireótið disapartate||374681||374681|471578||1 386278|G04BE0305|Vizarsin (Lyfis)|filmhtfl|100|mg|8|stk|1|pakki||G04BE03|01.02.2011||R|1|0|0|0|0|0|LYF|0|0|0|100|IKR|5627|3521|lyfalmen|V0144|3249|3|8|0|16,0000|LYFIS ehf|LYFIS ehf|Síldenafíl||1743||1743|3521||2 386465|QC01CE9001|Vetmedin vet.|tuggutfl|5|mg|50|stk|1|glas|fyrir hunda|QC01CE90|01.07.2015||R|0|0|0|0|0|0|BIV|0|0|0|100|DKK|5632|9321|vetalmen|||0|50|0||Vistor hf|Boehringer Ingelheim Vetmedica GmbH|Pimobendan||4823||4823|9321||1 386959|C03DA0402|Eplerenone Portfarma|filmhtfl|50|mg|100|stk|1|þpakki||C03DA04|01.08.2014||R|1|0|0|0|0|0|POF|0|0|0|100|DKK|25641|14947|lyfalmen|V0111|14780|2|100|0|100,0000|Alvogen|Alvogen|Eplerenón||10044||10044|14947||1 387012|S01EC5401|Simbrinza|augndr|12|mg/ml|5|ml|3|glas|10 + 2 mg/ml|S01EC54|01.01.2015||R|0|0|0|0|G|0|UKL|0|0|0|100|USD|8214|12428|lyfalmen|V0670|12428|1|15|0||Vistor hf|Alcon Laboratories (UK) Ltd.|Brimoníð og brinzolamið||8214||8214|12428||1 387579|N05BA1206|Alprazolam Krka|forðatfl|0,5|mg|60|stk|1|þpakki||N05BA12|01.08.2012||R|1|0|0|0|0|0|KRK|0|0|0|100|XEU|821|2017|lyfalmen|V0308|2017|2|60|0|30,0000|LYFIS ehf|Krka Sverige AB|Alprazólam||650||650|2017||2 387759|L03AB1001|PegIntron|sts|120|mcg|4|stk|1|pakki|fjölskammta pennar|L03AB10|01.04.2013||R|0|0|0|1|0|1|MLD|0|0|0|100|DKK|103048|133743|lyfsjukr|||1|4|0|64,0000|Vistor hf|Merck Sharp & Dohme Limited|Peginterferón alfa 2b||103048||103048|133743||1 387991|R03DC0304|Montelukast Teva|tuggutfl|5|mg|98|stk|1|þpakki||R03DC03|01.01.2013||R|1|0|0|0|G|0|TEV|0|0|0|100|XEU|5953|5934|lyfalmen|||2|98|0|49,0000|Medical ehf|Teva Pharma B.V.|Montelúkast||3496||3496|5934||2 388198|L01XE0901|Torisel|irþ|30|mg|1|hgl|1|pakki||L01XE09|01.09.2012||R|0|0|0|1|0|1|IPI|0|0|0|100|DKK|134845|173289|lyfsjukr|||1|1|0||Icepharma hf|Pfizer Limited|Temsirolímus||134845||134845|173289||1 388256|N01BB2001|Emla|krem|||5|g|5|túpa|+12 umbúð.|N01BB20|01.01.1987||R|0|0|0|0|0|0|AZD|0|0|0|100|SEK|2656|4778|lyfalmen|||1|25|0||Vistor hf|AstraZeneca A/S DK|Blöndur||2656||2656|4778||1 388264|N01BB2001|Emla|krem|||30|g|1|túpa||N01BB20|01.01.1987||R|0|0|0|0|0|0|AZD|0|0|0|100|SEK|2899|5112|lyfalmen|||1|30|0||Vistor hf|AstraZeneca A/S DK|Blöndur||2899||2899|5112||1 388272|N01BB2001|Emla|plástur|||2|stk|1|pakki||N01BB20|01.04.1994||L|0|0|0|0|0|0|AZD|0|0|0|100|IKR|||lyflausa|||0|2|0||Vistor hf|AstraZeneca A/S DK|Blöndur|||||||1 388280|N01BB2001|Emla|plástur|||20|stk|1|pakki||N01BB20|01.04.1994||R|0|0|0|0|0|0|AZD|0|0|0|100|SEK|5218|8304|lyfalmen|||1|20|0||Vistor hf|AstraZeneca A/S DK|Blöndur||5218||5218|8304||1 388482|A02BC0402|Rabeprazol Actavis|sh-tfl|10|mg|28|stk|1|þpakki||A02BC04|01.06.2011||R|0|0|0|0|0|0|APC|0|0|0|100|XEU|1477|1795|lyfalmen|V0466|1795|2|28|0|14,0000|Actavis Group PTC ehf|Actavis Group PTC ehf|Rabeprazól||489||489|1795||1 388836|H05BX0102|Cinacalcet WH|filmhtfl|90|mg|28|stk|1|þpakki||H05BX01|01.02.2016||R|1|0|0|0|0|0|WEH|0|0|0|100|XEU|59790|78323|lyfalmen|V0722|73279|2|28|0|42,0000|Williams & Halls efh|Williams & Halls ehf|Cinacalcet||||59790|78323||2 388877|QP54AA0301|Dectomax vet.|stl|10|mg/ml|200|ml|1|hgl||QP54AA03|01.04.2016||R|0|0|0|0|0|0|ZOE|1|0|0|100|DKK|16956|29225|vetorma|||0|200|0||Icepharma hf|Zoetis Finland OY|Doramectinum||16956||16956|29225||2 388898|S01ED5116|Taptiqom|augndr|||0,3|ml|90|Sk-ílá|15mcg/ml + 5mg/ml|S01ED51|01.07.2015||R|0|0|0|0|G|0|SAO|0|0|0|100|XEU|8665|13049|lyfalmen|||1|27|0|90,0000|Icepharma hf|Santen Oy|Tímólól í blöndum||8665||8665|13049||2 389106|G03FA0103|Femanor|töflur|||84|stk|1|pakki|þp 2+1 mg |G03FA01|01.08.1998||R|0|0|0|0|G|0|BIP|0|0|0|100|SEK|2397|4421|lyfalmen|V0410|4421|1|84|0|84,0000|Vistor hf|BioPhausia AB|Noretísterón og östrógen||2397||2397|4421||1 389122|G03FB0503|Femasekvens|töflur|||84|stk|1|pakki|þp samsett pk. |G03FB05|01.08.1998||R|0|0|0|0|G|0|BIP|0|0|0|100|SEK|1706|3470|lyfalmen|||1|84|0|84,0000|Vistor hf|BioPhausia AB|Noretísterón og östrógen||1706||1706|3470||1 389155|G03CA0312|Femanest|töflur|2|mg|84|stk|1|þpakki||G03CA03|01.05.1997||R|0|0|0|0|G|0|BIP|0|0|0|100|SEK|655|2024|lyfalmen|V0128|2024|1|84|0|84,0000|Vistor hf|BioPhausia AB|Estradíól||655||655|2024||1 389171|G03CA0312|Femanest|töflur|1|mg|84|stk|1|þpakki||G03CA03|01.05.1997||R|0|0|0|0|G|0|BIP|0|0|0|100|SEK|520|1838|lyfalmen|||1|84|0|42,0000|Vistor hf|BioPhausia AB|Estradíól||520||520|1838||1 389395|S01BC0301|Voltaren Ophtha|augndr|1|mg/ml|0,3|ml|10|sk-hyl|einnota hylki|S01BC03|01.04.1996||R|0|0|0|0|G|0|NOC|0|0|1|100|SEK|800|2223|lyfalmen|V0367|1610|1|3|0||Vistor hf|Novartis Healthcare A/S|Díklófenak||800||800|2223||1 389414|G04BE0305|Vizarsin (Lyfis)|filmhtfl|50|mg|4|stk|1|pakki||G04BE03|01.08.2010||R|1|0|0|0|0|0|LYF|0|0|0|100|IKR|2461|2177|lyfalmen|V0143|1457|3|4|0|4,0000|LYFIS ehf|LYFIS ehf|Síldenafíl||766||766|2177||2 389443|N04BC0504|Oprymea (Lyfis)|töflur|0,18|mg|100|stk|1|þpakki||N04BC05|01.07.2010||R|0|0|0|0|G|0|LYF|0|0|0|100|XEU|2899|4276|lyfalmen|V0267|4197|3|100|0|7,2000|LYFIS ehf|LYFIS ehf|Pramipexól||2291||2291|4276||2 389637|G03GA0502|Gonal-f|stl|900|ae/penna|1,5|ml|1|penni|áfylltur penni (66 mcg)|G03GA05|01.01.2012||R|0|0|0|1|G|0|MSE|0|0|0|100|SEK|42432|56369|lyfalmen|||1|1,5|0|12,0000|Icepharma hf|Merck Serono Europe Ltd|Follitrópín alfa||||42432|56369||2 389939|N05CF0106|Zopiclone Actavis|filmhtfl|7,5|mg|30|stk|1|þpakki||N05CF01|01.05.2013||R|1|0|0|0|0|0|APC|0|0|0|100|SEK|323|1246|lyfalmen|V0312|1246|2|30|0|30,0000|Actavis Group PTC ehf|Actavis Group PTC ehf|Zópíklón||90||90|1246||1 389944|L04AD0201|Advagraf|forðahlk|1|mg|50|stk|1|þpakki||L04AD02|01.03.2012||R|0|0|0|1|G|0|APE|0|0|0|100|XEU|15240|22099|lyfalmen|||1|50|0|10,0000|Vistor hf|Astellas Phama Europe B.V.|Tacrolimus||15240||15240|22099||1 390699|N05CM1801|Dexdor|irþ|100|mcg/ml|2|ml|25|lykjur|lausn|N05CM18|01.03.2012||R|0|0|0|1|0|1|ORC|0|0|0|100|DKK|72872|94869|lyfsjukr|||1|50|0|5,0000|Vistor hf|Orion Corporation|Dexmedetómid||72872||72872|94869||1 390757|A07AA0201|Mycostatin|mixtúra|100000|ae/ml|100|ml|1|glas||A07AA02|01.04.1974||R|0|0|0|0|G|0|BRS|0|0|1|100|DKK|2595|4694|lyfalmen|||1|100|0|6,6667|Vistor hf|Bristol-Myers Squibb|Nýstatín||2595||2595|4694||1 390971|M01AH0101|Celebra|hylki|100|mg|100|stk|1|þpakki||M01AH01|01.07.2002||R|1|0|0|0|G|0|PER|0|0|1|100|DKK|6198|9653|lyfalmen|V0429|6226|1|100|0|50,0000|Icepharma hf|Pfizer ApS|Celekoxíb||6198||6198|9653||1 390997|M01AH0101|Celebra|hylki|200|mg|20|stk|1|þpakki||M01AH01|01.07.2002||R|1|0|0|0|G|0|PER|0|0|1|100|DKK|2456|4503|lyfalmen|V0037|2125|1|20|0|20,0000|Icepharma hf|Pfizer ApS|Celekoxíb||2456||2456|4503||1 391010|G03GA0502|Gonal-f|stl|450|ae/penna|0,75|ml|1|penni|áfylltur penni (33 mcg)|G03GA05|01.01.2012||R|0|0|0|1|G|0|MSE|0|0|0|100|SEK|22096|30648|lyfalmen|||1|0,75|0|6,0000|Icepharma hf|Merck Serono Europe Ltd|Follitrópín alfa||||22096|30648||2 391268|M01AH0101|Celebra|hylki|200|mg|100|stk|1|þpakki||M01AH01|01.07.2002||R|1|0|0|0|G|0|PER|0|0|1|100|DKK|11983|17616|lyfalmen|V0196|7316|1|100|0|100,0000|Icepharma hf|Pfizer ApS|Celekoxíb||11983||11983|17616||1 391376|J05AE1401|Olysio|hylki|150|mg|28|stk|1|pakki||J05AE14|01.09.2014||R|0|0|0|1|0|1|JCI|0|0|0|100|SEK|1321561|1649232|lyfsjukr|||1|28|0|28,0000|Vistor hf|Janssen-Cilag International N.V.|Simeprevír||||1321561|1649232||1 391653|L01XE0102|Imatinib Accord|filmhtfl|400|mg|30|stk|1|þpakki||L01XE01|01.11.2013||R|0|0|0|1|0|1|AHL|0|1|0|100|DKK|307426|248171|lyfsjukr|||2|30|0||Alvogen|Accord Healthcare Limited|Imatiníb||195053||195053|248171||1 391954|N07BC0202|Metadon Abcur|töflur|20|mg|20|stk|1|þpakki||N07BC02|01.10.2013||R|1|0|1|0|G|0|ABC|0|0|0|100|SEK|2066|3966|lyfalmen|||1|20|0|20,0000|Icepharma hf|Abcur AB|Metadón||2066||2066|3966||2 392000|G03AA0706|Erlibelle|töflur|||63|stk|1|þpakki||G03AA07|01.08.2014||R|0|0|0|0|0|0|APC|0|0|0|100|XEU|569|1905|lyfalmen|V0545|1905|2|63|0|84,0000|Actavis Group PTC ehf|Actavis Group PTC ehf|Levónorgestrel og ethinylestradíól||569||569|1905||1 392225|V08CA0301|Omniscan|stl|0,5|mmol/ml|50|ml|10|plastf|röntgenskuggaefni fyrir MRT|V08CA03|01.12.2010||R|0|0|0|0|0|1|GEH|0|0|0|100|NOK|173198|220990|lyfsjukr|||1|500|0||Icepharma hf|GE Healthcare AS|Gadódíamíð||173198||173198|220990||2 392390|S01XA1802|Ikervis|augndr|1|mg/ml|0,3|ml|30|sk-ílá|fleyti, stakskammtar|S01XA18|01.02.2016||R|0|0|0|1|0|0|SAO|0|0|0|100|XEU|12854|18814|lyfalmen|||1|9|0||Icepharma hf|Santen Oy|Ciclosporin||12854||12854|18814||2 392402|N05AH0306|Olanzapin Actavis|filmhtfl|5|mg|100|stk|1|glas||N05AH03|01.11.2012||R|1|0|0|0|G|0|AGP|0|0|0|100|XEU|4048|5485|lyfalmen|||2|100|0|50,0000|Actavis Group hf|Actavis Group PTC ehf|Olanzapín||3170||3170|5485||1 392438|N07XX0901|Tecfidera|hylki|120|mg|14|stk|1|þpakki||N07XX09|01.12.2014||R|0|0|0|1|0|1|BIB|0|1|0|100|XEU|41893|55687|lyfsjukr|||1|14|0|3,5000|Icepharma hf|Biogen Idec Ltd|Dimethyl fumarate||41893||41893|55687||2 392563|A04AA0101|Zofran|mixtúra|0,8|mg/ml|50|ml|1|glas||A04AA01|01.03.2013||R|0|0|0|0|G|0|HES|0|0|1|100|DKK|9500|14198|lyfalmen|||1|50|0|2,5000|Vistor hf|Novartis Healthcare A/S|Ondansetrón||9500||9500|14198||1 393642|V07AB0013|Sterilt vatten/vann/vand Fresenius Kabi|leysir|||10|ml|20|plastl|fyrir stungulyf|V07AB|01.06.2015||L|0|0|0|0|0|0|FKA|0|0|0|100|IKR|||lyfalmen|||0|200|0||Vistor hf|Fresenius Kabi AB|Leysi- og þynningarvökvar, þ.m.t. skolvökvar|||||3099||1 393735|H02AB0908|Plenadren|töflur|20|mg|50|stk|1|glas|með breyttan losunarhraða|H02AB09|01.01.2013||R|1|0|0|0|G|0|SPR|0|0|1|100|DKK|63523|83045|lyfalmen|||1|50|0|33,3300|Lyfjaver ehf|ViroPharma SPRL|Hýdrókortisón||63523||63523|83045||3 393918|QJ51CF0204|Orbenin vet.|spenalyf|500|mg/dælu|1|stk|24|spr||QJ51CF02|01.09.1983|29.02.2016|R|0|0|0|0|0|0|ZOE|0|0|0|100|DKK|5020|9694|vetalmen|||0|24|0||Icepharma hf|Zoetis Finland OY|||5020||5020|9694||2 393934|N07BA0109|Nicotinell Fruit|tyggigúm|2|mg|204|stk|1|þpakki||N07BA01|01.06.1998||L|0|0|0|0|0|0|SDF|0|0|1|100|IKR|||lyflausa|||0|204|0|13,6000|Artasan ehf|GlaxoSmithKline Consumer Healthcare A/S|Nikótín|||||||1 393939|S01EE0403|Travoprost Portfarma|augndr|40|mcg/ml|2,5|ml|1|glas||S01EE04|01.01.2015||R|0|0|0|0|G|0|POF|0|0|0|100|USD|2034|3739|lyfalmen|V0669|3739|2|2,5|0|25,0000|Alvogen|Alvogen|Travóprost||1901||1901|3739||1 393942|N07BA0109|Nicotinell Fruit|tyggigúm|4|mg|204|stk|1|þpakki||N07BA01|01.06.1998||L|0|0|0|0|0|0|SDF|0|0|1|100|IKR|||lyflausa|||0|204|0|27,2000|Artasan ehf|GlaxoSmithKline Consumer Healthcare A/S|Nikótín|||||||1 393959|N07BA0107|Nicotinell Mint|tyggigúm|2|mg|204|stk|1|þpakki||N07BA01|01.06.1998||L|0|0|0|0|0|0|SDF|0|0|1|100|IKR|||lyflausa|||0|204|0|13,6000|Artasan ehf|GlaxoSmithKline Consumer Healthcare A/S|Nikótín|||||||1 394262|N07BA0107|Nicotinell Mint|tyggigúm|4|mg|204|stk|1|þpakki||N07BA01|01.06.1998||L|0|0|0|0|0|0|SDF|0|0|1|100|IKR|||lyflausa|||0|204|0|27,2000|Artasan ehf|GlaxoSmithKline Consumer Healthcare A/S|Nikótín|||||||1 395522|B03XA0201|Aranesp|stl|500|mcg/spr|1|ml|1|áf.spr|nálarvörn|B03XA02|01.08.2011||R|0|0|0|1|0|1|RAG|0|0|0|100|DKK|132109|168866|lyfsjukr|||1|1|0|111,1100|Vistor hf|Amgen|Darbepóetín alfa||131288||131288|168866||1 395539|C10BA0501|Atozet|filmhtfl|50|mg|30|stk|1|þpakki|10 mg + 40 mg|C10BA05|01.03.2015||R|0|0|0|0|0|0|MLD|0|0|0|100|DKK|5683|8944|lyfalmen|||1|30|0||Vistor hf|Merck Sharp & Dohme Limited|Atorvastin og ezetimibe||5683||5683|8944||1 395732|C09CA0305|Valsartan ratiopharm|filmhtfl|160|mg|98|stk|1|þpakki||C09CA03|01.02.2015||R|1|0|0|0|G|0|RGM|0|0|0|100|IKR|3895|3462|lyfalmen|V0679|3462|2|98|0|196,0000|Medical ehf|ratiopharm GmbH|Valsartan||1700||1700|3462||2 395886|R03AK0704|Symbicort Turbuhaler (Lyfjaver)|innönddu|164,5|mcg/sk|360|skammtar|1|pakki|160+4,5 mcg/sk|R03AK07|01.05.2011||R|0|0|0|0|G|0|LVR|0|0|0|100|NOK|16615|23991|lyfalmen|V0356|23991|3|360|0|90,0000|Lyfjaver ehf|Lyfjaver ehf|Formóteról og budesonide||16615||16615|23991||3 395954|V08CA0101|Magnevist|stl|469|mg/ml|30|ml|10|hgl|röntgenskuggaefni|V08CA01|01.04.2007||R|0|0|0|0|0|1|BGB|0|0|0|100|DKK|159372|203794|lyfsjukr|||1|300|0||Icepharma hf|Bayer Pharma AG|Gadópentetat||159372||159372|203794||2 396120|R03AK0705|Bufomix Easyhaler|innönddu|329|mcg/sk|60|skammtar|1|pakki|320+9 mcg/sk|R03AK07|01.11.2014||R|0|0|0|0|G|0|COR|0|0|0|100|DKK|4398|7176|lyfalmen|||2|60|0|30,0000|Vistor hf|Orion Corporation|Formóteról og budesonide||4398||4398|7176||1 396318|R06AX2201|Kestine|filmhtfl|10|mg|100|stk|1|þpakki||R06AX22|01.06.2012||R|1|0|0|0|G|0|APS|0|0|1|100|DKK|3599|6076|lyfalmen|||1|100|0|100,0000|Vistor hf|Almirall-Prodesfarma S.A.|Ebastín||3599||3599|6076||1 396319|QN01BA0201|Procamidor vet.|stl|20|mg/ml|100|ml|10|hgl||QN01BA02|01.03.2014||R|0|0|0|0|0|0|RPG|1|0|0|100|DKK|18925|36075|vetalmen|||0|1000|0||Icepharma hf|Richter Pharma AG|Procaine Hydrochlorid||18925||18925|36075||2 396865|QN03AX9001|Pexion|töflur|100|mg|100|stk|1|glas|handa hundum|QN03AX90|01.05.2014||R|0|0|0|0|0|0|BIV|0|0|0|100|DKK|4998|9653|vetalmen|||0|100|0||Vistor hf|Boehringer Ingelheim Vetmedica GmbH|Imepitoin||4998||4998|9653||1 397161|J01CA0414|Amoxicilline Actavis Disper|töflur|375|mg|20|stk|1|þpakki|hræra vel í vatni og drekka|J01CA04|01.03.2013||R|0|0|0|0|0|0|AVB|0|0|1|100|XEU|1122|2667|lyfalmen|||2|20|0|7,5000|Actavis Group PTC ehf|Actavis BV|Amoxicillín||1122||1122|2667||1 397458|N03AX1209|Gabapentin Sandoz|hylki|300|mg|100|stk|1|þpakki||N03AX12|01.12.2015||R|1|0|0|0|G|0|SHS|0|0|0|100|DKK|2324|2561|lyfalmen|V0250|2561|2|100|0|16,6667|Artasan ehf|Sandoz A/S|Gabapentín||1045||1045|2561||1 397494|L01XC0601|Erbitux|irl|5|mg/ml|20|ml|1|hgl|lausn|L01XC06|01.12.2011||R|0|0|0|1|0|1|MKA|0|1|0|100|SEK|25551|35018|lyfsjukr|||1|20|0||Icepharma hf|Merck KgaA|Cetúxímab||25551||25551|35018||2 397520|J01CF0104|Dicloxacillin Bluefish|hylki|500|mg|30|stk|1|þpakki||J01CF01|01.08.2015||R|0|0|0|0|0|0|BLP|0|0|1|100|IKR|2737|3737|lyfalmen|V0337|3737|2|30|0|7,5000|LYFIS ehf|Bluefish Pharmaceuticals AB|Díkloxacillín||1900||1900|3737||2 397745|L01BC0601|Xeloda|töflur|150|mg|60|stk|1|þpakki||L01BC06|01.01.2002||R|0|0|0|1|0|1|ROC|0|0|0|100|DKK|4905|7873|lyfsjukr|||1|60|0||Icepharma hf|Roche|Capecitabín||4905||4905|7873||2 397752|L01BC0601|Xeloda|töflur|500|mg|120|stk|1|þpakki||L01BC06|01.01.2002||R|0|0|0|1|0|1|ROC|0|0|0|100|DKK|28204|38373|lyfsjukr|||1|120|0||Icepharma hf|Roche|Capecitabín||28204||28204|38373||2 397796|A06AB5801|Picoprep|mixtduft|||2|pokar|1|pakki|lausn|A06AB58|01.10.2011||L|0|0|0|0|0|0|FEL|0|0|0|100|IKR|||lyfalmen|||0|2|0||Vistor hf|Ferring Lægemidler A/S|Natríumpicosúlfat|||||5452||1 398490|N02AA5908|Paracetamol/Kodein Actavis|filmhtfl|1060|mg|40|stk|1|þpakki|60+1000 mg|N02AA59|01.10.2015||R|1|0|1|0|0|0|AGP|0|0|1|100|XEU|2340|4343|lyfalmen|V0210|2398|2|40|0|26,6800|Actavis Group hf|Actavis Group PTC ehf|Kódein í blöndum nema með geðlyfjum||2340||2340|4343||1 398698|N05AH0412|Quetiapin Sandoz|forðatfl|400|mg|100|stk|1|þpakki||N05AH04|01.12.2014|31.03.2016|R|1|0|0|0|G|0|SHS|0|0|0|100|DKK|40307|47072|lyfalmen|||2|100|0|100,0000|Artasan ehf|Sandoz A/S|Quetíapín||35082||35082|47072||1 398821|A02BC0506|Esomeprazole Krka (LYFIS)|sþ-hylki|40|mg|56|stk|1|þpakki||A02BC05|01.08.2011||R|1|0|0|0|0|0|LYF|0|0|0|100|IKR|7175|3875|lyfalmen|V0012|2864|3|56|0|74,6700|LYFIS ehf|LYFIS ehf|Esómeprazól||2000||2000|3875||2 399264|R03BB0501|Eklira Genuair|innönddu|322|mcg|60|skammtar|3|innö.t||R03BB05|01.12.2015|31.03.2016|R|0|0|0|0|G|0|ZEN|0|0|0|100|SEK|14912|21647|lyfalmen|||1|180|0|90,0000|Vistor hf|AstraZeneca AB|Aclídínumbrómíð||14912||14912|21647||1 399309|G03GA0601|Puregon|stl|600|ae/rörly|0,72|ml|1|pakki||G03GA06|01.08.2015||R|0|0|0|1|G|0|MLD|0|0|0|100|DKK|28046|38173|lyfalmen|||1|0,72|0|8,0000|Vistor hf|Merck Sharp & Dohme Limited|Follitrópín beta||||28046|38173||1 399510|N02AX0204|Tradolan|filmhtfl|50|mg|100|stk|1|þpakki||N02AX02|01.05.2012||R|1|0|1|0|G|0|GLP|0|0|1|100|SEK|251|1468|lyfalmen|V0225|1468|1|100|0|16,6700|Vistor hf|G.L.Pharma GmbH|Tramadól||251||251|1468||1 399519|N03AX0901|Lamictal|dreifit.|50|mg|56|stk|1|þpakki||N03AX09|01.03.1999||R|1|0|0|0|G|0|GPH|0|0|0|100|IKR|2049|2355|lyfalmen|V0244|2047|1|56|0|9,3333|Vistor hf|GlaxoSmithKline Pharma A/S|Lamótrigín||896||896|2355||1 399733|B01AB0401|Fragmin|stl|25000|ae/ml|0,3|ml|10|áf.spr|7500 a.e. anti-Xa/ml/sprautu|B01AB04|01.04.1993||R|0|0|0|0|G|0|PER|0|0|1|100|DKK|8018|12158|lyfalmen|||1|3|0|30,0000|Icepharma hf|Pfizer ApS|Dalteparín||8018||8018|12158||1 399746|L03AA0202|Zarzio|stl/irl|30|millj ae|0,5|ml|5|áf.spr|lausn|L03AA02|01.03.2015||R|0|0|0|1|0|1|SAR|0|0|0|100|DKK|31825|42953|lyfsjukr|||1|2,5|0|4,2900|Artasan ehf|Sandoz GmbH (A)|Fílgrastím||||31825|42953||1 399782|D06BB0601|Vectavir|krem|10|mg/g|2|g|1|túpa||D06BB06|01.04.1997||L|0|0|0|0|0|0|OME|0|0|1|100|IKR|||lyflausa|||0|2|0||Vistor hf|Omega Pharma Nordic AB|Pencíklóvír|||||||1 399856|L03AB1101|Pegasys|stl|180|mcg/pen|0,5|ml|4|lyfjap|áfylltur lyfjapenni|L03AB11|01.05.2012||R|0|0|0|1|0|1|RRL|0|0|0|100|DKK|101343|131622|lyfsjukr|||1|2|0|27,6900|Icepharma hf|Roche Registration Limited|Peginterferón alfa 2a||101343||101343|131622||2 400044|S03CA0102|Sofradex|aug.eydr|||8|ml|1|glas||S03CA01|01.03.1980||R|0|0|0|0|G|0|SNO|0|0|1|100|NOK|1083|2613|lyfalmen|||1|8|0||Vistor hf|Sanofi-aventis Norge AS|Dexametasón og sýkingalyf||1083||1083|2613||1 400101|R05DB2002|Pektolin|mixtúra|||150|ml|1|glas||R05DB20|01.06.1981||L|0|0|0|0|0|0|ACA|0|0|1|100|IKR|||lyflausa|||0|150|0||Actavis Group hf|Actavis hf|Blöndur|||||||1 400143|C10AB0401|Lopid|hylki|300|mg|100|stk|1|þpakki||C10AB04|01.04.1988||R|1|0|0|0|0|0|PER|0|0|0|100|DKK|4525|7350|lyfalmen|||1|100|0|25,0000|Icepharma hf|Pfizer ApS|Gemfíbrózíl||4525||4525|7350||1 400267|N05BA0402|Sobril|töflur|25|mg|25|stk|1|þpakki||N05BA04|01.01.1985||R|1|0|0|0|0|0|PER|0|0|1|100|DKK|199|1396|lyfalmen|||1|25|0|12,5000|Icepharma hf|Pfizer ApS|Oxazepam||199||199|1396||1 400424|N05BA0402|Sobril|töflur|15|mg|100|stk|1|þpakki||N05BA04|01.01.1985||R|1|0|0|0|0|0|PER|0|0|0|100|DKK|342|1593|lyfalmen|||1|100|0|30,0000|Icepharma hf|Pfizer ApS|Oxazepam||342||342|1593||1 400432|N05BA0402|Sobril|töflur|15|mg|25|stk|1|þpakki||N05BA04|01.01.1985||R|1|0|0|0|0|0|PER|0|0|1|100|DKK|172|1359|lyfalmen|||1|25|0|7,5000|Icepharma hf|Pfizer ApS|Oxazepam||172||172|1359||1 400573|C10AX0901|Ezetrol|töflur|10|mg|28|stk|1|þpakki||C10AX09|01.07.2013||R|1|0|0|0|0|0|MLD|0|0|0|100|DKK|4791|7717|lyfalmen|||1|28|0|28,0000|Vistor hf|Merck Sharp & Dohme Limited|Ezetimíb||4791||4791|7717||1 400574|N07XX0901|Tecfidera|hylki|240|mg|56|stk|1|þpakki||N07XX09|01.12.2014||R|0|0|0|1|0|1|BIB|0|1|0|100|XEU|167572|213993|lyfsjukr|||1|56|0|28,0000|Icepharma hf|Biogen Idec Ltd|Dimethyl fumarate||167572||167572|213993||2 401084|M01AH0105|Cloxabix|hylki|200|mg|20|stk|1|þpakki||M01AH01|01.03.2013||R|1|0|0|0|G|0|WEH|0|0|1|100|XEU|2073|2750|lyfalmen|V0037|2125|2|20|0|20,0000|Williams & Halls efh|Williams & Halls ehf|Celekoxíb||1183||1183|2750||2 401801|B01AC2401|Brilique|filmhtfl|90|mg|56|stk|1|þpakki||B01AC24|01.06.2011||R|1|0|0|0|G|0|AZA|0|0|0|100|SEK|9133|13693|lyfalmen|V0459|12045|1|56|0|28,0000|Vistor hf|AstraZeneca AB|Ticagrelor||9133||9133|13693||1 401828|N06AA1001|Noritren|töflur|10|mg|100|stk|1|glas||N06AA10|01.01.1985||R|1|0|0|0|G|0|LBK|0|0|0|100|DKK|733|2131|lyfalmen|||1|100|0|13,3333|Lundbeck Export A/S|H. Lundbeck A/S|Nortriptýlín||733||733|2131||1 401851|N06AA1001|Noritren|töflur|25|mg|100|stk|1|glas||N06AA10|01.01.1985||R|1|0|0|0|G|0|LBK|0|0|0|100|DKK|1075|2602|lyfalmen|||1|100|0|33,3333|Lundbeck Export A/S|H. Lundbeck A/S|Nortriptýlín||1075||1075|2602||1 402203|D07AC1302|Ovixan|húðlausn|0,1|%|100|ml|1|dropaí||D07AC13|01.08.2013||R|0|0|0|0|G|0|GAB|0|0|1|100|SEK|1337|2962|lyfalmen|||2|100|0||Vistor hf|Galenica AB|Mómetasón||1337||1337|2962||1 402673|N06BX1301|Raxone|filmhtfl|150|mg|180|stk|1|glas||N06BX13|01.05.2016||R|1|0|0|1|0|1|SPD|0|0|0|100|DKK|988070|1234462|lyfsjukr|||1|180|0||Vistor hf|Santhera Pharmaceuticals GmbH|Idebenone||988070||988070|1234462||1 402743|QJ01RA0102|Streptocillin, vet.|stl|||100|ml|1|hgl||QJ01RA01|01.11.1979||R|0|0|0|0|0|0|BID|0|0|0|100|DKK|1775|3489|vetalmen|||0|100|0||Vistor hf|Boehringer Ingelheim Danmark|||1775||1775|3489|29.2.2016|1 402873|N06DA0302|Exelon (Lyfjaver)|forðapl|9,5|mg/sólh|30|pokar|1|pakki||N06DA03|01.10.2012||R|0|0|0|0|G|0|LVR|0|0|0|100|DKK|12511|18342|lyfalmen|V0349|18342|3|30|0|30,0000|Lyfjaver ehf|Lyfjaver ehf|Rívastigmín||12511||12511|18342||3 402988|J02AC0102|Candizol|hylki|50|mg|30|stk|1|þpakki||J02AC01|01.08.2014||R|1|0|0|0|0|0|ACA|0|0|1|100|IKR|5748|3324|lyfalmen|V0552|3201|2|30|0|7,5000|Actavis Group hf|Actavis hf|Flúkónazól||1600||1600|3324||1 403444|QG02AD9001|Estrumat, vet.|stl|0,25|mg/ml|20|ml|1|hgl||QG02AD90|01.01.1991||R|0|0|0|0|0|0|IBV|1|0|0|100|DKK|4566|8833|vetalmen|||0|20|0||Vistor hf|Intervet International BV|||4566||4566|8833||1 403524|N05AX1206|Aripiprazole ratiopharm|töflur|10|mg|56|stk|1|þpakki||N05AX12|01.10.2015||R|1|0|0|0|G|0|RAT|0|0|0|100|IKR|24606|22456|lyfalmen|V0683|21002|2|56|0|37,3300|LYFIS ehf|ratiopharm GmbH|Aripiprazól||15500||15500|22456||2 403550|C08CA0302|Lomir Retard|forðahlk|2,5|mg|100|stk|1|þpakki||C08CA03|01.10.1992||R|1|0|0|0|G|0|HES|0|0|0|100|DKK|4888|7850|lyfalmen|||1|100|0|50,0000|Vistor hf|Novartis Healthcare A/S|Ísradipín||4888||4888|7850||1 403856|L01BA0108|Methotrexate Pfizer|irþ|100|mg/ml|50|ml|1|hgl||L01BA01|01.10.2011||R|0|0|0|1|0|1|PER|0|0|0|100|DKK|32852|44252|lyfsjukr|||1|50|0||Icepharma hf|Pfizer ApS|Metótrexat||||32852|44252||1 403915|S01GX0101|Lomudal|augndr|20|mg/ml|13,5|ml|1|glas||S01GX01|01.07.1992||R|0|0|0|0|G|0|SNO|0|0|0|100|NOK|947|2426|lyfalmen|||1|13,5|0||Vistor hf|Sanofi-aventis Norge AS|Krómóglíkatsýra||947||947|2426||1 403966|B01AX0501|Arixtra|stl|7,5|mg/spr|0,6|ml|10|áf.spr||B01AX05|01.11.2015||R|0|0|0|0|G|0|APP|0|0|0|100|GBP|18108|26046|lyfalmen|V0473|26046|1|6|0|30,0000|Artasan ehf|Aspen Pharma Trading Limited|Fondaparinux||18108||18108|26046||1 404426|S01XA2019|Oftagel|augngel|2,5|mg/g|10|g|1|túpa||S01XA20|01.04.2004||L|0|0|0|0|G|0|SAO|0|0|0|100|XEU|||lyfalmen|||0|10|0||Icepharma hf|Santen Oy|Gervitár og aðrar óvirkar samsetningar|||||1907||2 404533|B01AD0201|Actilyse|sts/irs|50|mg|1|stk|1|hgl|+ leysir|B01AD02|01.07.1989||R|0|0|0|0|0|1|BOI|0|0|0|100|DKK|57863|75886|lyfsjukr|||1|1|0|0,5000|Vistor hf|Boehringer Ingelheim|Alteplasi||57863||57863|75886||1 404818|C03AA0305|Hydromed|töflur|25|mg|100|stk|1|þpakki||C03AA03|01.06.2013||R|1|0|0|0|G|0|MEV|0|0|0|100|DKK|1069|2594|lyfalmen|||2|100|0|100,0000|Vistor hf|MediLink A/S|hýdróklórtíazíð||1069||1069|2594||1 404832|R02AA0306|Strepsils Jordbær Sukkerfri|sogtfl|||36|stk|1|þpakki||R02AA03|01.03.2014||L|0|0|0|0|0|0|RBH|0|0|1|100|IKR|||lyflausa|||0|36|0|6,0000|Artasan ehf|Reckitt Benckiser Healthcare Ltd.-A|Díklórbenzýlalkóhól|||||||1 404939|B02BA0102|Konakion Novum|stl|10|mg/ml|1|ml|5|lykjur||B02BA01|01.04.1991||R|0|0|0|0|0|1|ROC|0|0|0|100|DKK|608|1959|lyfsjukr|||1|5|0|2,5000|Icepharma hf|Roche|Fýtómenadíón||608||608|1959||2 404997|A10BX1001|Lyxumia|stl|||2|áf-penni|1|pakki|10 og 20 mcg|A10BX10|01.10.2013||R|0|0|0|0|0|0|SGA|0|0|0|100|NOK|9169|13742|lyfalmen|||1|2|0|1,5000|Vistor hf|Sanofi-aventis groupe|Lixisenatíd||9169||9169|13742||1 405019|C03CA0110|Impugan|töflur|40|mg|250|stk|1|glas||C03CA01|01.11.2013|31.03.2016|R|1|0|0|0|G|0|AGT|0|0|0|100|SEK|792|2212|lyfalmen|||2|250|0|250,0000|Actavis Group hf|Actavis Group hf|Fúrósemíð||792||792|2212||1 405076|C03EA0114|Diuramin mite|töflur|27,5|mg|100|stk|1|þpakki|2,5+25 mg|C03EA01|01.05.2013||R|1|0|0|0|G|0|RGM|0|0|0|100|IKR|1398|3046|lyfalmen|V0559|2193|2|100|0|100,0000|Medical ehf|ratiopharm GmbH|Hýdróklórtíazíð og kalíumsparandi lyf||1398||1398|3046||2 405129|QP54AA0501|Stronghold|bl.lausn|45|mg|0,75|ml|3|túpa||QP54AA05|01.12.2014||R|0|0|0|0|0|0|ZBE|1|0|0|100|DKK|2811|4845|vetorma|||0|2,25|0||Icepharma hf|Zoetis Belgium S.A.|Selamectinum||2811||2811|4845||2 405168|V07AB0014|Natriumklorid Fresenius Kabi|leysir|9|mg/ml|20|ml|20|lykjur|fyrir stl|V07AB|01.06.2015||L|0|0|0|0|0|0|FKA|0|0|0|100|DKK|||lyfalmen|||0|400|0||Vistor hf|Fresenius Kabi AB|Leysi- og þynningarvökvar, þ.m.t. skolvökvar|||||2132||1 405535|C03DA0403|Eplerenon Bluefish|filmhtfl|50|mg|30|stk|1|þpakki||C03DA04|01.11.2015||R|1|0|0|0|0|0|BLP|0|0|0|100|IKR|9000|11858|lyfalmen|V0197|11858|2|30|0|30,0000|LYFIS ehf|Bluefish Pharmaceuticals AB|Eplerenón||7800||7800|11858||2 405589|J07BD5203|Priorix|sts|||0,5|ml|1|hgl|+ einnota dæla|J07BD52|01.03.1999||R|0|0|0|0|0|0|GPH|0|0|0|100|GBP|1661|3408|lyfalmen|||1|0,5|0||Vistor hf|GlaxoSmithKline Pharma A/S|mislingar í blöndum með hettusótt og rauðum hundum (veiklaða||1661||1661|3408||1 405597|J07BD5203|Priorix|sts|||0,5|ml|10|hgl||J07BD52|01.11.2001||R|0|0|0|0|0|0|GPH|0|0|0|100|GBP|17708|25495|lyfalmen|||1|5|0||Vistor hf|GlaxoSmithKline Pharma A/S|mislingar í blöndum með hettusótt og rauðum hundum (veiklaða||17708||17708|25495||1 405677|J01DD0401|Rocephalin|irþ|2|g|1|hgl|1|pakki|lausn|J01DD04|01.03.2013||R|0|0|0|0|0|1|ROC|0|0|0|100|DKK|3243|5586|lyfsjukr|||1|1|0|1,0000|Icepharma hf|Roche|Ceftríaxón||3243||3243|5586||2 405823|C10BA0501|Atozet|filmhtfl|90|mg|90|stk|1|þpakki|10 mg + 80 mg|C10BA05|01.03.2015||R|0|0|0|0|0|0|MLD|0|0|0|100|DKK|16309|23570|lyfalmen|||1|90|0||Vistor hf|Merck Sharp & Dohme Limited|Atorvastin og ezetimibe||16309||16309|23570||1 405998|A10BA0202|Metformin Actavis|filmhtfl|1000|mg|60|stk|1|þpakki||A10BA02|01.11.2014||R|1|0|0|0|G|0|APC|0|0|0|100|XEU|436|1722|lyfalmen|V0502|1722|2|60|0|30,0000|Actavis Group PTC ehf|Actavis Group PTC ehf|Metformín||436||436|1722||1 406106|C10A00001|Praluent|stl|150|mg/ml|1|ml|6|áfpen|lausn í áf.lyfjapenna|C10A000|01.02.2016||R|0|0|0|0|0|0|SGA|0|0|0|100|NOK|64557|84352|lyfalmen|||1|6|0||Vistor hf|Sanofi-aventis groupe|Alirocumab||||64557|84352||1 406322|N05AE0301|Serdolect|filmhtfl|4|mg|100|stk|1|glas||N05AE03|01.10.2006||R|1|0|0|0|0|0|LBK|0|0|0|100|DKK|17621|25376|lyfalmen|||1|100|0|25,0000|Lundbeck Export A/S|H. Lundbeck A/S|Sertindólum||17621||17621|25376||1 406371|N05AE0301|Serdolect|filmhtfl|12|mg|100|stk|1|glas||N05AE03|01.10.2006||R|1|0|0|0|0|0|LBK|0|0|0|100|DKK|53143|69916|lyfalmen|||1|100|0|75,0000|Lundbeck Export A/S|H. Lundbeck A/S|Sertindólum||53143||53143|69916||1 406389|N05AE0301|Serdolect|filmhtfl|16|mg|100|stk|1|glas||N05AE03|01.10.2006||R|1|0|0|0|0|0|LBK|0|0|0|100|DKK|61251|80171|lyfalmen|||1|100|0|100,0000|Lundbeck Export A/S|H. Lundbeck A/S|Sertindólum||61251||61251|80171||1 406678|N04BA0210|Sinemet 12,5/50|töflur|62,5|mg|100|stk|1|glas|12,5+50 mg|N04BA02|01.10.2015||R|1|0|0|0|G|0|MSD|0|0|0|100|DKK|1560|3269|lyfalmen|||1|100|0|8,3300|Vistor hf|M.S.D.|Levódópa og dópadekarboxýl­asa­hemill||1560||1560|3269||1 406894|H01AC0111|Omnitrope|stl|3,3|mg/ml|1,5|ml|5|rörlyk|lausn|H01AC01|01.04.2012||R|0|0|0|1|0|1|SDG|0|1|0|100|DKK|64250|83964|lyfsjukr|||1|7,5|0|37,5000|Artasan ehf|Sandoz GmbH (Kundl)|Sómatrópín||64250||64250|83964||1 407423|QJ01CE9002|Mamyzin vet.|sts|10|millj ae|10|hgl|1|pakki|+leysir 30 ml x 10 hgl, dreifa|QJ01CE90|01.02.2016||R|0|0|0|0|0|0|BIV|0|0|0|100|DKK|16422|31326|vetalmen|||0|10|0||Vistor hf|Boehringer Ingelheim Vetmedica GmbH|||||16422|31326||2 407923|N06AB1007|Escitalopram Bluefish|filmhtfl|10|mg|28|stk|1|þpakki||N06AB10|01.08.2015||R|1|0|0|0|0|0|BLP|0|0|0|100|IKR|1320|2939|lyfalmen|V0319|2939|2|28|0|28,0000|LYFIS ehf|Bluefish Pharmaceuticals AB|Escítalópram||1320||1320|2939||2 407981|N05BA0402|Sobril|töflur|10|mg|25|stk|1|þpakki||N05BA04|01.01.1985||R|1|0|0|0|0|0|PER|0|0|1|100|DKK|149|1327|lyfalmen|||1|25|0|5,0000|Icepharma hf|Pfizer ApS|Oxazepam||149||149|1327||1 407999|N05BA0402|Sobril|töflur|10|mg|100|stk|1|þpakki||N05BA04|01.01.1985||R|1|0|0|0|0|0|PER|0|0|0|100|DKK|306|1543|lyfalmen|||1|100|0|20,0000|Icepharma hf|Pfizer ApS|Oxazepam||306||306|1543||1 408145|B01AF0101|Xarelto|filmhtfl|2,5|mg|100|stk|1|þpakki|stakskammtaþynna|B01AF01|01.04.2015||R|1|1|0|0|G|0|BYP|0|0|0|100|DKK|15122|21936|lyfalmen|||1|100|0|12,5000|Icepharma hf|Bayer Pharma AG|Rivaoxaban||15122||15122|21936||2 408156|A10BB0904|Zodediab|töflur|30|mg|90|stk|1|þpakki||A10BB09|01.03.2015||R|1|0|0|0|G|0|IPC|0|0|0|100|IKR|2744|4068|lyfalmen|V0020|2344|2|90|0|45,0000|Alvogen|Alvogen IPco S.á.r.l.|Glíklazíð||2140||2140|4068||1 408266|N05BA1206|Alprazolam Krka|forðatfl|1|mg|60|stk|1|þpakki||N05BA12|01.08.2012||R|1|0|0|0|0|0|KRK|0|0|0|100|XEU|1736|2867|lyfalmen|V0310|2867|2|60|0|60,0000|LYFIS ehf|Krka Sverige AB|Alprazólam||1268||1268|2867||2 408740|D07AC0104|Diproderm|smyrsli|0,5|mg/g|100|g|1|túpa||D07AC01|01.03.1977||R|0|0|0|0|G|0|MBV|0|0|1|100|DKK|1523|3218|lyfalmen|||1|100|0||Vistor hf|Merck Sharp & Dohme B.V.|Betametasón||1523||1523|3218||1 409019|QP54AA0501|Stronghold|bl.lausn|60|mg|0,5|ml|3|túpa||QP54AA05|01.12.2014||R|0|0|0|0|0|0|ZBE|1|0|0|100|XEU|2915|5024|vetorma|||0|1,5|0||Icepharma hf|Zoetis Belgium S.A.|Selamectinum||2915||2915|5024||2 409078|J02AC0101|Diflucan|mixtúrud|10|mg/ml|35|ml|1|glas||J02AC01|01.07.1992||R|0|0|0|0|0|0|PER|0|0|1|100|DKK|3422|5832|lyfalmen|||1|35|0|1,7500|Icepharma hf|Pfizer ApS|Flúkónazól||3422||3422|5832||1 409425|R01AD0502|Rhinocort Turbuhaler|nefúðad|100|mcg/sk|200|skammtar|1|stauk||R01AD05|01.01.1992||R|0|0|0|0|G|0|AZD|0|0|1|100|SEK|3463|5889|lyfalmen|||1|200|0|100,0000|Vistor hf|AstraZeneca A/S DK|Búdesóníð||3463||3463|5889||1 409474|C09CA0701|Micardis|töflur|80|mg|98|stk|1|þpakki||C09CA07|01.02.2008||R|0|0|0|0|0|0|BII|0|0|0|100|DKK|9070|13606|lyfalmen|||1|98|0|196,0000|Vistor hf|Boehringer Ingelheim International |Telmisartan||9070||9070|13606||1 409488|N03AX1609|Pregabalin Sandoz GmbH|hylki|75|mg|56|stk|1|þpakki||N03AX16|01.02.2016||R|1|0|0|0|0|0|SDG|0|0|0|100|DKK|3351|4682|lyfalmen|V0686|3744|2|56|0|14,0000|Artasan ehf|Sandoz GmbH (Kundl)|Pregabalín||2586||2586|4682||1 409547|C09DX0401|Entresto|filmhtfl|200|mg|168|stk|1|þpakki|97 + 103 mg|C09DX04|01.04.2016||R|0|0|0|0|0|0|NEL|0|0|0|100|DKK|56623|74317|lyfalmen|V0728|74317|1|168|0|84,0000|Vistor hf|Novartis Europharm Ltd|Valsartan og sacubitril||56623||56623|74317||1 409745|N05AX1302|Xeplion|stl|100|mg|1|stk|1|áf.spr|forðadreifa|N05AX13|01.04.2012||R|0|0|0|0|0|0|JCI|0|0|0|100|SEK|56448|74096|lyfalmen|||1|1|0|40,0000|Vistor hf|Janssen-Cilag International N.V.|Paliperídón||56448||56448|74096||1 409763|C09CA0701|Micardis|töflur|40|mg|98|stk|1|þpakki||C09CA07|01.02.2008||R|0|0|0|0|0|0|BII|0|0|0|100|DKK|7356|11247|lyfalmen|||1|98|0|98,0000|Vistor hf|Boehringer Ingelheim International |Telmisartan||7356||7356|11247||1 409809|N02CC0105|Sumatriptan Bluefish|töflur|100|mg|18|stk|1|þpakki||N02CC01|01.12.2015||R|1|0|0|0|G|0|BLP|0|0|0|100|IKR|5650|4150|lyfalmen|V0234|4150|2|18|0|36,0000|LYFIS ehf|Bluefish Pharmaceuticals AB|Súmatriptan||2200||2200|4150||2 409927|G04BD1201|Betmiga|forðatfl|50|mg|90|stk|1|þpakki||G04BD12|01.07.2013||R|1|0|0|0|G|0|APE|0|0|0|100|XEU|15348|22247|lyfalmen|V0651|22247|1|90|0|90,0000|Vistor hf|Astellas Phama Europe B.V.|Mírabegrón||15348||15348|22247||1 409975|M01AH0105|Cloxabix|hylki|200|mg|100|stk|1|þpakki||M01AH01|01.03.2013||R|1|0|0|0|G|0|WEH|0|0|1|100|XEU|6963|8025|lyfalmen|V0196|7316|2|100|0|100,0000|Williams & Halls efh|Williams & Halls ehf|Celekoxíb||5015||5015|8025||2 410077|N02CC0402|Maxalt Smelt|frþ.tfl|5|mg|6|stk|1|þpakki||N02CC04|01.11.2013||R|0|0|0|0|G|0|MSD|0|0|0|100|DKK|3275|5630|lyfalmen|V0620|4931|1|6|0|3,0000|Vistor hf|M.S.D.|Rizatriptan||3275||3275|5630||1 410382|C03DA0103|Spiron|töflur|100|mg|100|stk|1|glas||C03DA01|01.09.2013||R|1|0|0|0|G|0|OPF|0|0|0|100|DKK|3292|5028|lyfalmen|V0093|5028|2|100|0|133,3300|Alvogen|Orion Corporation|Spírónólaktón||2838||2838|5028||1 410469|L04AB0202|Remsima|irþ|100|mg|1|hgl|1|pakki||L04AB02|01.01.2014||R|0|1|0|1|0|1|CHH|0|1|0|100|DKK|49006|64684|lyfsjukr|||2|1|0|26,6700|Alvogen|Celltrion Healthcare Hungary Kft.|Infliximab||49006||49006|64684||1 410639|P01BA0102|Klorokinfosfat Recip|filmhtfl|250|mg|20|stk|1|þpakki||P01BA01|01.08.2005||R|1|0|0|0|0|0|REP|0|0|0|100|SEK|969|2456|lyfalmen|||1|20|0|6,2000|Vistor hf|Recip AB|Klórókín||969||969|2456||1 410649|C09CA0305|Valsartan ratiopharm|filmhtfl|40|mg|14|stk|1|þpakki||C09CA03|01.02.2015||R|1|0|0|0|0|0|RGM|0|0|0|100|IKR|820|2251|lyfalmen|||2|14|0|7,0000|Medical ehf|ratiopharm GmbH|Valsartan||820||820|2251||2 410757|V03AE0203|Sevelamercarbonat W&H|filmhtfl|800|mg|180|stk|1|glas||V03AE02|01.04.2015|30.04.2016|R|1|1|0|0|0|0|WEH|0|0|0|100|IKR|20204|26127|lyfalmen|||2|180|0|22,5000|Williams & Halls efh|Williams & Halls ehf|Sevelamer||18167||18167|26127||2 411033|M03BX0105|Baklofen Mylan|töflur|10|mg|50|stk|1|þpakki||M03BX01|01.01.1990||R|1|0|0|0|G|0|MYL|0|0|1|100|SEK|579|1919|lyfalmen|||2|50|0|10,0000|Icepharma hf|Mylan AB|Baklófen||579||579|1919||2 411076|N05AD0301|Buronil|húðuðtfl|25|mg|100|stk|1|glas||N05AD03|01.12.2014||R|1|0|0|0|G|0|MEV|0|0|0|100|DKK|1480|3159|lyfalmen|V0557|3159|1|100|0|8,3333|Vistor hf|MediLink A/S|Melperón||1480||1480|3159||1 411184|N02BE0118|Paracetamol-ratiopharm|töflur|500|mg|100|stk|1|glas||N02BE01|01.10.2013||R|1|0|0|0|0|0|RGM|0|0|1|100|XEU|429|1641|lyfalmen|V0230|1626|2|100|0|16,6667|Medical ehf|ratiopharm GmbH|Paracetamól||377||377|1641||2 411324|N06AX2107|Duloxetine Mylan|sþ-hylki|30|mg|28|stk|1|þpakki||N06AX21|01.11.2015||R|0|0|0|0|0|0|GGE|0|0|0|100|SEK|2399|2778|lyfalmen|V0692|2778|2|28|0|14,0000|Mylan AB|Generics (UK) Ltd.|Duloxetín||1203||1203|2778||2 411389|N05CD0801|Dormicum|stl|5|mg/ml|10|ml|5|lykjur||N05CD08|01.10.1990||R|0|0|0|0|0|1|ROC|0|0|0|100|DKK|5764|9056|lyfsjukr|||1|50|0|16,6667|Icepharma hf|Roche|Mídazólam||5764||5764|9056||2 411616|N06BA0404|Methylphenidate Sandoz|forðatfl|36|mg|30|stk|1|glas||N06BA04|01.11.2013||R|1|1|1|0|0|0|SHS|0|0|0|100|DKK|6371|6954|lyfalmen|V0624|6954|2|30|0|36,0000|Artasan ehf|Sandoz A/S|Metýlfenídat||4237||4237|6954||1 411827|J05AF0501|Epivir|töflur|150|mg|60|stk|1|glas||J05AF05|01.03.1999||R|1|0|0|1|0|1|VII|0|0|0|100|GBP|23537|32470|lyfsjukr|||1|60|0|30,0000|GlaxoSmithKline ehf|ViiV Healthcare UK Ltd|Lamívúdín||23537||23537|32470||1 411859|J02AC0102|Candizol|hylki|150|mg|1|stk|1|þpakki||J02AC01|01.02.2014||L|1|0|0|0|0|0|ACA|0|0|1|100|IKR|||lyfalmen|V0554|1916|2|1|0|0,7500|Actavis Group hf|Actavis hf|Flúkónazól|||||1916||1 411918|N02CC0101|Imigran|nefúði|20|mg/sk|6|skammtar|1|pakki||N02CC01|01.07.2000||R|0|0|0|0|G|0|GPH|0|0|0|100|GBP|6137|9569|lyfalmen|||1|6|0|6,0000|Vistor hf|GlaxoSmithKline Pharma A/S|Súmatriptan||6137||6137|9569||1 412049|L02AE0301|Zoladex|vefjalyf|3,6|mg|1|áf.spr|1|pakki||L02AE03|01.01.1990||R|0|0|0|1|G|0|AZA|0|0|0|100|SEK|18643|26782|lyfalmen|V0183|24729|1|1|0|27,9070|Vistor hf|AstraZeneca AB|Góserelín||18643||18643|26782||1 412361|B01AB0501|Klexane|stl|100|mg/ml|3|ml|1|hgl|með rotv.|B01AB05|01.02.1999||R|0|0|0|0|0|1|SNO|0|0|0|100|NOK|2716|4861|lyfsjukr|||1|3|0|15,0000|Vistor hf|Sanofi-aventis Norge AS|Enoxaparín||2716||2716|4861||1 412395|QM01AE0301|Romefen, vet.|stl|100|mg/ml|100|ml|1|hgl||QM01AE03|01.10.1995||R|0|0|0|0|0|0|MER|1|0|0|100|XEU|2760|5407|vetalmen|||0|100|0||Vistor hf|Merial|||2760||2760|5407||1 412468|QM01AC0606|Meloxidolor|stl|5|mg/ml|20|ml|1|hgl||QM01AC06|01.07.2014||R|0|0|0|0|0|0|VEB|1|0|0|100|XEU|4412|8541|vetalmen|||0|20|0||Dýraheilsa ehf|Le Vet Beheer B.V.|||4412||4412|8541|29.2.2016|2 412547|L03AB0701|Avonex|stl|30|mcg/pen|0,5|ml|4|spr|lausn,áfylltur lyfjapenni|L03AB07|01.11.2011||R|0|0|0|1|0|1|BIB|0|0|0|100|XEU|91511|118444|lyfsjukr|||1|2|0|27,9100|Icepharma hf|Biogen Idec Ltd|Interferón beta-1a||91511||91511|118444||2 412581|N05AX1302|Xeplion|stl|75|mg|1|stk|1|áf.spr|forðadreifa|N05AX13|01.04.2012||R|0|0|0|0|0|0|JCI|0|0|0|100|SEK|50533|66615|lyfalmen|||1|1|0|30,0000|Vistor hf|Janssen-Cilag International N.V.|Paliperídón||50533||50533|66615||1 412825|L02BA0107|Tamoxifen Mylan|töflur|10|mg|100|stk|1|glas||L02BA01|01.01.1990||R|0|0|0|0|G|0|MYL|0|0|0|100|SEK|2910|5128|lyfalmen|||2|100|0|50,0000|Icepharma hf|Mylan AB|Tamoxífen||2910||2910|5128||2 412924|L02BA0107|Tamoxifen Mylan|töflur|20|mg|100|stk|1|glas||L02BA01|01.01.2010||R|1|0|0|0|G|0|MYL|0|0|0|100|SEK|3002|5254|lyfalmen|||2|100|0|100,0000|Icepharma hf|Mylan AB|Tamoxífen||3002||3002|5254||2 413220|V03AB1703|Methylthioninium chloride Proveblue|stl|5|mg/ml|10|ml|5|lykjur||V03AB17|01.05.2015||R|0|0|0|0|0|1|ROP|0|0|0|100|DKK|29921|40545|lyfsjukr|||1|50|0||Williams & Halls efh|Provepharm SAS|Metýltíónín||29921||29921|40545||2 413988|N02BE0107|Paratabs|filmhtfl|500|mg|20|stk|1|þpakki||N02BE01|01.03.2013||L|1|0|0|0|0|0|APC|0|0|1|100|IKR|||lyflausa|||0|20|0|3,3333|Actavis Group PTC ehf|Actavis Group PTC ehf|Paracetamól|||||||1 414097|N03AX1108|Topiramat Bluefish|filmhtfl|25|mg|60|stk|1|þpakki||N03AX11|01.05.2016||R|1|0|0|0|G|0|BLP|0|0|0|100|XEU|1860|1765|lyfalmen|V0247|1765|2|60|0|5,0000|LYFIS ehf|Bluefish Pharmaceuticals AB|Tópíramat||467||467|1765||2 414167|N06DA0205|Donesyn|filmhtfl|10|mg|98|stk|1|þpakki||N06DA02|01.05.2011||R|1|0|0|0|G|0|WEH|0|0|0|100|XEU|14153|7209|lyfalmen|V0342|7065|2|98|0|130,6700|Williams & Halls efh|Williams & Halls ehf|Dónepezíl||4422||4422|7209||2 414592|L03AX1301|Copaxone|stl|40|mg/spr|12|áf.spr|1|pakki||L03AX13|01.11.2015||R|0|0|0|1|0|1|TEP|0|0|0|100|NOK|126752|163224|lyfsjukr|||1|12|0|24,0000|Vistor hf|Teva Pharmaceuticals Limited UK|Glatíramer acetat||126752||126752|163224||1 414680|C03BA1102|Natrilix Retard|forðatfl|1,5|mg|90|stk|1|þpakki||C03BA11|01.03.1999||R|1|0|0|0|G|0|SEV|0|0|0|100|DKK|3381|5776|lyfalmen|||1|90|0|54,0000|Icepharma hf|Servier|Indapamíð||3381||3381|5776||2 414789|N03AF0104|Tegretol|mixtúra|20|mg/ml|300|ml|1|glas||N03AF01|01.09.2007||R|0|0|0|0|G|0|HES|0|0|0|100|DKK|1089|2621|lyfalmen|||1|300|0|6,0000|Vistor hf|Novartis Healthcare A/S|Karbamazepín||1089||1089|2621||1 415338|N05AA0201|Nozinan|filmhtfl|25|mg|100|stk|1|þpakki||N05AA02|01.11.2012||R|1|0|0|0|G|0|SNO|0|0|0|100|NOK|1493|3177|lyfalmen|||1|100|0|8,3333|Vistor hf|Sanofi-aventis Norge AS|Levómeprómazín||1493||1493|3177||1 415368|C02KX0501|Adempas|filmhtfl|2,5|mg|42|stk|1|þpakki||C02KX05|01.12.2014||R|1|0|0|1|0|1|BYE|0|1|0|100|DKK|180636|230241|lyfsjukr|||1|42|0|23,3300|Vistor hf|Bayer Pharma AG|Riociguatum||180636||180636|230241||1 415946|N03AX1405|Matever|filmhtfl|500|mg|100|stk|1|þpakki||N03AX14|01.02.2012||R|1|0|0|0|0|0|PSA|0|0|0|100|XEU|7546|6065|lyfalmen|V0253|6065|2|100|0|33,3300|Alvogen|Pharmathen S.A.|Levetíracetam||3591||3591|6065||1 416371|QM01AE9001|Quadrisol|hlaup|100|mg/ml|30|ml|1|spr|f. hesta|QM01AE90|01.04.2015||R|0|0|0|0|0|0|ZBE|0|0|0|100|DKK|1687|3316|vetalmen|||0|30|0||Icepharma hf|Zoetis Belgium S.A.|Vedaprófen||1687||1687|3316||2 416446|C09DA0101|Cozaar Comp|filmhtfl|62,5|mg|98|stk|1|þpakki|50+12,5 mg|C09DA01|01.09.1997||R|1|0|0|0|0|0|MSD|0|0|0|100|DKK|8434|8775|lyfalmen|V0088|2365|1|98|0|98,0000|Vistor hf|M.S.D.|Lósartan og þvagræsilyf||5560||5560|8775||1 416589|N03AX1604|Brieka|hylki|75|mg|56|stk|1|þpakki||N03AX16|01.10.2015||R|1|0|0|0|0|0|AGP|0|0|0|100|XEU|4489|4565|lyfalmen|V0686|3744|2|56|0|14,0000|Actavis Group hf|Actavis Group PTC ehf|Pregabalín||2501||2501|4565||1 416630|N06BA0702|Modafinil Bluefish|töflur|100|mg|30|stk|1|þpakki||N06BA07|01.10.2014||R|1|0|0|1|0|0|BLP|0|0|0|100|IKR|7200|7729|lyfalmen|V0657|7729|2|30|0|10,0000|LYFIS ehf|Bluefish Pharmaceuticals AB|Modafinil||4800||4800|7729||2 416818|A02BA0205|Zantac|mixtúra|15|mg/ml|300|ml|1|glas||A02BA02|01.03.2013||R|0|0|0|0|G|0|GPH|0|0|0|100|GBP|4403|7182|lyfalmen|||1|300|0|15,0000|Vistor hf|GlaxoSmithKline Pharma A/S|Ranitidín||4403||4403|7182|30.4.2016|1 416859|A01AA0101|Duraphat|tanndrei|22,6|mg/ml|10|ml|1|túpa||A01AA01|01.10.1995||R|0|0|0|0|G|0|GOG|0|0|1|100|XEU|2567|4655|lyfalmen|||1|10|0||Icepharma hf|Colgate Palmolive A/S|Natríumflúoríð||2567||2567|4655||2 416883|D10AX0301|Skinoren|krem|200|mg/g|30|g|1|túpa||D10AX03|01.07.1991||R|0|0|0|0|0|0|BAB|0|0|0|100|DKK|897|2357|lyfalmen|||1|30|0||Icepharma hf|Bayer AB|Azelainsýra||897||897|2357||2 417266|N05AH0409|Quetiapin Orion|filmhtfl|100|mg|100|stk|1|þpakki||N05AH04|01.10.2012|31.03.2016|R|1|0|0|0|G|0|OPF|0|0|0|100|IKR|5695|4357|lyfalmen|||2|100|0|25,0000|Alvogen|Orion Corporation|Quetíapín||2350||2350|4357||1 417832|J05AF0601|Ziagen|filmhtfl|300|mg|60|stk|1|þpakki||J05AF06|01.07.2005||R|1|1|0|1|0|1|VII|0|0|0|100|GBP|38524|51426|lyfsjukr|||1|60|0|30,0000|GlaxoSmithKline ehf|ViiV Healthcare UK Ltd|Abacavír||38524||38524|51426||1 417880|B02BD0901|BeneFIX|sts|1000|ae|1|hgl|1|pakki|+leysir|B02BD09|01.07.2012||R|0|0|0|1|0|1|IPI|0|1|0|100|DKK|88287|114366|lyfsjukr|||1|1|0|2,2200|Icepharma hf|Pfizer Limited|Storkuþáttur IX||88287||88287|114366||1 418043|B01AE0701|Pradaxa|hylki|150|mg|180|stk|1|þpakki|hart|B01AE07|01.10.2011||R|0|1|0|0|G|0|BII|0|0|0|100|DKK|28628|38909|lyfalmen|V0460|38909|1|180|0|90,0000|Vistor hf|Boehringer Ingelheim International|Dabigatran etexílat||||28628|38909||1 418119|N05AX1207|Lemilvo|töflur|5|mg|56|stk|1|þpakki||N05AX12|01.10.2015||R|1|1|0|0|0|0|AGP|0|0|0|100|XEU|26312|22199|lyfalmen|V0682|20512|2|56|0|18,6670|Actavis Group hf|Actavis Group PTC ehf|Aripiprazól||15313||15313|22199||1 418122|H02AB0205|Dexametason Abcur|töflur|4|mg|20|stk|1|þpakki||H02AB02|01.11.2013|30.04.2016|R|1|0|0|0|G|0|ABC|0|0|1|100|SEK|3747|6280|lyfalmen|||2|20|0|53,3300|Icepharma hf|Abcur AB|Dexametasón||3747||3747|6280||2 418592|L04AC0301|Kineret|stl|100|mg/spr|0,67|ml|28|áf.spr||L04AC03|01.06.2012||R|0|1|0|1|0|1|BIO|0|0|0|100|DKK|119639|154377|lyfsjukr|||1|18,76|0|28,0000|Swedish Orphan Biovitrum AB|Swedish Orphan Biovitrum AB|Anakinra||119639||119639|154377||3 418731|A07EC0201|Mesasal|eþ-stíll|500|mg|60|stk|1|pakki||A07EC02|01.10.1991||R|0|0|0|0|G|0|SNO|0|0|0|100|NOK|5352|8489|lyfalmen|V0014|8489|1|60|0|20,0000|Vistor hf|Sanofi-aventis Norge AS|Mesalazín (5-amínósalicýlsýra)||5352||5352|8489||1 418981|R06AX2703|Desloratadine Actavis|filmhtfl|5|mg|100|stk|1|þpakki||R06AX27|01.05.2012|29.02.2016|R|1|0|0|0|G|0|APC|0|0|1|100|XEU|1665|3414|lyfalmen|||2|100|0|100,0000|Actavis Group PTC ehf|Actavis Group PTC ehf|Deslóratadín||1665||1665|3414||1 419242|A11CC0301|Etalpha|hylki|0,25|mcg|100|stk|1|þpakki||A11CC03|01.11.1979||R|1|0|0|0|G|0|LEP|0|0|0|100|DKK|2452|4497|lyfalmen|||1|100|0|25,0000|Vistor hf|LEO Pharma A/S|Alfakalsídól||2452||2452|4497||1 419309|A11CC0301|Etalpha|hylki|1|mcg|100|stk|1|þpakki||A11CC03|01.11.1979||R|1|0|0|0|G|0|LEP|0|0|0|100|DKK|6320|9821|lyfalmen|||1|100|0|100,0000|Vistor hf|LEO Pharma A/S|Alfakalsídól||6320||6320|9821||1 419820|J05AE0201|Crixivan|hylki|400|mg|180|stk|1|glas||J05AE02|01.04.1997||R|1|0|0|1|0|1|MSD|0|0|0|100|DKK|44218|58628|lyfsjukr|||1|180|0|30,0000|Vistor hf|M.S.D.|Indínavír||44218||44218|58628||1 419828|N06BA0406|Medikinet CR|hylki|5|mg|30|stk|1|þpakki|með breyttan losunarhraða|N06BA04|01.01.2015||R|1|1|1|0|0|0|PUT|0|0|0|100|IKR|2854|5050|lyfalmen|||2|30|0|5,0000|LYFIS ehf|Medice Arzneimittel Putter GmbH|Metýlfenídat||2854||2854|5050||2 419838|A16AA0401|Cystagon|hylki|150|mg|100|stk|1|glas||A16AA04|01.02.2008||R|1|0|0|1|0|1|ORP|0|0|0|100|DKK|33405|44951|lyfsjukr|||1|100|0|7,5000|Swedish Orphan International AB|Orphan Europe (S)|Mecaptamín||33405||33405|44951||3 419945|D07AD0101|Dermovat|húðlausn|0,5|mg/ml|25|ml|1|glas|í hársvörð|D07AD01|01.09.1982||R|0|0|0|0|G|0|GPH|0|0|1|100|GBP|670|2044|lyfalmen|||1|25|0||Vistor hf|GlaxoSmithKline Pharma A/S|Klóbetasól||670||670|2044||1 420117|B01AB0401|Fragmin|stl|10000|ae/ml|1|ml|10|lykjur||B01AB04|01.04.1993||R|0|0|0|0|G|0|PER|0|0|1|100|DKK|10713|15868|lyfalmen|||1|10|0|40,0000|Icepharma hf|Pfizer ApS|Dalteparín||10713||10713|15868||1 420209|A02BC0110|Omeprazol ratiopharm|sþ-hylki|20|mg|100|stk|1|þpakki|hart|A02BC01|01.08.2015||R|1|0|0|0|G|0|RGM|0|0|0|100|IKR|4359|3035|lyfalmen|V0006|2825|2|100|0|100,0000|Medical ehf|ratiopharm GmbH|Ómeprazól||1390||1390|3035||2 420510|J01CA0413|Amoxin|mixtduft|100|mg/ml|60|ml|1|glas||J01CA04|01.01.2016||R|0|0|0|0|0|0|RAT|0|0|1|100|IKR|2242|3806|lyfalmen|V0479|3806|2|60|0|6,0000|LYFIS ehf|ratiopharm GmbH|Amoxicillín||1950||1950|3806||2 420568|A10BB1203|Glimepirid Bluefish|töflur|3|mg|90|stk|1|þpakki||A10BB12|01.10.2015||R|1|0|0|0|G|0|BLP|0|0|0|100|IKR|960|1810|lyfalmen|V0023|1810|2|90|0|135,0000|LYFIS ehf|Bluefish Pharmaceuticals AB|Glímepíríð||500||500|1810||2 421180|C01BD0101|Cordarone|töflur|100|mg|30|stk|1|þpakki||C01BD01|01.07.1989||R|1|0|0|0|G|0|SNO|0|0|0|100|NOK|873|2324|lyfalmen|V0036|2322|1|30|0|15,0000|Vistor hf|Sanofi-aventis Norge AS|Amíódarón||873||873|2324||1 421816|QN04BC0201|Prascend|töflur|1|mg|160|stk|1|þpakki|handa hestum|QN04BC02|01.05.2014||R|0|0|0|0|0|0|BIV|0|0|0|100|DKK|30065|57210|vetalmen|||0|160|0||Vistor hf|Boehringer Ingelheim Vetmedica GmbH|Pergolide||30065||30065|57210||1 421938|R06AX2705|Desloratadine Teva|filmhtfl|5|mg|100|stk|1|þpakki||R06AX27|01.09.2013||R|1|0|0|0|G|0|RGM|0|0|1|100|XEU|1988|3485|lyfalmen|V0458|3485|2|100|0|100,0000|Medical ehf|ratiopharm GmbH|Deslóratadín||1717||1717|3485||2 422115|N02AA0506|Oxikodon Depot Actavis|forðatfl|5|mg|28|stk|1|þpakki||N02AA05|01.10.2014||R|1|0|1|0|G|0|APC|0|0|0|100|XEU|538|1863|lyfalmen|V0596|1863|2|28|0|1,8600|Actavis Group PTC ehf|Actavis Group PTC ehf|Oxýcódon||538||538|1863||1 422121|C07AB0205|Seloken|töflur|50|mg|100|stk|1|þpakki||C07AB02|01.05.2009|31.03.2016|R|1|0|0|0|G|0|AZD|0|0|0|100|SEK|1286|2892|lyfalmen|||1|100|0|33,3300|Vistor hf|AstraZeneca A/S DK|Metóprólól||1286||1286|2892||1 422246|C07AB0206|Seloken ZOC|forðatfl|95|mg|98|stk|1|þpakki||C07AB02|01.07.1988||R|1|0|0|0|G|0|AZD|0|0|0|100|SEK|2898|5111|lyfalmen|V0049|3335|1|98|0|62,0700|Vistor hf|AstraZeneca A/S DK|Metóprólól||2898||2898|5111||1 422337|C07AB0206|Seloken ZOC|forðatfl|190|mg|98|stk|1|þpakki||C07AB02|01.07.1988||R|1|0|0|0|G|0|AZD|0|0|0|100|SEK|4765|7681|lyfalmen|V0054|5550|1|98|0|124,1300|Vistor hf|AstraZeneca A/S DK|Metóprólól||4765||4765|7681||1 422474|B02BB0101|Riastap|sts/irs|1|g|1|hgl|1|pakki|lausn|B02BB01|01.12.2011||R|0|0|0|1|0|1|CSB|0|0|0|100|SEK|60701|79475|lyfsjukr|||1|1|0|0,2000|Icepharma hf|CSL Behring GmbH|Manna Fíbrínógen||60701||60701|79475||2 422738|G03GA0503|Bemfola|stl|75|ae|0,125|ml|1|penni||G03GA05|01.01.2015||R|0|0|0|1|G|0|FBA|0|0|0|100|SEK|2931|5156|lyfalmen|||1|0,125|0|1,0000|Finox Biotech AG|Finox Biotech AG|Follitrópín alfa||2931||2931|5156||3 422937|B01AF0101|Xarelto|filmhtfl|2,5|mg|56|stk|1|þpakki||B01AF01|01.04.2015||R|1|1|0|0|G|0|BYP|0|0|0|100|DKK|8488|12805|lyfalmen|||1|56|0|7,0000|Icepharma hf|Bayer Pharma AG|Rivaoxaban||8488||8488|12805||2 423361|G03AA1201|Yasmin|filmhtfl|||63|stk|1|þpakki|3+0,03 mg|G03AA12|01.01.2014||R|0|0|0|0|0|0|BGB|0|0|0|100|DKK|2866|5067|lyfalmen|V0192|4211|1|63|0|84,0000|Icepharma hf|Bayer Pharma AG|Dróspírenón og ethinylestradíól||||2866|5067||2 423527|A02BC0506|Esomeprazole Krka (LYFIS)|sþ-hylki|20|mg|56|stk|1|þpakki||A02BC05|01.08.2011||R|1|0|0|0|0|0|LYF|0|0|0|100|IKR|4596|3875|lyfalmen|V0011|3020|3|56|0|37,3300|LYFIS ehf|LYFIS ehf|Esómeprazól||2000||2000|3875||2 423703|S01GA5101|Antistina-Privin|augndr|5,25|mg/ml|10|ml|1|glas|5+0,25 mg|S01GA51|01.05.2014||R|0|0|0|0|G|0|TEA|0|0|0|100|SEK|695|2079|lyfalmen|||1|10|0||Vistor hf|Laboratories THEA|Nafazólín í blöndum með öðrum efnum||695||695|2079||1 423737|J01GB0304|Gentamicin B. Braun|irl|3|mg/ml|120|ml|10|fl||J01GB03|01.07.2012||R|0|0|0|0|0|1|BRU|0|0|0|100|XEU|19426|27860|lyfsjukr|||2|1200|0|15,0000|Actavis Group hf|B.Braun Melsungen AG|Gentamícín||19426||19426|27860||1 423859|S01ED5101|Cosopt|augndr|5|mg/ml|5|ml|3|glös|+ dorzólamíð 20 mg|S01ED51|01.09.2015||R|0|0|0|0|G|0|SAO|0|0|0|100|DKK|5222|8310|lyfalmen|V0373|4500|1|15|0|75,0000|Icepharma hf|Santen Oy|Tímólól í blöndum||5222||5222|8310||2 425181|N05CD0306|Flunitrazepam Mylan|töflur|1|mg|100|stk|1|glas||N05CD03|01.10.1992||R|1|0|1|0|0|0|MYL|0|0|0|100|SEK|918|2386|lyfalmen|||2|100|0|100,0000|Icepharma hf|Mylan AB|Flúnítrazepam||918||918|2386||2 425608|N07BC5101|Suboxone|tungur.t|2,5|mg|28|stk|1|þpakki|2+0,5 mg|N07BC51|01.08.2011||R|0|0|1|1|0|1|RBP|0|0|0|100|DKK|3873|6453|lyfsjukr|||1|28|0|7,0000|Vistor hf|RB Pharmaceuticals Limited|Búprenorfín í blöndum||3873||3873|6453||1 425939|C09CA0102|Lopress|töflur|12,5|mg|100|stk|1|glas||C09CA01|01.06.2012||R|1|0|0|0|G|0|AHF|0|0|0|100|IKR|2248|4046|lyfalmen|||2|100|0|25,0000|Actavis Group PTC ehf|Actavis Group hf|Lósartan||2124||2124|4046||1 426593|J01CE0204|Kaavepenin|töflur|500|mg|20|stk|1|þpakki||J01CE02|01.10.1985||R|0|0|0|0|0|0|REP|0|0|1|100|SEK|576|1915|lyfalmen|||1|20|0|5,0000|Vistor hf|Recip AB|Fenoxýmetýlpenicillín||576||576|1915||1 426601|J01CE0204|Kaavepenin|töflur|500|mg|30|stk|1|þpakki||J01CE02|01.10.1985||R|0|0|0|0|0|0|REP|0|0|1|100|SEK|752|2157|lyfalmen|||1|30|0|7,5000|Vistor hf|Recip AB|Fenoxýmetýlpenicillín||752||752|2157||1 426859|N03AX1407|Levetiracetam Teva|filmhtfl|250|mg|50|stk|1|þpakki||N03AX14|01.02.2015||R|1|0|0|0|0|0|TEV|0|0|0|100|IKR|2129|1673|lyfalmen|V0515|1673|2|50|0|8,3300|Medical ehf|Teva Pharma B.V.|Levetíracetam||400||400|1673||2 427075|M01AE0115|Alvofen Express|hylki|400|mg|50|stk|1|þpakki||M01AE01|01.04.2014||L|1|0|0|0|0|0|IPC|0|0|1|100|IKR|||lyflausa|||0|50|0|16,6600|Alvogen|Alvogen IPco S.á.r.l.|Íbúprófen|||||||1 427186|C10BA0201|Inegy|töflur|90|mg|28|stk|1|þpakki|10 mg + 80 mg|C10BA02|01.07.2013||R|1|0|0|0|0|0|MLD|0|0|0|100|DKK|7552|11517|lyfalmen|||1|28|0|28,0000|Vistor hf|Merck Sharp & Dohme Limited|Ezetimíb og simvastatín||7552||7552|11517||1 427321|S01EE0402|IZBA|augndr|30|mcg/ml|2,5|ml|3|glös||S01EE04|01.10.2014||R|0|0|0|0|G|0|ALA|0|0|0|100|USD|7098|10892|lyfalmen|V0658|10892|1|7,5|0|75,0000|Vistor hf|Alcon Laboratories Ltd.|Travóprost||7098||7098|10892||1 427765|A06AB0801|Laxoberal|dropar|7,5|mg/ml|30|ml|1|plglas||A06AB08|01.09.2008||L|0|0|0|0|0|0|BII|0|0|0|100|IKR|||lyfalmen|||0|30|0|45,0000|Vistor hf|Boehringer Ingelheim International |Natríum pícósúlfat|||||2892||1 427803|R03AK0604|Relanio|innönddu|300|mcg/sk|180|skammtar|1|pakki|50+250 mcg|R03AK06|01.01.2014||R|0|0|0|0|G|0|EPL|0|0|0|100|IKR|19495|21080|lyfalmen|||2|180|0|90,0000|LYFIS ehf|ELPEN Pharmaceutical Co. Inc.|Salmeteról og fluticason||14500||14500|21080||2 428018|R06AX2201|Kestine|filmhtfl|10|mg|10|stk|1|þpakki||R06AX22|01.06.2012||L|1|0|0|0|0|0|APS|0|0|1|100|IKR|||lyflausa|||0|10|0|10,0000|Vistor hf|Almirall-Prodesfarma S.A.|Ebastín|||||||1 428089|C01DA0205|Nitroglyserin DAK|tungur.t|0,5|mg|25|stk|1|glas||C01DA02|01.05.2014||L|0|0|0|0|G|0|TPA|0|0|0|100|DKK|||lyfalmen|||0|25|0|5,0000|Vistor hf|Takeda Pharma A/S|Glýcerýltrínítrat|||||1991||1 428579|L03AA0202|Zarzio|stl/irl|48|millj ae|0,5|ml|5|áf.spr|lausn|L03AA02|01.03.2015||R|0|0|0|1|0|1|SAR|0|0|0|100|DKK|37843|50565|lyfsjukr|||1|2,5|0|6,8600|Artasan ehf|Sandoz GmbH (A)|Fílgrastím||||37843|50565||1 428828|N06DA0303|Nimvastid (Lyfis)|hylki|3|mg|112|stk|1|þpakki||N06DA03|01.04.2011||R|1|0|0|0|G|0|LYF|0|0|0|100|IKR|25104|31520|lyfalmen|V0344|31520|3|112|0|37,3300|LYFIS ehf|LYFIS ehf|Rívastigmín||22786||22786|31520||2 429098|B05BB0117|Natriumklorid Baxter Viaflo 9 mg/ml|irl|9|mg/ml|500|ml|20|pokar|lausn|B05BB01|01.07.2013||R|0|0|0|0|0|1|BAM|0|0|0|100|SEK|3368|5758|lyfsjukr|||1|10000|0||Icepharma hf|Baxter Medical AB|Elektrólýtar||3368||3368|5758||2 429503|J02AC0401|Noxafil|mixtúra|40|mg/ml|105|ml|1|glas||J02AC04|01.07.2014||R|0|0|0|1|0|1|MLD|0|0|0|100|DKK|85796|111216|lyfsjukr|||1|105|0|5,2500|Vistor hf|Merck Sharp & Dohme Limited|Posacónazól||85796||85796|111216||1 429837|C03DA0101|Aldactone|töflur|100|mg|100|stk|1|þpakki||C03DA01|01.11.1981||R|1|0|0|0|G|0|PER|0|0|0|100|DKK|4030|6669|lyfalmen|V0093|5028|1|100|0|133,3333|Icepharma hf|Pfizer ApS|Spírónólaktón||4030||4030|6669||1 429875|G03GA0503|Bemfola|stl|225|ae|0,375|ml|1|penni||G03GA05|01.01.2015||R|0|0|0|1|G|0|FBA|0|0|0|100|SEK|9685|14453|lyfalmen|||1|0,375|0|3,0000|Finox Biotech AG|Finox Biotech AG|Follitrópín alfa||9685||9685|14453||3 430009|N01AH0102|Leptanal|stl|50|mcg/ml|10|ml|5|lykjur||N01AH01|01.10.1989||R|0|0|1|0|0|1|JAS|0|0|0|100|SEK|995|2492|lyfsjukr|||1|50|0||Vistor hf|Janssen-Cilag AB|Fentanýl||995||995|2492||1 430074|N05CD0801|Dormicum|stl|1|mg/ml|5|ml|10|lykjur||N05CD08|01.07.1990||R|0|0|0|0|0|1|ROC|0|0|0|100|DKK|1892|3726|lyfsjukr|||1|50|0|3,3333|Icepharma hf|Roche|Mídazólam||1892||1892|3726||2 430157|QJ01EW1001|Tribrissen, vet.|stl|480|mg/ml|100|ml|1|hgl|80+400 mg/ml|QJ01EW10|01.10.1990||R|0|0|0|0|0|0|IBV|0|0|0|100|DKK|4545|7714|vetalmen|||0|100|0||Vistor hf|Intervet International BV|||3976||3976|7714||1 430232|L03AB1001|PegIntron|sts|100|mcg|4|áf-penni|1|pakki|fjölskammta pennar|L03AB10|01.11.2013||R|0|0|0|1|0|1|MLD|0|0|0|100|DKK|85929|111384|lyfsjukr|||1|4|0|53,3300|Vistor hf|Merck Sharp & Dohme Limited|Peginterferón alfa 2b||85929||85929|111384||1 430281|L02BG0303|Astrozol|filmhtfl|1|mg|98|stk|1|þpakki||L02BG03|01.08.2011||R|0|0|0|0|G|0|WEH|0|0|0|100|XEU|17776|5114|lyfalmen|V0184|5114|2|98|0|98,0000|Williams & Halls efh|Williams & Halls ehf|Anastrózól||2900||2900|5114||2 430521|G04BE0305|Vizarsin (Lyfis)|filmhtfl|100|mg|4|stk|1|pakki||G04BE03|01.08.2010||R|1|0|0|0|0|0|LYF|0|0|0|100|IKR|2717|2373|lyfalmen|V0144|1624|3|4|0|8,0000|LYFIS ehf|LYFIS ehf|Síldenafíl||909||909|2373||2 430729|A11DA0101|Tiacur|stl|50|mg/ml|2|ml|5|lykjur||A11DA01|01.09.2015||R|0|0|0|0|0|0|ABC|0|0|0|100|SEK|24559|33763|lyfalmen|||1|10|0|10,0000|Icepharma hf|Abcur AB|Thiamine (vit B1)||||24559|33763||2 430862|J01FA1005|Azithromycin Actavis|filmhtfl|500|mg|2|stk|1|þpakki||J01FA10|01.05.2013||R|1|0|0|0|0|0|AHF|0|0|1|100|XEU|882|2336|lyfalmen|V0173|2336|2|2|0|3,3300|Actavis Group PTC ehf|Actavis Group hf|Azitrómýcín||882||882|2336||1 431023|D06AX0101|Fucidin|smyrsli|20|mg/g|15|g|1|túpa||D06AX01|01.04.1989||R|0|0|0|0|0|0|LEP|0|0|1|100|DKK|983|2475|lyfalmen|||1|15|0||Vistor hf|LEO Pharma A/S|Fúsidínsýra||983||983|2475||1 431154|S01GX0201|Livostin|augndr|0,5|mg/ml|4|ml|1|glas||S01GX02|01.11.2013||L|0|0|0|0|0|0|MCS|0|0|0|100|IKR|||lyflausa|||0|4|0||Vistor hf|McNeil Sweden AB|Levókabastín|||||||1 431193|N02AB0306|Instanyl|nefúði|100|mcg|6|sk-ílát|1|pakki||N02AB03|01.08.2014||R|0|1|1|1|0|0|TPA|0|0|0|100|DKK|8708|13108|lyfalmen|||1|6|0|1,0000|Vistor hf|Takeda Pharma A/S|Fentanýl||8708||8708|13108||1 431495|L01CD0201|Taxotere|irþ|160|mg|8|ml|1|hgl|lausn|L01CD02|01.04.2011|30.04.2016|R|0|0|0|1|0|1|AVS|0|0|0|100|NOK|122153|157504|lyfsjukr|||1|8|0||Vistor hf|Aventis Pharma SA|Docetaxel||122153||122153|157504||1 431759|M01AB5503|Arthrotec Forte|töflur|75,2|mg|20|stk|1|þpakki|75+0,2 mg|M01AB55|01.09.2009||R|1|0|0|0|G|0|PER|0|0|1|100|DKK|1256|2851|lyfalmen|||1|20|0|15,0000|Icepharma hf|Pfizer ApS|Díklófenaknatríum í blöndum||||1256|2851||1 431783|M01AB5503|Arthrotec Forte|töflur|75,2|mg|100|stk|1|þpakki|75+0,2 mg|M01AB55|01.09.2009||R|1|0|0|0|G|0|PER|0|0|1|100|DKK|3860|6435|lyfalmen|||1|100|0|75,0000|Icepharma hf|Pfizer ApS|Díklófenaknatríum í blöndum||3860||3860|6435||1 431930|N06BA0406|Medikinet CR|hylki|60|mg|30|stk|1|þpakki|með breyttan losunarhraða|N06BA04|01.01.2015||R|1|1|1|0|0|0|PUT|0|0|0|100|IKR|11696|17221|lyfalmen|||2|30|0|60,0000|LYFIS ehf|Medice Arzneimittel Putter GmbH|Metýlfenídat||11696||11696|17221||2 431985|D07XC0101|Diprosalic|húðlausn|||100|ml|1|glas|0,5 mg/ml+20 mg/ml|D07XC01|01.04.2014||R|0|0|0|0|G|0|MBV|0|0|1|100|DKK|1842|3658|lyfalmen|||1|100|0||Vistor hf|Merck Sharp & Dohme B.V.|Betametasón||1842||1842|3658||1 432410|N06AX2105|Duloxetin Krka|sþ-hylki|60|mg|30|stk|1|þpakki||N06AX21|01.05.2015||R|0|0|0|0|0|0|KNM|0|0|0|100|IKR|4900|4536|lyfalmen|V0693|4380|2|30|0|30,0000|LYFIS ehf|Krka d.d. Novo mesto|Duloxetín||2480||2480|4536||2 432665|M09AX0101|Artzal|stl|10|mg/ml|2,5|ml|5|dælur|einnota dælur plast|M09AX01|01.10.2011||R|0|0|0|0|G|0|NDR|0|0|0|100|SEK|14977|21737|lyfalmen|||1|12,5|0|34,7222|Vistor hf|Nordic Drugs AB|Natríumhýalúrónat||||14977|21737||1 432972|QJ01CR0201|Combisyn|töflur|50|mg|100|stk|1|pakki||QJ01CR02|01.02.2012||R|0|0|0|0|0|0|NOB|0|0|0|100|IKR|2698|5289|vetalmen|||0|100|0||Norbrook Laboratories Limited|Norbrook Laboratories Limited|Amoxicillín og Clavulansýra||||2698|5289||2 433126|N02BE0102|Panodil Brus|freyðit|500|mg|20|stk|1|þpakki||N02BE01|01.05.2014||L|0|0|0|0|0|0|HCA|0|0|1|100|IKR|||lyfalmen|||0|20|0|3,3300|Artasan ehf|GlaxoSmithKline CH A/S|Paracetamól|||||1801||1 433194|N05AD0301|Buronil|húðuðtfl|25|mg|100|stk|1|glas||N05AD03|01.01.2013||R|1|0|0|0|G|0|MEV|0|0|0|100|DKK|1480|3159|lyfalmen|V0557|3159|1|100|0|8,3333|Vistor hf|MediLink A/S|Melperón||1480||1480|3159||1 433250|N04BX0201|Comtess|töflur|200|mg|100|stk|1|glas||N04BX02|01.07.1999||R|1|0|0|0|G|0|ORC|0|0|0|100|DKK|9824|14644|lyfalmen|||1|100|0|20,0000|Vistor hf|Orion Corporation|Entakapón||9824||9824|14644||1 433292|N02AA0106|Contalgin Uno|forðahlk|30|mg|28|stk|1|þpakki||N02AA01|01.05.1998||R|1|0|1|0|G|0|PER|0|0|0|100|DKK|2230|4192|lyfalmen|||1|28|0|8,4000|Icepharma hf|Pfizer ApS|Morfín||2230||2230|4192||1 433318|N02AA0106|Contalgin Uno|forðahlk|90|mg|28|stk|1|þpakki||N02AA01|01.05.1998||R|1|0|1|0|G|0|PER|0|0|0|100|DKK|4900|7867|lyfalmen|||1|28|0|25,2000|Icepharma hf|Pfizer ApS|Morfín||4900||4900|7867||1 433666|J02AC0401|Noxafil|sþ-tfl|100|mg|96|stk|1|þpakki||J02AC04|01.11.2015||R|0|0|0|1|0|1|MLD|0|0|0|100|DKK|414279|520827|lyfsjukr|||1|96|0|12,0000|Vistor hf|Merck Sharp & Dohme Limited|Posacónazól||414279||414279|520827||1 434088|V08CA0901|Gadovist|stl|1|mmol/ml|15|ml|10|hgl|lausn|V08CA09|01.03.2013||R|0|0|0|0|0|1|BYP|0|0|0|100|DKK|155791|199340|lyfsjukr|||1|150|0||Icepharma hf|Bayer Pharma AG|Gadóbútról||155791||155791|199340||2 434091|N06DX0102|Memantine Merz|filmhtfl|10|mg|100|stk|1|þpakki||N06DX01|01.07.2013||R|1|0|0|0|G|0|LBK|0|0|0|100|DKK|7322|5619|lyfalmen|V0605|5203|2|100|0|50,0000|Lundbeck Export A/S|H. Lundbeck A/S|Memantín||3267||3267|5619||1 434169|R03DC0304|Montelukast Teva|filmhtfl|10|mg|98|stk|1|þpakki||R03DC03|01.01.2013||R|1|0|0|0|G|0|TEV|0|0|0|100|XEU|5727|2274|lyfalmen|V0490|2274|2|98|0|98,0000|Medical ehf|Teva Pharma B.V.|Montelúkast||837||837|2274||2 434261|QN01AX9301|Tricaine Pharmaq|duft|1000|mg/g|1000|g|1|askja|lausn handa fiskum|QN01AX93|01.07.2013||R|0|0|0|0|0|0|PHL|0|0|0|100|NOK|69148|105825|veteldis|||0|1000|0||PHARMAQ Ltd.|PHARMAQ Ltd|Tricaine Methane Sulfónat||65648||65648|105825||1 434461|N03AX1501|Zonegran|hylki|50|mg|56|stk|1|þpakki||N03AX15|01.03.2014||R|1|0|0|0|G|0|EIS|0|0|0|100|SEK|7987|12116|lyfalmen|||1|56|0|14,0000|Vistor hf|Eisai Ltd|Zonisamíð||7987||7987|12116||1 434576|A02BC0403|Rabeprazol Krka|sþ-tfl|20|mg|98|stk|1|þpakki||A02BC04|01.03.2014||R|0|0|0|0|G|0|KRK|0|0|0|100|IKR|3931|3600|lyfalmen|V0010|3600|2|98|0|98,0000|LYFIS ehf|Krka Sverige AB|Rabeprazól||1800||1800|3600||2 434670|D01AC2001|Daktacort|krem|||50|g|1|túpa||D01AC20|01.10.1988||R|0|0|0|0|0|0|MCS|0|0|1|100|SEK|765|2175|lyfalmen|||1|50|0||Vistor hf|McNeil Sweden AB|Blöndur||765||765|2175||1 434829|C01CA2404|EpiPen|stl|0,3|mg/sk|1|stk|1|pakki|einnota penni i.m.|C01CA24|01.07.2007||R|0|0|0|0|G|0|MEB|0|0|1|100|SEK|4822|7759|lyfalmen|||1|1|0|0,6000|Vistor hf|Meda AB (V)|Adrenalín tartrat||4822||4822|7759||1 434837|C01CA2405|EpiPen Junior|stl|0,15|mg/sk|1|stk|1|pakki|einnota penni i.m.|C01CA24|01.07.2007||R|0|0|0|0|G|0|MEB|0|0|1|100|SEK|4822|7759|lyfalmen|||1|1|0|0,3000|Vistor hf|Meda AB (V)|Adrenalín tartrat||4822||4822|7759||1 434852|N06AB0302|Fontex|dreifit.|20|mg|100|stk|1|pakki|þp (10x10 stk)|N06AB03|01.06.1998||R|0|0|0|0|0|0|ELI|0|0|0|100|XEU|9125|13682|lyfalmen|V0315|5448|1|100|0|100,0000|Icepharma hf|Eli Lilly Danmark A/S|Flúoxetín||9125||9125|13682||2 435151|R06AX2706|Flynise|filmhtfl|5|mg|100|stk|1|þpakki||R06AX27|01.10.2015||L|1|0|0|0|0|0|APC|0|0|1|100|IKR|||lyflausa|||2|100|0|100,0000|Actavis Group PTC ehf|Actavis Group PTC ehf|Deslóratadín|||||||1 435728|N06AX1105|Mirtazapine Bluefish|munndr.t|45|mg|96|stk|1|þpakki||N06AX11|01.04.2014||R|0|0|0|0|0|0|BLP|0|0|0|100|IKR|5573|8793|lyfalmen|V0304|8793|2|96|0|144,0000|LYFIS ehf|Bluefish Pharmaceuticals AB|Mirtazapín||5573||5573|8793||2 436010|L01AA0901|Levact|irþ|2,5|mg/ml|100|mg|5|hgl|lausn|L01AA09|01.11.2011||R|0|0|0|1|0|1|AST|0|1|0|100|DKK|193521|246266|lyfsjukr|||1|500|0||Icepharma hf|Astellas Pharma GmbH|Bendamústín||193521||193521|246266||2 436022|C09DA0308|Diovan Comp 80/12,5 mg|töflur|92,5|mg|28|stk|1|pakki||C09DA03|01.10.1999||R|1|0|0|0|0|0|HES|0|0|0|100|DKK|3142|5447|lyfalmen|||1|28|0|28,0000|Vistor hf|Novartis Healthcare A/S|Valsartan og þvagræsilyf||3142||3142|5447||1 436147|M01AE0217|Naproxen-E Mylan|sh-tfl|250|mg|20|stk|1|þpakki||M01AE02|01.07.1993||L|1|0|0|0|0|0|MYL|0|0|1|100|IKR|||lyflausa|||0|20|0|10,0000|Icepharma hf|Mylan AB|Naproxen|||||||2 436394|H01BA0202|Octostim|nefúði|0,15|mg/sk|2,5|ml|1|úðagl||H01BA02|01.01.2013||R|0|0|0|1|0|1|FEL|0|0|0|100|DKK|38319|51167|lyfsjukr|||1|2,5|0|150,0000|Vistor hf|Ferring Lægemidler A/S|Desmópressín||38319||38319|51167||1 436410|D06AX0101|Fucidin|krem|20|mg/g|15|g|1|túpa||D06AX01|01.01.1989||R|0|0|0|0|0|0|LEP|0|0|1|100|DKK|962|2446|lyfalmen|||1|15|0||Vistor hf|LEO Pharma A/S|Fúsidínsýra||962||962|2446||1 436471|N06DX0105|Memantine Mylan|filmhtfl|10|mg|98|stk|1|þpakki||N06DX01|01.10.2013|31.03.2016|R|1|0|0|0|G|0|GEN|0|0|0|100|SEK|15182|6172|lyfalmen|||2|98|0|49,0000|Icepharma hf|Generics UK Ltd|Memantín||3669||3669|6172||2 436647|A16AA0402|Procysbi|hylki|25|mg|60|stk|1|glas||A16AA04|01.04.2016||R|0|1|0|1|0|1|RAP|0|0|0|100|XEU|65133|85081|lyfsjukr|||1|60|0|0,7500|Raptor Pharmaceuticals Europe B.V.|Raptor Pharmaceuticals Europe B.V.|Mecaptamín||65133||65133|85081||3 436877|L01AA0901|Levact|irþ|2,5|mg/ml|25|mg|20|hgl|lausn|L01AA09|01.11.2011||R|0|0|0|1|0|1|AST|0|1|0|100|DKK|215107|273113|lyfsjukr|||1|500|0||Icepharma hf|Astellas Pharma GmbH|Bendamústín||215107||215107|273113||2 436915|N05AD0101|Haldol|töflur|1|mg|100|stk|1|þpakki||N05AD01|01.12.1972||R|1|0|0|0|G|0|JAS|0|0|0|100|SEK|771|2183|lyfalmen|||1|100|0|12,5000|Vistor hf|Janssen-Cilag AB|Halóperídól||771||771|2183||1 437223|V10XX0301|Xofigo|stl|1000|kBq/ml|6|ml|1|hgl||V10XX03|01.06.2015||R|0|0|0|1|0|1|BGB|0|1|0|100|DKK|568388|712496|lyfsjukr|||1|6|0||Icepharma hf|Bayer Pharma AG|radium-223 dichloride||568388||568388|712496||2 437427|R06AX2704|Desloratadine ratiopharm|munndr.t|5|mg|10|stk|1|þpakki||R06AX27|01.04.2014||L|0|0|0|0|0|0|RGM|0|0|1|100|IKR|||lyflausa|||2|10|0|10,0000|Medical ehf|ratiopharm GmbH|Deslóratadín||||||| 437763|A10BD2001|Synjardy|filmhtfl|1005|mg|180|stk|1|þpakki|5mg/1000mg|A10BD20|01.01.2016||R|0|0|0|0|G|0|BOE|0|0|0|100|DKK|18708|26872|lyfalmen|V0712|26872|1|180|0|90,0000|Vistor hf|Boehringer Ingelheim International GmbH|Metforminum og empagliflozin||18708||18708|26872||1 437767|N03AG0102|Orfiril|sþ-tfl|150|mg|100|stk|1|glas||N03AG01|01.08.2015||R|1|1|0|0|G|0|DEA|0|0|0|100|XEU|1047|2563|lyfalmen|||1|100|0|10,0000|Vistor hf|Desitin Artzneimittel|Valpróínsýra||1047||1047|2563||1 437935|L01AA0901|Levact|irþ|2,5|mg/ml|25|mg|5|hgl|lausn|L01AA09|01.11.2011||R|0|0|0|1|0|1|AST|0|1|0|100|DKK|55637|73070|lyfsjukr|||1|125|0||Icepharma hf|Astellas Pharma GmbH|Bendamústín||55637||55637|73070||2 438353|B05BB0114|Natriumklorid Fresenius Kabi|irl|9|mg/ml|1000|ml|10|pokar|Kabipac|B05BB01|01.11.2015||R|0|0|0|0|0|1|FKA|0|0|0|100|DKK|1939|3791|lyfsjukr|||1|10000|0||Vistor hf|Fresenius Kabi AB|Elektrólýtar||1939||1939|3791||1 438416|S02CA0301|Ciproxin-Hydrocortison|eyrnadr|||10|ml|1|dropaí|2 mg + 10 mg/ml|S02CA03|01.09.2002||R|0|0|0|0|G|0|CLA|0|0|1|100|USD|1258|2854|lyfalmen|||1|10|0||Vistor hf|Alcon Nordic A/S|Hýdrókortisón og sýkingalyf||1258||1258|2854||1 438639|N06DX0107|Zalatine|filmhtfl|10|mg|98|stk|1|þpakki||N06DX01|01.03.2014||R|1|0|0|0|G|0|WEH|0|0|0|100|XEU|7178|5099|lyfalmen|V0605|5099|2|98|0|49,0000|Williams & Halls efh|Williams & Halls ehf|Memantín||2889||2889|5099||2 438759|L01XE1501|Zelboraf|filmhtfl|240|mg|56|stk|1|þpakki||L01XE15|01.08.2012||R|0|0|0|1|0|1|RRL|0|1|0|100|DKK|214842|256750|lyfsjukr|||1|56|0||Icepharma hf|Roche Registration Limited|Vemurafeníb||201951||201951|256750||2 438762|R06AX1301|Clarityn|töflur|10|mg|10|stk|1|þpakki||R06AX13|01.07.1989|29.02.2016|L|1|0|0|0|0|0|BAB|0|0|1|100|IKR|||lyflausa|||1|10|0|10,0000|Icepharma hf|Bayer AB|Lóratadín|||||||2 438770|R06AX1301|Clarityn|töflur|10|mg|30|stk|1|þpakki||R06AX13|01.07.1989|29.02.2016|L|1|0|0|0|0|0|BAB|0|0|1|100|IKR|||lyflausa|||1|30|0|30,0000|Icepharma hf|Bayer AB|Lóratadín|||||||2 438788|R06AX1301|Clarityn|töflur|10|mg|100|stk|1|þpakki||R06AX13|01.07.1989|29.02.2016|L|1|0|0|0|G|0|BAB|0|0|1|100|DKK|||lyfalmen|||1|100|0|100,0000|Icepharma hf|Bayer AB|Lóratadín|||||8402||2 438806|B03XA0201|Aranesp|stl|130|mcg/spr|0,65|ml|4|áf.spr|nálavörn|B03XA02|01.12.2010||R|0|0|0|1|0|1|RAG|0|0|0|100|DKK|146187|187396|lyfsjukr|||1|2,6|0|115,5600|Vistor hf|Amgen|Darbepóetín alfa||146187||146187|187396||1 439489|C07FB0201|Logimax|forðatfl|55|mg|98|stk|1|pakki|þp 5+50 mg|C07FB02|01.04.1997||R|1|0|0|0|G|0|AZD|0|0|0|100|SEK|5314|8436|lyfalmen|||1|98|0|98,0000|Vistor hf|AstraZeneca A/S DK|Metóprólól og önnur blóðþrýstingslækkandi lyf||5314||5314|8436||1 439594|C10BA0201|Inegy|töflur|50|mg|98|stk|1|þpakki|10 mg + 40 mg|C10BA02|01.07.2013||R|1|0|0|0|0|0|MLD|0|0|0|100|DKK|18999|27272|lyfalmen|||1|98|0|98,0000|Vistor hf|Merck Sharp & Dohme Limited|Ezetimíb og simvastatín||18999||18999|27272||1 439672|N06AX2106|Duloxetin W&H|sþ-hylki|30|mg|500|stk|1|glas||N06AX21|01.01.2016||R|2|0|0|0|G|0|WEH|0|0|0|100|XEU|50723|35369|lyfalmen|||2|500|0|250,0000|Williams & Halls efh|Williams & Halls ehf|Duloxetín||25829||25829|35369||2 439680|A10BX0401|Byetta|stl|10|mcg/sk|60|skammtar|1|penni|lausn|A10BX04|01.10.2015||R|0|0|0|0|0|0|BRI|0|0|0|100|SEK|14577|21186|lyfalmen|||1|60|0|40,0000|Vistor hf|Bristol-Myers Squibb/AstraZeneca EEIG|Exenatíð||14577||14577|21186||1 439719|S01EE0402|IZBA|augndr|30|mcg/ml|2,5|ml|1|glas||S01EE04|01.10.2014||R|0|0|0|0|G|0|ALA|0|0|0|100|USD|2366|4379|lyfalmen|V0658|3631|1|2,5|0|25,0000|Vistor hf|Alcon Laboratories Ltd.|Travóprost||2366||2366|4379||1 439794|R01AA0704|Otrivin ukonserveret|nefúði|1|mg/ml|10|ml|1|glas|sk-úðari|R01AA07|01.05.2001||L|0|0|0|0|0|0|NHE|0|0|1|100|IKR|||lyflausa|||0|10|0|12,5000|Artasan ehf|Novartis Healthcare A/S-A|Xýlómetazólín|||||||1 439908|G03AA0904|Denise|töflur|||126|stk|1|þpakki|150/20 mcg|G03AA09|01.05.2014||R|0|0|0|0|0|0|RGM|0|0|0|100|IKR|2900|3875|lyfalmen|||2|126|0|168,0000|Medical ehf|ratiopharm GmbH|Desógestrel og ethinylestradíól||2000||2000|3875|29.2.2016|2 440099|J01CR0202|Augmentin|mixtduft|91,4|mg/ml|70|ml|1|glas|80+11,4 mg/ml|J01CR02|01.08.1998||R|0|0|0|0|0|0|GPH|0|0|1|100|IKR|1066|2360|lyfalmen|V0163|2014|1|70|0|5,6000|Vistor hf|GlaxoSmithKline Pharma A/S|Amoxicillín og ensímblokkar||899||899|2360||1 440652|C09AA0211|Enalapril Krka|töflur|20|mg|250|stk|1|glas||C09AA02|01.02.2016||R|1|0|0|0|G|0|KRK|0|0|0|100|IKR|3115|5410|lyfalmen|V0483|5410|2|250|0|500,0000|LYFIS ehf|Krka Sverige AB|Enalapríl||3115||3115|5410||2 440677|J01CE0106|Penicillin Actavis|sts|600|mg/hgl|10|hgl|1|pakki|1 millj.ae|J01CE01|01.07.2004||R|0|0|0|0|0|1|AGT|0|0|0|100|DKK|1251|2844|lyfsjukr|||2|10|0|1,6700|Actavis Group hf|Actavis Group hf|Benzýlpenicillín||1251||1251|2844||1 440693|J01CE0106|Penicillin Actavis|sts|1,2|g/hgl|10|hgl|1|pakki|2 millj.ae|J01CE01|01.07.2004||R|0|0|0|0|0|1|AGT|0|0|0|100|DKK|1974|3839|lyfsjukr|||2|10|0|3,3300|Actavis Group hf|Actavis Group hf|Benzýlpenicillín||1974||1974|3839||1 440731|N05AX1209|Aripiprazole Sandoz|töflur|30|mg|56|stk|1|þpakki||N05AX12|01.04.2016||R|1|1|0|0|G|0|HSS|0|0|0|100|DKK|31032|34130|lyfalmen|V0717|33688|2|56|0|112,0000|Artasan ehf|Sandoz GmbH|Aripiprazól||24849||24849|34130||1 441006|C03DA0101|Aldactone|töflur|25|mg|100|stk|1|þpakki||C03DA01|01.12.1972||R|1|0|0|0|G|0|PER|0|0|0|100|DKK|913|2379|lyfalmen|V0046|1987|1|100|0|33,3333|Icepharma hf|Pfizer ApS|Spírónólaktón||913||913|2379||1 441279|D01AC2002|Pevisone|krem|||30|g|1|túpa||D01AC20|01.10.1988||R|0|0|0|0|0|0|JAS|0|0|1|100|SEK|1044|2559|lyfalmen|||1|30|0||Vistor hf|Janssen-Cilag AB|Blöndur||1044||1044|2559||1 441341|C03DA0102|Spirix|töflur|25|mg|100|stk|1|glas||C03DA01|01.11.2013||R|1|0|0|0|G|0|TPA|0|0|0|100|DKK|934|2408|lyfalmen|V0046|1987|2|100|0|33,3333|Vistor hf|Takeda Pharma A/S|Spírónólaktón||934||934|2408||1 441619|J05AR0801|Eviplera|filmhtfl|470|mg|30|stk|1|glas|200+25+245 mg|J05AR08|01.05.2012||R|0|0|0|1|0|1|GSL|0|0|0|100|DKK|107428|139190|lyfsjukr|||1|30|0||Gilead Nordic|Gilead Science International Ltd|Emtrícítabín, rilpívírin og tenófóvír||107428||107428|139190||2 441949|G03DC0202|Primolut N|töflur|5|mg|30|stk|1|þpakki||G03DC02|01.12.1972||R|0|0|0|0|G|0|BAP|0|0|0|100|DKK|932|2405|lyfalmen|||1|30|0|30,0000|Icepharma hf|Bayer Schering Pharma AG|Noretísterón||932||932|2405||2 442407|N05AH0312|Zalasta|töflur|15|mg|28|stk|1|þpakki||N05AH03|01.01.2013||R|1|0|0|0|G|0|KNM|0|0|0|100|XEU|2367|2767|lyfalmen|V0283|2767|2|28|0|42,0000|LYFIS ehf|Krka d.d. Novo mesto|Olanzapín||1195||1195|2767||2 442586|N03AX1608|Pregabalina Tecnigen|hylki|25|mg|56|stk|1|þpakki||N03AX16|01.01.2016||R|1|0|0|0|0|0|WEH|0|0|0|100|XEU|1855|1846|lyfalmen|V0685|1375|2|56|0|4,6667|Williams & Halls efh|Williams & Halls ehf|Pregabalín||526||526|1846||2 442678|B02BD0206|Advate|sts|1000|ae|1|hgl|1|pakki|+leysir|B02BD02|01.12.2015||R|0|0|0|1|0|1|BER|0|1|0|100|SEK|78730|102278|lyfsjukr|||1|1|0|2,0000|Lyfjaver ehf|Baxter AG (L)|Storkuþáttur VIII||78730||78730|102278||3 442705|B01AE0701|Pradaxa|hylki|150|mg|60|stk|1|þpakki|hart|B01AE07|01.10.2011||R|0|1|0|0|G|0|BII|0|0|0|100|DKK|10143|15083|lyfalmen|V0460|12970|1|60|0|30,0000|Vistor hf|Boehringer Ingelheim International|Dabigatran etexílat||||10143|15083||1 443135|H04AA0102|GlucaGen Hypokit|sts|1|mg|1|stk|1|hgl|dæla|H04AA01|01.01.1989||R|0|0|0|0|G|0|NAS|0|0|1|100|DKK|2981|5225|lyfalmen|||1|1|0|1,0000|Vistor hf|Novo-Nordisk A/S|Glúkagon||2981||2981|5225||1 443181|QM01AH9201|Trocoxil|tuggutfl|6|mg|2|stk|1|þpakki||QM01AH92|01.11.2014||R|0|0|0|0|0|0|ZBE|0|0|0|100|DKK|1196|2351|vetalmen|||0|2|0||Icepharma hf|Zoetis Belgium S.A.|Mavakoxíb||1196||1196|2351||2 443358|N02AA0101|Contalgin|forðatfl|200|mg|90|stk|1|þpakki||N02AA01|01.04.1993||R|1|0|1|0|G|0|PER|0|0|0|100|DKK|21837|30320|lyfalmen|||1|90|0|180,0000|Icepharma hf|Pfizer ApS|Morfín||21837||21837|30320||1 443500|L01XA0211|Carboplatin Actavis|irþ|10|mg/ml|45|ml|1|hgl||L01XA02|01.05.2013||R|0|0|0|1|0|1|APC|0|0|0|100|XEU|3160|5472|lyfsjukr|||2|45|0||Actavis Group PTC ehf|Actavis Group PTC ehf|Karbóplatín||3160||3160|5472||1 443861|N06AB0311|Fluoxetin Mylan|hylki|20|mg|30|stk|1|glas||N06AB03|01.11.2015||R|1|0|0|0|G|0|MYL|0|0|0|100|SEK|685|1940|lyfalmen|V0038|1940|2|30|0|30,0000|Icepharma hf|Mylan AB|Flúoxetín||594||594|1940||2 443903|N06AB0311|Fluoxetin Mylan|hylki|20|mg|100|stk|1|glas||N06AB03|01.11.2015||R|1|0|0|0|G|0|MYL|0|0|0|100|SEK|1858|3035|lyfalmen|V0039|3035|2|100|0|100,0000|Icepharma hf|Mylan AB|Flúoxetín||1390||1390|3035||2 443904|J01FA0902|Clarithromycin ratiopharm|filmhtfl|500|mg|14|stk|1|þpakki||J01FA09|01.06.2014||R|1|0|0|0|0|0|TSB|0|0|1|100|IKR|2700|4838|lyfalmen|||2|14|0|14,0000|Medical ehf|Teva Sweden AB|Klaritrómýcín||2700||2700|4838||2 444041|N05AH0501|Sycrest|tungur.t|10|mg|20|stk|1|þpakki||N05AH05|01.10.2011||R|0|0|0|0|0|0|ORR|0|0|0|100|DKK|7122|10925|lyfalmen|||1|20|0|10,0000|Lundbeck Export A/S|N.V. Organon|Asenapíne||7122||7122|10925||1 444098|L01BA0110|Metojectpen|stl|15|mg|1|áf-penni|1|pakki||L01BA01|01.05.2016||R|0|0|0|1|G|0|WIL|0|0|0|100|XEU|2732|4883|lyfalmen|||1|1|0||Williams & Halls efh|medac Gesellschaft|Metótrexat||2732||2732|4883||2 444102|A06AB0603|Senokot (Icepharma)|töflur|7,5|mg|60|stk|1|þpakki||A06AB06|01.10.2012||R|1|0|0|0|0|0|FMV|0|0|0|100|GBP|927|2398|lyfalmen|||3|60|0||Icepharma hf|Icepharma hf|Senna||927||927|2398||2 444315|N06AB0302|Fontex|dreifit.|20|mg|30|stk|1|pakki|þp (2 x 15 stk)|N06AB03|01.06.1998||R|0|0|0|0|0|0|ELI|0|0|0|100|DKK|2776|4943|lyfalmen|V0061|2968|1|30|0|30,0000|Icepharma hf|Eli Lilly Danmark A/S|Flúoxetín||2776||2776|4943||2 444362|N01AF0302|Pentocur|sts|1|g|10|hgl|1|pakki||N01AF03|01.07.2013||R|0|0|0|0|0|1|ABC|0|0|0|100|SEK|21736|30192|lyfsjukr|||2|10|0||Icepharma hf|Abcur AB|Tíópentalnatríum||21736||21736|30192||2 444430|N04BA0208|Madopar Quick "62,5"|lausnart|62,5|mg|100|stk|1|glas|50+12,5 mg|N04BA02|01.11.2000||R|0|0|0|0|G|0|ROC|0|0|0|100|DKK|1914|3757|lyfalmen|||1|100|0|8,3333|Icepharma hf|Roche|Levódópa og dópadekarboxýl­asa­hemill||1914||1914|3757||2 444574|N07CA0102|Betahistin ratiopharm|töflur|8|mg|100|stk|1|þpakki||N07CA01|01.12.2013||R|1|0|0|0|0|0|ROY|0|0|0|100|IKR|2018|3900|lyfalmen|||2|100|0|33,3300|Medical ehf|ratiopharm Oy|Betahistín||2018||2018|3900||2 444765|A05AA0207|Ursochol|hylki|250|mg|100|stk|1|þpakki||A05AA02|01.11.2014||R|1|0|0|0|G|0|IRO|0|0|0|100|XEU|4891|7854|lyfalmen|||2|100|0|33,3300|Artasan ehf|Orifarm Generics A/S|Úrsódeoxýkól sýra||4891||4891|7854||1 445022|A10BD1101|Jentadueto|filmhtfl|1002,5|mg|180|stk|1|þpakki|2,5mg/1000mg|A10BD11|01.11.2015||R|0|0|0|0|G|0|BOE|0|0|0|100|DKK|16265|23509|lyfalmen|V0705|23509|1|180|0|90,0000|Vistor hf|Boehringer Ingelheim International GmbH|Metforminum og linagliptinum||16265||16265|23509||1 445149|R03AK1001|Relvar Ellipta|innönddu|114|mcg/sk|30|skammtar|1|pakki|92+22 mcg|R03AK10|01.04.2014||R|0|0|0|0|G|0|RGO|0|0|0|100|GBP|4972|7966|lyfalmen|||1|30|0||Vistor hf|Glaxo Group Limited|Vilanterol og flútícason||4972||4972|7966||1 445155|D07CA0102|Fucidin-Hydrocortison|krem|30|mg/g|30|g|1|túpa|20 + 10 mg|D07CA01|01.02.1998||R|0|0|0|0|G|0|LEO|0|0|1|100|DKK|1410|3063|lyfalmen|||1|30|0||Vistor hf|LEO A/S|Hýdrókortisón og sýklalyf||1410||1410|3063||1 445357|N06AX1105|Mirtazapine Bluefish|munndr.t|15|mg|30|stk|1|þpakki||N06AX11|01.03.2015||R|0|0|0|0|G|0|BLP|0|0|0|100|IKR|998|1810|lyfalmen|V0329|1810|2|30|0|15,0000|LYFIS ehf|Bluefish Pharmaceuticals AB|Mirtazapín||500||500|1810||2 445705|A10AE0406|Toujeo [SoloStar]|stl|300|ein/ml|1,5|ml|3|pennar|áfylltir lyfjapennar|A10AE04|01.10.2015||R|0|1|0|0|G|0|SDE|0|0|0|100|NOK|5658|8910|lyfalmen|||1|4,5|0|33,7500|Vistor hf|Sanofi - aventis Deutschland GmbH|Insulín glargín||5658||5658|8910||1 446268|C08CA0502|Adalat Oros|forðatfl|20|mg|98|stk|1|þpakki||C08CA05|01.03.2013||R|1|0|0|0|G|0|BYP|0|0|0|100|DKK|4524|7349|lyfalmen|||1|98|0|65,3333|Icepharma hf|Bayer Pharma AG|Nífedipín||||4524|7349||2 446618|N03AF0301|Inovelon|mixtúra|40|mg/ml|460|ml|1|fl||N03AF03|01.09.2012||R|0|0|0|1|G|0|EIS|0|0|0|100|SEK|16475|23798|lyfalmen|||1|460|0|13,1400|Vistor hf|Eisai Ltd|Rúfínamíð||16475||16475|23798||1 447040|N06AX2105|Duloxetin Krka|sþ-hylki|60|mg|100|stk|1|þpakki||N06AX21|01.05.2015||R|0|0|0|0|0|0|KNM|0|0|0|100|IKR|18000|12133|lyfalmen|V0694|11739|2|100|0|100,0000|LYFIS ehf|Krka d.d. Novo mesto|Duloxetín||8000||8000|12133||2 447052|B01AB0401|Fragmin|stl|25000|ae/ml|0,72|ml|5|áf.spr|18000 a.e. anti-Xa/ml/sprautu|B01AB04|01.04.2008||R|0|0|0|0|G|0|PER|0|0|1|100|DKK|10704|15855|lyfalmen|||1|3,6|0|36,0000|Icepharma hf|Pfizer ApS|Dalteparín||10704||10704|15855||1 447110|B01AB0401|Fragmin|stl|25000|ae/ml|0,4|ml|5|áf.spr|10000 a.e. anti-Xa/ml/sprautu|B01AB04|01.04.2008||R|0|0|0|0|G|0|PER|0|0|1|100|DKK|6140|9573|lyfalmen|||1|2|0|20,0000|Icepharma hf|Pfizer ApS|Dalteparín||6140||6140|9573||1 447136|B01AB0401|Fragmin|stl|25000|ae/ml|0,5|ml|5|áf.spr|12500 a.e. anti-Xa/ml/sprautu|B01AB04|01.04.2008||R|0|0|0|0|G|0|PER|0|0|1|100|DKK|7539|11499|lyfalmen|||1|2,5|0|25,0000|Icepharma hf|Pfizer ApS|Dalteparín||7539||7539|11499||1 447145|A10BF0101|Glucobay|töflur|50|mg|30|stk|1|þpakki||A10BF01|01.09.2014||R|1|0|0|0|G|0|BGB|0|0|0|100|DKK|804|2229|lyfalmen|||1|30|0|5,0000|Icepharma hf|Bayer Pharma AG|Acarbósa||||804|2229||2 447151|B01AB0401|Fragmin|stl|25000|ae/ml|0,6|ml|5|áf.spr|15000 a.e. anti-Xa/ml/sprautu|B01AB04|01.04.2008||R|0|0|0|0|G|0|PER|0|0|1|100|DKK|9319|13949|lyfalmen|||1|3|0|30,0000|Icepharma hf|Pfizer ApS|Dalteparín||9319||9319|13949||1 447596|C07AG0205|Carveratio|töflur|25|mg|100|stk|1|þpakki||C07AG02|01.06.2015||R|0|0|0|0|G|0|RGM|0|0|0|100|IKR|2887|5096|lyfalmen|||2|100|0|66,6700|Medical ehf|ratiopharm GmbH|Carvedílól||2887||2887|5096||2 447753|N06AX1105|Mirtazapine Bluefish|munndr.t|30|mg|30|stk|1|þpakki||N06AX11|01.04.2014||R|0|0|0|0|G|0|BLP|0|0|0|100|IKR|1262|1810|lyfalmen|V0330|1810|2|30|0|30,0000|LYFIS ehf|Bluefish Pharmaceuticals AB|Mirtazapín||500||500|1810||2 447785|C10AA0703|Rosuvastatin Krka|filmhtfl|5|mg|30|stk|1|þpakki||C10AA07|01.07.2014||R|1|0|0|0|0|0|KRK|0|0|0|100|IKR|3300|5664|lyfalmen|||2|30|0|15,0000|LYFIS ehf|Krka Sverige AB|Rósuvastatín||3300||3300|5664||2 448125|C08CA0501|Adalat|töflur|10|mg|100|stk|1|þpakki||C08CA05|01.03.2013||R|1|0|0|0|G|0|BYP|0|0|0|100|DKK|2214|4170|lyfalmen|||1|100|0|33,3333|Icepharma hf|Bayer Pharma AG|Nífedipín||||2214|4170||2 448245|N07BA0150|Nicotinell Spearmint|tyggigúm|4|mg|24|stk|1|þpakki||N07BA01|01.09.2013||L|0|0|0|0|0|0|SDF|0|0|1|100|IKR|||lyflausa|||0|24|0|3,2000|Artasan ehf|GlaxoSmithKline Consumer Healthcare A/S|Nikótín|||||||1 448688|M03BX0103|Lioresal|töflur|25|mg|50|stk|1|þpakki||M03BX01|01.12.1972||R|1|0|0|0|G|0|HES|0|0|0|100|DKK|1849|3667|lyfalmen|V0202|3344|1|50|0|25,0000|Vistor hf|Novartis Healthcare A/S|Baklófen||1849||1849|3667||1 448897|C09DX0401|Entresto|filmhtfl|100|mg|168|stk|1|þpakki|49 + 51 mg|C09DX04|01.04.2016||R|0|0|0|0|0|0|NEL|0|0|0|100|DKK|56623|74317|lyfalmen|V0727|74317|1|168|0|84,0000|Vistor hf|Novartis Europharm Ltd|Valsartan og sacubitril||56623||56623|74317||1 449125|N06AB0604|Sertralin Bluefish|filmhtfl|100|mg|100|stk|1|þpakki||N06AB06|01.03.2016||R|1|0|0|0|G|0|BLP|0|0|0|100|IKR|4353|3875|lyfalmen|V0323|3289|2|100|0|200,0000|LYFIS ehf|Bluefish Pharmaceuticals AB|Sertralín||2000||2000|3875||2 449470|B05BB0120|Natriumhydrogenkarbonat B.Braun|irl|500|mmól/l|0,25|l|1|fl|lausn|B05BB01|01.02.2012||R|0|0|0|0|0|1|BRU|0|0|0|100|XEU|1018|2523|lyfsjukr|||2|0,25|0||Actavis Group hf|B.Braun Melsungen AG|Elektrólýtar||1018||1018|2523||1 449485|N03AX1603|Pregabalin Krka|hylki|75|mg|56|stk|1|þpakki||N03AX16|01.03.2015||R|1|0|0|0|0|0|KNM|0|0|0|100|XEU|5618|4472|lyfalmen|V0686|3744|2|56|0|14,0000|LYFIS ehf|Krka d.d. Novo mesto|Pregabalín||2434||2434|4472||2 449611|C07AB0311|Atenolol Mylan|töflur|100|mg|98|stk|1|þpakki||C07AB03|01.01.1991||R|1|0|0|0|G|0|MYL|0|0|0|100|SEK|982|2353|lyfalmen|||2|98|0|130,6667|Icepharma hf|Mylan AB|Atenólól||894||894|2353||2 449819|J01CE0106|Penicillin Actavis|sts|3|g/hgl|10|hgl|1|pakki|5 millj.ae|J01CE01|01.07.2004||R|0|0|0|0|0|1|AGT|0|0|0|100|DKK|4680|7564|lyfsjukr|||2|10|0|8,3300|Actavis Group hf|Actavis Group hf|Benzýlpenicillín||4680||4680|7564||1 449868|B01AF0101|Xarelto|filmhtfl|10|mg|10|stk|1|þpakki||B01AF01|01.01.2014||R|1|1|0|0|G|0|BYP|0|0|0|100|DKK|3073|5352|lyfalmen|||1|10|0|5,0000|Icepharma hf|Bayer Pharma AG|Rivaoxaban||3073||3073|5352||2 449911|A10AC0110|Humulin NPH KwikPen|stl|100|ae/ml|3|ml|5|pennar|áfylltur penni|A10AC01|01.01.2012||R|0|0|0|0|G|0|ELI|0|0|0|100|XEU|4532|7360|lyfalmen|||1|15|0|37,5000|Icepharma hf|Eli Lilly Danmark A/S|Insúlín (manna)||4532||4532|7360||2 450009|QN51AA0101|Euthasol vet.|stl|400|mg/ml|100|ml|1|fl||QN51AA01|01.07.2012||R|0|0|1|0|0|0|LEV|1|0|0|100|XEU|4311|8349|vetalmen|||0|100|0||Le Vet B.V.|Le Vet B.V.|Pentobarbital||4311||4311|8349||2 450054|G03CA0401|Ovestin|töflur|2|mg|30|stk|1|þpakki||G03CA04|01.12.2014||R|0|0|0|0|G|0|APP|0|0|0|100|DKK|1093|2627|lyfalmen|||1|30|0|30,0000|Artasan ehf|Aspen Pharma Trading Limited|Estríól||1093||1093|2627||1 450201|V03AB3501|Bridion|stl|100|mg/ml|2|ml|10|hgl||V03AB35|01.07.2014||R|0|0|0|1|0|1|MLD|0|0|0|100|DKK|119842|154630|lyfsjukr|||1|20|0||Vistor hf|Merck Sharp & Dohme Limited|Sugammadex||119842||119842|154630||1 450413|V03AB3701|Praxbind|stl/irl|2,5|g|50|ml|2|hgl||V03AB37|01.05.2016||R|0|0|0|0|0|1|BOE|0|0|0|100|DKK|356030|448382|lyfsjukr|||1|100|0||Vistor hf|Boehringer Ingelheim International GmbH|Idarucizumab||356030||356030|448382||1 450775|N05CF0201|Stilnoct|töflur|10|mg|100|stk|1|þpakki||N05CF02|01.10.1992||R|1|0|0|0|0|0|SNO|0|0|0|100|NOK|2210|3393|lyfalmen|V0313|2595|1|100|0|100,0000|Vistor hf|Sanofi-aventis Norge AS|Zolpidem||1650||1650|3393||1 450979|QP54AA0107|Noromectin Drench|mixtúra|0,8|mg/ml|2,5|l|1|fl||QP54AA01|01.11.2011||R|0|0|0|0|0|0|NOB|0|0|0|100|IKR|7198|12406|vetorma|||0|2,5|0||Norbrook Laboratories Limited|Norbrook Laboratories Limited|Ivermectinum||7198||7198|12406||2 450993|R07AX0101|INOmax|innö.gas|800|ppm|10|l|1|gashyl||R07AX01|01.09.2014||R|0|1|0|1|0|1|LIN|0|0|0|100|XEU|18985|27253|lyfsjukr|||1|10|0||Ísaga ehf - Linde Heathcare|Linde Healthcare AB|Nituroxíð||||18985|27253||5 451153|V08CA0301|Omniscan|stl|0,5|mmol/ml|10|ml|10|spr|áfylltar sprautur|V08CA03|01.07.2003||R|0|0|0|0|0|1|GEH|0|0|0|100|NOK|34640|46513|lyfsjukr|||1|100|0||Icepharma hf|GE Healthcare AS|Gadódíamíð||34640||34640|46513||2 451293|N05AX1204|ABILIFY MAINTENA|sts|400|mg|1|hgl|1|pakki||N05AX12|01.07.2014||R|0|0|0|0|0|0|UKA|0|0|0|100|DKK|43297|57463|lyfalmen|||1|1|0|30,0800|Lundbeck Export A/S|Otsuka Pharmaceutical Europe Ltd.|Aripiprazól||43297||43297|57463||1 451419|V08CA0301|Omniscan|stl|0,5|mmol/ml|15|ml|10|spr|áfylltar sprautur|V08CA03|01.07.2003||R|0|0|0|0|0|1|GEH|0|0|0|100|NOK|38512|51411|lyfsjukr|||1|150|0||Icepharma hf|GE Healthcare AS|Gadódíamíð||38512||38512|51411||2 451476|V08CA0301|Omniscan|stl|0,5|mmol/ml|20|ml|10|spr|áfylltar sprautur|V08CA03|01.07.2003||R|0|0|0|0|0|1|GEH|0|0|0|100|NOK|51351|67649|lyfsjukr|||1|200|0||Icepharma hf|GE Healthcare AS|Gadódíamíð||51351||51351|67649||2 451761|L01AB0101|Myleran|filmhtfl|2|mg|100|stk|1|glas||L01AB01|01.06.2013||R|0|0|0|1|G|0|APP|0|0|0|100|XEU|40495|53919|lyfalmen|||1|100|0||Artasan ehf|Aspen Pharma Trading Limited|Búsúlfan||40495||40495|53919||1 452022|D01AC0801|Fungoral|sápa|20|mg/ml|120|ml|1|fl||D01AC08|01.01.2012||L|0|0|0|0|0|0|MCS|0|0|1|100|IKR|||lyflausa|||0|120|0||Vistor hf|McNeil Sweden AB|Ketókónazól|||||||1 452258|R03AK1101|Flutiform|innúðal|260|mcg/sk|120|skammtar|1|pakki|250+10 mcg/sk|R03AK11|01.01.2014||R|0|0|0|0|G|0|HAR|0|0|0|100|DKK|7311|11185|lyfalmen|||1|120|0|60,0000|Icepharma hf|Norpharma a/s (N)|Formóteról og flútikasón||7311||7311|11185||2 452284|M01AB1501|Toradol|stl|30|mg/ml|1|ml|5|lykjur||M01AB15|01.04.1992||R|0|0|0|0|G|0|ROA|0|0|1|100|DKK|1288|2895|lyfalmen|||1|5|0|5,0000|Icepharma hf|Roche A.S.|Ketórólak||1288||1288|2895||2 452467|QI09AB0401|Rhiniseng|stl|||50|ml|1|hgl|dreifa|QI09AB04|01.03.2011||R|0|0|0|0|0|0|LHS|0|0|0|100|XEU|9912|17084|vetorma|||0|50|0||Dýraheilsa ehf|Laboratorios Hipra S.A.|Óvirkar bakteríur í bóluefnum||9912||9912|17084||2 452482|V07AB0009|Sterilt Vann B. Braun|leysir|||100|ml|20|hgl|leysir f.stungulyf|V07AB|01.01.2009||L|0|0|0|0|0|0|BRA|0|0|0|100|IKR|||lyfalmen|||0|2000|0||Actavis Group hf|Braun|Leysi- og þynningarvökvar, þ.m.t. skolvökvar|||||5437||1 452500|L01XE0001|Cotellic|filmhtfl|20|mg|63|stk|1|þpakki|3 x 21|L01XE00|01.02.2016||R|1|0|0|1|0|1|RRL|0|0|0|100|DKK|860919|1076322|lyfsjukr|||1|63|0||Icepharma hf|Roche Registration Limited|Cobimetinib||||860919|1076322||2 452594|A02BC0403|Rabeprazol Krka|sþ-tfl|20|mg|56|stk|1|þpakki||A02BC04|01.03.2014||R|0|0|0|0|G|0|KRK|0|0|0|100|IKR|3500|2499|lyfalmen|V0010|2057|2|56|0|56,0000|LYFIS ehf|Krka Sverige AB|Rabeprazól||1000||1000|2499||2 452814|QC01CE9001|Vetmedin vet.|tuggutfl|1,25|mg|50|stk|1|glas|fyrir hunda|QC01CE90|01.07.2015||R|0|0|0|0|0|0|BIV|0|0|0|100|DKK|1587|2968|vetalmen|||0|50|0||Vistor hf|Boehringer Ingelheim Vetmedica GmbH|Pimobendan||1510||1510|2968||1 452862|D06BB1001|Aldara|krem|50|mg/g|250|mg|12|stk|einnota pokar|D06BB10|01.03.2000||R|0|0|0|0|0|0|LAB|0|0|1|100|SEK|9028|13548|lyfalmen|||1|3000|0||Vistor hf|Laboratories 3M Santé|Imikvímóð||9028||9028|13548||1 452866|B05AA0114|Albuman|irl|200|g/líter|100|ml|1|hgl|lausn|B05AA01|01.03.2013||R|0|0|0|0|0|1|SPP|0|0|0|100|XEU|7320|11197|lyfsjukr|||1|100|0||Williams & Halls efh|Sanquin Plasma Product|Albúmín||7320||7320|11197||2 452904|N02AA0501|Oxycontin|forðatfl|10|mg|28|stk|1|þpakki||N02AA05|01.04.2003||R|1|0|1|0|G|0|NOP|0|0|0|100|DKK|1233|2819|lyfalmen|V0597|2302|1|28|0|3,7300|Icepharma hf|Norpharma |Oxýcódon||1233||1233|2819||2 452920|N02AA0501|Oxycontin|forðatfl|10|mg|98|stk|1|þpakki||N02AA05|01.04.2003||R|1|0|1|0|G|0|NOP|0|0|0|100|DKK|3702|6218|lyfalmen|V0598|4782|1|98|0|13,0700|Icepharma hf|Norpharma |Oxýcódon||3702||3702|6218||2 452995|N02AA0501|Oxycontin|forðatfl|20|mg|28|stk|1|þpakki||N02AA05|01.04.2003||R|1|0|1|0|G|0|NOP|0|0|0|100|DKK|2357|4366|lyfalmen|V0584|3136|1|28|0|7,4700|Icepharma hf|Norpharma |Oxýcódon||2357||2357|4366||2 453126|QP54AA0101|Eqvalan, vet.|pasta|18,7|mg/g|6,4|g|1|sk-dæl||QP54AA01|01.01.1991||R|0|0|0|0|0|0|MEF|0|0|0|100|XEU|1309|2256|vetorma|||0|6,4|0||Vistor hf|Merial (MSD)|Ivermectinum||1309||1309|2256||1 453175|N02AA0501|Oxycontin|forðatfl|20|mg|98|stk|1|þpakki||N02AA05|01.04.2003||R|1|0|1|0|G|0|NOP|0|0|0|100|DKK|7104|10900|lyfalmen|V0585|7951|1|98|0|26,1300|Icepharma hf|Norpharma |Oxýcódon||7104||7104|10900||2 453498|N02AA0501|Oxycontin|forðatfl|40|mg|28|stk|1|þpakki||N02AA05|01.04.2003||R|1|0|1|0|G|0|NOP|0|0|0|100|DKK|3966|6581|lyfalmen|||1|28|0|14,9300|Icepharma hf|Norpharma |Oxýcódon||3966||3966|6581||2 453559|N03AX1604|Brieka|hylki|25|mg|56|stk|1|þpakki||N03AX16|01.10.2015||R|1|0|0|0|0|0|AGP|0|0|0|100|XEU|1922|1868|lyfalmen|V0685|1375|2|56|0|4,6667|Actavis Group hf|Actavis Group PTC ehf|Pregabalín||542||542|1868||1 453571|N02AA0501|Oxycontin|forðatfl|40|mg|98|stk|1|þpakki||N02AA05|01.04.2003||R|1|0|1|0|G|0|NOP|0|0|0|100|DKK|13251|19361|lyfalmen|V0587|13064|1|98|0|52,2700|Icepharma hf|Norpharma|Oxýcódon||13251||13251|19361||2 453753|N05AE0401|Zeldox|sts|20|mg/hgl|1|hgl|1|pakki|+leysir|N05AE04|01.03.2002||R|0|0|0|0|0|1|PER|0|0|0|100|DKK|2446|4489|lyfsjukr|||1|1|0|0,5000|Icepharma hf|Pfizer ApS|Ziprasidon||2446||2446|4489||1 454036|A09AA0206|Creon 10.000|sh-hylki|||100|stk|1|plglas||A09AA02|01.07.2013||R|1|0|0|0|G|0|APR|0|0|0|100|DKK|2841|5033|lyfalmen|V0706|5033|1|100|0|16,6700|Vistor hf|Abbott Products GmbH|Hvatablöndur (lípasi, próteasi o.s.frv.)||2841||2841|5033||1 454439|N06DA0201|Aricept|töflur|5|mg|28|stk|1|þpakki||N06DA02|01.09.1998||R|1|0|0|0|G|0|PER|0|0|0|100|DKK|9215|13806|lyfalmen|||1|28|0|18,6667|Icepharma hf|Pfizer ApS|Dónepezíl||9215||9215|13806||1 454442|QH01BB0204|Oxytobel|stl|10|ae/ml|50|ml|12|hgl||QH01BB02|01.11.2015||R|0|0|0|0|0|0|Bel|1|0|0|100|DKK|4717|9120|vetalmen|||0|600|0||Icepharma hf|Bela-Pharma GmbH & CO KG|Oxytocin||4717||4717|9120||2 454678|N06DA0201|Aricept|töflur|10|mg|28|stk|1|þpakki||N06DA02|01.09.1998||R|1|0|0|0|G|0|PER|0|0|0|100|DKK|10750|15919|lyfalmen|||1|28|0|37,3333|Icepharma hf|Pfizer ApS|Dónepezíl||10750||10750|15919||1 454686|N06DA0201|Aricept|töflur|10|mg|98|stk|1|þpakki||N06DA02|01.09.1998||R|1|0|0|0|G|0|PER|0|0|0|100|DKK|36744|39314|lyfalmen|V0342|7065|1|98|0|130,6667|Icepharma hf|Pfizer ApS|Dónepezíl||28948||28948|39314||1 454819|N02BE0115|Paracet|eþ-stíll|60|mg|10|stk|1|pakki||N02BE01|01.07.2011||L|0|0|0|0|0|0|WEI|0|0|1|100|IKR|||lyflausa|||0|10|0|0,2000|Actavis Group PTC ehf|Weifa AS|Paracetamól|||||||1 454850|L01XX1701|Hycamtin|irs|4|mg/hgl|1|hgl|1|pakki||L01XX17|01.02.1999||R|0|0|0|1|0|1|NEL|0|0|0|100|DKK|52682|69258|lyfsjukr|||1|1|0||Vistor hf|Novartis Europharm Ltd|Tópótecan||52623||52623|69258||1 454918|QJ01CE0902|Penovet, vet.|stl|300000|ae/ml|100|ml|1|hgl||QJ01CE09|01.10.1997||R|0|0|0|0|0|0|BID|0|0|0|100|DKK|1020|2005|vetalmen|||0|100|0||Vistor hf|Boehringer Ingelheim Danmark|||1020||1020|2005||1 454955|J01CA0414|Amoxicilline Actavis Disper|töflur|750|mg|20|stk|1|þpakki|hræra vel í vatni og drekka|J01CA04|01.03.2013||R|0|0|0|0|0|0|AVB|0|0|1|100|XEU|1310|2925|lyfalmen|||2|20|0|15,0000|Actavis Group PTC ehf|Actavis BV|Amoxicillín||1310||1310|2925||1 455171|B05BB0114|Natriumklorid Fresenius Kabi|irl|9|mg/ml|100|ml|40|pokar|Kabipac|B05BB01|01.11.2015||R|0|0|0|0|0|1|FKA|0|0|0|100|DKK|4307|7050|lyfsjukr|||1|4000|0||Vistor hf|Fresenius Kabi AB|Elektrólýtar||4307||4307|7050||1 455266|A10BD2001|Synjardy|filmhtfl|1012,5|mg|60|stk|1|þpakki|12,5mg/1000mg|A10BD20|01.01.2016||R|0|0|0|0|G|0|BOE|0|0|0|100|DKK|6351|9864|lyfalmen|V0713|8957|1|60|0|30,0000|Vistor hf|Boehringer Ingelheim International GmbH|Metforminum og empagliflozin||6351||6351|9864||1 455325|L04AX0601|Imnovid|hylki|2|mg|21|stk|1|þpakki||L04AX06|01.04.2016||R|0|1|0|1|0|1|CEE|0|0|0|100|XEU|1221067|1524245|lyfsjukr|||1|21|0|14,0000|Celgene Europe ltd|Celgene Europe ltd|Pomalidómide||1221067||1221067|1524245||2 455406|L01XA0102|Cisplatin Mylan|irþ|1|mg/ml|100|ml|1|hgl||L01XA01|01.11.2013||R|0|0|0|1|0|1|HAS|0|0|0|100|IKR|6344|9854|lyfsjukr|||2|100|0||LYFIS ehf|Mylan Hospital AS|Cisplatín||||6344|9854||2 455501|QM01AE9001|Quadrisol|hlaup|100|mg/ml|30|ml|3|spr|f. hesta|QM01AE90|01.02.2015||R|0|0|0|0|0|0|ZBE|0|0|0|100|DKK|5063|9776|vetalmen|||0|90|0||Icepharma hf|Zoetis Belgium S.A.|Vedaprófen||5063||5063|9776||2 455949|J01AA0207|Doxylin|töflur|100|mg|10|stk|1|þpakki||J01AA02|01.10.2008||R|1|0|0|0|0|0|AGT|0|0|1|100|XEU|465|1762|lyfalmen|||2|10|0|10,0000|Actavis Group hf|Actavis Group hf|Doxýcýklín||465||465|1762||1 455956|J01AA0207|Doxylin|töflur|100|mg|15|stk|1|þpakki||J01AA02|01.01.2009||R|1|0|0|0|0|0|AGT|0|0|1|100|XEU|804|2229|lyfalmen|||2|15|0|15,0000|Actavis Group hf|Actavis Group hf|Doxýcýklín||804||804|2229||1 455972|J01AA0207|Doxylin|töflur|100|mg|30|stk|1|þpakki||J01AA02|01.10.2008||R|1|0|0|0|0|0|AGT|0|0|1|100|XEU|1642|3382|lyfalmen|||2|30|0|30,0000|Actavis Group hf|Actavis Group hf|Doxýcýklín||1642||1642|3382||1 456895|N05AH0206|Clozapin Medical|töflur|100|mg|100|stk|1|þpakki||N05AH02|01.06.2015||R|1|0|0|0|G|0|MED|0|0|0|100|IKR|5630|6559|lyfalmen|V0277|6559|2|100|0|33,3300|Medical ehf|Medical ehf|Klózapín||3950||3950|6559||2 456989|R03AK0604|Relanio|innönddu|550|mcg/sk|180|skammtar|1|pakki|50+500 mcg|R03AK06|01.01.2014||R|0|0|0|0|G|0|EPL|0|0|0|100|IKR|26905|27288|lyfalmen|||2|180|0|90,0000|LYFIS ehf|ELPEN Pharmaceutical Co. Inc.|Salmeteról og fluticason||19010||19010|27288||2 457149|N06AB1007|Escitalopram Bluefish|filmhtfl|20|mg|98|stk|1|þpakki||N06AB10|01.08.2015||R|1|0|0|0|G|0|BLP|0|0|0|100|IKR|4950|1948|lyfalmen|V0327|1948|2|98|0|196,0000|LYFIS ehf|Bluefish Pharmaceuticals AB|Escítalópram||600||600|1948||2 457204|L02AE0307|Reseligo|vefjalyf|10,8|mg|1|áf.spr|1|pakki||L02AE03|01.05.2016||R|0|0|0|1|G|0|IPC|0|0|0|100|SEK|50873|62513|lyfalmen|V0451|62513|2|1|0|83,7200|Alvogen|Alvogen IPco S.á.r.l.|Góserelín||47290||47290|62513||1 457282|N06AB1007|Escitalopram Bluefish|filmhtfl|15|mg|98|stk|1|þpakki||N06AB10|01.08.2015||R|1|0|0|0|G|0|BLP|0|0|0|100|IKR|5470|3600|lyfalmen|V0326|3600|2|98|0|147,0000|LYFIS ehf|Bluefish Pharmaceuticals AB|Escítalópram||1800||1800|3600||2 457508|J07AH0801|Nimenrix|sts|5|mcg|0,5|ml|1|hgl|+áfyllt sprauta|J07AH08|01.07.2013||R|0|0|0|0|0|0|IPI|0|0|0|100|GBP|6492|10058|lyfalmen|||1|0,5|0||Icepharma hf|Pfizer Limited|Hreinsaðir fjórgildi A,C,Y,W-135 og fl.||6492||6492|10058||1 457692|L01BA0109|Metoject|stl|50|mg/ml|0,45|ml|1|áfspr||L01BA01|01.12.2012||R|0|0|0|1|G|0|WIL|0|0|0|100|SEK|2973|5214|lyfalmen|||1|0,45|0||Williams & Halls efh|medac Gesellschaft|Metótrexat||2973||2973|5214||2 457726|A02BC0402|Rabeprazol Actavis|sh-tfl|20|mg|28|stk|1|þpakki||A02BC04|01.05.2011||R|0|0|0|0|0|0|APC|0|0|0|100|XEU|2416|1662|lyfalmen|V0003|1662|2|28|0|28,0000|Actavis Group PTC ehf|Actavis Group PTC ehf|Rabeprazól||392||392|1662||1 458067|N05CM0201|Heminevrin|hylki|300|mg|25|stk|1|glas||N05CM02|01.12.1998||R|1|0|0|0|0|0|CHE|0|0|1|100|DKK|1017|2522|lyfalmen|||1|25|0|5,0000|Vistor hf|CHEPLAPHARM Arzneimittel GmbH|Clómetíazól||1017||1017|2522||1 458149|L01XE2101|Stivarga|filmhtfl|40|mg|84|stk|1|glas|3 x 28|L01XE21|01.06.2014||R|0|0|0|1|0|1|BGB|0|0|0|100|DKK|611178|765714|lyfsjukr|||1|84|0||Icepharma hf|Bayer Pharma AG|Regorafenib||611178||611178|765714||2 458349|J01CA0801|Selexid|töflur|200|mg|20|stk|1|þpakki||J01CA08|01.12.1980||R|0|0|0|0|0|0|LEP|0|0|1|100|DKK|1172|2735|lyfalmen|V0577|2336|1|20|0|6,6667|Vistor hf|LEO Pharma A/S|Pívmecillínam||1172||1172|2735||1 458491|C05AA0801|Doloproct|eþ-krem|||30|g|1|túpa||C05AA08|01.02.2015||R|0|0|0|0|0|0|BAB|0|0|0|100|DKK|1214|2793|lyfalmen|||1|30|0||Icepharma hf|Bayer AB|Flúókortólón||1214||1214|2793||2 458666|B02BD0206|Advate|sts|1500|ae|1|hgl|1|pakki|+leysir|B02BD02|01.12.2015||R|0|0|0|1|0|1|BAL|0|1|0|100|SEK|120446|155381|lyfsjukr|||1|1|0|3,0000|Lyfjaver ehf|Baxter Medical AB (L)|Storkuþáttur VIII||||120446|155381||3 458805|B01AF0201|Eliquis|filmhtfl|2,5|mg|60|stk|1|þpakki||B01AF02|01.09.2014||R|1|1|0|0|G|0|BRP|0|0|0|100|DKK|9350|12842|lyfalmen|V0653|12777|1|60|0|15,0000|Icepharma hf|Bristol-Myers Squibb/Pfizer EEIG|Apixaban ||8515||8515|12842||1 459037|L01XE2301|Tafinlar|hylki|75|mg|120|stk|1|glas||L01XE23|01.11.2013||R|1|0|0|1|0|1|NEL|0|1|0|100|DKK|1144426|1428926|lyfsjukr|||1|120|0||Vistor hf|Novartis Europharm Ltd|Dabrafeníb||1144426||1144426|1428926||1 459225|M05BA0805|Zoledronic Acid Hospira|irl|5|mg|100|ml|1|poki|lausn|M05BA08|01.01.2016||R|0|1|0|1|0|0|VOG|0|0|0|100|IKR|39258|52354|lyfalmen|V0715|52354|2|100|0|1,2500|Alvogen HS|Hospira UK Ltd.|Zoledronsýra||39258||39258|52354||1 459242|L03AB1301|Plegridy|stl|||2|áf.spr|1|pakki|63 og 94 mcg|L03AB13|01.07.2015||R|0|0|0|1|0|1|BIB|0|0|0|100|XEU|114386|147844|lyfsjukr|||1|2|0|17,6400|Icepharma hf|Biogen Idec Ltd|Peginterferón beta-1a||114386||114386|147844||2 459354|J01FF0101|Dalacin|stl|150|mg/ml|2|ml|1|lykja||J01FF01|01.11.1979||R|0|0|0|0|0|1|PER|0|0|0|100|DKK|761|2170|lyfsjukr|||1|2|0|0,1667|Icepharma hf|Pfizer ApS|Klindamýcín||761||761|2170||1 459420|J01FF0101|Dalacin|stl|150|mg/ml|4|ml|1|lykja||J01FF01|01.11.1979||R|0|0|0|0|0|1|PER|0|0|0|100|DKK|1395|3042|lyfsjukr|||1|4|0|0,3333|Icepharma hf|Pfizer ApS|Klindamýcín||1395||1395|3042||1 459447|QJ01DD9101|Convenia|sts|80|mg/ml|10|ml|1|hgl|+leysir, lausn|QJ01DD91|01.04.2015||R|0|0|0|0|0|0|ZBE|0|0|0|100|DKK|18853|35938|vetalmen|||0|10|0||Icepharma hf|Zoetis Belgium S.A.|||18853||18853|35938||2 459678|N06AX2106|Duloxetin W&H|sþ-hylki|30|mg|28|stk|1|þpakki||N06AX21|01.08.2015||R|1|0|0|0|0|0|WEH|0|0|0|100|XEU|2516|2914|lyfalmen|V0692|2778|2|28|0|14,0000|Williams & Halls efh|Williams & Halls ehf|Duloxetín||1302||1302|2914||2 459812|N05AH0411|Quetiapine Teva|filmhtfl|25|mg|100|stk|1|þpakki||N05AH04|01.09.2014||R|1|0|0|0|G|0|TSB|0|0|0|100|IKR|2500|2155|lyfalmen|V0284|2135|2|100|0|6,2500|Medical ehf|Teva Sweden AB|Quetíapín||750||750|2155||2 459859|B02AA0201|Cyklokapron|töflur|500|mg|30|stk|1|þpakki||B02AA02|01.04.1989||R|1|0|0|0|G|0|MAS|0|0|1|100|SEK|1519|3213|lyfalmen|||1|30|0|7,5000|Vistor hf|Meda AS|Tranexamsýra||1519||1519|3213||1 460062|L01AA0902|Bendamustine Accord|st/irþ|2,5|mg/ml|100|mg|5|hgl|lausn|L01AA09|01.01.2016||R|0|0|0|1|0|1|ACC|0|1|0|100|DKK|67041|87494|lyfsjukr|||2|500|0||Artasan ehf|Accord Healthcare Limited|Bendamústín||67041||67041|87494||1 460170|J07BC0202|Avaxim|stl|||0,5|ml|1|dæla|einnota dæla|J07BC02|01.04.1998||R|0|0|0|0|0|0|SPM|0|0|0|100|XEU|3571|6037|lyfalmen|||1|0,5|0||Icepharma hf|Sanofi Pasteur MSD|Lifrarbólga-A, dauð veira (inactiv­ated whole virus)||3571||3571|6037||2 460293|J04AB0201|Rimactan|hylki|150|mg|100|stk|1|þpakki||J04AB02|01.09.2012||R|1|0|0|0|G|0|SAD|0|0|0|100|DKK|7315|11191|lyfalmen|||1|100|0|25,0000|Icepharma hf|Sandoz GmbH|Rífampicín||7315||7315|11191||2 460339|L01XC0301|Herceptin|stl|600|mg/hgl|5|ml|1|hgl||L01XC03|01.12.2013||R|0|0|0|1|0|1|ROC|0|1|0|100|DKK|216501|274847|lyfsjukr|||1|5|0||Icepharma hf|Roche|Trastuzumab||216501||216501|274847||2 460826|QJ01CR0201|Combisyn|töflur|250|mg|100|stk|1|pakki||QJ01CR02|01.11.2011||R|0|0|0|0|0|0|NOB|0|0|0|100|XEU|5577|10751|vetalmen|||0|100|0||Norbrook Laboratories Limited|Norbrook Laboratories Limited|Amoxicillín og Clavulansýra||5577||5577|10751||2 461035|N02AA0506|Oxikodon Depot Actavis|forðatfl|20|mg|98|stk|1|glas||N02AA05|01.08.2015||R|1|0|1|0|G|0|APC|0|0|0|100|XEU|4961|7951|lyfalmen|V0585|7951|2|98|0|26,1300|Actavis Group PTC ehf|Actavis Group PTC ehf|Oxýcódon||4961||4961|7951||1 461107|L03AB1001|PegIntron|sts|80|mcg|4|áf-penni|1|pakki|fjölskammta pennar|L03AB10|01.11.2013||R|0|0|0|1|0|1|MLD|0|0|0|100|DKK|77527|100757|lyfsjukr|||1|4|0|42,6700|Vistor hf|Merck Sharp & Dohme Limited|Peginterferón alfa 2b||77527||77527|100757||1 461113|L01XE1801|Jakavi|töflur|20|mg|56|stk|1|þpakki||L01XE18|01.02.2014||R|1|0|0|1|0|1|NEL|0|1|0|100|DKK|496663|623290|lyfsjukr|||1|56|0||Vistor hf|Novartis Europharm Ltd|Ruxolitinib||496663||496663|623290||1 461206|J02AC0104|Fluconazol ratiopharm|hylki|150|mg|1|stk|1|þpakki||J02AC01|01.08.2013||L|1|0|0|0|0|0|RGM|0|0|1|100|IKR|||lyfalmen|V0554|1916|2|1|0|0,7500|Medical ehf|ratiopharm GmbH|Flúkónazól|||||1916||2 461441|L04AX0601|Imnovid|hylki|4|mg|21|stk|1|þpakki||L04AX06|01.04.2016||R|0|1|0|1|0|1|CEE|0|0|0|100|XEU|1258825|1571206|lyfsjukr|||1|21|0|28,0000|Celgene Europe ltd|Celgene Europe ltd|Pomalidómide||1258825||1258825|1571206||2 461641|V03AB3501|Bridion|stl|100|mg/ml|5|ml|10|hgl||V03AB35|01.09.2015||R|0|0|0|1|0|1|MLD|0|0|0|100|DKK|299604|378203|lyfsjukr|||1|50|0||Vistor hf|Merck Sharp & Dohme Limited|Sugammadex||299604||299604|378203||1 461731|N02BE5102|Parkodin|töflur|510|mg|10|stk|1|pakki|þp 10+500 mg|N02BE51|01.01.1989||R|1|0|0|0|0|0|AGP|0|0|1|100|IKR|202|1400|lyfalmen|||2|10|0|1,6667|Actavis Group hf|Actavis Group PTC ehf|Paracetamól í blöndum nema með geðlyfjum (psycholeptica)||202||202|1400||1 461774|M09AX0102|Hyalgan|stl|10,3|mg/ml|2|ml|1|spr||M09AX01|01.08.2015||R|0|0|0|0|G|0|TPA|0|0|0|100|DKK|6449|9999|lyfalmen|V0209|9999|2|2|0|5,7222|Vistor hf|Takeda Pharma A/S|Natríumhýalúrónat||6449||6449|9999||1 462028|D07AD0101|Dermovat|krem|0,5|mg/g|25|g|1|túpa||D07AD01|01.09.1982||R|0|0|0|0|G|0|GPH|0|0|1|100|GBP|437|1724|lyfalmen|||1|25|0||Vistor hf|GlaxoSmithKline Pharma A/S|Klóbetasól||437||437|1724||1 462044|D07AD0101|Dermovat|smyrsli|0,5|mg/g|25|g|1|túpa||D07AD01|01.09.1982||R|0|0|0|0|G|0|GPH|0|0|1|100|GBP|487|1793|lyfalmen|||1|25|0||Vistor hf|GlaxoSmithKline Pharma A/S|Klóbetasól||487||487|1793||1 462049|C08CA0501|Adalat|töflur|20|mg|100|stk|1|þpakki||C08CA05|01.03.2013||R|1|0|0|0|G|0|BYP|0|0|0|100|DKK|2552|4635|lyfalmen|||1|100|0|66,6667|Icepharma hf|Bayer Pharma AG|Nífedipín||||2552|4635||2 462070|A10BX0901|Forxiga|filmhtfl|10|mg|98|stk|1|þpakki||A10BX09|01.09.2015||R|1|0|0|0|G|0|BRI|0|0|0|100|SEK|18812|27015|lyfalmen|||1|98|0|98,0000|Vistor hf|Bristol-Myers Squibb/AstraZeneca EEIG|Dapagliflozín||18812||18812|27015||1 462358|A07EA0601|Entocort|endaþ.dr|20|mcg/ml|7|stk|1|þpakki|samsett pk|A07EA06|01.04.1993||R|0|0|0|0|G|0|TTT|0|0|0|100|SEK|5896|9237|lyfalmen|||1|7|0|7,0000|Icepharma hf|Tillotts Pharma GmbH|Búdesóníð||5896||5896|9237||2 462813|A07AA0906|Vancomycin Xellia|hylki|125|mg|28|stk|1|þpakki|hart hylki|A07AA09|01.01.2011||R|1|0|0|0|G|0|XEL|0|0|1|100|DKK|14794|21485|lyfalmen|||2|28|0|1,7500|Actavis Group hf|Xellia Pharmaceuticals ApS|Vankómýcín||14794||14794|21485||1 462986|QM01AE9101|Rimadyl vet.|stl|50|mg/ml|20|ml|1|hgl||QM01AE91|01.06.2000||R|0|0|0|0|0|0|ZOE|1|0|0|100|DKK|5958|11474|vetalmen|||0|20|0||Icepharma hf|Zoetis Finland OY|||||5958|11474||2 463197|C10AA0106|Simvastatin Bluefish|filmhtfl|10|mg|100|stk|1|þpakki||C10AA01|01.10.2014||R|1|0|0|0|G|0|BLP|0|0|0|100|IKR|743|1711|lyfalmen|V0108|1711|2|100|0|33,3400|LYFIS ehf|Bluefish Pharmaceuticals AB|Simvastatín||428||428|1711||2 463251|N06DX0106|Memantine ratiopharm|filmhtfl|10|mg|100|stk|1|glas||N06DX01|01.10.2013||R|1|0|0|0|G|0|RGM|0|0|0|100|XEU|6369|5359|lyfalmen|V0605|5203|2|100|0|50,0000|Medical ehf|ratiopharm GmbH|Memantín||3078||3078|5359||2 463262|N06AB1007|Escitalopram Bluefish|filmhtfl|10|mg|98|stk|1|þpakki||N06AB10|01.08.2015||R|1|0|0|0|G|0|BLP|0|0|0|100|IKR|2698|1535|lyfalmen|V0325|1535|2|98|0|98,0000|LYFIS ehf|Bluefish Pharmaceuticals AB|Escítalópram||300||300|1535||2 463612|QM01AE9101|Rimadyl vet.|töflur|50|mg|100|stk|1|pakki||QM01AE91|01.06.2000||R|0|0|0|0|0|0|ZOE|0|0|0|100|DKK|4753|9188|vetalmen|||0|100|0||Icepharma hf|Zoetis Finland OY|||4753||4753|9188||2 463642|J01XA0107|Vancomycin Xellia|irs|1|g/hgl|1|hgl|1|pakki||J01XA01|01.04.2013||R|0|0|0|0|0|1|XEL|0|0|0|100|XEU|626|1984|lyfsjukr|||2|1|0|0,5000|Actavis Group hf|Xellia Pharmaceuticals ApS|Vankómýcín||626||626|1984||1 463654|J05AE1001|Prezista|filmhtfl|800|mg|30|stk|1|plglas||J05AE10|01.08.2013||R|1|0|0|1|0|1|JCI|0|0|0|100|SEK|51665|68047|lyfsjukr|||1|30|0|20,0000|Vistor hf|Janssen-Cilag International N.V.|Darunavír||||51665|68047||1 463861|D07AC1301|Elocon|smyrsli|0,1|%|100|g|1|túpa||D07AC13|01.02.2014||R|0|0|0|0|G|0|MBV|0|0|1|100|DKK|1938|3790|lyfalmen|||1|100|0||Vistor hf|Merck Sharp & Dohme B.V.|Mómetasón||1938||1938|3790||1 463941|M01AX0501|Glucomed|töflur|625|mg|60|stk|1|þpakki||M01AX05|01.11.2012||L|1|0|0|0|0|0|LEX|0|0|1|100|IKR|||lyflausa|||0|60|0|52,8000|Icepharma hf|Laboratories Expansvience|Glúkósamín|||||||2 464164|N02BE0101|Panodil|filmhtfl|500|mg|30|stk|1|þpakki||N02BE01|01.04.1992||L|1|0|0|0|0|0|HCA|0|0|1|100|IKR|||lyflausa|||0|30|0|5,0000|Artasan ehf|GlaxoSmithKline CH A/S|Paracetamól|||||||1 464226|C07AG0205|Carveratio|töflur|12,5|mg|100|stk|1|þpakki||C07AG02|01.06.2015||R|0|0|0|0|G|0|RGM|0|0|0|100|IKR|2614|4720|lyfalmen|||2|100|0|33,3300|Medical ehf|ratiopharm GmbH|Carvedílól||2614||2614|4720||2 464545|L01XX0502|Hydroxyurea medac|hylki|500|mg|100|stk|1|þpakki||L01XX05|01.01.2016||R|0|0|0|1|G|0|WIL|0|0|0|100|XEU|8482|12797|lyfalmen|||1|100|0||Williams & Halls efh|medac Gesellschaft|Hýdroxýkarbamíð||8482||8482|12797||2 464591|J01FA0902|Clarithromycin ratiopharm|filmhtfl|250|mg|14|stk|1|þpakki||J01FA09|01.06.2014||R|1|0|0|0|0|0|TSB|0|0|1|100|IKR|1756|3539|lyfalmen|||2|14|0|7,0000|Medical ehf|Teva Sweden AB|Klaritrómýcín||1756||1756|3539||2 465065|S01EE0104|Latanoprost Actavis|augndr|50|mcg/ml|7,5|ml|1|pakki|3 glös í pakka|S01EE01|01.10.2011||R|0|0|0|0|G|0|APC|0|0|0|100|DKK|1621|3353|lyfalmen|V0376|3353|2|7,5|0|75,0000|Actavis Group PTC ehf|Actavis Group PTC ehf|Latanóprost||1621||1621|3353||1 465307|C08DA0103|Isoptin retard|forðatfl|120|mg|98|stk|1|þpakki||C08DA01|01.01.2016||R|1|0|0|0|G|0|GPB|0|0|0|100|DKK|1723|3494|lyfalmen|||1|98|0|49,0000|Vistor hf|BGP Products AB|Verapamíl||1723||1723|3494|| 465333|L01BA0109|Metoject|stl|50|mg/ml|0,6|ml|1|áfspr||L01BA01|01.12.2012||R|0|0|0|1|G|0|WIL|0|0|0|100|SEK|3294|5656|lyfalmen|||1|0,6|0||Williams & Halls efh|medac Gesellschaft|Metótrexat||3294||3294|5656||2 466003|N06AB0310|Seromex|hylki|20|mg|30|stk|1|þpakki||N06AB03|01.02.2013||R|1|0|0|0|G|0|RGM|0|0|0|100|IKR|1540|2223|lyfalmen|V0038|1940|2|30|0|30,0000|Medical ehf|ratiopharm GmbH|Flúoxetín||800||800|2223||2 466029|N06AB0310|Seromex|hylki|20|mg|100|stk|1|þpakki||N06AB03|01.02.2013||R|1|0|0|0|G|0|RGM|0|0|0|100|IKR|3844|3462|lyfalmen|V0039|3035|2|100|0|100,0000|Medical ehf|ratiopharm GmbH|Flúoxetín||1700||1700|3462||2 466086|N02AA0101|Contalgin|forðatfl|10|mg|25|stk|1|þpakki||N02AA01|01.07.1992||R|1|0|1|0|G|0|PER|0|0|0|100|DKK|556|1887|lyfalmen|||1|25|0|2,5000|Icepharma hf|Pfizer ApS|Morfín||556||556|1887||1 466094|N02AA0101|Contalgin|forðatfl|10|mg|100|stk|1|þpakki||N02AA01|01.08.1984||R|1|0|1|0|G|0|PER|0|0|0|100|DKK|1733|3508|lyfalmen|||1|100|0|10,0000|Icepharma hf|Pfizer ApS|Morfín||1733||1733|3508||1 466122|G03AA0702|Microgyn|töflur|||63|stk|1|þpakki||G03AA07|01.08.2013||R|0|0|0|0|0|0|BGB|0|0|0|100|DKK|1148|2702|lyfalmen|V0545|1905|1|63|0|84,0000|Icepharma hf|Bayer Pharma AG|Levónorgestrel og ethinylestradíól||||1148|2702||2 466169|N02AA0101|Contalgin|forðatfl|30|mg|25|stk|1|þpakki||N02AA01|01.07.1992||R|1|0|1|0|G|0|PER|0|0|0|100|DKK|1314|2931|lyfalmen|||1|25|0|7,5000|Icepharma hf|Pfizer ApS|Morfín||1314||1314|2931||1 466219|N02AA0101|Contalgin|forðatfl|30|mg|100|stk|1|þpakki||N02AA01|01.08.1984||R|1|0|1|0|G|0|PER|0|0|0|100|DKK|4552|7388|lyfalmen|||1|100|0|30,0000|Icepharma hf|Pfizer ApS|Morfín||4552||4552|7388||1 466278|L01XC1401|Kadcyla|irþ|100|mg|1|hgl|1|pakki||L01XC14|01.06.2014||R|0|1|0|1|0|1|RRL|0|1|0|100|DKK|251395|318245|lyfsjukr|||1|1|0||Icepharma hf|Roche Registration Limited|Trastuzumab emtansine||251395||251395|318245||2 466394|N03AX1501|Zonegran|hylki|100|mg|98|stk|1|þpakki||N03AX15|01.03.2014||R|1|0|0|0|G|0|EIS|0|0|0|100|SEK|18731|26904|lyfalmen|||1|98|0|49,0000|Vistor hf|Eisai Ltd|Zonisamíð||18731||18731|26904||1 466466|N02AA0101|Contalgin|forðatfl|60|mg|25|stk|1|þpakki||N02AA01|01.10.1995||R|1|0|1|0|G|0|PER|0|0|0|100|DKK|2442|4483|lyfalmen|||1|25|0|15,0000|Icepharma hf|Pfizer ApS|Morfín||2442||2442|4483||1 466482|L04AD0102|Sandimmun Neoral|hylki|25|mg|50|stk|1|þpakki||L04AD01|01.07.1994||R|0|0|0|0|G|0|HES|0|0|0|100|DKK|6643|10266|lyfalmen|||1|50|0|5,0000|Vistor hf|Novartis Healthcare A/S|Ciklospórín||6643||6643|10266||1 466610|N02BE0120|Paracetamol Sandoz|filmhtfl|500|mg|30|stk|1|þpakki||N02BE01|01.03.2016||L|1|0|0|0|0|0|SHS|0|0|1|100|IKR|||lyflausa|||2|30|0|5,0000|Artasan ehf|Sandoz A/S|Paracetamól|||||||1 466680|N02AA0101|Contalgin|forðatfl|100|mg|25|stk|1|þpakki||N02AA01|01.07.1992||R|1|0|1|0|G|0|PER|0|0|0|100|DKK|4018|6653|lyfalmen|||1|25|0|25,0000|Icepharma hf|Pfizer ApS|Morfín||4018||4018|6653||1 466723|V03AN0501|Lyfjaloft AGA 100%|lyfjagas|100|%|2,5|l|1|hylki|undir þrýstingi|V03AN05|01.10.2013||L|0|0|0|0|0|0|AGA|0|0|0|100|IKR|||lyflausa|||2|2,5|0||Ísaga ehf|AGA AB|Lyfjagös|||||||5 466739|C09DX0401|Entresto|filmhtfl|200|mg|56|stk|1|þpakki|97 + 103 mg|C09DX04|01.04.2016||R|0|0|0|0|0|0|NEL|0|0|0|100|DKK|18874|27100|lyfalmen|V0728|24772|1|56|0|28,0000|Vistor hf|Novartis Europharm Ltd|Valsartan og sacubitril||18874||18874|27100||1 466813|N06AG0201|Aurorix|töflur|150|mg|100|stk|1|þpakki||N06AG02|01.10.1990||R|1|0|0|0|G|0|MAS|0|0|0|100|SEK|3112|5406|lyfalmen|V0063|4415|1|100|0|50,0000|Vistor hf|Meda AS|Móklóbemíð||3112||3112|5406||1 467432|QJ01CA0401|Clamoxyl, vet.|töflur|200|mg|100|stk|1|þpakki||QJ01CA04|01.04.2015||R|0|0|0|0|0|0|ZOE|0|0|0|100|DKK|8168|15667|vetalmen|||0|100|0||Icepharma hf|Zoetis Finland OY|||8168||8168|15667||2 467459|B05BB0117|Natriumklorid Baxter Viaflo 9 mg/ml|irl|9|mg/ml|50|ml|50|pokar|lausn|B05BB01|01.07.2013||R|0|0|0|0|0|1|BAM|0|0|0|100|SEK|6133|9564|lyfsjukr|||1|2500|0||Icepharma hf|Baxter Medical AB|Elektrólýtar||6133||6133|9564||2 467563|L04AD0102|Sandimmun Neoral|hylki|50|mg|50|stk|1|þpakki||L04AD01|01.07.1994||R|0|0|0|0|G|0|HES|0|0|0|100|DKK|12997|19011|lyfalmen|||1|50|0|10,0000|Vistor hf|Novartis Healthcare A/S|Ciklospórín||12997||12997|19011||1 467699|G03FA1701|Angemin|töflur|||84|stk|1|þpakki|2+1 mg|G03FA17|01.10.2012||R|0|0|0|0|0|0|BGB|0|0|0|100|DKK|5521|8721|lyfalmen|||1|84|0|84,0000|Icepharma hf|Bayer Pharma AG|Dróspírenón og östrogen||5521||5521|8721||2 467720|L04AD0102|Sandimmun Neoral|hylki|100|mg|50|stk|1|þpakki||L04AD01|01.07.1994||R|0|0|0|0|G|0|HES|0|0|0|100|DKK|24833|34109|lyfalmen|||1|50|0|20,0000|Vistor hf|Novartis Healthcare A/S|Ciklospórín||24833||24833|34109||1 467756|A10BX1001|Lyxumia|stl|20|mcg|2|áf-penni|1|pakki||A10BX10|01.10.2013||R|0|0|0|0|0|0|SGA|0|0|0|100|NOK|9169|13742|lyfalmen|||1|2|0|2,0000|Vistor hf|Sanofi-aventis groupe|Lixisenatíd||9169||9169|13742||1 467810|J01DI0201|Zinforo|irþ|600|mg|10|hgl|1|pakki|lausn|J01DI02|01.04.2013||R|0|0|0|0|0|1|AZA|0|0|0|100|SEK|80326|104297|lyfsjukr|||1|10|0|5,0000|Vistor hf|AstraZeneca AB|Ceftarólin||80326||80326|104297||1 467993|N05AD0101|Haldol|stl|5|mg/ml|1|ml|5|lykjur||N05AD01|01.08.2000||R|0|0|0|0|0|1|JAS|0|0|0|100|SEK|413|1691|lyfsjukr|||1|5|0|3,1250|Vistor hf|Janssen-Cilag AB|Halóperídól||413||413|1691||1 468082|N06AB0401|Cipramil|töflur|10|mg|100|stk|1|plglas||N06AB04|01.04.1993||R|1|0|0|0|G|0|LBK|0|0|0|100|DKK|5486|6198|lyfalmen|V0317|2606|1|100|0|50,0000|Lundbeck Export A/S|H. Lundbeck A/S|Cítalópram||3688||3688|6198||1 468116|N01AH0102|Leptanal|stl|50|mcg/ml|2|ml|5|lykjur||N01AH01|01.11.2001||R|0|0|1|0|0|1|JAS|0|0|0|100|SEK|278|1505|lyfsjukr|||1|10|0||Vistor hf|Janssen-Cilag AB|Fentanýl||278||278|1505||1 468124|N06AB0401|Cipramil|töflur|20|mg|100|stk|1|glas||N06AB04|01.04.1993||R|1|0|0|0|G|0|LBK|0|0|0|100|DKK|8292|6165|lyfalmen|V0318|3508|1|100|0|100,0000|Lundbeck Export A/S|H. Lundbeck A/S|Cítalópram||3664||3664|6165||1 468537|QP54AA0501|Stronghold|bl.lausn|15|mg|0,25|ml|3|túpa||QP54AA05|01.12.2014||R|0|0|0|0|0|0|ZBE|1|0|0|100|XEU|2087|3597|vetorma|||0|0,75|0||Icepharma hf|Zoetis Belgium S.A.|Selamectinum||2087||2087|3597||2 468568|J01XA0107|Vancomycin Xellia|irs|500|mg/hgl|1|hgl|1|pakki||J01XA01|01.04.2013||R|0|0|0|0|0|1|XEL|0|0|0|100|XEU|356|1612|lyfsjukr|||2|1|0|0,2500|Actavis Group hf|Xellia Pharmaceuticals ApS|Vankómýcín||356||356|1612||1 468803|M05BA0705|Risedronat Actavis|filmhtfl|35|mg|12|stk|1|þpakki||M05BA07|01.03.2011||R|1|0|0|0|G|0|APC|0|0|0|100|IKR|4530|2355|lyfalmen|V0207|2355|2|12|0|84,0000|Actavis Group PTC ehf|Actavis Group PTC ehf|Rísedrónsýru||896||896|2355||1 468825|QM01AC0603|Rheumocam|stl|20|mg/ml|50|ml|1|hgl|handa nautg, svínum og hestum|QM01AC06|01.09.2013||R|0|0|0|0|0|0|CHP|1|0|0|100|XEU|5537|10675|vetalmen|||0|50|0||Icepharma hf|Chanelle Pharmaceuticals|||5537||5537|10675||2 468932|B05BB0115|Ringer-acetat Fresenius Kabi|irl|||500|ml|20|plpok|Freeflex umbúðir|B05BB01|01.11.2015||R|0|0|0|0|0|1|FKA|0|0|0|100|DKK|6504|10074|lyfsjukr|||1|10000|0||Vistor hf|Fresenius Kabi AB|Elektrólýtar||6504||6504|10074||1 468996|A02BC0402|Rabeprazol Actavis|sþ-tfl|10|mg|100|stk|1|glas||A02BC04|01.01.2012||R|0|0|0|0|G|0|APC|0|0|0|100|IKR|4172|5246|lyfalmen|V0467|4463|2|100|0|50,0000|Actavis Group PTC ehf|Actavis Group PTC ehf|Rabeprazól||2996||2996|5246||1 469086|A10BD2001|Synjardy|filmhtfl|1005|mg|60|stk|1|þpakki|5mg/1000mg|A10BD20|01.01.2016||R|0|0|0|0|G|0|BOE|0|0|0|100|DKK|6351|9864|lyfalmen|V0712|8957|1|60|0|30,0000|Vistor hf|Boehringer Ingelheim International GmbH|Metforminum og empagliflozin||6351||6351|9864||1 469346|C10AB0401|Lopid|töflur|600|mg|98|stk|1|þpakki||C10AB04|01.07.1991||R|1|0|0|0|0|0|PER|0|0|0|100|DKK|3623|6109|lyfalmen|||1|98|0|49,0000|Icepharma hf|Pfizer ApS|Gemfíbrózíl||3623||3623|6109||1 469422|G03AB0501|Gracial|töflur|||66|stk|1|pakki|þp 3 x (15+7 stk)|G03AB05|01.08.2015||R|0|0|0|0|0|0|APP|0|0|0|100|DKK|2219|4176|lyfalmen|||1|66|0|66,0000|Artasan ehf|Aspen Pharma Trading Limited|Desógestrel og ethinylestradíól||2219||2219|4176||1 469480|B05BA0311|Glucos Fresenius Kabi|irl|500|mg/ml|500|ml|20|pokar|Freeflex umbúðir|B05BA03|01.12.2011||R|0|0|0|0|0|1|FKA|0|0|0|100|DKK|6877|10588|lyfsjukr|||1|10000|0||Vistor hf|Fresenius Kabi AB|Kolvetni||6877||6877|10588||1 469794|N07BA0150|Nicotinell Spearmint|tyggigúm|2|mg|204|stk|1|þpakki||N07BA01|01.09.2013||L|0|0|0|0|0|0|SDF|0|0|1|100|IKR|||lyflausa|||0|204|0|13,6000|Artasan ehf|GlaxoSmithKline Consumer Healthcare A/S|Nikótín|||||||1 469817|N02AX0206|Nobligan Retard|forðatfl|200|mg|100|stk|1|pakki||N02AX02|01.05.2000||R|1|0|1|0|G|0|GRU|0|0|1|100|DKK|5446|8618|lyfalmen|V0228|8252|1|100|0|66,6667|Icepharma hf|Grunenthal|Tramadól||5446||5446|8618||2 469847|M01AH0106|Celecoxib Actavis|hylki|200|mg|20|stk|1|þpakki||M01AH01|01.12.2014||R|1|0|0|0|G|0|AGP|0|0|1|100|XEU|2233|2671|lyfalmen|V0037|2125|2|20|0|20,0000|Actavis Group hf|Actavis Group PTC ehf|Celekoxíb||1125||1125|2671||1 469874|N02AX0206|Nobligan Retard|forðatfl|150|mg|100|stk|1|pakki||N02AX02|01.05.2000||R|1|0|1|0|G|0|GRU|0|0|1|100|DKK|4529|7356|lyfalmen|V0227|6387|1|100|0|50,0000|Icepharma hf|Grunenthal|Tramadól||4529||4529|7356||2 469932|N02AX0206|Nobligan Retard|forðatfl|100|mg|100|stk|1|pakki||N02AX02|01.05.2000||R|1|0|1|0|G|0|GRU|0|0|1|100|DKK|2888|5097|lyfalmen|V0226|4616|1|100|0|33,3333|Icepharma hf|Grunenthal|Tramadól||2888||2888|5097||2 470148|N06BA0404|Methylphenidate Sandoz|forðatfl|54|mg|30|stk|1|glas||N06BA04|01.09.2013||R|1|1|1|0|0|0|SHS|0|0|0|100|DKK|8232|9009|lyfalmen|V0622|9009|2|30|0|54,0000|Artasan ehf|Sandoz A/S|Metýlfenídat||5730||5730|9009||1 470352|M05BA0804|Zoledronic acid medac|irþ|4|mg/hgl|5|ml|1|hgl|lausn|M05BA08|01.12.2013|30.04.2016|R|0|1|0|1|0|1|WIL|0|0|0|100|XEU|13017|19039|lyfsjukr|||2|5|0|1,0000|Williams & Halls efh|medac Gesellschaft|Zoledronsýra||13017||13017|19039||2 470385|R03BA0501|Flixotide|innúðal|250|mcg/sk|120|skammtar|1|stauk||R03BA05|01.04.1995||R|0|0|0|0|G|0|GPH|0|0|0|100|GBP|4086|6746|lyfalmen|||1|120|0|50,0000|Vistor hf|GlaxoSmithKline Pharma A/S|Flútíkasón||4086||4086|6746||1 470397|N05CM1801|Dexdor|irþ|100|mcg/ml|4|ml|4|hgl|lausn|N05CM18|01.03.2012||R|0|0|0|1|0|1|ORC|0|0|0|100|DKK|24148|33243|lyfsjukr|||1|16|0|1,6000|Vistor hf|Orion Corporation|Dexmedetómid||24148||24148|33243||1 470471|B01AX0501|Arixtra|stl|2,5|mg/spr|0,5|ml|10|áf.spr||B01AX05|01.01.2016||R|0|0|0|0|G|0|APP|0|0|0|100|GBP|6061|9465|lyfalmen|V0478|9465|1|5|0|10,0000|Artasan ehf|Aspen Pharma Trading Limited|Fondaparinux||6061||6061|9465||1 470551|H05BX0103|Cinacalcet Sandoz|filmhtfl|30|mg|28|stk|1|þpakki||H05BX01|01.05.2016||R|1|0|0|0|0|0|SHS|0|0|0|100|DKK|20378|28233|lyfalmen|V0720|28233|2|28|0|14,0000|Artasan ehf|Sandoz A/S|Cinacalcet||20187||20187|28233||1 470933|QJ51RC2002|Ampiclox vet.|spenalyf|||3|g|24|spr|spenadælur|QJ51RC20|01.03.2015||R|0|0|0|0|0|0|ZOE|0|0|0|100|DKK|3988|7737|vetalmen|||0|72|0||Icepharma hf|Zoetis Finland OY|||3988||3988|7737||2 471042|QM01AE9101|Rimadyl vet.|tuggutfl|20|mg|20|stk|1|pakki||QM01AE91|01.04.2015||R|0|0|0|0|0|0|ZOE|0|0|0|100|DKK|990|1946|vetalmen|||0|20|0||Icepharma hf|Zoetis Finland OY|||990||990|1946||2 471425|A10BB0701|Mindiab|töflur|5|mg|100|stk|1|þpakki||A10BB07|01.07.1990||R|1|0|0|0|G|0|PER|0|0|0|100|DKK|820|2251|lyfalmen|||1|100|0|50,0000|Icepharma hf|Pfizer ApS|Glípízíð||820||820|2251||1 471938|L01AA0101|Sendoxan|töflur|50|mg|100|stk|1|þpakki||L01AA01|01.01.1988|29.02.2016|R|0|0|0|0|G|0|BAM|0|0|0|100|SEK|5334|8464|lyfalmen|||1|100|0||Icepharma hf|Baxter Medical AB|Cýklófosfamíð||5334||5334|8464||2 471953|QV03AB9001|Antisedan, vet.|stl|5|mg/ml|10|ml|1|hgl||QV03AB90|01.08.2006||R|0|0|0|0|0|0|ORC|1|0|0|100|DKK|4231|8198|vetalmen|||0|10|0||Vistor hf|Orion Corporation|Atipamesól||4231||4231|8198||1 472092|C07AB0206|Seloken ZOC|forðatfl|47,5|mg|98|stk|1|þpakki||C07AB02|01.07.1989||R|1|0|0|0|G|0|AZD|0|0|0|100|SEK|1786|3580|lyfalmen|V0048|2353|1|98|0|31,0300|Vistor hf|AstraZeneca A/S DK|Metóprólól||1786||1786|3580||1 472099|R02AA0307|Strepsils Warm|sogtfl|||24|stk|1|þpakki||R02AA03|01.08.2011||L|0|0|0|0|0|0|RBH|0|0|1|100|IKR|||lyflausa|||0|24|0|4,0000|Artasan ehf|Reckitt Benckiser Healthcare Ltd.-A|Díklórbenzýlalkóhól|||||||1 472332|J07BC0201|Havrix|stl|1440|ein/ml|0,5|ml|1|dæla|einnota dæla|J07BC02|01.10.1995||R|0|0|0|0|0|0|GPH|0|0|0|100|GBP|3145|5451|lyfalmen|||1|0,5|0||Vistor hf|GlaxoSmithKline Pharma A/S|Lifrarbólga-A, dauð veira (inactiv­ated whole virus)||3145||3145|5451|29.2.2016|1 472338|S01AA2701|APROKAM|sts|50|mg|10|hgl|1|pakki|lausn|S01AA27|01.04.2013||R|0|0|0|1|0|1|TEA|0|0|0|100|SEK|11223|16570|lyfsjukr|||1|10|0||Vistor hf|Laboratories THEA|Cefuroxím||11223||11223|16570||1 472599|A02BC0506|Esomeprazole Krka (LYFIS)|sþ-hylki|40|mg|98|stk|1|glas||A02BC05|01.08.2011||R|1|0|0|0|G|0|LYF|0|0|0|100|IKR|6868|5417|lyfalmen|V0012|5012|3|98|0|130,6700|LYFIS ehf|LYFIS ehf|Esómeprazól||3120||3120|5417||2 472756|N02BE0120|Paracetamol Sandoz|filmhtfl|500|mg|300|stk|1|glas||N02BE01|01.10.2015||R|1|0|0|0|0|0|SHS|0|0|1|100|DKK|1022|2039|lyfalmen|V0231|2039|2|300|0|50,0000|Artasan ehf|Sandoz A/S|Paracetamól||666||666|2039||1 472759|R06AX2701|Aerius|filmhtfl|5|mg|100|stk|1|þpakki||R06AX27|01.11.2012||R|1|0|0|0|G|0|MLD|0|0|1|100|DKK|3936|6540|lyfalmen|V0458|3485|1|100|0|100,0000|Vistor hf|Merck Sharp & Dohme Limited|Deslóratadín||3936||3936|6540||1 472984|S01EC5401|Simbrinza|augndr|12|mg/ml|5|ml|1|glas|10 + 2 mg/ml|S01EC54|01.01.2015||R|0|0|0|0|G|0|UKL|0|0|0|100|USD|2802|4979|lyfalmen|V0670|4143|1|5|0||Vistor hf|Alcon Laboratories (UK) Ltd.|Brimoníð og brinzolamið||2802||2802|4979||1 474007|B05AA0507|Promiten|stl|150|mg/ml|20|ml|20|lykjur|plastlykjur|B05AA05|01.03.1999||R|0|0|0|0|0|1|MAB|0|0|0|100|SEK|10447|15501|lyfsjukr|||1|400|0||Vistor hf|Meda AB|Dextran||10447||10447|15501||1 474043|N01AH0601|Remifentanil Actavis|sts/irs|2|mg|5|hgl|1|pakki|þykkni,lausn|N01AH06|01.06.2012||R|0|0|1|0|0|1|AGP|0|0|0|100|XEU|2487|4545|lyfsjukr|||2|5|0||Actavis Group hf|Actavis Group PTC ehf|Remífentaníl||2487||2487|4545||1 474106|M02AA1301|Deep Relief|hlaup|5|%|50|g|1|túpa||M02AA13|01.06.2000||L|0|0|0|0|0|0|MEN|0|0|1|100|IKR|||lyflausa|||0|50|0||Icepharma hf|Mentholatum Company Ltd.|Íbúprófen|||||||2 474120|N03AX1604|Brieka|hylki|150|mg|56|stk|1|þpakki||N03AX16|01.10.2015||R|1|0|0|0|0|0|AGP|0|0|0|100|XEU|7451|6490|lyfalmen|V0687|5952|2|56|0|28,0000|Actavis Group hf|Actavis Group PTC ehf|Pregabalín||3900||3900|6490||1 474197|M02AA1301|Deep Relief|hlaup|5|%|15|g|1|túpa||M02AA13|01.06.2000||L|0|0|0|0|0|0|MEN|0|0|1|100|IKR|||lyflausa|||0|15|0||Icepharma hf|Mentholatum Company Ltd.|Íbúprófen|||||||2 474608|QB03AC0001|Uniferon|stl|200|mg/ml|100|ml|12|hgl|lausn|QB03AC|01.08.2011||R|0|0|0|0|0|0|PHM|0|0|0|100|DKK|27016|51425|vetalmen|||0|1200|0||Icepharma hf|Pharmacosmos A/S|Járn hýdróxíð||27016||27016|51425||2 474628|N05AH0313|Olanzapin Sandoz|filmhtfl|10|mg|250|stk|1|glas||N05AH03|01.05.2013||R|2|0|0|0|G|0|SHS|0|0|0|100|DKK|28574|11705|lyfalmen|||2|250|0|250,0000|Artasan ehf|Sandoz A/S|Olanzapín||7689||7689|11705||1 474657|N04BC0504|Oprymea (Lyfis)|töflur|0,088|mg|30|stk|1|þpakki||N04BC05|01.07.2010||R|0|0|0|0|G|0|LYF|0|0|0|100|XEU|710|2099|lyfalmen|V0266|2093|3|30|0|1,0600|LYFIS ehf|LYFIS ehf|Pramipexól||710||710|2099||2 474855|N07BC0202|Metadon Abcur|töflur|10|mg|20|stk|1|þpakki||N07BC02|01.03.2016||R|1|0|1|0|G|0|ABC|0|0|0|100|SEK|1033|2544|lyfalmen|||1|20|0|8,0000|Icepharma hf|Abcur AB|Metadón||1033||1033|2544||2 475338|QI09AL0101|Eryseng Parvo|stl|||50|ml|1|hgl|dreifa|QI09AL01|01.10.2014||R|0|0|0|0|0|0|LHS|0|0|0|100|IKR|9978|17198|vetorma|||0|50|0||Dýraheilsa ehf|Laboratorios Hipra S.A.|Porcine parvovirus + erysipelothrix||9978||9978|17198||2 475434|B01AA0301|Kovar|töflur|2|mg|100|stk|1|glas||B01AA03|01.10.1995||R|1|0|0|0|G|0|APC|0|0|0|100|IKR|1100|2636|lyfalmen|||2|100|0|26,6667|Actavis Group PTC ehf|Actavis Group PTC ehf|Warfarín||1100||1100|2636||1 475491|N02AA5902|Parkodin forte|töflur|530|mg|20|stk|1|pakki|þp 30+500 mg|N02AA59|01.04.1992||R|1|0|0|0|0|0|AGP|0|0|1|100|IKR|497|1806|lyfalmen|||2|20|0|6,6667|Actavis Group hf|Actavis Group PTC ehf|Kódein í blöndum nema með geðlyfjum||497||497|1806||1 475533|N02AA5902|Parkodin forte|töflur|530|mg|30|stk|1|pakki|þp 30+500 mg|N02AA59|01.04.1992||R|1|0|0|0|0|0|AGP|0|0|1|100|IKR|627|1985|lyfalmen|||2|30|0|10,0000|Actavis Group hf|Actavis Group PTC ehf|Kódein í blöndum nema með geðlyfjum||627||627|1985||1 475715|N02AA5902|Parkodin forte|töflur|530|mg|100|stk|1|pakki|þp 30+500 mg|N02AA59|01.04.1992||R|1|0|1|0|0|0|AGP|0|0|1|100|IKR|1364|3000|lyfalmen|||2|100|0|33,3333|Actavis Group hf|Actavis Group PTC ehf|Kódein í blöndum nema með geðlyfjum||1364||1364|3000||1 475798|R03AC1302|Oxis Turbuhaler|innönddu|4,5|mcg/sk|60|skammtar|1|stauk||R03AC13|01.10.1997|30.04.2016|R|0|0|0|0|G|0|AZD|0|0|1|100|SEK|2601|4702|lyfalmen|||1|60|0|11,2500|Vistor hf|AstraZeneca A/S DK|Formóteról||2601||2601|4702||1 475822|R03AC1302|Oxis Turbuhaler|innönddu|9|mcg/sk|60|skammtar|1|stauk||R03AC13|01.10.1997|30.04.2016|R|0|0|0|0|G|0|AZD|0|0|1|100|SEK|3392|5791|lyfalmen|||1|60|0|22,5000|Vistor hf|AstraZeneca A/S DK|Formóteról||3392||3392|5791||1 475862|A02BC0110|Omeprazol ratiopharm|sþ-hylki|20|mg|28|stk|1|þpakki|hart|A02BC01|01.04.2015||L|1|0|0|0|0|0|RAT|0|0|0|100|IKR|||lyflausa|||0|28|0|28,0000|LYFIS ehf|ratiopharm GmbH|Ómeprazól|||||||2 476434|B03XA0201|Aranesp|stl|60|mcg/spr|0,3|ml|4|áf.spr|nálavörn|B03XA02|01.11.2010||R|0|0|0|1|0|1|RAG|0|0|0|100|DKK|58818|77094|lyfsjukr|||1|1,2|0|53,3300|Vistor hf|Amgen|Darbepóetín alfa||||58818|77094||1 476580|R03AC0206|Ventoline|innönd.l|2|mg/ml|20|lykjur|1|pakki|lausn f. eimgjafa|R03AC02|01.04.1992||R|0|0|0|0|G|0|GPH|0|0|1|100|IKR|1146|2700|lyfalmen|||1|20|0|10,0000|Vistor hf|GlaxoSmithKline Pharma A/S|Salbútamól||1146||1146|2700||1 476873|B05BA0314|Glucos Baxter Viaflo|irl|100|mg/ml|500|ml|20|pokar|lausn|B05BA03|01.09.2015||R|0|0|0|0|0|1|BAM|0|0|0|100|SEK|4429|7218|lyfsjukr|||1|10000|0||Icepharma hf|Baxter Medical AB|Kolvetni||||4429|7218||2 477017|C10AX0901|Ezetrol|töflur|10|mg|98|stk|1|þpakki||C10AX09|01.07.2013||R|1|0|0|0|0|0|MLD|0|0|0|100|DKK|15654|22668|lyfalmen|||1|98|0|98,0000|Vistor hf|Merck Sharp & Dohme Limited|Ezetimíb||15654||15654|22668||1 477059|P01BB5101|Malarone|filmhtfl|350|mg|12|stk|1|þpakki|250 + 100 mg|P01BB51|01.02.2006||R|1|0|0|0|0|0|GPH|0|0|0|100|GBP|4506|7324|lyfalmen|||1|12|0|3,0000|Vistor hf|GlaxoSmithKline Pharma A/S|Prógúaníl í blöndum||4506||4506|7324||1 477099|L04AA3201|Otezla|filmhtfl|||27|stk|1|þpakki|10+20+30 mg upphafs.pkn|L04AA32|01.05.2016||R|1|0|0|1|0|1|CLC|0|0|0|100|XEU|52587|69213|lyfsjukr|||1|27|0||Celgene AB|Celgene Europe Limited|Apremilast||52587||52587|69213||2 477295|N05AH0413|Quetiapin ratiopharm|forðatfl|300|mg|100|stk|1|þpakki||N05AH04|01.05.2015||R|1|0|0|0|G|0|TEV|0|0|0|100|IKR|28055|33688|lyfalmen|V0272|33688|2|100|0|75,0000|Medical ehf|Teva Pharma B.V.|Quetíapín||24500||24500|33688||2 477547|V07AB0003|Sterilt vatten Fresenius Kabi|leysir|||20|ml|10|hgl|fyrir stungulyf|V07AB|01.02.2007||L|0|0|0|0|0|0|FRP|0|0|0|100|IKR|||lyfalmen|||0|200|0||Icepharma hf|Fresenius Kabi|Leysi- og þynningarvökvar, þ.m.t. skolvökvar|||||3024||2 477554|V07AB0003|Sterilt vatten Fresenius Kabi|leysir|||50|ml|10|hgl|fyrir stungulyf|V07AB|01.02.2007||L|0|0|0|0|0|0|FRP|0|0|0|100|IKR|||lyfalmen|||0|500|0||Icepharma hf|Fresenius Kabi|Leysi- og þynningarvökvar, þ.m.t. skolvökvar|||||3103||2 477631|H02AB0103|Diprospan|stl|7|mg/ml|1|ml|1|lykja|dreifa|H02AB01|01.10.2013||R|0|0|0|0|G|0|MBV|0|0|1|100|DKK|653|2021|lyfalmen|||1|1|0|4,6700|Vistor hf|Merck Sharp & Dohme B.V.|Betametasón||653||653|2021||1 477752|V07AB0014|Natriumklorid Fresenius Kabi|leysir|9|mg/ml|20|ml|10|hgl|fyrir stungulyf|V07AB|01.08.2004||L|0|0|0|0|0|0|FKA|0|0|0|100|IKR|||lyfalmen|||0|200|0||Vistor hf|Fresenius Kabi AB|Leysi- og þynningarvökvar, þ.m.t. skolvökvar|||||3024||1 477760|V07AB0014|Natriumklorid Fresenius Kabi|leysir|9|mg/ml|50|ml|10|hgl|fyrir stungulyf|V07AB|01.08.2004||L|0|0|0|0|0|0|FKA|0|0|0|100|DKK|||lyfalmen|||0|500|0||Vistor hf|Fresenius Kabi AB|Leysi- og þynningarvökvar, þ.m.t. skolvökvar|||||3100||1 477786|V07AB0014|Natriumklorid Fresenius Kabi|leysir|9|mg/ml|100|ml|10|hgl|fyrir stl|V07AB|01.11.2015||L|0|0|0|0|0|0|FKA|0|0|0|100|DKK|||lyfalmen|||0|1000|0||Vistor hf|Fresenius Kabi AB|Leysi- og þynningarvökvar, þ.m.t. skolvökvar|||||2755||1 477941|L01XX4401|Zaltrap|irþ|25|mg/ml|4|ml|1|hgl|lausn|L01XX44|01.06.2013|30.04.2016|R|0|0|0|1|0|1|SGA|0|0|0|100|NOK|41384|55043|lyfsjukr|||1|4|0||Vistor hf|Sanofi-aventis groupe|Afliberceptum||41384||41384|55043||1 478119|A10BA0202|Metformin Actavis|filmhtfl|500|mg|100|stk|1|glas||A10BA02|01.12.2011||R|1|0|0|0|G|0|APC|0|0|0|100|XEU|406|1681|lyfalmen|V0500|1600|2|100|0|25,0000|Actavis Group PTC ehf|Actavis Group PTC ehf|Metformín||406||406|1681||1 478360|QM01AC0603|Rheumocam|stl|5|mg/ml|20|ml|1|hgl|handa hundum og köttum|QM01AC06|01.09.2013||R|0|0|0|0|0|0|CHP|1|0|0|100|XEU|6741|12960|vetalmen|||0|20|0||Icepharma hf|Chanelle Pharmaceuticals|||6741||6741|12960||2 479407|L04AA1302|Leflunomide medac|filmhtfl|20|mg|100|stk|1|glas||L04AA13|01.07.2011||R|0|1|0|1|G|0|WIL|0|0|0|100|XEU|23023|31820|lyfalmen|||2|100|0|100,0000|Williams & Halls efh|medac Gesellschaft|Leflúnómíð||23023||23023|31820||2 479904|L01XE1401|Bosulif|filmhtfl|100|mg|28|stk|1|þpakki||L01XE14|01.09.2014||R|1|0|0|1|0|1|PZE|0|0|0|100|DKK|108743|140826|lyfsjukr|||1|28|0||Icepharma hf|Pfizer Ltd.|Bósútíníb||108743||108743|140826||1 480223|QP54AA0301|Dectomax vet.|stl|10|mg/ml|50|ml|1|hgl||QP54AA03|01.04.2015||R|0|0|0|0|0|0|ZOE|1|0|0|100|DKK|4770|8222|vetorma|||0|50|0||Icepharma hf|Zoetis Finland OY|Doramectinum||4770||4770|8222||2 480867|N06DA0205|Donesyn|filmhtfl|5|mg|98|stk|1|þpakki||N06DA02|01.05.2011||R|1|0|0|0|G|0|WEH|0|0|0|100|XEU|11379|7209|lyfalmen|V0341|7065|2|98|0|65,3333|Williams & Halls efh|Williams & Halls ehf|Dónepezíl||4422||4422|7209||2 481176|N06AX1201|Zyban|forðatfl|150|mg|100|stk|1|þpakki||N06AX12|01.09.2000||R|1|0|0|0|0|0|GPH|0|0|0|100|GBP|12967|18970|lyfalmen|||1|100|0|50,0000|Vistor hf|GlaxoSmithKline Pharma A/S|Bupropionum||12967||12967|18970||1 481208|D07AC1302|Ovixan|krem|0,1|%|30|g|1|túpa||D07AC13|01.06.2013||R|0|0|0|0|G|0|GAB|0|0|1|100|SEK|706|2094|lyfalmen|||0|30|0||Vistor hf|Galenica AB|Mómetasón||706||706|2094||1 481375|R03AC1901|Striverdi Respimat|innöndl|2,5|mcg|60|skammtar|1|rörlyk||R03AC19|01.08.2014||R|0|0|0|0|G|0|BII|0|0|1|100|DKK|4282|7016|lyfalmen|||1|60|0|30,0000|Vistor hf|Boehringer Ingelheim International|Olodaterol||4282||4282|7016||1 481534|N02AX0204|Tradolan|filmhtfl|50|mg|20|stk|1|þpakki||N02AX02|01.05.2012||R|1|0|1|0|G|0|GLP|0|0|1|100|SEK|132|1304|lyfalmen|V0055|1304|1|20|0|3,3300|Vistor hf|G.L.Pharma GmbH|Tramadól||132||132|1304||1 482183|G03BA0307|Nebido|stl|250|mg/ml|4|ml|1|hgl||G03BA03|01.05.2014||R|0|0|0|0|G|0|BGB|0|0|0|100|DKK|14476|21047|lyfalmen|||1|4|0|55,5600|Icepharma hf|Bayer Pharma AG|Testósterón||14476||14476|21047||2 482457|N02BA5102|Treo|freyðit|||20|stk|1|glas||N02BA51|01.12.2012||L|0|0|0|0|0|0|MAB|0|0|1|100|IKR|||lyflausa|||0|20|0|3,3333|Vistor hf|Meda AB|Acetýlsalicýlsýra í blöndum, þó ekki með geðlyfjum (psychole|||||||1 483104|L01XC0801|Vectibix|irþ|20|mg/ml|5|ml|1|hgl|lausn|L01XC08|01.03.2013||R|0|1|0|1|0|1|AEB|0|0|0|100|DKK|61067|67496|lyfsjukr|||1|5|0||Vistor hf|Amgen Europe B.V.|Panitúmúmab||51230||51230|67496||1 483217|B01AF0101|Xarelto|filmhtfl|20|mg|98|stk|1|þpakki||B01AF01|01.05.2012||R|1|1|0|0|G|0|BAP|0|0|0|100|DKK|29484|39992|lyfalmen|||1|98|0|98,0000|Icepharma hf|Bayer Schering Pharma AG|Rivaoxaban||||29484|39992||2 483371|B05AA0114|Albuman|irl|40|g/líter|400|ml|1|hgl|lausn|B05AA01|01.03.2013||R|0|0|0|0|0|1|SPP|0|0|0|100|XEU|5858|9185|lyfsjukr|||1|400|0||Williams & Halls efh|Sanquin Plasma Product|Albúmín||5858||5858|9185||2 483477|A02BC0403|Rabeprazol Krka|sþ-tfl|10|mg|56|stk|1|þpakki||A02BC04|01.03.2014||R|0|0|0|0|G|0|KRK|0|0|0|100|IKR|1765|2499|lyfalmen|V0467|2499|2|56|0|28,0000|LYFIS ehf|Krka Sverige AB|Rabeprazól||1000||1000|2499||2 483602|J02AC0101|Diflucan|irl|2|mg/ml|50|ml|1|fl||J02AC01|01.04.1990||R|0|0|0|0|0|1|PER|0|0|0|100|DKK|2463|4512|lyfsjukr|||1|50|0|0,5000|Icepharma hf|Pfizer ApS|Flúkónazól||2463||2463|4512||1 483663|B03BA0302|Vibeden|stl|1|mg/ml|1|ml|3|lykja||B03BA03|01.07.2012||R|0|0|0|0|G|0|SHS|0|0|1|100|DKK|6036|9430|lyfalmen|||1|3|0|150,0000|Artasan ehf|Sandoz A/S|Hýdroxókóbalamín||6036||6036|9430||1 483685|J02AC0101|Diflucan|irl|2|mg/ml|100|ml|1|hgl||J02AC01|01.03.2001||R|0|0|0|0|0|1|PER|0|0|0|100|DKK|4252|6975|lyfsjukr|||1|100|0|1,0000|Icepharma hf|Pfizer ApS|Flúkónazól||4252||4252|6975||1 483711|S01ED5114|Latanoprost/Timolol Portfarma|augndr|5,05|mg/ml|2,5|ml|1|glas|5mg/ml+50mcg/ml|S01ED51|01.01.2012||R|0|0|0|0|G|0|POF|0|0|0|100|DKK|1766|3553|lyfalmen|V0374|3553|2|2,5|0|25,0000|Alvogen|Alvogen|Tímólól í blöndum||1766||1766|3553||1 483968|C03AA0305|Hydromed|töflur|12,5|mg|100|stk|1|þpakki||C03AA03|01.06.2013||R|0|0|0|0|G|0|MEV|0|0|0|100|DKK|903|2365|lyfalmen|||2|100|0|50,0000|Vistor hf|MediLink A/S|hýdróklórtíazíð||903||903|2365||1 483996|N02AX0212|Tramadol Actavis|hylki|50|mg|20|stk|1|þpakki||N02AX02|01.09.2011||R|1|0|1|0|G|0|AGP|0|0|1|100|XEU|258|1477|lyfalmen|V0055|1304|2|20|0|3,3300|Actavis Group hf|Actavis Group PTC ehf|Tramadól||258||258|1477||1 484022|L02AE0401|Decapeptyl Depot|sts|3,75|mg|1|stk|3|spr|+ leysir|L02AE04|01.01.1995||R|0|0|0|1|0|1|FER|0|0|0|100|DKK|50813|66969|lyfsjukr|||1|3|0|112,5000|Vistor hf|Ferring|Triptórelín||50813||50813|66969||1 484238|D11AX1001|Propecia|töflur|1|mg|28|stk|1|þpakki||D11AX10|01.08.1999||R|1|0|0|0|0|0|MSD|0|0|0|100|DKK|4894|7858|lyfalmen|||1|28|0|28,0000|Vistor hf|M.S.D.|Fínasteríð||4894||4894|7858||1 484327|L03AA1301|Neulasta|stl|6|mg/spr|0,6|ml|1|spr|nálavörn|L03AA13|01.11.2010||R|0|0|0|1|0|1|AEB|0|0|0|100|DKK|119938|154749|lyfsjukr|||1|0,6|0|20,0000|Vistor hf|Amgen Europe B.V.|Pegfilgrastím||119938||119938|154749||1 484618|A01AD0201|Andolex|munnskol|1,5|mg/ml|300|ml|1|glas|lausn|A01AD02|01.01.1996||R|0|0|0|0|G|0|MEB|0|0|1|100|SEK|1175|2739|lyfalmen|||1|300|0|50,0000|Vistor hf|Meda AB (V)|Benzýdamín||1175||1175|2739||1 484658|B01AF0101|Xarelto|filmhtfl|10|mg|30|stk|1|þpakki||B01AF01|01.01.2014||R|1|1|0|0|G|0|BYP|0|0|0|100|DKK|9219|13811|lyfalmen|||1|30|0|15,0000|Icepharma hf|Bayer Pharma AG|Rivaoxaban||9219||9219|13811||2 484721|L04AD0201|Advagraf|forðahlk|3|mg|50|stk|1|þpakki||L04AD02|01.03.2012||R|0|0|0|1|G|0|APE|0|0|0|100|XEU|45135|59787|lyfalmen|||1|50|0|30,0000|Vistor hf|Astellas Phama Europe B.V.|Tacrolimus||45135||45135|59787||1 485006|S01BA0401|Ultracortenol|augnsm|5|mg/g|5|g|1|túpa||S01BA04|01.01.2012||R|0|0|0|0|G|0|ANS|0|0|1|100|XEU|1104|2642|lyfalmen|||1|5|0||Anstalt zur gewerblichen Produktion|Anstalt zur gewerblichen Produktion|Prednisólón||1104||1104|2642||1 485067|A07EC0301|Dipentum|töflur|500|mg|100|stk|1|glas||A07EC03|01.01.2016||R|1|0|0|0|G|0|ATN|0|0|0|100|DKK|9337|13974|lyfalmen|V0714|13974|1|100|0|50,0000|Pharmanovia A/S|Atnahs Pharma UK Ltd|Olsalazín||9337||9337|13974||2 485252|L01CD0202|Docetaxel Actavis|irþ|20|mg/ml|7|ml|1|hgl|lausn|L01CD02|01.04.2013|31.03.2016|R|0|0|0|1|0|1|AVB|0|0|0|100|XEU|8006|12142|lyfsjukr|||2|7|0||Actavis Group PTC ehf|Actavis BV|Docetaxel||8006||8006|12142||1 485304|C02KX0501|Adempas|filmhtfl|2|mg|84|stk|1|þpakki||C02KX05|01.12.2014||R|1|0|0|1|0|1|BYE|0|1|0|100|DKK|363877|458141|lyfsjukr|||1|84|0|37,3300|Vistor hf|Bayer Pharma AG|Riociguatum||363877||363877|458141||1 485549|R03AK0705|Bufomix Easyhaler|innönddu|329|mcg/sk|180|skammtar|1|pakki|320+9 mcg/sk|R03AK07|01.11.2014||R|0|0|0|0|G|0|COR|0|0|0|100|DKK|12961|18962|lyfalmen|||2|180|0|90,0000|Vistor hf|Orion Corporation|Formóteról og budesonide||12961||12961|18962||1 485764|J05AX1201|Tivicay|filmhtfl|50|mg|30|stk|1|glas||J05AX12|01.04.2014||R|1|0|0|1|0|1|VIH|0|0|0|100|GBP|81103|105280|lyfsjukr|||1|30|0|30,0000|Vistor hf|ViiV Healthcare UK Ltd|Dolutegravír||81103||81103|105280||1 486779|M01AE0218|Naproxen Mylan|töflur|250|mg|20|stk|1|þpakki||M01AE02|01.04.1995||L|1|0|0|0|0|0|MYL|0|0|1|100|IKR|||lyflausa|||0|20|0|10,0000|Icepharma hf|Mylan AB|Naproxen|||||||2 486860|S01BA0101|Maxidex|augndr|1|mg/ml|5|ml|1|glas||S01BA01|01.01.1977||R|0|0|0|0|G|0|SAC|0|0|1|100|USD|480|1783|lyfalmen|||1|5|0||Vistor hf|S.A. Alcon - Couvreur N.V.|Dexametasón||480||480|1783||1 486886|S01CA0101|Maxitrol|augndr|||5|ml|1|glas||S01CA01|01.07.1990||R|0|0|0|0|G|0|SAC|0|0|1|100|USD|571|1908|lyfalmen|||1|5|0||Vistor hf|S.A. Alcon - Couvreur N.V.|Dexametasón||571||571|1908||1 487341|A10BG0302|Pioglitazone Actavis|töflur|30|mg|98|stk|1|þpakki||A10BG03|01.09.2012||R|1|1|0|0|G|0|APC|0|0|0|100|XEU|11050|13687|lyfalmen|||2|98|0|98,0000|Actavis Group PTC ehf|Actavis Group PTC ehf|Píóglítazón||9129||9129|13687||1 487361|H02AB0910|Hydrokortison Orion|töflur|10|mg|100|stk|1|þpakki||H02AB09|01.11.2015||R|0|0|0|0|G|0|ARN|0|0|1|100|DKK|2370|4384|lyfalmen|||2|100|0|33,3300|Vistor hf|Orion Corporation|Hýdrókortisón||2370||2370|4384||1 487692|L04AB0101|Enbrel|sts|10|mg|4|hgl|1|pakki|+ leysir, lausn|L04AB01|01.12.2012||R|0|1|0|1|0|1|IPI|0|1|0|100|DKK|29359|39834|lyfsjukr|||1|4|0|5,7200|Icepharma hf|Pfizer Limited|Etanercept||29359||29359|39834||1 487725|L03AB0502|IntronA|stl|60|millj ae|1,2|ml|1|penni|Fjölskammtapenni|L03AB05|01.10.2012||R|0|0|0|1|0|1|MLD|0|0|0|100|DKK|49272|65020|lyfsjukr|||1|1,2|0|30,0000|Vistor hf|Merck Sharp & Dohme Limited|Interferón alfa-2b||49272||49272|65020||1 487796|L04AA1302|Leflunomide medac|töflur|10|mg|100|stk|1|glas||L04AA13|01.07.2011||R|0|1|0|1|G|0|WIL|0|0|0|100|XEU|27434|33109|lyfalmen|V0453|33109|2|100|0|50,0000|Williams & Halls efh|medac Gesellschaft|Leflúnómíð||24042||24042|33109||2 487827|M01AB0517|Diclomex|sþ-tfl|50|mg|100|stk|1|þpakki||M01AB05|01.04.2013||R|1|0|0|0|G|0|RGM|0|0|1|100|IKR|1033|1948|lyfalmen|V0469|1948|2|100|0|50,0000|Medical ehf|ratiopharm GmbH|Díklófenak||600||600|1948||2 488049|M01AX0101|Relifex|töflur|500|mg|20|stk|1|þpakki||M01AX01|01.04.1995||R|1|0|0|0|G|0|MAB|0|0|1|100|SEK|659|2029|lyfalmen|||1|20|0|10,0000|Vistor hf|Meda AB|Nabúmeton||659||659|2029||1 488056|M01AX0101|Relifex|töflur|500|mg|60|stk|1|plglas||M01AX01|01.07.1998||R|1|0|0|0|G|0|MAB|0|0|1|100|SEK|1628|3363|lyfalmen|V0198|2735|1|60|0|30,0000|Vistor hf|Meda AB|Nabúmeton||1628||1628|3363||1 488468|L01XE1801|Jakavi|töflur|5|mg|56|stk|1|þpakki||L01XE18|01.02.2014||R|1|0|0|1|0|1|NEL|0|1|0|100|DKK|249741|316188|lyfsjukr|||1|56|0||Vistor hf|Novartis Europharm Ltd|Ruxolitinib||249741||249741|316188||1 488767|D05BB0201|Neotigason|hylki|10|mg|50|stk|1|þpakki||D05BB02|01.04.1992||R|1|0|0|1|G|0|APC|0|0|0|100|DKK|6225|9690|lyfalmen|||1|50|0|14,2857|Actavis Group PTC ehf|Actavis Group PTC ehf|Acitretín||6225||6225|9690||1 488791|D05BB0201|Neotigason|hylki|25|mg|50|stk|1|þpakki||D05BB02|01.04.1992||R|1|0|0|1|G|0|APC|0|0|0|100|DKK|9960|14831|lyfalmen|||1|50|0|35,7143|Actavis Group PTC ehf|Actavis Group PTC ehf|Acitretín||9960||9960|14831||1 489050|N06AX1105|Mirtazapine Bluefish|munndr.t|30|mg|96|stk|1|þpakki||N06AX11|01.04.2014||R|0|0|0|0|G|0|BLP|0|0|0|100|IKR|2700|2636|lyfalmen|V0331|2636|2|96|0|96,0000|LYFIS ehf|Bluefish Pharmaceuticals AB|Mirtazapín||1100||1100|2636||2 489149|G03GA0503|Bemfola|stl|150|ae|0,25|ml|1|penni||G03GA05|01.01.2015||R|0|0|0|1|G|0|FBA|0|0|0|100|SEK|6323|9825|lyfalmen|||1|0,25|0|2,0000|Finox Biotech AG|Finox Biotech AG|Follitrópín alfa||6323||6323|9825||3 489259|B03XA0201|Aranesp|stl|80|mcg/spr|0,4|ml|4|áf.spr|nálavörn|B03XA02|01.11.2010||R|0|0|0|1|0|1|RAG|0|0|0|100|DKK|80252|104203|lyfsjukr|||1|1,6|0|71,1100|Vistor hf|Amgen|Darbepóetín alfa||||80252|104203||1 489348|N05AX1209|Aripiprazole Sandoz|töflur|15|mg|56|stk|1|þpakki||N05AX12|01.04.2016||R|1|1|0|0|G|0|HSS|0|0|0|100|DKK|15728|21402|lyfalmen|V0684|21002|2|56|0|56,0000|Artasan ehf|Sandoz GmbH|Aripiprazól||14734||14734|21402||1 489591|M01AB0506|Voltaren Rapid|töflur|50|mg|10|stk|1|þpakki||M01AB05|01.01.1996|29.02.2016|R|1|0|0|0|0|0|HES|0|0|1|100|DKK|310|1364|lyfalmen|||1|10|0|5,0000|Vistor hf|Novartis Healthcare A/S|Díklófenak||176||176|1364||1 489609|M01AB0506|Voltaren Rapid|töflur|50|mg|30|stk|1|þpakki||M01AB05|01.01.1996||R|1|0|0|0|G|0|HES|0|0|1|100|DKK|805|1709|lyfalmen|V0188|1516|1|30|0|15,0000|Vistor hf|Novartis Healthcare A/S|Díklófenak||426||426|1709||1 490198|N03AX1606|Pregabalin Mylan|hylki|225|mg|56|stk|1|þpakki||N03AX16|01.11.2015||R|0|0|0|0|0|0|GGE|0|0|0|100|SEK|6846|6779|lyfalmen|V0688|6779|2|56|0|42,0000|Mylan AB|Generics (UK) Ltd.|Pregabalín||4110||4110|6779||2 490417|G03FB0504|Evorel Sequi|forðapl|||8|stk|1|pakki||G03FB05|01.08.1999||R|0|0|0|0|G|0|JAS|0|0|0|100|SEK|2009|3887|lyfalmen|||1|8|0|28,0000|Vistor hf|Janssen-Cilag AB|Noretísterón og östrógen||2009||2009|3887||1 490425|G03FA0104|Evorel Conti|forðapl|||8|stk|1|pakki||G03FA01|01.08.1999||R|0|0|0|0|G|0|JAS|0|0|0|100|SEK|1861|3684|lyfalmen|||1|8|0|28,0000|Vistor hf|Janssen-Cilag AB|Noretísterón og östrógen||1861||1861|3684||1 490510|G03CX0103|Tibolon Orifarm|töflur|2,5|mg|84|stk|1|þpakki|3 x 28 stk|G03CX01|01.11.2014||R|0|0|0|0|G|0|IRO|0|0|0|100|XEU|4762|7247|lyfalmen|V0133|7247|2|84|0|84,0000|Artasan ehf|Orifarm Generics A/S|Tíbólón||4450||4450|7247||1 490797|C10AA0501|Zarator|töflur|10|mg|30|stk|1|þpakki||C10AA05|01.03.1998||R|1|0|0|0|0|0|PER|0|0|0|100|DKK|3731|6258|lyfalmen|||1|30|0|15,0000|Icepharma hf|Pfizer ApS|Atorvastatín||3731||3731|6258||1 490805|C10AA0501|Zarator|töflur|10|mg|100|stk|1|þpakki||C10AA05|01.03.1998||R|1|0|0|0|0|0|PER|0|0|0|100|DKK|9620|9705|lyfalmen|V0112|1810|1|100|0|50,0000|Icepharma hf|Pfizer ApS|Atorvastatín||6236||6236|9705||1 490813|C10AA0501|Zarator|töflur|20|mg|30|stk|1|þpakki||C10AA05|01.03.1998||R|1|0|0|0|0|0|PER|0|0|0|100|DKK|3561|6024|lyfalmen|||1|30|0|30,0000|Icepharma hf|Pfizer ApS|Atorvastatín||3561||3561|6024||1 490821|C10AA0501|Zarator|töflur|20|mg|100|stk|1|þpakki||C10AA05|01.03.1998||R|1|0|0|0|0|0|PER|0|0|0|100|DKK|11744|13071|lyfalmen|V0113|2567|1|100|0|100,0000|Icepharma hf|Pfizer ApS|Atorvastatín||8681||8681|13071||1 490854|C10AA0501|Zarator|töflur|40|mg|100|stk|1|þpakki||C10AA05|01.03.1998||R|1|0|0|0|0|0|PER|0|0|0|100|DKK|13790|16202|lyfalmen|V0114|2567|1|100|0|200,0000|Icepharma hf|Pfizer ApS|Atorvastatín||10956||10956|16202||1 491321|L04AB0101|Enbrel|stl|50|mg|4|áf.spr|1|pakki|lausn|L04AB01|01.08.2013||R|0|1|0|1|0|1|IPI|0|1|0|100|DKK|120342|155252|lyfsjukr|||1|4|0|28,5800|Icepharma hf|Pfizer Limited|Etanercept||||120342|155252||1 491695|N06AX2107|Duloxetine Mylan|sþ-hylki|60|mg|28|stk|1|þpakki||N06AX21|01.10.2015||R|0|0|0|0|0|0|GGE|0|0|0|100|SEK|3839|4088|lyfalmen|V0693|4088|2|28|0|28,0000|Mylan AB|Generics (UK) Ltd.|Duloxetín||2155||2155|4088||2 491753|C10AC0103|Questran Loc|mixtduft|4|g|50|sk-pokar|1|pakki||C10AC01|01.12.2014||R|0|0|0|0|0|0|BBB|0|0|0|100|DKK|3338|5717|lyfalmen|||1|50|0|14,2800|Vistor hf|Bristol-Myers Squibb AB|Kólestýramín||3338||3338|5717||1 492377|L01XE1401|Bosulif|filmhtfl|500|mg|28|stk|1|þpakki||L01XE14|01.09.2014||R|1|0|0|1|0|1|PZE|0|0|0|100|DKK|489340|614182|lyfsjukr|||1|28|0||Icepharma hf|Pfizer Ltd.|Bósútíníb||489340||489340|614182||1 492405|N04BA0202|Madopar Depot|forðahlk|125|mg|100|stk|1|glas|100+25 mg|N04BA02|01.01.1991||R|1|0|0|0|G|0|ROC|0|0|0|100|DKK|2687|4821|lyfalmen|||1|100|0|16,6667|Icepharma hf|Roche|Levódópa og dópadekarboxýl­asa­hemill||2687||2687|4821||2 492512|A02BC0102|Losec|sh-tfl|10|mg|14|stk|1|þpakki||A02BC01|01.09.2009||L|1|0|0|0|0|0|AZD|0|0|0|100|IKR|||lyflausa|||0|14|0|7,0000|Vistor hf|AstraZeneca A/S DK|Ómeprazól|||||||1 492520|A02BC0102|Losec|sh-tfl|10|mg|100|stk|1|glas||A02BC01|01.01.1999||R|1|0|0|0|0|0|AZD|0|0|0|100|SEK|6606|10215|lyfalmen|V0002|4639|1|100|0|50,0000|Vistor hf|AstraZeneca A/S DK|Ómeprazól||6606||6606|10215||1 492546|A02BC0102|Losec|sh-tfl|20|mg|14|stk|1|þpakki||A02BC01|01.05.2009||L|1|0|0|0|0|0|AZD|0|0|0|100|IKR|||lyflausa|||0|14|0|14,0000|Vistor hf|AstraZeneca A/S DK|Ómeprazól|||||||1 492815|C10BA0501|Atozet|filmhtfl|20|mg|90|stk|1|þpakki|10 mg + 10 mg|C10BA05|01.03.2015||R|0|0|0|0|0|0|MLD|0|0|0|100|DKK|15502|22459|lyfalmen|||1|90|0||Vistor hf|Merck Sharp & Dohme Limited|Atorvastin og ezetimibe||15502||15502|22459||1 493113|R02AA0306|Strepsils Jordbær Sukkerfri|sogtfl|||24|stk|1|þpakki||R02AA03|01.09.2011||L|0|0|0|0|0|0|RBH|0|0|1|100|IKR|||lyflausa|||0|24|0|4,0000|Artasan ehf|Reckitt Benckiser Healthcare Ltd.-A|Díklórbenzýlalkóhól|||||||1 493218|B03AC0001|Monofer|irl|100|mg/ml|5|ml|1|hgl||B03AC|01.07.2013||R|0|1|0|0|G|0|PAC|0|0|1|100|DKK|24819|34092|lyfalmen|||1|5|0|5,0000|Vistor hf|Pharmacosmos A/S|Járn, stungulyf||24819||24819|34092||1 493226|A02BC0113|Omeprazol Sandoz|sþ-hylki|20|mg|14|stk|1|þpakki||A02BC01|01.10.2015||L|1|0|0|0|0|0|SHS|0|0|0|100|IKR|||lyflausa|||2|14|0|14,0000|Artasan ehf|Sandoz A/S|Ómeprazól|||||||1 493313|G04BD0704|Tolterodin Actavis|forðahlk|2|mg|100|stk|1|þpakki||G04BD07|01.01.2013||R|1|0|0|0|G|0|APC|0|0|0|100|XEU|3418|5827|lyfalmen|||2|100|0|50,0000|Actavis Group PTC ehf|Actavis Group PTC ehf|Tólteródín||3418||3418|5827||1 494013|N06AA0601|Surmontil|töflur|25|mg|100|stk|1|glas||N06AA06|01.10.1995||R|1|0|0|0|G|0|SNO|0|0|0|100|NOK|988|2482|lyfalmen|||1|100|0|16,6667|Vistor hf|Sanofi-aventis Norge AS|Trímípramín||988||988|2482||1 494138|N02CX0101|Sandomigrin|töflur|0,5|mg|100|stk|1|þpakki||N02CX01|01.04.1974||R|1|0|0|0|G|0|HES|0|0|0|100|DKK|2192|4139|lyfalmen|||1|100|0|33,3333|Vistor hf|Novartis Healthcare A/S|Pízótífen||2192||2192|4139||1 494237|L01XC0201|MabThera|irþ|100|mg|10|ml|2|hgl|lausn|L01XC02|01.11.2003||R|0|1|0|1|0|1|RRL|0|1|0|100|DKK|64171|83864|lyfsjukr|||1|20|0||Icepharma hf|Roche Registration Limited|Rítúxímab||64171||64171|83864||2 494286|L01XC0201|MabThera|irþ|500|mg|50|ml|1|hgl|lausn|L01XC02|01.11.2003||R|0|1|0|1|0|1|RRL|0|1|0|100|DKK|160429|205109|lyfsjukr|||1|50|0||Icepharma hf|Roche Registration Limited|Rítúxímab||160429||160429|205109||2 494466|J05AE1401|Olysio|hylki|150|mg|7|stk|1|pakki||J05AE14|01.09.2014||R|0|0|0|1|0|1|JCI|0|0|0|100|SEK|330386|416488|lyfsjukr|||1|7|0|7,0000|Vistor hf|Janssen-Cilag International N.V.|Simeprevír||||330386|416488||1 494559|D10AF0101|Dalacin|húðfl|10|mg/ml|60|ml|1|glas|fleyti|D10AF01|01.10.1995||R|0|0|0|0|0|0|PER|0|0|0|100|DKK|2011|3890|lyfalmen|||1|60|0||Icepharma hf|Pfizer ApS|Klindamýcín||2011||2011|3890||1 494574|N03AX1108|Topiramat Bluefish|filmhtfl|200|mg|60|stk|1|þpakki||N03AX11|01.03.2016||R|1|0|0|0|G|0|BLP|0|0|0|100|XEU|9033|13555|lyfalmen|V0252|13555|2|60|0|40,0000|LYFIS ehf|Bluefish Pharmaceuticals AB|Tópíramat||9033||9033|13555||2 494578|A02BC0508|Esomeprazol Actavis|sþ-tfl|20|mg|14|stk|1|þpakki||A02BC05|01.10.2015||L|1|0|0|0|0|0|APC|0|0|0|100|IKR|||lyflausa|||2|14|0|9,3300|Actavis Group PTC ehf|Actavis Group PTC ehf|Esómeprazól|||||||1 494682|G03CA0320|Estrofem 2 mg|töflur|2|mg|84|stk|1|skífup||G03CA03|01.12.1980||R|0|0|0|0|G|0|NAS|0|0|0|100|DKK|2007|3885|lyfalmen|V0128|2024|1|84|0|84,0000|Vistor hf|Novo-Nordisk A/S|Estradíól||2007||2007|3885||1 494724|G03FA0102|Kliogest|töflur|||84|stk|1|skífup||G03FA01|01.10.1986||R|0|0|0|0|G|0|NAS|0|0|0|100|DKK|2917|5137|lyfalmen|V0410|4421|1|84|0|84,0000|Vistor hf|Novo-Nordisk A/S|Noretísterón og östrógen||2917||2917|5137||1 494740|QA12CC0203|Sedaman vet|irl|200|mg/ml|100|ml|1|hgl||QA12CC02|01.04.2014||R|0|0|0|0|0|0|OOR|0|0|0|100|DKK|2441|4798|vetalmen|||0|100|0||Icepharma hf|Orion Corporation|Magnesíum súlfat||2441||2441|4798||2 494831|B01AC0702|Persantin retard|forðahlk|200|mg|60|stk|1|glas|hart hylki|B01AC07|01.04.2006||R|1|0|0|0|G|0|BII|0|0|0|100|DKK|1622|3355|lyfalmen|||1|60|0|30,0000|Vistor hf|Boehringer Ingelheim International |Dípýrídamól||1622||1622|3355||1 494885|A16AA0402|Procysbi|hylki|75|mg|250|stk|1|glas||A16AA04|01.04.2016||R|0|1|0|1|0|1|RAP|0|0|0|100|XEU|814163|1018171|lyfsjukr|||1|250|0|9,3700|Raptor Pharmaceuticals Europe B.V.|Raptor Pharmaceuticals Europe B.V.|Mecaptamín||814163||814163|1018171||3 495283|A04AA0101|Zofran|töflur|8|mg|15|stk|1|þpakki||A04AA01|01.01.1991||R|1|0|0|0|G|0|HES|0|0|1|100|DKK|19522|6743|lyfalmen|V0384|4346|1|15|0|7,5000|Vistor hf|Novartis Healthcare A/S|Ondansetrón||4084||4084|6743||1 495382|A04AA0101|Zofran|stl|2|mg/ml|2|ml|5|lykjur||A04AA01|01.01.1991||R|0|0|0|0|G|0|HES|0|0|1|100|DKK|7593|6865|lyfalmen|||1|10|0|1,2500|Vistor hf|Novartis Healthcare A/S|Ondansetrón||4172||4172|6865||1 495757|N06AX2601|Brintellix|filmhtfl|10|mg|28|stk|1|þpakki||N06AX26|01.10.2014||R|1|0|0|0|0|0|LBK|0|0|0|100|DKK|5731|9010|lyfalmen|||1|28|0|28,0000|Lundbeck Export A/S|H. Lundbeck A/S|Vortioxetín||5731||5731|9010||1 495820|J05AH0101|Relenza|innúðadu|5|mg/úðask|20|skammtar|1|stauk|+diskhaler|J05AH01|01.02.2000||R|0|0|0|0|0|0|GPH|0|0|0|100|GBP|2638|4753|lyfalmen|||1|20|0|5,0000|Vistor hf|GlaxoSmithKline Pharma A/S|Zanamivír||2638||2638|4753||1 496040|N06DA0303|Nimvastid (Lyfis)|hylki|4,5|mg|112|stk|1|þpakki||N06DA03|01.04.2011||R|1|0|0|0|G|0|LYF|0|0|0|100|IKR|27510|33649|lyfalmen|V0345|33649|3|112|0|56,0000|LYFIS ehf|LYFIS ehf|Rívastigmín||24469||24469|33649||2 496174|QJ01MA9001|Baytril vet.|töflur|150|mg|10|stk|1|þpakki||QJ01MA90|01.03.2009||R|0|0|0|0|0|0|BAN|0|0|0|100|DKK|4066|7885|vetalmen|||0|10|0||Icepharma hf|Bayer Animal Health GmbH|Enrofloxacinum||4066||4066|7885||2 496468|A10BG0302|Pioglitazone Actavis|töflur|15|mg|98|stk|1|þpakki||A10BG03|01.09.2012||R|1|1|0|0|G|0|APC|0|0|0|100|XEU|6381|5495|lyfalmen|V0572|5495|2|98|0|49,0000|Actavis Group PTC ehf|Actavis Group PTC ehf|Píóglítazón||3177||3177|5495||1 496648|C03CA0101|Furix|stl|10|mg/ml|4|ml|5|lykjur||C03CA01|01.05.2014||R|0|0|0|0|G|0|TPA|0|0|0|100|DKK|464|1761|lyfalmen|||2|20|0|5,0000|Vistor hf|Takeda Pharma A/S|Fúrósemíð||464||464|1761||1 496935|N02AG0201|Ketogan|eþ-stíll|||10|stk|1|pakki|10 + 50 mg|N02AG02|01.07.1994||R|0|0|1|0|G|0|PER|0|0|0|100|DKK|416|1695|lyfalmen|||1|10|0|4,0000|Icepharma hf|Pfizer ApS|Cetóbemídón og krampalosandi lyf í blöndum||416||416|1695||1 496950|N02AG0201|Ketogan|töflur|||20|stk|1|þpakki|5 + 25 mg|N02AG02|01.07.1994||R|1|0|1|0|G|0|PER|0|0|0|100|DKK|752|2157|lyfalmen|||1|20|0|4,0000|Icepharma hf|Pfizer ApS|Cetóbemídón og krampalosandi lyf í blöndum||752||752|2157||1 497003|L01XE0103|Mylaukim|filmhtfl|400|mg|30|stk|1|þpakki||L01XE01|01.09.2014||R|0|0|0|1|0|1|WEH|0|1|0|100|XEU|175163|223434|lyfsjukr|||2|30|0||Williams & Halls efh|Williams & Halls ehf|Imatiníb||175163||175163|223434||2 497012|A07AA1201|Dificlir|filmhtfl|200|mg|20|stk|1|þpakki||A07AA12|01.08.2012||R|1|0|0|0|0|1|APE|0|0|0|100|XEU|219897|279070|lyfsjukr|||1|20|0|10,0000|Vistor hf|Astellas Phama Europe B.V.|Fidaxomicin||219897||219897|279070||1 497065|M01AE0219|Alpoxen|töflur|500|mg|100|stk|1|þpakki||M01AE02|01.05.2014||R|0|0|0|0|G|0|AGP|0|0|1|100|SEK|1598|3117|lyfalmen|V0127|3117|2|100|0|100,0000|Actavis Group hf|Actavis Group PTC ehf|Naproxen||1449||1449|3117||1 497099|N02AG0201|Ketogan|töflur|||100|stk|1|þpakki|5 + 25 mg|N02AG02|01.07.1994||R|1|0|1|0|G|0|PER|0|0|0|100|DKK|2868|5070|lyfalmen|||1|100|0|20,0000|Icepharma hf|Pfizer ApS|Cetóbemídón og krampalosandi lyf í blöndum||2868||2868|5070||1 497107|M01AE0219|Alpoxen|töflur|250|mg|100|stk|1|þpakki||M01AE02|01.05.2014||R|0|0|0|0|G|0|AGP|0|0|1|100|SEK|792|2212|lyfalmen|||2|100|0|50,0000|Actavis Group hf|Actavis Group PTC ehf|Naproxen||792||792|2212||1 497286|C08CA0105|Amlodipin Bluefish|töflur|5|mg|100|stk|1|þpakki||C08CA01|01.12.2014||R|1|0|0|0|G|0|BLP|0|0|0|100|IKR|1153|2038|lyfalmen|V0056|1995|2|100|0|100,0000|LYFIS ehf|Bluefish Pharmaceuticals AB|Amlódipín||665||665|2038||2 497289|C09AA0201|Daren|töflur|5|mg|30|stk|1|þpakki||C09AA02|01.07.1990||R|1|0|0|0|G|0|ACA|0|0|0|100|XEU|302|1538|lyfalmen|||2|30|0|15,0000|Actavis Group hf|Actavis hf|Enalapríl||302||302|1538||1 497290|M05BA0702|Optinate Septimum|filmhtfl|35|mg|12|stk|1|þpakki||M05BA07|01.01.2016||R|1|0|0|0|0|0|APC|0|0|0|100|NOK|8417|4647|lyfalmen|V0207|2355|1|12|0|84,0000|Actavis Group PTC ehf|Actavis Group PTC ehf|Rísedrónsýru||2561||2561|4647||1 497297|C09AA0201|Daren|töflur|5|mg|100|stk|1|þpakki||C09AA02|01.07.1990||R|1|0|0|0|G|0|ACA|0|0|0|100|XEU|579|1919|lyfalmen|V0448|1919|2|100|0|50,0000|Actavis Group hf|Actavis hf|Enalapríl||579||579|1919||1 497313|C09AA0201|Daren|töflur|20|mg|100|stk|1|þpakki||C09AA02|01.07.1990||R|1|0|0|0|G|0|ACA|0|0|0|100|XEU|1075|2602|lyfalmen|V0449|2567|2|100|0|200,0000|Actavis Group hf|Actavis hf|Enalapríl||1075||1075|2602||1 497885|QM01AE9101|Rimadyl vet.|tuggutfl|50|mg|20|stk|1|pakki||QM01AE91|01.04.2015||R|0|0|0|0|0|0|ZOE|0|0|0|100|DKK|1550|3046|vetalmen|||0|20|0||Icepharma hf|Zoetis Finland OY|||1550||1550|3046||2 497983|N04BC0407|Ropinirol Actavis|forðatfl|4|mg|84|stk|1|þpakki||N04BC04|01.12.2012||R|1|0|0|0|G|0|APC|0|0|0|100|XEU|7078|9919|lyfalmen|V0533|9919|2|84|0|56,0000|Actavis Group PTC ehf|Actavis Group PTC ehf|Rópíníról||6391||6391|9919||1 497995|S01EC0303|Dorzolamide Portfarma|augndr|20|mg/ml|5|ml|1|glas||S01EC03|01.10.2011||R|0|0|0|0|G|0|POF|0|0|0|100|XEU|1120|2664|lyfalmen|||2|5|0|16,6667|Alvogen|Alvogen|Dorzólamíð||1120||1120|2664||1 498051|A10BX0204|Repaglinide Krka|töflur|2|mg|120|stk|1|þpakki||A10BX02|01.11.2014||R|1|0|0|0|G|0|KNM|0|0|0|100|IKR|2300|4288|lyfalmen|V0472|4288|2|120|0|60,0000|LYFIS ehf|Krka d.d. Novo mesto|Repaglíníð||2300||2300|4288||2 498964|N05AE0401|Zeldox|hylki|20|mg|56|stk|1|þpakki|hart hylki|N05AE04|01.03.2002||R|1|0|0|0|0|0|PER|0|0|0|100|DKK|15064|21856|lyfalmen|V0608|10623|1|56|0|14,0000|Icepharma hf|Pfizer ApS|Ziprasidon||15064||15064|21856||1 498980|N05AE0401|Zeldox|hylki|40|mg|56|stk|1|þpakki|hart hylki|N05AE04|01.03.2002||R|1|0|0|0|0|0|PER|0|0|0|100|DKK|15573|22557|lyfalmen|||1|56|0|28,0000|Icepharma hf|Pfizer ApS|Ziprasidon||15573||15573|22557||1 499004|N05AE0401|Zeldox|hylki|60|mg|56|stk|1|þpakki|hart hylki|N05AE04|01.03.2002||R|1|0|0|0|G|0|PER|0|0|0|100|DKK|17197|24792|lyfalmen|||1|56|0|42,0000|Icepharma hf|Pfizer ApS|Ziprasidon||17197||17197|24792||1 499020|N05AE0401|Zeldox|hylki|80|mg|56|stk|1|þpakki|hart hylki|N05AE04|01.03.2002||R|1|0|0|0|G|0|PER|0|0|0|100|DKK|23618|32573|lyfalmen|||1|56|0|56,0000|Icepharma hf|Pfizer ApS|Ziprasidon||23618||23618|32573||1 499070|R01AD0501|Rhinocort Aqua|nefúði|32|mcg/sk|120|skammtar|1|fl||R01AD05|01.03.2013||R|0|0|0|0|G|0|AZD|0|0|1|100|SEK|1001|2500|lyfalmen|||1|120|0|19,2000|Vistor hf|AstraZeneca A/S DK|Búdesóníð||1001||1001|2500||1 499109|N05AH0410|Quetiapin Actavis|forðatfl|50|mg|100|stk|1|þpakki||N05AH04|01.07.2013||R|1|0|0|0|0|0|APC|0|0|0|100|XEU|11358|15300|lyfalmen|V0275|13235|2|100|0|12,5000|Actavis Group PTC ehf|Actavis Group PTC ehf|Quetíapín||10301||10301|15300|| 499273|B01AF0101|Xarelto|filmhtfl|20|mg|28|stk|1|þpakki||B01AF01|01.05.2012||R|1|1|0|0|G|0|BAP|0|0|0|100|DKK|8605|12966|lyfalmen|||1|28|0|28,0000|Icepharma hf|Bayer Schering Pharma AG|Rivaoxaban||||8605|12966||2 499436|R03AK1101|Flutiform|innúðal|130|mcg/sk|120|skammtar|1|pakki|125+5 mcg/sk|R03AK11|01.01.2014||R|0|0|0|0|G|0|HAR|0|0|0|100|DKK|5573|8793|lyfalmen|||1|120|0|30,0000|Icepharma hf|Norpharma a/s (N)|Formóteról og flútikasón||5573||5573|8793||2 499920|N06AX2601|Brintellix|filmhtfl|20|mg|28|stk|1|þpakki||N06AX26|01.10.2014||R|1|0|0|0|0|0|LBK|0|0|0|100|DKK|11046|16326|lyfalmen|||1|28|0|56,0000|Lundbeck Export A/S|H. Lundbeck A/S|Vortioxetín||11046||11046|16326||1 501225|C09DA0310|Valsartan/Hydrochlorothiazide ratiopharm|filmhtfl|185|mg|98|stk|1|þpakki|160/25 mg|C09DA03|01.11.2012||R|1|0|0|0|G|0|RGM|0|0|0|100|IKR|4880|3907|lyfalmen|||2|98|0|98,0000|Medical ehf|ratiopharm GmbH|Valsartan og þvagræsilyf||2023||2023|3907||2 501277|N06AX2109|Duloxetine ratiopharm|sþ-hylki|60|mg|100|stk|1|glas||N06AX21|01.12.2015||R|0|0|0|0|0|0|RGM|0|0|0|100|IKR|11839|12133|lyfalmen|V0694|11739|2|100|0|100,0000|Medical ehf|ratiopharm GmbH|Duloxetín||8000||8000|12133||2 501278|G04BD1201|Betmiga|forðatfl|25|mg|30|stk|1|þpakki||G04BD12|01.07.2013||R|1|0|0|0|G|0|APE|0|0|0|100|XEU|5259|8361|lyfalmen|||1|30|0|15,0000|Vistor hf|Astellas Phama Europe B.V.|Mírabegrón||5259||5259|8361||1 501364|N06BA0403|Ritalin Uno|hylki|60|mg|30|stk|1|glas||N06BA04|01.11.2015||R|1|1|1|0|0|0|HES|0|0|0|100|DKK|10619|15738|lyfalmen|||1|30|0|60,0000|Vistor hf|Novartis Healthcare A/S|Metýlfenídat||10619||10619|15738||1 501660|B01AF0101|Xarelto|filmhtfl|2,5|mg|168|stk|1|þpakki||B01AF01|01.04.2015||R|1|1|0|0|G|0|BYP|0|0|0|100|DKK|25078|34419|lyfalmen|||1|168|0|21,0000|Icepharma hf|Bayer Pharma AG|Rivaoxaban||25078||25078|34419||2 502047|N04BA0201|Madopar|hylki|125|mg|100|stk|1|glas|100+25 mg|N04BA02|01.12.1983||R|1|0|0|0|G|0|ROC|0|0|0|100|DKK|2524|4596|lyfalmen|V0434|4178|1|100|0|16,6667|Icepharma hf|Roche|Levódópa og dópadekarboxýl­asa­hemill||2524||2524|4596||2 502888|N07BC0202|Metadon Abcur|töflur|10|mg|100|stk|1|þpakki||N07BC02|01.03.2016||R|1|0|1|0|G|0|ABC|0|0|0|100|SEK|4285|7020|lyfalmen|||1|100|0|40,0000|Icepharma hf|Abcur AB|Metadón||4285||4285|7020||2 502904|A10BX0901|Forxiga|filmhtfl|10|mg|28|stk|1|þpakki||A10BX09|01.11.2015||R|1|0|0|0|G|0|BRI|0|0|0|100|SEK|5822|9136|lyfalmen|||1|28|0|28,0000|Vistor hf|Bristol-Myers Squibb/AstraZeneca EEIG|Dapagliflozín||5822||5822|9136||1 502956|A11DA0101|Tiacur|stl|25|mg/ml|2|ml|5|lykjur||A11DA01|01.09.2015||R|0|0|0|0|0|0|ABC|0|0|0|100|SEK|15613|22612|lyfalmen|||1|10|0|5,0000|Icepharma hf|Abcur AB|Thiamine (vit B1)||||15613|22612||2 503151|L02AE0401|Decapeptyl Depot|sts|3,75|mg|1|stk|1|spr|+ leysir|L02AE04|01.01.1995||R|0|0|0|1|0|1|FER|0|0|0|100|DKK|18596|26718|lyfsjukr|||1|1|0|37,5000|Vistor hf|Ferring|Triptórelín||18596||18596|26718||1 503265|N06AB1007|Escitalopram Bluefish|filmhtfl|15|mg|28|stk|1|þpakki||N06AB10|01.08.2015||R|1|0|0|0|0|0|BLP|0|0|0|100|IKR|2090|3999|lyfalmen|||2|28|0|42,0000|LYFIS ehf|Bluefish Pharmaceuticals AB|Escítalópram||2090||2090|3999||2 503266|N03AX2201|Fycompa|filmhtfl|6|mg|28|stk|1|þpakki||N03AX22|01.01.2015||R|1|0|0|0|G|0|EUR|0|0|0|100|SEK|21138|29436|lyfalmen|||1|28|0|21,0000|Vistor hf|Eisai Europe Ltd.|Perampanel||21138||21138|29436||1 503406|R03BB0501|Eklira Genuair|innönddu|322|mcg|60|skammtar|1|innö.t||R03BB05|01.12.2015||R|0|0|0|0|G|0|ZEN|0|0|0|100|SEK|4988|7988|lyfalmen|V0707|7988|1|60|0|30,0000|Vistor hf|AstraZeneca AB|Aclídínumbrómíð||4988||4988|7988||1 503491|N06DA0303|Nimvastid (Lyfis)|hylki|1,5|mg|28|stk|1|þpakki||N06DA03|01.04.2011||R|1|0|0|0|G|0|LYF|0|0|0|100|IKR|6070|8359|lyfalmen|V0354|8359|3|28|0|4,6700|LYFIS ehf|LYFIS ehf|Rívastigmín||5258||5258|8359||2 504014|N04BC0407|Ropinirol Actavis|forðatfl|8|mg|84|stk|1|þpakki||N04BC04|01.12.2012|29.02.2016|R|1|0|0|0|G|0|APC|0|0|0|100|XEU|26382|19836|lyfalmen|||2|84|0|112,0000|Actavis Group PTC ehf|Actavis Group PTC ehf|Rópíníról||13596||13596|19836||1 504020|B05AA0114|Albuman|irl|40|g/líter|250|ml|1|hgl|lausn|B05AA01|01.04.2013||R|0|0|0|0|0|1|SPP|0|0|0|100|XEU|3818|6377|lyfsjukr|||1|250|0||Williams & Halls efh|Sanquin Plasma Product|Albúmín||3818||3818|6377||2 504119|A10BB1202|Glimeryl|töflur|4|mg|90|stk|1|þpakki||A10BB12|01.11.2011||R|1|0|0|0|G|0|AGP|0|0|0|100|XEU|1469|2408|lyfalmen|V0494|1810|2|90|0|180,0000|Actavis Group hf|Actavis Group PTC ehf|Glímepíríð||934||934|2408||1 504120|R03AL0301|ANORO|innönddu|77|mcg/sk|30|skammtar|1|innö.t|55+22 mcg|R03AL03|01.11.2014||R|0|0|0|0|G|0|RGO|0|0|0|100|GBP|7080|10867|lyfalmen|||1|30|0||Vistor hf|Glaxo Group Limited|Vilanterol og umeclidinium bromide||7080||7080|10867||1 504169|G04BE0302|Revatio|mixtduft|10|mg/ml|112|ml|1|glas||G04BE03|01.04.2016||R|0|0|0|1|0|1|IPI|0|0|0|100|DKK|33711|45338|lyfsjukr|||1|112|0|22,4000|Icepharma hf|Pfizer Limited|Síldenafíl||33711||33711|45338||1 504266|G03CA0401|Ovestin|töflur|1|mg|90|stk|1|þpakki||G03CA04|01.01.1988||R|0|0|0|0|G|0|APP|0|0|0|100|DKK|1520|3214|lyfalmen|V0704|3214|1|90|0|45,0000|Artasan ehf|Aspen Pharma Trading Limited|Estríól||1520||1520|3214||1 504878|N05BA0801|Lexotan|töflur|3|mg|100|stk|1|þpakki||N05BA08|01.01.1987||R|1|0|0|0|0|0|ROC|0|0|1|100|DKK|1031|2541|lyfalmen|||1|100|0|30,0000|Icepharma hf|Roche|Brómazepam||1031||1031|2541||2 504923|QN04BC0201|Prascend|töflur|1|mg|60|stk|1|þpakki|handa hestum|QN04BC02|01.05.2014||R|0|0|0|0|0|0|BIV|0|0|0|100|DKK|12439|23770|vetalmen|||0|60|0||Vistor hf|Boehringer Ingelheim Vetmedica GmbH|Pergolide||12439||12439|23770||1 505495|J01CE0107|Benzylpenicillin Panpharma|sts/irs|3|g/hgl|10|hgl|1|pakki|lausn|J01CE01|01.02.2016||R|0|0|0|0|0|1|PAP|0|0|0|100|DKK|4680|7564|lyfsjukr|||2|10|0|8,3300|Icepharma hf|Panpharma S.A.|Benzýlpenicillín||||4680|7564||2 505503|J01CE0107|Benzylpenicillin Panpharma|sts/irs|0,6|g/hgl|10|hgl|1|pakki|lausn|J01CE01|01.02.2016||R|0|0|0|0|0|1|PAP|0|0|0|100|DKK|1251|2844|lyfsjukr|||2|10|0|1,6700|Icepharma hf|Panpharma S.A.|Benzýlpenicillín||||1251|2844||2 505647|N07BA0147|Nicorette QuickMist|munnhúði|1|mg/sk|300|skammtar|1|fl|2 x 150 úðaskammtar|N07BA01|01.11.2012||L|0|0|0|0|0|0|MCN|0|0|1|100|IKR|||lyflausa|||0|300|0|0,8800|Vistor hf|McNeil Denmark ApS|Nikótín|||||||1 505834|L01DB0101|Adriamycin|stl|2|mg/ml|5|ml|1|plhgl||L01DB01|01.05.2008||R|0|0|0|1|0|1|PER|0|0|0|100|DKK|1603|3329|lyfsjukr|||1|5|0||Icepharma hf|Pfizer ApS|Doxórúbicín||1603||1603|3329||1 505875|L01DB0101|Adriamycin|stl|2|mg/ml|10|ml|1|plhgl||L01DB01|01.05.2008||R|0|0|0|1|0|1|PER|0|0|0|100|DKK|3202|5529|lyfsjukr|||1|10|0||Icepharma hf|Pfizer ApS|Doxórúbicín||3202||3202|5529||1 505883|L01DB0101|Adriamycin|stl|2|mg/ml|25|ml|1|plhgl||L01DB01|01.05.2008||R|0|0|0|1|0|1|PER|0|0|0|100|DKK|7306|11178|lyfsjukr|||1|25|0||Icepharma hf|Pfizer ApS|Doxórúbicín||7306||7306|11178||1 506036|N03AX2201|Fycompa|filmhtfl|4|mg|28|stk|1|þpakki||N03AX22|01.01.2015||R|1|0|0|0|G|0|EUR|0|0|0|100|SEK|21138|29436|lyfalmen|||1|28|0|14,0000|Vistor hf|Eisai Europe Ltd.|Perampanel||21138||21138|29436||1 506176|N07BC0202|Metadon Abcur|töflur|5|mg|100|stk|1|þpakki||N07BC02|01.10.2013||R|1|0|1|0|G|0|ABC|0|0|0|100|SEK|2427|4463|lyfalmen|||1|100|0|25,0000|Icepharma hf|Abcur AB|Metadón||2427||2427|4463||2 506809|N05AX1207|Lemilvo|töflur|5|mg|100|stk|1|glas||N05AX12|01.03.2016||R|1|1|0|0|0|0|AGP|0|0|0|100|XEU|46692|37285|lyfalmen|V0682|36629|2|100|0|33,3300|Actavis Group hf|Actavis Group PTC ehf|Aripiprazól||27344||27344|37285||1 506972|N06AA1201|Sinquan|hylki|50|mg|100|stk|1|þpakki||N06AA12|01.12.1972||R|1|0|0|0|G|0|PER|0|0|0|100|DKK|2189|4135|lyfalmen|||1|100|0|50,0000|Icepharma hf|Pfizer ApS|Doxepín||2189||2189|4135||1 506998|A06AB0202|Toilax|sh-tfl|5|mg|25|stk|1|þpakki||A06AB02|01.12.1975||L|1|0|0|0|0|0|ERC|0|0|0|100|IKR|||lyflausa|||0|25|0|12,5000|Vistor hf|Orion Pharma|Bisakódýl|||||||1 507004|A06AB0202|Toilax|sh-tfl|5|mg|100|stk|1|þpakki||A06AB02|01.12.1975||R|1|0|0|0|0|0|ERC|0|0|0|100|DKK|355|1611|lyfalmen|||1|100|0|50,0000|Vistor hf|Orion Pharma|Bisakódýl||355||355|1611||1 507103|QP52AF0201|Banminth, vet.|pasta|21,7|mg/g|24|g|1|spr||QP52AF02|01.07.1995||R|0|0|0|0|0|0|ZOE|0|0|0|100|DKK|585|1008|vetorma|||0|24|0||Icepharma hf|Zoetis Finland OY|||585||585|1008||2 507315|L03AB1001|PegIntron|sts|120|mcg|4|áf-penni|1|pakki|fjölskammta pennar|L03AB10|01.11.2013||R|0|0|0|1|0|1|MLD|0|0|0|100|DKK|114688|148220|lyfsjukr|||1|4|0|64,0000|Vistor hf|Merck Sharp & Dohme Limited|Peginterferón alfa 2b||114688||114688|148220||1 507758|R03AK0604|Relanio|innönddu|550|mcg/sk|60|skammtar|1|pakki|50+500 mcg|R03AK06|01.01.2014||R|0|0|0|0|G|0|EPL|0|0|0|100|IKR|9000|9794|lyfalmen|||2|60|0|30,0000|LYFIS ehf|ELPEN Pharmaceutical Co. Inc.|Salmeteról og fluticason||6300||6300|9794||2 507834|N07CA0102|Betahistin ratiopharm|töflur|16|mg|100|stk|1|þpakki||N07CA01|01.12.2013||R|1|0|0|0|0|0|ROY|0|0|0|100|IKR|3105|5396|lyfalmen|||2|100|0|66,6700|Medical ehf|ratiopharm Oy|Betahistín||3105||3105|5396||2 507915|C03DA0103|Spiron|töflur|50|mg|100|stk|1|glas||C03DA01|01.09.2013||R|1|0|0|0|G|0|OPF|0|0|0|100|DKK|1733|3508|lyfalmen|V0092|3508|2|100|0|66,6600|Alvogen|Orion Corporation|Spírónólaktón||1733||1733|3508||1 507916|S01AA1301|Fucithalmic|augndr|10|mg/g|5|g|1|túpa||S01AA13|01.08.2015||R|0|0|0|0|G|0|AML|0|0|1|100|DKK|951|2431|lyfalmen|||1|5|0||Vistor hf|Amdipharm Limited|Fúsidínsýra||951||951|2431||1 508350|N03AX1603|Pregabalin Krka|hylki|150|mg|56|stk|1|þpakki||N03AX16|01.03.2015||R|1|0|0|0|0|0|KNM|0|0|0|100|XEU|9104|6523|lyfalmen|V0687|5952|2|56|0|28,0000|LYFIS ehf|Krka d.d. Novo mesto|Pregabalín||3924||3924|6523||2 508589|J02AC0102|Candizol|hylki|150|mg|2|stk|1|þpakki||J02AC01|01.02.2015||R|1|0|0|0|0|0|ACA|0|0|1|100|IKR|612|1897|lyfalmen|V0555|1842|2|2|0|1,5000|Actavis Group hf|Actavis hf|Flúkónazól||563||563|1897||1 508622|C08DA0103|Isoptin retard|forðatfl|240|mg|98|stk|1|þpakki||C08DA01|01.10.1993||R|1|0|0|0|G|0|ABS|0|0|0|100|DKK|2271|4248|lyfalmen|V0710|4248|1|98|0|98,0000|Vistor hf|Abbott Scandinavia AB|Verapamíl||2271||2271|4248||1 508671|QJ01MA9001|Baytril vet.|mixtúra|25|mg/ml|100|ml|1|plastf||QJ01MA90|01.03.2009||R|0|0|0|0|0|0|BAN|0|0|0|100|DKK|4539|8782|vetalmen|||0|100|0||Icepharma hf|Bayer Animal Health GmbH|Enrofloxacinum||||4539|8782||2 508689|QJ01MA9001|Baytril vet.|stl|50|mg/ml|50|ml|1|hgl|lausn|QJ01MA90|01.01.2009||R|0|0|0|0|0|0|BAN|0|0|0|100|DKK|4089|7928|vetalmen|||0|50|0||Icepharma hf|Bayer Animal Health GmbH|Enrofloxacinum||4089||4089|7928||2 508705|QJ01MA9001|Baytril vet.|stl|100|mg/ml|100|ml|1|hgl|lausn|QJ01MA90|01.01.2009||R|0|0|0|0|0|0|BAN|0|0|0|100|DKK|12116|23157|vetalmen|||0|100|0||Icepharma hf|Bayer Animal Health GmbH|Enrofloxacinum||12116||12116|23157||2 508921|L01CD0401|Jevtana|irþ|60|mg|1|hgl|1|pakki|+ leysir|L01CD04|01.08.2011||R|0|0|0|1|0|1|SAA|0|1|0|100|NOK|521657|654375|lyfsjukr|||1|1|0||Vistor hf|Sanofi - Aventis|Cabazitaxel||521657||521657|654375||1 509042|N05AF0502|Cisordinol Depot|stl|200|mg/ml|1|ml|10|lykjur||N05AF05|01.03.1984||R|0|0|0|0|G|0|LBK|0|0|0|100|DKK|8480|12794|lyfalmen|||1|10|0|133,3333|Lundbeck Export A/S|H. Lundbeck A/S|Zúklópentixól||8480||8480|12794||1 509127|QG02CB0301|Finilac|mixtúra|50|mcg/ml|15|ml|1|glas||QG02CB03|01.03.2016||R|0|0|0|0|0|0|BVL|0|0|0|100|IKR|5425|10463|vetalmen|||0|15|0||Dýraheilsa ehf|Le Vet B.V.|Kabergólín||||5425|10463||2 509359|N06AX1611|Duofaxin|forðatfl|75|mg|28|stk|1|þpakki||N06AX16|01.07.2015||R|1|0|0|0|0|0|MEV|0|0|0|100|DKK|979|2324|lyfalmen|V0336|2324|2|28|0|21,0000|Vistor hf|MediLink A/S|Venlafaxín||873||873|2324||1 509504|QJ51CR0201|Clavubactin vet.|töflur|312,5|mg|100|stk|1|þpakki|250 mg+ 62,5 mg|QJ51CR02|01.03.2015||R|0|0|0|0|0|0|BVL|0|0|0|100|IKR|5785|11146|vetalmen|||0|100|0||Dýraheilsa ehf|Le Vet B.V.|Amoxillinum og ensim hemill||5785||5785|11146||2 509577|G03HB0102|Diane mite|töflur|||63|stk|1|þpakki||G03HB01|01.06.2013||R|0|1|0|0|0|0|BGB|0|0|0|100|DKK|1955|3813|lyfalmen|V0134|3035|1|63|0|84,0000|Icepharma hf|Bayer Pharma AG|Cýpróterón og östrógen||1955||1955|3813||2 509653|J05AR0101|Combivir|filmhtfl|450|mg|60|stk|1|þpakki|150+300 mg|J05AR01|01.05.2004||R|1|0|0|1|0|1|VII|0|0|0|100|GBP|44709|59249|lyfsjukr|||1|60|0|30,0000|GlaxoSmithKline ehf|ViiV Healthcare UK Ltd|Zídóvúdín og lamívúdín||44709||44709|59249||1 510200|B02BD0204|Helixate NexGen|sts|1000|ae/hgl|1|hgl|1|pakki|+leysir og bl.sett|B02BD02|01.11.2013||R|0|0|0|1|0|1|BAY|0|1|0|100|SEK|81616|105929|lyfsjukr|||1|1|0|2,0000|Icepharma hf|Bayer AB "Bayer Schering Pharma"|Storkuþáttur VIII||||81616|105929||2 510255|B03XA0103|NeoRecormon|stl|2000|ae/spr|0,3|ml|6|spr||B03XA01|01.02.2002||R|0|0|0|1|0|1|ROC|0|0|0|100|DKK|14781|21467|lyfsjukr|||1|1,8|0|12,0000|Icepharma hf|Roche|Epóetín||14781||14781|21467||2 510263|B03XA0103|NeoRecormon|stl|3000|ae/spr|0,3|ml|6|spr||B03XA01|01.02.2002||R|0|0|0|1|0|1|ROC|0|0|0|100|DKK|22125|30684|lyfsjukr|||1|1,8|0|18,0000|Icepharma hf|Roche|Epóetín||22125||22125|30684||2 510271|B03XA0103|NeoRecormon|stl|5000|ae/spr|0,3|ml|6|spr||B03XA01|01.02.2002||R|0|0|0|1|0|1|ROC|0|0|0|100|DKK|36292|48603|lyfsjukr|||1|1,8|0|30,0000|Icepharma hf|Roche|Epóetín||36292||36292|48603||2 510305|B03XA0103|NeoRecormon|stl|10000|ae/spr|0,6|ml|6|spr||B03XA01|01.02.2002||R|0|0|0|1|0|1|ROC|0|0|0|100|DKK|56093|73647|lyfsjukr|||1|3,6|0|60,0000|Icepharma hf|Roche|Epóetín||56093||56093|73647||2 510553|C03CA0101|Furix|töflur|40|mg|100|stk|1|glas||C03CA01|01.04.2014||R|1|0|0|0|G|0|TPA|0|0|0|100|DKK|427|1710|lyfalmen|V0601|1567|2|100|0|100,0000|Vistor hf|Takeda Pharma A/S|Fúrósemíð||427||427|1710||1 510608|L01XX4401|Zaltrap|irþ|25|mg/ml|8|ml|1|hgl|lausn|L01XX44|01.06.2013|30.04.2016|R|0|0|0|1|0|1|SGA|0|0|0|100|NOK|82768|107386|lyfsjukr|||1|8|0||Vistor hf|Sanofi-aventis groupe|Afliberceptum||82768||82768|107386||1 510810|B03XA0201|Aranesp|stl|150|mcg/spr|0,3|ml|4|áf.spr|nálavörn|B03XA02|01.11.2010||R|0|0|0|1|0|1|RAG|0|0|0|100|DKK|146589|187896|lyfsjukr|||1|1,2|0|133,3300|Vistor hf|Amgen|Darbepóetín alfa||||146589|187896||1 510974|G04CB0102|Finol|töflur|5|mg|98|stk|1|glas||G04CB01|01.01.1998||R|1|0|0|0|G|0|ACA|0|0|0|100|XEU|3700|4577|lyfalmen|V0445|4577|2|98|0|98,0000|Actavis Group hf|Actavis hf|Fínasteríð||2510||2510|4577||1 511303|G03FB0501|Trisekvens|töflur|||84|stk|1|skífup||G03FB05|01.12.1980||R|0|0|0|0|G|0|NAS|0|0|0|100|DKK|2391|4413|lyfalmen|||1|84|0|84,0000|Vistor hf|Novo-Nordisk A/S|Noretísterón og östrógen||2391||2391|4413||1 511361|A10BB1203|Glimepirid Bluefish|töflur|1|mg|90|stk|1|þpakki||A10BB12|01.10.2015||R|1|0|0|0|G|0|BLP|0|0|0|100|IKR|593|1397|lyfalmen|V0021|1397|2|90|0|45,0000|LYFIS ehf|Bluefish Pharmaceuticals AB|Glímepíríð||200||200|1397||2 511493|B05AA0509|Rheomacrodex med NaCl|irl|100|mg/ml|500|ml|12|pokar||B05AA05|01.07.1991||R|0|0|0|0|0|1|MAB|0|0|0|100|SEK|19892|28502|lyfsjukr|||1|6000|0||Vistor hf|Meda AB|Dextran||19892||19892|28502||1 511501|B05AA0502|Macrodex 60 mg/ml med NaCl|irl|||500|ml|12|pokar||B05AA05|01.07.1991||R|0|0|0|0|0|1|MAB|0|0|0|100|SEK|12443|18249|lyfsjukr|||1|6000|0||Vistor hf|Meda AB|Dextran||12443||12443|18249||1 511932|G02BA0303|Jaydess|leginnle|13,5|mg|1|stk|1|þpakki||G02BA03|01.01.2014||R|0|1|0|0|0|0|BAB|0|0|0|100|DKK|14421|20971|lyfalmen|||1|1|0||Icepharma hf|Bayer AB|Plast lyfjalykkja (IUD) með prógestógen||14421||14421|20971||2 512608|B05XA3101|Peditrace|irþ|||10|ml|10|hgl||B05XA31|01.07.1993||R|0|0|0|0|0|1|FKA|0|0|0|100|DKK|4668|7547|lyfsjukr|||1|100|0||Vistor hf|Fresenius Kabi AB|Elektrólýtar í blöndum með öðrum efnum||4668||4668|7547||1 513133|C08CA0105|Amlodipin Bluefish|töflur|10|mg|100|stk|1|þpakki||C08CA01|01.01.2015||R|1|0|0|0|G|0|BLP|0|0|0|100|IKR|1826|2038|lyfalmen|V0057|2038|2|100|0|200,0000|LYFIS ehf|Bluefish Pharmaceuticals AB|Amlódipín||665||665|2038||2 513195|C10AA0106|Simvastatin Bluefish|filmhtfl|20|mg|100|stk|1|þpakki||C10AA01|01.02.2014||R|1|0|0|0|G|0|BLP|0|0|0|100|IKR|836|1841|lyfalmen|V0109|1841|2|100|0|66,6700|LYFIS ehf|Bluefish Pharmaceuticals AB|Simvastatín||522||522|1841||2 513309|D04AB0101|Xylocain|smyrsli|5|%|35|g|1|pakki||D04AB01|01.09.2003||L|0|0|0|0|0|0|AZD|0|0|1|100|IKR|||lyflausa|||0|35|0||Vistor hf|AstraZeneca A/S DK|Lídókaín|||||||1 513391|QJ51CR0201|Clavubactin vet.|töflur|62,5|mg|100|stk|1|þpakki|50 mg + 12,5 mg|QJ51CR02|01.03.2015||R|0|0|0|0|0|0|BVL|0|0|0|100|IKR|2789|5462|vetalmen|||0|100|0||Dýraheilsa ehf|Le Vet B.V.|Amoxillinum og ensim hemill||2789||2789|5462||2 513474|N05AH0501|Sycrest|tungur.t|5|mg|60|stk|1|þpakki||N05AH05|01.10.2011||R|0|0|0|0|0|0|ORR|0|0|0|100|DKK|24560|33764|lyfalmen|||1|60|0|15,0000|Lundbeck Export A/S|N.V. Organon|Asenapíne||24560||24560|33764||1 513494|QM01AH9201|Trocoxil|tuggutfl|30|mg|2|stk|1|þpakki||QM01AH92|01.11.2014||R|0|0|0|0|0|0|ZBE|0|0|0|100|DKK|2391|4699|vetalmen|||0|2|0||Icepharma hf|Zoetis Belgium S.A.|Mavakoxíb||2391||2391|4699||2 513758|QJ01CR0201|Combisyn|stl|175|mg/ml|100|ml|1|hgl|140+35 mg/ml|QJ01CR02|01.11.2011||R|0|0|0|0|0|0|NOB|0|0|0|100|XEU|1882|3699|vetalmen|||0|100|0||Norbrook Laboratories Limited|Norbrook Laboratories Limited|Amoxicillín og Clavulansýra||1882||1882|3699||2 513947|QM01AE9101|Rimadyl vet.|tuggutfl|100|mg|100|stk|1|pakki||QM01AE91|01.04.2015||R|0|0|0|0|0|0|ZOE|0|0|0|100|DKK|9435|18071|vetalmen|||0|100|0||Icepharma hf|Zoetis Finland OY|||9435||9435|18071||2 514090|C09AA0211|Enalapril Krka|töflur|5|mg|250|stk|1|glas||C09AA02|01.06.2015||R|1|0|0|0|G|0|KRK|0|0|0|100|IKR|2000|3875|lyfalmen|V0450|3875|2|250|0|125,0000|LYFIS ehf|Krka Sverige AB|Enalapríl||2000||2000|3875||2 514265|R03AC0302|Bricanyl Turbuhaler|innönddu|0,25|mg/sk|200|skammtar|1|stauk||R03AC03|01.07.1993||R|0|0|0|0|G|0|AZD|0|0|1|100|SEK|1561|3271|lyfalmen|||1|200|0|25,0000|Vistor hf|AstraZeneca A/S DK|Terbútalín||1561||1561|3271||1 514840|N06BA0901|Strattera|hylki|100|mg|28|stk|1|þpakki|hart|N06BA09|01.07.2013||R|1|0|0|1|0|0|ELI|0|0|0|100|XEU|18187|26155|lyfalmen|||1|28|0|35,0000|Icepharma hf|Eli Lilly Danmark A/S|Atomoxetín||||18187|26155||2 514870|N06AX2105|Duloxetin Krka|sþ-hylki|30|mg|30|stk|1|þpakki||N06AX21|01.05.2015||R|0|0|0|0|0|0|KNM|0|0|0|100|IKR|3800|3159|lyfalmen|V0692|2976|2|30|0|15,0000|LYFIS ehf|Krka d.d. Novo mesto|Duloxetín||1480||1480|3159||2 515049|N06AX1801|Edronax|töflur|4|mg|60|stk|1|þpakki||N06AX18|01.06.2000||R|1|0|0|0|G|0|PER|0|0|0|100|IKR|4026|4386|lyfalmen|||1|60|0|30,0000|Icepharma hf|Pfizer ApS|Reboxetin||2371||2371|4386||1 515399|G03GA0503|Bemfola|stl|300|ae|0,5|ml|1|penni||G03GA05|01.01.2015||R|0|0|0|1|G|0|FBA|0|0|0|100|SEK|12725|18637|lyfalmen|||1|0,5|0|4,0000|Finox Biotech AG|Finox Biotech AG|Follitrópín alfa||12725||12725|18637||3 516219|J01FA1006|Azithromycin Eberth|irs|500|mg|10|ml|1|hgl||J01FA10|01.12.2012||R|0|0|0|0|0|1|FRI|0|0|0|100|DKK|4773|6778|lyfsjukr|||1|10|0|1,0000|Alvogen|Dr. Friedrich Eberth Arzneimittel GmbH|Azitrómýcín||4109||4109|6778||1 516630|D06BX0201|Picato|hlaup|500|mcg/g|0,47|g|2|túpur||D06BX02|01.02.2016||R|0|0|0|0|0|0|LEP|0|0|1|100|DKK|16939|24437|lyfalmen|||1|0,94|0||Vistor hf|LEO Pharma A/S|Ingenol mebutate||||16939|24437||1 516972|A04AA0107|Ondansetron Bluefish|filmhtfl|8|mg|30|stk|1|þpakki||A04AA01|01.12.2015||R|1|0|0|0|G|0|BLP|0|0|1|100|IKR|8700|8692|lyfalmen|V0384|8692|2|30|0|15,0000|LYFIS ehf|Bluefish Pharmaceuticals AB|Ondansetrón||5500||5500|8692||2 517693|N05AH0413|Quetiapin ratiopharm|forðatfl|200|mg|100|stk|1|þpakki||N05AH04|01.05.2015||R|1|0|0|0|G|0|TEV|0|0|0|100|IKR|18600|24108|lyfalmen|V0273|23842|2|100|0|50,0000|Medical ehf|Teva Pharma B.V.|Quetíapín||16700||16700|24108||2 517714|A10BX0201|Novonorm|töflur|0,5|mg|90|stk|1|þpakki||A10BX02|01.10.2000||R|0|0|0|0|G|0|NAS|0|0|0|100|DKK|2624|4734|lyfalmen|V0462|3380|1|90|0|11,2500|Vistor hf|Novo-Nordisk A/S|Repaglíníð||2624||2624|4734|| 517728|N03AF0301|Inovelon|filmhtfl|400|mg|100|stk|1|þpakki||N03AF03|01.01.2015||R|0|0|0|1|G|0|EIS|0|0|0|100|SEK|31169|42123|lyfalmen|||1|100|0|28,5700|Vistor hf|Eisai Ltd|Rúfínamíð||31169||31169|42123||1 517755|A10BX0201|Novonorm|töflur|1|mg|90|stk|1|þpakki||A10BX02|01.10.2000||R|0|0|0|0|G|0|NAS|0|0|0|100|DKK|2857|5055|lyfalmen|V0471|3441|1|90|0|22,5000|Vistor hf|Novo-Nordisk A/S|Repaglíníð||2857||2857|5055||1 517813|A10BX0201|Novonorm|töflur|2|mg|90|stk|1|þpakki||A10BX02|01.10.2000||R|0|0|0|0|G|0|NAS|0|0|0|100|DKK|3072|5351|lyfalmen|V0472|3216|1|90|0|45,0000|Vistor hf|Novo-Nordisk A/S|Repaglíníð||3072||3072|5351||1 517824|C01CA0302|Noradrenalin Abcur|irþ|1|mg/ml|10|ml|10|lykjur||C01CA03|01.05.2013||R|0|0|0|0|0|1|ABC|0|0|0|100|SEK|30654|41472|lyfsjukr|||2|100|0|16,6600|Icepharma hf|Abcur AB|Noradrenalín||30654||30654|41472||2 517990|R06AX2201|Kestine|filmhtfl|20|mg|10|stk|1|þpakki||R06AX22|01.06.2012||L|1|0|0|0|0|0|APS|0|0|1|100|IKR|||lyflausa|||0|10|0|20,0000|Vistor hf|Almirall-Prodesfarma S.A.|Ebastín|||||||1 518224|N04BD0202|Rasagilin Krka|töflur|1|mg|112|stk|1|þpakki||N04BD02|01.01.2016||R|0|0|0|0|G|0|KNM|0|0|0|100|IKR|48669|64257|lyfalmen|V0711|61290|2|112|0|112,0000|LYFIS ehf|Krka d.d. Novo mesto|Rasagilín||48669||48669|64257||2 518241|M01AB0509|Modifenac|forðahlk|75|mg|20|stk|1|þpakki||M01AB05|01.11.2000||R|1|0|0|0|G|0|AGT|0|0|1|100|DKK|967|2453|lyfalmen|||1|20|0|15,0000|Actavis Group hf|Actavis Group hf|Díklófenak||967||967|2453||1 518258|M01AB0509|Modifenac|forðahlk|75|mg|100|stk|1|þpakki|með breyttan losunarhraða|M01AB05|01.11.2000||R|1|0|0|0|G|0|AGT|0|0|1|100|DKK|3553|6013|lyfalmen|||1|100|0|75,0000|Actavis Group hf|Actavis Group hf|Díklófenak||3553||3553|6013||1 518332|G03AC0901|Cerazette|töflur|75|mcg|84|stk|1|þpakki|3x28 stk|G03AC09|01.01.2001||R|0|0|0|0|0|0|ORG|0|0|0|100|DKK|1851|3670|lyfalmen|V0590|2625|1|84|0|84,0000|Vistor hf|N.V. Organon|Desógestrel||1851||1851|3670||1 518750|A02BC0508|Esomeprazol Actavis|sþ-tfl|20|mg|28|stk|1|þpakki||A02BC05|01.01.2015||R|1|0|0|0|0|0|APC|0|0|0|100|XEU|1125|2490|lyfalmen|V0004|2490|2|28|0|18,6700|Actavis Group PTC ehf|Actavis Group PTC ehf|Esómeprazól||994||994|2490||1 518897|A10BH0501|Trajenta|filmhtfl|5|mg|90|stk|1|þpakki||A10BH05|01.12.2012||R|1|0|0|0|G|0|BII|0|0|0|100|DKK|17106|24667|lyfalmen|||1|90|0|90,0000|Vistor hf|Boehringer Ingelheim International|Línaglíptín||17106||17106|24667||1 518944|J01CE0205|Kaavepenin Frukt|mixt.kyr|50|mg/ml|125|ml|1|glas||J01CE02|01.10.1985||R|0|0|0|0|0|0|REP|0|0|1|100|SEK|942|2419|lyfalmen|||1|125|0|3,1250|Vistor hf|Recip AB|Fenoxýmetýlpenicillín||942||942|2419||1 519112|QJ01EW1002|Equibactin vet.|pasta|400|mg|45|g|1|áfspr|333,3 + 66,7 mg|QJ01EW10|01.03.2016||R|0|0|0|0|0|0|BVL|0|0|0|100|IKR|2463|4841|vetalmen|||0|45|0||Dýraheilsa ehf|Le Vet B.V.|||||2463|4841||2 519450|C03CA0101|Furix|stl|10|mg/ml|25|ml|5|lykjur||C03CA01|01.05.2014||R|0|0|0|0|G|0|TPA|0|0|0|100|DKK|3549|6007|lyfalmen|||2|125|0|31,2500|Vistor hf|Takeda Pharma A/S|Fúrósemíð||3549||3549|6007||1 519463|J01EE0108|Eusaprim|mixtúra|48|mg/ml|100|ml|1|glas|8+40 mg/ml|J01EE01|01.07.2011||R|0|0|0|0|0|0|APP|0|0|1|100|SEK|1411|3064|lyfalmen|||1|100|0|2,5000|Artasan ehf|Aspen Pharma Trading Limited|Súlfametoxazól og trímetóprím||1411||1411|3064||1 519819|M09AX0102|Hyalgan|stl|10,3|mg/ml|2|ml|1|spr|einnota sprauta|M09AX01|01.01.2001||R|0|0|0|0|G|0|NYC|0|0|0|100|DKK|6449|9999|lyfalmen|V0209|9999|2|2|0|5,7222|Vistor hf|Nycomed Danmark A/S|Natríumhýalúrónat||6449||6449|9999||1 520029|N03AX1404|Levetiracetam Actavis|filmhtfl|250|mg|100|stk|1|glas||N03AX14|01.04.2015||R|1|0|0|0|0|0|APC|0|0|0|100|XEU|7535|3988|lyfalmen|V0515|3346|2|100|0|16,6700|Actavis Group PTC ehf|Actavis Group PTC ehf|Levetíracetam||2082||2082|3988||1 520160|J01XA0108|Vancomycin Actavis|irs|500|mg/hgl|1|hgl|1|pakki||J01XA01|01.03.2016||R|0|0|0|0|0|1|AGP|0|0|0|100|XEU|798|1614|lyfsjukr|||2|1|0|0,2500|Actavis Group hf|Actavis Group PTC ehf|Vankómýcín||357||357|1614||1 520186|N05AX0803|Risperdal Consta|sts|37,5|mg|1|hgl|1|pakki|+ leysir|N05AX08|01.05.2014||R|0|0|0|0|G|0|JAS|0|0|0|100|SEK|21333|29683|lyfalmen|||1|1|0|13,8900|Vistor hf|Janssen-Cilag AB|Risperídón||||21333|29683||1 520239|G04BE0301|Viagra|filmhtfl|25|mg|4|stk|1|pakki||G04BE03|01.07.1999||R|1|0|0|0|0|0|PER|0|0|0|100|DKK|4192|6892|lyfalmen|||1|4|0|2,0000|Icepharma hf|Pfizer ApS|Síldenafíl||4192||4192|6892||1 520288|G04BE0301|Viagra|filmhtfl|50|mg|4|stk|1|pakki||G04BE03|01.07.1999||R|1|0|0|0|0|0|PER|0|0|0|100|DKK|5636|8880|lyfalmen|V0143|1457|1|4|0|4,0000|Icepharma hf|Pfizer ApS|Síldenafíl||5636||5636|8880||1 520338|G04BE0301|Viagra|filmhtfl|50|mg|12|stk|1|pakki||G04BE03|01.07.1999||R|1|0|0|0|0|0|PER|0|0|0|100|DKK|15914|23026|lyfalmen|V0143|4371|1|12|0|12,0000|Icepharma hf|Pfizer ApS|Síldenafíl||15914||15914|23026||1 520346|G04BE0301|Viagra|filmhtfl|100|mg|4|stk|1|pakki||G04BE03|01.07.1999||R|1|0|0|0|0|0|PER|0|0|0|100|DKK|5178|8249|lyfalmen|V0144|1624|1|4|0|8,0000|Icepharma hf|Pfizer ApS|Síldenafíl||5178||5178|8249||1 520379|G04BE0301|Viagra|filmhtfl|100|mg|12|stk|1|pakki||G04BE03|01.07.1999||R|1|0|0|0|0|0|PER|0|0|0|100|DKK|14327|20842|lyfalmen|V0144|4873|1|12|0|24,0000|Icepharma hf|Pfizer ApS|Síldenafíl||14327||14327|20842||1 520502|C08CA0102|Amlo|töflur|5|mg|100|stk|1|plglas||C08CA01|01.03.1998||R|1|0|0|0|G|0|ACA|0|0|0|100|IKR|1355|2086|lyfalmen|V0056|1995|2|100|0|100,0000|Actavis Group hf|Actavis hf|Amlódipín||700||700|2086||1 520577|C08CA0102|Amlo|töflur|10|mg|100|stk|1|plglas||C08CA01|01.03.1998||R|1|0|0|0|G|0|ACA|0|0|0|100|IKR|2163|2086|lyfalmen|V0057|2038|2|100|0|200,0000|Actavis Group hf|Actavis hf|Amlódipín||700||700|2086||1 520759|M03BC5101|Norgesic|töflur|||30|stk|1|þpakki||M03BC51|01.03.1981||R|1|0|0|0|G|0|MEB|0|0|1|100|SEK|304|1541|lyfalmen|||1|30|0|7,5000|Vistor hf|Meda AB (V)|Orfenadrín í blöndum||304||304|1541||1 522003|QJ51RC2302|Streptocillin, vet.|spenalyf|||8|g|40|spr||QJ51RC23|01.12.1982||R|0|0|0|0|0|0|BID|0|0|0|100|DKK|8595|16477|vetalmen|||0|320|0||Vistor hf|Boehringer Ingelheim Danmark|Prókaínpenicillín í blöndum með öðrum sýklalyfjum||8595||8595|16477||1 522327|N03AX1604|Brieka|hylki|225|mg|56|stk|1|þpakki||N03AX16|01.10.2015||R|1|0|0|0|0|0|AGP|0|0|0|100|XEU|9829|7653|lyfalmen|V0688|6779|2|56|0|42,0000|Actavis Group hf|Actavis Group PTC ehf|Pregabalín||4745||4745|7653||1 522427|L03AB1301|Plegridy|stl|125|mcg|2|áf-penni|1|pakki||L03AB13|01.07.2015||R|0|0|0|1|0|1|BIB|0|0|0|100|XEU|114386|147844|lyfsjukr|||1|2|0|28,0900|Icepharma hf|Biogen Idec Ltd|Peginterferón beta-1a||114386||114386|147844||2 522706|L04AC0201|Simulect|sts|20|mg|1|hgl|1|pakki|+leysir|L04AC02|01.06.2004||R|0|0|0|1|0|1|NEL|0|0|0|100|DKK|156717|200492|lyfsjukr|||1|1|0|0,5000|Vistor hf|Novartis Europharm Ltd|Basiliximab||156717||156717|200492||1 522797|N02AX0204|Tradolan|filmhtfl|50|mg|250|stk|1|þpakki||N02AX02|01.08.1998||R|1|0|1|0|G|0|GLP|0|0|1|100|DKK|2320|4315|lyfalmen|||1|250|0|41,6700|Vistor hf|G.L.Pharma GmbH|Tramadól||2320||2320|4315||1 523008|G03AA1208|Cleosensa|filmhtfl|||63|stk|1|þpakki|3+0,03 mg|G03AA12|01.07.2014||R|0|0|0|0|0|0|AGP|0|0|0|100|XEU|2244|4211|lyfalmen|V0192|4211|2|63|0|84,0000|Actavis Group hf|Actavis Group PTC ehf|Dróspírenón og ethinylestradíól||2244||2244|4211||1 523043|N02AA5902|Parkodin forte|töflur|530|mg|40|stk|1|pakki|þp 30+500 mg|N02AA59|01.11.1998||R|1|0|0|0|0|0|AGP|0|0|1|100|IKR|982|2474|lyfalmen|||2|40|0|13,3333|Actavis Group hf|Actavis Group PTC ehf|Kódein í blöndum nema með geðlyfjum||982||982|2474||1 523151|N05AH0410|Quetiapin Actavis|filmhtfl|100|mg|100|stk|1|þpakki||N05AH04|01.08.2013||R|1|0|0|0|G|0|AGP|0|0|0|100|XEU|4521|4258|lyfalmen|V0285|4103|2|100|0|25,0000|Actavis Group hf|Actavis Group PTC ehf|Quetíapín||2278||2278|4258||1 523274|S01XA2008|Artelac|augndr|||10|ml|1|plglas||S01XA20|01.05.1998||L|0|0|0|0|G|0|GEM|0|0|0|100|IKR|||lyfalmen|||0|10|0||Actavis Group hf|Gerhard Mann|Gervitár og aðrar óvirkar samsetningar|||||1541||1 523350|B02BD0801|NovoSeven|sts|2|mg|1|hgl|1|pakki|+áfyllt sprauta, með leysi|B02BD08|01.10.2015||R|0|1|0|1|0|1|NAS|0|0|0|100|DKK|169602|216517|lyfsjukr|||1|1|0|0,0400|Vistor hf|Novo-Nordisk A/S|Eptacog alfa (virkjað)||169602||169602|216517||1 523758|L01XE0801|Tasigna|hylki|150|mg|112|stk|1|þpakki||L01XE08|01.03.2013||R|0|1|0|1|0|1|NEL|0|1|0|100|DKK|291766|368455|lyfsjukr|||1|112|0||Vistor hf|Novartis Europharm Ltd|Nilotiníb||291766||291766|368455||1 523779|R06AD0201|Phenergan|töflur|25|mg|100|stk|1|þpakki||R06AD02|01.10.1995||R|1|0|0|0|G|0|SNO|0|0|1|100|NOK|915|2382|lyfalmen|||1|100|0|100,0000|Vistor hf|Sanofi-aventis Norge AS|Prómetazín||915||915|2382||1 523967|N02AA0506|Oxikodon Depot Actavis|forðatfl|20|mg|28|stk|1|þpakki||N02AA05|01.10.2014||R|1|0|1|0|G|0|APC|0|0|0|100|XEU|1463|3136|lyfalmen|V0584|3136|2|28|0|7,4700|Actavis Group PTC ehf|Actavis Group PTC ehf|Oxýcódon||1463||1463|3136||1 524215|C01DA1401|Imdur|forðatfl|30|mg|28|stk|1|þpakki||C01DA14|01.07.1993||R|1|0|0|0|G|0|AZD|0|0|0|100|SEK|352|1607|lyfalmen|||1|28|0|21,0000|Vistor hf|AstraZeneca A/S DK|Ísósorbíð mónónítrat||352||352|1607||1 524223|C01DA1401|Imdur|forðatfl|30|mg|98|stk|1|þpakki||C01DA14|01.07.1993||R|1|0|0|0|G|0|AZD|0|0|0|100|SEK|2185|4130|lyfalmen|||1|98|0|73,5000|Vistor hf|AstraZeneca A/S DK|Ísósorbíð mónónítrat||2185||2185|4130||1 524257|L02BB0001|Xtandi|hylki|40|mg|112|stk|1|þpakki||L02BB|01.07.2014||R|1|0|0|0|0|1|APE|0|1|0|100|XEU|433878|545203|lyfsjukr|||1|112|0||Vistor hf|Astellas Phama Europe B.V.|Enzalutamid||433878||433878|545203||1 524276|A02BC0401|Pariet|sh-tfl|20|mg|98|stk|1|þpakki||A02BC04|01.06.2011||R|0|0|0|0|0|0|EIS|0|0|0|100|IKR|8619|6125|lyfalmen|V0010|3600|1|98|0|98,0000|Vistor hf|Eisai Ltd|Rabeprazól||3635||3635|6125||1 524934|QM01AE9001|Quadrisol|hlaup|100|mg/ml|30|ml|1|spr|f. hesta|QM01AE90|01.07.2010||R|0|0|0|0|0|0|ZBE|0|0|0|100|DKK|1687|3316|vetalmen|||0|30|0||Icepharma hf|Zoetis Belgium S.A.|Vedaprófen||1687||1687|3316||2 524937|N05AX1209|Aripiprazole Sandoz|töflur|10|mg|56|stk|1|þpakki||N05AX12|01.04.2016||R|1|1|0|0|G|0|HSS|0|0|0|100|DKK|16986|21801|lyfalmen|V0683|21002|2|56|0|37,3300|Artasan ehf|Sandoz GmbH|Aripiprazól||15024||15024|21801||1 524981|D11AX2101|Mirvaso|hlaup|3|mg/g|30|g|1|túpa||D11AX21|01.03.2016||R|0|0|0|0|0|0|GAL|0|0|0|100|XEU|6747|10409|lyfalmen|||1|30|0||Icepharma hf|Galderma International|Brimonidine||6747||6747|10409||2 525014|M03BC5101|Norgesic|töflur|||100|stk|1|þpakki||M03BC51|01.06.1981||R|1|0|0|0|G|0|MEB|0|0|1|100|SEK|627|1985|lyfalmen|||1|100|0|25,0000|Vistor hf|Meda AB (V)|Orfenadrín í blöndum||627||627|1985||1 525030|M01AB0505|Voltaren|stl|25|mg/ml|3|ml|5|lykjur|lausn|M01AB05|01.05.2007||R|0|0|0|0|0|0|HES|0|0|1|100|DKK|687|2068|lyfalmen|||1|15|0|3,7500|Vistor hf|Novartis Healthcare A/S|Díklófenak||687||687|2068||1 525147|M01AB0504|Klofen-L|forðahlk|100|mg|30|stk|1|glas||M01AB05|01.01.1993||R|1|0|0|0|G|0|ACA|0|0|1|100|XEU|1523|3218|lyfalmen|||2|30|0|30,0000|Actavis Group hf|Actavis hf|Díklófenak||1523||1523|3218||1 525170|M01AB0504|Klofen-L|forðahlk|100|mg|100|stk|1|glas||M01AB05|01.01.1993||R|1|0|0|0|G|0|ACA|0|0|1|100|XEU|4414|7198|lyfalmen|||2|100|0|100,0000|Actavis Group hf|Actavis hf|Díklófenak||4414||4414|7198||1 525188|N06BA0701|Modiodal|töflur|100|mg|30|stk|1|þpakki||N06BA07|01.03.2002||R|1|0|0|1|0|0|TBP|0|0|0|100|DKK|6639|8452|lyfalmen|V0657|7729|1|30|0|10,0000|Vistor hf|Teva Pharma B.V.|Modafinil||5325||5325|8452||1 525219|QG03XA9101|Improvac|stl|300|mcg|20|ml|12|fl||QG03XA91|01.04.2015||R|0|0|0|0|0|0|ZBE|0|0|0|100|DKK|12513|21567|vetorma|||0|240|0||Icepharma hf|Zoetis Belgium S.A.|gonadotropin releasing factor analogue, conjugated||12513||12513|21567||2 525593|N06DX0103|Nemdatine|filmhtfl|10|mg|100|stk|1|glas||N06DX01|01.08.2013|31.03.2016|R|1|0|0|0|G|0|APC|0|0|0|100|XEU|7410|5663|lyfalmen|||2|100|0|50,0000|Actavis Group PTC ehf|Actavis Group PTC ehf|Memantín||3299||3299|5663||1 525720|B01AF0101|Xarelto|filmhtfl|20|mg|100|stk|1|þpakki||B01AF01|01.05.2012||R|1|1|0|0|G|0|BAP|0|0|0|100|DKK|30482|41254|lyfalmen|||1|100|0|100,0000|Icepharma hf|Bayer Schering Pharma AG|Rivaoxaban||||30482|41254||2 525857|B05XA0103|Kaliumklorid B.Braun|irþ|1|mmol/ml|50|ml|20|hgl||B05XA01|01.09.2010||R|0|0|0|0|0|1|BRA|0|0|0|100|XEU|4814|7748|lyfsjukr|||2|1000|0||Actavis Group hf|Braun|Kalíumklóríð||4814||4814|7748||1 525865|B05XA0303|Natriumklorid B.Braun|irþ|1|mmol/ml|50|ml|20|hgl||B05XA03|01.09.2010||R|0|0|0|0|0|1|BRA|0|0|0|100|XEU|4382|7154|lyfsjukr|||2|1000|0||Actavis Group hf|Braun|Natríumklóríð||4382||4382|7154||1 525945|J01MA0205|Ciprofloxacin Villerton|irl|2|mg/ml|100|ml|10|pokar||J01MA02|01.02.2016||R|0|0|0|0|0|1|VIN|0|0|0|100|DKK|2291|4276|lyfsjukr|||2|1000|0|4,0000|Icepharma hf|Villerton Invest SA|Cíprófloxacín||||2291|4276||2 525998|V07AB0004|Natriumklorid 9 mg/ml Braun|leysir|0,9|%|50|ml|20|hgl|leysir f.stungulyf|V07AB|01.01.2009||L|0|0|0|0|0|0|BRA|0|0|0|100|IKR|||lyfalmen|||0|1000|0||Actavis Group hf|Braun|Leysi- og þynningarvökvar, þ.m.t. skolvökvar|||||4487||1 526004|V07AB0009|Sterilt Vann B. Braun|leysir|||50|ml|20|hgl|leysir f.stungulyf|V07AB|01.01.2009||L|0|0|0|0|0|0|BRA|0|0|0|100|IKR|||lyfalmen|||0|1000|0||Actavis Group hf|Braun|Leysi- og þynningarvökvar, þ.m.t. skolvökvar|||||4549||1 526367|N02BE0119|Therimin Honung & Citron|mixtduft|500|mg|10|sk-pokar|1|pakki||N02BE01|01.01.2015||L|0|0|0|0|0|0|NAA|0|0|1|100|IKR|||lyflausa|||0|10|0|16,6700|Artasan ehf|Novartis Healthcare A/S|Paracetamól|||||||1 526368|N04BA0201|Madopar|töflur|250|mg|100|stk|1|glas|200+50 mg|N04BA02|01.11.1981||R|1|0|0|0|G|0|ROC|0|0|0|100|DKK|3832|6397|lyfalmen|V0435|6397|1|100|0|33,3333|Icepharma hf|Roche|Levódópa og dópadekarboxýl­asa­hemill||3832||3832|6397||2 526376|N03AG0103|Orfiril Retard|forðatfl|300|mg|100|stk|1|glas||N03AG01|01.10.1995||R|1|1|0|0|G|0|DEA|0|0|0|100|XEU|5520|8720|lyfalmen|||1|100|0|20,0000|Vistor hf|Desitin Artzneimittel|Valpróínsýra||5520||5520|8720||1 526521|C03DA0404|Kalspar|filmhtfl|50|mg|100|stk|1|þpakki||C03DA04|01.08.2015||R|1|0|0|0|0|0|WEH|0|0|0|100|XEU|15013|14780|lyfalmen|V0111|14780|2|100|0|100,0000|Williams & Halls efh|Williams & Halls ehf|Eplerenón||9923||9923|14780||2 526798|N03AG0102|Orfiril|sh-tfl|600|mg|100|stk|1|glas||N03AG01|01.10.1995||R|1|1|0|0|G|0|DEA|0|0|0|100|XEU|3498|5937|lyfalmen|||1|100|0|40,0000|Vistor hf|Desitin Artzneimittel|Valpróínsýra||3498||3498|5937||1 527112|N02BE0116|Pinex Smelt|munndr.t|250|mg|20|stk|1|þpakki||N02BE01|01.09.2011||L|0|0|0|0|0|0|APC|0|0|1|100|IKR|||lyflausa|||0|20|0|1,6700|Actavis Group PTC ehf|Actavis Group PTC ehf|Paracetamól|||||||1 527143|J01XD0102|Flagyl|irl|5|g/1000ml|100|ml|20|pokar||J01XD01|01.12.1983||R|0|0|0|0|0|1|SNO|0|0|0|100|NOK|11058|16342|lyfsjukr|||1|2000|0|6,6667|Vistor hf|Sanofi-aventis Norge AS|Metrónídazól||11058||11058|16342||1 527453|N03AX1404|Levetiracetam Actavis|filmhtfl|1000|mg|100|stk|1|glas||N03AX14|01.04.2015||R|1|0|0|0|0|0|APC|0|0|0|100|XEU|16809|5506|lyfalmen|V0516|5506|2|100|0|66,6700|Actavis Group PTC ehf|Actavis Group PTC ehf|Levetíracetam||3185||3185|5506||1 527523|S01GX0601|Emadine|augndr|0,5|mg/ml|5|ml|1|glas||S01GX06|01.05.2003||R|0|0|0|0|G|0|ALA|0|0|0|100|USD|1270|2870|lyfalmen|||1|5|0||Vistor hf|Alcon Laboratories Ltd.|Emedastín||1270||1270|2870||1 527914|QS02CA0103|Saniotic vet.|eyrnadr|||20|ml|1|glas|fyrir hundi og ketti|QS02CA01|01.08.2015||R|0|0|0|0|0|0|RPG|0|0|0|100|XEU|1619|3182|vetalmen|||0|20|0||Icepharma hf|Richter Pharma AG|||1619||1619|3182||2 528055|C03DA0103|Spiron|töflur|25|mg|100|stk|1|glas||C03DA01|01.09.2013||R|1|0|0|0|G|0|OPF|0|0|0|100|DKK|890|1987|lyfalmen|V0046|1987|2|100|0|33,3333|Alvogen|Orion Corporation|Spírónólaktón||628||628|1987||1 528214|N04BC0505|Oprymea|forðatfl|0,52|mg|100|stk|1|þpakki||N04BC05|01.02.2014||R|0|0|0|0|G|0|KNM|0|0|0|100|IKR|12319|15437|lyfalmen|V0635|15368|2|100|0|20,8000|LYFIS ehf|Krka d.d. Novo mesto|Pramipexól||10400||10400|15437||2 528267|A02BC0501|Nexium|sþ-tfl|20|mg|100|stk|1|glas||A02BC05|01.11.2013||R|1|0|0|0|0|0|AZD|0|0|0|100|SEK|10279|6370|lyfalmen|V0011|5393|1|100|0|66,6700|Vistor hf|AstraZeneca A/S DK|Esómeprazól||3813||3813|6370||1 528418|D07AC1302|Ovixan|krem|0,1|%|100|g|1|túpa||D07AC13|01.06.2013||R|0|0|0|0|G|0|GAB|0|0|1|100|SEK|2029|3915|lyfalmen|||0|100|0||Vistor hf|Galenica AB|Mómetasón||2029||2029|3915||1 528472|R03AK0704|Symbicort Turbuhaler (Lyfjaver)|innönddu|164,5|mcg/sk|120|skammtar|1|pakki|160+4,5 mcg/sk|R03AK07|01.05.2011||R|0|0|0|0|G|0|LVR|0|0|0|100|NOK|5605|8837|lyfalmen|V0356|7997|3|120|0|30,0000|Lyfjaver ehf|Lyfjaver ehf|Formóteról og budesonide||5605||5605|8837||3 528584|A07EC0202|Pentasa|forðatfl|1|g|60|stk|1|þpakki|6 x 10 stk|A07EC02|01.06.2012||R|1|0|0|0|G|0|FEL|0|0|0|100|DKK|6102|9521|lyfalmen|||1|60|0|40,0000|Vistor hf|Ferring Lægemidler A/S|Mesalazín (5-amínósalicýlsýra)||6102||6102|9521||1 528874|N02CC0405|Rizatriptan ratiopharm|munndr.t|10|mg|18|stk|1|þpakki||N02CC04|01.11.2013||R|0|0|0|0|G|0|RGM|0|0|0|100|XEU|4150|3790|lyfalmen|V0621|3790|2|18|0|18,0000|Medical ehf|ratiopharm GmbH|Rizatriptan||1938||1938|3790||2 529289|R02AA0301|Strepsils|sogtfl|||24|stk|1|þpakki||R02AA03|01.09.1982||L|0|0|0|0|0|0|RBH|0|0|1|100|IKR|||lyflausa|||0|24|0|4,0000|Artasan ehf|Reckitt Benckiser Healthcare Ltd.-A|Díklórbenzýlalkóhól|||||||1 529438|QJ51RC2002|Ampiclox vet.|spenalyf|||3|g|24|spr|spenadælur|QJ51RC20|01.06.1998|29.02.2016|R|0|0|0|0|0|0|ZOE|0|0|0|100|DKK|4008|7774|vetalmen|||0|72|0||Icepharma hf|Zoetis Finland OY|||4008||4008|7774||2 529446|QJ01CA0401|Clamoxyl, vet.|töflur|40|mg|100|stk|1|þpakki||QJ01CA04|01.10.1987||R|0|0|0|0|0|0|ZOE|0|0|0|100|DKK|4240|8215|vetalmen|||0|100|0||Icepharma hf|Zoetis Finland OY|||4240||4240|8215||2 529735|N03AB0501|Pro-Epanutin|irþ|50|mg/ml|10|ml|10|hgl||N03AB05|01.12.2001||R|0|0|0|0|0|1|PER|0|0|0|100|DKK|60869|79688|lyfsjukr|||1|100|0|11,1000|Icepharma hf|Pfizer ApS|Fosfenýtóín||60869||60869|79688||1 529787|L01XC1801|KEYTRUDA|irþ|50|mg|1|hgl|1|pakki||L01XC18|01.10.2015||R|0|1|0|1|0|1|MLD|0|0|0|100|DKK|252051|319061|lyfsjukr|||1|1|0||Vistor hf|Merck Sharp & Dohme Limited|Pembrolizumab||252051||252051|319061||1 529993|QM01AH9201|Trocoxil|tuggutfl|20|mg|2|stk|1|þpakki||QM01AH92|01.11.2014||R|0|0|0|0|0|0|ZBE|0|0|0|100|DKK|1783|3504|vetalmen|||0|2|0||Icepharma hf|Zoetis Belgium S.A.|Mavakoxíb||1783||1783|3504||2 530109|C10AA0703|Rosuvastatin Krka|filmhtfl|40|mg|30|stk|1|þpakki||C10AA07|01.07.2014||R|1|0|0|0|0|0|KRK|0|0|0|100|IKR|6500|10069|lyfalmen|||2|30|0|120,0000|LYFIS ehf|Krka Sverige AB|Rósuvastatín||6500||6500|10069||2 530162|A06AD6502|Movicol|mixtduft|13,8|g|8|pokar|1|pakki||A06AD65|01.07.2014||L|0|0|0|0|0|0|NOI|0|0|0|100|IKR|||lyflausa|||0|8|0||Artasan ehf|Norgine A/S|Makrógól 3350|||||||1 530172|J05AX1601|Exviera|filmhtfl|250|mg|56|stk|1|þpakki||J05AX16|01.10.2015||R|1|0|0|1|0|1|ABV|0|1|0|100|DKK|152197|194870|lyfsjukr|||1|56|0|28,0000|Vistor hf|AbbVie Ltd.|Dasabuvir||152197||152197|194870||1 530188|A06AD6502|Movicol|mixtduft|13,8|g|50|pokar|1|pakki||A06AD65|01.09.2011||L|0|0|0|0|0|0|NOI|0|0|0|100|XEU|||lyfalmen|V0592|6007|0|50|0|25,0000|Artasan ehf|Norgine A/S|Makrógól 3350|||||6362||1 530322|B01AC0602|Hjarta-Aspirín|sþ-tfl|75|mg|100|stk|1|glas||B01AC06|01.02.2014||L|1|0|0|0|0|0|LYF|0|0|0|100|IKR|||lyflausa|||0|100|0|100,0000|LYFIS ehf|LYFIS ehf|Asetýlsalicýlsýra|||||||2 530701|QN05CM9204|Nerfasin vet.|stl|20|mg/ml|25|ml|1|hgl|nautg. hestar,hundar og kettir|QN05CM92|01.07.2013||R|0|0|0|0|0|0|BVL|1|0|0|100|XEU|1447|2844|vetalmen|||0|25|0||Dýraheilsa ehf|Le Vet B.V.|||1447||1447|2844||2 530741|G03FA0105|Activelle|töflur|||84|stk|1|pakki|þp 1+0,5 mg|G03FA01|01.03.2000||R|0|0|0|0|G|0|NAS|0|0|0|100|DKK|2535|4611|lyfalmen|||1|84|0|84,0000|Vistor hf|Novo-Nordisk A/S|Noretísterón og östrógen||2535||2535|4611||1 530828|B05BA0311|Glucos Fresenius Kabi|irl|200|mg/ml|500|ml|20|pokar|Freeflex umbúðir|B05BA03|01.12.2011||R|0|0|0|0|0|1|FKA|0|0|0|100|DKK|5643|8889|lyfsjukr|||1|10000|0||Vistor hf|Fresenius Kabi AB|Kolvetni||5643||5643|8889||1 531305|N03AX1108|Topiramat Bluefish|filmhtfl|50|mg|60|stk|1|þpakki||N03AX11|01.09.2015||R|1|0|0|0|G|0|BLP|0|0|0|100|XEU|2903|3329|lyfalmen|||2|60|0|10,0000|LYFIS ehf|Bluefish Pharmaceuticals AB|Tópíramat||1603||1603|3329|31.3.2016|2 531459|R03CC0303|Bricanyl Retard|forðatfl|7,5|mg|100|stk|1|glas||R03CC03|01.01.1985||R|1|0|0|0|G|0|AZD|0|0|0|100|SEK|2465|4515|lyfalmen|||1|100|0|50,0000|Vistor hf|AstraZeneca A/S DK|Terbútalín||2465||2465|4515||1 531611|H01BB0201|Syntocinon|stl|10|ae/ml|1|ml|5|lykjur||H01BB02|01.04.2015||R|0|0|0|0|0|1|STI|0|0|0|100|NOK|4106|6774|lyfsjukr|||1|5|0|3,3333|Lyfjaver ehf|Sigma-Tau Industrie Farmaceutiche|Oxýtócín||4106||4106|6774||3 531829|N06AX1105|Mirtazapine Bluefish|munndr.t|15|mg|30|stk|1|þpakki||N06AX11|01.05.2015||R|0|0|0|0|G|0|BLP|0|0|0|100|IKR|998|1810|lyfalmen|V0329|1810|2|30|0|15,0000|LYFIS ehf|Bluefish Pharmaceuticals AB|Mirtazapín||500||500|1810||2 532374|P02CA0101|Vermox|mixtúra|20|mg/ml|30|ml|1|glas||P02CA01|01.12.1982||R|0|0|0|0|0|0|JAS|0|0|0|100|SEK|638|2000|lyfalmen|||1|30|0|3,0000|Vistor hf|Janssen-Cilag AB|Mebendazól||638||638|2000||1 532707|N04BD0203|Rasagilin WH|töflur|1|mg|100|stk|1|þpakki||N04BD02|01.05.2016||R|0|0|0|0|G|0|WEH|0|0|0|100|XEU|41131|54723|lyfalmen|V0711|54723|2|100|0|100,0000|Williams & Halls efh|Williams & Halls ehf|Rasagilín||41131||41131|54723||2 532821|L01XX3203|Bortezomib W&H|sts|3,5|mg/hgl|1|hgl|1|pakki|lausn|L01XX32|01.02.2016||R|0|1|0|1|0|1|WEH|0|0|0|100|XEU|104523|135577|lyfsjukr|||2|1|0||Williams & Halls efh|Williams & Halls ehf|Bortezomíb||104523||104523|135577||2 532983|B05BA0312|Glucos Baxter Viaflo 50 mg/ml|irl|50|mg/ml|1000|ml|10|pokar|lausn|B05BA03|01.07.2013||R|0|0|0|0|0|1|BAM|0|0|0|100|SEK|1963|3824|lyfsjukr|||1|10000|0||Icepharma hf|Baxter Medical AB|Kolvetni||1963||1963|3824||2 533737|R03CC0303|Bricanyl Retard|forðatfl|5|mg|100|stk|1|glas||R03CC03|01.04.1986||R|1|0|0|0|G|0|AZD|0|0|0|100|SEK|1717|3485|lyfalmen|||1|100|0|33,3333|Vistor hf|AstraZeneca A/S DK|Terbútalín||1717||1717|3485||1 533779|A02BC0111|Omeprazol Pensa|sþ-hylki|20|mg|28|stk|1|þpakki||A02BC01|01.12.2012||L|1|0|0|0|0|0|PEN|0|0|0|100|IKR|||lyflausa|||0|28|0|28,0000|Lyfjaver ehf|Pensa Pharma AB|Ómeprazól|||||||3 534141|A02BC0113|Omeprazol Sandoz|sþ-hylki|20|mg|100|stk|1|glas||A02BC01|01.10.2015||R|1|0|0|0|G|0|SHS|0|0|0|100|DKK|2486|2825|lyfalmen|V0006|2825|2|100|0|100,0000|Artasan ehf|Sandoz A/S|Ómeprazól||1237||1237|2825||1 534166|N05AB0302|Trilafon Dekanoat|stl|108,2|mg/ml|1|ml|10|lykjur||N05AB03|01.04.2014||R|0|0|0|0|G|0|COR|0|0|0|100|DKK|16597|23966|lyfalmen|||1|10|0|154,5714|Vistor hf|Orion Corporation|Perfenazín||16597||16597|23966||1 534471|L04AA1001|Rapamune|filmhtfl|1|mg|100|stk|1|þpakki||L04AA10|01.06.2012||R|0|0|0|1|G|0|IPI|0|0|0|100|DKK|52101|68598|lyfalmen|||1|100|0|33,3300|Icepharma hf|Pfizer Limited|Sirolimus||52101||52101|68598||1 534497|QJ01CA0402|Vetrimoxin L.A.|stl|150|mg/ml|100|ml|1|hgl||QJ01CA04|01.11.2014||R|0|0|0|0|0|0|CES|0|0|0|100|XEU|1934|3801|vetalmen|||0|100|0||Icepharma hf|Ceva Sante Animale|||1934||1934|3801|31.3.2016|2 534512|C10AA0703|Rosuvastatin Krka|filmhtfl|10|mg|100|stk|1|þpakki||C10AA07|01.07.2014||R|1|0|0|0|0|0|KRK|0|0|0|100|IKR|7700|7041|lyfalmen|V0117|7020|2|100|0|100,0000|LYFIS ehf|Krka Sverige AB|Rósuvastatín||4300||4300|7041||2 534885|L01AA0601|Holoxan|sts/irs|1000|mg|1|stk|1|hgl||L01AA06|01.07.2013||R|0|0|0|1|0|1|BAM|0|0|0|100|SEK|5262|8365|lyfsjukr|||1|1|0||Icepharma hf|Baxter Medical AB|Ífosfamíð||5262||5262|8365||2 535265|C03DA0102|Spirix|töflur|50|mg|100|stk|1|glas||C03DA01|01.11.2013||R|1|0|0|0|G|0|TPA|0|0|0|100|DKK|1993|3865|lyfalmen|V0092|3508|2|100|0|66,6667|Vistor hf|Takeda Pharma A/S|Spírónólaktón||1993||1993|3865||1 535773|P03AA5401|Tenutex|áburður|245|mg/g|100|g|1|túpa|(20 mg + 225 mg)/g|P03AA54|01.12.1997||L|0|0|0|0|0|0|BIG|0|0|0|100|IKR|||lyflausa|||0|100|0||Icepharma hf|Bioglan AB|Dísúlfíram í blöndum|||||||2 535777|N06AX2108|Aritavi|sþ-hylki|30|mg|28|stk|1|glas||N06AX21|01.12.2015||R|1|0|0|0|0|0|AGP|0|0|0|100|XEU|1783|3011|lyfalmen|V0692|2778|2|28|0|14,0000|Actavis Group hf|Actavis Group PTC ehf|Duloxetín||1372||1372|3011||1 536037|S01EB0105|Isopto Carpine|augndr|20|mg/ml|10|ml|1|glas||S01EB01|01.03.2000||R|0|0|0|0|G|0|SAC|0|0|0|100|USD|368|1629|lyfalmen|||1|10|0|25,0000|Vistor hf|S.A. Alcon - Couvreur N.V.|Pílókarpín||368||368|1629||1 536052|S01EB0105|Isopto Carpine|augndr|40|mg/ml|10|ml|1|glas||S01EB01|01.03.2000||R|0|0|0|0|G|0|SAC|0|0|0|100|USD|383|1649|lyfalmen|||1|10|0|25,0000|Vistor hf|S.A. Alcon - Couvreur N.V.|Pílókarpín||383||383|1649||1 536133|A10BA0202|Metformin Actavis|filmhtfl|1000|mg|30|stk|1|þpakki||A10BA02|01.11.2012||R|1|0|0|0|G|0|APC|0|0|0|100|XEU|359|1470|lyfalmen|V0502|861|2|30|0|15,0000|Actavis Group PTC ehf|Actavis Group PTC ehf|Metformín||253||253|1470||1 536289|L03AB0502|IntronA|stl|30|millj ae|1,2|ml|1|penni|Fjölskammtapenni|L03AB05|01.10.2012||R|0|0|0|1|0|1|MLD|0|0|0|100|DKK|26493|36209|lyfsjukr|||1|1,2|0|15,0000|Vistor hf|Merck Sharp & Dohme Limited|Interferón alfa-2b||26493||26493|36209||1 536384|N03AX1609|Pregabalin Sandoz GmbH|hylki|150|mg|56|stk|1|þpakki||N03AX16|01.02.2016||R|1|0|0|0|0|0|SDG|0|0|0|100|DKK|6023|6670|lyfalmen|V0687|5952|2|56|0|28,0000|Artasan ehf|Sandoz GmbH (Kundl)|Pregabalín||4031||4031|6670||1 536460|N05AX1302|Xeplion|stl|150|mg|1|stk|1|áf.spr|forðadreifa|N05AX13|01.04.2012||R|0|0|0|0|0|0|JCI|0|0|0|100|SEK|92045|119119|lyfalmen|||1|1|0|60,0000|Vistor hf|Janssen-Cilag International N.V.|Paliperídón||92045||92045|119119||1 536712|N05AX1209|Aripiprazole Sandoz|töflur|5|mg|28|stk|1|þpakki||N05AX12|01.04.2016||R|1|1|0|0|0|0|HSS|0|0|0|100|DKK|9686|14454|lyfalmen|V0690|14454|2|28|0|9,3300|Artasan ehf|Sandoz GmbH|Aripiprazól||9686||9686|14454||1 536745|L01AA0601|Holoxan|sts/irs|500|mg|1|stk|1|hgl||L01AA06|01.07.2013||R|0|0|0|1|0|1|BAM|0|0|0|100|SEK|2632|4745|lyfsjukr|||1|1|0||Icepharma hf|Baxter Medical AB|Ífosfamíð||2632||2632|4745||2 536963|D06BX0201|Picato|hlaup|150|mcg/g|0,47|g|3|túpur||D06BX02|01.02.2016||R|0|0|0|0|0|0|LEP|0|0|1|100|DKK|16754|24182|lyfalmen|||1|1,41|0||Vistor hf|LEO Pharma A/S|Ingenol mebutate||||16754|24182||1 537465|B05BB0114|Natriumklorid Fresenius Kabi|irl|9|mg/ml|250|ml|30|pokar|Freeflex umbúðir|B05BB01|01.12.2011||R|0|0|0|0|0|1|FKA|0|0|0|100|DKK|5516|8714|lyfsjukr|||1|7500|0||Vistor hf|Fresenius Kabi AB|Elektrólýtar||5516||5516|8714||1 537866|C01DA0205|Nitroglyserin DAK|tungur.t|0,25|mg|25|stk|1|glas||C01DA02|01.05.2014||L|0|0|0|0|G|0|TPA|0|0|0|100|DKK|||lyfalmen|||0|25|0|2,5000|Vistor hf|Takeda Pharma A/S|Glýcerýltrínítrat|||||1976||1 538138|N05AE0403|Ziprasidon Actavis|hylki|20|mg|56|stk|1|þpakki|hart hylki|N05AE04|01.11.2015||R|1|0|0|0|0|0|APC|0|0|0|100|XEU|6903|10623|lyfalmen|V0608|10623|2|56|0|14,0000|Actavis Group PTC ehf|Actavis Group PTC ehf|Ziprasidon||6903||6903|10623||1 538181|A02AD0106|Rennie|sog/tugg|||24|stk|1|þpakki||A02AD01|01.10.1995||L|0|0|0|0|0|0|BAB|0|0|0|100|IKR|||lyflausa|||0|24|0|2,4000|Icepharma hf|Bayer AB|Blöndur saltsambanda|||||||2 538199|A02AD0106|Rennie|sog/tugg|||48|stk|1|þpakki||A02AD01|01.10.1995||L|0|0|0|0|0|0|BAB|0|0|0|100|IKR|||lyflausa|||0|48|0|4,8000|Icepharma hf|Bayer AB|Blöndur saltsambanda|||||||2 538207|A02AD0106|Rennie|sog/tugg|||96|stk|1|þpakki||A02AD01|01.10.1995||L|0|0|0|0|0|0|BAB|0|0|0|100|IKR|||lyflausa|||0|96|0|9,6000|Icepharma hf|Bayer AB|Blöndur saltsambanda|||||||2 538496|L03AB0702|Rebif|stl|22|mcg/spr|0,5|ml|12|spr|Áfylltar sprautur|L03AB07|01.05.1999||R|0|0|0|1|0|1|MSE|0|0|0|100|SEK|105226|136452|lyfsjukr|||1|6|0|61,3953|Icepharma hf|Merck Serono Europe Ltd|Interferón beta-1a||105226||105226|136452||2 538555|L01BA0110|Metojectpen|stl|12,5|mg|1|áf-penni|1|pakki||L01BA01|01.05.2016||R|0|0|0|1|G|0|WIL|0|0|0|100|XEU|2647|4766|lyfalmen|||1|1|0||Williams & Halls efh|medac Gesellschaft|Metótrexat||2647||2647|4766||2 538696|C09CA0305|Valsartan ratiopharm|filmhtfl|80|mg|98|stk|1|þpakki||C09CA03|01.02.2015||R|1|0|0|0|G|0|RGM|0|0|0|100|IKR|3328|3462|lyfalmen|V0678|3462|2|98|0|98,0000|Medical ehf|ratiopharm GmbH|Valsartan||1700||1700|3462||2 538713|R03BB0701|Incruse|innönddu|55|mcg|30|skammtar|1|innö.t|afmældir skammtar|R03BB07|01.10.2015||R|0|0|0|0|G|0|RGO|0|0|0|100|GBP|4781|7703|lyfalmen|||1|30|0|30,0000|Vistor hf|Glaxo Group Limited|Umeclidiniumbrómið||4781||4781|7703||1 538794|N05AH0412|Quetiapin Sandoz|forðatfl|300|mg|100|stk|1|þpakki||N05AH04|01.12.2014|31.03.2016|R|1|0|0|0|G|0|SHS|0|0|0|100|DKK|30628|34002|lyfalmen|||2|100|0|75,0000|Artasan ehf|Sandoz A/S|Quetíapín||24748||24748|34002||1 539031|N03AG0401|Sabrilex|töflur|500|mg|100|stk|1|þpakki||N03AG04|01.10.1992||R|1|0|0|1|G|0|SNO|0|0|0|100|NOK|6319|9820|lyfalmen|||1|100|0|25,0000|Vistor hf|Sanofi-aventis Norge AS|Vígabatrín||6319||6319|9820||1 539551|N05BA0105|Stesolid|töflur|2|mg|25|stk|1|glas||N05BA01|01.12.1972||R|1|0|0|0|0|0|AGT|0|0|1|100|DKK|563|1897|lyfalmen|||2|25|0|5,0000|Actavis Group hf|Actavis Group hf|Díazepam||563||563|1897||1 539577|N05BA0105|Stesolid|töflur|2|mg|100|stk|1|glas||N05BA01|01.12.1972||R|1|0|0|0|0|0|AGT|0|0|0|100|DKK|729|2126|lyfalmen|||2|100|0|20,0000|Actavis Group hf|Actavis Group hf|Díazepam||729||729|2126||1 539783|D01AC2001|Daktacort|krem|||15|g|1|túpa||D01AC20|01.04.1986||L|0|0|0|0|0|0|MCS|0|0|1|100|IKR|||lyflausa|||0|15|0||Vistor hf|McNeil Sweden AB|Blöndur|||||||1 539973|G01AA1001|Dalacin|sk-krem|20|mg/g|40|g|1|sett|+7 stjökur|G01AA10|01.10.1994||R|0|0|0|0|G|0|PER|0|0|0|100|DKK|1594|3316|lyfalmen|||1|40|0|8,0000|Icepharma hf|Pfizer ApS|Klindamýcín||1594||1594|3316||1 540009|B05BA1021|SmofKabiven|irl|550|kcal|493|ml|6|pokar|fleyti|B05BA10|01.03.2014||R|0|0|0|0|0|1|FKA|0|0|0|100|DKK|19464|27912|lyfsjukr|||1|2958|0||Vistor hf|Fresenius Kabi AB|Blöndur||19464||19464|27912||1 540070|D06BA0101|Flamazine|krem|10|mg/g|250|g|1|dos||D06BA01|01.10.1988||R|0|0|0|0|0|0|SON|0|0|1|100|DKK|2475|4529|lyfalmen|||1|250|0||Icepharma hf|Smith & Nephew|Silfursúlfadíazín||2475||2475|4529||2 540133|H05BX0102|Cinacalcet WH|filmhtfl|60|mg|28|stk|1|þpakki||H05BX01|01.02.2016||R|1|0|0|0|0|0|WEH|0|0|0|100|XEU|40643|54106|lyfalmen|V0721|50118|2|28|0|28,0000|Williams & Halls efh|Williams & Halls ehf|Cinacalcet||||40643|54106||2 540544|N02CC0405|Rizatriptan ratiopharm|munndr.t|10|mg|6|stk|1|þpakki||N02CC04|01.11.2013||R|0|0|0|0|G|0|RGM|0|0|0|100|XEU|1427|1943|lyfalmen|V0621|1263|2|6|0|6,0000|Medical ehf|ratiopharm GmbH|Rizatriptan||596||596|1943||2 540648|N05AX1207|Lemilvo|töflur|15|mg|56|stk|1|þpakki||N05AX12|01.10.2015||R|1|1|0|0|G|0|AGP|0|0|0|100|XEU|20885|22730|lyfalmen|V0684|21002|2|56|0|56,0000|Actavis Group hf|Actavis Group PTC ehf|Aripiprazól||15699||15699|22730||1 540958|L04AX0401|Revlimid|hylki|2,5|mg|21|stk|1|þpakki|hart|L04AX04|01.09.2015||R|1|1|0|1|0|1|CEE|0|1|0|100|XEU|647837|811308|lyfsjukr|||1|21|0|5,2500|Celgene Europe ltd|Celgene Europe ltd|Lenalídómíd||||647837|811308||2 540970|QP54AB5207|Equest Pramox vet|hlaup|||11,8|g|1|sk-dæl|19,5mg/g+121,7mg/g|QP54AB52|01.12.2012||R|0|0|0|0|0|0|ZOE|0|0|0|100|XEU|2289|3945|vetorma|||0|11,8|0||Icepharma hf|Zoetis Finland OY|||2289||2289|3945||2 541169|R02AA0302|Strepsils med honning og citron|sogtfl|||24|stk|1|þpakki||R02AA03|01.09.1982||L|0|0|0|0|0|0|RBH|0|0|1|100|IKR|||lyflausa|||0|24|0|4,0000|Artasan ehf|Reckitt Benckiser Healthcare Ltd.-A|Díklórbenzýlalkóhól|||||||1 541846|C02KX0501|Adempas|filmhtfl|0,5|mg|42|stk|1|þpakki||C02KX05|01.12.2014||R|1|0|0|1|0|1|BYE|0|1|0|100|DKK|180636|230241|lyfsjukr|||1|42|0|4,6700|Vistor hf|Bayer Pharma AG|Riociguatum||180636||180636|230241||1 542216|J01GB0304|Gentamicin B. Braun|irl|1|mg/ml|80|ml|10|fl||J01GB03|01.08.2011||R|0|0|0|0|0|1|BRA|0|0|0|100|XEU|5213|8297|lyfsjukr|||2|800|0|3,3300|Actavis Group hf|Braun|Gentamícín||5213||5213|8297||1 542434|N05AX1208|Aripiprazol W&H|töflur|5|mg|56|stk|1|þpakki||N05AX12|01.01.2016||R|0|1|0|0|0|0|WEH|0|0|0|100|XEU|18330|20512|lyfalmen|V0682|20512|2|56|0|18,6670|Williams & Halls efh|Williams & Halls ehf|Aripiprazól||14087||14087|20512||2 542634|N05AX1207|Lemilvo|töflur|10|mg|56|stk|1|þpakki||N05AX12|01.10.2015||R|1|1|0|0|G|0|AGP|0|0|0|100|XEU|22858|22758|lyfalmen|V0683|21002|2|56|0|37,3300|Actavis Group hf|Actavis Group PTC ehf|Aripiprazól||15719||15719|22758||1 542744|B05BB0214|Plasmalyte Glucos|irl|50|mg/ml|1000|ml|10|pokar||B05BB02|01.09.2015||R|0|0|0|0|0|1|BAM|0|0|0|100|SEK|7188|11016|lyfsjukr|||1|10000|0||Icepharma hf|Baxter Medical AB|Elektrólýtar í blöndum með kol­vetnum||||7188|11016||2 543236|N05AA0201|Nozinan|töflur|5|mg|100|stk|1|þpakki||N05AA02|01.10.2012||R|1|0|0|0|0|0|SNO|0|0|0|100|NOK|510|1824|lyfalmen|||1|100|0|1,6667|Vistor hf|Sanofi-aventis Norge AS|Levómeprómazín||510||510|1824||1 543274|N05AX0803|Risperdal Consta|sts|25|mg|1|hgl|1|pakki|+ leysir|N05AX08|01.05.2014||R|0|0|0|0|G|0|JAS|0|0|0|100|SEK|14793|21483|lyfalmen|||1|1|0|9,2600|Vistor hf|Janssen-Cilag AB|Risperídón||||14793|21483||1 543320|M05BA0409|Alendronat Bluefish|töflur|70|mg|12|stk|1|þpakki||M05BA04|01.09.2014||R|1|0|0|0|G|0|BLP|0|0|0|100|XEU|3373|2755|lyfalmen|V0203|2755|2|12|0|84,0000|LYFIS ehf|Bluefish Pharmaceuticals AB|Alendrónsýra||1186||1186|2755||2 543330|C07AA0302|Visken|töflur|10|mg|98|stk|1|þpakki||C07AA03|01.12.1983||R|1|0|0|0|G|0|HES|0|0|0|100|DKK|2581|4675|lyfalmen|||1|98|0|65,3333|Vistor hf|Novartis Healthcare A/S|Pindólól||2581||2581|4675||1 543374|S01ED5113|Dorzolamide/Timolol Portfarma|augndr|5|mg/ml|5|ml|1|glas|+ dorzólamid 20mg/ml|S01ED51|01.11.2011||R|0|0|0|0|G|0|POF|0|0|0|100|XEU|999|2497|lyfalmen|V0373|1500|2|5|0|25,0000|Alvogen|Alvogen|Tímólól í blöndum||999||999|2497||1 543592|N01AB0701|Suprane|innönd.l|||240|ml|6|glas||N01AB07|01.09.2014||R|0|0|0|0|0|1|BAM|0|0|0|100|SEK|69864|91065|lyfsjukr|||1|1440|0||Icepharma hf|Baxter Medical AB|Desflúran||||69864|91065||2 543710|A06AC0101|Vi-Siblin|kyrni|610|mg/g|250|g|1|stauk||A06AC01|01.06.1999||L|0|0|0|0|0|0|REP|0|0|0|100|IKR|||lyflausa|||0|250|0|21,7857|Vistor hf|Recip AB|Semen psyllii (ispaghula)|||||||1 543744|R01AA0503|Nezeril|nefúði|0,5|mg/ml|7,5|ml|1|glas|sk-úðari|R01AA05|01.10.1994||L|0|0|0|0|0|0|OME|0|0|1|100|IKR|||lyflausa|||0|7,5|0|9,3750|Vistor hf|Omega Pharma Nordic AB|Oxýmetazólín|||||||1 544186|G04BE0307|Sildenafil Mylan|filmhtfl|50|mg|12|stk|1|þpakki||G04BE03|01.08.2013||R|1|0|0|0|0|0|MYL|0|0|0|100|SEK|3566|4371|lyfalmen|V0143|4371|2|12|0|12,0000|Icepharma hf|Mylan AB|Síldenafíl||2360||2360|4371||2 544385|J06BA0208|Privigen|irl|100|mg/ml|400|ml|1|hgl||J06BA02|01.02.2014||R|0|0|0|0|0|1|CSB|0|1|0|100|SEK|255147|322911|lyfsjukr|||1|400|0||Icepharma hf|CSL Behring GmbH|Immúnóglóbúlín, normal, manna, gefin í æð||255147||255147|322911||2 544429|L04AD0202|Prograf|hylki|0,5|mg|50|stk|1|þpakki||L04AD02|01.06.2010||R|0|0|0|1|G|0|ASP|0|0|0|100|XEU|11539|17004|lyfalmen|||1|50|0|5,0000|Vistor hf|Astellas Pharma A/S|Tacrolimus||11539||11539|17004||1 545090|N04BC0505|Oprymea|forðatfl|2,1|mg|100|stk|1|þpakki||N04BC05|01.02.2014||R|0|0|0|0|G|0|KNM|0|0|0|100|IKR|32957|32803|lyfalmen|V0636|32660|2|100|0|84,0000|LYFIS ehf|Krka d.d. Novo mesto|Pramipexól||23800||23800|32803||2 545104|L01XC0201|MabThera|stl|1400|mg|11,7|ml|1|hgl|lausn|L01XC02|01.10.2014||R|0|1|0|1|0|1|RRL|0|1|0|100|DKK|230433|292174|lyfsjukr|||1|11,7|0||Icepharma hf|Roche Registration Limited|Rítúxímab||230433||230433|292174||2 545110|H05BX0103|Cinacalcet Sandoz|filmhtfl|90|mg|28|stk|1|þpakki||H05BX01|01.05.2016||R|1|0|0|0|0|0|SHS|0|0|0|100|DKK|55978|73279|lyfalmen|V0722|73279|2|28|0|42,0000|Artasan ehf|Sandoz A/S|Cinacalcet||55802||55802|73279||1 545176|G03HB0103|Cypretyl|töflur|||63|stk|1|þpakki||G03HB01|01.10.2012||R|0|1|0|0|0|0|RGM|0|0|0|100|XEU|1537|3035|lyfalmen|V0134|3035|2|63|0|84,0000|Medical ehf|ratiopharm GmbH|Cýpróterón og östrógen||1390||1390|3035||2 545681|D06AX0901|Bactroban|smyrsli|20|mg/g|15|g|1|túpa||D06AX09|01.07.1994||R|0|0|0|0|0|0|GPH|0|0|1|100|GBP|953|2434|lyfalmen|||1|15|0||Vistor hf|GlaxoSmithKline Pharma A/S|Múpírócín||953||953|2434|31.3.2016|1 545814|N05AF0501|Cisordinol|töflur|2|mg|100|stk|1|glas||N05AF05|01.06.1984||R|1|0|0|0|G|0|LBK|0|0|0|100|DKK|777|2192|lyfalmen|||1|100|0|6,6667|Lundbeck Export A/S|H. Lundbeck A/S|Zúklópentixól||777||777|2192||1 545848|N05AF0501|Cisordinol|töflur|10|mg|100|stk|1|glas||N05AF05|01.06.1984||R|1|0|0|0|G|0|LBK|0|0|0|100|DKK|1896|3732|lyfalmen|||1|100|0|33,3333|Lundbeck Export A/S|H. Lundbeck A/S|Zúklópentixól||1896||1896|3732||1 545996|V01AA0507|Alutard SQ, birkifrjo|stl|||5|ml|4|hgl|byrjunarsett|V01AA05|01.07.1999||R|0|0|0|1|G|0|ALK|0|0|0|100|DKK|26834|36640|lyfalmen|||1|20|0||Vistor hf|ALK-Abello A/S|trjáfrjó||26834||26834|36640||1 546002|V01AA0507|Alutard SQ, birkifrjo|stl|0,1|mi.SQ/ml|5|ml|1|hgl|framhaldssett|V01AA05|01.07.1999||R|0|0|0|1|G|0|ALK|0|0|0|100|DKK|21635|30065|lyfalmen|||1|5|0||Vistor hf|ALK-Abello A/S|trjáfrjó||21635||21635|30065||1 546044|V01AA0210|Alutard SQ, vallarfoxgras|stl|||5|ml|4|hgl|byrjunarsett|V01AA02|01.07.1999||R|0|0|0|1|G|0|ALK|0|0|0|100|DKK|26992|36840|lyfalmen|||1|20|0||Vistor hf|ALK-Abello A/S|grasfrjó||26992||26992|36840||1 546051|V01AA0210|Alutard SQ, vallarfoxgras|stl|0,1|mi.SQ/ml|5|ml|1|hgl|framhaldssett|V01AA02|01.07.1999||R|0|0|0|1|G|0|ALK|0|0|0|100|DKK|22931|31704|lyfalmen|||1|5|0||Vistor hf|ALK-Abello A/S|grasfrjó||22931||22931|31704||1 546143|N02BE0108|Paratabs Retard|forðatfl|500|mg|30|stk|1|þpakki||N02BE01|01.10.1993||L|1|0|0|0|0|0|ACA|0|0|1|100|IKR|||lyflausa|||0|30|0|5,0000|Actavis Group hf|Actavis hf|Paracetamól|||||||1 546151|A02BC0510|Eradizol|sþ-tfl|20|mg|14|stk|1|þpakki||A02BC05|01.10.2015||L|1|0|0|0|0|0|POF|0|0|0|100|IKR|||lyflausa|||2|14|0|9,3300|Alvogen|Alvogen|Esómeprazól|||||||1 546168|N02BE0108|Paratabs Retard|forðatfl|500|mg|100|stk|1|glas||N02BE01|01.10.1993||R|1|0|0|0|0|0|ACA|0|0|1|100|XEU|1124|2669|lyfalmen|||2|100|0|16,6667|Actavis Group hf|Actavis hf|Paracetamól||1124||1124|2669||1 546722|C09DA0310|Valsartan/Hydrochlorothiazide ratiopharm|filmhtfl|92,5|mg|98|stk|1|þpakki|80/12,5 mg|C09DA03|01.11.2012||R|1|0|0|0|G|0|RGM|0|0|0|100|IKR|3218|2774|lyfalmen|V0580|2774|2|98|0|98,0000|Medical ehf|ratiopharm GmbH|Valsartan og þvagræsilyf||1200||1200|2774||2 546838|J01CE0107|Benzylpenicillin Panpharma|sts/irs|1,2|g/hgl|10|hgl|1|pakki|lausn|J01CE01|01.02.2016||R|0|0|0|0|0|1|PAP|0|0|0|100|DKK|1974|3839|lyfsjukr|||2|10|0|3,3300|Icepharma hf|Panpharma S.A.|Benzýlpenicillín||||1974|3839||2 546844|A02BC0402|Rabeprazol Actavis|sh-tfl|20|mg|100|stk|1|glas||A02BC04|01.10.2012||R|0|0|0|0|G|0|APC|0|0|0|100|IKR|3931|3737|lyfalmen|V0010|3673|2|100|0|100,0000|Actavis Group PTC ehf|Actavis Group PTC ehf|Rabeprazól||1900||1900|3737||1 547519|N03AX1209|Gabapentin Sandoz|hylki|400|mg|100|stk|1|þpakki||N03AX12|01.12.2015||R|1|0|0|0|G|0|SHS|0|0|0|100|DKK|2959|2972|lyfalmen|V0251|2972|2|100|0|22,2200|Artasan ehf|Sandoz A/S|Gabapentín||1344||1344|2972||1 547612|A02BX0202|Antepsin|töflur|1|g|60|stk|1|þpakki||A02BX02|01.01.1986||L|1|0|0|0|0|0|ORC|0|0|0|100|IKR|||lyfalmen|||0|60|0|15,0000|Vistor hf|Orion Corporation|Súkralfat|||||4958||1 547659|A02BC0506|Esomeprazole Krka (LYFIS)|sþ-hylki|20|mg|28|stk|1|þpakki||A02BC05|01.08.2011||R|1|0|0|0|0|0|LYF|0|0|0|100|IKR|2267|2499|lyfalmen|V0004|2490|3|28|0|18,6700|LYFIS ehf|LYFIS ehf|Esómeprazól||1000||1000|2499||2 547687|B01AC1601|Integrilin|irl|0,75|mg/ml|100|ml|1|fl||B01AC16|01.07.2000||R|0|0|0|1|0|1|RGO|0|0|0|100|GBP|9547|14263|lyfsjukr|||1|100|0|0,3800|Vistor hf|Glaxo Group Limited|Eptifibatíð||9547||9547|14263||1 547695|B01AC1601|Integrilin|stl|2|mg/ml|10|ml|1|hgl||B01AC16|01.07.2000||R|0|0|0|1|0|1|RGO|0|0|0|100|GBP|3070|5348|lyfsjukr|||1|10|0|0,1000|Vistor hf|Glaxo Group Limited|Eptifibatíð||3070||3070|5348||1 547925|B05BB0214|Plasmalyte Glucos|irl|50|mg/ml|500|ml|20|pokar||B05BB02|01.09.2015||R|0|0|0|0|0|1|BAM|0|0|0|100|SEK|10002|14889|lyfsjukr|||1|10000|0||Icepharma hf|Baxter Medical AB|Elektrólýtar í blöndum með kol­vetnum||||10002|14889||2 548121|L03AB0801|Betaferon|sts|250|mcg/ml|15|spr|1|pakki|+leysir|L03AB08|01.07.2013||R|0|0|0|1|0|1|BYP|0|0|0|100|DKK|94753|122544|lyfsjukr|||1|15|0|30,0000|Icepharma hf|Bayer Pharma AG|Interferón beta-1b||94753||94753|122544||2 548326|M01AE0112|ibuxin rapid|filmhtfl|400|mg|10|stk|1|þpakki||M01AE01|01.09.2012||L|0|0|0|0|0|0|RAT|0|0|1|100|IKR|||lyflausa|||0|10|0|3,3300|LYFIS ehf|ratiopharm GmbH|Íbúprófen|||||||2 548506|D07AC1301|Elocon|húðlausn|0,1|%|30|ml|1|túpa||D07AC13|01.02.2014||R|0|0|0|0|G|0|MBV|0|0|1|100|DKK|589|1933|lyfalmen|||1|30|0||Vistor hf|Merck Sharp & Dohme B.V.|Mómetasón||589||589|1933||1 548563|S01XA2011|Oculac|augndr|50|mg/ml|10|ml|1|glas|með rotvörn|S01XA20|01.11.2013||L|0|0|0|0|G|0|CLA|0|0|0|100|DKK|||lyfalmen|||0|10|0||Vistor hf|Alcon Nordic A/S|Gervitár og aðrar óvirkar samsetningar|||||1743||1 548722|N06AX2107|Duloxetine Mylan|sþ-hylki|60|mg|98|stk|1|þpakki||N06AX21|01.10.2015||R|0|0|0|0|0|0|GGE|0|0|0|100|SEK|14205|12161|lyfalmen|V0694|11504|2|98|0|98,0000|Mylan AB|Generics (UK) Ltd.|Duloxetín||8020||8020|12161||2 548894|B02BC3002|TISSEEL|vefjalím|||2|ml|10|áf.spr|+ Duo sett|B02BC30|01.01.2013||R|0|0|0|1|0|1|BAA|0|0|0|100|SEK|150782|193111|lyfsjukr|||1|20|0||Icepharma hf|Baxter AG|Blöndur||150782||150782|193111||2 549139|N05AD0102|Haldol Depot|stl|100|mg/ml|1|ml|5|lykjur||N05AD01|01.01.1987||R|0|0|0|0|G|0|JAS|0|0|0|100|SEK|7661|11667|lyfalmen|||1|5|0|151,5152|Vistor hf|Janssen-Cilag AB|Halóperídól||7661||7661|11667||1 549255|N06DX0102|Memantine Merz|filmhtfl|20|mg|28|stk|1|þpakki||N06DX01|01.07.2013||R|1|0|0|0|G|0|LBK|0|0|0|100|DKK|4540|5250|lyfalmen|V0606|4972|2|28|0|28,0000|Lundbeck Export A/S|H. Lundbeck A/S|Memantín||2999||2999|5250||1 549674|B01AF0101|Xarelto|filmhtfl|15|mg|98|stk|1|þpakki||B01AF01|01.05.2012||R|1|1|0|0|G|0|BAP|0|0|0|100|DKK|29484|39992|lyfalmen|||1|98|0|73,5000|Icepharma hf|Bayer Schering Pharma AG|Rivaoxaban||||29484|39992||2 550020|J07AP0302|Typherix|stl|||0,5|ml|1|spr|m/ aðsk. nál|J07AP03|01.08.2013||R|0|0|0|0|0|0|GPH|0|0|0|100|GBP|2177|3703|lyfalmen|||1|0,5|0||Vistor hf|GlaxoSmithKline Pharma A/S|Taugaveiki, hreinsaðir mótefnavakar||1875||1875|3703||1 550256|J02AC0102|Candizol|hylki|50|mg|7|stk|1|þpakki||J02AC01|01.08.2014||R|1|0|0|0|0|0|ACA|0|0|1|100|IKR|1567|1794|lyfalmen|V0551|1783|2|7|0|1,7500|Actavis Group hf|Actavis hf|Flúkónazól||488||488|1794||1 550624|N02BE0103|Panodil Junior|mixtúra|24|mg/ml|60|ml|1|glas||N02BE01|01.11.1981||L|0|0|0|0|0|0|HCA|0|0|1|100|IKR|||lyflausa|||0|60|0|0,4800|Artasan ehf|GlaxoSmithKline CH A/S|Paracetamól|||||||1 550731|N02BE0103|Panodil Junior|eþ-stíll|125|mg|10|stk|1|pakki||N02BE01|01.11.1981||L|0|0|0|0|0|0|HCA|0|0|1|100|IKR|||lyflausa|||0|10|0|0,4167|Artasan ehf|GlaxoSmithKline CH A/S|Paracetamól|||||||1 550803|A10BX0204|Repaglinide Krka|töflur|1|mg|120|stk|1|þpakki||A10BX02|01.11.2013||R|1|0|0|0|G|0|KNM|0|0|0|100|IKR|2518|4588|lyfalmen|V0471|4588|2|120|0|30,0000|LYFIS ehf|Krka d.d. Novo mesto|Repaglíníð||2518||2518|4588||2 551043|B01AC0701|Persantin|húðuðtfl|100|mg|100|stk|1|þpakki||B01AC07|01.05.2014||R|1|0|0|0|G|0|BOI|0|0|0|100|DKK|1531|3229|lyfalmen|||1|100|0|25,0000|Vistor hf|Boehringer Ingelheim|Dípýrídamól||1531||1531|3229||1 551328|S01GX0801|Zaditen|augndr|0,25|mg/ml|0,4|ml|20|sk-hyl||S01GX08|01.06.2013||L|0|0|0|0|0|0|TEA|0|0|0|100|IKR|||lyflausa|||0|8|0||Vistor hf|Laboratories THEA|Ketotifen|||||||1 551388|B05BC0101|Mannitol Baxter Viaflo|irl|150|mg/ml|500|ml|20|plpok|lausn|B05BC01|01.08.2012||R|0|0|0|0|0|1|BAM|0|0|0|100|SEK|7722|11751|lyfsjukr|||1|10000|0||Icepharma hf|Baxter Medical AB|Mannitól||7722||7722|11751||2 551408|N02CC0302|Zomig Rapimelt|munnltfl|2,5|mg|12|stk|1|þpakki||N02CC03|01.05.2001||R|0|0|0|0|G|0|AZA|0|0|0|100|SEK|4670|7550|lyfalmen|||1|12|0|12,0000|Vistor hf|AstraZeneca AB|Zolmítriptan||4670||4670|7550||1 551572|H02AB0802|Lederspan|stl|20|mg/ml|1|ml|1|hgl|dreifa|H02AB08|01.11.2003||R|0|0|0|0|G|0|MAB|0|0|1|100|SEK|1559|3268|lyfalmen|||1|1|0|2,6667|Vistor hf|Meda AB|Tríamcínólón||1559||1559|3268|| 551606|M01AX0101|Relifex|töflur|500|mg|100|stk|1|þpakki||M01AX01|01.04.1995||R|1|0|0|0|G|0|MAB|0|0|1|100|SEK|2496|4558|lyfalmen|V0198|4558|1|100|0|50,0000|Vistor hf|Meda AB|Nabúmeton||2496||2496|4558||1 551846|A02BC0401|Pariet|sh-tfl|10|mg|28|stk|1|þpakki||A02BC04|01.05.2001||R|0|0|0|0|0|0|EIS|0|0|0|100|IKR|2157|1900|lyfalmen|V0466|1795|1|28|0|14,0000|Vistor hf|Eisai Ltd|Rabeprazól||565||565|1900||1 551853|A02BC0401|Pariet|sh-tfl|10|mg|56|stk|1|þpakki||A02BC04|01.05.2001||R|0|0|0|0|0|0|EIS|0|0|0|100|IKR|3752|3590|lyfalmen|V0467|2499|1|56|0|28,0000|Vistor hf|Eisai Ltd|Rabeprazól||1793||1793|3590||1 551879|A02BC0401|Pariet|sh-tfl|20|mg|14|stk|1|þpakki||A02BC04|01.11.2001||R|0|0|0|0|0|0|EIS|0|0|0|100|IKR|1510|1151|lyfalmen|V0003|831|1|14|0|14,0000|Vistor hf|Eisai Ltd|Rabeprazól||21||21|1151||1 551929|A02BC0401|Pariet|sh-tfl|20|mg|28|stk|1|þpakki||A02BC04|01.05.2001||R|0|0|0|0|0|0|EIS|0|0|0|100|IKR|3631|1900|lyfalmen|V0003|1662|1|28|0|28,0000|Vistor hf|Eisai Ltd|Rabeprazól||565||565|1900||1 551937|A02BC0401|Pariet|sh-tfl|20|mg|56|stk|1|þpakki||A02BC04|01.05.2001||R|0|0|0|0|0|0|EIS|0|0|0|100|IKR|7272|3590|lyfalmen|V0010|2057|1|56|0|56,0000|Vistor hf|Eisai Ltd|Rabeprazól||1793||1793|3590||1 552328|B05BB0119|Ringer-Acetat Baxter Viaflo|irl|||1000|ml|10|pokar|lausn|B05BB01|01.07.2013||R|0|0|0|0|0|1|BAM|0|0|0|100|SEK|1655|3400|lyfsjukr|||1|10000|0||Icepharma hf|Baxter Medical AB|Elektrólýtar||1655||1655|3400||2 552377|M01AE0102|Ibufen|filmhtfl|400|mg|50|stk|1|glas||M01AE01|01.11.2012||L|1|0|0|0|0|0|AGP|0|0|1|100|IKR|||lyflausa|||0|50|0|16,6600|Actavis Group hf|Actavis Group PTC ehf|Íbúprófen|||||||1 552764|QN01AX9301|Tricaine Pharmaq|duft|1000|mg/g|100|g|1|askja|lausn handa fiskum|QN01AX93|01.07.2013||R|0|0|0|0|0|0|PHL|0|0|0|100|GBP|16331|26326|veteldis|||0|100|0||PHARMAQ Ltd.|PHARMAQ Ltd|Tricaine Methane Sulfónat||16331||16331|26326||1 552901|N03AF0201|Trileptal|filmhtfl|150|mg|100|stk|1|þpakki||N03AF02|01.10.2000||R|1|0|0|0|G|0|HES|0|0|0|100|DKK|2856|5053|lyfalmen|||1|100|0|15,0000|Vistor hf|Novartis Healthcare A/S|Oxkarbazepín||2856||2856|5053||1 553206|N02CC0601|Relpax|filmhtfl|40|mg|18|stk|1|þpakki||N02CC06|01.08.2009||R|1|0|0|0|G|0|PER|0|0|0|100|DKK|10656|15789|lyfalmen|V0237|15789|1|18|0|18,0000|Icepharma hf|Pfizer ApS|Eletriptan||||10656|15789||1 553231|C10AA0506|Atorvaratio|filmhtfl|10|mg|100|stk|1|þpakki||C10AA05|01.07.2014||R|1|0|0|0|G|0|TSB|0|0|0|100|IKR|3260|1810|lyfalmen|V0112|1810|2|100|0|50,0000|Medical ehf|Teva Sweden AB|Atorvastatín||500||500|1810||2 553339|N02CC0601|Relpax|filmhtfl|40|mg|6|stk|1|þpakki||N02CC06|01.10.2001||R|1|0|0|0|G|0|PER|0|0|0|100|DKK|3644|6138|lyfalmen|V0237|5263|1|6|0|6,0000|Icepharma hf|Pfizer ApS|Eletriptan||3644||3644|6138||1 553720|L01XE1801|Jakavi|töflur|15|mg|56|stk|1|þpakki||L01XE18|01.02.2014||R|1|0|0|1|0|1|NEL|0|1|0|100|DKK|496663|623290|lyfsjukr|||1|56|0||Vistor hf|Novartis Europharm Ltd|Ruxolitinib||496663||496663|623290||1 553923|B02BD0204|Helixate NexGen|sts|500|ae/hgl|1|hgl|1|pakki|+leysir og bl.sett|B02BD02|01.11.2013||R|0|0|0|1|0|1|BAY|0|1|0|100|SEK|41066|54641|lyfsjukr|||1|1|0|1,0000|Icepharma hf|Bayer AB "Bayer Schering Pharma"|Storkuþáttur VIII||||41066|54641||2 554154|QA12CE9902|Selevitan, vet.|stl|||100|ml|5|hgl||QA12CE99|01.05.1983||R|0|0|0|0|0|0|BID|1|0|0|100|DKK|6652|12791|vetalmen|||0|500|0||Vistor hf|Boehringer Ingelheim Danmark|Selen blöndur||6652||6652|12791||1 554582|B01AC0403|Clopidogrel Actavis|filmhtfl|75|mg|100|stk|1|glas||B01AC04|01.11.2013||R|1|0|0|0|G|0|APC|0|0|0|100|XEU|6272|6328|lyfalmen|V0029|6308|2|100|0|100,0000|Actavis Group PTC ehf|Actavis Group PTC ehf|Klópídógrel||3782||3782|6328||1 554720|L04AX0601|Imnovid|hylki|3|mg|21|stk|1|þpakki||L04AX06|01.04.2016||R|0|1|0|1|0|1|CEE|0|0|0|100|XEU|1240017|1547814|lyfsjukr|||1|21|0|21,0000|Celgene Europe ltd|Celgene Europe ltd|Pomalidómide||1240017||1240017|1547814||2 555196|L04AC1001|Cosentyx|stl|150|mg|2|áf-penni|1|pakki||L04AC10|01.07.2015||R|0|0|0|1|0|1|NEL|0|1|0|100|DKK|145216|160040|lyfsjukr|||1|2|0||Vistor hf|Novartis Europharm Ltd|Secukinumab||124192||124192|160040||1 555235|N05AB0303|Peratsin|húðuðtfl|4|mg|100|stk|1|glas||N05AB03|01.02.2013||R|1|0|0|0|G|0|ORC|0|0|0|100|DKK|2017|3898|lyfalmen|||2|100|0|13,3300|Vistor hf|Orion Corporation|Perfenazín||2017||2017|3898||1 555268|N05AB0303|Peratsin|húðuðtfl|8|mg|100|stk|1|glas||N05AB03|01.02.2013||R|1|0|0|0|G|0|ORC|0|0|0|100|DKK|2299|4287|lyfalmen|||2|100|0|26,6700|Vistor hf|Orion Corporation|Perfenazín||2299||2299|4287||1 555292|N05AB0303|Peratsin|húðuðtfl|2|mg|100|stk|1|glas||N05AB03|01.02.2013||R|1|0|0|0|G|0|ORC|0|0|0|100|DKK|1735|3510|lyfalmen|||2|100|0|6,6700|Vistor hf|Orion Corporation|Perfenazín||1735||1735|3510||1 555572|S01XA2201|JETREA|stþ|0,5|mg/hgl|0,2|ml|1|hgl||S01XA22|01.12.2014||R|0|1|0|1|0|1|THO|0|0|0|100|USD|500914|628577|lyfsjukr|||1|0,2|0||Vistor hf|ThromboGenics NV|Ocriplasmínum||500914||500914|628577||1 555864|G04BD0804|Solifenacin Actavis|filmhtfl|5|mg|90|stk|1|þpakki||G04BD08|01.03.2015||R|1|0|0|0|G|0|AGP|0|0|0|100|XEU|13048|16989|lyfalmen|V0440|16988|2|90|0|90,0000|Actavis Group hf|Actavis Group PTC ehf|Sólífenacín||11528||11528|16989||1 556694|C10A00001|Praluent|stl|150|mg/ml|1|ml|2|áfpen|lausn í áf.lyfjapenna|C10A000|01.02.2016||R|0|0|0|0|0|0|SGA|0|0|0|100|NOK|185918|236810|lyfalmen|||1|2|0||Vistor hf|Sanofi-aventis groupe|Alirocumab||||185918|236810||1 556921|H01AC0104|Saizen|sts|5,83|mg/ml|1,03|ml|1|rörlyk||H01AC01|01.05.2011||R|0|0|0|1|0|1|EMA|0|1|0|100|SEK|19390|27811|lyfsjukr|||1|1,03|0|9,0000|Icepharma hf|E. Merck AB|Sómatrópín||19390||19390|27811||2 556936|N03AF0201|Trileptal|filmhtfl|300|mg|100|stk|1|þpakki||N03AF02|01.02.2000||R|1|0|0|0|G|0|HES|0|0|0|100|DKK|4328|7079|lyfalmen|||1|100|0|30,0000|Vistor hf|Novartis Healthcare A/S|Oxkarbazepín||4328||4328|7079||1 556951|N03AF0201|Trileptal|filmhtfl|600|mg|100|stk|1|þpakki||N03AF02|01.02.2000||R|1|0|0|0|G|0|HES|0|0|0|100|DKK|8438|12736|lyfalmen|||1|100|0|60,0000|Vistor hf|Novartis Healthcare A/S|Oxkarbazepín||8438||8438|12736||1 557546|D10AF0202|Zineryt|áburður|||30|ml|1|glas|+ leysir|D10AF02|01.07.1985|31.03.2016|R|0|0|0|0|0|0|ASP|0|0|0|100|XEU|1433|3095|lyfalmen|||1|30|0||Vistor hf|Astellas Pharma A/S|Erýtrómýcín||1433||1433|3095||1 557907|N02BE0109|Panodil Hot|mixtduft|500|mg|10|skammtar|1|pakki||N02BE01|01.10.2014||L|0|0|0|0|0|0|HCA|0|0|1|100|IKR|||lyflausa|||0|10|0|1,6700|Artasan ehf|GlaxoSmithKline CH A/S|Paracetamól|||||||1 557980|M01AH0105|Cloxabix|hylki|100|mg|20|stk|1|þpakki||M01AH01|01.03.2013||R|1|0|0|0|G|0|WEH|0|0|1|100|XEU|2547|4387|lyfalmen|||2|20|0|10,0000|Williams & Halls efh|Williams & Halls ehf|Celekoxíb||2372||2372|4387||2 558175|QM01AE9101|Rimadyl vet.|tuggutfl|20|mg|100|stk|1|pakki||QM01AE91|01.04.2015||R|0|0|0|0|0|0|ZOE|0|0|0|100|DKK|4043|7841|vetalmen|||0|100|0||Icepharma hf|Zoetis Finland OY|||4043||4043|7841||2 558770|L04AA2701|Gilenya|hylki|0,5|mg|28|stk|1|þpakki||L04AA27|01.09.2011||R|0|1|0|1|0|1|NEL|0|1|0|100|DKK|217862|276539|lyfsjukr|||1|28|0|28,0000|Vistor hf|Novartis Europharm Ltd|Fingolimod||||217862|276539||1 559286|C05BA0101|Hirudoid|krem|3|mg/g|100|g|1|túpa||C05BA01|01.08.1984||L|0|0|0|0|0|0|STD|0|0|0|100|IKR|||lyflausa|||0|100|0||Icepharma hf|STADA Arzneimittel AG|Heparínóíð|||||||2 559401|S01ED5104|Fotil|augndr|25|mg/ml|5|ml|1|glas|5+20 mg/ml|S01ED51|01.10.1995||R|0|0|0|0|G|0|SAO|0|0|0|100|XEU|1322|2942|lyfalmen|||1|5|0|25,0000|Icepharma hf|Santen Oy|Tímólól í blöndum||1322||1322|2942||2 559476|C05BA0101|Hirudoid|hlaup|3|mg/g|100|g|1|túpa||C05BA01|01.08.1984||L|0|0|0|0|0|0|STD|0|0|0|100|IKR|||lyflausa|||0|100|0||Icepharma hf|STADA Arzneimittel AG|Heparínóíð|||||||2 559948|G03CA0303|Estring|sk-hring|7,5|mcg/sólh|1|stk|1|pakki||G03CA03|01.07.1994||R|0|0|0|0|G|0|PER|0|0|0|100|DKK|4394|7170|lyfalmen|||1|1|0|90,0000|Icepharma hf|Pfizer ApS|Estradíól||4394||4394|7170||1 559971|C01DA0201|Discotrine|forðapl|10|mg/sólh|30|stk|1|þpakki||C01DA02|01.01.1994||R|0|0|0|0|G|0|MEB|0|0|0|100|SEK|2768|4932|lyfalmen|||1|30|0|60,0000|Vistor hf|Meda AB (V)|Glýcerýltrínítrat||2768||2768|4932||1 560060|S01XA2004|Vidisic|augngel|2|mg/g|10|g|1|túpa||S01XA20|01.04.1993||L|0|0|0|0|G|0|GEM|0|0|0|100|XEU|||lyfalmen|||0|10|0||Actavis Group hf|Gerhard Mann|Gervitár og aðrar óvirkar samsetningar|||||1517||1 560085|L01CD0105|Abraxane|irs|5|mg/ml|100|mg|1|hgl||L01CD01|01.05.2016||R|0|0|0|1|0|1|CLC|0|0|0|100|XEU|43385|57574|lyfsjukr|||1|100|0||Celgene AB|Celgene Europe Limited|Paklítaxel||43385||43385|57574||2 560326|J05AB0102|Zovir|töflur|200|mg|25|stk|1|þpakki||J05AB01|01.07.1989||R|1|0|0|0|G|0|GPH|0|0|1|100|GBP|1196|2665|lyfalmen|V0044|2281|1|25|0|1,2500|Vistor hf|GlaxoSmithKline Pharma A/S|Acíklóvír||1121||1121|2665||1 560367|D06BB0303|Zovir|krem|50|mg/g|2|g|1|túpa||D06BB03|01.07.1994||L|0|0|0|0|0|0|HCA|0|0|1|100|IKR|||lyflausa|||0|2|0||Artasan ehf|GlaxoSmithKline CH A/S|Acíklóvír|||||||1 560375|S01AD0301|Zovir|augnsm|30|mg/g|4,5|g|1|túpa||S01AD03|01.01.1988||R|0|0|0|0|G|0|GPH|0|0|1|100|GBP|1416|3071|lyfalmen|||1|4,5|0||Vistor hf|GlaxoSmithKline Pharma A/S|Acíklóvír||1416||1416|3071||1 560383|J05AB0102|Zovir|mixtúra|40|mg/ml|125|ml|1|glas||J05AB01|01.01.1995||R|0|0|0|0|G|0|GPH|0|0|1|100|GBP|4840|7784|lyfalmen|||1|125|0|1,2500|Vistor hf|GlaxoSmithKline Pharma A/S|Acíklóvír||4840||4840|7784||1 560391|J05AB0102|Zovir|mixtúra|80|mg/ml|100|ml|1|glas||J05AB01|01.01.1995||R|0|0|0|0|G|0|GPH|0|0|1|100|GBP|5326|8453|lyfalmen|||1|100|0|2,0000|Vistor hf|GlaxoSmithKline Pharma A/S|Acíklóvír||5326||5326|8453||1 560490|C01CX0801|Simdax|irþ|2,5|mg/ml|5|ml|1|lykja||C01CX08|01.09.2001||R|0|0|0|1|0|1|ORC|0|0|0|100|DKK|87147|112924|lyfsjukr|||1|5|0|1,1400|Vistor hf|Orion Corporation|Levosimendan||87147||87147|112924||1 560557|C01CX0801|Simdax|irþ|2,5|mg/ml|5|ml|4|lykjur||C01CX08|01.09.2001||R|0|0|0|1|0|1|ORC|0|0|0|100|DKK|400874|504155|lyfsjukr|||1|20|0|4,5500|Vistor hf|Orion Corporation|Levosimendan||400874||400874|504155||1 560695|L01XE0102|Imatinib Accord|filmhtfl|100|mg|60|stk|1|þpakki||L01XE01|01.11.2013||R|0|0|0|1|0|1|POF|0|1|0|100|DKK|151498|137902|lyfsjukr|||2|60|0||Alvogen|Alvogen|Imatiníb||106392||106392|137902||1 561159|S01ED5105|Fotil forte|augndr|45|mg/ml|5|ml|1|glas|5+40 mg/ml|S01ED51|01.10.1995||R|0|0|0|0|G|0|SAO|0|0|0|100|XEU|1446|3112|lyfalmen|||1|5|0|25,0000|Icepharma hf|Santen Oy|Tímólól í blöndum||1446||1446|3112||2 561780|C02KX0501|Adempas|filmhtfl|1,5|mg|42|stk|1|þpakki||C02KX05|01.12.2014||R|1|0|0|1|0|1|BYE|0|1|0|100|DKK|180636|230241|lyfsjukr|||1|42|0|14,0000|Vistor hf|Bayer Pharma AG|Riociguatum||180636||180636|230241||1 562014|C09BA0201|Darazið|töflur|32,5|mg|100|stk|1|glas|20+12,5 mg|C09BA02|01.06.2011||R|1|0|0|0|G|0|APC|0|0|0|100|XEU|1747|2607|lyfalmen|V0098|2150|2|100|0|100,0000|Actavis Group PTC ehf|Actavis Group PTC ehf|Enalapríl og þvagræsilyf||1079||1079|2607||1 562176|B02BD0901|BeneFIX|sts|500|ae|1|hgl|1|pakki|+leysir|B02BD09|01.02.2013||R|0|0|0|1|0|1|IPI|0|0|0|100|DKK|44208|58615|lyfsjukr|||1|1|0|1,1100|Icepharma hf|Pfizer Limited|Storkuþáttur IX||44208||44208|58615||1 562254|S01EE0105|Monoprost|augndr|50|mcg/ml|0,2|ml|90|sk-hyl|90 (18x5)|S01EE01|01.03.2013||R|0|0|0|0|G|0|TEA|0|0|0|100|SEK|4234|6950|lyfalmen|||1|18|0|90,0000|Vistor hf|Laboratories THEA|Latanóprost||4234||4234|6950||1 562577|J06BA0207|Kiovig|irl|100|mg/ml|300|ml|1|hgl||J06BA02|01.05.2013||R|0|0|0|0|0|1|BAA|0|1|0|100|SEK|253439|320787|lyfsjukr|||1|300|0||Icepharma hf|Baxter AG|Immúnóglóbúlín, normal, manna, gefin í æð||253439||253439|320787||2 562668|L04AA2601|Benlysta|irs|400|mg/hgl|1|hgl|1|pakki|lausn|L04AA26|01.12.2011||R|0|0|0|1|0|1|GGL|0|1|0|100|GBP|85054|110277|lyfsjukr|||1|1|0|16,0000|GlaxoSmithKline ehf|Glaxo Group Limited|Belimumab||85054||85054|110277||1 563111|L04AX0501|Esbriet|hylki|267|mg|63|stk|1|þpakki|hart|L04AX05|01.07.2012||R|1|1|0|1|0|0|RRL|0|0|0|100|DKK|100721|130849|lyfalmen|V0484|130849|1|63|0|7,0000|Icepharma hf|Roche Registration Limited|Pírfenidon||100721||100721|130849||2 563184|A10BD1101|Jentadueto|filmhtfl|1002,5|mg|60|stk|1|þpakki|2,5mg/1000mg|A10BD11|01.11.2015||R|0|0|0|0|G|0|BOE|0|0|0|100|DKK|5368|8511|lyfalmen|V0705|7836|1|60|0|30,0000|Vistor hf|Boehringer Ingelheim International GmbH|Metforminum og linagliptinum||5368||5368|8511||1 563379|D07AC1701|Cutivat|krem|0,5|mg/g|30|g|1|túpa||D07AC17|01.07.1995||R|0|0|0|0|G|0|GPH|0|0|1|100|GBP|637|1999|lyfalmen|||1|30|0||Vistor hf|GlaxoSmithKline Pharma A/S|Flútíkasón||637||637|1999||1 563395|D07AC1701|Cutivat|smyrsli|50|mcg/g|30|g|1|túpa||D07AC17|01.07.1995||R|0|0|0|0|G|0|GPH|0|0|1|100|GBP|633|1993|lyfalmen|||1|30|0||Vistor hf|GlaxoSmithKline Pharma A/S|Flútíkasón||633||633|1993||1 563502|N02AA0101|Contalgin|forðatfl|5|mg|100|stk|1|þpakki||N02AA01|01.10.1993||R|1|0|1|0|G|0|PER|0|0|0|100|DKK|1226|2810|lyfalmen|||1|100|0|5,0000|Icepharma hf|Pfizer ApS|Morfín||1226||1226|2810||1 563527|H05BX0102|Cinacalcet WH|filmhtfl|30|mg|28|stk|1|þpakki||H05BX01|01.02.2016||R|1|0|0|0|0|0|WEH|0|0|0|100|XEU|22199|30778|lyfalmen|V0720|28233|2|28|0|14,0000|Williams & Halls efh|Williams & Halls ehf|Cinacalcet||||22199|30778||2 563577|S01ED5104|Fotil|augndr|25|mg/ml|0,25|ml|60|sk-hyl|án rotvarnar|S01ED51|01.10.1995||R|0|0|0|0|G|0|SAO|0|0|0|100|XEU|3064|5339|lyfalmen|||1|15|0|60,0000|Icepharma hf|Santen Oy|Tímólól í blöndum||3064||3064|5339||2 563593|S01ED5105|Fotil forte|augndr|45|mg/ml|0,25|ml|60|sk-hyl|án rotvarnar|S01ED51|01.10.1995||R|0|0|0|0|G|0|SAO|0|0|0|100|XEU|3176|5494|lyfalmen|||1|15|0|60,0000|Icepharma hf|Santen Oy|Tímólól í blöndum||3176||3176|5494||2 563730|QJ01CE9003|Penethaone vet.|sts|5|m.ae/hgl|1|hgl|1|pakki|+leysir|QJ01CE90|01.03.2016||R|0|0|0|0|0|0|DIV|0|0|0|100|IKR|1486|2921|vetalmen|||0|1|0||Dýraheilsa ehf|Divasa-Farmavic S.A.|||||1486|2921||2 563756|H01CB0501|Signifor|stl|0,3|mg|1|ml|60|lykjur||H01CB05|01.11.2012||R|0|0|0|0|0|0|NEL|0|0|0|100|DKK|412052|518057|lyfalmen|||1|60|0|15,0000|Vistor hf|Novartis Europharm Ltd|PAsireótið disapartate||412052||412052|518057||1 563899|QP54AA0105|Noromectin|áhella|0,5|% w/v|1000|ml|1|fl|lausn|QP54AA01|01.11.2011||R|0|0|0|0|0|0|NOB|0|0|0|100|IKR|10463|18034|vetorma|||0|1000|0||Norbrook Laboratories Limited|Norbrook Laboratories Limited|Ivermectinum||10463||10463|18034||2 563918|N02AA0505|Oxycodone ratiopharm|forðatfl|5|mg|28|stk|1|þpakki||N02AA05|01.04.2013||R|1|0|1|0|G|0|RAT|0|0|0|100|XEU|595|1941|lyfalmen|V0596|1863|2|28|0|1,8600|LYFIS ehf|ratiopharm GmbH|Oxýcódon||595||595|1941||2 564088|J05AB0401|Rebetol|hylki|200|mg|168|stk|1|þpakki|hart|J05AB04|01.02.2002||R|1|0|0|1|0|1|MLD|0|0|0|100|DKK|61841|80917|lyfsjukr|||1|168|0|33,6000|Vistor hf|Merck Sharp & Dohme Limited|Ribavirin||61841||61841|80917||1 564110|A02BX1302|Galieve Cool Mint|mixtúra|||150|ml|1|glas|dreifa|A02BX13|01.10.2014||L|0|0|0|0|0|0|RBS|0|0|0|100|IKR|||lyflausa|||0|150|0||Artasan ehf|Reckitt Benckiser (Scandinavia) A/S|Algínsýra|||||||1 564270|B02BD0206|Advate|sts|250|ae|1|hgl|1|pakki|+leysir|B02BD02|01.12.2015||R|0|0|0|1|0|1|BER|0|1|0|100|SEK|21190|29502|lyfsjukr|||1|1|0|0,5000|Lyfjaver ehf|Baxter AG (L)|Storkuþáttur VIII||21190||21190|29502||3 564441|R06AX2701|Aerius|mixtúra|0,5|mg/ml|120|ml|1|glas||R06AX27|01.11.2012||R|1|0|0|0|G|0|MLD|0|0|1|100|DKK|945|2423|lyfalmen|||1|120|0|12,0000|Vistor hf|Merck Sharp & Dohme Limited|Deslóratadín||945||945|2423||1 564918|A02BC0113|Omeprazol Sandoz|sþ-hylki|20|mg|28|stk|1|þpakki||A02BC01|01.10.2015||L|1|0|0|0|0|0|SHS|0|0|0|100|IKR|||lyflausa|||2|28|0|28,0000|Artasan ehf|Sandoz A/S|Ómeprazól|||||||1 565046|B05BB0114|Natriumklorid Fresenius Kabi|irl|9|mg/ml|250|ml|20|pokar|Kabipac|B05BB01|01.11.2015||R|0|0|0|0|0|1|FKA|0|0|0|100|DKK|2350|4357|lyfsjukr|||1|5000|0||Vistor hf|Fresenius Kabi AB|Elektrólýtar||2350||2350|4357||1 565306|A02BX1302|Galieve Cool Mint|mixtúra|||300|ml|1|glerfl|dreifa|A02BX13|01.12.2010||L|0|0|0|0|0|0|RBS|0|0|0|100|IKR|||lyflausa|||0|300|0||Artasan ehf|Reckitt Benckiser (Scandinavia) A/S|Algínsýra|||||||1 565400|N05AH0411|Quetiapine Teva|filmhtfl|200|mg|100|stk|1|þpakki||N05AH04|01.12.2014||R|1|0|0|0|G|0|TSB|0|0|0|100|IKR|7600|7454|lyfalmen|V0286|7415|2|100|0|50,0000|Medical ehf|Teva Sweden AB|Quetíapín||4600||4600|7454||2 565457|A07EC0301|Dipentum|töflur|500|mg|100|stk|1|glas||A07EC03|01.10.1994||R|1|0|0|0|G|0|ATN|0|0|0|100|DKK|9337|13974|lyfalmen|V0714|13974|1|100|0|50,0000|Pharmanovia A/S|Atnahs Pharma UK Ltd|Olsalazín||9337||9337|13974||1 565982|H01BA0401|Glypressin|stl|0,1|mg/ml|8,5|ml|5|lykjur|lausn|H01BA04|01.08.2012||R|0|0|0|0|0|1|FEL|0|0|0|100|DKK|21781|30249|lyfsjukr|||1|42,5|0|0,3600|Vistor hf|Ferring Lægemidler A/S|Terlípressín||21781||21781|30249||1 566182|S01EC0401|Azopt|augndr|10|mg/ml|5|ml|1|glas||S01EC04|01.01.2001||R|0|0|0|0|G|0|ALA|0|0|0|100|USD|1418|3074|lyfalmen|V0444|2293|1|5|0|25,0000|Vistor hf|Alcon Laboratories Ltd.|Brinzólamíð||1418||1418|3074||1 566243|G03AA1207|Cleonita|filmhtfl|||84|stk|1|þpakki|0,02mg/3mg|G03AA12|01.07.2014||R|0|0|0|0|0|0|AGP|0|0|0|100|XEU|2731|4881|lyfalmen|V0193|4881|2|84|0|84,0000|Actavis Group hf|Actavis Group PTC ehf|Dróspírenón og ethinylestradíól||2731||2731|4881||1 566924|R03AK0705|Bufomix Easyhaler|innönddu|164,5|mcg/sk|360|skammtar|1|pakki|160+4,5 mcg/sk|R03AK07|01.11.2014||R|0|0|0|0|G|0|COR|0|0|0|100|DKK|13146|19216|lyfalmen|||2|360|0|90,0000|Vistor hf|Orion Corporation|Formóteról og budesonide||13146||13146|19216||1 567028|L01XE0701|Tyverb|filmhtfl|250|mg|84|stk|1|glas||L01XE07|01.02.2012||R|1|0|0|1|0|1|NEL|0|0|0|100|DKK|217036|275512|lyfsjukr|||1|84|0||Vistor hf|Novartis Europharm Ltd|Labatinibum||217036||217036|275512||1 567338|G04BD1201|Betmiga|forðatfl|50|mg|90|stk|1|glas||G04BD12|01.07.2014||R|1|0|0|0|G|0|APE|0|0|0|100|XEU|15348|22247|lyfalmen|V0651|22247|1|90|0|90,0000|Vistor hf|Astellas Phama Europe B.V.|Mírabegrón||15348||15348|22247||1 567400|G03CA0401|Ovestin|sk-krem|1|mg/g|15|g|1|túpa|+stjaka|G03CA04|01.06.2015||L|0|0|0|0|G|0|APP|0|0|0|100|DKK|||lyfalmen|||0|15|0|75,0000|Artasan ehf|Aspen Pharma Trading Limited|Estríól|||||2768||1 567460|C01CA2407|Jext|stl|150|mcg|1|stk|1|pakki|áfylltur penni|C01CA24|01.10.2011||R|0|0|0|0|G|0|ALK|0|0|1|100|DKK|5153|8215|lyfalmen|||1|1|0|0,3000|Vistor hf|ALK-Abello A/S|Adrenalín tartrat||||5153|8215||1 567503|N05AX0801|Risperdal|filmhtfl|1|mg|60|stk|1|þpakki||N05AX08|01.01.1995||R|1|0|0|0|G|0|JAS|0|0|0|100|SEK|2592|4690|lyfalmen|V0291|2361|1|60|0|12,0000|Vistor hf|Janssen-Cilag AB|Risperídón||2592||2592|4690||1 567510|C07AG0101|Trandate|filmhtfl|200|mg|100|stk|1|glas||C07AG01|01.06.2013||R|1|0|0|0|G|0|APP|0|0|0|100|GBP|2688|4822|lyfalmen|||1|100|0|33,3333|Artasan ehf|Aspen Pharma Trading Limited|Labetalól||2688||2688|4822||1 567511|N05AX0801|Risperdal|filmhtfl|2|mg|60|stk|1|þpakki||N05AX08|01.01.1995||R|1|0|0|0|G|0|JAS|0|0|0|100|SEK|5022|8034|lyfalmen|V0292|3806|1|60|0|24,0000|Vistor hf|Janssen-Cilag AB|Risperídón||5022||5022|8034||1 567545|R01AC0201|Livostin|nefúði|0,5|mg/úðask|15|ml|1|glas||R01AC02|01.06.1998||L|0|0|0|0|0|0|MCS|0|0|1|100|IKR|||lyflausa|||0|15|0|12,5000|Vistor hf|McNeil Sweden AB|Levókabastín|||||||1 568709|R01AX0601|Bactroban Nasal|nefsm|20|mg/g|3|g|1|túpa||R01AX06|01.07.1994||R|0|0|0|0|0|0|GPH|0|0|1|100|GBP|1017|2522|lyfalmen|||1|3|0||Vistor hf|GlaxoSmithKline Pharma A/S|Mupirocin||1017||1017|2522||1 568812|N03AX2201|Fycompa|filmhtfl|2|mg|7|stk|1|þpakki||N03AX22|01.01.2015||R|1|0|0|0|G|0|EUR|0|0|0|100|SEK|5285|8396|lyfalmen|||1|7|0|1,7500|Vistor hf|Eisai Europe Ltd.|Perampanel||5285||5285|8396||1 568840|C08CA0201|Feldil|forðatfl|5|mg|100|stk|1|glas||C08CA02|01.04.2003||R|1|0|0|0|G|0|ACA|0|0|0|100|XEU|2576|2558|lyfalmen|V0058|2499|2|100|0|100,0000|Actavis Group hf|Actavis hf|Felódipín||1043||1043|2558||1 568865|C08CA0201|Feldil|forðatfl|10|mg|100|stk|1|glas||C08CA02|01.04.2003||R|1|0|0|0|G|0|ACA|0|0|0|100|XEU|3473|3993|lyfalmen|V0059|3875|2|100|0|200,0000|Actavis Group hf|Actavis hf|Felódipín||2086||2086|3993||1 568945|N05AX1206|Aripiprazole ratiopharm|töflur|15|mg|56|stk|1|þpakki||N05AX12|01.10.2015||R|1|0|0|0|G|0|RAT|0|0|0|100|IKR|20454|22525|lyfalmen|V0684|21002|2|56|0|56,0000|LYFIS ehf|ratiopharm GmbH|Aripiprazól||15550||15550|22525||2 569257|J05AR1301|Triumeq|filmhtfl|950|mg|30|stk|1|glas|50+600+300 mg|J05AR13|01.12.2014||R|0|1|0|1|0|1|VII|0|0|0|100|GBP|132017|169772|lyfsjukr|||1|30|0||GlaxoSmithKline ehf|ViiV Healthcare UK Ltd|Abacavír, dolutegravír og lamivudín||132017||132017|169772||1 569378|L01AA0601|Holoxan|sts/irs|2000|mg|1|stk|1|hgl||L01AA06|01.07.2013||R|0|0|0|1|0|1|BAM|0|0|0|100|SEK|10557|15653|lyfsjukr|||1|1|0||Icepharma hf|Baxter Medical AB|Ífosfamíð||10557||10557|15653||2 569467|M03BX0103|Lioresal|stl|2|mg/ml|5|ml|1|lykja|stl.intrathecal.|M03BX01|01.10.1995||R|0|0|0|1|0|1|HES|0|0|0|100|DKK|13658|19921|lyfsjukr|||1|5|0|18,1800|Vistor hf|Novartis Healthcare A/S|Baklófen||13658||13658|19921||1 569483|M03BX0103|Lioresal|stl|0,5|mg/ml|20|ml|1|lykja|stl.intrathecal.|M03BX01|01.10.1995||R|0|0|0|1|0|1|HES|0|0|0|100|DKK|15707|22741|lyfsjukr|||1|20|0|18,1800|Vistor hf|Novartis Healthcare A/S|Baklófen||15707||15707|22741||1 570258|N06BA0702|Modafinil Bluefish|töflur|100|mg|30|stk|1|þpakki||N06BA07|01.11.2015||R|1|0|0|1|0|0|BLP|0|0|0|100|IKR|7200|7729|lyfalmen|V0657|7729|2|30|0|10,0000|LYFIS ehf|Bluefish Pharmaceuticals AB|Modafinil||4800||4800|7729||2 570421|L01BA0110|Metojectpen|stl|10|mg|1|áf-penni|1|pakki||L01BA01|01.05.2016||R|0|0|0|1|G|0|WIL|0|0|0|100|XEU|2537|4614|lyfalmen|||1|1|0||Williams & Halls efh|medac Gesellschaft|Metótrexat||2537||2537|4614||2 571030|QM01AA9001|Danilon equidos|kyrni|1,5|g|10|g|18|pokar||QM01AA90|01.07.2014||R|0|0|0|0|0|0|EST|0|0|0|100|DKK|3011|5883|vetalmen|||0|180|0||Vistor hf|Laboratorios Dr. ESTEVE S.A.|Suxibuzone||3011||3011|5883||1 571158|A04AA0107|Ondansetron Bluefish|filmhtfl|8|mg|15|stk|1|þpakki||A04AA01|01.12.2015||R|1|0|0|0|G|0|BLP|0|0|1|100|IKR|3100|5389|lyfalmen|V0384|4346|2|15|0|7,5000|LYFIS ehf|Bluefish Pharmaceuticals AB|Ondansetrón||3100||3100|5389||2 571181|R07AA0201|Curosurf|innö.guf|80|mg/ml|1,5|ml|1|hgl||R07AA02|01.01.2015||R|0|0|0|1|0|1|TPA|0|0|0|100|DKK|73490|95651|lyfsjukr|||1|1,5|0|0,7500|Vistor hf|Takeda Pharma A/S|Náttúrulegir fosfólípíðar||73490||73490|95651||1 571217|B02BD0206|Advate|sts|500|ae|1|hgl|1|pakki|+leysir|B02BD02|01.04.2014||R|0|0|0|1|0|1|BER|0|1|0|100|SEK|40130|53457|lyfsjukr|||1|1|0|1,0000|Lyfjaver ehf|Baxter AG (L)|Storkuþáttur VIII||||40130|53457||3 571285|L01XE1301|Giotrif|filmhtfl|40|mg|28|stk|1|þpakki||L01XE13|01.05.2016||R|0|0|0|1|0|1|BOE|0|0|0|100|DKK|263689|333535|lyfsjukr|||1|28|0||Vistor hf|Boehringer Ingelheim International GmbH|Afatiníb||263689||263689|333535||1 571358|L01XC1501|Gazyvaro|irþ|1000|mg|1|hgl|1|pakki||L01XC15|01.02.2015||R|0|0|0|1|0|1|RRL|0|0|0|100|DKK|484360|607988|lyfsjukr|||1|1|0||Icepharma hf|Roche Registration Limited|Obinutuzumab||484360||484360|607988||2 571524|A02BX1303|Galieve Peppermint|tuggutfl|||24|stk|1|þpakki|dreifa|A02BX13|01.12.2010||L|0|0|0|0|0|0|RBS|0|0|0|100|IKR|||lyflausa|||0|24|0||Artasan ehf|Reckitt Benckiser (Scandinavia) A/S|Algínsýra|||||||1 571628|N06AX2109|Duloxetine ratiopharm|sþ-hylki|30|mg|100|stk|1|glas||N06AX21|01.12.2015||R|0|0|0|0|0|0|RGM|0|0|0|100|IKR|7600|10206|lyfalmen|||2|100|0|50,0000|Medical ehf|ratiopharm GmbH|Duloxetín||6600||6600|10206||2 572422|L04AD0201|Advagraf|forðahlk|5|mg|50|stk|1|þpakki||L04AD02|01.03.2012||R|0|0|0|1|G|0|APE|0|0|0|100|XEU|70933|92417|lyfalmen|||1|50|0|50,0000|Vistor hf|Astellas Phama Europe B.V.|Tacrolimus||70933||70933|92417||1 572798|A02BX1303|Galieve Peppermint|tuggutfl|||48|stk|1|þpakki|dreifa|A02BX13|01.12.2010||L|0|0|0|0|0|0|RBS|0|0|0|100|IKR|||lyflausa|||0|48|0||Artasan ehf|Reckitt Benckiser (Scandinavia) A/S|Algínsýra|||||||1 573065|A02BC0506|Esomeprazole Krka (LYFIS)|sþ-hylki|20|mg|98|stk|1|glas||A02BC05|01.08.2011||R|1|0|0|0|G|0|LYF|0|0|0|100|IKR|3828|5417|lyfalmen|V0011|5285|3|98|0|65,3300|LYFIS ehf|LYFIS ehf|Esómeprazól||3120||3120|5417||2 573069|N03AX1108|Topiramat Bluefish|filmhtfl|50|mg|60|stk|1|þpakki||N03AX11|01.05.2016||R|1|0|0|0|G|0|BLP|0|0|0|100|XEU|2828|3304|lyfalmen|V0248|3304|2|60|0|10,0000|LYFIS ehf|Bluefish Pharmaceuticals AB|Tópíramat||1585||1585|3304||2 573072|D11AX2101|Mirvaso|hlaup|3|mg/g|30|g|1|túpa||D11AX21|01.11.2015|31.03.2016|R|0|0|0|0|0|0|GAL|0|0|0|100|XEU|6826|10518|lyfalmen|||1|30|0||Icepharma hf|Galderma International|Brimonidine||6826||6826|10518||2 573120|N03AX0903|Lamotrin|dreifit.|100|mg|98|stk|1|þpakki||N03AX09|01.12.2010||R|0|0|0|0|G|0|ACA|0|0|0|100|IKR|5300|3550|lyfalmen|V0245|3528|2|98|0|32,6700|Actavis Group hf|Actavis hf|Lamótrigín||1764||1764|3550||1 573177|S01ED5110|Duotrav|augndr|||2,5|ml|1|glas|40 mcg/ml+5 mg/ml|S01ED51|01.10.2011||R|0|0|0|0|G|0|ALA|0|0|0|100|USD|3637|6128|lyfalmen|V0464|4854|1|2,5|0|25,0000|Vistor hf|Alcon Laboratories Ltd.|Tímólól í blöndum||3637||3637|6128||1 573382|J05AX6501|Harvoni|filmhtfl|490|mg|28|stk|1|glas|400 mg + 90 mg|J05AX65|01.09.2015||R|1|0|0|1|0|1|GIL|0|0|0|100|DKK|2238558|2789719|lyfsjukr|||1|28|0||Gilead Sience Sweden AB|Gilead Science International Limited|Sofosbuvir og ledipasvir||||2238558|2789719|| 573436|N06DX0102|Memantine Merz|filmhtfl|20|mg|98|stk|1|þpakki||N06DX01|01.07.2013||R|1|0|0|0|G|0|LBK|0|0|0|100|DKK|13173|11389|lyfalmen|V0607|10877|2|98|0|98,0000|Lundbeck Export A/S|H. Lundbeck A/S|Memantín||7459||7459|11389||1 573477|L01XC0301|Herceptin|sts|150|mg/hgl|1|hgl|1|pakki||L01XC03|01.01.2002||R|0|0|0|1|0|1|ROC|0|1|0|100|DKK|76143|99006|lyfsjukr|||1|1|0||Icepharma hf|Roche|Trastuzumab||76143||76143|99006||2 573634|J01DH0201|Meronem|sts/irs|500|mg/hgl|500|mg|10|hgl||J01DH02|01.10.1995||R|0|0|0|0|0|1|AZA|0|0|0|100|SEK|15177|22012|lyfsjukr|||1|5000|0|2,5000|Vistor hf|AstraZeneca AB|Meropenem||15177||15177|22012||1 573642|J01DH0201|Meronem|sts/irs|1|g/hgl|1|g|10|hgl||J01DH02|01.10.1995||R|0|0|0|0|0|1|AZA|0|0|0|100|SEK|24882|34171|lyfsjukr|||1|10|0|5,0000|Vistor hf|AstraZeneca AB|Meropenem||24882||24882|34171||1 573790|M01AB0506|Voltaren Rapid|töflur|50|mg|100|stk|1|þpakki||M01AB05|01.01.1996||R|1|0|0|0|G|0|HES|0|0|1|100|DKK|2189|2667|lyfalmen|V0189|2123|1|100|0|50,0000|Vistor hf|Novartis Healthcare A/S|Díklófenak||1122||1122|2667||1 573999|G04BE0307|Sildenafil Mylan|filmhtfl|100|mg|12|stk|1|þpakki||G04BE03|01.08.2013||R|1|0|0|0|0|0|MYL|0|0|0|100|SEK|5206|4873|lyfalmen|V0144|4873|2|12|0|24,0000|Icepharma hf|Mylan AB|Síldenafíl||2725||2725|4873||2 574357|N06AX2106|Duloxetin W&H|sþ-hylki|60|mg|500|stk|1|glas||N06AX21|01.01.2016||R|2|0|0|0|0|0|WEH|0|0|0|100|XEU|73777|54217|lyfalmen|||2|500|0|500,0000|Williams & Halls efh|Williams & Halls ehf|Duloxetín||40731||40731|54217||2 574423|L01XC1301|Perjeta|irþ|420|mg|14|ml|1|hgl||L01XC13|01.06.2013||R|0|0|0|1|0|1|RRL|0|1|0|100|DKK|371011|467014|lyfsjukr|||1|14|0||Icepharma hf|Roche Registration Limited|Pertuzumab||371011||371011|467014||2 574900|N05AH0410|Quetiapin Actavis|forðatfl|200|mg|100|stk|1|þpakki||N05AH04|01.09.2013||R|1|0|0|0|G|0|APC|0|0|0|100|XEU|20073|23842|lyfalmen|V0273|23842|2|100|0|50,0000|Actavis Group PTC ehf|Actavis Group PTC ehf|Quetíapín||16507||16507|23842|| 575324|N06AB0601|Zoloft|töflur|50|mg|28|stk|1|þpakki||N06AB06|01.10.1995||R|1|0|0|0|G|0|PER|0|0|0|100|DKK|2196|2128|lyfalmen|V0151|1689|1|28|0|28,0000|Icepharma hf|Pfizer ApS|Sertralín||731||731|2128||1 575340|N06AB0601|Zoloft|töflur|50|mg|98|stk|1|þpakki||N06AB06|01.10.1995||R|1|0|0|0|G|0|PER|0|0|0|100|DKK|6841|6441|lyfalmen|V0322|1956|1|98|0|98,0000|Icepharma hf|Pfizer ApS|Sertralín||3864||3864|6441|| 575357|N06AB0601|Zoloft|töflur|100|mg|28|stk|1|þpakki||N06AB06|01.03.2001||R|1|0|0|0|G|0|PER|0|0|0|100|DKK|4050|2128|lyfalmen|V0152|2128|1|28|0|56,0000|Icepharma hf|Pfizer ApS|Sertralín||731||731|2128||1 575365|N06AB0601|Zoloft|töflur|100|mg|98|stk|1|þpakki||N06AB06|01.03.2001||R|1|0|0|0|G|0|PER|0|0|0|100|DKK|12330|6441|lyfalmen|V0323|3223|1|98|0|196,0000|Icepharma hf|Pfizer ApS|Sertralín||3864||3864|6441||1 575504|B02BD0801|NovoSeven|sts|8|mg|1|hgl|1|pakki|+áfyllt sprauta með leysi|B02BD08|01.10.2015||R|0|1|0|1|0|1|NAS|0|0|0|100|DKK|765085|957132|lyfsjukr|||1|1|0|0,1600|Vistor hf|Novo-Nordisk A/S|Eptacog alfa (virkjað)||765085||765085|957132||1 575571|J01CA0413|Amoxin|filmhtfl|500|mg|20|stk|1|þpakki||J01CA04|01.03.2013||R|0|0|0|0|0|0|RGM|0|0|1|100|IKR|1117|1948|lyfalmen|V0159|1948|2|20|0|10,0000|Medical ehf|ratiopharm GmbH|Amoxicillín||600||600|1948||2 575589|J01CA0413|Amoxin|filmhtfl|500|mg|30|stk|1|þpakki||J01CA04|01.03.2013||R|0|0|0|0|0|0|RGM|0|0|1|100|IKR|1285|2361|lyfalmen|V0160|2361|2|30|0|15,0000|Medical ehf|ratiopharm GmbH|Amoxicillín||900||900|2361||2 575621|J01CA0413|Amoxin|filmhtfl|750|mg|20|stk|1|þpakki||J01CA04|01.03.2013||R|0|0|0|0|0|0|RGM|0|0|1|100|IKR|1453|2361|lyfalmen|V0158|2361|2|20|0|15,0000|Medical ehf|ratiopharm GmbH|Amoxicillín||900||900|2361||2 576032|N03AX0903|Lamotrin|dreifit.|25|mg|42|stk|1|þpakki||N03AX09|01.12.2010||R|0|0|0|0|G|0|ACA|0|0|0|100|IKR|945|1585|lyfalmen|V0243|1405|2|42|0|3,5000|Actavis Group hf|Actavis hf|Lamótrigín||336||336|1585||1 576123|L04AX0601|Imnovid|hylki|1|mg|21|stk|1|þpakki||L04AX06|01.04.2016||R|0|1|0|1|0|1|CEE|0|0|0|100|XEU|1202204|1500785|lyfsjukr|||1|21|0|7,0000|Celgene Europe ltd|Celgene Europe ltd|Pomalidómide||1202204||1202204|1500785||2 576714|L01BB0201|Puri-nethol|töflur|50|mg|25|stk|1|glas||L01BB02|01.12.2012||R|0|0|0|0|G|0|APP|0|0|0|100|XEU|9025|13544|lyfalmen|||1|25|0||Artasan ehf|Aspen Pharma Trading Limited|Merkaptópúrín||9025||9025|13544||1 577135|C09DX0401|Entresto|filmhtfl|100|mg|56|stk|1|þpakki|49 + 51 mg|C09DX04|01.04.2016||R|0|0|0|0|0|0|NEL|0|0|0|100|DKK|18874|27100|lyfalmen|V0727|24772|1|56|0|28,0000|Vistor hf|Novartis Europharm Ltd|Valsartan og sacubitril||18874||18874|27100||1 577455|C10AA0506|Atorvaratio|filmhtfl|20|mg|100|stk|1|þpakki||C10AA05|01.07.2014||R|1|0|0|0|G|0|TSB|0|0|0|100|IKR|4000|2567|lyfalmen|V0113|2567|2|100|0|100,0000|Medical ehf|Teva Sweden AB|Atorvastatín||1050||1050|2567||2 577711|C01CA0601|Fenylefrin Abcur|stl|0,05|mg/ml|10|ml|10|lykjur||C01CA06|01.09.2013||R|0|0|0|0|0|1|ABC|0|0|0|100|SEK|11370|16772|lyfsjukr|||2|100|0|1,2500|Icepharma hf|Abcur AB|Phenylephrin||11370||11370|16772||2 578261|J07AH0703|NeisVac-C|stl|||0,5|ml|1|spr|áfyllt sprauta|J07AH07|01.07.2015||R|0|0|0|0|0|0|PIS|0|0|0|100|USD|4205|6910|lyfalmen|||1|0,5|0||Icepharma hf|Pfizer ApS|Hreinsuð meningókokka C, poly­sakkaríð mótefnavakar||4205||4205|6910||2 578654|QP52AA5104|Zantel|töflur|550|mg|20|stk|1|þpakki|50+500 mg|QP52AA51|01.07.2011||R|0|0|0|0|0|0|ICE|0|0|0|100|USD|5829|10047|vetorma|||0|20|0||Icepharma hf|Icepharma hf|||5829||5829|10047||2 579110|R03CC0301|Bricanyl|stl|0,5|mg/ml|1|ml|10|lykjur||R03CC03|01.12.1972||R|0|0|0|0|G|0|AZD|0|0|0|100|SEK|1063|2585|lyfalmen|||1|10|0|0,3300|Vistor hf|AstraZeneca A/S DK|Terbútalín||1063||1063|2585||1 579171|C08DA0103|Isoptin retard|forðatfl|240|mg|98|stk|1|þpakki||C08DA01|01.01.2016||R|1|0|0|0|G|0|GPB|0|0|0|100|DKK|2271|4248|lyfalmen|V0710|4248|1|98|0|98,0000|Vistor hf|BGP Products AB|Verapamíl||2271||2271|4248|| 579421|A02BC0506|Esomeprazole Krka (LYFIS)|sþ-hylki|40|mg|28|stk|1|þpakki||A02BC05|01.08.2011||R|1|0|0|0|0|0|LYF|0|0|0|100|IKR|1671|2499|lyfalmen|V0005|2344|3|28|0|37,3300|LYFIS ehf|LYFIS ehf|Esómeprazól||1000||1000|2499||2 579854|L04AX0305|Methotrexate Pfizer|töflur|2,5|mg|30|stk|1|glas||L04AX03|01.01.1994||R|0|0|0|0|G|0|PER|0|0|0|100|DKK|324|1568|lyfalmen|||1|30|0|30,0000|Icepharma hf|Pfizer ApS|Metótrexat||324||324|1568||1 579932|C03DA0402|Eplerenone Portfarma|filmhtfl|25|mg|30|stk|1|þpakki||C03DA04|01.06.2014||R|1|0|0|0|0|0|POF|0|0|0|100|DKK|7207|4128|lyfalmen|V0107|4091|2|30|0|15,0000|Alvogen|Alvogen|Eplerenón||2184||2184|4128||1 579972|C03DA0403|Eplerenon Bluefish|filmhtfl|50|mg|100|stk|1|þpakki||C03DA04|01.05.2015||R|1|0|0|0|0|0|BLP|0|0|0|100|IKR|30623|15161|lyfalmen|V0111|14780|2|100|0|100,0000|LYFIS ehf|Bluefish Pharmaceuticals AB|Eplerenón||10200||10200|15161||2 580042|C05AA0801|Doloproct|eþ-stíll|||10|stk|1|þpakki||C05AA08|01.02.2015||R|0|0|0|0|0|0|BAB|0|0|0|100|DKK|662|2033|lyfalmen|||1|10|0||Icepharma hf|Bayer AB|Flúókortólón||662||662|2033||2 580104|N07BB0501|Selincro|filmhtfl|18|mg|14|stk|1|þpakki||N07BB05|01.06.2013||R|1|0|0|0|0|0|LBK|0|0|0|100|DKK|7605|11590|lyfalmen|||1|14|0|14,0000|Lundbeck Export A/S|H. Lundbeck A/S|Nalmefenum||7605||7605|11590||1 580144|L01CD0203|Docetaxel Kabi|irþ|20|mg/ml|8|ml|1|hgl|lausn|L01CD02|01.01.2016||R|0|0|0|1|0|1|PLC|0|0|0|100|DKK|6707|10354|lyfsjukr|||1|8|0||Icepharma hf|Fresenius Kabi Oncology Plc.|Docetaxel||6707||6707|10354||2 580960|B05BB0117|Natriumklorid Baxter Viaflo 9 mg/ml|irl|9|mg/ml|1000|ml|10|pokar|lausn|B05BB01|01.07.2013||R|0|0|0|0|0|1|BAM|0|0|0|100|SEK|1566|3278|lyfsjukr|||1|10000|0||Icepharma hf|Baxter Medical AB|Elektrólýtar||1566||1566|3278||2 581417|S01ED5116|Taptiqom|augndr|||0,3|ml|30|Sk-ílá|15mcg/ml + 5mg/ml|S01ED51|01.07.2015||R|0|0|0|0|G|0|SAO|0|0|0|100|XEU|2888|5097|lyfalmen|||1|9|0|30,0000|Icepharma hf|Santen Oy|Tímólól í blöndum||2888||2888|5097||2 581661|N02CC0403|Rizatriptan Portfarma|munndr.t|5|mg|6|stk|1|þpakki||N02CC04|01.01.2015||R|0|0|0|0|G|0|POF|0|0|0|100|XEU|3222|4931|lyfalmen|V0620|4931|2|6|0|3,0000|Alvogen|Alvogen|Rizatriptan||2767||2767|4931||1 581890|QN02AF0103|Torphasol vet.|stl|10|mg/ml|20|ml|1|hgl||QN02AF01|01.02.2011||R|0|0|0|0|0|0|ANI|1|0|0|100|XEU|12771|24400|vetalmen|||0|20|0||Dýraheilsa ehf|aniMedica GmbH|Bútorfanóltartrat||12771||12771|24400||2 581969|S01EE0401|Travatan|augndr|40|mcg/ml|2,5|ml|1|glas||S01EE04|01.07.2011||R|0|0|0|0|G|0|ASN|0|0|0|100|USD|2367|4380|lyfalmen|V0669|3739|0|2,5|0|25,0000|Alcon Nordic A/S|Alcon Laboratories Ltd.|Travóprost||2367||2367|4380||1 581991|QM01AE9101|Rimadyl vet.|tuggutfl|50|mg|100|stk|1|pakki||QM01AE91|01.04.2015||R|0|0|0|0|0|0|ZOE|0|0|0|100|DKK|6156|11850|vetalmen|||0|100|0||Icepharma hf|Zoetis Finland OY|||6156||6156|11850||2 582080|H01AC0107|Humatrope 6 mg|sts|6|mg/rörly|1|rörlykj|1|pakki||H01AC01|01.04.1989||R|0|0|0|1|0|1|ELI|0|1|0|100|XEU|19392|27813|lyfsjukr|||1|1|0|9,0000|Icepharma hf|Eli Lilly Danmark A/S|Sómatrópín||19392||19392|27813||2 582114|H01AC0108|Humatrope 12 mg|sts|12|mg/rörly|1|rörlykj|1|pakki||H01AC01|01.04.1989||R|0|0|0|1|0|1|ELI|0|1|0|100|XEU|37948|50697|lyfsjukr|||1|1|0|18,0000|Icepharma hf|Eli Lilly Danmark A/S|Sómatrópín||37948||37948|50697||2 582122|G03GA0503|Bemfola|stl|450|ae|0,75|ml|1|penni||G03GA05|01.01.2015||R|0|0|0|1|G|0|FBA|0|0|0|100|SEK|17318|24959|lyfalmen|||1|0,75|0|6,0000|Finox Biotech AG|Finox Biotech AG|Follitrópín alfa||17318||17318|24959||3 582130|H01AC0109|Humatrope 24 mg|sts|24|mg/rörly|1|rörlykj|1|pakki||H01AC01|01.04.1989||R|0|0|0|1|0|1|ELI|0|1|0|100|XEU|75896|98694|lyfsjukr|||1|1|0|36,0000|Icepharma hf|Eli Lilly Danmark A/S|Sómatrópín||75896||75896|98694||2 582221|V08AB0201|Omnipaque|stl|140|mg J/ml|200|ml|10|plastf||V08AB02|01.04.2011||R|0|0|0|0|0|1|GEH|0|0|0|100|NOK|22773|31504|lyfsjukr|||1|2000|0||Icepharma hf|GE Healthcare AS|Jóhexól||22773||22773|31504||2 582452|V08AB0201|Omnipaque|stl|300|mg J/ml|100|ml|10|plastf||V08AB02|01.06.2004||R|0|0|0|0|0|1|GEH|0|0|0|100|NOK|26124|35742|lyfsjukr|||1|1000|0||Icepharma hf|GE Healthcare AS|Jóhexól||26124||26124|35742||2 582635|V08AB0201|Omnipaque|stl|300|mg J/ml|500|ml|6|plastf||V08AB02|01.06.2004||R|0|0|0|0|0|1|GEH|0|0|0|100|NOK|59318|77726|lyfsjukr|||1|3000|0||Icepharma hf|GE Healthcare AS|Jóhexól||59318||59318|77726||2 582882|V08AB0901|Visipaque|stl|270|mg J/ml|100|ml|10|plastf|lausn|V08AB09|01.06.2004||R|0|0|0|0|0|1|GEH|0|0|0|100|NOK|23157|31990|lyfsjukr|||1|1000|0||Icepharma hf|GE Healthcare AS|Jódixanól||23157||23157|31990||2 582990|H01AC0104|Saizen|sts|8|mg/ml|1,5|ml|1|rörlyk||H01AC01|01.05.2011||R|0|0|0|1|0|1|EMA|0|1|0|100|SEK|32917|44334|lyfsjukr|||1|1,5|0|18,0000|Icepharma hf|E. Merck AB|Sómatrópín||32917||32917|44334||2 583105|S01EE0101|Xalatan|augndr|50|mcg/sk|2,5|ml|1|glas||S01EE01|01.08.2013||R|0|0|0|0|G|0|PER|0|0|0|100|DKK|2240|3618|lyfalmen|V0376|1118|1|2,5|0|25,0000|Icepharma hf|Pfizer ApS|Latanóprost||1813||1813|3618||1 583401|V08AB0901|Visipaque|stl|270|mg J/ml|200|ml|10|plastf|lausn|V08AB09|01.06.2004||R|0|0|0|0|0|1|GEH|0|0|0|100|NOK|47308|62536|lyfsjukr|||1|2000|0||Icepharma hf|GE Healthcare AS|Jódixanól||47308||47308|62536||2 583443|C07AA0705|Sotalol Mylan|töflur|80|mg|100|stk|1|þpakki||C07AA07|01.01.1994||R|1|0|0|0|G|0|MYL|0|0|0|100|SEK|937|2412|lyfalmen|||2|100|0|50,0000|Icepharma hf|Mylan AB|Sótalól||937||937|2412||2 583450|V08AB0901|Visipaque|stl|270|mg J/ml|500|ml|6|plastf|lausn|V08AB09|01.06.2004||R|0|0|0|0|0|1|GEH|0|0|0|100|NOK|79892|103748|lyfsjukr|||1|3000|0||Icepharma hf|GE Healthcare AS|Jódixanól||79892||79892|103748||2 583518|V08AB0901|Visipaque|stl|320|mg J/ml|100|ml|10|plastf|lausn|V08AB09|01.06.2004||R|0|0|0|0|0|1|GEH|0|0|0|100|NOK|25311|34714|lyfsjukr|||1|1000|0||Icepharma hf|GE Healthcare AS|Jódixanól||25311||25311|34714||2 583609|V08AB0901|Visipaque|stl|320|mg J/ml|200|ml|10|plastf|lausn|V08AB09|01.06.2004||R|0|0|0|0|0|1|GEH|0|0|0|100|NOK|40497|53921|lyfsjukr|||1|2000|0||Icepharma hf|GE Healthcare AS|Jódixanól||40497||40497|53921||2 583708|V08AB0901|Visipaque|stl|320|mg J/ml|500|ml|6|plastf|lausn|V08AB09|01.06.2004||R|0|0|0|0|0|1|GEH|0|0|0|100|NOK|75932|98740|lyfsjukr|||1|3000|0||Icepharma hf|GE Healthcare AS|Jódixanól||75932||75932|98740||2 583776|L01XE2301|Tafinlar|hylki|50|mg|28|stk|1|glas||L01XE23|01.11.2013||R|1|0|0|1|0|1|NEL|0|1|0|100|DKK|178015|226981|lyfsjukr|||1|28|0||Vistor hf|Novartis Europharm Ltd|Dabrafeníb||178015||178015|226981||1 584133|L03AB0502|IntronA|stl|18|millj ae|1,2|ml|1|penni|Fjölskammtapenni|L03AB05|01.10.2012||R|0|0|0|1|0|1|MLD|0|0|0|100|DKK|16425|23730|lyfsjukr|||1|1,2|0|9,0000|Vistor hf|Merck Sharp & Dohme Limited|Interferón alfa-2b||16425||16425|23730||1 584479|G04BE0307|Sildenafil Mylan|filmhtfl|50|mg|4|stk|1|þpakki||G04BE03|01.08.2013|31.03.2016|R|1|0|0|0|0|0|MYL|0|0|0|100|SEK|1539|2192|lyfalmen|||2|4|0|4,0000|Icepharma hf|Mylan AB|Síldenafíl||777||777|2192||2 584610|N03AX1609|Pregabalin Sandoz GmbH|hylki|25|mg|56|stk|1|þpakki||N03AX16|01.02.2016||R|1|0|0|0|0|0|SDG|0|0|0|100|DKK|1761|1894|lyfalmen|V0685|1375|2|56|0|4,6667|Artasan ehf|Sandoz GmbH (Kundl)|Pregabalín||561||561|1894||1 585130|N06DA0301|Exelon|forðapl|13,3|mg/sólh|60|pokar|1|pakki||N06DA03|01.02.2014|29.02.2016|R|0|1|0|0|G|0|NEL|0|0|0|100|DKK|37380|49979|lyfalmen|||1|60|0|84,0000|Vistor hf|Novartis Europharm Ltd|Rívastigmín||37380||37380|49979||1 585516|A10BX1201|Jardiance|filmhtfl|25|mg|90|stk|1|þpakki||A10BX12|01.07.2015||R|1|0|0|0|G|0|BOE|0|0|0|100|DKK|18347|26375|lyfalmen|||1|90|0|128,5700|Vistor hf|Boehringer Ingelheim International GmbH|Empagliflozin||18347||18347|26375||1 585661|B01AB0101|Heparin Leo|stl|100|ae/ml|10|ml|10|hgl||B01AB01|01.03.2014||R|0|0|0|0|0|0|LEP|0|0|1|100|DKK|5360|8500|lyfalmen|||1|100|0|1,0000|Vistor hf|LEO Pharma A/S|Heparín||5360||5360|8500||1 585679|B01AB0101|Heparin Leo|stl|5000|ae/ml|5|ml|5|hgl||B01AB01|01.12.1972||R|0|0|0|0|0|1|LEP|0|0|0|100|DKK|3998|6625|lyfsjukr|||1|25|0|12,5000|Vistor hf|LEO Pharma A/S|Heparín||3998||3998|6625||1 585975|C07AB0312|Atenolol LYFIS|filmhtfl|25|mg|100|stk|1|þpakki||C07AB03|01.05.2012||R|1|0|0|0|G|0|LYF|0|0|0|100|XEU|415|1495|lyfalmen|V0541|1495|2|100|0|33,3300|LYFIS ehf|LYFIS ehf|Atenólól||271||271|1495||2 586107|L04AD0102|Sandimmun Neoral|mixtúra|100|mg/ml|50|ml|1|glas||L04AD01|01.07.1994||R|0|0|0|0|G|0|HES|0|0|0|100|DKK|27316|37250|lyfalmen|||1|50|0|20,0000|Vistor hf|Novartis Healthcare A/S|Ciklospórín||27316||27316|37250||1 586223|J01GB0304|Gentamicin B. Braun|irl|3|mg/ml|80|ml|10|fl||J01GB03|01.08.2011||R|0|0|0|0|0|1|BRA|0|0|0|100|XEU|12542|18385|lyfsjukr|||2|800|0|10,0000|Actavis Group hf|Braun|Gentamícín||12542||12542|18385||1 586241|J01GB0101|Tobi Podhaler|innönddu|28|mg|224|stk|1|þpakki|hart hylki+innönd.tæki|J01GB01|01.04.2012||R|0|0|0|1|0|1|NEL|0|1|0|100|DKK|335356|422669|lyfsjukr|||1|224|0|56,0000|Vistor hf|Novartis Europharm Ltd|Tobramýcín||335356||335356|422669||1 586694|N06DX0103|Nemdatine|filmhtfl|20|mg|28|stk|1|þpakki||N06DX01|01.07.2013|31.03.2016|R|1|0|0|0|G|0|APC|0|0|0|100|XEU|4595|5093|lyfalmen|||2|28|0|28,0000|Actavis Group PTC ehf|Actavis Group PTC ehf|Memantín||2885||2885|5093||1 586967|B01AF0201|Eliquis|filmhtfl|5|mg|168|stk|1|þpakki||B01AF02|01.09.2014||R|1|1|0|0|G|0|BRP|0|0|0|100|DKK|26151|35777|lyfalmen|V0652|35777|1|168|0|84,0000|Icepharma hf|Bristol-Myers Squibb/Pfizer EEIG|Apixaban ||||26151|35777||1 587112|M01AH0106|Celecoxib Actavis|hylki|200|mg|100|stk|1|þpakki||M01AH01|01.12.2014||R|1|0|0|0|G|0|AGP|0|0|1|100|XEU|8008|7682|lyfalmen|V0196|7316|2|100|0|100,0000|Actavis Group hf|Actavis Group PTC ehf|Celekoxíb||4766||4766|7682||1 587437|N06DX0103|Nemdatine|filmhtfl|10|mg|28|stk|1|þpakki||N06DX01|01.07.2013|31.03.2016|R|1|0|0|0|G|0|APC|0|0|0|100|XEU|2486|2859|lyfalmen|||2|28|0|14,0000|Actavis Group PTC ehf|Actavis Group PTC ehf|Memantín||1262||1262|2859||1 587522|L04AB0601|Simponi|stl|100|mg|1|áf-penni|1|penni|áfylltur penni|L04AB06|01.11.2014||R|0|1|0|1|0|1|JAN|0|1|0|100|DKK|141099|181068|lyfsjukr|||1|1|0|60,2400|Vistor hf|Janssen Biologics B.V.|Golimumab||141099||141099|181068||1 587613|A02BC0112|Omezolmyl|sþ-hylki|40|mg|100|stk|1|þpakki||A02BC01|01.03.2015||R|0|0|0|0|G|0|MYL|0|0|0|100|SEK|6365|3053|lyfalmen|V0001|2643|2|100|0|200,0000|Icepharma hf|Mylan AB|Ómeprazól||1403||1403|3053||2 587641|C09DA0602|Candpress Comp|töflur|28,5|mg|100|stk|1|þpakki|16 + 12,5 mg|C09DA06|01.01.2012||R|1|0|0|0|0|0|AGP|0|0|0|100|XEU|4104|6032|lyfalmen|V0095|6032|2|100|0|100,0000|Actavis Group hf|Actavis Group PTC ehf|Candesartan og þvagræsilyf||3567||3567|6032||1 588001|A10BB1203|Glimepirid Bluefish|töflur|4|mg|90|stk|1|þpakki||A10BB12|01.10.2015||R|1|0|0|0|G|0|BLP|0|0|0|100|IKR|1522|1810|lyfalmen|V0494|1810|2|90|0|180,0000|LYFIS ehf|Bluefish Pharmaceuticals AB|Glímepíríð||500||500|1810||2 588195|N05AX1208|Aripiprazol W&H|töflur|10|mg|56|stk|1|þpakki||N05AX12|01.01.2016||R|0|1|0|0|G|0|WEH|0|0|0|100|XEU|18330|21002|lyfalmen|V0683|21002|2|56|0|37,3300|Williams & Halls efh|Williams & Halls ehf|Aripiprazól||14443||14443|21002||2 588457|N06DX0105|Memantine Mylan|filmhtfl|20|mg|98|stk|1|þpakki||N06DX01|01.10.2013|31.03.2016|R|1|0|0|0|G|0|GEN|0|0|0|100|SEK|30846|12866|lyfalmen|||2|98|0|98,0000|Icepharma hf|Generics UK Ltd|Memantín||8532||8532|12866||2 588574|J01FF0101|Dalacin|hylki|300|mg|20|stk|1|þpakki||J01FF01|01.10.1995||R|1|0|0|0|0|0|PER|0|0|1|100|DKK|1937|3788|lyfalmen|V0461|3787|1|20|0|5,0000|Icepharma hf|Pfizer ApS|Klindamýcín||1937||1937|3788||1 588608|B01AC0501|Ticlid|töflur|250|mg|100|stk|1|þpakki||B01AC05|01.04.1995||R|1|0|0|0|G|0|SNO|0|0|0|100|NOK|6933|10665|lyfalmen|||1|100|0|50,0000|Vistor hf|Sanofi-aventis Norge AS|Tíklópídín||6933||6933|10665||1 588669|N03AX2201|Fycompa|filmhtfl|12|mg|28|stk|1|þpakki||N03AX22|01.01.2015||R|1|0|0|0|G|0|EUR|0|0|0|100|SEK|21138|29436|lyfalmen|||1|28|0|42,0000|Vistor hf|Eisai Europe Ltd.|Perampanel||21138||21138|29436||1 588911|N05AH0306|Olanzapin Actavis|filmhtfl|10|mg|100|stk|1|glas||N05AH03|01.11.2012||R|1|0|0|0|G|0|AGP|0|0|0|100|XEU|8296|5704|lyfalmen|V0282|5341|2|100|0|100,0000|Actavis Group hf|Actavis Group PTC ehf|Olanzapín||3329||3329|5704||1 588912|N03AX1609|Pregabalin Sandoz GmbH|hylki|225|mg|56|stk|1|þpakki||N03AX16|01.02.2016||R|1|0|0|0|0|0|SDG|0|0|0|100|DKK|7970|7766|lyfalmen|V0688|6779|2|56|0|42,0000|Artasan ehf|Sandoz GmbH (Kundl)|Pregabalín||4827||4827|7766||1 588982|R03AK0604|Relanio|innönddu|300|mcg/sk|60|skammtar|1|pakki|50+250 mcg|R03AK06|01.01.2014||R|0|0|0|0|G|0|EPL|0|0|0|100|IKR|6000|7729|lyfalmen|||2|60|0|30,0000|LYFIS ehf|ELPEN Pharmaceutical Co. Inc.|Salmeteról og fluticason||4800||4800|7729||2 589153|L01XE2301|Tafinlar|hylki|50|mg|120|stk|1|glas||L01XE23|01.11.2013||R|1|0|0|1|0|1|NEL|0|1|0|100|DKK|762950|954476|lyfsjukr|||1|120|0||Vistor hf|Novartis Europharm Ltd|Dabrafeníb||762950||762950|954476||1 589358|QP54AA0501|Stronghold|bl.lausn|120|mg|1|ml|3|túpa||QP54AA05|01.04.2004||R|0|0|0|0|0|0|ZBE|1|0|0|100|XEU|5385|9282|vetorma|||0|3|0||Icepharma hf|Zoetis Belgium S.A.|Selamectinum||5385||5385|9282||2 589366|QP54AA0501|Stronghold|bl.lausn|15|mg|0,25|ml|3|túpa||QP54AA05|01.04.2004||R|0|0|0|0|0|0|ZBE|1|0|0|100|XEU|2087|3597|vetorma|||0|0,75|0||Icepharma hf|Zoetis Belgium S.A.|Selamectinum||2087||2087|3597||2 589374|QP54AA0501|Stronghold|bl.lausn|240|mg|2|ml|3|túpa||QP54AA05|01.04.2004||R|0|0|0|0|0|0|ZBE|1|0|0|100|XEU|5196|8956|vetorma|||0|6|0||Icepharma hf|Zoetis Belgium S.A.|Selamectinum||5196||5196|8956||2 589382|QP54AA0501|Stronghold|bl.lausn|30|mg|0,25|ml|3|túpa||QP54AA05|01.04.2004||R|0|0|0|0|0|0|ZBE|1|0|0|100|XEU|2806|4836|vetorma|||0|0,75|0||Icepharma hf|Zoetis Belgium S.A.|Selamectinum||2806||2806|4836||2 589390|QP54AA0501|Stronghold|bl.lausn|60|mg|0,5|ml|3|túpa||QP54AA05|01.04.2004||R|0|0|0|0|0|0|ZBE|1|0|0|100|XEU|2915|5024|vetorma|||0|1,5|0||Icepharma hf|Zoetis Belgium S.A.|Selamectinum||2915||2915|5024||2 589408|QP54AA0501|Stronghold|bl.lausn|45|mg|0,75|ml|3|túpa||QP54AA05|01.04.2004||R|0|0|0|0|0|0|ZBE|1|0|0|100|DKK|2811|4845|vetorma|||0|2,25|0||Icepharma hf|Zoetis Belgium S.A.|Selamectinum||2811||2811|4845||2 589888|N01AF0302|Pentocur|sts|0,5|g|10|hgl|1|pakki||N01AF03|01.07.2013||R|0|0|0|0|0|1|ABC|0|0|0|100|SEK|11138|16453|lyfsjukr|||2|10|0||Icepharma hf|Abcur AB|Tíópentalnatríum||11138||11138|16453||2 590092|L04AB0401|Humira|stl|40|mg/penna|0,8|ml|2|pennar|áfylltur penni|L04AB04|01.07.2013||R|0|1|0|1|0|1|ABV|0|1|0|100|DKK|128891|165884|lyfsjukr|||1|1,6|0|27,5900|Vistor hf|AbbVie Ltd.|Adalimumab||128891||128891|165884||1 590497|D01AC0101|Canesten|krem|10|mg/g|20|g|1|túpa||D01AC01|01.12.1982||L|0|0|0|0|0|0|BAE|0|0|1|100|IKR|||lyflausa|||0|20|0||Icepharma hf|Bayer AB|Klótrímazól|||||||2 590562|C01DA1403|Ismo|forðatfl|60|mg|98|stk|1|glas||C01DA14|01.10.1999||R|1|0|0|0|G|0|ACA|0|0|0|100|XEU|2717|2676|lyfalmen|V0041|2668|2|98|0|147,0000|Actavis Group hf|Actavis hf|Ísósorbíð mónónítrat||1129||1129|2676||1 590919|B01AD1101|Metalyse|sts/irs|10000|ein|1|stk|1|hgl|+ leysir áfyllt sprauta|B01AD11|01.07.2001||R|0|0|0|0|0|1|BOI|0|0|0|100|DKK|151189|193617|lyfsjukr|||1|1|0|0,7500|Vistor hf|Boehringer Ingelheim|Tenekteplasi||151189||151189|193617||1 591110|C10AA0507|Atorvastatin Hexal|filmhtfl|20|mg|100|stk|1|þpakki||C10AA05|01.10.2015||R|1|0|0|0|G|0|SSA|0|0|0|100|DKK|2213|2848|lyfalmen|V0113|2567|2|100|0|100,0000|Artasan ehf|Hexal A/S|Atorvastatín||1254||1254|2848||1 591260|N06DA0302|Exelon (Lyfjaver)|forðapl|4,6|mg/sólh|30|pokar|1|pakki||N06DA03|01.10.2012||R|0|0|0|0|G|0|LVR|0|0|0|100|DKK|11479|16922|lyfalmen|V0347|16922|3|30|0|14,5300|Lyfjaver ehf|Lyfjaver ehf|Rívastigmín||11479||11479|16922||3 591317|C03DA0403|Eplerenon Bluefish|filmhtfl|50|mg|100|stk|1|þpakki||C03DA04|01.10.2014||R|1|0|0|0|0|0|BLP|0|0|0|100|IKR|30623|15161|lyfalmen|V0111|14780|2|100|0|100,0000|LYFIS ehf|Bluefish Pharmaceuticals AB|Eplerenón||10200||10200|15161||2 591445|H02AB0205|Dexametason Abcur|töflur|1|mg|100|stk|1|þpakki||H02AB02|01.11.2013||R|1|0|0|0|G|0|ABC|0|0|1|100|SEK|8380|12656|lyfalmen|||2|100|0|66,6700|Icepharma hf|Abcur AB|Dexametasón||8380||8380|12656||2 591540|J01CR0202|Augmentin|töflur|625|mg|21|stk|1|þpakki|500+125 mg|J01CR02|01.09.2015||R|0|0|0|0|0|0|GPH|0|0|1|100|IKR|1215|2795|lyfalmen|V0168|2795|1|21|0|10,0000|Vistor hf|GlaxoSmithKline Pharma A/S|Amoxicillín og ensímblokkar||1215||1215|2795||1 592498|QC09CA07|Semintra|mixtúra|4|mg/ml|30|ml|1|glas|fyrir ketti|QC09CA07|01.04.2016||R|0|0|0|0|0|0|BIV|0|0|0|100|DKK|3369|6562|vetalmen|||1|30|0||Vistor hf|Boehringer Ingelheim Vetmedica GmbH|Telmisartanum||3369||3369|6562||1 592534|L04AD0104|Ciqorin|hylki|50|mg|50|stk|1|þpakki||L04AD01|01.04.2014||R|0|0|0|0|G|0|TEV|0|0|0|100|IKR|12500|14198|lyfalmen|||2|50|0|10,0000|Medical ehf|Teva Pharma B.V.|Ciklospórín||9500||9500|14198||2 592977|L01XE1201|Caprelsa|filmhtfl|300|mg|30|stk|1|þpakki||L01XE12|01.07.2012||R|1|1|0|1|0|1|AZA|0|0|0|100|SEK|676406|846840|lyfsjukr|||1|30|0||Vistor hf|AstraZeneca AB|Vandetaníb||676406||676406|846840||1 593200|B02BD0206|Advate|sts|250|ae|1|hgl|1|pakki|+leysir|B02BD02|01.04.2014||R|0|0|0|1|0|1|BER|0|1|0|100|SEK|21190|29502|lyfsjukr|||1|1|0|0,5000|Lyfjaver ehf|Baxter AG (L)|Storkuþáttur VIII||||21190|29502||3 593384|N03AE0101|Rivotril|töflur|0,5|mg|50|stk|1|glas||N03AE01|01.01.1978||R|1|0|0|0|G|0|ROC|0|0|0|100|DKK|458|1753|lyfalmen|V0238|744|1|50|0|3,1250|Icepharma hf|Roche|Klónazepam||458||458|1753||2 593392|N03AE0101|Rivotril|töflur|0,5|mg|150|stk|1|glas||N03AE01|01.01.1978||R|1|0|0|0|G|0|ROC|0|0|0|100|DKK|806|2232|lyfalmen|V0238|2232|1|150|0|9,3750|Icepharma hf|Roche|Klónazepam||806||806|2232||2 593434|N03AE0101|Rivotril|töflur|2|mg|100|stk|1|glas||N03AE01|01.01.1978||R|1|0|0|0|G|0|ROC|0|0|0|100|DKK|1181|2748|lyfalmen|||1|100|0|25,0000|Icepharma hf|Roche|Klónazepam||1181||1181|2748||2 593438|N06AX2106|Duloxetin W&H|sþ-hylki|60|mg|98|stk|1|þpakki||N06AX21|01.08.2015||R|1|0|0|0|0|0|WEH|0|0|0|100|XEU|14460|11504|lyfalmen|V0694|11504|2|98|0|98,0000|Williams & Halls efh|Williams & Halls ehf|Duloxetín||7543||7543|11504||2 593654|N07BA0146|Nicotinell Tropical Fruit|tyggigúm|4|mg|204|stk|1|þpakki||N07BA01|01.11.2011||L|0|0|0|0|0|0|SDF|0|0|1|100|IKR|||lyflausa|||0|204|0|27,2000|Artasan ehf|GlaxoSmithKline Consumer Healthcare A/S|Nikótín|||||||1 594325|H02AB0802|Lederspan|stl|20|mg/ml|1|ml|12|hgl|dreifa|H02AB08|01.12.2003||R|0|0|0|0|G|0|MAB|0|0|1|100|SEK|17582|25322|lyfalmen|||1|12|0|32,0000|Vistor hf|Meda AB|Tríamcínólón||17582||17582|25322||1 594542|N03AX1604|Brieka|hylki|300|mg|56|stk|1|þpakki||N03AX16|01.10.2015||R|1|0|0|0|0|0|AGP|0|0|0|100|XEU|9778|7166|lyfalmen|V0689|6672|2|56|0|56,0000|Actavis Group hf|Actavis Group PTC ehf|Pregabalín||4391||4391|7166||1 594713|QP52AF0201|Banminth, vet.|pasta|21,7|mg/g|10|g|1|spr||QP52AF02|01.07.1995||R|0|0|0|0|0|0|ZOE|0|0|0|100|DKK|299|515|vetorma|||0|10|0||Icepharma hf|Zoetis Finland OY|||299||299|515||2 595066|H05BA0102|Miacalcic|stl|100|ae/ml|1|ml|5|lykjur||H05BA01|01.03.1979||R|0|0|0|0|0|1|HES|0|0|0|100|DKK|5011|8019|lyfsjukr|||1|5|0|5,0000|Vistor hf|Novartis Healthcare A/S|Samtengt laxakalsítónín||5011||5011|8019||1 595198|G04BD1201|Betmiga|forðatfl|25|mg|90|stk|1|þpakki||G04BD12|01.07.2013||R|1|0|0|0|G|0|APE|0|0|0|100|XEU|15348|22247|lyfalmen|||1|90|0|45,0000|Vistor hf|Astellas Phama Europe B.V.|Mírabegrón||15348||15348|22247||1 595250|D01BA0206|Terbinafin Bluefish|töflur|250|mg|98|stk|1|þpakki||D01BA02|01.02.2016||R|1|0|0|0|0|0|BLP|0|0|0|100|IKR|7265|9381|lyfalmen|||2|98|0|98,0000|LYFIS ehf|Bluefish Pharmaceuticals AB|Terbínafín||6000||6000|9381||2 595966|B02BD0207|ReFacto AF|sts|250|ae|1|áf.spr|1|pakki|+leysir|B02BD02|01.11.2014||R|0|0|0|1|0|1|PZE|0|1|0|100|DKK|20674|28849|lyfsjukr|||1|1|0|0,5000|Icepharma hf|Pfizer Ltd.|Storkuþáttur VIII||20674||20674|28849||1 595991|J07BB0201|Fluarix|stl|||0,5|ml|1|áfspr||J07BB02|01.10.1994||R|0|0|0|0|0|0|GPH|0|0|0|100|GBP|575|1914|lyfalmen|||1|0,5|0||Vistor hf|GlaxoSmithKline Pharma A/S|Inflúensa, hreinsaðir mótefnavakar||575||575|1914||1 596085|B03XA0201|Aranesp|stl|50|mcg/spr|0,5|ml|4|áf.spr|nálavörn|B03XA02|01.11.2010||R|0|0|0|1|0|1|RAG|0|0|0|100|DKK|49015|64695|lyfsjukr|||1|2|0|44,4400|Vistor hf|Amgen|Darbepóetín alfa||||49015|64695||1 596881|N05CM1801|Dexdor|irþ|100|mcg/ml|2|ml|5|lykjur|lausn|N05CM18|01.03.2012||R|0|0|0|1|0|1|ORC|0|0|0|100|DKK|15092|21895|lyfsjukr|||1|10|0|1,0000|Vistor hf|Orion Corporation|Dexmedetómid||15092||15092|21895||1 597401|J01FF0101|Dalacin|hylki|150|mg|24|stk|1|þpakki||J01FF01|01.06.1979||R|1|0|0|0|0|0|PER|0|0|1|100|DKK|2069|3970|lyfalmen|||1|24|0|3,0000|Icepharma hf|Pfizer ApS|Klindamýcín||2069||2069|3970||1 597433|L01XC1101|Yervoy|stþ|5|mg/ml|10|ml|1|hgl|lausn|L01XC11|01.05.2012||R|0|1|0|1|0|1|BMS|0|1|0|100|DKK|570922|715647|lyfsjukr|||1|10|0||Vistor hf|Bristol-Myers Squibb Pharma EEIG|Ipilimumab||570922||570922|715647||1 597565|L03AB1301|Plegridy|stl|125|mcg|2|áf.spr|1|pakki||L03AB13|01.07.2015||R|0|0|0|1|0|1|BIB|0|0|0|100|XEU|114386|147844|lyfsjukr|||1|2|0|28,0900|Icepharma hf|Biogen Idec Ltd|Peginterferón beta-1a||114386||114386|147844||2 597567|D01AC0301|Pevaryl|krem|10|mg/g|30|g|1|túpa||D01AC03|01.05.1978||L|0|0|0|0|0|0|MCS|0|0|1|100|IKR|||lyflausa|||0|30|0||Vistor hf|McNeil Sweden AB|Ekónazól|||||||1 598021|S01EC0101|Diamox|töflur|250|mg|100|stk|1|glas||S01EC01|01.06.2014||R|1|0|0|0|G|0|MPH|0|0|0|100|SEK|2379|4397|lyfalmen|||1|100|0|33,3333|Icepharma hf|Mercury Pharmaceuticals Ltd.|Acetazólamíð||2379||2379|4397||2 598094|R06AD0101|Vallergan|mixtúra|5|mg/ml|150|ml|1|glas||R06AD01|01.03.2004||R|0|0|0|0|0|0|SNO|0|0|1|100|NOK|328|1574|lyfalmen|||1|150|0|25,0000|Vistor hf|Sanofi-aventis Norge AS|Alímemazín||328||328|1574||1 598499|M01AE0112|ibuxin rapid|filmhtfl|400|mg|30|stk|1|þpakki||M01AE01|01.09.2012||L|0|0|0|0|0|0|RAT|0|0|1|100|IKR|||lyflausa|||0|30|0|10,0000|LYFIS ehf|ratiopharm GmbH|Íbúprófen|||||||2 598925|M01AE0114|Nurofen Apelsin|mixtúra|40|mg/ml|100|ml|1|glas||M01AE01|01.04.2013||L|0|0|0|0|0|0|REC|0|0|1|100|DKK|||lyfalmen|||0|100|0|3,3333|Vistor hf|Reckitt Benckiser Healthcare Ltd|Íbúprófen|||||1802||1 599010|L01XE1701|INLYTA|filmhtfl|5|mg|56|stk|1|þpakki||L01XE17|01.05.2013||R|1|0|0|1|0|1|PZE|0|1|0|100|DKK|546683|685501|lyfsjukr|||1|56|0||Icepharma hf|Pfizer Ltd.|Axitinib||546683||546683|685501||1 599052|N05AX1209|Aripiprazole Sandoz|töflur|5|mg|14|stk|1|þpakki||N05AX12|01.04.2016||R|1|1|0|0|0|0|HSS|0|0|0|100|DKK|7038|10809|lyfalmen|V0690|7227|2|14|0|4,6600|Artasan ehf|Sandoz GmbH|Aripiprazól||7038||7038|10809||1 599320|QV03AB9002|Narcostop|stl|5|mg/ml|10|ml|1|hgl|fyrir hunda og ketti|QV03AB90|01.07.2013||R|0|0|0|0|0|0|BVL|1|0|0|100|XEU|4009|7776|vetalmen|||0|10|0||Dýraheilsa ehf|Le Vet B.V.|Atipamesól||4009||4009|7776||2 599460|S01XA2011|Oculac|augndr|50|mg/ml|0,4|ml|20|sk-hyl|án rotvarnar|S01XA20|01.11.2013||L|0|0|0|0|G|0|CLA|0|0|0|100|DKK|||lyfalmen|||0|8|0||Vistor hf|Alcon Nordic A/S|Gervitár og aðrar óvirkar samsetningar|||||2082||1 599462|N05AX0803|Risperdal Consta|sts|50|mg|1|hgl|1|pakki|+ leysir|N05AX08|01.05.2014||R|0|0|0|0|G|0|JAS|0|0|0|100|SEK|27184|37083|lyfalmen|||1|1|0|18,5200|Vistor hf|Janssen-Cilag AB|Risperídón||||27184|37083||1 599883|N06AX1610|Venlafaxine Bluefish|forðahlk|75|mg|100|stk|1|þpakki|hart|N06AX16|01.05.2015||R|1|0|0|0|G|0|BLP|0|0|0|100|IKR|3700|3187|lyfalmen|V0334|3153|2|100|0|75,0000|LYFIS ehf|Bluefish Pharmaceuticals AB|Venlafaxín||1500||1500|3187||2 954851|V09AB0301|DaTSCAN|stl|74|MBq/ml|5|ml|1|hgl||V09AB03|01.10.2013||R|0|0|0|1|0|1|GEL|0|0|0|100|NOK|114205|147619|lyfsjukr|||1|5|0||Icepharma hf|GE Healthcare Limited|Lofendýlat||114205||114205|147619||2 957657|A12BA0201|Polycítra - forskriftarlyf|mixtúra|||500|ml|1|fl|Potassium citrats 102 mg/g|A12BA02|01.04.2014||R|0|0|0|0|0|0|PAR|0|0|0|100|IKR|15120|21933|lyfalmen|||0|500|0|12,7500|PharmArctica ehf|PharmArctica - forskriftarlyf|potassium citrate||15120||15120|21933||2 957665|A12BA0102|Kalíum Klórið - forskriftarlyf|mixtúra|33|mg/g|300|ml|1|fl|35,34 mg/ml|A12BA01|01.04.2014||R|0|0|0|0|0|0|PAR|0|0|0|100|IKR|2610|4715|lyfalmen|||0|300|0|3,5400|PharmArctica ehf|PharmArctica - forskriftarlyf|Kalíumklóríð||2610||2610|4715||2 962234|R05DA2001|SEM mixtúra - forskriftarlyf|mixtúra|||300|ml|1|fl|Kodein 2,53 mg/ml|R05DA20|01.04.2014||R|0|0|0|0|0|0|PAR|0|0|1|100|IKR|1610|3338|lyfalmen|||0|300|0||PharmArctica ehf|PharmArctica - forskriftarlyf|Blöndur||1610||1610|3338||2 962242|R05DA2001|SEM mixtúra - forskriftarlyf|mixtúra|||100|ml|1|fl|Kodein 2,53 mg/ml|R05DA20|01.04.2014||R|0|0|0|0|0|0|PAR|0|0|1|100|IKR|1030|2540|lyfalmen|||0|100|0||PharmArctica ehf|PharmArctica - forskriftarlyf|Blöndur||1030||1030|2540||2 965858|QI04AB0901|Gudair|stl|||30|ml|1|glas|dreifa|QI04AB09|01.09.2014||R|0|0|0|0|0|0|CZV|1|0|0|100|XEU|5859|10099|vetorma|||0|30|0||Vistor hf|CZ Veterinaria SA|Bóluefni gegn Mycobacterium||||5859|10099||1 967367|N05AH0408|Quetiapin Bluefish|filmhtfl|300|mg|60|stk|1|þpakki||N05AH04|01.09.2012||R|1|0|0|0|G|0|BLP|0|0|0|100|IKR|25000|9381|lyfalmen|||2|60|0|45,0000|LYFIS ehf|Bluefish Pharmaceuticals AB|Quetíapín||6000||6000|9381||2 968365|D07CB0101|TNG-smyrsl - forskriftarlyf|smyrsli|||15|ml|1|dos||D07CB01|01.04.2014||R|0|0|0|0|0|0|PAR|0|0|1|100|IKR|1522|3217|lyfalmen|||0|15|0||PharmArctica ehf|PharmArctica - forskriftarlyf|Triamcinolonum og sýklalyf||1522||1522|3217||2 968373|V03AB1505|Naloxonhydrochlorid - forskriftarlyf|mixtúra|1|mg/ml|500|ml|1|fl||V03AB15|01.04.2014||R|0|0|0|0|0|0|PAR|0|0|1|100|IKR|18870|27095|lyfalmen|||0|500|0||PharmArctica ehf|PharmArctica - forskriftarlyf|Naloxón||18870||18870|27095||2 968399|A03AA0704|Dicykloverine hydrochloride-forsk.lyf|mixtúra|2|mg/ml|100|ml|1|fl||A03AA07|01.04.2014||R|0|0|0|1|0|0|PAR|0|0|0|100|IKR|7066|10848|lyfalmen|||0|100|0|2,5000|PharmArctica ehf|PharmArctica - forskriftarlyf|Dícýklóverín||7066||7066|10848||2 968406|D05AA0001|Tjara 26 / ASVEP - forskriftarlyf|smyrsli|||100|ml|1|dos||D05AA|01.04.2014||R|0|0|0|0|0|0|PAR|0|0|0|100|IKR|2929|5154|lyfalmen|||0|100|0||PharmArctica ehf|PharmArctica - forskriftarlyf|Tjörur||2929||2929|5154||2 968414|D05AA0002|Koltjörusmyrsl - forskriftarlyf|smyrsli|||100|ml|1|dos||D05AA|01.04.2014||R|0|0|0|0|0|0|PAR|0|0|0|100|IKR|3650|6146|lyfalmen|||0|100|0||PharmArctica ehf|PharmArctica - forskriftarlyf|Tjörur||3650||3650|6146||2 969991|N06BA0105|Amfetamine sulfate - forskriftarlyf|töflur|5|mg|30|stk|1|glas||N06BA01|01.08.2015||R|0|0|1|0|0|0|PAR|0|0|0|100|IKR|2495|4556|lyfalmen|||0|30|0|10,0000|PharmArctica ehf|PharmArctica - forskriftarlyf|Amfetamín||2495||2495|4556||2 970013|A01AD1102|Magical Mouthwash - forskriftarlyf|mixtúra|||100|ml|1|fl||A01AD11|01.04.2015||R|0|0|0|0|0|0|PAR|0|0|1|100|IKR|3988|6611|lyfalmen|||0|100|0||PharmArctica ehf|PharmArctica - forskriftarlyf|Ýmis lyf||3988||3988|6611||2 980005|C07AA0513|Propranolol hydrochloride-forskriftarlyf|mixtúra|2|mg/ml|100|ml|1|fl||C07AA05|01.12.2014||R|0|0|0|0|0|0|PAR|0|0|0|100|IKR|4995|7997|lyfalmen|||0|100|0||PharmArctica ehf|PharmArctica - forskriftarlyf|Própranólól||4995||4995|7997||2